Citrus Sinensis ID: 001940
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 993 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.171 | 0.182 | 0.410 | 3e-29 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.170 | 0.205 | 0.403 | 6e-27 | |
| P18160 | 2410 | Dual specificity protein | yes | no | 0.185 | 0.076 | 0.395 | 4e-26 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.185 | 0.138 | 0.339 | 5e-24 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.170 | 0.131 | 0.392 | 8e-24 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.183 | 0.198 | 0.364 | 4e-23 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.203 | 0.124 | 0.331 | 2e-22 | |
| Q23915 | 1094 | Probable serine/threonine | no | no | 0.180 | 0.163 | 0.354 | 3e-22 | |
| Q54IP4 | 653 | Dual specificity protein | no | no | 0.161 | 0.245 | 0.387 | 6e-22 | |
| Q7TQP6 | 835 | Serine/threonine-protein | yes | no | 0.193 | 0.229 | 0.341 | 8e-22 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 131 bits (330), Expect = 3e-29, Method: Compositional matrix adjust.
Identities = 76/185 (41%), Positives = 103/185 (55%), Gaps = 15/185 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+DL +G G+YG VYH W G++VA+K+ F+G +A+F E ++
Sbjct: 667 NDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAA------LAEFRSEVRIMRR 720
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNVV F G V P+ L+ VTEF+ GSL + L + ID R+R+ +A+D A GM
Sbjct: 721 LRHPNVVFFLGAVTRPPN--LSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGM 778
Query: 920 EYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWM 976
LH IVH DLK NLLV+ K+GD GLS++K T +S GT WM
Sbjct: 779 NCLHTSTPTIVHRDLKTPNLLVD----NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWM 834
Query: 977 APELL 981
APE+L
Sbjct: 835 APEVL 839
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 123 bits (309), Expect = 6e-27, Method: Compositional matrix adjust.
Identities = 75/186 (40%), Positives = 109/186 (58%), Gaps = 17/186 (9%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
DL ++G+G++G+V+ +W GSDVA+K + F +ER + +F +E ++ L
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFH---AER---VNEFLREVAIMKRL 603
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFG 918
HPN+V F G V P+ L+ VTE++ GSL + L K +D R+RL +A D A G
Sbjct: 604 RHPNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 661
Query: 919 MEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPW 975
M YLH +N IVH DLK NLLV+ ++ K+ D GLS++K T +S GT W
Sbjct: 662 MNYLHNRNPPIVHRDLKSPNLLVD----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 717
Query: 976 MAPELL 981
MAPE+L
Sbjct: 718 MAPEVL 723
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3 | Back alignment and function description |
|---|
Score = 120 bits (302), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 81/205 (39%), Positives = 111/205 (54%), Gaps = 21/205 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I ++LE + +G G +G V G WR +DVAIK I F K S + F E +
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSS-----LVMFQNEVGI 2164
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK--RLIIAMD 914
LS L HPNVV F G G + VTE+M GSL+QFL +++ RL +A+D
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224
Query: 915 AAFGMEYLHGKN--IVHFDLKCENLLVNMR-DPQRPV--------CKIGDLGLSKVK--Q 961
A GM YLHG I+H DL N+L++ DP+ PV CKI D GLS++K Q
Sbjct: 2225 IAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKMEQ 2284
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSH 986
+ ++ V G +P+MAPE+ G S+
Sbjct: 2285 ASQMTQSV-GCIPYMAPEVFKGDSN 2308
|
Essential for spore differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 114 bits (284), Expect = 5e-24, Method: Compositional matrix adjust.
Identities = 69/203 (33%), Positives = 111/203 (54%), Gaps = 19/203 (9%)
Query: 790 IARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD 849
I+ + I D++ +E+G G + V G W+G DVA+K++ ++ K RE +I +
Sbjct: 1061 ISSSVTMINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSN----KDKAREEMIQE 1116
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL------QKKDRTI 903
F E LL SL HPN+V+ YG + + V EF+ +G+L + + Q++ +
Sbjct: 1117 FKAEVELLGSLQHPNLVTCYGYSLN----PMCIVMEFLPSGNLFELIHSKPSEQQQSIKL 1172
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
D L IA D A GM++LH +NI+H DLK NLL++ + KI DLG+++ T
Sbjct: 1173 DSTLILAIAFDIARGMQHLHTRNIIHRDLKSSNLLMD----KHFNIKIADLGIARETSFT 1228
Query: 964 LVSGGVRGTLPWMAPELLSGKSH 986
+ GT+ W APE+L +S+
Sbjct: 1229 QTMTTI-GTVAWTAPEILRHESY 1250
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 113 bits (282), Expect = 8e-24, Method: Compositional matrix adjust.
Identities = 73/186 (39%), Positives = 101/186 (54%), Gaps = 17/186 (9%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G YG V+ G WRG++VA+K + K LI+D KE LL L HPN+V
Sbjct: 857 IGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLK------LISDLRKEVDLLCKLRHPNIVL 910
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN- 926
F G + S VTE++ GSL L + +D RL + D A GM YLH +N
Sbjct: 911 FMGACTEP--SSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNP 968
Query: 927 -IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
I+H DLK +NLLV+ D + K+ D GL+ VK T + + GT W+APE+L+ +
Sbjct: 969 IIIHRDLKTDNLLVD--DSWQ--VKVADFGLATVKSHTF-AKTMCGTTGWVAPEVLAEEG 1023
Query: 986 HMVTEK 991
+ TEK
Sbjct: 1024 Y--TEK 1027
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 111 bits (277), Expect = 4e-23, Method: Compositional matrix adjust.
Identities = 71/195 (36%), Positives = 105/195 (53%), Gaps = 13/195 (6%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I +L+ +LG GT+G VY G WRGS VAIK+IK + +++ +F KE +
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKIN-----EDVNNQVLEEFRKELTI 711
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS L HPN+V P+ L +TE++ GSL L K ++ + +A+ A
Sbjct: 712 LSRLRHPNIVLLMAACTAPPN--LCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIA 769
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
GM YLH ++H D+K NLL++ + KI D GLSK+K ++ G+ WM
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD----EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWM 825
Query: 977 APELLSGKSHMVTEK 991
+PELL G+ + TEK
Sbjct: 826 SPELLMGEDY--TEK 838
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 108 bits (270), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 74/223 (33%), Positives = 117/223 (52%), Gaps = 21/223 (9%)
Query: 766 IEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD 825
I++DY D K E + + + R + I D++ +++G G+YG V++GKW+G D
Sbjct: 1334 IDIDYMADIDK----EDSFLTSANMCRWI--INYDEISIGKQIGLGSYGIVFNGKWKGVD 1387
Query: 826 VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885
VA+K+ K SE + L +F E LS L H N+V+F G P+ + VTE
Sbjct: 1388 VAVKKFVKQ----KLSETQLL--EFRAEMAFLSELKHSNIVTFIGACIKKPN--ICIVTE 1439
Query: 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD 943
+M G+L+ L+ D I +L + AA G++YLH N IVH D+K N+LV+
Sbjct: 1440 YMRMGNLRDVLKNPDIKITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVD--- 1496
Query: 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ KI D G +++K+ GT W APE++ G+ +
Sbjct: 1497 -EHFNVKIADFGFARIKEDNTTMTRC-GTPCWTAPEVIRGEKY 1537
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q23915|KINX_DICDI Probable serine/threonine-protein kinase kinX OS=Dictyostelium discoideum GN=kinX PE=3 SV=2 | Back alignment and function description |
|---|
Score = 108 bits (269), Expect = 3e-22, Method: Compositional matrix adjust.
Identities = 67/189 (35%), Positives = 105/189 (55%), Gaps = 10/189 (5%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+IK +DL+ + E+GSG +G V+ G++ G+ VAIK+I P+ R L +E
Sbjct: 16 SIKYEDLDFISEIGSGGFGKVFKGEYLGAPVAIKKI--HILPDDPN-RVDLEKFLNREIE 72
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+ HPNV+ F GI + +G L VTE + G L+ +L+ + + R IA+D
Sbjct: 73 TIKLFTHPNVIQFVGISEN--NGILFIVTELIEGGDLQYYLKNQSIDLPWFLRANIALDV 130
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLP 974
+ M YLH K+IVH DLK NLLV+ + K+ D G ++ V++ S + GT
Sbjct: 131 SLAMSYLHSKSIVHRDLKSTNLLVD----KNWKIKVCDFGFARIVEEDNNKSMTICGTDN 186
Query: 975 WMAPELLSG 983
WM+PE+++G
Sbjct: 187 WMSPEMITG 195
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 107 bits (266), Expect = 6e-22, Method: Compositional matrix adjust.
Identities = 71/183 (38%), Positives = 101/183 (55%), Gaps = 23/183 (12%)
Query: 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
+LGSG +GSVY G RG +VAIK++ + F E + +F KE L++ L +P+++
Sbjct: 179 KLGSGAFGSVYKGIVRGKEVAIKKLTQTVF------EENTMNEFKKEVSLMAKLRNPHLL 232
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAAFGMEYLH 923
F G D L+ VTE M GS+ L+ K+ T I ++ ++IA D GM +LH
Sbjct: 233 LFMGACTAPED--LSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIARDTVLGMTWLH 290
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPWMAP 978
NI+H DLK NLLV+ Q V K+ D GLSK K + L G G+ +MAP
Sbjct: 291 ASNILHLDLKPANLLVD----QNWVVKVADFGLSKYMKPDSKDKLL---GQAGSPLYMAP 343
Query: 979 ELL 981
E+L
Sbjct: 344 EML 346
|
Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3 | Back alignment and function description |
|---|
Score = 106 bits (265), Expect = 8e-22, Method: Compositional matrix adjust.
Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 16/208 (7%)
Query: 779 KIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG 838
K + + AE +R + + E+ +GSG++G VY G+ R VAIKR +A+ +
Sbjct: 442 KADVLLLRAELPSRFHLQLSEIEFHEI--IGSGSFGKVYKGRCRNKIVAIKRYRANTYCS 499
Query: 839 KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK 898
K + F +E +L L+HP VV F G D P A VT+++ GSL L +
Sbjct: 500 KSD-----VDMFCREVSILCQLNHPCVVQFVGACLDDPS-QFAIVTQYISGGSLFSLLHE 553
Query: 899 KDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
+ R +D + +LIIA+D A GMEYLH I+H DL N+L + + V + D G
Sbjct: 554 QKRILDLQSKLIIAVDVAKGMEYLHSLTQPIIHRDLNSHNIL--LYEDGHAV--VADFGE 609
Query: 957 SKVKQQTLVSGGVR--GTLPWMAPELLS 982
S+ Q + G L WMAPE+ +
Sbjct: 610 SRFLQSLDEDNMTKQPGNLRWMAPEVFT 637
|
May play a role in cardiac physiology. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 993 | ||||||
| 225446134 | 1217 | PREDICTED: uncharacterized protein LOC10 | 0.981 | 0.801 | 0.638 | 0.0 | |
| 255570521 | 1090 | serine/threonine protein kinase, putativ | 0.954 | 0.869 | 0.638 | 0.0 | |
| 297735348 | 978 | unnamed protein product [Vitis vinifera] | 0.882 | 0.895 | 0.603 | 0.0 | |
| 449462731 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.871 | 0.568 | 0.0 | |
| 449525772 | 1102 | PREDICTED: uncharacterized protein LOC10 | 0.966 | 0.871 | 0.567 | 0.0 | |
| 356550754 | 1087 | PREDICTED: uncharacterized protein LOC10 | 0.959 | 0.876 | 0.575 | 0.0 | |
| 357479749 | 1113 | Protein kinase-like protein [Medicago tr | 0.958 | 0.855 | 0.571 | 0.0 | |
| 356564856 | 1073 | PREDICTED: uncharacterized protein LOC10 | 0.940 | 0.870 | 0.563 | 0.0 | |
| 147856633 | 4128 | hypothetical protein VITISV_010028 [Viti | 0.836 | 0.201 | 0.587 | 0.0 | |
| 297793271 | 1045 | kinase family protein [Arabidopsis lyrat | 0.920 | 0.874 | 0.563 | 0.0 |
| >gi|225446134|ref|XP_002270697.1| PREDICTED: uncharacterized protein LOC100266729 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1281 bits (3316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 667/1045 (63%), Positives = 791/1045 (75%), Gaps = 70/1045 (6%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 105 MDSPSAT---PSSAHGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 161
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 162 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 221
Query: 121 FLFSHSDQDG-SNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQDG S+H+VD DD +ERRYVDALNN+ND +DFRK Q +SP +S+IDDIH+A
Sbjct: 222 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQVGESPTMSAIDDIHLA 279
Query: 180 ERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
E+FFN++SLEGG+HNQ Q+NLH LT+PHM SGQ Q PV+QRYNEME W+PAY
Sbjct: 280 EQFFNSISLEGGLHNQRNCEMPMSQFNLHHLTIPHMGSGQHQ-PVAQRYNEMESQWNPAY 338
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
+SPRH+GHHD RPL E+PSSPSSARFRMPFGE +R+PEEY+RQ VN Y+ Q
Sbjct: 339 FSPRHHGHHDA-RPLAEYPSSPSSARFRMPFGELPDKCIDRLPEEYSRQPVNPQAPYDHQ 397
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
PQ S+N++W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GN
Sbjct: 398 PQASDNVVWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGN 454
Query: 347 GLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLN 404
GLP V CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLN
Sbjct: 455 GLPPVANPCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLN 514
Query: 405 PRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPE 458
PR E+AR +SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTGPE
Sbjct: 515 PRAEDARAQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDPRYIRTGPE 574
Query: 459 MGNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQN 516
+GN +FHD AAA P ++ P EER VRYGN +PYGAD +Y VSHGH A LWRNVQN
Sbjct: 575 LGNGVFHDQAAAAGPAINVPPLEERAVRYGNLPYPYGADNLYQVSHGHVPAHALWRNVQN 634
Query: 517 PIHVTP-LEASGPVI--NGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTA 573
P+H P EAS +GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A
Sbjct: 635 PMHGAPSYEASTSTCQASGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSA 694
Query: 574 TPPEYYYSQTQKMNPQSYNQQNQLP-------------------DPVHQSDSFSALVQDK 614
P +Y Y K+NP ++ Q+ Q P +P+H ++S L+ DK
Sbjct: 695 LP-DYSYGHATKLNPNTHGQEGQHPFTPGPVPSPSDMLKFAAPMEPLHFTNSSPTLMDDK 753
Query: 615 LVSSTTDCNLGLRV-----NNVSEAVRTDENCNLGQEKAANHVVKVEETDVKRSCL-EQN 668
V+S NL NNV++ V + + K H+ KVE+ D+ + L E+N
Sbjct: 754 FVASA---NLSYNPESRNDNNVNQTVIMEAKQAFREGKEEIHMEKVEDNDMPVTSLPEKN 810
Query: 669 MIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAAL 726
+K SL + + N+ KP + ED+KL NLS LPELIASVKRAAL
Sbjct: 811 NNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEEDAKLDVSNLSFLPELIASVKRAAL 870
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAE 786
E AEEVKAKV+E+ D+V ++TKEA +NE E N G++E+D DND V T KIEPT AE
Sbjct: 871 ESAEEVKAKVQENADAVHA-SSTKEA-SNELETANALGDLELDSDNDNVNTFKIEPTKAE 928
Query: 787 AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERL 846
EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSERERL
Sbjct: 929 EEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERERL 988
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
IADFWKEAL+LSSLHHPNVVSFYGIVRDGP GSLATVTEFMVNGSLKQFLQKKDRTIDRR
Sbjct: 989 IADFWKEALILSSLHHPNVVSFYGIVRDGPGGSLATVTEFMVNGSLKQFLQKKDRTIDRR 1048
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
KR IIAMDA+FGMEYLHGKNIVHFDLKCENLLVNMRDP RPVCKIGDLGLSKVKQ TLVS
Sbjct: 1049 KRRIIAMDASFGMEYLHGKNIVHFDLKCENLLVNMRDPHRPVCKIGDLGLSKVKQHTLVS 1108
Query: 967 GGVRGTLPWMAPELLSGKSHMVTEK 991
GGVRGTLPWMAPELLSGK++MVTEK
Sbjct: 1109 GGVRGTLPWMAPELLSGKTNMVTEK 1133
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255570521|ref|XP_002526218.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223534457|gb|EEF36159.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1276 bits (3302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 650/1018 (63%), Positives = 769/1018 (75%), Gaps = 70/1018 (6%)
Query: 15 AGSNDD-VPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE 73
AGS+D+ PRVK LCSFLG I+PRPQDGKLRYVGGETRIVSLPRD+++EELM++MRELYE
Sbjct: 18 AGSHDENTPRVKLLCSFLGSIMPRPQDGKLRYVGGETRIVSLPRDISFEELMNKMRELYE 77
Query: 74 GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNH 133
GA VLKYQQPDEDLDALVSVVNDDDV NMMEEYEKL SGDGFTRLRIFLFSH DQDGS+H
Sbjct: 78 GASVLKYQQPDEDLDALVSVVNDDDVTNMMEEYEKLDSGDGFTRLRIFLFSHPDQDGSSH 137
Query: 134 YVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMAERFFNTMSLEGGIH 193
YVDGD+RESERRYVDALNN+NDG DFR+ Q DSP+I I+D+H+ E FF+ M+L+ G+H
Sbjct: 138 YVDGDERESERRYVDALNNLNDGADFRR-QQADSPLIGPIEDVHLHEHFFSPMNLDSGLH 196
Query: 194 NQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRP 246
NQ PQYNLH + +P QRYNEMEGPWSPA+YSPRH+GHHDP RP
Sbjct: 197 NQRSGEMLIPQYNLHHVAIP------------QRYNEMEGPWSPAFYSPRHHGHHDP-RP 243
Query: 247 LPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGN 300
L EFP+SP S+R+R FGE +RV EEYAR +NHHP Y+ QP + +N++WMPPG
Sbjct: 244 LTEFPNSPPSSRYRTQFGEFPDRGMDRVSEEYARSQLNHHPAYDHQPPYPDNVVWMPPGT 303
Query: 301 VSGD-KSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGNGLPQVPLSCAECR 359
+SGD K+GFPGNL HG V +G+ CEHCR+ + RNQLHL+QPN+GN + QV SC EC
Sbjct: 304 ISGDNKAGFPGNLLHGPTVVEGSSTCEHCRVAFQRNQLHLEQPNVGNPVHQVANSCTECH 363
Query: 360 QNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLNPRIEEARTHMSGA 417
NRE+ +LNA+ K+ MYPKD ND RS+YNE+H HERGW LQHQL+P +EARTH+SGA
Sbjct: 364 PNREHFMLNADTKVHHAMYPKDQNDPRSIYNEAHSHERGWSLQHQLSPHADEARTHISGA 423
Query: 418 GRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHDPAAAVVPHLHT 477
GR+N+HY+VDGPG+N P GH NL DG H S NH+HHR G E+GN++FHD A A + HLH
Sbjct: 424 GRINEHYIVDGPGINYPLGHSNLADGQHASSNHSHHRAGHELGNDVFHDQAVAAMHHLHI 483
Query: 478 PSAEERVVRYGNFPYGADTI--YPVSHGHATAQNLWRNVQNPIHVTPLEASGPV--INGS 533
P +EER VRYGNF YG T YP+SHGH Q LWRNVQNP+H TP + S +NG+
Sbjct: 484 PPSEERAVRYGNFAYGYGTENPYPISHGHLHPQTLWRNVQNPVHGTPYDTSSATSQVNGT 543
Query: 534 ITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQKMNPQSYNQ 593
+ PA LRG +EG+ R +D+ +S ++ +Q++ GF GT T PEY Y + K+ P Y
Sbjct: 544 VNPALLRGTLEGSQRTGNDLDNMHSRLESAQKILGFDGT-TAPEYSYGHSLKLTPNHYGP 602
Query: 594 QNQ-----------LPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCN 642
+N+ LP + S + +S T+ N L +N+ E + ++
Sbjct: 603 ENKQLFTPETVRPPLPREIRSSSA---------ISGTSGYNPELSSSNIMEVTKMEKPV- 652
Query: 643 LGQEKAANHVVKVEETDVKRS-CLEQNMIPE--------KPIGSTSLLAMEVSGNIEKPG 693
LG EK A + ++E DV+ EQ+M+ + + S S E +G+I K G
Sbjct: 653 LGMEKEAIYAEQIENLDVQNLLSTEQDMVARGNGDAALLETLHSNSSRHTEGAGDIVKGG 712
Query: 694 EKSPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAP 753
E PS E SKL LS LPELIASVK+AALE AEEVKA V E++ S + +KEA
Sbjct: 713 ETDPSAVMETSKLSLDRLSFLPELIASVKKAALEEAEEVKAVVNENEHS----SASKEAT 768
Query: 754 ANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTY 813
+E+E VN H E E+D ++D + T +IEPT AE EAI RGLQTIKNDDLEE+RELGSGTY
Sbjct: 769 PSESEAVNAHEEPELDSESDNINTNEIEPTKAEEEAIERGLQTIKNDDLEEIRELGSGTY 828
Query: 814 GSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873
G+VYHGKW+GSDVAIKRIKASCFAG+PSERERLIADFWKEAL+LSSLHHPNVVSFYGIVR
Sbjct: 829 GAVYHGKWKGSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPNVVSFYGIVR 888
Query: 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLK 933
DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFD+K
Sbjct: 889 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDMK 948
Query: 934 CENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
CENLLVNMRDPQRPVCKIGDLGLSKVKQ TLVSGGVRGTLPWMAPELLSGKSHMVTEK
Sbjct: 949 CENLLVNMRDPQRPVCKIGDLGLSKVKQHTLVSGGVRGTLPWMAPELLSGKSHMVTEK 1006
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735348|emb|CBI17788.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1140 bits (2948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 609/1009 (60%), Positives = 720/1009 (71%), Gaps = 133/1009 (13%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 1 MDSPSAT---PSSAHGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 57
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 58 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 117
Query: 121 FLFSHSDQDG-SNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQDG S+H+VD DD +ERRYVDALNN+ND +DFRK Q P S
Sbjct: 118 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQMPMS------------ 163
Query: 180 ERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYG 239
Q+NLH LT+PHM SGQ Q PV+QRYNEME W+PAY+SPRH+G
Sbjct: 164 -----------------QFNLHHLTIPHMGSGQHQ-PVAQRYNEMESQWNPAYFSPRHHG 205
Query: 240 HHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENL 293
HHD RPL E+PSSPSSARFRMPFGE +R+PEEY+RQ VN Y+ QPQ S+N+
Sbjct: 206 HHDA-RPLAEYPSSPSSARFRMPFGELPDKCIDRLPEEYSRQPVNPQAPYDHQPQASDNV 264
Query: 294 IWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGNGLPQVPL 353
+W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GNGLP V
Sbjct: 265 VWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGNGLPPVAN 321
Query: 354 SCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLNPRIEEAR 411
CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLNPR E+AR
Sbjct: 322 PCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLNPRAEDAR 381
Query: 412 THMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPEMGNELFH 465
+SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTGPE+GN +FH
Sbjct: 382 AQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDPRYIRTGPELGNGVFH 441
Query: 466 DPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYPVSHGHATAQNLWRNVQNPIHVTPLEA 525
D AAA P ++ P EE +T Q
Sbjct: 442 DQAAAAGPAINVPPLEEPST-------------------STCQ----------------- 465
Query: 526 SGPVINGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQK 585
+GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A P+Y Y K
Sbjct: 466 ----ASGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSAL-PDYSYGHATK 520
Query: 586 MNPQSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCNLGQ 645
+NP ++ Q+ Q P F+ ++ + +A R G+
Sbjct: 521 LNPNTHGQEGQHP--------FTPVIME-----------------AKQAFRE------GK 549
Query: 646 EKAANHVVKVEETDVKRSCL-EQNMIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPE 702
E+ H+ KVE+ D+ + L E+N +K SL + + N+ KP + E
Sbjct: 550 EEI--HMEKVEDNDMPVTSLPEKNNNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEE 607
Query: 703 DSKLLAHNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNI 762
D+KL NLS LPELIASVKRAALE AEEVKAKV+E+ D+V ++TKEA +NE E N
Sbjct: 608 DAKLDVSNLSFLPELIASVKRAALESAEEVKAKVQENADAVHA-SSTKEA-SNELETANA 665
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
G++E+D DND V T KIEPT AE EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+
Sbjct: 666 LGDLELDSDNDNVNTFKIEPTKAEEEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWK 725
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVAIKRIKASCFAG+PSERERLIADFWKEAL+LSSLHHPNVVSFYGIVRDGP GSLAT
Sbjct: 726 GSDVAIKRIKASCFAGRPSERERLIADFWKEALILSSLHHPNVVSFYGIVRDGPGGSLAT 785
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
VTEFMVNGSLKQFLQKKDRTIDRRKR IIAMDA+FGMEYLHGKNIVHFDLKCENLLVNMR
Sbjct: 786 VTEFMVNGSLKQFLQKKDRTIDRRKRRIIAMDASFGMEYLHGKNIVHFDLKCENLLVNMR 845
Query: 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
DP RPVCKIGDLGLSKVKQ TLVSGGVRGTLPWMAPELLSGK++MVTEK
Sbjct: 846 DPHRPVCKIGDLGLSKVKQHTLVSGGVRGTLPWMAPELLSGKTNMVTEK 894
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462731|ref|XP_004149094.1| PREDICTED: uncharacterized protein LOC101215475 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/1049 (56%), Positives = 727/1049 (69%), Gaps = 89/1049 (8%)
Query: 1 MDSP--SPNVPGSG--STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP + P S S GS+D+ PRVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+P
Sbjct: 1 MDSPLTRSSTPNSSPISNPGSHDENPRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVP 60
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+TYEELM +MRELY+GA VLKYQQPDED DALVSVVNDDDVINMMEEY+K+GSGDGFT
Sbjct: 61 RDITYEELMVKMRELYDGAAVLKYQQPDEDPDALVSVVNDDDVINMMEEYDKVGSGDGFT 120
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFSH +QD S +VDGD+R++ERRYVDALNN ND NDF + Q +SP +S IDD+
Sbjct: 121 RLRIFLFSHPEQDASLPFVDGDERDTERRYVDALNNSNDMNDFVRQQQQNSPALSGIDDM 180
Query: 177 HMAERFFNTMSLEGGIHNQ------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
H E F N M++EG +H Q QY+LHQLT+PH+ SG QQQ V+QRY+EME PWSP
Sbjct: 181 HGTEHFLNPMNIEGSLHTQRSCEPLSQYHLHQLTIPHVGSGGQQQSVAQRYSEMEAPWSP 240
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
A SPRH+G +D RP+ ++PSSP AR+RMPF + ER+PE+Y RQ +NH YE
Sbjct: 241 ALLSPRHHGPYDS-RPMGDYPSSPF-ARYRMPFPDLPDKYLERMPEDYVRQQMNHQHMYE 298
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ++EN++W+P G ++ ++SGFPGN+ HGH V DGN CEHCR +HR Q H++Q N
Sbjct: 299 HQPQYNENIVWLPNGTIN-EESGFPGNILHGHGVPDGNSSCEHCRANFHRYQAHMEQVNT 357
Query: 345 GNGLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD---NDSRSVYNESHCHERGWVLQ 400
NGLP E QNRE L+ A+ K G++P + ND RS YNE+ HE+GW++Q
Sbjct: 358 LNGLP------LEYTQNREALMQKADTKFHHGIFPNEQNINDHRSAYNETPPHEKGWIMQ 411
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
HQ++ R ++ RTH+SG GRL DHY+VDG G N+P N+ DG+H S N
Sbjct: 412 HQMSVRGDDTRTHVSGTGRLTDHYIVDGSGSNLPSTQSNVADGYHASTN---------FH 462
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP-VSHGHATAQNLWRNVQNPIH 519
+E+F D H+ P E+R V Y + YG + YP ++ H WRNVQNP+H
Sbjct: 463 DEVFRDQVVPSGQHMCVPPPEDRGVGYMPYGYGGEPHYPPMAQRHMPGNASWRNVQNPLH 522
Query: 520 VTP-LEASGPVI----NGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
V P EAS V N SI P Y++ +G+PRI +GVD N W + SQ+V G G AT
Sbjct: 523 VAPPYEAS--VFHQQGNASINPGYIKAMQDGSPRIHMGVDHQNPWHESSQKVLGVDG-AT 579
Query: 575 PPEYYYSQTQKMNPQSYNQQNQ-----------------LPDPVHQSDSFSALVQDKLVS 617
E+ + K N + NQ + P+ +SDS SA +Q+K+V+
Sbjct: 580 GTEHLPAHVLKTNSTTVGHDNQQFTSLEHIQPHLDKINLVASPMQRSDSSSAFIQEKMVA 639
Query: 618 ST-TDCNLGLR-VNNVSEAVRTDENCNLGQEKAANHVVK------VEETDVKRSCLEQN- 668
N LR V+ V+EA+ + G+ H++K + E + N
Sbjct: 640 PFHPSQNPQLRAVSAVNEAMMMERKVVHGE--GNGHMIKDMGKPDISEAHTASHPGQNNT 697
Query: 669 ------MIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVK 722
+ P + + ST + +G+ KP ++ E KL LS LPELIASVK
Sbjct: 698 DDTYSKVAPLELLNSTCTNSAVENGDGLKPSVETL----EKPKLSVSRLSFLPELIASVK 753
Query: 723 RAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEP 782
RAALE +EE VEE+ +PD+ K+ NE N H E E++ +++ ++ +IEP
Sbjct: 754 RAALEVSEETM--VEETALR-RPDSIEKKETTNEQHSSNNHVEPELETESEN-QSSRIEP 809
Query: 783 TIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE 842
T AE EAI+RGLQTIKNDDLEE+RELGSGTYG+VYHGKWRGSDVAIKRIKASCFAG+PSE
Sbjct: 810 TKAEEEAISRGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSE 869
Query: 843 RERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
RERLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRT
Sbjct: 870 RERLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRT 929
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV+Q
Sbjct: 930 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQH 989
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
TLVSGGVRGTLPWMAPELLSGKS+MVTEK
Sbjct: 990 TLVSGGVRGTLPWMAPELLSGKSNMVTEK 1018
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449525772|ref|XP_004169890.1| PREDICTED: uncharacterized protein LOC101228819 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1081 bits (2796), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/1049 (56%), Positives = 726/1049 (69%), Gaps = 89/1049 (8%)
Query: 1 MDSP--SPNVPGSG--STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP + P S S GS+D+ PRVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+P
Sbjct: 1 MDSPLTRSSTPNSSPISNPGSHDENPRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVP 60
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+TYEELM +MRELY+GA VLKYQQPDED DALVSVVNDDDVINMMEEY+K+GSGDGFT
Sbjct: 61 RDITYEELMVKMRELYDGAAVLKYQQPDEDPDALVSVVNDDDVINMMEEYDKVGSGDGFT 120
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFSH +QD S +VDGD+R++ERRYVDALNN ND NDF + Q +SP +S IDD+
Sbjct: 121 RLRIFLFSHPEQDASLPFVDGDERDTERRYVDALNNSNDMNDFVRQQQQNSPALSGIDDM 180
Query: 177 HMAERFFNTMSLEGGIHNQ------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
H E F N M++EG +H Q QY+LHQLT+PH+ SG QQQ V+QRY+EME PWSP
Sbjct: 181 HGTEHFLNPMNIEGSLHTQRSCEPLSQYHLHQLTIPHVGSGGQQQSVAQRYSEMEAPWSP 240
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
A SPRH+G +D RP+ ++PSSP AR+RMPF + ER+PE+Y RQ +NH YE
Sbjct: 241 ALLSPRHHGPYDS-RPMGDYPSSPF-ARYRMPFPDLPDKYLERMPEDYVRQQMNHQHMYE 298
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ++EN++W+P G ++ ++SGFPGN+ HGH V DGN CEHCR +HR Q H++Q N
Sbjct: 299 HQPQYNENIVWLPNGTIN-EESGFPGNILHGHGVPDGNSSCEHCRANFHRYQAHMEQVNT 357
Query: 345 GNGLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD---NDSRSVYNESHCHERGWVLQ 400
NGLP E QNRE L+ A+ K G++P + ND RS YNE+ HE+GW++Q
Sbjct: 358 LNGLP------LEYTQNREALMQKADTKFHHGIFPNEQNINDHRSAYNETPPHEKGWIMQ 411
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
HQ++ R ++ RTH+SG GRL DHY+VDG G N+P N+ DG+H S N
Sbjct: 412 HQMSVRGDDTRTHVSGTGRLTDHYIVDGSGSNLPSTQSNVADGYHASTN---------FH 462
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP-VSHGHATAQNLWRNVQNPIH 519
+E+F D H+ P E+R V Y + YG + YP ++ H WRNVQNP+H
Sbjct: 463 DEVFRDQVVPSGQHMCVPPPEDRGVGYMPYGYGGEPHYPPMAQRHMPGNASWRNVQNPLH 522
Query: 520 VTP-LEASGPVI----NGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
V P EAS V N SI P Y++ +G+PRI +GVD N W + SQ+ G G AT
Sbjct: 523 VAPPYEAS--VFHQQGNASINPGYIKAMQDGSPRIHIGVDHQNPWHESSQKALGVDG-AT 579
Query: 575 PPEYYYSQTQKMNPQSYNQQNQ-----------------LPDPVHQSDSFSALVQDKLVS 617
E+ + K N + NQ + P+ +SDS SA +Q+K+V+
Sbjct: 580 GTEHLPAHVLKTNSTTVGHDNQQFTSLEHIQPHLDKINLVASPMQRSDSSSAFIQEKMVA 639
Query: 618 STTDC-NLGLR-VNNVSEAVRTDENCNLGQEKAANHVVK------VEETDVKRSCLEQN- 668
N LR V+ V+EA+ + G+ H++K + E + N
Sbjct: 640 PFHPSQNPQLRAVSAVNEAMMMERKVVHGE--GNGHMIKDMGKPDISEAHTASHPGQNNT 697
Query: 669 ------MIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVK 722
+ P + + ST + +G+ KP ++ E KL LS LPELIASVK
Sbjct: 698 DDTYSKVAPLELLNSTCTNSAVENGDGLKPSVETL----EKPKLSVSRLSFLPELIASVK 753
Query: 723 RAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEP 782
RAALE +EE VEE+ +PD+ K+ NE N H E E++ +++ ++ +IEP
Sbjct: 754 RAALEVSEETM--VEETALR-RPDSIEKKETTNEQHSSNNHVEPELETESEN-QSSRIEP 809
Query: 783 TIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE 842
T AE EAI+RGLQTIKNDDLEE+RELGSGTYG+VYHGKWRGSDVAIKRIKASCFAG+PSE
Sbjct: 810 TKAEEEAISRGLQTIKNDDLEEIRELGSGTYGAVYHGKWRGSDVAIKRIKASCFAGRPSE 869
Query: 843 RERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
RERLIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRT
Sbjct: 870 RERLIADFWKEALILSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRT 929
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV+Q
Sbjct: 930 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVRQH 989
Query: 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
TLVSGGVRGTLPWMAPELLSGKS+MVTEK
Sbjct: 990 TLVSGGVRGTLPWMAPELLSGKSNMVTEK 1018
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550754|ref|XP_003543749.1| PREDICTED: uncharacterized protein LOC100779077 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1078 bits (2789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/1041 (57%), Positives = 726/1041 (69%), Gaps = 88/1041 (8%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSP P +GS +GS +D RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+ RD++
Sbjct: 1 MDSPI-RSPATGSGSGSGEDNRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVHRDIS 59
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +MRELY+GA VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFTRLRI
Sbjct: 60 YEELMGKMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFTRLRI 119
Query: 121 FLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHM-A 179
FLFS S+QDGS+H++DGDD SERRYVDALN++NDG+DFR+LQ + P++S ++DIH+ A
Sbjct: 120 FLFSQSEQDGSSHFIDGDD--SERRYVDALNSLNDGSDFRRLQQGEFPMMSPVEDIHVVA 177
Query: 180 ERFFNTMSLEGGIHNQPQ-------YNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
++F++ +S+E GIH+Q YN+H LTV H S + QRYNEM+ PW+PAY
Sbjct: 178 DQFYSPISVESGIHSQRSGDLSMSPYNMHHLTVQHPKS------MGQRYNEMDAPWNPAY 231
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
YSPRH+G H EFPSSPS R+R+PF E +RV EEY R HVNHHP Y+ Q
Sbjct: 232 YSPRHHGLH-------EFPSSPSGTRYRVPFPELPDKCIDRVSEEYVRHHVNHHPVYDNQ 284
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
Q+SEN++W+P G G+KS FPGN+ H +V DGN +CE CR+ +HR Q H++ NI N
Sbjct: 285 LQYSENVMWVPTGAAHGEKSAFPGNILHSPHVVDGNSICEQCRMGFHRGQPHMEHSNISN 344
Query: 347 GLPQVPLSCAECRQ-NRENLVLNAEAKL-PGMYPKD--NDSRSVYNESHCHERGWVLQHQ 402
GLPQ CAEC NR+ +NA+AKL P +YP + ND RSVYN++ HERGW LQH
Sbjct: 345 GLPQAANPCAECPPPNRDTFTVNADAKLHPAIYPNEPNNDHRSVYNDTQNHERGWGLQHP 404
Query: 403 LNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNE 462
R+EE+R H+SG+GR+ D P N GHG++ DGH++S N+ H + GPE+G E
Sbjct: 405 -TARVEESRVHVSGSGRM-----FDVPVANFSLGHGSVTDGHNLSSNYVHQQAGPELGPE 458
Query: 463 LFHDPAAAVVPHLHTPSAEERVVRYGNFP--YGADTIYPVSHGHATAQNLWRNVQNPIHV 520
LF D +P + P EE V+YGN P YG D Y V GH WRN P+H+
Sbjct: 459 LFPDQTVTSIPPIQIPPLEECNVQYGNSPSPYGLDCNYAVPRGHPPG--FWRNTPVPVHI 516
Query: 521 TPL--EASGPV-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPE 577
P A+ P +N + +RG EG+ +G DS N W+D SQ++ G GTA P E
Sbjct: 517 GPSYEAATSPQPLNSMMNVGLIRG--EGSTGFFIGPDSQNHWVDSSQKLTGHDGTAIP-E 573
Query: 578 YYYSQTQKMNPQSYNQQNQLPD------PVHQSDSFSALVQDKLVSSTTDCNLGLRV--- 628
Y Y+ +NP Q+NQ PD P ++ + L +L S+ + +V
Sbjct: 574 YPYAHA--LNPVPLGQENQHPDIVDTIHPPQDMNAGTCLEPLQLPKSSFNMVQNQQVLRD 631
Query: 629 -NNVSEAVRTDENCNLGQEKAANHVVKVEET-----DVKRSCLEQNMIPEKPIGSTSLLA 682
+++EA + N LG+ V+K+E+ S EQN I E + A
Sbjct: 632 DTHLTEAKSFESNSLLGE----GIVIKIEDNVENPGAQTISSSEQNKIAEHACEA----A 683
Query: 683 MEVSGN------------IEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAALEGAE 730
V N +EK +K PS PEDSK L S LPELIASVK+AALE AE
Sbjct: 684 ASVESNNLKSKPEADCVHVEKLADKDPS-VPEDSKHLVDQFSFLPELIASVKKAALEDAE 742
Query: 731 EVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAI 790
E+KA +E +S ++ TK+ NE E N HG++E+D +ND V T KIE T AE EA
Sbjct: 743 ELKAAADEPANSQNHNSDTKDETTNEVEPTNAHGDLELDSENDHVDTNKIESTRAEEEAF 802
Query: 791 ARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADF 850
A GLQTI NDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER RLI DF
Sbjct: 803 ANGLQTINNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLITDF 862
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
WKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFM+NGSLKQFL KKDRTIDRRKRLI
Sbjct: 863 WKEALMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDRTIDRRKRLI 922
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ TLVSGGVR
Sbjct: 923 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLVSGGVR 982
Query: 971 GTLPWMAPELLSGKSHMVTEK 991
GTLPWMAPELLSGKS+MV+EK
Sbjct: 983 GTLPWMAPELLSGKSNMVSEK 1003
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479749|ref|XP_003610160.1| Protein kinase-like protein [Medicago truncatula] gi|355511215|gb|AES92357.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 595/1042 (57%), Positives = 725/1042 (69%), Gaps = 90/1042 (8%)
Query: 1 MDSP----SPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLP 56
MDSP SP GSG GSNDD RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+
Sbjct: 27 MDSPTAIRSPATTGSG--PGSNDDGRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVS 84
Query: 57 RDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFT 116
RD+++EELM +MRELYEG VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFT
Sbjct: 85 RDISFEELMGKMRELYEGVAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFT 144
Query: 117 RLRIFLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDI 176
RLRIFLFS S+QDGS H++DGDD ERRYVDALN++ND ++ R+LQ + P+I +++DI
Sbjct: 145 RLRIFLFSQSEQDGSAHFIDGDD--PERRYVDALNSLNDASELRRLQQMEFPLIGTVEDI 202
Query: 177 HMAERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWS 229
H+ +++ + + +E GI +Q QY LH + + Q QQP+ QRYNE++ PW+
Sbjct: 203 HVGDQYISPVGMENGILSQRSGELAMSQYGLHHMPI------QHQQPMGQRYNEIDAPWN 256
Query: 230 PAYYSPRHYG--HHDPPRPLPEFPSSPSSARFRMPF------GEERVPEEYARQHVNHHP 281
YYSPRH+G HHD L E+PSSPS R+RMPF G +RV +EYAR H+NHHP
Sbjct: 257 SGYYSPRHHGQCHHDSRTSLVEYPSSPSGPRYRMPFPEMPDKGIDRVSDEYARHHINHHP 316
Query: 282 TYEPQPQFSENLIWMPPGNV-SGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLD 340
Y+ QP + EN++W+P G GDKSGFPGN+ HG + DGN +CEHCR+++ R Q HL+
Sbjct: 317 VYDNQPPYPENVVWLPTGPAHGGDKSGFPGNVLHGSHALDGNNICEHCRMSFQRPQPHLE 376
Query: 341 QPNIGNGLPQVPLSCAECRQNRENLVLNAEAKL-PGMYPKDNDSRSVYNESHCHERGWVL 399
PN+ LP V + C EC +R+ L++NA+AKL P MYP N++ HERG L
Sbjct: 377 HPNM---LPSVAIPCPECPSSRDALIVNADAKLQPPMYP---------NDTQNHERGCGL 424
Query: 400 QHQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEM 459
QHQ +GR+ DHY+ D P ++ PGHG+++DGH + NH H GPE+
Sbjct: 425 QHQ-------------NSGRVGDHYVGDVPIISFSPGHGSMIDGHALPSNHVHQPVGPEL 471
Query: 460 GNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQNP 517
G ELF D A +PHL P EE V+YGN PYG D Y + G A LWRN P
Sbjct: 472 GVELFPDQTMANIPHLKIPPLEESSVQYGNPPSPYGVDKNYAMPRGQAPGYTLWRNGPTP 531
Query: 518 IHVTPLEASGPV---INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
+H+ P + + ++G I +RG EG+P VG DS + W+D SQ+ G G+AT
Sbjct: 532 VHIGPPHEATTLPQPVDGVINAGIIRG--EGSPGFFVGPDSQSLWVDSSQKFSGHDGSAT 589
Query: 575 PPEYYYSQTQKMNPQSYNQQNQLP---DPVHQSDSFSAL-----VQDKLVSSTTDCNLGL 626
P EY ++ K+NP + Q+N P D +H +A VQ + S N G+
Sbjct: 590 P-EYPHTNAPKLNPMAIGQENPHPIIVDAIHPPQDVNASIYMEPVQLQKSSFHMVHNNGV 648
Query: 627 RVNN--VSEAVRTDENCNLGQEKAANHVVKVEETDVKR-SCLEQNMIPEKPIGSTSLLAM 683
N+ ++E V LG+ + A VE+++V+ S EQN I E + +T+
Sbjct: 649 LKNDAHLTEGVSLQSISLLGERQEAKKEDAVEKSNVQSISFPEQNQIVED-VSNTAASVA 707
Query: 684 EVSGNIEKP------GEK---SPSDRPEDSKLLAHNLSILPELIASVKRAALEGAEEVKA 734
E + + KP GEK PEDSK L +ILPELIASVK+AALE +EVK
Sbjct: 708 ECNDSFLKPASGCEHGEKVADKDCSAPEDSKGLVDQFNILPELIASVKKAALECHDEVKP 767
Query: 735 KVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGL 794
+E+ + ++ TKE ANE E VN+HG++E+D +ND V T KIEPT AEAEAIARGL
Sbjct: 768 TGKENANCQMDNSNTKEEKANEVEPVNVHGDLELDSENDRVDTSKIEPTKAEAEAIARGL 827
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
QTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER RLIADFWKEA
Sbjct: 828 QTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERARLIADFWKEA 887
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL KKDRTIDRRKRLIIAMD
Sbjct: 888 LMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLHKKDRTIDRRKRLIIAMD 947
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK-----IGDLGLSKVKQQTLVSGGV 969
AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK IGDLGLSKVKQ TLVSGGV
Sbjct: 948 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKVLASIIGDLGLSKVKQHTLVSGGV 1007
Query: 970 RGTLPWMAPELLSGKSHMVTEK 991
RGTLPWMAPELLSGKS+MV+EK
Sbjct: 1008 RGTLPWMAPELLSGKSNMVSEK 1029
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356564856|ref|XP_003550663.1| PREDICTED: uncharacterized protein LOC100782903 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1036 bits (2680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 589/1046 (56%), Positives = 715/1046 (68%), Gaps = 112/1046 (10%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSP P +GS +GS +D RVKFLCSFLG I+PRPQDGKLRYVGGETRIVS+PRD++
Sbjct: 1 MDSPI-RSPATGSGSGSGEDNRRVKFLCSFLGSIMPRPQDGKLRYVGGETRIVSVPRDIS 59
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM RMRELY+GA VLKYQQPDEDLDALVSVVNDDDV+NMMEEY+KLGSGDGFTRLRI
Sbjct: 60 YEELMGRMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVVNMMEEYDKLGSGDGFTRLRI 119
Query: 121 FLFSHSDQDGSNHYVDGDDRESERRYVDALNNMNDGN--DFRKLQHPDSPVISSIDDIHM 178
FLFS S+QDGS+H++DGDD SERRYVDALN++NDG+ DFR+LQ + ++S ++DIH+
Sbjct: 120 FLFSQSEQDGSSHFIDGDD--SERRYVDALNSLNDGSNSDFRRLQQGEFSMMSPVEDIHV 177
Query: 179 A-ERFFNTMSLEGGIHNQPQ-------YNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
A ++F+N +++E GIH+Q YN+H LTV Q Q + QRYNEM+ PW+P
Sbjct: 178 AADQFYNPINVESGIHSQRSGDLSMSPYNMHHLTV------QHPQALGQRYNEMDAPWNP 231
Query: 231 AYYSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
AYYSPRH+G HD FPSSPS R+R+PF E +RVPEEYAR HVNHHP Y+
Sbjct: 232 AYYSPRHHGLHD-------FPSSPSGTRYRVPFPELPDKCIDRVPEEYARHHVNHHPVYD 284
Query: 285 PQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNI 344
QPQ+SEN++WMP G+KS FPGN+ H +V D N +CE CR+ +HR Q HL+ NI
Sbjct: 285 NQPQYSENVMWMP---AHGEKSAFPGNIIHSPHVVDENSICEQCRMGFHRGQPHLEHSNI 341
Query: 345 GNGLPQVPLSCAECRQ-NRENLVLNAEAKL-PGMYPKD--NDSRSVYNESHCHERGWVLQ 400
NG+ QV CAEC NR+ A+AKL +YP + ND RSV+N++ HERGW LQ
Sbjct: 342 SNGVSQVGNLCAECPPPNRDTFA--ADAKLHSAIYPNEPSNDHRSVFNDTQNHERGWGLQ 399
Query: 401 HQLNPRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMG 460
H R+EE+R H+S GHG++ D H++ N+ + GPE+G
Sbjct: 400 HP-TARVEESRVHVS-------------------LGHGSVTDAHNLPSNYVQQQAGPELG 439
Query: 461 NELFHDPAAAVVPHLHTPSAEERVVRYGNF--PYGADTIYPVSHGHATAQNLWRNVQNPI 518
ELF + VP + P E+ VRYGN PYG D+ Y V G WRN P+
Sbjct: 440 TELFPEQTVTPVPPIQFPPLEDCNVRYGNSASPYGVDSNYAVPRG--LPPGFWRNTPVPV 497
Query: 519 HVTPL--EASGPV-INGSITPA-YLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTAT 574
H+ P A+ P +NG + A +RG E +P +G DS N W+D SQ++ G GTA
Sbjct: 498 HIGPSYEAATSPQPVNGLMNAAGLIRG--EASPGFFIGPDSQNHWVDSSQKLTGHDGTAI 555
Query: 575 PPEYYYSQTQKMNPQSYNQQNQLP---DPVHQSDSFSA---LVQDKLVSSTTDCNLGLRV 628
P EY Y+ +NP Q+NQ P D +H +A L +L S+ + +V
Sbjct: 556 P-EYPYAHA--LNPLPLGQENQHPVIVDFIHPPQDMNAGTCLKPLQLPKSSFNMVPNQQV 612
Query: 629 ----NNVSEAVRTDENCNLGQE-------------------KAANHVVKVEETDVKRSCL 665
+++EA + N +G+ N + + S +
Sbjct: 613 LRDDTHLTEAKSFESNGLIGEGIVVKIEDNVQNPGTQTISFSVQNKIAENACEAAAASSV 672
Query: 666 EQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAA 725
E N + KP ++EK +K PS PEDSK L S LPELIASVK+AA
Sbjct: 673 ESNNLKSKPEADCV--------HVEKLADKDPS-VPEDSKHLVDQFSFLPELIASVKKAA 723
Query: 726 LEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIA 785
LE A ++KA V+E DS ++ TK+ NE E N HG++E+D +ND V T KIEPT A
Sbjct: 724 LEDAVQLKAAVDEHADSPNHNSDTKDETTNEVEPANAHGDLELDSENDHVDTNKIEPTRA 783
Query: 786 EAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERER 845
E EAIA+GLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSER R
Sbjct: 784 EEEAIAKGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERAR 843
Query: 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR 905
LIADFWKEAL+LSSLHHPNVVSFYGIVRDGPDGSLATVTEFM+NGSLKQFL KKDRTIDR
Sbjct: 844 LIADFWKEALMLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMINGSLKQFLHKKDRTIDR 903
Query: 906 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+CKIGDLGLSKVKQ TLV
Sbjct: 904 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPICKIGDLGLSKVKQHTLV 963
Query: 966 SGGVRGTLPWMAPELLSGKSHMVTEK 991
SGGVRGTLPWMAPELLSGKS+MV+EK
Sbjct: 964 SGGVRGTLPWMAPELLSGKSNMVSEK 989
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147856633|emb|CAN82456.1| hypothetical protein VITISV_010028 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2596), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 529/901 (58%), Positives = 648/901 (71%), Gaps = 70/901 (7%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDSPS S GSND+ PRVKFLCSF G ILPRPQDGKLRYVGGETRIVS+PRD+
Sbjct: 131 MDSPSAT---PSSAXGSNDENPRVKFLCSFSGSILPRPQDGKLRYVGGETRIVSVPRDIG 187
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELM +M+EL++ A VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 188 YEELMGKMKELFDMAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 247
Query: 121 FLFSHSDQD-GSNHYVDGDDRESERRYVDALNNMNDGNDFRKLQHPDSPVISSIDDIHMA 179
FLFSH DQD GS+H+VD DD +ERRYVDALNN+ND +DFRK Q +SP +S+IDDIH+A
Sbjct: 248 FLFSHPDQDGGSSHFVDVDD--TERRYVDALNNLNDASDFRKQQVGESPTMSAIDDIHLA 305
Query: 180 ERFFNTMSLEGGIHNQ-------PQYNLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAY 232
E+FFN++SLEGG+HNQ Q+NLH LT+PHM SG Q QPV+QRYNEME W+PAY
Sbjct: 306 EQFFNSISLEGGLHNQRNCEMPMSQFNLHHLTIPHMGSG-QHQPVAQRYNEMESQWNPAY 364
Query: 233 YSPRHYGHHDPPRPLPEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQ 286
+SPRH+GHHD RPL E+PSSPSSARFRMPFGE +R PEEY+RQ VN Y+ Q
Sbjct: 365 FSPRHHGHHD-ARPLAEYPSSPSSARFRMPFGELPDKCIDRXPEEYSRQPVNPQAPYDHQ 423
Query: 287 PQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN 346
PQ S+N++W+P G +S +K+GFPG++ HG NVF+GN +CEHCR+T+HR HL+QPN+GN
Sbjct: 424 PQASDNVVWLPTGAISSEKAGFPGSMLHGPNVFEGNSICEHCRMTFHR---HLEQPNMGN 480
Query: 347 GLPQVPLSCAECRQNRENLVLNAEAKLP-GMYPKD-NDSRSVYNESHCHERGWVLQHQLN 404
GLP V CAEC RE+ +LN +AK+ G+YPK+ ND RS+YNE+H HERGW+LQHQLN
Sbjct: 481 GLPPVANPCAECPPGRESFLLNTDAKMQHGIYPKEHNDPRSLYNETHNHERGWILQHQLN 540
Query: 405 PRIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHH------RTGPE 458
PR E+AR +SGAGRLND Y+VDG G+N P HGNL+D HHVS N+ HH RTG E
Sbjct: 541 PRAEDARAQISGAGRLNDPYIVDGSGVNFPVAHGNLLDNHHVSSNYVHHEDXRYIRTGXE 600
Query: 459 MGNELFHDPAAAVVPHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHATAQNLWRNVQN 516
+GN +FHD AAA P ++ P EER VRYGN +PYGAD +Y VSHGH A LWRNVQN
Sbjct: 601 LGNGVFHDQAAAAGPAINVPPLEERAVRYGNLPYPYGADNLYQVSHGHVPAHALWRNVQN 660
Query: 517 PIHVTP-LEASGPVIN--GSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTA 573
P+H P EAS GS+ P +RG EG+PR VG+D+ N W + SQ++ GF G+A
Sbjct: 661 PMHGAPSYEASTSTCQAXGSVNPGPIRGTREGSPRFCVGLDNQNPWGESSQKILGFDGSA 720
Query: 574 TPPEYYYSQTQKMNPQSYNQQNQLP-------------------DPVHQSDSFSALVQDK 614
P+Y Y K+NP ++ Q+ Q P +P+H ++S L+ DK
Sbjct: 721 L-PDYSYGHATKLNPNTHGQEGQHPFTPGPVPSPSDMLKFAAPMEPLHFTNSSPTLMDDK 779
Query: 615 LVSSTTDCNLGLRV-----NNVSEAVRTDENCNLGQEKAANHVVKVEETDVKRSCL-EQN 668
V+S NL NNV++ V + + K H+ KVE+ D+ + L E+N
Sbjct: 780 FVASA---NLSYNPESRNDNNVNQTVIMEAKQAFREGKEEIHMEKVEDNDMPVTSLPEKN 836
Query: 669 MIPEKPIGSTSL--LAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRAAL 726
+K SL + + N+ KP + ED+KL NLS LPELIASVKRAAL
Sbjct: 837 NNADKKCEVASLEPVNLPAEDNVFKPVVNDCAPLEEDAKLDVSNLSFLPELIASVKRAAL 896
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAE 786
E AEEVKAKV+E+ D+V ++TKEA +NE E N G++E+D DND V T KIEPT AE
Sbjct: 897 ESAEEVKAKVQENADAVHA-SSTKEA-SNELETANALGDLELDSDNDNVNTFKIEPTKAE 954
Query: 787 AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERL 846
EA++RGLQTIKNDDLEE+RELGSGTYG+VYHGKW+GSDVAIKRIKASCFAG+PSERERL
Sbjct: 955 EEALSRGLQTIKNDDLEEIRELGSGTYGAVYHGKWKGSDVAIKRIKASCFAGRPSERERL 1014
Query: 847 I 847
+
Sbjct: 1015 V 1015
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793271|ref|XP_002864520.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310355|gb|EFH40779.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 997 bits (2577), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 565/1003 (56%), Positives = 669/1003 (66%), Gaps = 89/1003 (8%)
Query: 18 NDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGAVV 77
ND+ RVKFLCSFLG ILPRPQDGKLRYVGGETRIVS+ RD+ YEELMS+MRELY+GA V
Sbjct: 19 NDEPHRVKFLCSFLGSILPRPQDGKLRYVGGETRIVSVNRDIRYEELMSKMRELYDGAAV 78
Query: 78 LKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHSDQDGSNHYVDG 137
LKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRIFLFS +QDGS HYV+
Sbjct: 79 LKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRIFLFSSPEQDGSLHYVER 138
Query: 138 DD-RESERRYVDALNNMNDGNDFRKLQ-HPDSPVISSIDDIHMAERFFNTMSLEGGIHNQ 195
DD RESERRYVDALNN+ +G DFRKLQ +PDSP + +D+ M E N +S+E G +Q
Sbjct: 139 DDQRESERRYVDALNNLIEGTDFRKLQQYPDSPRFNFVDEFSMVEPMLNQLSIETGGGSQ 198
Query: 196 -------PQY-NLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSPAYYSPRHYGHHDPPRPL 247
QY NLHQL +P + SGQ ++QRY E+EG WSP YYSPRH+GHHDP R
Sbjct: 199 RGTEIPTAQYSNLHQLRIPRVGSGQM---LAQRYGEVEGTWSP-YYSPRHHGHHDP-RTF 253
Query: 248 PEFPSSPSSARFRMPFGE------ERVPEEYARQHVNHHPTYEPQPQFSENLIWMPPGNV 301
EFPSSPSSAR+RMP+GE +R+PEEY R +HHP YE Q E+++W+P G +
Sbjct: 254 QEFPSSPSSARYRMPYGEIPDKGFDRMPEEYVRPQASHHPLYEHQAHIPESVVWVPAGAM 313
Query: 302 SGD-KSGFPGNLFH-GHNVFDGNGLCEHCRLTYHRNQLHLDQPNIGN-GLPQVPLSCAEC 358
+ K GFPGN+ H G ++G +CE+CR+ YHRN L+QPNIGN G P P+ CA C
Sbjct: 314 PPESKGGFPGNVLHSGPGGYEGGNVCENCRVPYHRNHQLLEQPNIGNNGFP--PVHCAHC 371
Query: 359 RQNRENLVLNAEAKLP--GMYPKDNDSRSVYNESHCHERGWVLQHQLN---PRIEEARTH 413
NRE+ +LN + K G YP NE+ HERG ++Q Q+N PRIEE R+H
Sbjct: 372 PPNRESFLLNTDPKPTHHGAYP---------NETFGHERGRMVQQQVNSNPPRIEEGRSH 422
Query: 414 MSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTGPEMGNELFHD-PAAAVV 472
+S GR NDHY D P N P R G E+ NE FHD P +
Sbjct: 423 ISNVGRPNDHYTPDYPVSNYP----------------LAQRAGHEISNEGFHDKPLGGIP 466
Query: 473 PHLHTPSAEERVVRYGN--FPYGADTIYPVSHGHA-TAQNLWRNVQNPIHVTPLEASGPV 529
+ SAEERV YGN +P G ++I H H QN+W+NV NP+ P P+
Sbjct: 467 LNSANRSAEERVFHYGNNLYPPGPESIQSAGHSHMHPQQNIWQNVSNPVAGPP---GLPM 523
Query: 530 -INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFKGTATPPEYYYSQTQKMNP 588
ING++ +R +E PR ++GV++ + QR+ GF G +P + YY +
Sbjct: 524 QINGTVNQTIIRNPIETAPRYSIGVENQGVLVGSPQRISGFDGMPSPGQPYYPNPHLQDR 583
Query: 589 QSYNQQNQLPDPVHQSDSFSALVQDKLVSSTTDCNLGLRVNNVSEAVRTDENCNLGQEKA 648
N +P + V++ L NL + ++T E+ K
Sbjct: 584 AFPLDPNWVPSENPTVHNEHLQVREPLSGPLLQTNLNAAPIMQTPVIQTPES------KL 637
Query: 649 ANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLA 708
A K D S + +P+ +EVS PE ++L
Sbjct: 638 AQGGEKFNYVDTGVSNGVPYLDKPQPLAEGKKDMVEVS--------------PEGAELSV 683
Query: 709 HNLSILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEM 768
LS LPEL+ SVKRAALEGA EVKA EES + V+P+ NE+E +N E E+
Sbjct: 684 ERLSFLPELMESVKRAALEGAAEVKAHPEESKNQVRPELVE-----NESEHMNAQDEPEI 738
Query: 769 DYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAI 828
D DND KIE T AEAEA +RGLQ+I+NDDLEE+RELG GTYGSVYHGKW+GSDVAI
Sbjct: 739 DSDNDNPNNFKIEQTKAEAEARSRGLQSIRNDDLEEIRELGHGTYGSVYHGKWKGSDVAI 798
Query: 829 KRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888
KRIKASCFAGKPSERERLI DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV EFMV
Sbjct: 799 KRIKASCFAGKPSERERLIEDFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVAEFMV 858
Query: 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
NGSLKQFLQKKDRTIDRRKRLIIAMD AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP+
Sbjct: 859 NGSLKQFLQKKDRTIDRRKRLIIAMDTAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPI 918
Query: 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
CKIGDLGLSKVKQ+TLVSGGVRGTLPWMAPELLSGKS+MV+EK
Sbjct: 919 CKIGDLGLSKVKQKTLVSGGVRGTLPWMAPELLSGKSNMVSEK 961
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 993 | ||||||
| TAIR|locus:2174552 | 1054 | AT5G57610 [Arabidopsis thalian | 0.713 | 0.672 | 0.428 | 1.6e-143 | |
| TAIR|locus:2032895 | 1147 | AT1G16270 [Arabidopsis thalian | 0.254 | 0.220 | 0.619 | 1.9e-124 | |
| TAIR|locus:2206350 | 1248 | AT1G79570 [Arabidopsis thalian | 0.200 | 0.159 | 0.763 | 1.2e-123 | |
| TAIR|locus:2044702 | 1257 | AT2G35050 [Arabidopsis thalian | 0.252 | 0.199 | 0.621 | 3.4e-118 | |
| TAIR|locus:2102787 | 1171 | AT3G46920 [Arabidopsis thalian | 0.199 | 0.169 | 0.747 | 6.2e-117 | |
| TAIR|locus:2093146 | 1117 | AT3G24715 [Arabidopsis thalian | 0.200 | 0.178 | 0.768 | 1.3e-114 | |
| TAIR|locus:2197788 | 1042 | AT1G04700 [Arabidopsis thalian | 0.330 | 0.314 | 0.510 | 5.7e-111 | |
| TAIR|locus:2200296 | 765 | AT1G67890 [Arabidopsis thalian | 0.175 | 0.227 | 0.414 | 7.8e-26 | |
| TAIR|locus:2084314 | 773 | AT3G06620 [Arabidopsis thalian | 0.175 | 0.225 | 0.439 | 8.3e-26 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.163 | 0.157 | 0.418 | 8.5e-25 |
| TAIR|locus:2174552 AT5G57610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1403 (498.9 bits), Expect = 1.6e-143, P = 1.6e-143
Identities = 339/791 (42%), Positives = 443/791 (56%)
Query: 1 MDSPSPNVPGSGSTAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVT 60
MDS S N + + ND+ RVKFLCSFLG ILPRPQDGKLRYVGGETRIVS+ RD+
Sbjct: 1 MDSGSVNSSVTSLVSSLNDEPHRVKFLCSFLGSILPRPQDGKLRYVGGETRIVSVNRDIR 60
Query: 61 YEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120
YEELMS+MRELY+GA VLKYQQPDEDLDALVSVVNDDDV NMMEEY+KLGSGDGFTRLRI
Sbjct: 61 YEELMSKMRELYDGAAVLKYQQPDEDLDALVSVVNDDDVTNMMEEYDKLGSGDGFTRLRI 120
Query: 121 FLFSHSDQDGSNHYVDGDD-RESERRYVDALNNMNDGNDFRKLQ-HPDSPVISSIDDIHM 178
FLFS +QDGS HYV+ DD RESERRYVDALNN+ +G DFRKLQ +PDSP + +DD M
Sbjct: 121 FLFSTPEQDGSLHYVERDDQRESERRYVDALNNLIEGTDFRKLQQYPDSPRFNLVDDFSM 180
Query: 179 AERFFNTMSLEGGIHNQ-----P--QY-NLHQLTVPHMNSGQQQQPVSQRYNEMEGPWSP 230
E N +S+E G +Q P QY NLHQL +P + SGQ ++QRY E+EG WSP
Sbjct: 181 VEPMLNQLSIETGGGSQRGNEIPTAQYSNLHQLRIPRVGSGQM---LAQRYGEVEGTWSP 237
Query: 231 AYYSPRHYGHHDXXXXXXXXXXXXXXARFRMPFGE------ERVPEEYARQHVNHHPTYE 284
+YSPRH+GHHD AR+RMP+GE +R+PEEY R +HHP YE
Sbjct: 238 -FYSPRHHGHHDPRTFQEFPSSPSS-ARYRMPYGEIPDKGLDRMPEEYVRPQASHHPFYE 295
Query: 285 PQPQFSENLIWMPPGNVSGD-KSGFPGNLFHGH-NVFDGNGLCEHCRLTYHRNQLHLDQP 342
Q ++++W+P G + + K GFPGN+ HG ++G CE+CR+ YHRN L+Q
Sbjct: 296 HQAHIPDSVVWVPAGAMPPESKGGFPGNVLHGGPGGYEGGNGCENCRVPYHRNHQLLEQS 355
Query: 343 NIGN-GLPQVPLSCAECRQNRENLVLNAEAKLP--GMYPKDNDSRSVYNESHCHERGWVL 399
NIGN G P P+ CA C NRE+ +LN + K G YP NE+ +RGW++
Sbjct: 356 NIGNNGFP--PVHCAHCPPNRESFLLNTDPKPTHHGAYP---------NETFGPDRGWMV 404
Query: 400 QHQLNP---RIEEARTHMSGAGRLNDHYLVDGPGMNIPPGHGNLVDGHHVSPNHAHHRTG 456
Q Q+NP RIEE R+H+S GR NDHY D P N P G R G
Sbjct: 405 QQQVNPNPPRIEEGRSHISNVGRPNDHYTPDYPVSNYPLGQ----------------RAG 448
Query: 457 PEMGNELFHDPAAAVVP-HLHTPSAEERVVRYGN--FPYGADTIYPVSHGHA--TAQNLW 511
E+ NE FHD +P + SAEER YGN +P G D+I+ H H N+W
Sbjct: 449 HEISNEGFHDKPLGGIPLNSANRSAEERGFHYGNNLYPPGPDSIHSAGHSHMHHPQPNIW 508
Query: 512 RNVQNPIHVTPLEASGPV-INGSITPAYLRGAVEGNPRIAVGVDSPNSWIDPSQRVPGFK 570
+NV NPI P P+ ING++ +R +E PR + G+++ + QR+ GF
Sbjct: 509 QNVSNPIAGPP---GLPMQINGTVNQTVIRNPIETAPRYSTGMENQGVLVGSPQRISGFD 565
Query: 571 GTATPPEYYYSQTQKMNPQSYNQQNQLP--DPVHQSDSFSALVQDKLVSSTTDCNLGLRV 628
G ++ + Y + N +P +P ++ V++ L NL
Sbjct: 566 GMSSLGQPSYPNPHLQDRAFPLDPNWVPSENPTVHNEHLQ--VREPLPGPLLQTNLTAAP 623
Query: 629 NNVSEAVRTDENCNLGQE-KAANHVVKVEETDVKRSCLEQNMIPEKPIGSTSLLAMEVSG 687
+ ++T L Q + N+V T + Q+ P+ G + G
Sbjct: 624 IMQTPVMQTSVESKLAQGGEQFNYV----NTGISNGVPYQDK-PQPLAGGKKDM-----G 673
Query: 688 NIEKPGEKSPSDRPEDSKLLAHNLSILPELIASVKRXXXXXXXXXXXXXXXSDDSVKPDT 747
N+ + + + E ++L LS LPEL+ SVKR + D V+P+
Sbjct: 674 NLVEVNPSAAT--LEGAELSVERLSFLPELMESVKRAALEGAAEVKAHPEEAKDQVRPEL 731
Query: 748 TTKEAPANEAE 758
E+ A+
Sbjct: 732 VENESEHMNAQ 742
|
|
| TAIR|locus:2032895 AT1G16270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 1.9e-124, Sum P(3) = 1.9e-124
Identities = 158/255 (61%), Positives = 196/255 (76%)
Query: 739 SDDSVKPDTTTKEAPANEAELVNIH-GEIEMDYDNDTVKTLKIEPTX-XXXXXXXRGLQT 796
+++ V P E+ +A + N+ + E + + + + P GLQ
Sbjct: 798 TENRVDPQMKVTESEEFDAMVENLRTSDCEQEDEKSETRNAGLPPVGPSLADYDTSGLQI 857
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I NDDLEE++ELGSGT+G+VYHGKWRGSDVAIKRIK SCFAG+ SE+ERL +FW EA +
Sbjct: 858 IMNDDLEELKELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWGEAEI 917
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS LHHPNVV+FYG+V+DGP +LATVTE+MV+GSL+ L +KDR +DRRKRLIIAMDAA
Sbjct: 918 LSKLHHPNVVAFYGVVKDGPGATLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIAMDAA 977
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
FGMEYLH KNIVHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLVSGGVRGTLPWM
Sbjct: 978 FGMEYLHAKNIVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGTLPWM 1037
Query: 977 APELLSGKSHMVTEK 991
APELL+G S V+EK
Sbjct: 1038 APELLNGSSSKVSEK 1052
|
|
| TAIR|locus:2206350 AT1G79570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 1.2e-123, Sum P(4) = 1.2e-123
Identities = 152/199 (76%), Positives = 178/199 (89%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
GLQ IKN+DLEE+RELGSGT+G+VYHGKWRGSDVAIKRIK SCFAG+ SE+ERL +FW
Sbjct: 955 GLQIIKNEDLEELRELGSGTFGTVYHGKWRGSDVAIKRIKKSCFAGRSSEQERLTGEFWG 1014
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +LS LHHPNVV+FYG+V+DGP G+LATVTE+MV+GSL+ L +KDR +DRRKRLIIA
Sbjct: 1015 EAEILSKLHHPNVVAFYGVVKDGPGGTLATVTEYMVDGSLRHVLVRKDRHLDRRKRLIIA 1074
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
MDAAFGMEYLH KN VHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLVSGGVRGT
Sbjct: 1075 MDAAFGMEYLHSKNTVHFDLKCDNLLVNLKDPSRPICKVGDFGLSKIKRNTLVSGGVRGT 1134
Query: 973 LPWMAPELLSGKSHMVTEK 991
LPWMAPELL+G S V+EK
Sbjct: 1135 LPWMAPELLNGSSSKVSEK 1153
|
|
| TAIR|locus:2044702 AT2G35050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 3.4e-118, Sum P(3) = 3.4e-118
Identities = 159/256 (62%), Positives = 196/256 (76%)
Query: 740 DDSVKPDTTTKEAP-ANEAELVNIHGEIEMDYDNDTVKTLKIE-PTXXXXXXXX--RGLQ 795
D ++KPD +T P N + + + ++ T TL P R LQ
Sbjct: 908 DGNIKPDVSTITIPDLNTVDTQEDYSQSQIKGAESTDATLNAGVPLIDFMAADSGMRSLQ 967
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
IKNDDLEE++ELGSGT+G+VYHGKWRG+DVAIKRIK SCF G+ SE+ERL ++FW EA
Sbjct: 968 VIKNDDLEELKELGSGTFGTVYHGKWRGTDVAIKRIKRSCFIGRSSEQERLTSEFWHEAE 1027
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+LS LHHPNV++FYG+V+DGP G+LATVTE+MVNGSL+ L +R +DRRKRLIIAMDA
Sbjct: 1028 ILSKLHHPNVMAFYGVVKDGPGGTLATVTEYMVNGSLRHVLLS-NRHLDRRKRLIIAMDA 1086
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
AFGMEYLH K+IVHFDLKC+NLLVN++DP RP+CK+GD GLSK+K+ TLV+GGVRGTLPW
Sbjct: 1087 AFGMEYLHSKSIVHFDLKCDNLLVNLKDPARPICKVGDFGLSKIKRNTLVTGGVRGTLPW 1146
Query: 976 MAPELLSGKSHMVTEK 991
MAPELLSG S V+EK
Sbjct: 1147 MAPELLSGSSSKVSEK 1162
|
|
| TAIR|locus:2102787 AT3G46920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 796 (285.3 bits), Expect = 6.2e-117, Sum P(3) = 6.2e-117
Identities = 148/198 (74%), Positives = 170/198 (85%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
LQ IK+ DLEE+RELGSGT+G+VYHGKWRG+DVAIKRI CFAGKPSE+ER+I DFW E
Sbjct: 880 LQIIKDSDLEELRELGSGTFGTVYHGKWRGTDVAIKRINDRCFAGKPSEQERMIDDFWNE 939
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
A L+ LHHPNVV+FYG+V D P GS+ATVTE+MVNGSL+ LQK R DR KR +IAM
Sbjct: 940 AQNLAGLHHPNVVAFYGVVLDSPGGSVATVTEYMVNGSLRNALQKNVRNFDRCKRQLIAM 999
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
D AFGMEYLHGK IVHFDLK +NLLVN+RDP RP+CK+GDLGLSKVK QTL+SGGVRGTL
Sbjct: 1000 DIAFGMEYLHGKKIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLISGGVRGTL 1059
Query: 974 PWMAPELLSGKSHMVTEK 991
PWMAPELL+G S +V+EK
Sbjct: 1060 PWMAPELLNGTSSLVSEK 1077
|
|
| TAIR|locus:2093146 AT3G24715 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 1.3e-114, Sum P(4) = 1.3e-114
Identities = 153/199 (76%), Positives = 177/199 (88%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
GLQ IKN DLE++ ELGSGTYG+VYHG WRG+DVAIKRI+ SCFAG+ SE+ERL DFW+
Sbjct: 827 GLQIIKNADLEDLTELGSGTYGTVYHGTWRGTDVAIKRIRNSCFAGRSSEQERLTKDFWR 886
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA +LS+LHHPNVV+FYGIV DG G+LATVTEFMVNGSL+ L KKDR +D RK++IIA
Sbjct: 887 EAQILSNLHHPNVVAFYGIVPDGTGGTLATVTEFMVNGSLRHALLKKDRLLDTRKKIIIA 946
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
MDAAFGMEYLH KNIVHFDLKCENLLVN+RDPQRP+CK+GDLGLS++K+ TLVSGGVRGT
Sbjct: 947 MDAAFGMEYLHSKNIVHFDLKCENLLVNLRDPQRPICKVGDLGLSRIKRNTLVSGGVRGT 1006
Query: 973 LPWMAPELLSGKSHMVTEK 991
LPWMAPELL+G S V+EK
Sbjct: 1007 LPWMAPELLNGSSTRVSEK 1025
|
|
| TAIR|locus:2197788 AT1G04700 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 809 (289.8 bits), Expect = 5.7e-111, Sum P(3) = 5.7e-111
Identities = 172/337 (51%), Positives = 221/337 (65%)
Query: 657 ETDVKRSCLEQNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHNLSILPE 716
ET+ S ++++ E+ I + L +V SD SKLL L I+ +
Sbjct: 626 ETNSDDSDTQKSLPREESIHYSGLPLRKVGSRETTFMHTQGSDDFFKSKLLGPQL-IVED 684
Query: 717 LIASVKRXXXXXXXXXXXXXXXSDDSVKPDTTTKEAPANEAELVNIHGEIEMDY--DNDT 774
+ V SDD K T KE + E E+E Y +T
Sbjct: 685 VTNEVISDNLLSATIVPQVNRESDDDHKSYTREKEITNADHE-----SEMEEKYKKSRNT 739
Query: 775 VKTLKIEPTXXXXXXXXRGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKAS 834
+ E GLQ IKN DLE++ ELGSGT+G+VY+GKWRG+DVAIKRIK S
Sbjct: 740 DDSFS-EAAMVEIEAGIYGLQIIKNTDLEDLHELGSGTFGTVYYGKWRGTDVAIKRIKNS 798
Query: 835 CFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ 894
CF+G SE+ R DFW+EA +L++LHHPNVV+FYG+V DGP G++ATVTE+MVNGSL+
Sbjct: 799 CFSGGSSEQARQTKDFWREARILANLHHPNVVAFYGVVPDGPGGTMATVTEYMVNGSLRH 858
Query: 895 FLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
LQ+KDR +DRRK+L+I +D+AFGMEYLH KNIVHFDLKC+NLLVN+RDPQRP+CK+GD
Sbjct: 859 VLQRKDRLLDRRKKLMITLDSAFGMEYLHMKNIVHFDLKCDNLLVNLRDPQRPICKVGDF 918
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
GLS++K+ TLVSGGVRGTLPWMAPELL+G S+ V+EK
Sbjct: 919 GLSRIKRNTLVSGGVRGTLPWMAPELLNGSSNRVSEK 955
|
|
| TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 326 (119.8 bits), Expect = 7.8e-26, Sum P(2) = 7.8e-26
Identities = 78/188 (41%), Positives = 108/188 (57%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+DL ++G G+ G+VYHG W GSDVA+K F+ K E +I F +E L+
Sbjct: 485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVK-----VFS-KQEYSEEIITSFKQEVSLMKR 538
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNV+ F G V P L VTEF+ GSL + LQ+ +D R+R+ +A D A GM
Sbjct: 539 LRHPNVLLFMGAVAS-PQ-RLCIVTEFLPRGSLFRLLQRNKSKLDLRRRIHMASDIARGM 596
Query: 920 EYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
YLH I+H DLK NLLV+ + K+ D GLS++K +T ++ RGT WMA
Sbjct: 597 NYLHHCSPPIIHRDLKSSNLLVD----RNWTVKVADFGLSRIKHETYLTTNGRGTPQWMA 652
Query: 978 PELLSGKS 985
PE+L ++
Sbjct: 653 PEVLRNEA 660
|
|
| TAIR|locus:2084314 AT3G06620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 327 (120.2 bits), Expect = 8.3e-26, P = 8.3e-26
Identities = 83/189 (43%), Positives = 110/189 (58%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
DDL ++G G+ G+VYHG W GSDVA+K F+ + E +I F +E LL+
Sbjct: 492 DDLTIGEQVGQGSCGTVYHGLWFGSDVAVK-----VFSKQEYSAE-VIESFKQEVLLMKR 545
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPNV+ F G V P L V+EF+ GSL + LQK +D R+R+ +A+D A GM
Sbjct: 546 LRHPNVLLFMGAVTS-PQ-RLCIVSEFLPRGSLFRLLQKSTSKLDWRRRIHMALDIARGM 603
Query: 920 EYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-LVSGGVRGTLPWM 976
YLH I+H DLK NLLV D V K+ D GLS++K +T L S +GT WM
Sbjct: 604 NYLHHCSPPIIHRDLKSSNLLV---DKNWTV-KVADFGLSRIKHETYLTSKSGKGTPQWM 659
Query: 977 APELLSGKS 985
APE+L +S
Sbjct: 660 APEVLRNES 668
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 320 (117.7 bits), Expect = 8.5e-25, P = 8.5e-25
Identities = 74/177 (41%), Positives = 103/177 (58%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G+YG VY G W G++VA+K+ G+ E +F E ++ L HPN+V
Sbjct: 754 IGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGEALE------EFRSEVRIMKKLRHPNIVL 807
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN- 926
F G V P+ L+ VTEF+ GSL + + + + +D R+RL +A+DAA GM YLH N
Sbjct: 808 FMGAVTRPPN--LSIVTEFLPRGSLYRLIHRPNNQLDERRRLRMALDAARGMNYLHSCNP 865
Query: 927 -IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELL 981
IVH DLK NLLV+ + V K+ D GLS++K T +S GT WMAPE+L
Sbjct: 866 MIVHRDLKSPNLLVD----KNWVVKVCDFGLSRMKHSTYLSSKSTAGTAEWMAPEVL 918
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00031430001 | SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (1063 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 993 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-48 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-47 | |
| cd06410 | 97 | cd06410, PB1_UP2, Uncharacterized protein 2 | 1e-46 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-44 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-38 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-35 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-27 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-22 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-21 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-21 | |
| smart00666 | 81 | smart00666, PB1, PB1 domain | 7e-21 | |
| pfam00564 | 84 | pfam00564, PB1, PB1 domain | 1e-20 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-20 | |
| cd05992 | 81 | cd05992, PB1, The PB1 domain is a modular domain m | 5e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-19 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-16 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-14 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 7e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 8e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-04 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.001 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-48
Identities = 67/190 (35%), Positives = 89/190 (46%), Gaps = 22/190 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
LE ++LG G +G VY G +G VA+K +K E +F +EA
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-------SEEEREEFLEEAS 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HPN+V G+ G L VTE+M G L FL+K + + L +A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQG--EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQI 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
A GMEYL KN VH DL N LV + V KI D GLS+ GG +
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT----ENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 973 LPWMAPELLS 982
+ WMAPE L
Sbjct: 168 IKWMAPESLK 177
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 3e-47
Identities = 67/198 (33%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L ++LG G +G VY GK +G +VA+K +K E+ I +F +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-------EQQIEEFLREAR 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HPNVV G+ + + L V E+M G L +L+K + L A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTE--EEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQI 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
A GMEYL KN +H DL N LV + V KI D GLS+ G + +
Sbjct: 112 ARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 974 PWMAPELLSGKSHMVTEK 991
WMAPE L K T K
Sbjct: 168 RWMAPESL--KEGKFTSK 183
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|99731 cd06410, PB1_UP2, Uncharacterized protein 2 | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 1e-46
Identities = 62/99 (62%), Positives = 79/99 (79%), Gaps = 4/99 (4%)
Query: 27 LCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPD 84
LCS+ GRILPRP DG+LRYVGGETRIVS+ R ++++EL+S++ EL+ V LKYQ PD
Sbjct: 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPD 60
Query: 85 EDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123
EDLDAL+SV ND+D+ NMMEEY++L G RLR+FLF
Sbjct: 61 EDLDALISVSNDEDLKNMMEEYDRL--SGGSARLRVFLF 97
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. Length = 97 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 5e-46
Identities = 65/199 (32%), Positives = 92/199 (46%), Gaps = 24/199 (12%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L ++LG G +G VY G +G +VA+K +K E+ I +F +EA
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS-------EQQIEEFLREAR 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
++ L HPN+V G+ + + L V E+M G L +L+K + + + L A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTE--EEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GMEYL KN +H DL N LV V KI D GLS+ G +
Sbjct: 112 IARGMEYLESKNFIHRDLAARNCLVGENL----VVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 973 LPWMAPELLSGKSHMVTEK 991
+ WMAPE L K T K
Sbjct: 168 IRWMAPESL--KEGKFTSK 184
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 5e-44
Identities = 61/182 (33%), Positives = 95/182 (52%), Gaps = 15/182 (8%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G+VY + + + VAIK IK + L+ + +E +L L+HPN+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK-------KEDSSSLLEELLREIEILKKLNHPNI 53
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V YG+ D L V E+ GSLK L++ + + + L I + G+EYLH
Sbjct: 54 VKLYGVFEDENHLYL--VMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN 111
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPELLSGK 984
I+H DLK EN+L++ + + K+ D GLSK + + + GT +MAPE+L GK
Sbjct: 112 GIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 985 SH 986
+
Sbjct: 169 GY 170
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 4e-41
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 16/186 (8%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E + +LG G++G VY + + + VAIK IK + ++ +E +L L
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIK-------KKKIKKDRERILREIKILKKL 54
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN+V Y + D + L V E+ G L L+K+ R + R + +E
Sbjct: 55 KHPNIVRLYDVFED--EDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLR-QILSALE 111
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
YLH K IVH DLK EN+L++ + K+ D GL++ GT +MAPE+
Sbjct: 112 YLHSKGIVHRDLKPENILLD----EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEV 167
Query: 981 LSGKSH 986
L GK +
Sbjct: 168 LLGKGY 173
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 4e-40
Identities = 73/202 (36%), Positives = 94/202 (46%), Gaps = 31/202 (15%)
Query: 806 RELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++LG G +G VY GK +G +VA+K +K SE ER DF KEA ++ L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----ASEEER--KDFLKEARVMKKL 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIA 912
HPNVV G+ + + L V E+M G L +L+K T+ + L A
Sbjct: 54 GHPNVVRLLGVCTE--EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRG 971
+ A GMEYL K VH DL N LV + V KI D GLS+ G
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKISDFGLSRDVYDDDYYRKKTGG 167
Query: 972 TLP--WMAPELLSGKSHMVTEK 991
LP WMAPE L K + T K
Sbjct: 168 KLPIRWMAPESL--KDGIFTSK 187
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 63/188 (33%), Positives = 95/188 (50%), Gaps = 16/188 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E +R+LGSG++G+VY K +G+ VA+K +K K SE+ + +E +L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILK------KRSEKSKKDQTARREIRILRR 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L HPN+V D L V E+ G L +L + + + IA+ G+
Sbjct: 55 LSHPNIVRLIDAFED--KDHLYLVMEYCEGGDLFDYL-SRGGPLSEDEAKKIALQILRGL 111
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLPWMAP 978
EYLH I+H DLK EN+L++ + V KI D GL+K ++ S GT +MAP
Sbjct: 112 EYLHSNGIIHRDLKPENILLD----ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 979 ELLSGKSH 986
E+L G +
Sbjct: 168 EVLLGGNG 175
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 9e-35
Identities = 64/191 (33%), Positives = 93/191 (48%), Gaps = 24/191 (12%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++GSVY K G +A+K ++ S + + E +E +LSSL H
Sbjct: 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE------REIRILSSLQH 58
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----TIDRRKRLIIAMDAAFG 918
PN+V +YG RD +L E++ GSL L+K + I + R I+ G
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILE-----G 113
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG---VRGTLPW 975
+ YLH IVH D+K N+LV+ V K+ D G +K G VRGT W
Sbjct: 114 LAYLHSNGIVHRDIKGANILVDSDG----VVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 976 MAPELLSGKSH 986
MAPE++ G+ +
Sbjct: 170 MAPEVIRGEEY 180
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 68/188 (36%), Positives = 94/188 (50%), Gaps = 22/188 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + +L+ +G G +G V G +RG VA+K +K + F EA +
Sbjct: 3 INSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK---------DDSTAAQAFLAEASV 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDA 915
+++L HPN+V G+V G L VTE+M GSL +L+ + R I ++L A+D
Sbjct: 54 MTTLRHPNLVQLLGVVLQG--NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP- 974
GMEYL KN VH DL N+LV+ V K+ D GL+K Q S G LP
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDL----VAKVSDFGLAKEASQGQDS----GKLPV 163
Query: 975 -WMAPELL 981
W APE L
Sbjct: 164 KWTAPEAL 171
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 65/186 (34%), Positives = 94/186 (50%), Gaps = 20/186 (10%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+L ++ELGSG +G V+ GKWRG DVAIK I+ G SE DF +EA ++
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIRE----GAMSED-----DFIEEAKVMMK 55
Query: 860 LHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L HPN+V YG+ + P + VTE+M NG L +L+++ + L + D
Sbjct: 56 LSHPNLVQLYGVCTKQRP---IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEA 112
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWM 976
MEYL +H DL N LV + V K+ D GL++ + Q S G + + W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWA 168
Query: 977 APELLS 982
PE+
Sbjct: 169 PPEVFD 174
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 59/188 (31%), Positives = 91/188 (48%), Gaps = 16/188 (8%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
E + ++G G +G VY + + G +VAIK IK ++E++I E +L
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE----SKEKKEKII----NEIQILK 52
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
HPN+V +YG L V EF GSLK L+ ++T+ + + + G
Sbjct: 53 KCKHPNIVKYYGSYLK--KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKG 110
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+EYLH I+H D+K N+L+ K+ D GLS T + GT WMAP
Sbjct: 111 LEYLHSNGIIHRDIKAANILLTSDG----EVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
Query: 979 ELLSGKSH 986
E+++GK +
Sbjct: 167 EVINGKPY 174
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 62/187 (33%), Positives = 96/187 (51%), Gaps = 23/187 (12%)
Query: 805 VRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ +G G +G V G+ + DVAIK +KA S+++RL DF EA ++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-----SDKQRL--DFLTEASIMGQ 61
Query: 860 LHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
HPN++ G+V + P + +TE+M NGSL +FL++ D + + + A G
Sbjct: 62 FDHPNIIRLEGVVTKSRP---VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTLPW 975
M+YL N VH DL N+LVN VCK+ D GLS+ + T + G + + W
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNL----VCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174
Query: 976 MAPELLS 982
APE ++
Sbjct: 175 TAPEAIA 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 66/189 (34%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWRG DVAIK IK G SE E F +EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE----GSMSEDE-----FIEEAK 51
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L H +V YG+ + P + VTE+M NG L +L++ + + L + D
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRP---IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
GM YL K +H DL N LV+ + K+ D GLS+ + + S G +
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 973 LPWMAPELL 981
+ W PE+L
Sbjct: 165 VRWSPPEVL 173
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 57/193 (29%), Positives = 95/193 (49%), Gaps = 21/193 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L+ +++LG G +G V ++ G VA+K + S E+ +DF +E
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSG-------EEQHRSDFERE 56
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L +L H N+V + G+ SL + E++ +GSL+ +LQ+ I+ ++ L+ +
Sbjct: 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS 116
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--G 971
GM+YL + +H DL N+LV + + V KI D GL+KV + V+ G
Sbjct: 117 QICKGMDYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVLPEDKDYYYVKEPG 172
Query: 972 TLP--WMAPELLS 982
P W APE L
Sbjct: 173 ESPIFWYAPECLR 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 60/180 (33%), Positives = 87/180 (48%), Gaps = 20/180 (11%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
LGSG++GSVY G D +K A + + +E LLS L HPN+V
Sbjct: 8 LGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLH 923
+ G R+ +L E + GSL + L+K + I R I+ G+EYLH
Sbjct: 67 YLGTEREE--DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLH 119
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELL 981
+N VH D+K N+LV D V K+ D G++K V+ S +G+ WMAPE++
Sbjct: 120 DRNTVHRDIKGANILV---DTNGVV-KLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVI 173
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 58/188 (30%), Positives = 91/188 (48%), Gaps = 21/188 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I ++ +R+LG+G +G V+ G W + VA+K +K K DF EA
Sbjct: 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---------DFLAEAQ 53
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
++ L HP ++ Y + + P + VTE M GSL ++LQ + +LI +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP---IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A GM YL +N +H DL N+LV + +CK+ D GL++V ++ +
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADFGLARVIKEDIYEAREGAKF 166
Query: 974 P--WMAPE 979
P W APE
Sbjct: 167 PIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 59/188 (31%), Positives = 93/188 (49%), Gaps = 21/188 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ R+LG+G +G V+ G W G+ VA+K +K + F +EA
Sbjct: 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQ 53
Query: 856 LLSSLHHPNVVSFYGIVRDG-PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
++ L H +V Y + + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEP---IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRG 971
A GM YL +N +H DL N+LV + VCKI D GL+++ + + G +
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADFGLARLIEDDEYTAREGAKF 166
Query: 972 TLPWMAPE 979
+ W APE
Sbjct: 167 PIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 64/188 (34%), Positives = 94/188 (50%), Gaps = 20/188 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L ++ELGSG +G V+ GKWR VAIK I G SE DF +EA
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINE----GAMSEE-----DFIEEAK 51
Query: 856 LLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HP +V YG+ + P L VTEFM NG L +L+++ + + L + D
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKP---LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGT 972
GMEYL + +H DL N LV+ V K+ D G+++ + + S G +
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMTRYVLDDEYTSSSGAKFP 164
Query: 973 LPWMAPEL 980
+ W PE+
Sbjct: 165 VKWSPPEV 172
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 68/192 (35%), Positives = 96/192 (50%), Gaps = 22/192 (11%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
DLE V+ LG G+ G VY H K G A+K+I G R++L+ + + L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRH-KPTGKIYALKKIH---VDGDEEFRKQLLREL--KTLR 54
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
P VV YG +G ++ V E+M GSL L KK I IA
Sbjct: 55 SCE--SPYVVKCYGAFYK--EGEISIVLEYMDGGSLADLL-KKVGKIPEPVLAYIARQIL 109
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTL 973
G++YLH K +I+H D+K NLL+N + KI D G+SKV + TL + V GT+
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGISKVLENTLDQCNTFV-GTV 164
Query: 974 PWMAPELLSGKS 985
+M+PE + G+S
Sbjct: 165 TYMSPERIQGES 176
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 54/191 (28%), Positives = 92/191 (48%), Gaps = 20/191 (10%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E ++++G G++G VY + R SD +K I S ERE + E +L
Sbjct: 3 EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEIDLSNM--SEKEREDAL----NEVKILKK 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLIIAMDAA 916
L+HPN++ +Y + G L V E+ G L Q ++ K+ + + L +
Sbjct: 56 LNHPNIIKYYESFEE--KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG-VRGTLPW 975
++YLH + I+H D+K +N+ + + K+GD G+SKV T+ V GT +
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYY 169
Query: 976 MAPELLSGKSH 986
++PEL K +
Sbjct: 170 LSPELCQNKPY 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 30/194 (15%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G +G VY G G VAIK+I E + +E LL +L HPN
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLE---KIKEEA---LKSIMQEIDLLKNLKHPN 60
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------G 918
+V + G + SL + E+ NGSL+Q ++K + L+ A + G
Sbjct: 61 IVKYIGSIETS--DSLYIILEYAENGSLRQIIKKFGPF---PESLV----AVYVYQVLQG 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+ YLH + ++H D+K N+L V K+ D G++ K+ + V GT WMA
Sbjct: 112 LAYLHEQGVIHRDIKAANILTTKDG----VVKLADFGVATKLNDVSKDDASVVGTPYWMA 167
Query: 978 PELLSGKSHMVTEK 991
PE++ +
Sbjct: 168 PEVIEMS--GASTA 179
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 60/180 (33%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 806 RELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
R+LGSG +G V+ G W+ VAIK +K S+ DF KE L L H +
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILK--------SDDLLKQQDFQKEVQALKRLRHKH 63
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLH 923
++S + + G + +TE M GSL FL+ + + LI +A A GM YL
Sbjct: 64 LISLFAVCSVGE--PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPELLS 982
+N +H DL N+LV + VCK+ D GL+++ K+ +S + W APE S
Sbjct: 122 EQNSIHRDLAARNILVG----EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAAS 177
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 61/190 (32%), Positives = 92/190 (48%), Gaps = 21/190 (11%)
Query: 802 LEEVRELGSGTYGSVY------HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+ +R+LG G +G V G G VA+K +K P IAD KE
Sbjct: 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-------PESGGNHIADLKKEIE 58
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L +L+H N+V + GI + + + EF+ +GSLK++L + I+ +++L A+
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQI 118
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRG 971
GM+YL + VH DL N+LV KIGD GL+K K+ V +
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174
Query: 972 TLPWMAPELL 981
+ W APE L
Sbjct: 175 PVFWYAPECL 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 52/215 (24%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIA 848
++ D + RELG G +G V+ G+ VA+K +K + R+
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA---SNDARK---- 53
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
DF +EA LL++ H N+V FYG+ +G V E+M +G L +FL+ K
Sbjct: 54 DFEREAELLTNFQHENIVKFYGVCTEG--DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKS 111
Query: 909 -------------LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
L IA+ A GM YL ++ VH DL N LV V KIGD G
Sbjct: 112 PDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG----YDLVVKIGDFG 167
Query: 956 LS---------KVKQQTLVSGGVRGTLP--WMAPE 979
+S +V T+ LP WM PE
Sbjct: 168 MSRDVYTTDYYRVGGHTM--------LPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 63/191 (32%), Positives = 95/191 (49%), Gaps = 22/191 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ +L+ ++ +G G +G V G +RG+ VA+K IK A F EA +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA----------FLAEASV 52
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDA 915
++ L H N+V G++ + G L VTE+M GSL +L+ + R++ L+ ++D
Sbjct: 53 MTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP- 974
MEYL N VH DL N+LV+ + V K+ D GL+K T + G LP
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGLTKEASSTQDT----GKLPV 163
Query: 975 -WMAPELLSGK 984
W APE L K
Sbjct: 164 KWTAPEALREK 174
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 28/191 (14%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ + ++G G G VY R G +VAIK+++ + + LI E L++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK------QNKELII---NEILIMKD 71
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN+V +Y L V E+M GSL + + ++ + + + G+
Sbjct: 72 CKHPNIVDYYDSYLV--GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGL 129
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG----LSKVKQQ--TLVSGGVRGTL 973
EYLH +N++H D+K +N+L++ K+ D G L+K K + ++V GT
Sbjct: 130 EYLHSQNVIHRDIKSDNILLSKDG----SVKLADFGFAAQLTKEKSKRNSVV-----GTP 180
Query: 974 PWMAPELLSGK 984
WMAPE++ K
Sbjct: 181 YWMAPEVIKRK 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 60/189 (31%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ G SE DF +EA
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIRE----GAMSEE-----DFIEEAQ 51
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HP +V YG+ + + V EFM +G L +L+ + + L + +D
Sbjct: 52 VMMKLSHPKLVQLYGVCTE--RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDV 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTL 973
GM YL N++H DL N LV + V K+ D G+++ + Q S G + +
Sbjct: 110 CEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV 165
Query: 974 PWMAPELLS 982
W +PE+ S
Sbjct: 166 KWSSPEVFS 174
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 58/182 (31%), Positives = 90/182 (49%), Gaps = 22/182 (12%)
Query: 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG G YG VY G W+ VA+K +K E + +F KEA ++ + HPN
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPN 63
Query: 865 VVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYL 922
+V G+ R+ P +TEFM G+L +L++ +R ++ L +A + MEYL
Sbjct: 64 LVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 120
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS--GGVRGTLPWMAPEL 980
KN +H DL N LV + + K+ D GLS++ + G + + W APE
Sbjct: 121 EKKNFIHRDLAARNCLVG----ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 981 LS 982
L+
Sbjct: 177 LA 178
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 3e-22
Identities = 58/190 (30%), Positives = 89/190 (46%), Gaps = 25/190 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GTYG VY + + + VA+K+I+ +E+E +E LL L
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME------NEKEGFPITAIREIKLLQKL 55
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFM---VNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HPN+V IV GS+ V E+M + G L K T + K + +
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--FTESQIKCYMKQL--LE 111
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL----SKVKQQTLVSGGVRGTL 973
G++YLH I+H D+K N+L+N V K+ D GL +K + + TL
Sbjct: 112 GLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARPYTKRNSADYTNRVI--TL 165
Query: 974 PWMAPELLSG 983
+ PELL G
Sbjct: 166 WYRPPELLLG 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 61/185 (32%), Positives = 87/185 (47%), Gaps = 24/185 (12%)
Query: 807 ELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+LG G++G V G+W S VA+K +K+ K S+ ++ DF KEA ++ SL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS----DKLSD---IMDDFLKEAAIMHSLD 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGME 920
H N++ YG+V P L VTE GSL L+K L A+ A GM
Sbjct: 55 HENLIRLYGVVLTHP---LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR 111
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPWM 976
YL K +H DL N+L+ D KIGD GL + + ++ ++ W
Sbjct: 112 YLESKRFIHRDLAARNILLASDD----KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 977 APELL 981
APE L
Sbjct: 168 APESL 172
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 32/205 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIAD 849
+ + + +RELG G++G VY G +G + VAIK + + S RER+ +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-----ASMRERI--E 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRT---- 902
F EA ++ + +VV G+V G V E M G LK +L+ +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 903 --IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+K + +A + A GM YL K VH DL N +V KIGD G+++ +
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL----TVKIGDFGMTRDI 169
Query: 960 KQQTLVSGGVRGTLP--WMAPELLS 982
+ G +G LP WMAPE L
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLK 194
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 1e-21
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 36/204 (17%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ D + +R LG G +G VY G +RG D VA+K + SC E+ +D
Sbjct: 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESD 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT-----VTEFMVNGSLKQFLQKKDRTID 904
F EAL++S +H N+V G+ S + E M G LK FL++ +
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGV-------SFERLPRFILLELMAGGDLKSFLRENRPRPE 108
Query: 905 R------RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R + L A D A G +YL + +H D+ N L+ + P R V KI D G+++
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMAR 167
Query: 959 -VKQQTLVSGGVRGTLP--WMAPE 979
+ + + G R LP WM PE
Sbjct: 168 DIYRASYYRKGGRAMLPIKWMPPE 191
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 61/188 (32%), Positives = 93/188 (49%), Gaps = 22/188 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V++LG+G +G V+ G + G + VAIK +K + F EA
Sbjct: 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEAN 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L+ L HP +V Y +V P + +TE+M NGSL FL K I +I M A
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEP---IYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAA 109
Query: 916 --AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--LVSGGVRG 971
A GM ++ KN +H DL+ N+LV+ + CKI D GL+++ + G +
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADFGLARLIEDNEYTAREGAKF 165
Query: 972 TLPWMAPE 979
+ W APE
Sbjct: 166 PIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 97.1 bits (240), Expect = 2e-21
Identities = 63/192 (32%), Positives = 96/192 (50%), Gaps = 21/192 (10%)
Query: 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHP 863
+R+LG G++G VY + VA+K + K + + + F +E +L+SL H P
Sbjct: 5 LRKLGEGSFGEVYLAR-DRKLVALKVLAK-----KLESKSKEVERFLREIQILASLNHPP 58
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEY 921
N+V Y +D +GSL V E++ GSL+ L+K R + + L I +EY
Sbjct: 59 NIVKLYDFFQD--EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-------KQQTLVSGGVRGTLP 974
LH K I+H D+K EN+L+ D V K+ D GL+K+ + GT
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 975 WMAPELLSGKSH 986
+MAPE+L G S
Sbjct: 174 YMAPEVLLGLSL 185
|
Length = 384 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 66/182 (36%), Positives = 98/182 (53%), Gaps = 21/182 (11%)
Query: 806 RELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G +G VY G +G+ +VA+K +C + P + +R F +EA +L HPN
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKR---KFLQEAEILKQYDHPN 53
Query: 865 VVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+V G+ V+ P + V E + GSL FL+KK + +K L +++DAA GMEYL
Sbjct: 54 IVKLIGVCVQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLP--WMAPE 979
KN +H DL N LV + V KI D G+S+ ++ + VS G +P W APE
Sbjct: 111 SKNCIHRDLAARNCLVGENN----VLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTAPE 165
Query: 980 LL 981
L
Sbjct: 166 AL 167
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 21/189 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D+ E LG G+YGSVY + G VAIK + P E + + + KE +L
Sbjct: 6 DILEK--LGEGSYGSVYKAIHKETGQVVAIKVV--------PVEED--LQEIIKEISILK 53
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
P +V +YG + L V E+ GS+ ++ ++T+ + I G
Sbjct: 54 QCDSPYIVKYYGSYFK--NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKG 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMA 977
+EYLH +H D+K N+L+N + K+ D G+S T+ V GT WMA
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMA 167
Query: 978 PELLSGKSH 986
PE++ +
Sbjct: 168 PEVIQEIGY 176
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 57/192 (29%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADF 850
I+ +D+ R +G G +G VY G + + VA+K K PS RE+ F
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREK----F 54
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+EA ++ HP++V G++ + P + V E G L+ +LQ ++D ++
Sbjct: 55 LQEAYIMRQFDHPHIVKLIGVITENP---VWIVMELAPLGELRSYLQVNKYSLDLASLIL 111
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVSGGV 969
+ + + YL K VH D+ N+LV+ P C K+GD GLS+ +
Sbjct: 112 YSYQLSTALAYLESKRFVHRDIAARNVLVS-----SPDCVKLGDFGLSRYLEDESYYKAS 166
Query: 970 RGTLP--WMAPE 979
+G LP WMAPE
Sbjct: 167 KGKLPIKWMAPE 178
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 61/196 (31%), Positives = 96/196 (48%), Gaps = 25/196 (12%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLI 847
L+ +K +LE+++ LGSG +G+VY G W VAIK ++ + +E L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEIL- 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
EA +++S+ HP+VV GI + +T+ M G L +++ I +
Sbjct: 58 ----DEAYVMASVDHPHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQY 110
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQT 963
L + A GM YL K +VH DL N+LV + PQ KI D GL+K+ +++
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLDVDEKEY 166
Query: 964 LVSGGVRGTLPWMAPE 979
GG + + WMA E
Sbjct: 167 HAEGG-KVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|214770 smart00666, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 7e-21
Identities = 39/89 (43%), Positives = 59/89 (66%), Gaps = 11/89 (12%)
Query: 38 PQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE---GAVVLKYQQPDEDLDALVSVV 94
D KLRY GGETR +S+PRD+++E+L S++ + + + LKYQ DED D LVS+
Sbjct: 1 TVDVKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLT 56
Query: 95 NDDDVINMMEEYEKLGSGDGFTRLRIFLF 123
+D+D+ +EEY+ LGS +LR+ +F
Sbjct: 57 SDEDLEEAIEEYDSLGSK----KLRLHVF 81
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. Length = 81 |
| >gnl|CDD|215996 pfam00564, PB1, PB1 domain | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-20
Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 38 PQDGKLRYVGGETRIVSLPRDVTYEELMSRMRE-LYEGAVVLKYQQPDEDLDALVSVVND 96
KLRY GG R +S+ +++EEL S++ + V K + PDED D LVS+ +D
Sbjct: 1 TVRVKLRYGGGIRRFLSVSPGISFEELRSKVEQRFGLDRVDFKLKYPDEDGD-LVSITSD 59
Query: 97 DDVINMMEEYEKLGSGDGFTRLRIFLF 123
+D+ +EE LGS LR+ +F
Sbjct: 60 EDLEEAIEEARSLGSK----TLRLHVF 82
|
Length = 84 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 59/184 (32%), Positives = 82/184 (44%), Gaps = 26/184 (14%)
Query: 806 RELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ELG G +GSV G + G +VA+K +K A E F +EA +++ L
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE-------FLREASVMAQL 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HP +V G+ + G L V E G L ++L+K R I +A A GM
Sbjct: 54 DHPCIVRLIGVCK-GE--PLMLVMELAPLGPLLKYLKK-RREIPVSDLKELAHQVAMGMA 109
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPW 975
YL K+ VH DL N+L+ R KI D G+S+ + G R L W
Sbjct: 110 YLESKHFVHRDLAARNVLLVNRH----QAKISDFGMSRALGAGSDYYRATTAG-RWPLKW 164
Query: 976 MAPE 979
APE
Sbjct: 165 YAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 63/193 (32%), Positives = 97/193 (50%), Gaps = 28/193 (14%)
Query: 802 LEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+EEV +G+G +G V G+ R VAIK +K+ +E++R DF EA +
Sbjct: 8 IEEV--IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-----TEKQR--RDFLSEASI 58
Query: 857 LSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+ HPN++ G+V + P + +TEFM NG+L FL++ D + + +
Sbjct: 59 MGQFDHPNIIHLEGVVTKSRP---VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI 115
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGVRG 971
A GM+YL N VH DL N+LVN VCK+ D GLS+ + + + G
Sbjct: 116 AAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 972 TLP--WMAPELLS 982
+P W APE ++
Sbjct: 172 KIPIRWTAPEAIA 184
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 70/191 (36%), Positives = 94/191 (49%), Gaps = 22/191 (11%)
Query: 802 LEEVRELGSGTYGSV----YH--GKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+ +++LG G +GSV Y G VA+K+++ S E L DF +E
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ-------HSTAEHL-RDFEREIE 57
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L SL H N+V + G+ +L V E++ GSL+ +LQK +D RK L+ A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTL 973
GMEYL K VH DL N+LV KIGD GL+KV Q VR G
Sbjct: 118 CKGMEYLGSKRYVHRDLATRNILVE----SENRVKIGDFGLTKVLPQDKEYYKVREPGES 173
Query: 974 P--WMAPELLS 982
P W APE L+
Sbjct: 174 PIFWYAPESLT 184
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 66/189 (34%), Positives = 97/189 (51%), Gaps = 24/189 (12%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K++ F E ++ + E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVP---FDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRR-KRLIIAMDAAFGMEY 921
V +YG +RD D +L+ E+M GS+K L+ T+ R+ R I+ G+EY
Sbjct: 67 VQYYGCLRD--DETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE-----GVEY 119
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG----VRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q SG V GT WM+
Sbjct: 120 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 176 PEVISGEGY 184
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|99716 cd05992, PB1, The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-20
Identities = 30/85 (35%), Positives = 51/85 (60%), Gaps = 6/85 (7%)
Query: 40 DGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDD 98
K++Y G R V + R +++E+L S++ E + AV K + PDED D LV++ +D+D
Sbjct: 2 RVKVKYGGEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYPDEDGD-LVTISSDED 60
Query: 99 VINMMEEYEKLGSGDGFTRLRIFLF 123
+ +EE + GS +LR+F+F
Sbjct: 61 LEEAIEEARRSGSK----KLRLFVF 81
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. Length = 81 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 7e-20
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
DDLE + ELG+G G V H + G +A+K I+ + +++++ +E +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLH-RPTGKIMAVKTIRLE---INEAIQKQIL----RELDI 52
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG + +G ++ E+M GSL + L++ I R IA+
Sbjct: 53 LHKCNSPYIVGFYGAFYN--NGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVL 110
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YLH K I+H D+K N+LVN R K+ D G+S +L V GT +
Sbjct: 111 KGLTYLHEKHKIIHRDVKPSNILVNSRGQ----IKLCDFGVSGQLVNSLAKTFV-GTSSY 165
Query: 976 MAPELLSGKSHMV 988
MAPE + G + V
Sbjct: 166 MAPERIQGNDYSV 178
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ +++LG+G +G V+ G W G + VA+K +K + + F +EA
Sbjct: 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---------FLEEAQ 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R + + +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQ 110
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGT 972
A GM Y+ N +H DL+ N+LV VCKI D GL+++ + + G +
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADFGLARLIEDNEYTARQGAKFP 166
Query: 973 LPWMAPE 979
+ W APE
Sbjct: 167 IKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 57/177 (32%), Positives = 89/177 (50%), Gaps = 20/177 (11%)
Query: 807 ELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+LG G +G V+ G W G+ VAIK +K + + F +EA ++ L H +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---------FLQEAQVMKKLRHEKL 63
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLHG 924
V Y +V + P + VTE+M GSL FL+ + R +L+ +A A GM Y+
Sbjct: 64 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPE 979
N VH DL+ N+LV + VCK+ D GL+++ + + G + + W APE
Sbjct: 121 MNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 59/179 (32%), Positives = 91/179 (50%), Gaps = 22/179 (12%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867
+G G +G+V G++ G VA+K IK A F +E +++ LHH N+V
Sbjct: 14 IGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQA----------FLEETAVMTKLHHKNLVR 63
Query: 868 FYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEYLHGK 925
G I+ +G L V E M G+L FL+ + R + +L+ ++D A GMEYL K
Sbjct: 64 LLGVILHNG----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK 119
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984
+VH DL N+LV+ + V K+ D GL++V + + + + W APE L K
Sbjct: 120 KLVHRDLAARNILVS----EDGVAKVSDFGLARVGSMGVDNS--KLPVKWTAPEALKHK 172
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 57/191 (29%), Positives = 98/191 (51%), Gaps = 21/191 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + ++ V++LG+G +G V+ G + S VA+K +K + + F +EA
Sbjct: 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---------VQAFLEEAN 53
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAM 913
L+ +L H +V Y +V ++ P + +TE+M GSL FL+ + +LI +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEP---IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRG 971
A GM Y+ KN +H DL+ N+LV+ + +CKI D GL++V + G +
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADFGLARVIEDNEYTAREGAKF 166
Query: 972 TLPWMAPELLS 982
+ W APE ++
Sbjct: 167 PIKWTAPEAIN 177
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 4e-19
Identities = 62/187 (33%), Positives = 93/187 (49%), Gaps = 24/187 (12%)
Query: 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G+G +G V G+ R VAIK +KA +E++R DF EA ++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-----TEKQR--RDFLSEASIMGQF 62
Query: 861 HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN++ G+V + P + VTE+M NGSL FL+K D + + + A GM
Sbjct: 63 DHPNIIHLEGVVTKSKP---VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPW 975
+YL VH DL N+LVN VCK+ D GLS+V + + G + + W
Sbjct: 120 KYLSDMGYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 976 MAPELLS 982
APE ++
Sbjct: 176 TAPEAIA 182
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 5e-19
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 808 LGSGTYGSVYHG--KWRG---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+G+G +G V+ G K G VAIK +K +E++R DF EA ++ H
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-----TEKQR--QDFLSEASIMGQFSH 65
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
N++ G+V + +TE+M NG+L ++L+ D + + + A GM+YL
Sbjct: 66 HNIIRLEGVVTKFKPAMI--ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL 123
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLPWMAP 978
N VH DL N+LVN CK+ D GLS+V + T + G + + W AP
Sbjct: 124 SDMNYVHRDLAARNILVN----SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 979 ELLS 982
E ++
Sbjct: 180 EAIA 183
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 53/217 (24%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ + ELG G +G VY G+ G + VAIK +K + +P ++ +F +E
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQ----EFRQE 58
Query: 854 ALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFL-----------QKKDR 901
A L+S L HPN+V G+ ++ P + E++ +G L +FL + D
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQP---TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115
Query: 902 TI----DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
T+ D L IA+ A GMEYL + VH DL N LV V KI D GLS
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTV-KISDFGLS 171
Query: 958 K-------VKQQTLVSGGVRGTLP--WMAPE-LLSGK 984
+ + Q+ + LP WM PE +L GK
Sbjct: 172 RDIYSADYYRVQS------KSLLPVRWMPPEAILYGK 202
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 7e-19
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 36/197 (18%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFA-GKPSE--RERLIADFWKEALLL 857
E++ +LG GTYG VY + + + VA+K+I+ G PS RE I+ LL
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE--IS-------LL 52
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRL---IIA 912
L HPN+V ++ + L V E+ + LK++L K+ + K + ++
Sbjct: 53 KELKHPNIVKLLDVIHT--ERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGV 969
G+ Y H I+H DLK +N+L+N V K+ D GL++ + +T V
Sbjct: 110 -----GLAYCHSHRILHRDLKPQNILINR----DGVLKLADFGLARAFGIPLRTYTHEVV 160
Query: 970 RGTLPWMAPELLSGKSH 986
TL + APE+L G H
Sbjct: 161 --TLWYRAPEILLGSKH 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 27/191 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +GSGTYG VY + + VAIK IK P + +E +L
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE-----PGDD---FEIIQQEISML 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HPN+V+++G L V E+ GSL+ Q + + + +
Sbjct: 55 KECRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV------KQQTLVSGGVRG 971
G+ YLH +H D+K N+L+ + K+ D G+S K+++ + G
Sbjct: 113 GLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGVSAQLTATIAKRKSFI-----G 163
Query: 972 TLPWMAPELLS 982
T WMAPE+ +
Sbjct: 164 TPYWMAPEVAA 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 59/180 (32%), Positives = 90/180 (50%), Gaps = 21/180 (11%)
Query: 804 EVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+V+ LG G +G V+ G W G+ VAIK +K + F +EA ++ L H
Sbjct: 11 DVK-LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---------FLQEAQIMKKLRH 60
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMDAAFGMEY 921
+V Y +V + P + VTEFM GSL FL++ D + +L+ +A A GM Y
Sbjct: 61 DKLVPLYAVVSEEP---IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG--GVRGTLPWMAPE 979
+ N +H DL+ N+LV VCKI D GL+++ + + G + + W APE
Sbjct: 118 IERMNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE 173
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 49/189 (25%), Positives = 89/189 (47%), Gaps = 18/189 (9%)
Query: 803 EEVRELGSGTYGS--VYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+R LG G +G +Y S V K + + + SE+ER A E ++LS L
Sbjct: 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLT----RLSEKERRDA--LNEIVILSLL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM--DAAFG 918
HPN++++Y D D +L E+ G+L + ++ + + +++
Sbjct: 57 QHPNIIAYYNHFMD--DNTLLIEMEYANGGTLYDKIVRQKGQL-FEEEMVLWYLFQIVSA 113
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMA 977
+ Y+H I+H D+K N+ + + K+GD G+SK+ + ++ V GT +M+
Sbjct: 114 VSYIHKAGILHRDIKTLNIFLTKAG----LIKLGDFGISKILGSEYSMAETVVGTPYYMS 169
Query: 978 PELLSGKSH 986
PEL G +
Sbjct: 170 PELCQGVKY 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 57/187 (30%), Positives = 97/187 (51%), Gaps = 14/187 (7%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++R +G G +G V+ K V IK+I + ++ ERL A E +L L
Sbjct: 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVE----QMTKDERLAAQ--NECQVLKLL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGM 919
HPN++ +Y + D +L V E+ G+L +++QK+ + +D L + +
Sbjct: 57 SHPNIIEYYENFLE--DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE 979
++H K I+H DLK +N+L++ + V KIGD G+SK+ + V GT +++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKH---KMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171
Query: 980 LLSGKSH 986
L GK +
Sbjct: 172 LCEGKPY 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-18
Identities = 65/194 (33%), Positives = 104/194 (53%), Gaps = 28/194 (14%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +++LG G+YGSVY K R SD A+K + G S++ER D E +L
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-RLSDNQFYALKEVDL----GSMSQKER--EDAVNEIRIL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------- 910
+S++HPN++S+ DG L V E+ G L + + K+ + ++LI
Sbjct: 54 ASVNHPNIISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKK----RKLIPEQEIWR 107
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
I + G++ LH + I+H DLK N+L+ D + KIGDLG+SKV ++ + +
Sbjct: 108 IFIQLLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI- 162
Query: 971 GTLPWMAPELLSGK 984
GT +MAPE+ G+
Sbjct: 163 GTPHYMAPEVWKGR 176
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 22/189 (11%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K+++ F + E + + E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQ---FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + +L+ E M GS+K L+ + + R I+ G+ Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE-----GVSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG----GVRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSVGNV-KLGDFGASKRLQTICLSGTGMKSVTGTPYWMS 177
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 178 PEVISGEGY 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 47/187 (25%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLI-----ADFWKEALLLSSL 860
R +G G +G V + KR FA K +++ + + E +L L
Sbjct: 6 RVIGKGAFGKVC--------IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+HP +V+ + +D + + V + ++ G L+ L +K + + + + I + +E
Sbjct: 58 NHPFLVNLWYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC-EIVLALE 114
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPE 979
YLH K I+H D+K +N+L++ ++ I D ++ KV TL + GT +MAPE
Sbjct: 115 YLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIATKVTPDTLTTSTS-GTPGYMAPE 169
Query: 980 LLSGKSH 986
+L + +
Sbjct: 170 VLCRQGY 176
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 1e-17
Identities = 63/197 (31%), Positives = 88/197 (44%), Gaps = 20/197 (10%)
Query: 803 EEVRELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
E +G GTYG VY K G + AIK+ K + + +E LL
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGD-----KEQYTGISQSACREIALLR 57
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATV---TEFMVNGSLKQFLQKKDRTIDRR--KRLIIAM 913
L H NVVS + + D S+ + E + +K Q K +I K L+ +
Sbjct: 58 ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGV 969
G+ YLH ++H DLK N+LV P+R V KIGDLGL+++ L V
Sbjct: 118 --LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 970 RGTLPWMAPELLSGKSH 986
T+ + APELL G H
Sbjct: 176 VVTIWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 2e-17
Identities = 64/189 (33%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A K+++ F + E + ++ E LL +L H +
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQ---FDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + +L E+M GS+K L+ + + R I+ GM Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE-----GMSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVR---GTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG G+R GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 178 PEVISGEGY 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 63/186 (33%), Positives = 100/186 (53%), Gaps = 15/186 (8%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
VR +G G+YG V + R G IK++ S RER A+ +EA LLS L H
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLR----NASRRERKAAE--QEAQLLSQLKH 58
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEY 921
PN+V+ Y +G DG L V F G L L ++K + + + + + A ++Y
Sbjct: 59 PNIVA-YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQY 117
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPEL 980
LH K+I+H DLK +N+ + + + K+GDLG+++V + Q ++ + GT +M+PEL
Sbjct: 118 LHEKHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 981 LSGKSH 986
S K +
Sbjct: 174 FSNKPY 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 63/189 (33%), Positives = 93/189 (49%), Gaps = 22/189 (11%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G VY + G ++A+K++ F E + + E LL +L H +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
V +YG +RD + L+ E+M GS+K L+ + R R I+ G+ Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ-----GVSY 121
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG----GVRGTLPWMA 977
LH IVH D+K N+L RD V K+GD G SK Q +SG V GT WM+
Sbjct: 122 LHSNMIVHRDIKGANIL---RDSAGNV-KLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 978 PELLSGKSH 986
PE++SG+ +
Sbjct: 178 PEVISGEGY 186
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 30/190 (15%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R +G G +G VYHG SD A+K + + ++ E + F KE +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN------RITDLEE-VEQFLKEGIIMKDF 53
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPNV+S GI +GS V +M +G L+ F++ + + + + A GME
Sbjct: 54 SHPNVLSLLGICLP-SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS---------KVKQQTLVSGGVRG 971
YL K VH DL N +++ + K+ D GL+ V T G +
Sbjct: 113 YLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDIYDKEYYSVHNHT----GAKL 164
Query: 972 TLPWMAPELL 981
+ WMA E L
Sbjct: 165 PVKWMALESL 174
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 52/161 (32%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +++LG GT+GSVY + + G VAIK++K F E L +E L L
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK-FY-SWEECMNL-----REVKSLRKL 54
Query: 861 -HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRK-RLIIAMDAAF 917
HPN+V + R+ + L V E+M G+L Q ++ + + R II
Sbjct: 55 NEHPNIVKLKEVFRE--NDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ- 110
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
G+ ++H H DLK ENLLV+ + V KI D GL++
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPE----VVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 53/187 (28%), Positives = 86/187 (45%), Gaps = 25/187 (13%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
LG G++G V + + + A+K + K + + + E +LS ++HP
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKII------KRKEVEHTLTERNILSRINHPF 54
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V + + + L V E+ G L L K+ R + R R A + +EYLH
Sbjct: 55 IVKLHYAFQT--EEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLHS 111
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPE 979
I++ DLK EN+L++ K+ D GL+K L S G R GT ++APE
Sbjct: 112 LGIIYRDLKPENILLD----ADGHIKLTDFGLAKE----LSSEGSRTNTFCGTPEYLAPE 163
Query: 980 LLSGKSH 986
+L GK +
Sbjct: 164 VLLGKGY 170
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 58/178 (32%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 808 LGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G +G V+ G + + VA+K +C P E L F EA +L HPN+V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVK----TCKEDLPQE---LKIKFLSEARILKQYDHPNIV 55
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN 926
G+ + V E + G FL+KK + ++ + A+DAA GM YL KN
Sbjct: 56 KLIGVCTQ--RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--WMAPELLS 982
+H DL N LV + V KI D G+S+ + + S +P W APE L+
Sbjct: 114 CIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALN 167
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 58/190 (30%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 802 LEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
L+++R LG G +G V + G VA+K +K C KE
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWK----KEIN 58
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+L +L+H N+V + G + L + E++ GSL+ +L K ++ + L+ A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQI 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTL 973
GM YLH ++ +H DL N+L+ D R V KIGD GL+K + VR G
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLL---DNDRLV-KIGDFGLAKAVPEGHEYYRVREDGDS 172
Query: 974 P--WMAPELL 981
P W A E L
Sbjct: 173 PVFWYAVECL 182
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 53/211 (25%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERER-LIADFWKEALLLSSLHHPN 864
+GSG++GSVY G G +A+K+++ + +R+R ++ +E LL L H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 865 VVSFYGIVRDG----------PDGSLATV-------TEFMVNGSLKQFLQKKDRTIDRRK 907
+V + G D P GS+A + E +V ++Q L+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILK---------- 117
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
G+ YLH + I+H D+K N+LV+ + KI D G+SK + +S
Sbjct: 118 ----------GLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGISKKLEANSLST 163
Query: 968 GVRGTLP-------WMAPELLSGKSHMVTEK 991
G P WMAPE++ K T K
Sbjct: 164 KTNGARPSLQGSVFWMAPEVV--KQTSYTRK 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 53/190 (27%), Positives = 94/190 (49%), Gaps = 20/190 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ ++LG+G +G V+ + + + VA+K +K + + F EA
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---------VEAFLAEAN 53
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ +L H +V + +V P + +TEFM GSL FL+ + + +LI +
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 110
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM ++ +N +H DL+ N+LV+ VCKI D GL++V + G +
Sbjct: 111 IAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 973 LPWMAPELLS 982
+ W APE ++
Sbjct: 167 IKWTAPEAIN 176
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 55/181 (30%), Positives = 90/181 (49%), Gaps = 18/181 (9%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G +G V+ G+ R + VA+K SC P + L A F +EA +L HPN
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK----SCRETLPPD---LKAKFLQEARILKQYSHPN 54
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V G+ + V E + G FL+ + + ++ + + +AA GMEYL
Sbjct: 55 IVRLIGVCTQ--KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGT-LPWMAPELL 981
K+ +H DL N LV ++ V KI D G+S+ ++ + +GG++ + W APE L
Sbjct: 113 KHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL 168
Query: 982 S 982
+
Sbjct: 169 N 169
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 71/207 (34%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVY----HGKWRGSD---VAIKRIKASCFAGKPSERERLIAD 849
IK D+ ELG G +G V+ H D VA+K +K + SE R D
Sbjct: 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESARQ--D 53
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-----------QK 898
F +EA LL+ L H ++V FYG+ +G L V E+M +G L +FL
Sbjct: 54 FQREAELLTVLQHQHIVRFYGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 899 KDRTIDR---RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
+D + + L IA A GM YL + VH DL N LV Q V KIGD G
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----QGLVVKIGDFG 167
Query: 956 LSK-VKQQTLVSGGVRGTLP--WMAPE 979
+S+ + G R LP WM PE
Sbjct: 168 MSRDIYSTDYYRVGGRTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 57/190 (30%), Positives = 84/190 (44%), Gaps = 28/190 (14%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADF-WKEALLLSS 859
+++ ++G GTYG VY + + G VAIK+IK I +E LL
Sbjct: 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIK-------LRFESEGIPKTALREIKLLKE 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L+HPN++ + R G L V EFM + L + ++ + R + G+
Sbjct: 55 LNHPNIIKLLDVFRHK--GDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGL 111
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GTL 973
+ H I+H DLK ENLL+N V K+ D GL++ VR T
Sbjct: 112 AFCHSHGILHRDLKPENLLINTEG----VLKLADFGLARS-----FGSPVRPYTHYVVTR 162
Query: 974 PWMAPELLSG 983
+ APELL G
Sbjct: 163 WYRAPELLLG 172
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 62/197 (31%), Positives = 86/197 (43%), Gaps = 30/197 (15%)
Query: 808 LGSGTYGSVYHGKWRGSD--------VAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
LGSG +G VY G VA+K ++ + E F KEA L+S+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-------FLKEAHLMSN 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT------IDRRKRLIIAM 913
+HPN+V G+ + + E M G L +L+ + ++ L I +
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLSK--VKQQTLVSGGVR 970
D A G YL + +H DL N LV+ + V KIGD GL++ K G
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-E 172
Query: 971 GTLP--WMAPE-LLSGK 984
G LP WMAPE LL GK
Sbjct: 173 GLLPVRWMAPESLLDGK 189
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 54/184 (29%), Positives = 84/184 (45%), Gaps = 25/184 (13%)
Query: 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--- 862
+G G YG+VY GK G VA+K I P + ++D +E LLS L
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDD---VSDIQREVALLSQLRQSQP 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PN+ +YG GP L + E+ GS++ + K I + +I + ++Y+
Sbjct: 62 PNITKYYGSYLKGP--RLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVALKYI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIG---DLGLSKVKQQTLVSGGVRGTLPWMAPE 979
H ++H D+K N+LV +C G L + K+ T V GT WMAPE
Sbjct: 118 HKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKRSTFV-----GTPYWMAPE 171
Query: 980 LLSG 983
+++
Sbjct: 172 VITE 175
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 59/192 (30%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG---SD----VAIKRIKASCFAGKPSERERLIADFWK 852
++L + LG+G +G V G SD VA+K +K + + SERE L++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS---SEREALMS---- 87
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLI 910
E ++S L +H N+V+ G G G + +TE+ G L FL++K + + L
Sbjct: 88 ELKIMSHLGNHENIVNLLGACTIG--GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS 145
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQT--LVSG 967
+ A GM +L KN +H DL N+L+ + KI D GL++ + + +V G
Sbjct: 146 FSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGKIVKICDFGLARDIMNDSNYVVKG 201
Query: 968 GVRGTLPWMAPE 979
R + WMAPE
Sbjct: 202 NARLPVKWMAPE 213
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 9e-16
Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 28/195 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + +G G++G VY + ++ VAIK I E E I D +E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-------EAEDEIEDIQQEIQFL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S P + +YG G L + E+ GS L K +D I +
Sbjct: 54 SQCRSPYITKYYGSFLKG--SKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLL 109
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVRG 971
G+EYLH + +H D+K N+L++ + V K+ D G+S K+ T V G
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLS---EEGDV-KLADFGVSGQLTSTMSKRNTFV-----G 160
Query: 972 TLPWMAPELLSGKSH 986
T WMAPE++ +
Sbjct: 161 TPFWMAPEVIKQSGY 175
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-16
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 801 DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E + ++G G++G V+ K A+K+I S + ERE I EA +L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR--EREEAI----DEARVLA 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDA 915
L ++ +Y D G L V E+ NG L + L+ + D+ R I
Sbjct: 55 KLDSSYIIRYYESFLD--KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QI 110
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLP 974
G+ +LH K I+H D+K NL ++ D KIGDLG++K+ T + + GT
Sbjct: 111 LLGLAHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLSDNTNFANTIVGTPY 166
Query: 975 WMAPELLSGK 984
+++PEL K
Sbjct: 167 YLSPELCEDK 176
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 55/185 (29%), Positives = 90/185 (48%), Gaps = 14/185 (7%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIK-ASCFAGKPSERERLIADFWK-EALLLSSLHHP 863
+G GTYG VY G +A+K+++ + AG+ R++ + + E L L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
N+V + G + L+ E++ GS+ L+ R ++ R G+ YLH
Sbjct: 69 NIVQYLGFET-TEE-YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF-TEQVLEGLAYLH 125
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG---VRGTLPWMAPEL 980
K I+H DLK +NLLV+ +CKI D G+SK + ++G++ WMAPE+
Sbjct: 126 SKGILHRDLKADNLLVD----ADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 981 LSGKS 985
+ S
Sbjct: 182 IHSYS 186
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 48/184 (26%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY G VA+K+++ R+ + KE LL L HP
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCL----KEIDLLKQLDHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDRTIDRRKRLIIAMDAAFGME 920
NV+ + + + L V E G L + + +K+ R I R + +E
Sbjct: 63 NVIKYLASFIE--NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-KQQTLVSGGVRGTLPWMAPE 979
++H K I+H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 980 LLSG 983
+
Sbjct: 177 RIHE 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 65/200 (32%), Positives = 91/200 (45%), Gaps = 32/200 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKAS-CFAGKPSERERLIADFWKEALL--L 857
EE+ E+G G YG+VY + G VA+K+++ G P R IA LL L
Sbjct: 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA------LLKQL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDG----SLATVTEFMVNGSLKQFLQK------KDRTIDRRK 907
S HPN+V + GP L V E V+ L +L K TI
Sbjct: 56 ESFEHPNIVRLLDVC-HGPRTDRELKLTLVFEH-VDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
R ++ G+++LH IVH DLK +N+LV D Q KI D GL+++ +
Sbjct: 114 RQLLR-----GVDFLHSHRIVHRDLKPQNILVT-SDGQ---VKIADFGLARIYSFEMALT 164
Query: 968 GVRGTLPWMAPELLSGKSHM 987
V TL + APE+L S+
Sbjct: 165 SVVVTLWYRAPEVLLQSSYA 184
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 28/194 (14%)
Query: 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
L+E+ LG G +G V+ K +G + A + ++ E L ++F +E + L
Sbjct: 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS 66
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK--------RLIIAM 913
H NVV G+ R+ + + E+ G LKQFL+ ++ K ++ +
Sbjct: 67 HKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK--------QQTLV 965
A GM++L VH DL N LV+ QR V K+ L LSK + L+
Sbjct: 125 QIALGMDHLSNARFVHRDLAARNCLVS---SQREV-KVSLLSLSKDVYNSEYYKLRNALI 180
Query: 966 SGGVRGTLPWMAPE 979
L W+APE
Sbjct: 181 P------LRWLAPE 188
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 56/198 (28%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG G +GSV G+ D VA+K +K I +F EA +
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT------YSEIEEFLSEAACMKDF 58
Query: 861 HHPNVVSFYGIVRDGPD-GSLAT---VTEFMVNGSLKQFL-----QKKDRTIDRRKRLII 911
HPNV+ G+ + + + FM +G L FL + + L
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG---- 967
+D A GMEYL +N +H DL N M VC + D GLSK + SG
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNC---MLREDMTVC-VADFGLSK----KIYSGDYYR 170
Query: 968 -GVRGTLP--WMAPELLS 982
G +P W+A E L+
Sbjct: 171 QGRIAKMPVKWIAIESLA 188
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 56/220 (25%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLI-------ADF 850
DD + + +G G++ +V K + ++ AIK + ++ +LI
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL----------DKRQLIKEKKVKYVKI 50
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
KE L + HP ++ Y +D + +L V E+ NG L Q+++K ++ R
Sbjct: 51 EKEVLTRLN-GHPGIIKLYYTFQD--EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY 107
Query: 911 IA--MDAAFGMEYLHGKNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVKQQTLVS 966
A + A +EYLH K I+H DLK EN+L+ +M KI D G +KV
Sbjct: 108 AAEILLA---LEYLHSKGIIHRDLKPENILLDKDMH------IKITDFGTAKVLDPNSSP 158
Query: 967 GGVR---------------------GTLPWMAPELLSGKS 985
+ GT +++PELL+ K
Sbjct: 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 49/190 (25%), Positives = 77/190 (40%), Gaps = 32/190 (16%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSE---RERLIADFWKEALLLSSLH 861
LG G +G V K + + A+K + K E E+ I L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI---------LEECN 51
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HP +V Y +D + + E+ + G L L+ + + R IA EY
Sbjct: 52 HPFIVKLYRTFKD--KKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEY 108
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPWM 976
LH + I++ DLK ENLL++ K+ D G +K K T GT ++
Sbjct: 109 LHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYV 159
Query: 977 APELLSGKSH 986
APE++ K +
Sbjct: 160 APEIILNKGY 169
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 63/197 (31%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
DD E ++ LG+G++G V + +GS A+K + KA K E E+ I
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI------ 54
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIA 912
L S+ HP +V+ YG +D D +L V E++ G L L+K R + A
Sbjct: 55 ---LQSIRHPFLVNLYGSFQD--DSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR--FYA 107
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGV 969
+EYLH +IV+ DLK ENLL+ D + KI D G +K + TL
Sbjct: 108 AQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYI-KITDFGFAKRVKGRTYTLC---- 159
Query: 970 RGTLPWMAPELLSGKSH 986
GT ++APE++ K +
Sbjct: 160 -GTPEYLAPEIILSKGY 175
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 62/184 (33%), Positives = 83/184 (45%), Gaps = 28/184 (15%)
Query: 807 ELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIAD-FWKEALLLSSLH 861
ELGSG +G V G ++ DVAIK +K +E E+ + D +EA ++ L
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLK--------NENEKSVRDEMMREAEIMHQLD 53
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+P +V G+ +L V E G L +FL K I + + + GM+Y
Sbjct: 54 NPYIVRMIGVCEAE---ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY 110
Query: 922 LHGKNIVHFDLKCEN-LLVNMRDPQRPVCKIGDLGLSKV-----KQQTLVSGGVRGTLPW 975
L GKN VH DL N LLVN + KI D GLSK S G + L W
Sbjct: 111 LEGKNFVHRDLAARNVLLVN-----QHYAKISDFGLSKALGADDSYYKARSAG-KWPLKW 164
Query: 976 MAPE 979
APE
Sbjct: 165 YAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 35/200 (17%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIK-ASCFAGKPSERERLIADFWKEALLLSS 859
++V ++G GTYG VY + + G VA+K+I+ + G PS R I+ LL
Sbjct: 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-------LLKE 54
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRR--KRLIIAMDAA 916
L+HPN+V +V + L V EF ++ LK+++ T +D K + +
Sbjct: 55 LNHPNIVRLLDVVHS--ENKLYLVFEF-LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ- 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQT--LVSGGV 969
G+ Y H ++H DLK +NLL++ + K+ D GL++ V+ T +V
Sbjct: 111 -GIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLARAFGVPVRTYTHEVV---- 161
Query: 970 RGTLPWMAPELLSGKSHMVT 989
TL + APE+L G T
Sbjct: 162 --TLWYRAPEILLGSRQYST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 5e-15
Identities = 66/214 (30%), Positives = 92/214 (42%), Gaps = 51/214 (23%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIA-------- 848
IK D+ RELG G +G V+ A C+ P++ + L+A
Sbjct: 2 IKRRDIVLKRELGEGAFGKVF--------------LAECYNLSPTKDKMLVAVKALKDPT 47
Query: 849 -----DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
DF +EA LL++L H ++V FYG+ DG L V E+M +G L +FL+
Sbjct: 48 LAARKDFQREAELLTNLQHEHIVKFYGVCGDG--DPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 898 ---------KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+ + + L IA A GM YL ++ VH DL N LV +
Sbjct: 106 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLL 161
Query: 949 CKIGDLGLSK-VKQQTLVSGGVRGTLP--WMAPE 979
KIGD G+S+ V G LP WM PE
Sbjct: 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 55/190 (28%), Positives = 86/190 (45%), Gaps = 23/190 (12%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+ G YG V+ K + G AIK IK + K + L E +LS P V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-----TERDILSQAQSPYV 55
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V Y + +L V E++ G L L+ + R+ IA + +EYLH
Sbjct: 56 VKLYYSFQG--KKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLHSN 112
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGG------VRGTLPWM 976
I+H DLK +N+L++ K+ D GLSK V++Q ++ + GT ++
Sbjct: 113 GIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 977 APELLSGKSH 986
APE++ G+ H
Sbjct: 169 APEVILGQGH 178
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 51/194 (26%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFW-KEALLLSS 859
+ + +G G +G V+ K R + VA+K++ A + E I + +E L +
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKV-----ALR--RLEGGIPNQALREIKALQA 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-RLIIAMDAAFG 918
HP VV + G V E+M L + L+ ++R + + + + M G
Sbjct: 56 CQHPYVVKLLDVFPHG--SGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-G 111
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GT 972
+ Y+H I+H DLK NLL++ V KI D GL+++ R T
Sbjct: 112 VAYMHANGIMHRDLKPANLLISADG----VLKIADFGLARL----FSEEEPRLYSHQVAT 163
Query: 973 LPWMAPELLSGKSH 986
+ APELL G
Sbjct: 164 RWYRAPELLYGARK 177
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 60/187 (32%), Positives = 93/187 (49%), Gaps = 21/187 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DDLE + ELG G YG V + + +A+KRI+A+ E++RL+ D + +
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATV---NSQEQKRLLMDL---DISM 54
Query: 858 SSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAM 913
S+ P V+FYG + R +G + E M + SL +F +K K TI IA+
Sbjct: 55 RSVDCPYTVTFYGALFR---EGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV 110
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+EYLH K +++H D+K N+L+N K+ D G+S ++ G
Sbjct: 111 SIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ----VKLCDFGISGYLVDSVAKTIDAGC 166
Query: 973 LPWMAPE 979
P+MAPE
Sbjct: 167 KPYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 66/220 (30%), Positives = 88/220 (40%), Gaps = 55/220 (25%)
Query: 802 LEEVRELGSGTYGSVY----------------HGKWRGSD--VAIKRIKASCFAGKPSER 843
L V +LG G +G V+ + VA+K ++ P
Sbjct: 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLR-------PDAS 59
Query: 844 ERLIADFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKD-- 900
+ DF KE +LS L PN+ G+ D P L + E+M NG L QFLQK
Sbjct: 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP---LCMIMEYMENGDLNQFLQKHVAE 116
Query: 901 --------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
+++ L +A A GM YL N VH DL N LV + KI
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG----KNYTIKIA 172
Query: 953 DLGLSKVKQQTLVSGG---VRGTLP----WMAPE-LLSGK 984
D G+S+ L S V+G P WMA E +L GK
Sbjct: 173 DFGMSR----NLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 27/191 (14%)
Query: 799 NDDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
ND E + ELG G +G VY K G A K I+ E E + DF E +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ--------IESEEELEDFMVEIDI 55
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS HPN+V Y + L + EF G+L + + +R + + +
Sbjct: 56 LSECKHPNIVGLYEAYFY--ENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+ +LH ++H DLK N+L+ + K+ D G+S K+ T +
Sbjct: 114 EALNFLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFI----- 164
Query: 971 GTLPWMAPELL 981
GT WMAPE++
Sbjct: 165 GTPYWMAPEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 63/198 (31%), Positives = 89/198 (44%), Gaps = 35/198 (17%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R LG G +GSV + + D VA+K +KA F+ I +F +EA +
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD------IEEFLREAACMKEF 58
Query: 861 HHPNVVSFYGI-VRDGPDGSLA---TVTEFMVNGSLKQFL-----QKKDRTIDRRKRLII 911
HPNV+ G+ +R G L + FM +G L FL ++ T+ + +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG---- 967
+D A GMEYL KN +H DL N M + VC + D GLSK + SG
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNC---MLNENMTVC-VADFGLSK----KIYSGDYYR 170
Query: 968 -GVRGTLP--WMAPELLS 982
G LP W+A E L+
Sbjct: 171 QGCASKLPVKWLALESLA 188
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 25/199 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + E+ LG G GSV + + G A+K I P +++++ +E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQIL----RELEIN 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL----KQFLQKKDRTIDRRKRLIIAM 913
S P +V +YG D S+ E+ GSL K+ ++ R I + IA
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAE 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI---GDLGLSKVKQQTLVSGGVR 970
G+ YLH + I+H D+K N+L+ R Q +C G+L S ++G
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVNS-------LAGTFT 164
Query: 971 GTLPWMAPELLSGKSHMVT 989
GT +MAPE + GK + +T
Sbjct: 165 GTSFYMAPERIQGKPYSIT 183
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 60/184 (32%), Positives = 83/184 (45%), Gaps = 28/184 (15%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GTYG VY + + V AIK I P R + +E L S L H N+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI--------PERDSRYVQPLHEEIALHSYLKHRNI 67
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRKRLIIAMDAAFG 918
V + G + G E + GSL L+ K ++TI + I+ G
Sbjct: 68 VQYLGSDSEN--GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-----G 120
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMA 977
++YLH IVH D+K +N+LVN V KI D G SK + + GTL +MA
Sbjct: 121 LKYLHDNQIVHRDIKGDNVLVNTYS---GVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 978 PELL 981
PE++
Sbjct: 178 PEVI 181
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 23/190 (12%)
Query: 808 LGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG+G + S Y + G+ +A+K++ SE+E ++ KE L++ L+HP++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYV--RNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEY 921
+ G + D E+M GS+ L K K+ I ++ G+ Y
Sbjct: 66 IRMLGATCE--DSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR-----GLSY 118
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQTLVSGGVRGTLPWM 976
LH I+H D+K NLL+ D +I D G +K G + GT+ +M
Sbjct: 119 LHENQIIHRDVKGANLLI---DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 977 APELLSGKSH 986
APE+L G+ +
Sbjct: 176 APEVLRGEQY 185
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 41/213 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ D L + LG G +G V + G D VA+K +K +E++ ++D
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-----TEKD--LSD 61
Query: 850 FWKEALLLSSL-HHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQ---------K 898
E ++ + H N+++ G+ ++GP L V E+ +G+L+ FL+
Sbjct: 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGP---LYVVVEYAAHGNLRDFLRARRPPGEYAS 118
Query: 899 KDRTIDRRKRLI------IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
D + L A A GME+L K +H DL N+LV V KI
Sbjct: 119 PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH----VMKIA 174
Query: 953 DLGLSK-VKQQTLVSGGVRGTLP--WMAPELLS 982
D GL++ + G LP WMAPE L
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALF 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 55/156 (35%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKD------- 900
DF KE ++S L +PN++ G+ V D P L +TE+M NG L QFL +++
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGDLNQFLSQREIESTFTH 119
Query: 901 ----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
++ L +A+ A GM+YL N VH DL N LV KI D G+
Sbjct: 120 ANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG----NHYTIKIADFGM 175
Query: 957 SKVKQQTLVSGGV-----RGTLP--WMAPE-LLSGK 984
S+ L SG R LP WMA E +L GK
Sbjct: 176 SR----NLYSGDYYRIQGRAVLPIRWMAWESILLGK 207
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 54/191 (28%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L+ +K +L+ V+ LGSG +G+VY G W +K I + + + +F E
Sbjct: 1 LRILKETELKRVKVLGSGAFGTVYKGIWVPEGETVK-IPVAIKILNETTGPKANVEFMDE 59
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
AL+++S+ HP++V G+ ++ VT+ M +G L ++ + I + L +
Sbjct: 60 ALIMASMDHPHLVRLLGVCLSP---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV 116
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVR 970
A GM YL + +VH DL N+LV + P KI D GL+++ ++ + G +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLEGDEKEYNADGGK 172
Query: 971 GTLPWMAPELL 981
+ WMA E +
Sbjct: 173 MPIKWMALECI 183
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 8e-14
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---VAIKRIKASCFAGKPSERERLIADFWKE 853
+K +D +R LG+G++G V ++ D VAIKR + S +++ + + E
Sbjct: 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSE 81
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L+ ++HP V+ YG +D + L V EF++ G FL++ R A
Sbjct: 82 RKILNYINHPFCVNLYGSFKD--ESYLYLVLEFVIGGEFFTFLRRNKR-FPNDVGCFYAA 138
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
EYL NIV+ DLK ENLL++ + K+ D G +KV + + GT
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMTDFGFAKVVDTRTYT--LCGTP 192
Query: 974 PWMAPELLSGKSH 986
++APE+L H
Sbjct: 193 EYIAPEILLNVGH 205
|
Length = 340 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 9e-14
Identities = 56/192 (29%), Positives = 95/192 (49%), Gaps = 17/192 (8%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIK-RIKASCFAGKPSERERLIADF 850
L+ +K + ++++ LGSG +G+VY G W G V I IK A P + ++
Sbjct: 1 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL--- 57
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
EA +++S+ +P+V GI ++ +T+ M G L ++++ I + L
Sbjct: 58 -DEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLN 113
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL + +VH DL N+LV + PQ KI D GL+K+ ++ +
Sbjct: 114 WCVQIAKGMNYLEERRLVHRDLAARNVLV--KTPQH--VKITDFGLAKLLGADEKEYHAE 169
Query: 968 GVRGTLPWMAPE 979
G + + WMA E
Sbjct: 170 GGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 9e-14
Identities = 62/194 (31%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIA-DFWKEALLLSS 859
E+ ++LG GTY VY + + + VAIK+IK G+ E + I +E LL
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKL----GERKEAKDGINFTALREIKLLQE 58
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI--IAMDAAF 917
L HPN++ + G ++ V EFM L++ + KD++I I +
Sbjct: 59 LKHPNIIGLLDVF--GHKSNINLVFEFM-ETDLEKVI--KDKSIVLTPADIKSYMLMTLR 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT----L 973
G+EYLH I+H DLK NLL+ V K+ D GL++ + S + T
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR----SFGSPNRKMTHQVVT 165
Query: 974 PWM-APELLSGKSH 986
W APELL G H
Sbjct: 166 RWYRAPELLFGARH 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 46/196 (23%)
Query: 808 LGSGTYGSVYHGKWRGSDV------AIKRIKASCFAGKPSERE--RLIADFWKEALLLSS 859
+G GT+G VY ++ A+K I+ + ++ + + IAD E +L
Sbjct: 8 IGGGTFGKVY----TAVNLDTGELMAVKEIRI-----QDNDPKTIKEIAD---EMKVLEL 55
Query: 860 LHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRR--KRLIIA 912
L HPN+V +YG+ R+ + E+ G+L++ L+ D + R +L+
Sbjct: 56 LKHPNLVKYYGVEVHRE----KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE- 110
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSG---- 967
G+ YLH IVH D+K N+ ++ V K+GD G + +K T G
Sbjct: 111 -----GLAYLHSHGIVHRDIKPANIFLDHNG----VIKLGDFGCAVKLKNNTTTMGEEVQ 161
Query: 968 GVRGTLPWMAPELLSG 983
+ GT +MAPE+++G
Sbjct: 162 SLAGTPAYMAPEVITG 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 48/211 (22%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIA-------- 848
IK ++ RELG G +G V+ A C+ P + + L+A
Sbjct: 2 IKRHNIVLKRELGEGAFGKVF--------------LAECYNLCPEQDKILVAVKTLKDAS 47
Query: 849 -----DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
DF +EA LL++L H ++V FYG+ +G L V E+M +G L +FL+
Sbjct: 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEG--DPLIMVFEYMKHGDLNKFLRAHGPDA 105
Query: 898 ------KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + L IA A GM YL ++ VH DL N LV + + KI
Sbjct: 106 VLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG----ENLLVKI 161
Query: 952 GDLGLSKVKQQT---LVSGGVRGTLPWMAPE 979
GD G+S+ T V G + WM PE
Sbjct: 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 44/211 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
+++E VR++G G +G V+ + G + VA+K +K A + ADF +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-------DMQADFQR 57
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---------- 902
EA L++ HPN+V G+ G + + E+M G L +FL+ +
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 903 -----------IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ ++L IA A GM YL + VH DL N LV + V KI
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVVKI 171
Query: 952 GDLGLS-KVKQQTLVSGGVRGTLP--WMAPE 979
D GLS + +P WM PE
Sbjct: 172 ADFGLSRNIYSADYYKASENDAIPIRWMPPE 202
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +LG GTY +V+ G+ + ++ VA+K I+ G P R E LL L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLK 62
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
H N+V+ + IV D SL V E++ + LKQ++ + I G+ Y
Sbjct: 63 HANIVTLHDIVHT--DKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPEL 980
H + ++H DLK +NLL+N +R K+ D GL++ K T TL + P++
Sbjct: 120 CHRRKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 981 LSGKSHMVTEKEL 993
L G S T+ ++
Sbjct: 176 LLGSSEYSTQIDM 188
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/195 (30%), Positives = 91/195 (46%), Gaps = 32/195 (16%)
Query: 806 RELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
RELG G++G VY G +G + VAIK + + S RER+ +F EA ++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-----SMRERI--EFLNEASVMK 64
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---------RKRL 909
+ +VV G+V G + E M G LK +L+ ++ +K +
Sbjct: 65 EFNCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGG 968
+A + A GM YL+ VH DL N +V + KIGD G+++ + + G
Sbjct: 123 QMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 969 VRGTLP--WMAPELL 981
+G LP WM+PE L
Sbjct: 179 GKGLLPVRWMSPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 32/204 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIAD 849
+ + + +RELG G++G VY G R + VA+K + S S RER+ +
Sbjct: 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----SLRERI--E 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--------KKDR 901
F EA ++ +VV G+V G V E M +G LK +L+ R
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGR 113
Query: 902 TIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+ +I +A + A GM YL+ K VH DL N +V KIGD G+++ +
Sbjct: 114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDI 169
Query: 960 KQQTLVSGGVRGTLP--WMAPELL 981
+ G +G LP WMAPE L
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESL 193
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 57/190 (30%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG GTY +VY G+ + +D VA+K I+ G P R E LL L H N
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLLKDLKHAN 65
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + I+ + SL V E++ + LKQ+L +I+ + G+ Y H
Sbjct: 66 IVTLHDIIHT--EKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSG 983
+ ++H DLK +NLL+N +R K+ D GL++ K T TL + P++L G
Sbjct: 123 RKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 984 KSHMVTEKEL 993
+ T+ ++
Sbjct: 179 STDYSTQIDM 188
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 58/190 (30%), Positives = 88/190 (46%), Gaps = 28/190 (14%)
Query: 811 GTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868
GTYG VY + + + VA+K++K E+E +E +L L HPN+V+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKME------KEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKN 926
+V + V E++ + LK ++ + K L++ + + G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLS--GVAHLHDNW 126
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGVRGTLPWMAPEL 980
I+H DLK NLL+N R + KI D GL S +K T LV TL + APEL
Sbjct: 127 ILHRDLKTSNLLLN----NRGILKICDFGLAREYGSPLKPYTQLVV-----TLWYRAPEL 177
Query: 981 LSGKSHMVTE 990
L G T
Sbjct: 178 LLGAKEYSTA 187
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 29/200 (14%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-KPSERERLIADFWKEALLLSS 859
D E + +G G++G+V + R SD I K + E+++L++ E +L
Sbjct: 1 DYEVLETIGKGSFGTVRKVR-RKSDGKILVWKEIDYGNMTEKEKQQLVS----EVNILRE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAA 916
L HPN+V +Y + D + +L V E+ G L Q +QK + I+ I
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 917 FGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLV 965
+ H G ++H DLK N+ ++ K+GD GL+K+ +T V
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 966 SGGVRGTLPWMAPELLSGKS 985
GT +M+PE L+ S
Sbjct: 172 -----GTPYYMSPEQLNHMS 186
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 56/194 (28%), Positives = 94/194 (48%), Gaps = 30/194 (15%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D ++ ++G GTYG VY G+ + G VA+K+I+ SE E + + +E LL
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE------SEEEGVPSTAIREISLLK 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAA 916
L HPN+V ++ + L + EF+ + LK++L K + +D
Sbjct: 55 ELQHPNIVCLQDVLMQ--ESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQIL 111
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------KVKQQTLVSGGV 969
G+ + H + ++H DLK +NLL++ + V K+ D GL+ +V +V
Sbjct: 112 QGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGLARAFGIPVRVYTHEVV---- 163
Query: 970 RGTLPWMAPELLSG 983
TL + APE+L G
Sbjct: 164 --TLWYRAPEVLLG 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 9e-13
Identities = 63/197 (31%), Positives = 87/197 (44%), Gaps = 37/197 (18%)
Query: 808 LGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+G G +G V + + D AIKR+K +A K R DF E +L L HH
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHR-----DFAGELEVLCKLGHH 67
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRK 907
PN+++ G G L E+ +G+L FL+K T+ ++
Sbjct: 68 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
L A D A GM+YL K +H DL N+LV + V KI D GLS + Q +
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLS--RGQEVYVK 179
Query: 968 GVRGTLP--WMAPELLS 982
G LP WMA E L+
Sbjct: 180 KTMGRLPVRWMAIESLN 196
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 56/195 (28%), Positives = 95/195 (48%), Gaps = 18/195 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++N+DLE + +LG+G GSV K + + + K K S R++++ +E +
Sbjct: 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAK-KVVHIGAKSSVRKQIL----RELQI 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDA 915
+ P +VSFYG + + + EFM GSL + +K ++ ++ +A+
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMC--MEFMDCGSLDRIYKKGGPIPVEILGKIAVAV-- 112
Query: 916 AFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLG-LSKVKQQTLVSGGVRGTL 973
G+ YL+ + I+H D+K N+LVN R Q +C G G L T V GT
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIADTFV-----GTS 166
Query: 974 PWMAPELLSGKSHMV 988
+M+PE + G + V
Sbjct: 167 TYMSPERIQGGKYTV 181
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 61/199 (30%), Positives = 87/199 (43%), Gaps = 32/199 (16%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
E V +G GTYG VY + + G VAIK + E E + E +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI-----IEDEEEEIKE----EYNI 55
Query: 857 LSSL-HHPNVVSFYGI----VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR--L 909
L +HPN+ +FYG G D L V E GS+ L K R +R +
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEW 114
Query: 910 I--IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
I I + G+ YLH ++H D+K +N+L+ + K+ D G+S TL
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAEVKLVDFGVSAQLDSTL--- 167
Query: 968 GVR----GTLPWMAPELLS 982
G R GT WMAPE+++
Sbjct: 168 GRRNTFIGTPYWMAPEVIA 186
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GTYG+V+ K R VA+KR++ + E + + +E LL L
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD------DDDEGVPSSALREICLLKEL 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H N+V Y ++ D L V E+ + LK++ + ID G+
Sbjct: 57 KHKNIVRLYDVLHS--DKKLTLVFEY-CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA 113
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+ H N++H DLK +NLL+N + K+ D GL++
Sbjct: 114 FCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 52/161 (32%), Positives = 70/161 (43%), Gaps = 30/161 (18%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFL----------Q 897
DF KE ++S L PN++ + + P L +TE+M NG L QFL +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDP---LCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
TI + +A A GM+YL N VH DL N LV KI D G+S
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY----TIKIADFGMS 177
Query: 958 KVKQQTLVSGGV-----RGTLP--WMAPE-LLSGKSHMVTE 990
+ L SG R LP WM+ E +L GK ++
Sbjct: 178 R----NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASD 214
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 62/193 (32%), Positives = 98/193 (50%), Gaps = 14/193 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+K+DD E++ ELG+G G V+ + S + + R K KP+ R ++I +E +
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG DG ++ E M GSL Q L+K R I + +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVI 113
Query: 917 FGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 976 MAPELLSGKSHMV 988
M+PE L G + V
Sbjct: 169 MSPERLQGTHYSV 181
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 57/191 (29%), Positives = 91/191 (47%), Gaps = 31/191 (16%)
Query: 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +LG GTY +VY G+ R G VA+K I G PS R I+ L+ L
Sbjct: 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-------LMKELK 56
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF---- 917
H N+V + ++ + L V E+M + LK+++ T R L +F
Sbjct: 57 HENIVRLHDVIH--TENKLMLVFEYM-DKDLKKYMD----THGVRGALDPNTVKSFTYQL 109
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
G+ + H ++H DLK +NLL+N +R K+ D GL++ + T + V T
Sbjct: 110 LKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGLARAFGIPVNTFSNEVV--T 163
Query: 973 LPWMAPELLSG 983
L + AP++L G
Sbjct: 164 LWYRAPDVLLG 174
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 33/207 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E++ ++G GTYG VY + + G VA+K+ + + E + +E LL
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 858 SSLHH-PNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L +V + SL V E++ + LK+F+ R R
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 914 DAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQT- 963
+ G+ + H ++H DLK +NLLV D Q+ + KI DLGL + VK T
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 964 -LVSGGVRGTLPWMAPELLSGKSHMVT 989
+V TL + APE+L G +H T
Sbjct: 171 EIV------TLWYRAPEVLLGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 48/193 (24%), Positives = 85/193 (44%), Gaps = 34/193 (17%)
Query: 811 GTYGSVYHGKWRGS------DVAIKRIK--ASCFAGKPSERERLIADFWKEALLLSSLHH 862
GT+G +++G +V +K +K AS + L+ +E+ LL L H
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS-----EIQVTLLL----QESCLLYGLSH 67
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-------KDRTIDRRKRLIIAMDA 915
N++ + + + + +M G+LK FLQ+ + + ++ + +A+
Sbjct: 68 QNILPILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGVRG 971
A GM YLH + ++H D+ N ++ D + V KI D LS+ + L R
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVI---DEELQV-KITDNALSRDLFPMDYHCLGDNENR- 181
Query: 972 TLPWMAPELLSGK 984
+ WMA E L K
Sbjct: 182 PVKWMALESLVNK 194
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 58/196 (29%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 800 DDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKAS-CFAGKPSERERLIADFWKEALL 856
DD E + +G G VY VAIKRI C + + L KE
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC----QTSVDELR----KEVQA 52
Query: 857 LSSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM- 913
+S +HPNVV +Y +V D L V ++ GSL ++ IIA
Sbjct: 53 MSQCNHPNVVKYYTSFVVGD----ELWLVMPYLSGGSLLDIMKSSYPR-GGLDEAIIATV 107
Query: 914 --DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVR 970
+ G+EYLH +H D+K N+L+ + KI D G+S + + VR
Sbjct: 108 LKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 971 ----GTLPWMAPELLS 982
GT WMAPE++
Sbjct: 164 KTFVGTPCWMAPEVME 179
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 55/186 (29%), Positives = 86/186 (46%), Gaps = 17/186 (9%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+LG GTY +V+ G K + VA+K I+ G P R E LL +L H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-------EVSLLKNLKHAN 64
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + I+ + L V E++ + LKQ+L + I G+ Y H
Sbjct: 65 IVTLHDIIHT--ERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSG 983
+ I+H DLK +NLL+N ++ K+ D GL++ K T TL + P++L G
Sbjct: 122 RKILHRDLKPQNLLIN----EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 984 KSHMVT 989
+ T
Sbjct: 178 STEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 23/183 (12%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+LE V +GSG G+VY R + A+K I + R I +E +L
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI----YGNHEDTVRRQIC---REIEILR 127
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
++HPNVV + + G + + EFM GSL+ ++ + R I++ G
Sbjct: 128 DVNHPNVVKCHDMFDHN--GEIQVLLEFMDGGSLEGTHIADEQFLADVARQILS-----G 180
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWM 976
+ YLH ++IVH D+K NLL+N + V KI D G+S++ QT+ + V GT+ +M
Sbjct: 181 IAYLHRRHIVHRDIKPSNLLINSA---KNV-KIADFGVSRILAQTMDPCNSSV-GTIAYM 235
Query: 977 APE 979
+PE
Sbjct: 236 SPE 238
|
Length = 353 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G+Y +VY G+ + + VA+K I+ G P R EA LL L H N+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-------EASLLKDLKHANI 65
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V+ + I+ +L V E++ LKQ++ + + G+ Y H +
Sbjct: 66 VTLHDIIH--TKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
++H DLK +NLL++ +R K+ D GL++ K
Sbjct: 123 RVLHRDLKPQNLLIS----ERGELKLADFGLARAK 153
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 57/189 (30%), Positives = 92/189 (48%), Gaps = 18/189 (9%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E LG+G++G V K +G+ AIK C + + + + +E +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIK-----CLKKREILKMKQVQHVAQEKSILM 73
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L HP +V+ +D + + + EF+V G L L+K R + + A +
Sbjct: 74 ELSHPFIVNMMCSFQD--ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA-ELVLA 130
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMA 977
EYLH K+I++ DLK ENLL+ D + V K+ D G +K V +T + GT ++A
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL---DNKGHV-KVTDFGFAKKVPDRTFT---LCGTPEYLA 183
Query: 978 PELLSGKSH 986
PE++ K H
Sbjct: 184 PEVIQSKGH 192
|
Length = 329 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-12
Identities = 61/193 (31%), Positives = 96/193 (49%), Gaps = 14/193 (7%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+K+DD E + ELG+G G V + + S + + R K KP+ R ++I +E +
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMAR-KLIHLEIKPAIRNQII----RELQV 56
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + P +V FYG DG ++ E M GSL Q L K+ + I +++
Sbjct: 57 LHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KEAKRIPEEILGKVSIAVL 113
Query: 917 FGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSY 168
Query: 976 MAPELLSGKSHMV 988
M+PE L G + V
Sbjct: 169 MSPERLQGTHYSV 181
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 54/186 (29%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
N+ E + ELG G +G VY K + G+ A K I+ ++ E + D+ E +
Sbjct: 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIE--------TKSEEELEDYMVEIEI 62
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L++ +HP +V G DG L + EF G++ + + DR + + +I
Sbjct: 63 LATCNHPYIVKLLGAFYW--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML 120
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLPW 975
++YLH I+H DLK N+L+ + K+ D G+S +TL GT W
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYW 176
Query: 976 MAPELL 981
MAPE++
Sbjct: 177 MAPEVV 182
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 42/188 (22%), Positives = 96/188 (51%), Gaps = 15/188 (7%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E ++++G G++G +Y K IK I + K E + KE +LL+ +
Sbjct: 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK------KEVILLAKM 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII-AMDAAFGM 919
HPN+V+F+ ++ +G L V E+ G L + + ++ + +++ + + G+
Sbjct: 57 KHPNIVTFFASFQE--NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMAP 978
+++H + I+H D+K +N+ ++ V K+GD G+++ ++ ++ GT +++P
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNG---MVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 979 ELLSGKSH 986
E+ + +
Sbjct: 172 EICQNRPY 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 55/183 (30%), Positives = 83/183 (45%), Gaps = 20/183 (10%)
Query: 806 RELGSGTYGSVYHG-----KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
R LG+G +G + G R VAI ++A C S+++R F EAL L
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-----SDKQRR--GFLAEALTLGQF 63
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
H N+V G++ G ++ VTE+M NG+L FL+K + + + + + A GM+
Sbjct: 64 DHSNIVRLEGVITRG--NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP--WMAP 978
YL VH L +LVN VCKI + + + + G P W AP
Sbjct: 122 YLSEMGYVHKGLAAHKVLVN----SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 979 ELL 981
E +
Sbjct: 178 EAI 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 63/190 (33%), Positives = 91/190 (47%), Gaps = 14/190 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
DD E++ ELG+G G V R S + + R K KP+ R ++I +E +L
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMAR-KLIHLEIKPAIRNQII----RELKVLHE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ P +V FYG DG ++ E M GSL Q L KK I I++ G+
Sbjct: 56 CNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KKAGRIPENILGKISIAVLRGL 112
Query: 920 EYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
YL K I+H D+K N+LVN R K+ D G+S ++ + V GT +M+P
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRGE----IKLCDFGVSGQLIDSMANSFV-GTRSYMSP 167
Query: 979 ELLSGKSHMV 988
E L G + V
Sbjct: 168 ERLQGTHYTV 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 16/182 (8%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ + G +GSVY K R G AIK +K S K ++ + A+++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAK----NQVTNVKAERAIMMIQGES 56
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P V Y + L V E++ G ++ + + IA + G+E L
Sbjct: 57 PYVAKLYYSFQSK--DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDL 113
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982
H + I+H D+K ENLL++ Q K+ D GLS+ L + GT ++APE +
Sbjct: 114 HQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETIL 166
Query: 983 GK 984
G
Sbjct: 167 GV 168
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 51/212 (24%)
Query: 805 VRELGSGTYGSVYHGKWR--GSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ ELG +G +Y G G D VAIK +K + +F +EA L++
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-------WGEFQQEASLMA 62
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL------------QKKDRTI--- 903
LHHPN+V G+V + + + E++ G L +FL +D T+
Sbjct: 63 ELHHPNIVCLLGVVTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 904 -DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS----- 957
D L IA+ A GMEYL VH DL N+L+ ++ KI DLGLS
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG----EQLHVKISDLGLSREIYS 176
Query: 958 ----KVKQQTLVSGGVRGTLPWMAPE-LLSGK 984
+V+ ++L+ + WM PE ++ GK
Sbjct: 177 ADYYRVQPKSLLP------IRWMPPEAIMYGK 202
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASC-FAGKPSERERLIADFWKEALLLSS 859
++V ++G GTYG VY + + G VA+K+I+ G PS R I+ LL
Sbjct: 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-------LLKE 55
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF-- 917
L+HPN+V ++ + L V EF+ + LK+F+ D + L + F
Sbjct: 56 LNHPNIVKLLDVIHT--ENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSYLFQL 109
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
G+ + H ++H DLK +NLL+N K+ D GL++ V +T V T
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVV--T 163
Query: 973 LPWMAPELLSG 983
L + APE+L G
Sbjct: 164 LWYRAPEILLG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 39/204 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + + ++G GTYG VY K G VA+K+++ +E+E +E +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD------NEKEGFPITAIREIKIL 60
Query: 858 SSLHHPNVVSFYGIVRDGPD--------GSLATVTEFM-------VNGSLKQFLQKKDRT 902
L+H N+V+ IV D D G+ V E+M + L F + ++
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--- 959
K+L ++ G+ Y H KN +H D+KC N+L+N + K+ D GL+++
Sbjct: 121 F--MKQL---LE---GLNYCHKKNFLHRDIKCSNILLN----NKGQIKLADFGLARLYNS 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSG 983
++ + V TL + PELL G
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLG 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 57/199 (28%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E+V ++G GTYG VY + R ++ +A+K+I+ E E + + +E LL
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE------QEDEGVPSTAIREISLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ H N+V +V + L V E++ + LK+ + D + D K + +
Sbjct: 56 KEMQHGNIVRLQDVVHS--EKRLYLVFEYL-DLDLKKHM---DSSPDFAKNPRLIKTYLY 109
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVR 970
G+ Y H ++H DLK +NLL++ R K+ D GL++ + +T V
Sbjct: 110 QILRGIAYCHSHRVLHRDLKPQNLLIDRR---TNALKLADFGLARAFGIPVRTFTHEVV- 165
Query: 971 GTLPWMAPELLSGKSHMVT 989
TL + APE+L G H T
Sbjct: 166 -TLWYRAPEILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-11
Identities = 51/180 (28%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++RE+G G++G+VY + + VAIK++ ++GK S + D KE L L
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRFLQKLR 73
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HPN + + G L V E+ + GS L+ + + + + A G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELL 981
LH N++H D+K N+L++ + + K+GD G + + + GT WMAPE++
Sbjct: 131 LHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSASIMAP---ANXFVGTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 51/193 (26%), Positives = 88/193 (45%), Gaps = 24/193 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE-----RERLIADFWKEA 854
DDLE ++ +G+GT+G V+ + RI +A K R + E
Sbjct: 1 DDLERIKTVGTGTFGRVH--------LVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK 52
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + HP ++ + D L + E++ G L +L+ L A +
Sbjct: 53 RVLKEVSHPFIIRLFWTEHD--QRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASE 109
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTL 973
+EYLH K IV+ DLK EN+L++ ++ K+ D G +K ++ +T + GT
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLD-KEGH---IKLTDFGFAKKLRDRTWT---LCGTP 162
Query: 974 PWMAPELLSGKSH 986
++APE++ K H
Sbjct: 163 EYLAPEVIQSKGH 175
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 5e-11
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 37/173 (21%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALL 856
++ +GSG YG V K G VAIK+I + D +E L
Sbjct: 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKI------------SNVFDDLIDAKRILREIKL 52
Query: 857 LSSLHHPNVVSFYGIVR-DGPD--GSLATVTEFMVNGS-LKQFLQ-KKDRTIDRRKRLII 911
L L H N++ I+R P+ + VTE M + L + ++ + T D + +
Sbjct: 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQ 962
+ G++YLH N++H DLK N+LVN + C KI D GL++
Sbjct: 111 QI--LRGLKYLHSANVIHRDLKPSNILVN-SN-----CDLKICDFGLARGVDP 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 65/251 (25%), Positives = 108/251 (43%), Gaps = 40/251 (15%)
Query: 746 DTTTKEAP-------ANEAELVNIH-GEIEMDYDNDTVKTLK-----IEPTIAEAEAIAR 792
DTT P A+E +I G++E D+ ++ + PT +A +
Sbjct: 5 DTTPPLPPRSYSGGAADEDLYSDISDGDLEYSDDDSASESDDDDDDGLIPTKQKAREVVA 64
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFW 851
L ++ L G+ G V+ G D + +I K + LI
Sbjct: 65 SL------GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI-----GQKGTT---LI---- 106
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA+LL +++HP+V+ + G + + + L +L K+ R + + LII
Sbjct: 107 -EAMLLQNVNHPSVIRMKDTLVSGA---ITCMVLPHYSSDLYTYLTKRSRPLPIDQALII 162
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
G+ YLH + I+H D+K EN+ +N D VC IGDLG ++ G+ G
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFINDVD---QVC-IGDLGAAQFPVVAPAFLGLAG 218
Query: 972 TLPWMAPELLS 982
T+ APE+L+
Sbjct: 219 TVETNAPEVLA 229
|
Length = 357 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 48/217 (22%)
Query: 808 LGSGTYGSV-----YHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
LG G +G V + K R + VA+K +K + SE L+++F LL +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN---ASSSELRDLLSEF----NLLKQV 60
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------------------- 899
+HP+V+ YG DG L + E+ GSL+ FL++
Sbjct: 61 NHPHVIKLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 900 --DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+R + + A + GM+YL +VH DL N+LV + KI D GLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV----AEGRKMKISDFGLS 174
Query: 958 K-VKQQTLVSGGVRGTLP--WMAPELLSGKSHMVTEK 991
+ V ++ +G +P WMA E L H+ T +
Sbjct: 175 RDVYEEDSYVKRSKGRIPVKWMAIESLF--DHIYTTQ 209
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 27/192 (14%)
Query: 808 LGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G YG+VY G +G +A+K+++ +E+E +E LL SL H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--YEKLQEEVDLLKSLKHVNIV 65
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYL 922
+ G D D +++ EF+ GS+ L + + + + I+ G+ YL
Sbjct: 66 QYLGTCLD--DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILD-----GVAYL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPV------C--KIGDLGLSKVKQQTLVSGGVRGTLP 974
H +VH D+K N+ M P + C ++ +GL L S + GT
Sbjct: 119 HNNCVVHRDIKGNNV---MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTPY 173
Query: 975 WMAPELLSGKSH 986
WMAPE+++ +
Sbjct: 174 WMAPEVINESGY 185
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 59/204 (28%), Positives = 87/204 (42%), Gaps = 54/204 (26%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ +G GTYG VY + S VA+K+++ +ER+ + +E LL +L
Sbjct: 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD------NERDGIPISSLREITLLLNL 63
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF--- 917
HPN+V +V S+ F+V +Q L L+ M F
Sbjct: 64 RHPNIVELKEVVVGKHLDSI-----FLVMEYCEQDL----------ASLLDNMPTPFSES 108
Query: 918 -----------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQ 961
G++YLH I+H DLK NLL+ + KI D GL++ K
Sbjct: 109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFGLARTYGLPAKP 164
Query: 962 QT--LVSGGVRGTLPWMAPELLSG 983
T +V TL + APELL G
Sbjct: 165 MTPKVV------TLWYRAPELLLG 182
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 38/208 (18%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADF 850
+ IK +D+ +G G +G V + + AIK +K FA + R DF
Sbjct: 2 EDIKFEDV-----IGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHR-----DF 49
Query: 851 WKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------- 900
E +L L HHPN+++ G + G L E+ G+L FL+K
Sbjct: 50 AGELEVLCKLGHHPNIINLLGACEN--RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFA 107
Query: 901 ------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
T+ ++ L A D A GM+YL K +H DL N+LV + KI D
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG----ENLASKIADF 163
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLS 982
GLS+ ++ + R + WMA E L+
Sbjct: 164 GLSRGEEVYVKKTMGRLPVRWMAIESLN 191
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 27/192 (14%)
Query: 799 NDDLEEV----RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWK 852
DD E++ RE+G G++G+VY VAIK++ ++GK S + D K
Sbjct: 10 KDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMS---YSGKQSNEK--WQDIIK 64
Query: 853 EALLLSSLHHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E L L HPN + + G +R+ + V E+ + GS L+ + + + I
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREH---TAWLVMEYCL-GSASDILEVHKKPLQEVEIAAI 120
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ--QTLVSGGV 969
A G+ YLH +H D+K N+L+ + K+ D G + + + V
Sbjct: 121 CHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSASLVSPANSFV---- 172
Query: 970 RGTLPWMAPELL 981
GT WMAPE++
Sbjct: 173 -GTPYWMAPEVI 183
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 31/199 (15%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSS 859
LG GTYG V G VAIK++K + ++ +L+ +E +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ H N++ + +G + V + M LK+ + +K R + + + I+ + G+
Sbjct: 77 IKHENIMGLVDVYVEG--DFINLVMDIM-ASDLKKVVDRKIRLTESQVKCIL-LQILNGL 132
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG-------- 971
LH +H DL N+ +N + +CKI D GL++ S +
Sbjct: 133 NVLHKWYFMHRDLSPANIFIN----SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 972 -------TLPWMAPELLSG 983
TL + APELL G
Sbjct: 189 EMTSKVVTLWYRAPELLMG 207
|
Length = 335 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 23/192 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLIADF 850
+K +L +++ LGSG +G+V+ G W G VAIK I+ +G+ + +E I D
Sbjct: 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQE--ITD- 58
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + SL H +V GI P SL VT+ GSL +++ ++D ++ L
Sbjct: 59 --HMLAMGSLDHAYIVRLLGIC---PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLN 113
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL +VH +L N+L ++ + +I D G++ + +
Sbjct: 114 WCVQIAKGMYYLEEHRMVHRNLAARNIL--LKSDS--IVQIADFGVADLLYPDDKKYFYS 169
Query: 968 GVRGTLPWMAPE 979
+ + WMA E
Sbjct: 170 EHKTPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 60/195 (30%), Positives = 87/195 (44%), Gaps = 33/195 (16%)
Query: 808 LGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+G G +G V + + D AIKR+K +A K R DF E +L L HH
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHR-----DFAGELEVLCKLGHH 55
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRK 907
PN+++ G G L E+ +G+L FL+K T+ ++
Sbjct: 56 PNIINLLGACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
L A D A GM+YL K +H DL N+LV + V KI D GLS+ ++ +
Sbjct: 114 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGLSRGQEVYVKKT 169
Query: 968 GVRGTLPWMAPELLS 982
R + WMA E L+
Sbjct: 170 MGRLPVRWMAIESLN 184
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 16/186 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGK-PSERERLIADFWKEALLLSSLHH 862
LG GT+ ++Y G R + + K R F++ A L+S L H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 863 PNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
++V YG+ VRD V E++ G L FL ++ + +L +A A + Y
Sbjct: 61 KHLVKLYGVCVRDEN----IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQR---PVCKIGDLGLSKVKQQTLVSGGVR-GTLPWMA 977
L K +VH ++ +N+LV P K+ D G+ T++S R +PW+A
Sbjct: 117 LEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI----TVLSREERVERIPWIA 172
Query: 978 PELLSG 983
PE +
Sbjct: 173 PECIRN 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 57/168 (33%), Positives = 75/168 (44%), Gaps = 27/168 (16%)
Query: 806 RELGSGTYGSVYHGKWRGSD----VAIKRIK-ASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG G +GSV G+ D VA+K +K A C SE E DF EA+ +
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC---TRSEME----DFLSEAVCMKEF 57
Query: 861 HHPNVVSFYGIVRDGPDG----SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM--- 913
HPNV+ G+ + S + FM +G L FL R D + L M
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYS-RLGDCPQYLPTQMLVK 116
Query: 914 ---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
D A GMEYL K+ +H DL N ++N VC + D GLSK
Sbjct: 117 FMTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVC-VADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 793 GLQTIKN--DDLEEVRELGSGTYGSVYH--GKWRGSDVAIKRIKASCFAGKPSERERLIA 848
GL+++ + D E + +G GTYG VY K GS A+K + + E E I
Sbjct: 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI- 71
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPD---GSLATVTEFMVNGSLKQFLQKKDRTIDR 905
L S +HPNVV FYG+ G L V E GS+ + ++ R
Sbjct: 72 -------LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 906 RKRLIIAM---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQ 961
+I+ A G+++LH I+H D+K N+L+ K+ D G+S ++
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTS 180
Query: 962 QTLVSGGVRGTLPWMAPELLS 982
L GT WMAPE+++
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIA 201
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 23/195 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLI 847
++ +K +L++V+ LGSG +G+VY G W G + VAIK ++ + P + ++
Sbjct: 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEIL 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
EA +++ + P V GI ++ VT+ M G L ++++ I +
Sbjct: 58 ----DEAYVMAGVGSPYVCRLLGICL---TSTVQLVTQLMPYGCLLDYVRENKDRIGSQD 110
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
L + A GM YL +VH DL N+LV + P KI D GL++ + +
Sbjct: 111 LLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV--KSPNH--VKITDFGLARLLDIDETEY 166
Query: 965 VSGGVRGTLPWMAPE 979
+ G + + WMA E
Sbjct: 167 HADGGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 21/193 (10%)
Query: 799 NDDLEEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D E + +G GTYG V+ K GS A+K + + E E I L
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI--------L 68
Query: 857 LSSLHHPNVVSFYGIV--RDGPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ HPNVV FYG+ +D +G L V E GS+ ++ + +R + IIA
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 914 ---DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGV 969
+A G+++LH +H D+K N+L+ K+ D G+S ++ L
Sbjct: 129 ILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG----VKLVDFGVSAQLTSTRLRRNTS 184
Query: 970 RGTLPWMAPELLS 982
GT WMAPE+++
Sbjct: 185 VGTPFWMAPEVIA 197
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 54/184 (29%), Positives = 83/184 (45%), Gaps = 22/184 (11%)
Query: 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
ELGSG +G+V G ++ VA+K +K P+ ++ L+ +EA ++ L +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND--NNDPALKDELL----REANVMQQLDN 55
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V GI S V E G L +FLQK ++ + + + + GM+YL
Sbjct: 56 PYIVRMIGICEAE---SWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKYL 111
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAP 978
N VH DL N+L+ + KI D GLSK + G P W AP
Sbjct: 112 EETNFVHRDLAARNVLLVTQH----YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAP 167
Query: 979 ELLS 982
E ++
Sbjct: 168 ECMN 171
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ +GSGTYG VY + G AIK IK +P E ++ +E +++
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKL-----EPGEDFAVVQ---QEIIMM 60
Query: 858 SSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
H N+V+++G + RD L EF GSL+ + + ++ +
Sbjct: 61 KDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRET 115
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-GGVRGTLP 974
G+ YLH K +H D+K N+L+ K+ D G+S T+ GT
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGVSAQITATIAKRKSFIGTPY 171
Query: 975 WMAPEL 980
WMAPE+
Sbjct: 172 WMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 55/162 (33%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDR---- 901
DF KE +LS L PN++ G+ D + L +TE+M NG L QFL D+
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENG 122
Query: 902 -----------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
I L +A+ A GM+YL N VH DL N LV + K
Sbjct: 123 NDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG----ENLTIK 178
Query: 951 IGDLGLSKVKQQTLVSGGV-----RGTLP--WMAPE-LLSGK 984
I D G+S+ L +G R LP WMA E +L GK
Sbjct: 179 IADFGMSR----NLYAGDYYRIQGRAVLPIRWMAWECILMGK 216
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 21/197 (10%)
Query: 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
K D E++ +LG G+Y +VY GK + G VA+K I+ G P R EA
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-------EAS 55
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
LL L H N+V + I+ +L V E+ V+ L Q++ K + +
Sbjct: 56 LLKGLKHANIVLLHDIIHTKE--TLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQL 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK---QQTLVSGGVRGT 972
G+ Y+H + I+H DLK +NLL++ K+ D GL++ K T + V T
Sbjct: 113 LRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGLARAKSVPSHTYSNEVV--T 166
Query: 973 LPWMAPELLSGKSHMVT 989
L + P++L G + T
Sbjct: 167 LWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 57/191 (29%), Positives = 89/191 (46%), Gaps = 21/191 (10%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+ +LG G+Y +VY G R G VA+K I G P R EA LL L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-------EASLLKGLKH 62
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
N+V + I+ +L V E+M + L Q++ + + + G+ Y+
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGTLPWMAPE 979
HG++I+H DLK +NLL++ K+ D GL++ K QT S V TL + P+
Sbjct: 120 HGQHILHRDLKPQNLLISYLGE----LKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD 173
Query: 980 LLSGKSHMVTE 990
+L G + +
Sbjct: 174 VLLGATDYSSA 184
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 6e-10
Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 29/188 (15%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+V+ G +VAIK+I K ++E +I E L++ L +PN
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQ----KQPKKELII----NEILVMKELKNPN 77
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+F G + L V E++ GSL + + +D + + + +E+LH
Sbjct: 78 IVNFLDSFLVGDE--LFVVMEYLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHA 133
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPWMAP 978
++H D+K +N+L+ M K+ D G + K+ T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 979 ELLSGKSH 986
E+++ K++
Sbjct: 185 EVVTRKAY 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 17/180 (9%)
Query: 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY G VA+K+++ + AD KE LL L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-----ADCIKEIDLLKQLNHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL---QKKDRTIDRRKRLIIAMDAAFGME 920
NV+ +Y + D L V E G L + + +K+ R I + + +E
Sbjct: 63 NVIKYYASFIE--DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
++H + ++H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-10
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 28/176 (15%)
Query: 823 GSDVAIK--RIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PDG 878
G +VAIK R A E E A F +E L + L+HPN+V+ ++ G P G
Sbjct: 3 GHEVAIKLLRTDAP-------EEEHQRARFRRETALCARLYHPNIVA---LLDSGEAPPG 52
Query: 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936
L V E++ +L++ L + + ++ +DA + H + IVH DLK +N
Sbjct: 53 LLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA---LACAHNQGIVHRDLKPQN 109
Query: 937 LLVNMRDPQRPVCKIGDLGLSKV--------KQQTLVSGGVRGTLPWMAPELLSGK 984
++V+ RP K+ D G+ + + V GT + APE L G+
Sbjct: 110 IMVSQTG-VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 31/204 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E + +LG GT+G VY + G VA+K+I +E++ +E +L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMH------NEKDGFPITALREIKIL 61
Query: 858 SSLHHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
L HPNVV + + PD GS+ VT +M + L L+ + +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGG 968
+ G+ YLH +I+H D+K N+L++ + + KI D GL++ GG
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILID----NQGILKIADFGLARPYDGPPPNPKGGG 176
Query: 969 VRG---------TLPWMAPELLSG 983
G T + PELL G
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLG 200
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 21/184 (11%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
E + ELG G +G VY + + + V + A+ SE E + D+ E +L+S H
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEE--LEDYMVEIDILASCDH 61
Query: 863 PNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
PN+V +FY + +L + EF G++ + + +R + + ++
Sbjct: 62 PNIVKLLDAFY------YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV-SGGVRGTLPWMA 977
+ YLH I+H DLK N+L + K+ D G+S +T+ GT WMA
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171
Query: 978 PELL 981
PE++
Sbjct: 172 PEVV 175
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 51/179 (28%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 804 EVRELGSGTYGSVYHGK-WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++RE+G G++G+VY + R ++V IK ++GK S + D KE L + H
Sbjct: 29 DLREIGHGSFGAVYFARDVRTNEVVA--IKKMSYSGKQSNEK--WQDIIKEVKFLQRIKH 84
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PN + + G L V E+ + GS L+ + + + I A G+ YL
Sbjct: 85 PNSIEYKGCYLREHTAWL--VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYL 141
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELL 981
H N++H D+K N+L + +P + K+ D G + + + GT WMAPE++
Sbjct: 142 HSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASIASP---ANSFVGTPYWMAPEVI 193
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 58/204 (28%), Positives = 88/204 (43%), Gaps = 41/204 (20%)
Query: 806 RELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ LG G +G V + G D VA+K +K + ++ +AD E L
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-------TDKDLADLISEMEL 70
Query: 857 LSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKR-- 908
+ + H N+++ G+ +G L + E+ G+L++FL+ + D T D K
Sbjct: 71 MKLIGKHKNIINLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 909 --------LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-V 959
+ A A GMEYL + +H DL N+LV + V KI D GL++ V
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN----VMKIADFGLARGV 184
Query: 960 KQQTLVSGGVRGTLP--WMAPELL 981
G LP WMAPE L
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 29/191 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E + +G G YG V + + G VAIK+ K S + E + A +E +L L
Sbjct: 4 EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKES----EDDEDVKKTA--LREVKVLRQL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDAAFG 918
H N+V+ R G L V E+ V +L + L+ + + I + A
Sbjct: 58 RHENIVNLKEAFRR--KGRLYLVFEY-VERTLLELLEASPGGLPPDAVRSYIWQLLQAIA 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------GT 972
Y H NI+H D+K EN+LV+ + V K+ D G ++ L + T
Sbjct: 115 --YCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFAR----ALRARPASPLTDYVAT 164
Query: 973 LPWMAPELLSG 983
+ APELL G
Sbjct: 165 RWYRAPELLVG 175
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 26/192 (13%)
Query: 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V +G+GTYG VY G+ G AIK + + E E + + +L
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEI---NMLKKY 69
Query: 860 LHHPNVVSFYG-IVRDGP---DGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG ++ P D L V EF GS+ ++ K + I +
Sbjct: 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICRE 129
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G+ +LH ++H D+K +N+L+ + K+ D G+S +T+ G R
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTFI 182
Query: 971 GTLPWMAPELLS 982
GT WMAPE+++
Sbjct: 183 GTPYWMAPEVIA 194
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864
+G GT+ V + R G AIK +K K E+ + +E L L HPN
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHF---KSLEQ----VNNLREIQALRRLSPHPN 59
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
++ ++ D G LA V E M + +L + ++ + R + ++ ++++H
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
I H D+K EN+L+ + K+ D G
Sbjct: 119 NGIFHRDIKPENILIK-----DDILKLADFG 144
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 32/194 (16%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E V E+G G YG+VY + G VA+K ++ + + L +E LL L
Sbjct: 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV------QTNEDGLPLSTVREVALLKRL 56
Query: 861 H---HPNVVSFYGI---VRDGPDGSLATVTEFMVNGSLKQFLQKK-------DRTIDRRK 907
HPN+V + R + + V E V+ L+ +L K + D +
Sbjct: 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIKDLMR 115
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
+ + G+++LH IVH DLK EN+LV K+ D GL+++ +
Sbjct: 116 QFLR------GLDFLHANCIVHRDLKPENILVT----SGGQVKLADFGLARIYSCQMALT 165
Query: 968 GVRGTLPWMAPELL 981
V TL + APE+L
Sbjct: 166 PVVVTLWYRAPEVL 179
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 21/188 (11%)
Query: 800 DDLEEV----RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKE 853
DD EE+ E+G G++G+VY ++ VA+K++ ++GK + + D KE
Sbjct: 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMS---YSGKQTNEK--WQDIIKE 71
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L L HPN + + G + + V E+ + GS L+ + + + I
Sbjct: 72 VKFLQQLKHPNTIEYKGCYLK--EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITH 128
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A G+ YLH N++H D+K N+L + +P + K+ D G + + GT
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNIL--LTEPGQ--VKLADFGSASKSSP---ANSFVGTP 181
Query: 974 PWMAPELL 981
WMAPE++
Sbjct: 182 YWMAPEVI 189
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-09
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 50/214 (23%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+R +G G G VY + VA+K+I+ SE L F +EA + + L H
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDL-----SENPLLKKRFLREAKIAADLIH 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQ--------KKDRTIDRRKRLIIAM 913
P +V Y I DG T + G +LK L+ K+ K + A
Sbjct: 62 PGIVPVYSICSDG---DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE---KTSVGAF 115
Query: 914 DAAF-----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ------ 962
+ F +EY+H K ++H DLK +N+L+ + I D G + K+
Sbjct: 116 LSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE----VVILDWGAAIFKKLEEEDLL 171
Query: 963 -------------TLVSGGVRGTLPWMAPELLSG 983
+ G + GT +MAPE L G
Sbjct: 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205
|
Length = 932 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 55/213 (25%), Positives = 89/213 (41%), Gaps = 41/213 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G D VA+K +K+ E+ +
Sbjct: 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDL 67
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------- 899
+D E ++ + H N+++ G DG L + E+ G+L+++L+ +
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + A A GMEYL K +H DL N+LV + V KI
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMKI 181
Query: 952 GDLGLSK-VKQQTLVSGGVRGTLP--WMAPELL 981
D GL++ + G LP WMAPE L
Sbjct: 182 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 52/199 (26%), Positives = 81/199 (40%), Gaps = 35/199 (17%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + +GSG YG V G VAIK+I F + L +E +
Sbjct: 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTL-----RELKI 57
Query: 857 LSSLHHPNVVSFYGIVR-DGPDG-SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L H N+++ I+R G D + V + M L I + L
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHI-------IHSDQPLTEEHI 109
Query: 915 AAF------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------VKQQ 962
F G++Y+H N++H DLK NLLVN + +IGD G+++ + +
Sbjct: 110 RYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFGMARGLSSSPTEHK 165
Query: 963 TLVSGGVRGTLPWMAPELL 981
++ V T + APELL
Sbjct: 166 YFMTEYV-ATRWYRAPELL 183
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 18/194 (9%)
Query: 808 LGSGTYGSVYHGKWR---GSDVAIKRIKAS--CFAGKPSERERLIADFWKE-ALLLSSLH 861
LGSG +G VY + + + +A+K I F ER++ I D E ++ L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRKRLIIAMDAAFG 918
HPN+V +Y + L V + + L + L++K + + I +
Sbjct: 68 HPNIVRYYKTFLEN--DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 919 MEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH K IVH DL N+++ D I D GL+K KQ V GT+ +
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDK----VTITDFGLAKQKQPESKLTSVVGTILYSC 181
Query: 978 PELLSGKSHMVTEK 991
PE++ K+ EK
Sbjct: 182 PEIV--KNEPYGEK 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 29/191 (15%)
Query: 804 EVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++G G G+VY G +VAIK++ + ++E +I E L++
Sbjct: 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELII----NEILVMRENK 74
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HPN+V++ G + L V E++ GSL + + +D + + + +E+
Sbjct: 75 HPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEF 130
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH ++H D+K +N+L+ M K+ D G + K+ T+V GT W
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYW 181
Query: 976 MAPELLSGKSH 986
MAPE+++ K++
Sbjct: 182 MAPEVVTRKAY 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 40/201 (19%)
Query: 805 VRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ELG +G VY G G+ VAIK +K + RE +F EA++
Sbjct: 10 MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLRE----EFKHEAMMR 62
Query: 858 SSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK-----------DRTIDR 905
S L HPN+V G+V ++ P L+ + + + L +FL + D+T+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQP---LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 906 RKR----LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--- 958
+ I A GME+L ++VH DL N+LV + KI DLGL +
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF----DKLNVKISDLGLFREVY 175
Query: 959 VKQQTLVSGGVRGTLPWMAPE 979
+ G + WM+PE
Sbjct: 176 AADYYKLMGNSLLPIRWMSPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 55/192 (28%), Positives = 89/192 (46%), Gaps = 26/192 (13%)
Query: 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V +G+GTYG VY G+ G AIK + + E E + + +L
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----GDEEEEIKQEI---NMLKKY 59
Query: 860 LHHPNVVSFYG-IVRDGP---DGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG ++ P D L V EF GS+ ++ K T+ I +
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 119
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G+ +LH ++H D+K +N+L+ + K+ D G+S +T+ G R
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKLVDFGVSAQLDRTV---GRRNTFI 172
Query: 971 GTLPWMAPELLS 982
GT WMAPE+++
Sbjct: 173 GTPYWMAPEVIA 184
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 33/192 (17%)
Query: 801 DLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELL----FNEVVIMR 71
Query: 859 SLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
HPN+V Y +V D L V EF+ G+L + ++ + + +
Sbjct: 72 DYQHPNIVEMYSSYLVGD----ELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLAVL 125
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG----LSK--VKQQTLVSGGVR 970
+ +LH + ++H D+K +++L+ D + K+ D G +SK ++++LV
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLT-SDGR---VKLSDFGFCAQVSKEVPRRKSLV----- 176
Query: 971 GTLPWMAPELLS 982
GT WMAPE++S
Sbjct: 177 GTPYWMAPEVIS 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 46/189 (24%), Positives = 90/189 (47%), Gaps = 18/189 (9%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+ ++ G R G + + + S R F++ A ++S L H ++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRN-YSESFFEAASMMSQLSHKHL 61
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V YG+ G + + V E++ GSL +L+K I+ +L +A A+ + +L K
Sbjct: 62 VLNYGVCVCGDESIM--VQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 926 NIVHFDLKCENLLVNMRDPQR-----PVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAP 978
+ H ++ +N+L+ +R+ R P K+ D G+S + ++ L+ +PW+ P
Sbjct: 120 GLTHGNVCAKNVLL-IREEDRKTGNPPFIKLSDPGISITVLPKEILLE-----RIPWVPP 173
Query: 979 ELLSGKSHM 987
E + ++
Sbjct: 174 ECIENPQNL 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 54/193 (27%), Positives = 87/193 (45%), Gaps = 19/193 (9%)
Query: 803 EEVRELGSGTYGSVYHG---KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL--L 857
E V E+G G YG V+ K G VA+KR++ + E ++ + A+L L
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV-----QTGEEGMPLSTIREVAVLRHL 58
Query: 858 SSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAM 913
+ HPNVV + + R + L V E V+ L +L K + + +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+++LH +VH DLK +N+LV K+ D GL+++ + V TL
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----IKLADFGLARIYSFQMALTSVVVTL 173
Query: 974 PWMAPELLSGKSH 986
+ APE+L S+
Sbjct: 174 WYRAPEVLLQSSY 186
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 51/189 (26%), Positives = 95/189 (50%), Gaps = 20/189 (10%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKA--SCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ LG G++G+VY K + + A +R+K G+ + E + A+ +EA LLS L HP
Sbjct: 6 QRLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNETVQAN--QEAQLLSKLDHP 62
Query: 864 NVVSFYG--IVRDGPDGSLATVTEFMVNGSLK---QFLQKKDRTIDRRKRLIIAMDAAFG 918
+V F+ + RD + +TE+ L + L+ +T+ + + G
Sbjct: 63 AIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMA 977
+ Y+H + I+H DLK +N+ + + + KIGD G+S++ + ++ GT +M+
Sbjct: 119 VHYMHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 978 PELLSGKSH 986
PE L + +
Sbjct: 174 PEALKHQGY 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 18/182 (9%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G V + + G A K++ + E+ L E +L + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN-----EKKILEKVSSRFI 55
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLH 923
VS Y + D L V M G LK + + + + A G+E+LH
Sbjct: 56 VSLAYAF--ETKD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELLS 982
+ IV+ DLK EN+L++ +I DLGL+ ++K + G GT +MAPE+L
Sbjct: 113 QRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGKKIKGRA-GTPGYMAPEVLQ 167
Query: 983 GK 984
G+
Sbjct: 168 GE 169
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 55/210 (26%), Positives = 86/210 (40%), Gaps = 41/210 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K E+ ++D
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDL 67
Query: 851 WKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------- 899
E ++ + H N+++ G DG L + E+ G+L+++L+ +
Sbjct: 68 VSEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 900 -----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
D + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIADF 181
Query: 955 GLSK-VKQQTLVSGGVRGTLP--WMAPELL 981
GL++ V G LP WMAPE L
Sbjct: 182 GLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 52/195 (26%), Positives = 81/195 (41%), Gaps = 25/195 (12%)
Query: 807 ELGSGTYGSVYHGKWRG----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++G GTYG VY K + D A+K+I+ + + +E LL L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-------MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
PNV+S + D + + ++ ++ KK + R +
Sbjct: 58 PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRG 971
G+ YLH ++H DLK N+LV P+R KI D+G +++ L V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 972 TLPWMAPELLSGKSH 986
T + APELL G H
Sbjct: 178 TFWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 28/191 (14%)
Query: 804 EVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +G G++G V+ G VAIK I E E I D +E +LS
Sbjct: 8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P V +YG G L + E++ GS L+ D + + + G++Y
Sbjct: 61 SPYVTKYYGSYLKG--TKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH + +H D+K N+L++ ++ K+ D G+ +++K+ T V GT W
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 976 MAPELLSGKSH 986
MAPE++ ++
Sbjct: 168 MAPEVIQQSAY 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 6e-08
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ ++G GT+G V+ + + + VA+K++ +E+E +E +L L
Sbjct: 15 EKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME------NEKEGFPITALREIKILQLL 68
Query: 861 HHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIA 912
H NVV+ I R GS V EF + L L K T+ K+++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVS 966
+ G+ Y+H I+H D+K N+L+ +D + K+ D GL SK + +
Sbjct: 128 LLN--GLYYIHRNKILHRDMKAANILIT-KD---GILKLADFGLARAFSLSKNSKPNRYT 181
Query: 967 GGVRGTLPWMAPELLSGKSH 986
V TL + PELL G+
Sbjct: 182 NRVV-TLWYRPPELLLGERD 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 7e-08
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 27/169 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + + +GSG YG V + VAIK++ +P + ++E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS------RPFQSAIHAKRTYRELRLL 68
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+ H NV+ + P SL VT M L ++ + + D + L+
Sbjct: 69 KHMDHENVIGLLDVFT--PASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVY 125
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSK 958
+ G++Y+H I+H DLK N+ VN D C KI D GL++
Sbjct: 126 QI--LRGLKYIHSAGIIHRDLKPSNIAVN-ED-----CELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 17/180 (9%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+++G G + VY VA+K+++ + + D KE LL L+HP
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-----DCVKEIDLLKQLNHP 62
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ---FLQKKDRTIDRRKRLIIAMDAAFGME 920
NV+ + + D L V E G L Q + +K+ R I R + +E
Sbjct: 63 NVIKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
++H + ++H D+K N+ + V K+GDLGL + +T + + GT +M+PE
Sbjct: 121 HMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 28/191 (14%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ +G G++G VY G + VAIK I E E I D +E +LS
Sbjct: 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P + +YG G L + E++ GS L K ++ I + G++Y
Sbjct: 61 SPYITRYYGSYLKG--TKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPW 975
LH + +H D+K N+L++ ++ K+ D G+ +++K+ T V GT W
Sbjct: 117 LHSERKIHRDIKAANVLLS----EQGDVKLADFGVAGQLTDTQIKRNTFV-----GTPFW 167
Query: 976 MAPELLSGKSH 986
MAPE++ ++
Sbjct: 168 MAPEVIKQSAY 178
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 48/186 (25%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
++ ++G G++G V+ G + VAIK I E E I D +E +LS
Sbjct: 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCD 60
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P V +YG D L + E++ GS L+ +D + I + G++Y
Sbjct: 61 SPYVTKYYGSYLK--DTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDY 116
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPEL 980
LH + +H D+K N+L++ + K+ D G++ ++ + GT WMAPE+
Sbjct: 117 LHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
Query: 981 LSGKSH 986
+ ++
Sbjct: 173 IKQSAY 178
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 45/188 (23%), Positives = 92/188 (48%), Gaps = 16/188 (8%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+V+++G G++G K + G IK I S + K E R KE +LS++
Sbjct: 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESR------KEVAVLSNM 56
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL-KQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HPN+V + + +G+L V ++ G L K+ ++ + L + +
Sbjct: 57 KHPNIVQYQESFEE--NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWMAP 978
+++H + I+H D+K +N+ + +D K+GD G+++V T+ ++ GT +++P
Sbjct: 115 KHVHDRKILHRDIKSQNIFL-TKD---GTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
Query: 979 ELLSGKSH 986
E+ + +
Sbjct: 171 EICENRPY 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 49/188 (26%), Positives = 79/188 (42%), Gaps = 26/188 (13%)
Query: 806 RELGSGTYGSVYHGK----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
E+G+G +G V G+ + V +K ++AS P E+ F +E L+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLL----FLQEVQPYRELN 53
Query: 862 HPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI----DRRKRLIIAMDAA 916
HPNV+ G + P V EF G LK +L+ + + +A + A
Sbjct: 54 HPNVLQCLGQCIESIP---YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD--LGLSKVKQQTLVSGGVRGT-L 973
G+ +LH + +H DL N + KIGD L L + + ++ L
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166
Query: 974 PWMAPELL 981
W+APEL+
Sbjct: 167 RWLAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 11/154 (7%)
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
PS R+ +A F++ A L+S + H ++ +G+ G + + V EF+ +G L L+K+
Sbjct: 54 PSHRDIALA-FFETASLMSQVSHIHLAFVHGVCVRGSENIM--VEEFVEHGPLDVCLRKE 110
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPVCKIGDLGL 956
+ ++ +A A + YL KN+VH ++ +N+L+ + P K+ D G+
Sbjct: 111 KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV 170
Query: 957 SKVKQQTLVSGGVR-GTLPWMAPELLSGKSHMVT 989
S T +S R +PW+APE + G + + T
Sbjct: 171 S----FTALSREERVERIPWIAPECVPGGNSLST 200
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-07
Identities = 53/183 (28%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPS------ERERLIADFWKEALLLSS 859
+G GT+G VY + + + A+K + K ER L+ E+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
L SF D L VT++M G L LQK+ R + R + IA + +
Sbjct: 61 LK----FSFQ------TDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA-ELVLAL 109
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAP 978
E+LH +IV+ DLK EN+L++ +C D GLSK + GT ++AP
Sbjct: 110 EHLHKYDIVYRDLKPENILLDA-TGHIALC---DFGLSKANLTDNKTTNTFCGTTEYLAP 165
Query: 979 ELL 981
E+L
Sbjct: 166 EVL 168
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 31/172 (18%)
Query: 808 LGSGTYG---SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G YG S H K G VAIK+I P E + +E +L H N
Sbjct: 13 IGEGAYGMVCSATH-KPTGVKVAIKKIS-------PFEHQTFCQRTLREIKILRRFKHEN 64
Query: 865 VVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
++ I+R P S + V E M L + ++ + + D + + + G
Sbjct: 65 IIGILDIIR--PP-SFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQI--LRG 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGG 968
++Y+H N++H DLK NLL+N C KI D GL+++ G
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTN------CDLKICDFGLARIADPEHDHTG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 51/228 (22%), Positives = 85/228 (37%), Gaps = 60/228 (26%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
++++ LG G G V+ + +G+ A+K + +R ++ E +L
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM----IKRNKVKRVLT-EQEIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
++L HP + + Y S T V ++ G L + LQ++ K L
Sbjct: 56 ATLDHPFLPTLYA--------SFQTETYLCLVMDYCPGGELFRLLQRQ-----PGKCLSE 102
Query: 912 AMDAAF-------GMEYLHGKNIVHFDLKCENLLV---------------NMRDPQRPVC 949
A F +EYLH IV+ DLK EN+L+ PV
Sbjct: 103 E-VARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 950 KIGDLGLSKVKQQTLV------SGGVR-----GTLPWMAPELLSGKSH 986
K G + ++ R GT ++APE++SG H
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 52/195 (26%), Positives = 82/195 (42%), Gaps = 25/195 (12%)
Query: 807 ELGSGTYGSVYHGKWR-GSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++G GTYG VY K + G D A+K+I+ + + +E LL L H
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC----------REIALLRELKH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEF-------MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
PNV++ + D + + ++ ++ KK + R +
Sbjct: 58 PNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRG 971
G+ YLH ++H DLK N+LV P+R KI D+G +++ L V
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 972 TLPWMAPELLSGKSH 986
T + APELL G H
Sbjct: 178 TFWYRAPELLLGARH 192
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 47/162 (29%), Positives = 79/162 (48%), Gaps = 21/162 (12%)
Query: 804 EVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+++++GSG YG+V R G+ VAIK++ +P + E ++E LL +
Sbjct: 19 DLKQVGSGAYGTVCSALDRRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHMK 72
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H NV+ + PD SL +F + L + ++ + + DR + L+ M
Sbjct: 73 HENVIGLLDVFT--PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQM--L 128
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
G++Y+H I+H DLK NL VN + KI D GL++
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 44/183 (24%), Positives = 89/183 (48%), Gaps = 19/183 (10%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+VY G +VAI+++ + ++E +I E L++ +PN
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELII----NEILVMRENKNPN 78
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V++ G + L V E++ GSL + + +D + + + +E+LH
Sbjct: 79 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAPELLSG 983
++H D+K +N+L+ M K+ D G +++ + + GT WMAPE+++
Sbjct: 135 NQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 984 KSH 986
K++
Sbjct: 191 KAY 193
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 56/184 (30%), Positives = 84/184 (45%), Gaps = 26/184 (14%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-RLIADFWKEALLLSSLHHPN 864
+G G+YG V K + G VAIK+ F ++ + IA +E +L L H N
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKK-----FLESEDDKMVKKIA--MREIRMLKQLRHEN 61
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + R L V EF+ + L L+K +D + G+E+ H
Sbjct: 62 LVNLIEVFRR--KKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG-----VRGTLPWMAPE 979
NI+H D+K EN+LV+ Q V K+ D G ++ TL + G T + APE
Sbjct: 119 HNIIHRDIKPENILVS----QSGVVKLCDFGFAR----TLAAPGEVYTDYVATRWYRAPE 170
Query: 980 LLSG 983
LL G
Sbjct: 171 LLVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 47/188 (25%), Positives = 90/188 (47%), Gaps = 29/188 (15%)
Query: 807 ELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G G+VY G +VAIK++ + ++E +I E L++ +PN
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQ----QQPKKELII----NEILVMRENKNPN 77
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V++ G + L V E++ GSL + + +D + + + +++LH
Sbjct: 78 IVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHS 133
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKVKQQTLVSGGVRGTLPWMAP 978
++H D+K +N+L+ M K+ D G + K+ T+V GT WMAP
Sbjct: 134 NQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMV-----GTPYWMAP 184
Query: 979 ELLSGKSH 986
E+++ K++
Sbjct: 185 EVVTRKAY 192
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 50/197 (25%), Positives = 83/197 (42%), Gaps = 27/197 (13%)
Query: 806 RELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HH 862
+ LG G +G V + G D K + + K ++ ++D E ++ + H
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRK 907
N+++ G DG L + E+ G+L+++L+ + + + +
Sbjct: 78 KNIINLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVS 966
+ A A GMEYL + +H DL N+LV + V KI D GL++ V
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVT----EDNVMKIADFGLARDVHNIDYYK 191
Query: 967 GGVRGTLP--WMAPELL 981
G LP WMAPE L
Sbjct: 192 KTTNGRLPVKWMAPEAL 208
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
+DL+++ E+G G +G+V + S A+KRI+ S K E++RL+ D + ++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEK--EQKRLLMDL--DVVMR 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ----KKDRTIDRRKRLIIAM 913
SS P +V FYG + +G E M + SL +F + I IA+
Sbjct: 59 SS-DCPYIVKFYGALFR--EGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILGKIAV 114
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ YL + I+H D+K N+L++ + K+ D G+S ++ G
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 973 LPWMAPE 979
P+MAPE
Sbjct: 171 RPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 24/187 (12%)
Query: 806 RELGSGTYGSVYHGK----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+E+G+G +G V G+ + + V +K ++ S A + + F +EA SL
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMK-----FLEEAQPYRSLQ 53
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAF 917
H N++ G + L V EF G LK +L+ + T D +A + A
Sbjct: 54 HSNLLQCLGQCTEVTPYLL--VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLP 974
G+ +LH N +H DL N L+ KIGD GLS K + + + L
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLR 167
Query: 975 WMAPELL 981
W+APEL+
Sbjct: 168 WIAPELV 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 47/184 (25%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 802 LEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELL----FNEVVIMRD 75
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HH NVV Y G + L V EF+ G+L + ++ + + + +
Sbjct: 76 YHHENVVDMYNSYLVGDE--LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRAL 131
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
YLH + ++H D+K +++L+ K+ D G ++V ++ + GT WMAP
Sbjct: 132 SYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
Query: 979 ELLS 982
E++S
Sbjct: 188 EVIS 191
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 53/188 (28%), Positives = 83/188 (44%), Gaps = 21/188 (11%)
Query: 801 DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D++ LG G G+VY +A+K I E ++ I E +L
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI----TVELQKQIM---SELEILY 54
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
P ++ FYG + ++ TEFM GSL + + + + R IA+ G
Sbjct: 55 KCDSPYIIGFYGAFF--VENRISICTEFMDGGSLDVYRKIPEHVLGR-----IAVAVVKG 107
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAP 978
+ YL I+H D+K N+LVN R K+ D G+S ++ V GT +MAP
Sbjct: 108 LTYLWSLKILHRDVKPSNMLVNTRGQ----VKLCDFGVSTQLVNSIAKTYV-GTNAYMAP 162
Query: 979 ELLSGKSH 986
E +SG+ +
Sbjct: 163 ERISGEQY 170
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 35/149 (23%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 815 SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD-FWKEALLLSSLHHPNVVSFYGIVR 873
S+Y G + +V I+ K K + +++ D E L + N++ YG +
Sbjct: 35 SIYKGIFNNKEVIIRTFK------KFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88
Query: 874 DGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHF 930
D D L+ + E+ G L++ L K ++ + + +L +A+D G+ L+ N +
Sbjct: 89 DIVDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYK 147
Query: 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+L + LV + KI GL K+
Sbjct: 148 NLTSVSFLVT----ENYKLKIICHGLEKI 172
|
Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 56/191 (29%), Positives = 86/191 (45%), Gaps = 40/191 (20%)
Query: 804 EVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+++ +G G +G V + G +VAIK+I KP L ++E LL L
Sbjct: 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIM------KPFSTPVLAKRTYRELKLLKHLR 67
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFM--------VNGSL-KQFLQKKDRTIDRRKRLIIA 912
H N++S I P + VTE + + L KQF+Q I R
Sbjct: 68 HENIISLSDIFIS-PLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILR------- 119
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR 970
G++Y+H +VH DLK N+L+N C KI D GL+++ Q ++G V
Sbjct: 120 -----GLKYVHSAGVVHRDLKPSNILINEN------CDLKICDFGLARI-QDPQMTGYV- 166
Query: 971 GTLPWMAPELL 981
T + APE++
Sbjct: 167 STRYYRAPEIM 177
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 41/163 (25%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIK-ASCFAGKPSERERLIADFWKEALLL 857
+R +G G++G + SD A+K I+ + R KEA+LL
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR--------KEAVLL 52
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAA 916
+ + HPN+V+F DG L V E+ G L Q + ++ + L +
Sbjct: 53 AKMKHPNIVAFKESFE--ADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
G++++H K ++H D+K +N+ + Q K+GD G +++
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSARL 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 52/180 (28%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G +G V + R G A K+++ + E L E +L ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSR 60
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
VVS + D +L V M G LK + D + + A + G+E L
Sbjct: 61 FVVSL-AYAYETKD-ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELL 981
H + IV+ DLK EN+L++ R I DLGL+ ++ + + G V GT+ +MAPE++
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIR----ISDLGLAVEIPEGETIRGRV-GTVGYMAPEVV 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 22/185 (11%)
Query: 801 DLEEVRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
D E ++ +GSGTYG VY + G A+K IK +P + LI +E ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-----EPGDDFSLIQ---QEIFMVK 61
Query: 859 SLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H N+V+++G + R+ L E+ GSL+ + + + +
Sbjct: 62 ECKHCNIVAYFGSYLSRE----KLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETL 116
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPW 975
G+ YLH K +H D+K N+L+ K+ D G+ +K+ GT W
Sbjct: 117 QGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFGVAAKITATIAKRKSFIGTPYW 172
Query: 976 MAPEL 980
MAPE+
Sbjct: 173 MAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 21/186 (11%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPN 864
LG G +G V +++ + AIK +K + E E L+ + K +S HP
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR-DEVESLMCE--KRIFETANSERHPF 63
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V+ + + + + V E+ G L + + + A G++YLH
Sbjct: 64 LVNLFACFQT--EDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHE 119
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGVRGTLPWMAPEL 980
IV+ DLK +NLL+ D + V KI D GL K +T GT ++APE+
Sbjct: 120 NKIVYRDLKLDNLLL---DTEGFV-KIADFGLCKEGMGFGDRT---STFCGTPEFLAPEV 172
Query: 981 LSGKSH 986
L+ S+
Sbjct: 173 LTETSY 178
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 45/170 (26%), Positives = 80/170 (47%), Gaps = 28/170 (16%)
Query: 804 EVRELGSGTYGSVYHGKWRGSD--VAIKRIKAS-CFAGKPSERERLIADFWKEALLLSSL 860
++R LG G+ G V+ D VA+K+I + + K + RE I + L
Sbjct: 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI---------IRRL 59
Query: 861 HHPNVVSFYGIVRDGPDGS-----LATVTEFMVNGSLKQFLQKKDRTIDRRKRL------ 909
H N+V Y ++ GP GS + ++TE ++++++ + + L
Sbjct: 60 DHDNIVKVYEVL--GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ G++Y+H N++H DLK N+ +N D V KIGD GL+++
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 48/185 (25%), Positives = 90/185 (48%), Gaps = 19/185 (10%)
Query: 808 LGSGTYGSVYH-GKWRGSDV----AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++G V+ K G D A+K +K + + R ++ E +L+ ++H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM------ERDILAEVNH 57
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V + + +G L + +F+ G L L K+ + + +A + A +++L
Sbjct: 58 PFIVKLHYAFQT--EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHL 114
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
H I++ DLK EN+L++ + K+ D GLSK + GT+ +MAPE++
Sbjct: 115 HSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 170
Query: 982 SGKSH 986
+ + H
Sbjct: 171 NRRGH 175
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + GS A+K ++ K E+ ++A+ +LL +L HP +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-KKKEQNHIMAE---RNVLLKNLKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + L V +++ G L LQ++ ++ R R A + A + YLH
Sbjct: 59 VGLHYSFQTAE--KLYFVLDYVNGGELFFHLQRERCFLEPRARFY-AAEVASAIGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELL 981
NI++ DLK EN+L+ D Q V + D GL K V+ + S GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHVV-LTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 54/189 (28%), Positives = 82/189 (43%), Gaps = 19/189 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLL 857
D++E + ELG G YGSVY R + V A+K I+ K ++ E +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQ-------IIMELDIL 53
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDA 915
P +V FYG +G++ E+M GSL + T I I
Sbjct: 54 HKAVSPYIVDFYGAFFI--EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAV 111
Query: 916 AFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++L + NI+H D+K N+LVN K+ D G+S +L + G
Sbjct: 112 VKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ----VKLCDFGVSGNLVASLAKTNI-GCQS 166
Query: 975 WMAPELLSG 983
+MAPE +
Sbjct: 167 YMAPERIKS 175
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 26/190 (13%)
Query: 805 VRELGSGTYGSVYHGKWRGSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++ELG G YG V + + VAIK+I + F+ K + L +E LL
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAKRAL-----RELKLLRHF 58
Query: 861 H-HPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
H N+ Y IV G L E M L Q ++ D + I
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFI-YQILC 116
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVRG 971
G++Y+H N++H DLK NLLVN D + KI D GL+ + ++ V
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNA-DCE---LKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 972 TLPWMAPELL 981
T + APE++
Sbjct: 172 TRWYRAPEIM 181
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 22/185 (11%)
Query: 808 LGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
LG GT +Y G D K IK PS R+ +A F++ A ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA-FFETASMMRQV 61
Query: 861 HHPNVVSFYGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H ++V YG+ VRD + V EF+ G L F+ +K + + +A A +
Sbjct: 62 SHKHIVLLYGVCVRDVEN---IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASAL 118
Query: 920 EYLHGKNIVHFDLKCENLLV---NMRDPQRPVCKIGDLG--LSKVKQQTLVSGGVRGTLP 974
YL K++VH ++ +N+L+ + P K+ D G ++ + +Q V +P
Sbjct: 119 SYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-----RIP 173
Query: 975 WMAPE 979
W+APE
Sbjct: 174 WIAPE 178
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 28/193 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADF-WKEALL 856
+ E++ ++G G+YG V+ + R G VAIK+ S E + +I +E +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-------EDDPVIKKIALREIRM 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L L HPN+V+ + R L V E+ + L + L+K R + I
Sbjct: 54 LKQLKHPNLVNLIEVFRR--KRKLHLVFEYCDHTVLNE-LEKNPRGVPEHLIKKIIWQTL 110
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR------ 970
+ + H N +H D+K EN+L+ + K+ D G ++ +++G
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILITKQG----QIKLCDFGFAR-----ILTGPGDDYTDYV 161
Query: 971 GTLPWMAPELLSG 983
T + APELL G
Sbjct: 162 ATRWYRAPELLVG 174
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 27/195 (13%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E ++ LG+G YG V+ G G A+K +K + K + ER + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+++ L +LH+ +F D L + +++ G L L +++R ++ ++
Sbjct: 61 IRQSPFLVTLHY----AFQ------TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
+ +E+LH I++ D+K EN+L+ D V + D GLSK + + +
Sbjct: 111 SG-EIVLALEHLHKLGIIYRDIKLENILL---DSNGHVV-LTDFGLSKEFHEDEVERAYS 165
Query: 969 VRGTLPWMAPELLSG 983
GT+ +MAP+++ G
Sbjct: 166 FCGTIEYMAPDIVRG 180
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-06
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 10/134 (7%)
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
EA LL L HP V++ + G L + L +L + R + + +A
Sbjct: 210 EARLLRRLSHPAVLALLDV---RVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVA 266
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG---LSKVKQQTLVSGGV 969
++Y+HG+ I+H D+K EN+LVN P+ +C +GD G ++ T G+
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVN--GPED-IC-LGDFGAACFARGSWSTPFHYGI 322
Query: 970 RGTLPWMAPELLSG 983
GT+ APE+L+G
Sbjct: 323 AGTVDTNAPEVLAG 336
|
Length = 461 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 52/191 (27%), Positives = 91/191 (47%), Gaps = 23/191 (12%)
Query: 805 VRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++ LG G YG V+ G G A+K +K + ++ A E +L +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIV----RNQKDTAHTKAERNILEA 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
+ HP +V + G G L + E++ G L L+++ ++ ++ + + +
Sbjct: 57 VKHPFIVDLIYAFQTG--GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLAL 113
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
E+LH + I++ DLK EN+L+ D Q V K+ D GL K +++ G V GT+ +
Sbjct: 114 EHLHQQGIIYRDLKPENILL---DAQGHV-KLTDFGLCK---ESIHEGTVTHTFCGTIEY 166
Query: 976 MAPELLSGKSH 986
MAPE+L H
Sbjct: 167 MAPEILMRSGH 177
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 27/197 (13%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E +R LG+G YG V+ G G A+K +K + K + ER + +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+ L +LH+ +F D L + +++ G L L +++ + R+
Sbjct: 61 VRRCPFLVTLHY----AFQ------TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
IA + +++LH I++ D+K EN+L+ D + V + D GLSK + ++ +
Sbjct: 111 IA-EIVLALDHLHQLGIIYRDIKLENILL---DSEGHV-VLTDFGLSKEFLAEEEERAYS 165
Query: 969 VRGTLPWMAPELLSGKS 985
GT+ +MAPE++ G S
Sbjct: 166 FCGTIEYMAPEVIRGGS 182
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 54/189 (28%), Positives = 86/189 (45%), Gaps = 16/189 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ R LG G +G V + R G A KR++ + E L E +L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMAL-----NEKQILEK 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFG 918
++ VV+ + D +L V M G LK + + + L A + G
Sbjct: 57 VNSQFVVNL-AYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+E LH +N V+ DLK EN+L++ R I DLGL+ K+ + + G V GT+ +MA
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIR----ISDLGLAVKIPEGESIRGRV-GTVGYMA 169
Query: 978 PELLSGKSH 986
PE+L+ + +
Sbjct: 170 PEVLNNQRY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 43/202 (21%), Positives = 74/202 (36%), Gaps = 35/202 (17%)
Query: 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+ + K + VA+K+I E +L+ +E + L HPN+
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKIN---LDSCSKEDLKLL---QQEIITSRQLQHPNI 61
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---DAAFGMEYL 922
+ + D L V+ M GS + L K + L IA D ++Y+
Sbjct: 62 LPYVTSFIV--DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-QTLVSGGVRGT--------- 972
H K +H +K ++L+ V LS ++ +++ G R
Sbjct: 118 HSKGFIHRSVKASHILL---SGDGKVV------LSGLRYSVSMIKHGKRQRVVHDFPKSS 168
Query: 973 ---LPWMAPELLSGKSHMVTEK 991
LPW++PE+L EK
Sbjct: 169 VKNLPWLSPEVLQQNLQGYNEK 190
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 8e-06
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 43/205 (20%)
Query: 801 DLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIA--DFWK 852
D+E R +G G +G V W G VA+K++ P+ + L++ ++
Sbjct: 1 DVEPDRPIGYGAFGVV----WSVTDPRDGKRVALKKM--------PNVFQNLVSCKRVFR 48
Query: 853 EALLLSSLHHPNVVSFYGIVRD---GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
E +L H NV+S I++ P + VTE M + K + + + D K
Sbjct: 49 ELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK-- 106
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-------- 961
+ G++YLH I+H D+K NLLVN V KI D GL++V++
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLARVEEPDESKHMT 162
Query: 962 QTLVSGGVRGTLPWMAPELLSGKSH 986
Q +V+ R APE+L G H
Sbjct: 163 QEVVTQYYR------APEILMGSRH 181
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G +G V + R G A K+++ + E L E +L ++
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKRILEKVNSR 60
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
VVS + D +L V M G LK + D ++ + A + G+E L
Sbjct: 61 FVVSL-AYAYETKD-ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAPELL 981
+ IV+ DLK EN+L++ R R I DLGL+ ++ + V G V GT+ +MAPE++
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIR----ISDLGLAVQIPEGETVRGRV-GTVGYMAPEVI 173
Query: 982 SGKSH 986
+ + +
Sbjct: 174 NNEKY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 48/197 (24%), Positives = 92/197 (46%), Gaps = 27/197 (13%)
Query: 801 DLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKP-----SERERLIADF 850
+ E ++ LG+G YG V+ G G A+K ++ + K + ER + +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+++ L +LH+ +F + L + +++ G + L ++D + R
Sbjct: 61 VRQSPFLVTLHY----AFQ------TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY 110
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGG 968
+ +E+LH IV+ D+K EN+L+ D + V + D GLSK + ++ +
Sbjct: 111 SG-EIILALEHLHKLGIVYRDIKLENILL---DSEGHVV-LTDFGLSKEFLSEEKERTYS 165
Query: 969 VRGTLPWMAPELLSGKS 985
GT+ +MAPE++ GK
Sbjct: 166 FCGTIEYMAPEIIRGKG 182
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 72/297 (24%), Positives = 121/297 (40%), Gaps = 49/297 (16%)
Query: 727 EGAEEVKAKVEESDDSVKPDTTTKE-APANEAELVNIHGEI----------EMDYDNDTV 775
E AE+V E D ++ APA E + + ++ D D +
Sbjct: 61 EAAEKVSIMAPERADPTGAHRALEDAAPAGELLVPRSNADLFASAGDGPSGAEDSDASHL 120
Query: 776 KTLKIEPTIAEAEAIARGLQTIKNDD--LEEVRELGS---GTYGSVYHGKWRGS--DVAI 828
+ P A +A+ +K+DD L R + G +G ++ R S +
Sbjct: 121 DFDEAPPDAAGPVPLAQA--KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEA 178
Query: 829 KRIKASCFAGKPSERERLIADFWK-----------EALLLSSLHHPNVVSFYGIVRDGPD 877
+R S GKP + ERLIA K E L L L+H N++ I+R +
Sbjct: 179 RRGVNSTNQGKP-KCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEAN 237
Query: 878 GSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931
+ T + FM + + KDR + ++ R I+ +EY+H K ++H D
Sbjct: 238 TYMITQKYDFDLYSFMYDEAF----DWKDRPLLKQTRAIMKQLLC-AVEYIHDKKLIHRD 292
Query: 932 LKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+K EN+ +N +GD G + K++ G GT+ +PE+L+G +
Sbjct: 293 IKLENIFLNCDG----KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY 345
|
Length = 501 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 48/157 (30%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+GSG YGSV K G VAIK++ +P + E ++E LL + H NV
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLS------RPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 866 VSFYGIVRDGPDGSLATVTEF-MVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEY 921
+ + S +F +V ++ LQK + D+ + L+ M G++Y
Sbjct: 77 IGLLDVFTSAV--SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM--LCGLKY 132
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+H I+H DLK NL VN D + KI D GL++
Sbjct: 133 IHSAGIIHRDLKPGNLAVN-EDCE---LKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + A+K ++ K E++ ++A+ +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAIL-KKKEQKHIMAE---RNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + D L V +++ G L LQ++ + R R A + A + YLH
Sbjct: 59 VGLHYSFQT-AD-KLYFVLDYVNGGELFFHLQRERSFPEPRARFY-AAEIASALGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
NI++ DLK EN+L+ D Q V + D GL K + + + GT ++APE+L
Sbjct: 116 NIIYRDLKPENILL---DSQGHV-VLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 28/70 (40%), Positives = 43/70 (61%), Gaps = 5/70 (7%)
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWM 976
G+E+LH + I++ DLK EN+L++ R I DLGL+ ++K + G GT +M
Sbjct: 109 GLEHLHQRRIIYRDLKPENVLLDNDGNVR----ISDLGLAVELKDGQSKTKGYAGTPGFM 164
Query: 977 APELLSGKSH 986
APELL G+ +
Sbjct: 165 APELLQGEEY 174
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 802 LEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ ++G G+ G V K G VA+K++ K RE L + E +++
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELL----FNEVVIMRD 73
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H NVV Y G + L V EF+ G+L + ++ + +A+ A +
Sbjct: 74 YQHENVVEMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSV 131
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
LH + ++H D+K +++L+ K+ D G ++V ++ + GT WMAP
Sbjct: 132 --LHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 185
Query: 979 ELLS 982
EL+S
Sbjct: 186 ELIS 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 56/186 (30%), Positives = 80/186 (43%), Gaps = 30/186 (16%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G YG V K VAIK+I A+ F + + L +E LL L H NV
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNRIDAKRTL-----REIKLLRHLDHENV 66
Query: 866 VSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
++ I+ P A V E M + L Q ++ D + + G++
Sbjct: 67 IAIKDIMP--PPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLK 122
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKV---KQQTLVSGGVRGTLPW 975
Y+H N++H DLK NLL+N C KI D GL++ K + V T +
Sbjct: 123 YIHSANVLHRDLKPSNLLLNAN------CDLKICDFGLARTTSEKGDFMTEYVV--TRWY 174
Query: 976 MAPELL 981
APELL
Sbjct: 175 RAPELL 180
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 47/191 (24%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLH 861
LG G++G V+ + +G++ FA K +++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVFLAELKGTN--------QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
HP + Y + + L V E++ G L +Q + D + A + G+++
Sbjct: 55 HPFLTHLYCTFQTKEN--LFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQF 111
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK------VKQQTLVSGGVRGTLPW 975
LH K IV+ DLK +N+L++ KI D G+ K K T GT +
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDGH----IKIADFGMCKENMLGDAKTCTFC-----GTPDY 162
Query: 976 MAPELLSGKSH 986
+APE+L G+ +
Sbjct: 163 IAPEILLGQKY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
R LG G++G V + + S A+K +K + + + ++ +L + +HP
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL----QDDDVECTMTEKRILSLARNHP 56
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+ Y + PD L V EF VNG F +K R D + A + + +LH
Sbjct: 57 FLTQLYCCFQT-PD-RLFFVMEF-VNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
K I++ DLK +N+L++ + CK+ D G+ K + GT ++APE+L
Sbjct: 114 DKGIIYRDLKLDNVLLD-HEGH---CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 51/195 (26%), Positives = 90/195 (46%), Gaps = 36/195 (18%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIAD-------FWKEALL 856
+ LG G++G V + +G+D A+K +K ++ ++ D K L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLK----------KDVILQDDDVECTMTEKRVLA 50
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L+ HP + + + D L V E++ G L +Q+ R + R R A +
Sbjct: 51 LAG-KHPFLTQLHSCFQT-KD-RLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY-AAEIV 106
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----G 971
G+++LH + I++ DLK +N+L++ KI D G+ K + GGV G
Sbjct: 107 LGLQFLHERGIIYRDLKLDNVLLDSEGH----IKIADFGMCKEG----ILGGVTTSTFCG 158
Query: 972 TLPWMAPELLSGKSH 986
T ++APE+LS + +
Sbjct: 159 TPDYIAPEILSYQPY 173
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 23/183 (12%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V + R + A+K I+ + + SE +A E +L+ ++ P +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSR-SEVTHTLA----ERTVLAQVNCPFI 55
Query: 866 V----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
V SF L V F+ G L LQ++ R R R A + +E
Sbjct: 56 VPLKFSFQS------PEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA-ELLCALEN 108
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPEL 980
LH N+++ DLK EN+L++ + +C D GL K+ + + GT ++APEL
Sbjct: 109 LHKFNVIYRDLKPENILLDYQG-HIALC---DFGLCKLNMKDDDKTNTFCGTPEYLAPEL 164
Query: 981 LSG 983
L G
Sbjct: 165 LLG 167
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 27/87 (31%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 896 LQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
L++ + +D L + A GM +L KN +H DL N+L+ + KI D G
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDFG 259
Query: 956 LS---KVKQQTLVSGGVRGTLPWMAPE 979
L+ + +V G R + WMAPE
Sbjct: 260 LARDIRNDSNYVVKGNARLPVKWMAPE 286
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 34/205 (16%)
Query: 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKAS--CFAGKPSERERLI-- 847
R LQ +K +D + V+ +G G +G +V + R K+S +A K + +I
Sbjct: 36 RKLQ-MKAEDYDVVKVIGRGAFG----------EVQLVRHKSSQKVYAMKLLSKFEMIKR 84
Query: 848 ---ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
A FW+E +++ + P VV + +D D L V E+M G L + D +
Sbjct: 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQD--DKYLYMVMEYMPGGDLVNLMSNYD--VP 140
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+ + ++ +H ++H D+K +N+L++ + K+ D G +T
Sbjct: 141 EKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLADFGTCMKMDET- 195
Query: 965 VSGGVR-----GTLPWMAPELLSGK 984
G VR GT +++PE+L +
Sbjct: 196 --GMVRCDTAVGTPDYISPEVLKSQ 218
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 5e-05
Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 44/171 (25%)
Query: 805 VRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFA--GKPSERERLIADFWKEALL 856
+++LG G YG V W+ D VA+K+I F ++ +R ++E +
Sbjct: 12 LQKLGKGAYGIV----WKAIDRRTKEVVALKKI----FDAFRNATDAQRT----FREIMF 59
Query: 857 LSSL-HHPNVVSFYGIVRDGPDGSLATVTEFM---VNGSLKQFLQKKDRTIDRRKRLII- 911
L L HPN+V +++ D + V E+M ++ ++ + + D KR I+
Sbjct: 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE-----DVHKRYIMY 114
Query: 912 ----AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
A ++Y+H N++H DLK N+L+N D + K+ D GL++
Sbjct: 115 QLLKA------LKYIHSGNVIHRDLKPSNILLN-SDCR---VKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 6e-05
Identities = 47/177 (26%), Positives = 84/177 (47%), Gaps = 14/177 (7%)
Query: 808 LGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V + + + A+K ++ K E+ + + +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMS----ERNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
V + + L V +++ G L LQ++ ++ R R A + A + YLH
Sbjct: 59 VGLHFSFQTA--DKLYFVLDYINGGELFYHLQRERCFLEPRARFY-AAEIASALGYLHSL 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
NIV+ DLK EN+L+ D Q + + D GL K + + GT ++APE+L
Sbjct: 116 NIVYRDLKPENILL---DSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 16/178 (8%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
+G G++G V K + G A+K ++ + E++ ++A+ +LL ++ HP +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNR-KEQKHIMAE---RNVLLKNVKHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAAFGMEYLHG 924
V + + L V +F+ G L LQ++ + R R A + +A G YLH
Sbjct: 59 VGLHYSFQT--TEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG--YLHS 114
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-QQTLVSGGVRGTLPWMAPELL 981
NIV+ DLK EN+L+ D Q V + D GL K Q+ + GT ++APE++
Sbjct: 115 INIVYRDLKPENILL---DSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 7e-05
Identities = 31/119 (26%), Positives = 54/119 (45%), Gaps = 9/119 (7%)
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+PN + Y V G + + +++ +G L L+K+ + + + II +
Sbjct: 67 DNPNFIKLYYSV-TTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKII-RQLVEALN 123
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPE 979
LH NI+H D+K EN+L + + +C D GL K+ GTL + +PE
Sbjct: 124 DLHKHNIIHNDIKLENVLYDRAKDRIYLC---DYGLCKIIGTPSCY---DGTLDYFSPE 176
|
Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 802 LEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
LE ++G G+ G V K G VA+K + K RE L + E +++
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR----KQQRRELL----FNEVVIMRD 74
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
H NVV Y G + L + EF+ G+L + + ++ + ++ A +
Sbjct: 75 YQHQNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQA--L 130
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-SKVKQQTLVSGGVRGTLPWMAP 978
YLH + ++H D+K +++L+ + K+ D G +++ + + GT WMAP
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGR----VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 979 ELLS 982
E++S
Sbjct: 187 EVIS 190
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 18/181 (9%)
Query: 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
++G G YG V+ K + + VA+KR+K S R L E +L++
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVL-----TERDILTTTKSEW 62
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAAFGMEYLH 923
+V +D D L E++ G + L + R +A M A ++ LH
Sbjct: 63 LVKLLYAFQD--DEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDALH 118
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983
+H DLK EN L++ K+ D GLSK S V G+ +MAPE+L G
Sbjct: 119 ELGYIHRDLKPENFLID----ASGHIKLTDFGLSKGIVTYANS--VVGSPDYMAPEVLRG 172
Query: 984 K 984
K
Sbjct: 173 K 173
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 9e-05
Identities = 45/186 (24%), Positives = 86/186 (46%), Gaps = 32/186 (17%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIAD------FWKEALLLSS 859
LG G++G V + +G+D AIK +K ++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLK----------KDVILQDDDVDCTMTEKRILALA 52
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
HP + + + + D L V E+ VNG F ++ R D + A + +
Sbjct: 53 AKHPFLTALHCCFQT-KD-RLFFVMEY-VNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
+LH +++ DLK +N+L++ CK+ D G+ K + +++G GT +
Sbjct: 110 MFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162
Query: 976 MAPELL 981
+APE+L
Sbjct: 163 IAPEIL 168
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 48/184 (26%), Positives = 84/184 (45%), Gaps = 18/184 (9%)
Query: 808 LGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G++G V + +G++ AIK +K ++ + L L+ HP +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVE---RRVLALAW-EHPFL 58
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
+ + L V E++ G L +Q R + R R A + G+++LH K
Sbjct: 59 THLFCTFQT--KEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFY-AAEIICGLQFLHKK 115
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GTLPWMAPELLS 982
I++ DLK +N+L++ +D KI D G+ K+ G GT ++APE+L
Sbjct: 116 GIIYRDLKLDNVLLD-KDGH---IKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILK 169
Query: 983 GKSH 986
G+ +
Sbjct: 170 GQKY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 43/161 (26%), Positives = 76/161 (47%), Gaps = 14/161 (8%)
Query: 800 DDLEEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V K G A+K+++ S + E+E++ A E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS----EMLEKEQV-AHVRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ +P VV Y +D + L + E++ G + L KKD + R IA +
Sbjct: 56 AEADNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA-ETIL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++ +H +H D+K +NLL++ + K+ D GL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E ++ + +G YG+VY + + + A+K+I + ++ +++ E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILR-NQIQQVFV----ERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ +P VVS + L V E++ G L+ R+ A +
Sbjct: 56 TFAENPFVVSMFCSFET--KRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVL 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+EYLH IVH DLK +NLL+ K+ D GLSK+
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLITSMGH----IKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 16/189 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ R LG G +G V + R G A K+++ + E L E +L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMAL-----NEKQILEK 56
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFG 918
++ VVS + D +L V M G LK + + + + A + G
Sbjct: 57 VNSRFVVSL-AYAYETKD-ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+E LH + IV+ DLK EN+L++ R I DLGL+ V + + G V GT+ +MA
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIR----ISDLGLAVHVPEGQTIKGRV-GTVGYMA 169
Query: 978 PELLSGKSH 986
PE++ + +
Sbjct: 170 PEVVKNERY 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 30/190 (15%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLH 861
LG G++G V + +G K FA K +++ ++ D ++ +L +
Sbjct: 3 LGKGSFGKVLLAELKG--------KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE 54
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+P + Y + L V EF+ G L +Q K R D + A + G+++
Sbjct: 55 NPFLTHLYCTFQT--KEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQF 111
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWM 976
LH K I++ DLK +N++++ RD KI D G+ K V G R GT ++
Sbjct: 112 LHSKGIIYRDLKLDNVMLD-RDGH---IKIADFGMCKEN----VFGDNRASTFCGTPDYI 163
Query: 977 APELLSGKSH 986
APE+L G +
Sbjct: 164 APEILQGLKY 173
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 51/182 (28%), Positives = 81/182 (44%), Gaps = 25/182 (13%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K ++ K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-----VAHTVTESRVLQNTRHPFL 57
Query: 866 VSF-YGI-VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
+ Y D L V E+ G L L ++ + R R A + +EYLH
Sbjct: 58 TALKYAFQTHD----RLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPE 979
+++V+ D+K ENL+++ +D KI D GL K + + G GT ++APE
Sbjct: 113 SRDVVYRDIKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 165
Query: 980 LL 981
+L
Sbjct: 166 VL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 49/181 (27%), Positives = 76/181 (41%), Gaps = 23/181 (12%)
Query: 808 LGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLQNTRHPFL 57
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+ Y L V E+ NG F ++R + + + YLH
Sbjct: 58 TALKYSF---QTHDRLCFVMEY-ANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMAPEL 980
++V+ DLK ENL+++ +D KI D GL K + + G GT ++APE+
Sbjct: 114 CDVVYRDLKLENLMLD-KDGH---IKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 981 L 981
L
Sbjct: 167 L 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 60/254 (23%), Positives = 91/254 (35%), Gaps = 82/254 (32%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L + LG G +G V G D VA+K +K A SE + L+++
Sbjct: 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA---SEHKALMSE 60
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQ--------FLQKKDR 901
+L+ +H NVV+ G P+G L + EF G+L F +++
Sbjct: 61 L---KILIHIGNHLNVVNLLGACTK-PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREK 116
Query: 902 T---------------IDRRKR-------------------------------------- 908
+ +DRR
Sbjct: 117 SPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDL 176
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV- 965
+ + A GME+L + +H DL N+L++ + V KI D GL++ K V
Sbjct: 177 ICYSFQVARGMEFLASRKCIHRDLAARNILLSENN----VVKICDFGLARDIYKDPDYVR 232
Query: 966 SGGVRGTLPWMAPE 979
G R L WMAPE
Sbjct: 233 KGSARLPLKWMAPE 246
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 51/179 (28%), Positives = 77/179 (43%), Gaps = 19/179 (10%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GT+G V K G A+K +K K +A E+ +L + HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDE-----VAHTLTESRVLKNTRHPFL 57
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
S + L V E+ VNG F ++R + + ++YLH
Sbjct: 58 TSLKYSFQT--KDRLCFVMEY-VNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG 114
Query: 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPELL 981
IV+ DLK ENL+++ +D KI D GL K T+ + GT ++APE+L
Sbjct: 115 KIVYRDLKLENLMLD-KDGH---IKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVL 167
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-04
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD E ++ +G G +G V+ + + + A+K ++ S + IA E +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-----IAHVRAERDIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA-MDAA 916
+ P +V Y +D + L V E+M G L L +KD + R IA + A
Sbjct: 56 ADADSPWIVKLYYSFQD--EEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLA 113
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++ +H +H D+K +N+L++ D K+ D GL K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILID-ADGH---IKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-04
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 14/158 (8%)
Query: 805 VRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
V+ + G +G VY G K A+K +K + K + ++ A+ ++AL LS
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK-NMVHQVQAE--RDALALSK--S 63
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P +V Y ++ + L V E+++ G +K L + I+ + A ++YL
Sbjct: 64 PFIVHLYYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYL 120
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
H I+H DLK +N+L++ K+ D GLSKV
Sbjct: 121 HRHGIIHRDLKPDNMLIS----NEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 48/198 (24%), Positives = 91/198 (45%), Gaps = 35/198 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVA-----------IKRIKASCFAGKPSERERLIA 848
+D E ++ +G G +G V K + +D +KR + +CF ER+ L+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR---EERDVLVN 57
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +D + +L V ++ V G L L K +DR +
Sbjct: 58 G---DNQWITTLHYA--------FQD--ENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R +A + ++ +H + VH D+K +N+L++M R + D G L ++ T+
Sbjct: 105 RFYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIR----LADFGSCLKLMEDGTVQ 159
Query: 966 SGGVRGTLPWMAPELLSG 983
S GT +++PE+L
Sbjct: 160 SSVAVGTPDYISPEILQA 177
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 25/188 (13%)
Query: 806 RELGSGTYGSVYHGK-WRGSDVA---IKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+E+G+G +G V + + + VA +K +KA+ E+ +F ++ L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQN----EFLQQGDPYRILQ 53
Query: 862 HPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLI--IAMDAAF 917
HPN++ G V P V E+ G LK +L Q++ + + L+ +A + A
Sbjct: 54 HPNILQCLGQCVEAIP---YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD--LGLSKVKQQTLVS-GGVRGTLP 974
G+ ++H N +H DL N + K+GD +G S+ K+ + + L
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166
Query: 975 WMAPELLS 982
W+APEL+
Sbjct: 167 WLAPELVG 174
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 8/93 (8%)
Query: 891 SLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
K +D +D L + A GM++L KN +H D+ N+L+ V
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVA 251
Query: 950 KIGDLGLSK---VKQQTLVSGGVRGTLPWMAPE 979
KI D GL++ +V G R + WMAPE
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 45/188 (23%), Positives = 82/188 (43%), Gaps = 25/188 (13%)
Query: 802 LEEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ + +GSG YGSV Y + R VA+K++ +P + ++E LL
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR-QKVAVKKLS------RPFQSLIHARRTYRELRLLK 69
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ H NV+ + P S+ E ++ L ++ + + + + LI +
Sbjct: 70 HMKHENVIGLLDVFT--PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL 127
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G++Y+H I+H DLK N+ VN + +I D GL++ + G T
Sbjct: 128 --LRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRILDFGLARQADDEMT--GYVATR 179
Query: 974 PWMAPELL 981
+ APE++
Sbjct: 180 WYRAPEIM 187
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 26/67 (38%), Positives = 35/67 (52%), Gaps = 7/67 (10%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV-SGGVRGT 972
A GME+L + +H DL N+L++ + V KI D GL++ K V G R
Sbjct: 183 ARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 973 LPWMAPE 979
L WMAPE
Sbjct: 239 LKWMAPE 245
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 7e-04
Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 16/183 (8%)
Query: 808 LGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G +G V K G A K++ K E+ L+ E +L ++ P +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALL-----EKEILEKVNSPFI 55
Query: 866 VSF-YGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923
V+ Y L V M G LK +R ++ + + + G+ +LH
Sbjct: 56 VNLAYAF---ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983
+IV+ D+K EN+L++ + C++ DLGL+ + GT +MAPE+L
Sbjct: 113 SMDIVYRDMKPENVLLDDQGN----CRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE 168
Query: 984 KSH 986
+ +
Sbjct: 169 EPY 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-04
Identities = 52/191 (27%), Positives = 84/191 (43%), Gaps = 27/191 (14%)
Query: 800 DDLEEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + + +GSG YGSV + K G VA+K++ +P + ++E L
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLS------RPFQSIIHAKRTYRELRL 69
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + H NV+ + P SL VT M L ++ + T D + LI
Sbjct: 70 LKHMKHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLI 126
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ G++Y+H +I+H DLK NL VN + KI D GL++ + G
Sbjct: 127 YQI--LRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILDFGLARHTDDEMT--GYV 178
Query: 971 GTLPWMAPELL 981
T + APE++
Sbjct: 179 ATRWYRAPEIM 189
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 17/112 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
D+L+ + LG+G +G V G VA+K +KAS ERE L++
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS---AHTDEREALMS---- 90
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI 903
E +LS L H N+V+ G G G + +TE+ G L FL+KK T
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHG--GPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 29/168 (17%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++EV +G G+YG V G VAIK+I F S+ R++ +E LL
Sbjct: 4 IQEV--IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFE-HVSDATRIL----REIKLLRL 55
Query: 860 LHHPNVVSFYGIV-----RDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAM 913
L HP++V I+ R+ D + V E M L Q ++ D T + + + +
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKD--IYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQL 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKV 959
++Y+H N+ H DLK +N+L N C KI D GL++V
Sbjct: 113 --LRALKYIHTANVFHRDLKPKNILANAD------CKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 46/203 (22%), Positives = 87/203 (42%), Gaps = 50/203 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+DLE + E+GSGT G VY +++ G +A+K+++ + G E +R++ D ++L
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDL---DVVL 68
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------- 910
S P +V YG F+ + + ++ +D+ + I
Sbjct: 69 KSHDCPYIVKCYGY--------------FITDSDVFICMELMSTCLDKLLKRIQGPIPED 114
Query: 911 ----IAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGL------SKV 959
+ + + YL K ++H D+K N+L++ K+ D G+ SK
Sbjct: 115 ILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKLCDFGISGRLVDSKA 170
Query: 960 KQQTLVSGGVRGTLPWMAPELLS 982
K ++ G +MAPE +
Sbjct: 171 KTRS------AGCAAYMAPERID 187
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.001
Identities = 42/191 (21%), Positives = 86/191 (45%), Gaps = 22/191 (11%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEF-----MVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
+H N++S + P SL + +++ +L Q +Q + +D + +
Sbjct: 74 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQM 128
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184
Query: 976 MAPELLSGKSH 986
APE++ G +
Sbjct: 185 RAPEVILGMGY 195
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 35/196 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-----------VAIKRIKASCFAGKPSERERLIA 848
DD E ++ +G G +G V K + ++ +KR + +CF ER L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR---EERNVLVN 57
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRK 907
+ +++LH+ +D + L V ++ V G L L K +DR +
Sbjct: 58 G---DCQWITTLHYA--------FQD--ENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA 104
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG--LSKVKQQTLV 965
R IA + + +H + VH D+K +N+L++M R + D G L + T+
Sbjct: 105 RFYIA-EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIR----LADFGSCLKMNQDGTVQ 159
Query: 966 SGGVRGTLPWMAPELL 981
S GT +++PE+L
Sbjct: 160 SSVAVGTPDYISPEIL 175
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 23/195 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLI-----ADFW 851
+K +D E V+ +G G +G V + + +A K + +I A FW
Sbjct: 40 MKAEDYEVVKVIGRGAFGEV--------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E +++ + P VV + +D D L V E+M G L + D ++ R
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYT 148
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVR 970
A + ++ +H +H D+K +N+L++ + K+ D G K+ ++ +V
Sbjct: 149 A-EVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 971 -GTLPWMAPELLSGK 984
GT +++PE+L +
Sbjct: 204 VGTPDYISPEVLKSQ 218
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 45/189 (23%), Positives = 84/189 (44%), Gaps = 24/189 (12%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++++ +GSG G V G +VA+K++ +P + + ++E +LL +
Sbjct: 24 QQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKRAYRELVLLKCV 77
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+H N++S + P SL V E M + +L Q + + +D + +
Sbjct: 78 NHKNIISLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIHME---LDHERMSYLLYQ 131
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V KI D GL++ + T
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTACTNFMMTPYVVTRY 187
Query: 975 WMAPELLSG 983
+ APE++ G
Sbjct: 188 YRAPEVILG 196
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 26/67 (38%), Positives = 35/67 (52%), Gaps = 7/67 (10%)
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLV-SGGVRGT 972
A GME+L + +H DL N+L++ + V KI D GL++ K V G R
Sbjct: 189 AKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 973 LPWMAPE 979
L WMAPE
Sbjct: 245 LKWMAPE 251
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 24/166 (14%)
Query: 803 EEVRELGSGTYGSV--YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + G +VAIK++ +P + ++E +L+ +
Sbjct: 19 QNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLS------RPFQNVTHAKRAYRELVLMKLV 72
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+H N++ + P SL V E M + +L Q +Q D +R L+ M
Sbjct: 73 NHKNIIGLLNVFT--PQKSLEEFQDVYLVMELM-DANLCQVIQM-DLDHERMSYLLYQM- 127
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
G+++LH I+H DLK N++V KI D GL++
Sbjct: 128 -LCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTA 168
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 0.003
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
++ E ++++G+G +G V+ K + + S K E+ +L+ E ++
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI----EVNVMRE 68
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---IDRRKRLIIAMDAA 916
L H N+V + + + L + EF G L + +QK + I+ + I
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 917 FGMEYLH-------GKNIVHFDLKCENLLVNMRDPQ-------------RPVCKIGDLGL 956
+ Y H G+ ++H DLK +N+ ++ RP+ KIGD GL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 957 SKVKQQTLVSGGVRGTLPWMAPELL 981
SK ++ GT + +PELL
Sbjct: 189 SKNIGIESMAHSCVGTPYYWSPELL 213
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 993 | |||
| cd06410 | 97 | PB1_UP2 Uncharacterized protein 2. The PB1 domain | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.98 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.97 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.96 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.94 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.94 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.94 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.94 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.94 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.94 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.94 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.93 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.93 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.93 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.93 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.93 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.92 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.92 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.92 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.92 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.92 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.92 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.92 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.92 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.92 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.92 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.92 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.92 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.92 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.92 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.91 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.91 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.91 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.91 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.91 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.91 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.91 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.91 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.91 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.91 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.91 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.91 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.91 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.91 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.91 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.91 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.91 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.91 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.91 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.91 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.91 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.91 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.91 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.91 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.91 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.91 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.9 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.9 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.9 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.9 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.9 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.9 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.9 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.9 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.9 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.9 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.9 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.9 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.9 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.89 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.89 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.89 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.89 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.89 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.89 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.89 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.89 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.89 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.89 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.89 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.88 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.88 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.88 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.88 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.88 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.88 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.88 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.87 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.87 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.87 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.87 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.85 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.85 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.84 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.84 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.84 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.83 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.83 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.79 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.79 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.61 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.61 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.41 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.28 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.23 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.2 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.16 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.14 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.08 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.08 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| smart00666 | 81 | PB1 PB1 domain. Phox and Bem1p domain, present in | 98.95 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.87 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.82 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.48 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.45 | |
| PF00564 | 84 | PB1: PB1 domain; InterPro: IPR000270 The Phox and | 98.45 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| cd05992 | 81 | PB1 The PB1 domain is a modular domain mediating s | 98.28 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.18 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.08 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.93 | |
| cd06407 | 82 | PB1_NLP A PB1 domain is present in NIN like protei | 97.91 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.88 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.72 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.72 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.61 | |
| cd06408 | 86 | PB1_NoxR The PB1 domain is present in the Epichloe | 97.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.51 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.5 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.44 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.37 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.33 | |
| cd06405 | 79 | PB1_Mekk2_3 The PB1 domain is present in the two m | 97.31 | |
| cd06401 | 81 | PB1_TFG The PB1 domain found in TFG protein, an on | 97.09 | |
| cd06398 | 91 | PB1_Joka2 The PB1 domain is present in the Nicotia | 97.04 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.0 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.85 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.85 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.75 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.75 | |
| cd06404 | 83 | PB1_aPKC PB1 domain is an essential modular domain | 96.67 | |
| cd06396 | 81 | PB1_NBR1 The PB1 domain is an essential part of NB | 96.62 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.61 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.51 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.23 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.03 | |
| cd06397 | 82 | PB1_UP1 Uncharacterized protein 1. The PB1 domain | 95.95 | |
| cd06402 | 87 | PB1_p62 The PB1 domain is an essential part of p62 | 95.7 | |
| PLN02236 | 344 | choline kinase | 95.67 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.51 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.38 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.98 | |
| cd06406 | 80 | PB1_P67 A PB1 domain is present in p67 proteins wh | 94.65 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.52 | |
| cd06403 | 80 | PB1_Par6 The PB1 domain is an essential part of Pa | 94.43 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 94.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 93.48 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 93.17 |
| >cd06410 PB1_UP2 Uncharacterized protein 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=275.32 Aligned_cols=95 Identities=65% Similarity=1.140 Sum_probs=91.7
Q ss_pred EeecCCeeecCCCCCCeeeecCceeEEEccCCCChHHHHHHHHHHhCCc--eEEEeeCCCCCCCceeeecChhhHHHHHH
Q 001940 27 LCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEGA--VVLKYQQPDEDLDALVSVVNDDDVINMME 104 (993)
Q Consensus 27 mcsyGG~i~pr~~d~~l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~~~--~~lkyqLp~edld~LisV~~deDl~~m~~ 104 (993)
||||||+|+||++||+|+|+||+||||+|+|++||+||++||+++++.. ++||||||+||||+||||++||||+|||+
T Consensus 1 ~cs~GG~i~pr~~dg~l~Y~GG~tr~i~V~r~~s~~el~~kl~~~~~~~~~~~lky~Lp~edld~Lisv~~DeDl~~M~~ 80 (97)
T cd06410 1 LCSYGGRILPRPPDGQLRYVGGETRIVSVDRSISFKELVSKLSELFGAGVVVTLKYQLPDEDLDALISVSNDEDLKNMME 80 (97)
T ss_pred CcccCCEEeCcCCCCCEEEcCCceEEEEEcCCCCHHHHHHHHHHHhCCCCceEEEEEcCCCCcceeEEecCcHHHHHHHH
Confidence 8999999999999999999999999999999999999999999999875 59999999999999999999999999999
Q ss_pred HHHHhcCCCCCCeEEEEEe
Q 001940 105 EYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 105 eydr~~~~~~~~rlR~flf 123 (993)
||||+ +.+++|+|||||
T Consensus 81 e~~~~--~~~~~rirvflf 97 (97)
T cd06410 81 EYDRL--SGGSARLRVFLF 97 (97)
T ss_pred hhccc--cCCCceEEEEEC
Confidence 99998 567799999998
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=323.58 Aligned_cols=185 Identities=29% Similarity=0.532 Sum_probs=162.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|.+.+.||.|+|++||+|+++ +..||||.+.+..+. ...++.+..|+.+|+.|+|||||+++++++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~------~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-- 80 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN------KKLVELLLSEIKILKELKHPNIVRLLDCIED-- 80 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC------HHHHHHHHHHHHHHHhcCCcceeeEEEEEec--
Confidence 468999999999999999999884 778999999876432 2344678899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC--CeEEEEec
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR--PVCKIGDL 954 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~--g~VKLiDF 954 (993)
.+.+|||||||.||||.++|++++ .+++..++.++.||+.||++||+++||||||||+||||+.....+ ..+||+||
T Consensus 81 ~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF 159 (429)
T KOG0595|consen 81 DDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADF 159 (429)
T ss_pred CCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence 578999999999999999998876 499999999999999999999999999999999999998653233 68999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|+...........||++.|||||++... +|..++|+
T Consensus 160 GfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADL 197 (429)
T KOG0595|consen 160 GFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADL 197 (429)
T ss_pred chhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhH
Confidence 999999888778889999999999999855 45556664
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.29 Aligned_cols=191 Identities=27% Similarity=0.345 Sum_probs=162.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+.|.+.+.||+|+||.|-+|.. +++.||||++++......... ........+|+++|++|+|||||+++++|..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~-~~~~~~v~~EieILkkL~HP~IV~~~d~f~~- 247 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRA-IAKTRDVQNEIEILKKLSHPNIVRIKDFFEV- 247 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccccc-ccchhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence 456788999999999999999977 588999999998876553321 1122346799999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+..|||||||+||+|++.+-.++. +.+...+.+++||+.||.|||+.||+||||||+|||+..+. +...+||+|||
T Consensus 248 -~ds~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-e~~llKItDFG 324 (475)
T KOG0615|consen 248 -PDSSYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-EDCLLKITDFG 324 (475)
T ss_pred -CCceEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC-cceEEEecccc
Confidence 4668999999999999999977654 78888899999999999999999999999999999998554 66899999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCc--cCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKS--HMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~--y~tse~DI 993 (993)
+|+..........+|||+.|.|||++.++. ++..++||
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDi 364 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDI 364 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchhee
Confidence 999988777788999999999999997554 45556665
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=310.02 Aligned_cols=184 Identities=47% Similarity=0.774 Sum_probs=159.1
Q ss_pred CCCceEEEEecccCceEEEEEEEcCcc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kgt~-VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..++.+.+.||.|+||+||+|.|+++. ||||++......... .+.|.+|+.+|.+|+|||||+++|+|.+..
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~------~~~f~~E~~il~~l~HpNIV~f~G~~~~~~- 112 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES------RKAFRREASLLSRLRHPNIVQFYGACTSPP- 112 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH------HHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 344555667999999999999999999 999999876443211 568999999999999999999999999842
Q ss_pred CcEEEEEeeccCCcHHHHHHh-ccCccCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEEEccCCCCCC-eEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRP-VCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~-~~k~Lse~~~lkIalQIL~GLeYLHs~g-IIHRDIKPeNILLd~~d~e~g-~VKLiDF 954 (993)
..++||||||++|+|.++|.. ....+++..++.|++||++||+|||+.+ |||||||++|||++ .+. ++||+||
T Consensus 113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~----~~~~~~KI~DF 188 (362)
T KOG0192|consen 113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD----LKGKTLKIADF 188 (362)
T ss_pred CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc----CCCCEEEECCC
Confidence 269999999999999999988 4677999999999999999999999999 99999999999998 555 9999999
Q ss_pred CCccccccc-cccCCCCCCCCccccccccC-CccCCCCCCC
Q 001940 955 GLSKVKQQT-LVSGGVRGTLPWMAPELLSG-KSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~-~~s~s~~GTp~YmAPEVL~G-k~y~tse~DI 993 (993)
|+++..... .......||+.|||||++.+ +..++.++||
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~Dv 229 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDV 229 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchh
Confidence 999987654 33344789999999999997 4778888886
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=301.34 Aligned_cols=181 Identities=28% Similarity=0.430 Sum_probs=157.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
....++|+++++||+|+||+||.++. +++.+|+|++++.....+ ..++....|..+|.+++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-----~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-----KEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-----hhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 34568899999999999999999977 467799999998765433 33567889999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+|||+||+.||+|+..|++.+. +++..+..++.+|+.||.|||++|||||||||+|||+| ..|+++|+|
T Consensus 96 t--~~kLylVld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd----~~GHi~LtD 168 (357)
T KOG0598|consen 96 T--EEKLYLVLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLD----EQGHIKLTD 168 (357)
T ss_pred c--CCeEEEEEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeec----CCCcEEEec
Confidence 9 6789999999999999999988765 77777777777999999999999999999999999999 778999999
Q ss_pred cCCcccc-ccccccCCCCCCCCccccccccCCccCC
Q 001940 954 LGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 954 FGLAk~~-~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
||+|+.. .....+..+|||+.|||||++.+++|..
T Consensus 169 FgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~ 204 (357)
T KOG0598|consen 169 FGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDK 204 (357)
T ss_pred cccchhcccCCCccccccCCccccChHHHhcCCCCc
Confidence 9999954 4445566789999999999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=296.63 Aligned_cols=182 Identities=34% Similarity=0.501 Sum_probs=158.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+...+++.++.||+|..|+|||++++ ++.+|+|++... .+....+++.+|+++++.++||+||.+||+|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-------~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-------IDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-------CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 34456778899999999999999985 777999999543 123455688999999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
... .+.|+||||++|+|.+++...++ +++....+|+.++++||.|||+ .+||||||||+||||+ .+|.|||||
T Consensus 149 ~~~-~isI~mEYMDgGSLd~~~k~~g~-i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN----skGeVKicD 222 (364)
T KOG0581|consen 149 NGE-EISICMEYMDGGSLDDILKRVGR-IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN----SKGEVKICD 222 (364)
T ss_pred CCc-eEEeehhhcCCCCHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec----cCCCEEecc
Confidence 422 59999999999999999987754 8999999999999999999995 8999999999999998 778999999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||.|+.+... ...+++||..|||||.+.|..|... .||
T Consensus 223 FGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~-sDI 260 (364)
T KOG0581|consen 223 FGVSGILVNS-IANTFVGTSAYMSPERISGESYSVK-SDI 260 (364)
T ss_pred ccccHHhhhh-hcccccccccccChhhhcCCcCCcc-cce
Confidence 9999988777 6678999999999999999866544 665
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=305.30 Aligned_cols=186 Identities=28% Similarity=0.436 Sum_probs=162.0
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
...+.|+.+++||+|+||.||+|++ +++.||+|++..... ++.......+||.||++|.|||||+|.++..+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~------~~~~~~t~~REI~ILr~l~HpNIikL~eivt~ 187 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE------KEGFPITAIREIKILRRLDHPNIIKLEEIVTS 187 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC------CCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence 3446788999999999999999988 577799999986532 12233466799999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...+.+|||+||| .-||..++....-.+++.+++.|+.||+.||+|||++||+|||||.+||||| .+|.+||+||
T Consensus 188 ~~~~siYlVFeYM-dhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLid----n~G~LKiaDF 262 (560)
T KOG0600|consen 188 KLSGSIYLVFEYM-DHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILID----NNGVLKIADF 262 (560)
T ss_pred cCCceEEEEEecc-cchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEc----CCCCEEeccc
Confidence 6567899999999 5699999988777899999999999999999999999999999999999999 7789999999
Q ss_pred CCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+.+.... ..+..+-|+||+|||+|+|...|++.+||
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDl 303 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDL 303 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceee
Confidence 9999765443 34556679999999999999999999996
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=304.15 Aligned_cols=181 Identities=28% Similarity=0.446 Sum_probs=159.6
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|+..+.||+|||++||++++ +++.||+|++.+..+... ...+.+.+|++|.+.|+|||||+++++|++ .
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~-----~~reKv~~EIeIHr~L~HpnIV~f~~~FED--s 90 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKP-----KQREKVLNEIEIHRSLKHPNIVQFYHFFED--S 90 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCc-----chHHHHHHHHHHHHhcCCCcEEeeeeEeec--C
Confidence 6799999999999999999988 588999999988655432 223567899999999999999999999999 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
++.|||+|+|..++|..++++ .+.+++.++++++.||+.||.|||+.+|||||||..|||++ ++..|||+|||||
T Consensus 91 ~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~----~~~~VKIgDFGLA 165 (592)
T KOG0575|consen 91 NNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN----ENMNVKIGDFGLA 165 (592)
T ss_pred CceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec----CcCcEEeccccee
Confidence 789999999999999999984 45699999999999999999999999999999999999998 7789999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...+.. ....++||||.|.|||++.++.+ +.++||
T Consensus 166 t~le~~~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDi 201 (592)
T KOG0575|consen 166 TQLEYDGERKKTLCGTPNYIAPEVLNKSGH-SFEVDI 201 (592)
T ss_pred eeecCcccccceecCCCcccChhHhccCCC-CCchhh
Confidence 987744 56678999999999999995544 556665
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=292.75 Aligned_cols=187 Identities=27% Similarity=0.401 Sum_probs=162.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~ 873 (993)
.....|++.+.||+|+||+|++|.. ++..||||+++........ ....+.+.+|+.++++++ ||||++++.++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~---~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKS---QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccc---cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 4567899999999999999999987 5788999988765322111 122345668999999999 999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC-CeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR-PVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~-g~VKLi 952 (993)
. ...+++||||+.||+|++++.+ ...+.+..+.+++.||+.|++|||++||+||||||+|||++ .+ +.+||+
T Consensus 91 t--~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld----~~~~~~Kl~ 163 (370)
T KOG0583|consen 91 T--PTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD----GNEGNLKLS 163 (370)
T ss_pred c--CCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec----CCCCCEEEe
Confidence 8 4559999999999999999998 44588899999999999999999999999999999999998 44 799999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~-~~~~~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
|||++... .........+||+.|+|||++.++. |...++||
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDv 206 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADV 206 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhh
Confidence 99999988 4555677889999999999999999 99999996
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=304.29 Aligned_cols=182 Identities=30% Similarity=0.428 Sum_probs=163.0
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~ 875 (993)
.++|.++++||.|+||.||+|+. .+..||||.++...... ++ -.-+||+..|++|. |||||++++++.+.
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~-----ee--~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW-----EE--CMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH-----HH--HHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 46789999999999999999987 47789999999765432 11 13468999999999 99999999999985
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
. ..+++||||| .++|+++++.+++.+++..++.|+.||++||+|+|++|++||||||+|||+. ....|||+|||
T Consensus 82 ~-~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~----~~~~iKiaDFG 155 (538)
T KOG0661|consen 82 D-RILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS----GNDVIKIADFG 155 (538)
T ss_pred C-ceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec----ccceeEecccc
Confidence 3 3899999999 7899999999999999999999999999999999999999999999999997 46799999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+........+.++-|-||+|||+++...+|+.++||
T Consensus 156 LARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~ 193 (538)
T KOG0661|consen 156 LAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDM 193 (538)
T ss_pred cccccccCCCcchhhhcccccchHHhhhccccCCchHH
Confidence 99988877777788999999999999999999999996
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=284.91 Aligned_cols=181 Identities=24% Similarity=0.326 Sum_probs=157.3
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+.|+.+.++|+|+||.||+++. +|+.||||++.... +....-+...+|+.+|++|+|+|+|.++.+|.. .
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese------dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr--k 73 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE------DDPVVKKIALREIRMLKQLKHENLVNLIEVFRR--K 73 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC------ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh--c
Confidence 3588889999999999999987 48889999987541 223334567899999999999999999999988 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||+|||+. ++.+-|.+....++...+.+++.|++.|+.|+|+++||||||||+||||+ .++.+||||||+|
T Consensus 74 rklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit----~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 74 RKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT----QNGVVKLCDFGFA 148 (396)
T ss_pred ceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe----cCCcEEeccchhh
Confidence 789999999965 55555666666689999999999999999999999999999999999999 7889999999999
Q ss_pred cccc-cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+. .....+.++.|-||+|||.+.|...+...+||
T Consensus 149 R~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDi 185 (396)
T KOG0593|consen 149 RTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDI 185 (396)
T ss_pred HhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccc
Confidence 9876 45556678899999999999999999999997
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=275.49 Aligned_cols=178 Identities=29% Similarity=0.467 Sum_probs=159.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
...++|++++.||.|+||+|.+++.+ +.-+|+|++++... .+.+.++....|..+|+.+.||+|+++++.|.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-----VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-----VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-----HHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 45678999999999999999999884 66789999987543 455667789999999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+||||||+.||.|+.+|++.++ +++..++.++.||+.||+|||+++|++|||||+|||+| ++|.+||+||
T Consensus 116 --~~~lymvmeyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD----~~G~iKitDF 188 (355)
T KOG0616|consen 116 --NSNLYMVMEYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD----QNGHIKITDF 188 (355)
T ss_pred --CCeEEEEEeccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec----cCCcEEEEec
Confidence 6789999999999999999988765 88999999999999999999999999999999999999 8899999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
|+|+..... +...|||+.|+|||+++.++|..
T Consensus 189 GFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynk 220 (355)
T KOG0616|consen 189 GFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNK 220 (355)
T ss_pred cceEEecCc--EEEecCCccccChHHhhcCCCCc
Confidence 999976554 45689999999999999888754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=287.04 Aligned_cols=182 Identities=27% Similarity=0.455 Sum_probs=166.1
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++.+.||+|+||+|-+|.. .++.||||.|++..+.. +...-.+.+|++||..|+||||+++|.+|+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkd-----eqDlvhIRREIeIMSsLNHPhII~IyEVFEN-- 124 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKD-----EQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-- 124 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhccc-----HHHHHHHHHHHHHHhhcCCCceeehhhhhcC--
Confidence 35688999999999999999976 48899999999876543 2233478899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+.|||||..+|.|++++.+.+. +++.++..|++||+.|+.|+|+++++|||||.+|||+| +++.+||+|||+
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD----~N~NiKIADFGL 199 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD----QNNNIKIADFGL 199 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec----CCCCeeeeccch
Confidence 6789999999999999999988765 89999999999999999999999999999999999999 788999999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+..+.+....+.+||++-|.+||++.|.+|...++|
T Consensus 200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVD 235 (668)
T KOG0611|consen 200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVD 235 (668)
T ss_pred hhhhccccHHHHhcCCcccCCccccCCCCCCCCccc
Confidence 999988888889999999999999999999999988
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=271.33 Aligned_cols=181 Identities=31% Similarity=0.432 Sum_probs=158.7
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|..+++||+|+||.||+|++ +++.||||+++.....+. .-....+|+++|+.++|+||+.++++|.. .
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdG------i~~talREIK~Lqel~h~nIi~LiD~F~~--~ 73 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDG------INRTALREIKLLQELKHPNIIELIDVFPH--K 73 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccC------ccHHHHHHHHHHHHccCcchhhhhhhccC--C
Confidence 4688889999999999999988 588899999997644322 12356789999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+.||+||| ..+|..+|+.+...++...++.++.++++||+|||++.|+||||||.|+||+ .++.+||+|||+|
T Consensus 74 ~~l~lVfEfm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis----~~g~lKiADFGLA 148 (318)
T KOG0659|consen 74 SNLSLVFEFM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS----SDGQLKIADFGLA 148 (318)
T ss_pred CceEEEEEec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc----CCCcEEeecccch
Confidence 7799999999 6799999999988999999999999999999999999999999999999998 7789999999999
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... .....+-|-||+|||++.|...+.+.+||
T Consensus 149 r~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDm 185 (318)
T KOG0659|consen 149 RFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDM 185 (318)
T ss_pred hccCCCCcccccceeeeeccChHHhccchhcCCcchh
Confidence 9775443 22233679999999999999999999986
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=282.05 Aligned_cols=180 Identities=33% Similarity=0.573 Sum_probs=150.5
Q ss_pred CCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
++|...+.||+|+||.||+|...+ +.||||++....... .++|..|+.+|.+++|+|||+|+|||.+...
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--------~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--------EREFLNEVEILSRLRHPNLVKLLGYCLEGGE- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--------hhHHHHHHHHHhcCCCcCcccEEEEEecCCc-
Confidence 567777889999999999999965 789999777542210 1359999999999999999999999998422
Q ss_pred cEEEEEeeccCCcHHHHHHhccC-ccCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGK---NIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k-~Lse~~~lkIalQIL~GLeYLHs~---gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
..+||+|||.+|+|.++|..... .++|..+++||.++++||+|||.. .|||||||++|||+| ++...||+||
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD----~~~~aKlsDF 221 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD----EDFNAKLSDF 221 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC----CCCCEEccCc
Confidence 58999999999999999987665 789999999999999999999985 499999999999999 7889999999
Q ss_pred CCcccccc-ccccCCC-CCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQ-TLVSGGV-RGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~-~~~s~s~-~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|+.... ....... .||.+|+|||.+.. ..-+.+.||
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDV 261 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDV 261 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhcc-CCcCccccc
Confidence 99976654 3222222 79999999999975 455666665
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=278.69 Aligned_cols=185 Identities=28% Similarity=0.380 Sum_probs=160.9
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|+.++.|++|+||.||+|+++ ++.||+|+++-..- ++.. --.-++|+.+|.+++|||||.+-.+....
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GF----PItsLREIniLl~~~H~NIV~vkEVVvG~ 147 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGF----PITSLREINILLKARHPNIVEVKEVVVGS 147 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCC----cchhHHHHHHHHhcCCCCeeeeEEEEecc
Confidence 3467999999999999999999985 66799999986531 1111 12456899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.-+.+||||||| .-||..++.+....+...+++.++.|+++||+|||.+.|+|||||++|+|++ ..|.+||+|||
T Consensus 148 ~~d~iy~VMe~~-EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~----~~G~lKiaDFG 222 (419)
T KOG0663|consen 148 NMDKIYIVMEYV-EHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS----HKGILKIADFG 222 (419)
T ss_pred ccceeeeeHHHH-HhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec----cCCcEEecccc
Confidence 778899999999 5699999998887899999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+.+.... ..+..+-|+||+|||+++|.+.+++.+|+
T Consensus 223 LAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDM 261 (419)
T KOG0663|consen 223 LAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDM 261 (419)
T ss_pred hhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhh
Confidence 999886653 34566789999999999999999999985
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=283.59 Aligned_cols=159 Identities=25% Similarity=0.401 Sum_probs=139.6
Q ss_pred HHHHhccccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc
Q 001940 788 EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865 (993)
Q Consensus 788 e~ia~~i~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI 865 (993)
+.+......+..++|+++..||+|+||.||+|+. +|..+|+|++++..+. +...++.++.|-.+|.....++|
T Consensus 129 e~lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-----~~~Qv~hV~aERdiL~~~ds~~v 203 (550)
T KOG0605|consen 129 EYLRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-----KKNQVEHVRAERDILAEVDSPWV 203 (550)
T ss_pred HHHHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-----hhhhHHHHHHHHHHhhhcCCCcE
Confidence 3344444467889999999999999999999976 5788999999987543 33446788899999999999999
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCC
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e 945 (993)
|++|..|++ ..++||||||++||++..+|.+.+. +++..+..++.+++.|++-||+.|+|||||||+|+||| .
T Consensus 204 VKLyYsFQD--~~~LYLiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD----~ 276 (550)
T KOG0605|consen 204 VKLYYSFQD--KEYLYLIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLID----A 276 (550)
T ss_pred EEEEEEecC--CCeeEEEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeec----C
Confidence 999999999 5789999999999999999988764 78888888888999999999999999999999999999 7
Q ss_pred CCeEEEEecCCcc
Q 001940 946 RPVCKIGDLGLSK 958 (993)
Q Consensus 946 ~g~VKLiDFGLAk 958 (993)
.|++||+|||||.
T Consensus 277 ~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 277 KGHIKLSDFGLST 289 (550)
T ss_pred CCCEeeccccccc
Confidence 8899999999985
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=286.99 Aligned_cols=185 Identities=29% Similarity=0.430 Sum_probs=156.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.....||.+.+.||+|+|++||+|+. .++.+|||++.+..+. ++..++-+.+|-.+|.+| .||.|++||-.|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Ii-----ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYII-----KEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHH-----hhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 34567899999999999999999987 4778999999876543 444455677888899999 799999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++ +..+|+|+||+++|+|.++|++.+. +++...++++.||+.||+|||++|||||||||+||||| .++++||+
T Consensus 144 QD--~~sLYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd----~dmhikIT 216 (604)
T KOG0592|consen 144 QD--EESLYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLD----KDGHIKIT 216 (604)
T ss_pred ec--ccceEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEc----CCCcEEEe
Confidence 99 6789999999999999999988754 89999999999999999999999999999999999999 78999999
Q ss_pred ecCCccccccccc--------------cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLV--------------SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~--------------s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||.|+.+..... ..+++||..|.+||+|... ......||
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~-~~~~~sDi 270 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS-PAGPSSDL 270 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC-CCCcccch
Confidence 9999996533211 1458999999999999865 33444443
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=268.38 Aligned_cols=181 Identities=22% Similarity=0.358 Sum_probs=150.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+.+ ++.||||++++.... .......+.+|+.++.+++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~--~ 73 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML-----EKEQVGHIRAERDILVEADSLWVVKMFYSFQD--K 73 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 47999999999999999999874 678999999764221 12234567889999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+||||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~----~~~~vkL~DFGla 148 (363)
T cd05628 74 LNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD----SKGHVKLSDFGLC 148 (363)
T ss_pred CeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCCEEEeeccCc
Confidence 68999999999999999997654 588999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc------------------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~------------------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... .....+||+.|+|||++.+..+. .++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~Dv 219 (363)
T cd05628 149 TGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDW 219 (363)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-Cchhh
Confidence 7542110 01235799999999999877544 56675
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=276.29 Aligned_cols=182 Identities=25% Similarity=0.412 Sum_probs=152.8
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|+++++||.|+||+|||+.. ++..||.|.++-.. ......+.+..|+.+|++|+|||||++|++-...++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~------md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM------MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh------ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 4688889999999999999977 68889999887322 223344678899999999999999999995444435
Q ss_pred CcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCCEEEccCCCCCCeEE
Q 001940 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHG--KN--IVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs--~g--IIHRDIKPeNILLd~~d~e~g~VK 950 (993)
..++||||||..|+|..+++. ..+.+++..+++++.|+++||..+|+ .. |+||||||.||+|+ .+|.||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~----~~gvvK 168 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT----ANGVVK 168 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc----CCCcee
Confidence 569999999999999998864 34669999999999999999999999 45 99999999999999 778999
Q ss_pred EEecCCcccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 951 IGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 951 LiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+|||+++...... ...+++|||.||+||.+.+.+|.. +.|
T Consensus 169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~-kSD 210 (375)
T KOG0591|consen 169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNF-KSD 210 (375)
T ss_pred eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCc-chh
Confidence 99999999876553 456789999999999999887653 444
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=265.17 Aligned_cols=181 Identities=24% Similarity=0.412 Sum_probs=150.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+.+ ++.||||++...... .......+.+|+.+|+.++|+||++++++|.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-----EKEQVAHVRAERDILAEADNPWVVKLYYSFQD--E 73 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--C
Confidence 47999999999999999999884 778999999864321 12234567889999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+.+|+|.+++.... .+++..++.|+.||+.||+|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~ 148 (364)
T cd05599 74 NYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD----AKGHIKLSDFGLC 148 (364)
T ss_pred CeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEeecccc
Confidence 78999999999999999997654 489999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc---------------------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL---------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~---------------------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... .....+||+.|||||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 222 (364)
T cd05599 149 TGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDW 222 (364)
T ss_pred eeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeee
Confidence 7532110 0112469999999999987654 466675
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=270.00 Aligned_cols=182 Identities=30% Similarity=0.439 Sum_probs=154.2
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC-cceEEEEEEcCC-
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGP- 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN-IVrL~G~f~d~s- 876 (993)
.|+.+++||+|+||+||+|+. +|+.||+|+++...... -.-....+|+.+|+.|+|+| |+.+++++....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E------G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE------GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc------CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 466667899999999999987 47789999998764310 11124568999999999999 999999998742
Q ss_pred ---CCcEEEEEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 877 ---DGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 877 ---~~~L~LVmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.+.++||+||+ ..+|..++.... ..++...++.+++||++||.|||+++|+||||||+||||+ ..|.+|
T Consensus 86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~----~~G~lK 160 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS----SSGVLK 160 (323)
T ss_pred ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC----CCCcEe
Confidence 23899999999 779999998765 3578889999999999999999999999999999999999 678999
Q ss_pred EEecCCcccccc-ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+|+...- .......++|.+|+|||++.|..++.+.+||
T Consensus 161 laDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDi 204 (323)
T KOG0594|consen 161 LADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDI 204 (323)
T ss_pred eeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcch
Confidence 999999997653 3335567799999999999999999999996
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=266.08 Aligned_cols=147 Identities=27% Similarity=0.397 Sum_probs=128.7
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||+||+++. +++.||||++.+... ......+.+.+|+.++++++||||++++++|.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~ 73 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-----FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD--A 73 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-----HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 4789999999999999999987 477899999875422 122344678899999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+|+||||+.+|+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~----~~~~~kl~DfGla 148 (377)
T cd05629 74 QYLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID----RGGHIKLSDFGLS 148 (377)
T ss_pred CeeEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEEeecccc
Confidence 68999999999999999997653 588889999999999999999999999999999999998 5678999999998
Q ss_pred c
Q 001940 958 K 958 (993)
Q Consensus 958 k 958 (993)
+
T Consensus 149 ~ 149 (377)
T cd05629 149 T 149 (377)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=260.29 Aligned_cols=179 Identities=26% Similarity=0.386 Sum_probs=152.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+|++. ++.||||+++..... .......+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~--~ 73 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-----KLNEVRHVLTERDILTTTKSEWLVKLLYAFQD--D 73 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc--C
Confidence 46999999999999999999884 678999999864321 12234568889999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kL~Dfg~a 148 (333)
T cd05600 74 EYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID----ASGHIKLTDFGLS 148 (333)
T ss_pred CEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEEEeCcCC
Confidence 78999999999999999997654 488899999999999999999999999999999999998 6678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.... ......||+.|+|||++.+. ..+.++||
T Consensus 149 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv 181 (333)
T cd05600 149 KGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDY 181 (333)
T ss_pred ccccc--ccCCcccCccccChhHhcCC-CCCCccce
Confidence 86544 23456799999999999887 44566775
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.9e-28 Score=265.11 Aligned_cols=181 Identities=19% Similarity=0.285 Sum_probs=148.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|++++.||+|+||.||+|+.. ++.||||++.+.... .......+.+|+.+|++++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~--~ 73 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-----MRNQAAHVKAERDILAEADNEWVVKLYYSFQD--K 73 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc--C
Confidence 36999999999999999999874 678999998754221 12234567889999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+|
T Consensus 74 ~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~ikL~DFG~a 148 (376)
T cd05598 74 DNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLC 148 (376)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC----CCCCEEEEeCCCC
Confidence 78999999999999999997654 478888899999999999999999999999999999998 6678999999997
Q ss_pred cccccc--------------------------------------------cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT--------------------------------------------LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~--------------------------------------------~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......+||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 227 (376)
T cd05598 149 TGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDW 227 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceee
Confidence 522100 01123579999999999987765 456675
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=262.01 Aligned_cols=183 Identities=28% Similarity=0.425 Sum_probs=154.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+|+++ ++.||||+++..... .....+.+.+|+.++++++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 88 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-----KMKQVQHVAQEKSILMELSHPFIVNMMCSFQ 88 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345678999999999999999999884 677999999764321 1223457889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 89 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl~D 161 (329)
T PTZ00263 89 D--ENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLD----NKGHVKVTD 161 (329)
T ss_pred c--CCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEC----CCCCEEEee
Confidence 8 578999999999999999997654 478888999999999999999999999999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++...... ....||+.|+|||++.+..+ ..++||
T Consensus 162 fg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~Di 198 (329)
T PTZ00263 162 FGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGH-GKAVDW 198 (329)
T ss_pred ccCceEcCCCc--ceecCChhhcCHHHHcCCCC-CCccee
Confidence 99998664332 24579999999999987765 466775
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=266.50 Aligned_cols=180 Identities=21% Similarity=0.297 Sum_probs=149.1
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|++++.||+|+||+||+|+. +++.||||++.+.... .....+.+.+|+.+++.++|+||+++++++.+ .+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~--~~ 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-----NRNQVAHVKAERDILAEADNEWVVKLYYSFQD--KD 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec--CC
Confidence 588999999999999999988 4677999999764322 22334578899999999999999999999997 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+.+|+||||||+||||+ ..+.+||+|||+++
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~----~~~~~kL~DFGl~~ 149 (381)
T cd05626 75 NLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILID----LDGHIKLTDFGLCT 149 (381)
T ss_pred EEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEEC----CCCCEEEeeCcCCc
Confidence 8999999999999999997654 478888899999999999999999999999999999998 56789999999975
Q ss_pred ccccc------------------------------------------------cccCCCCCCCCccccccccCCccCCCC
Q 001940 959 VKQQT------------------------------------------------LVSGGVRGTLPWMAPELLSGKSHMVTE 990 (993)
Q Consensus 959 ~~~~~------------------------------------------------~~s~s~~GTp~YmAPEVL~Gk~y~tse 990 (993)
..... ......+||+.|||||++.+..+ ..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~ 228 (381)
T cd05626 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQL 228 (381)
T ss_pred ccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCc
Confidence 32100 00123579999999999987664 466
Q ss_pred CCC
Q 001940 991 KEL 993 (993)
Q Consensus 991 ~DI 993 (993)
+||
T Consensus 229 ~Di 231 (381)
T cd05626 229 CDW 231 (381)
T ss_pred cce
Confidence 775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-29 Score=283.91 Aligned_cols=176 Identities=31% Similarity=0.469 Sum_probs=154.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|.+.+.||+|+||+||||+.+ .+.||||.+.+... .++.++.+.+|++|+++|+|||||.++++|+. .
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr------~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt--~ 73 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR------NEKELKNLRQEVRILRSLKHPNIVEMLESFET--S 73 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC------chHHHHHHHHHHHHHHhcCCcchhhHHHhhcc--c
Confidence 46888899999999999999775 56699999987532 23446789999999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+|+|+||+.| +|+.+|...+ .++++.+..|+.+++.||.|||+.+|+|||+||.|||++ ..+.+|+||||+|
T Consensus 74 ~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~----~~~~~KlcdFg~A 147 (808)
T KOG0597|consen 74 AHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE----KGGTLKLCDFGLA 147 (808)
T ss_pred ceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec----CCCceeechhhhh
Confidence 789999999966 9999998765 499999999999999999999999999999999999998 7789999999999
Q ss_pred ccccc-ccccCCCCCCCCccccccccCCccCCC
Q 001940 958 KVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 958 k~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
+.+.. ......+.|||.|||||++.+..|+.+
T Consensus 148 r~m~~~t~vltsikGtPlYmAPElv~e~pyd~~ 180 (808)
T KOG0597|consen 148 RAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHT 180 (808)
T ss_pred hhcccCceeeeeccCcccccCHHHHcCCCccch
Confidence 97643 344567889999999999999888754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=265.28 Aligned_cols=180 Identities=19% Similarity=0.284 Sum_probs=148.8
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+++++||+|+||+||+|+. .++.||||++.+... ........+.+|+.++++++|+||+++++.|.+ .+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-----~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~ 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-----LLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KD 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CC
Confidence 589999999999999999988 467799999875421 123345678899999999999999999999998 57
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++|||||.+|+|.+++.+.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~----~~g~~kL~DFGla~ 149 (382)
T cd05625 75 NLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILID----RDGHIKLTDFGLCT 149 (382)
T ss_pred EEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEeECCCCc
Confidence 8999999999999999997654 478888999999999999999999999999999999998 66789999999975
Q ss_pred cccc------------------------------------------------ccccCCCCCCCCccccccccCCccCCCC
Q 001940 959 VKQQ------------------------------------------------TLVSGGVRGTLPWMAPELLSGKSHMVTE 990 (993)
Q Consensus 959 ~~~~------------------------------------------------~~~s~s~~GTp~YmAPEVL~Gk~y~tse 990 (993)
.... .......+||+.|||||++.+..+. .+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~ 228 (382)
T cd05625 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QL 228 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-Ce
Confidence 2210 0011235799999999999877654 56
Q ss_pred CCC
Q 001940 991 KEL 993 (993)
Q Consensus 991 ~DI 993 (993)
+||
T Consensus 229 ~Di 231 (382)
T cd05625 229 CDW 231 (382)
T ss_pred eeE
Confidence 665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=277.33 Aligned_cols=191 Identities=30% Similarity=0.408 Sum_probs=154.4
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCC------CchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAG------KPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~------k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
..+.|++++.||+|.||.|-+|+. .++-||||++.+..... ....+..-++...+|+.+|++|+|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 446899999999999999999988 47789999997654321 1111222346789999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
.+..+...+.+|||+|||..|.+...=.. ...+++.++++|+++++.||+|||.+|||||||||+|+||+ .+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~----~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS----SDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc----CCCcE
Confidence 99999888999999999998877553222 12288999999999999999999999999999999999998 67899
Q ss_pred EEEecCCccccccc------cccCCCCCCCCccccccccC---CccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQT------LVSGGVRGTLPWMAPELLSG---KSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~------~~s~s~~GTp~YmAPEVL~G---k~y~tse~DI 993 (993)
||+|||.+...... ......+|||.|||||...+ ..+.....||
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~Di 302 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDI 302 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhh
Confidence 99999998855222 12234679999999999987 5566666665
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=252.38 Aligned_cols=181 Identities=26% Similarity=0.344 Sum_probs=150.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+..+.||+|+||.||++.+ +++.||||++....... ......+.+|+.+++.++|+||+++++++.+ .+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~--~~ 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKRILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-----hhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc--CC
Confidence 378899999999999999987 47889999987643221 1122457789999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+.+|+|.+++... ...+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~----~~~~~kl~Dfg~~ 149 (285)
T cd05631 74 ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLD----DRGHIRISDLGLA 149 (285)
T ss_pred eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 799999999999999887653 34588999999999999999999999999999999999998 5678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.............||..|||||++.+..+ +.++||
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv 184 (285)
T cd05631 150 VQIPEGETVRGRVGTVGYMAPEVINNEKY-TFSPDW 184 (285)
T ss_pred EEcCCCCeecCCCCCCCccCHhhhcCCCC-CcccCc
Confidence 87544333345679999999999987654 456775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=283.21 Aligned_cols=182 Identities=27% Similarity=0.382 Sum_probs=162.4
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.-|++.+.||+|+.|.|.+|++ +|+.+|||++.+..... +.....+.+|+.||+.|.||||+++|++|.+ +
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s-----~s~~~~IerEIviMkLi~HpnVl~LydVwe~--~ 84 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS-----SSQPAGIEREIVIMKLIEHPNVLRLYDVWEN--K 84 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccc-----cccccchhhhhHHHHHhcCCCeeeeeeeecc--C
Confidence 4689999999999999999988 68999999998763211 1122467799999999999999999999998 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+|+|+||+++|.|+++|-.++. +.+.++++++.||+.|+.|||..+|+||||||+|+||| .++.|||+|||||
T Consensus 85 ~~lylvlEyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd----~~~nIKIADFGMA 159 (786)
T KOG0588|consen 85 QHLYLVLEYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD----VKNNIKIADFGMA 159 (786)
T ss_pred ceEEEEEEecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh----cccCEeeecccee
Confidence 789999999999999999988775 77888888999999999999999999999999999999 5556999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...........-||++-|+|||++.|.+|...++||
T Consensus 160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDV 195 (786)
T KOG0588|consen 160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDV 195 (786)
T ss_pred ecccCCccccccCCCcccCCchhhcCCCCCCCcccc
Confidence 988777777888999999999999999999999997
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=258.12 Aligned_cols=182 Identities=23% Similarity=0.367 Sum_probs=151.4
Q ss_pred CceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
+|++++.||+|+||+||+++. +++.||+|++.+..... .....+.+.+|+.+++.++ |+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQ----KAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhh----hhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 588999999999999999876 46779999997643221 2233456788999999995 9999999999887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Df 149 (332)
T cd05614 77 --EAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD----SEGHVVLTDF 149 (332)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC----CCCCEEEeeC
Confidence 578999999999999999987654 488999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccc--cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~--~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++..... ......+||+.|||||++.+....+.++||
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 190 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDW 190 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCcccc
Confidence 999854322 122346799999999999887767777886
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=256.96 Aligned_cols=179 Identities=27% Similarity=0.433 Sum_probs=151.0
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|..+ ++.||||++...... ..+..+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 73 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-----RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD--Q 73 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc--C
Confidence 47899999999999999999885 778999998754221 12234568899999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~----~~~~~kl~Dfg~~ 148 (291)
T cd05612 74 RFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD----KEGHIKLTDFGFA 148 (291)
T ss_pred CeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEEecCcc
Confidence 68999999999999999997654 488899999999999999999999999999999999998 5678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .....||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di 181 (291)
T cd05612 149 KKLRDR--TWTLCGTPEYLAPEVIQSKGH-NKAVDW 181 (291)
T ss_pred hhccCC--cccccCChhhcCHHHHcCCCC-CchhhH
Confidence 865432 234579999999999987764 456665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=265.59 Aligned_cols=183 Identities=27% Similarity=0.432 Sum_probs=151.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|...+.||+|+||.||++... +..+|||.+..... .. .+.+.+|+.+|++|+|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~-----~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS-----PT---SESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc-----hh---HHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 345778899999999999999885 58899998875411 11 456889999999999999999999744422
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCC-CCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e-~g~VKLiDFG 955 (993)
...++++|||+.+|+|.+++.+.+..+++..++.+++||++||+|||++|||||||||+|||++ . ++.+||+|||
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~----~~~~~~KlaDFG 163 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD----PSNGDVKLADFG 163 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe----CCCCeEEeccCc
Confidence 2368999999999999999998765799999999999999999999999999999999999998 4 5799999999
Q ss_pred Ccccccc----ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQ----TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~----~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++.... ......+.||+.|||||++........++||
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDi 205 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDI 205 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcCCCcCCccchh
Confidence 9987653 2223467899999999999862222247775
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=258.63 Aligned_cols=183 Identities=22% Similarity=0.300 Sum_probs=152.0
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+++.+ ++.||||++.+... ......+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-----LKRAETACFREERDVLVNGDRRWITNLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-----hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec--C
Confidence 47999999999999999999884 67899999875321 122234568889999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+.+++|.+++.+....+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~ 149 (331)
T cd05597 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD----KNGHIRLADFGSC 149 (331)
T ss_pred CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC----CCCCEEEEECCce
Confidence 789999999999999999987666689999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc--ccCCCCCCCCccccccccC----CccCCCCCCC
Q 001940 958 KVKQQTL--VSGGVRGTLPWMAPELLSG----KSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~--~s~s~~GTp~YmAPEVL~G----k~y~tse~DI 993 (993)
....... ......||+.|||||++.+ ....+.++||
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 191 (331)
T cd05597 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDW 191 (331)
T ss_pred eecCCCCCccccceeccccccCHHHHhhccccccCCCCccee
Confidence 7543322 1223469999999999974 3445666775
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=280.90 Aligned_cols=177 Identities=28% Similarity=0.479 Sum_probs=154.0
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..|+...+||+|+.|.||.|+. +++.||||++...+...+ +-+..|+.+|+.++|+|||.+++.|.. .
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k--------eLilnEi~Vm~~~~H~NiVnfl~Sylv--~ 342 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK--------ELLLNEILVMRDLHHPNIVNFLDSYLV--G 342 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch--------hhhHHHHHHHHhccchHHHHHHHHhcc--c
Confidence 4588889999999999999977 467799999998754432 357789999999999999999999887 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+|||||+||+|.+++.... +++.++..|+++++.||+|||.++|||||||.+|||++ .++.+||+|||+|
T Consensus 343 deLWVVMEym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~----~~g~vKltDFGFc 416 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT----MDGSVKLTDFGFC 416 (550)
T ss_pred ceeEEEEeecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec----cCCcEEEeeeeee
Confidence 67999999999999999997654 89999999999999999999999999999999999998 5678999999999
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+.... .....+||+.|||||++..+. |..++||
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDI 452 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDI 452 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcc-cCccccc
Confidence 8775543 456788999999999998764 5677776
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=259.19 Aligned_cols=185 Identities=29% Similarity=0.452 Sum_probs=147.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
++..++|++.++||+|+||.||+|.+. ++.||||+++.... ....+.+.+|+.+++.+ +||||++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-------ASEHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-------hHHHHHHHHHHHHHHHhccCcceee
Confidence 355678999999999999999999752 35699999874311 12235688999999999 8999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------------------------------
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------------------------------------------- 900 (993)
++++|... .+.+++||||+++|+|.+++....
T Consensus 76 ~~~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (338)
T cd05102 76 LLGACTKP-NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTS 154 (338)
T ss_pred EEeEecCC-CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccC
Confidence 99998763 456899999999999999997532
Q ss_pred --------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc--
Q 001940 901 --------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-- 964 (993)
Q Consensus 901 --------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~-- 964 (993)
..+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+++......
T Consensus 155 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~----~~~~~kl~DfG~a~~~~~~~~~ 230 (338)
T cd05102 155 GSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDY 230 (338)
T ss_pred cccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc----CCCcEEEeecccccccccCcch
Confidence 2367778889999999999999999999999999999998 56789999999998653221
Q ss_pred -ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 -VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 -~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......+|+.|||||++.+.. ++.++||
T Consensus 231 ~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi 259 (338)
T cd05102 231 VRKGSARLPLKWMAPESIFDKV-YTTQSDV 259 (338)
T ss_pred hcccCCCCCccccCcHHhhcCC-CCcccCH
Confidence 122344678899999998765 4566775
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=257.75 Aligned_cols=175 Identities=25% Similarity=0.333 Sum_probs=145.6
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.||+|+||.||+++. .++.||||+++..... .......+.+|+.++++++||||+++++++.. .+.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 73 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-----AKDEVAHTLTESRVLQNTRHPFLTALKYSFQT--HDRLCFV 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc--CCEEEEE
Confidence 3699999999999987 4778999999864321 12234567889999999999999999999988 5789999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc-
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ- 962 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~- 962 (993)
|||+.+++|.+++.... .+++..+..|+.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DfG~a~~~~~~ 148 (323)
T cd05571 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEeeCCCCcccccC
Confidence 99999999999987654 588999999999999999999999999999999999998 567899999999875322
Q ss_pred ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.......+||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 178 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 178 (323)
T ss_pred CCcccceecCccccChhhhcCCCC-CccccC
Confidence 222345679999999999987654 456775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=259.62 Aligned_cols=181 Identities=25% Similarity=0.414 Sum_probs=152.8
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+.. ++.||||+++...... ......+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-----RNQIAHVRAERDILADADSPWIVKLYYSFQD--E 73 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-----ccHHHHHHHHHHHHHhcCCCCccchhhheec--C
Confidence 47999999999999999999985 7889999998653221 1234568899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.+. ..+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~----~~~~~kL~Dfg~~ 148 (350)
T cd05573 74 EHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID----ADGHIKLADFGLC 148 (350)
T ss_pred CeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEeecCCCC
Confidence 7899999999999999999876 4588999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc------------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~------------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......||+.|+|||++.+. ..+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di 213 (350)
T cd05573 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDW 213 (350)
T ss_pred ccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceee
Confidence 8654332 22345699999999999877 44556665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=260.38 Aligned_cols=181 Identities=23% Similarity=0.371 Sum_probs=150.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+++.+ ++.||||+++..... .......+.+|+.++..++|+||+++++.+.+ .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~--~ 73 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-----EKEQVAHIRAERDILVEADGAWVVKMFYSFQD--K 73 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 47899999999999999999884 678999999754221 12234578889999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~----~~~~vkL~DfG~~ 148 (360)
T cd05627 74 RNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD----AKGHVKLSDFGLC 148 (360)
T ss_pred CEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEeeccCC
Confidence 78999999999999999997654 488999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc------------------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL------------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~------------------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... .....+||+.|||||++.+..+. .++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~Di 219 (360)
T cd05627 149 TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDW 219 (360)
T ss_pred cccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-Cccee
Confidence 7432110 01235799999999999877654 56675
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=264.15 Aligned_cols=185 Identities=22% Similarity=0.370 Sum_probs=153.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+++.+ ++.+|+|++.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 345678999999999999999999884 667999998753221 1122345778999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ ...+|+||||+.+|+|.+++... .+++..++.++.||+.||+|||+.+|+||||||+|||++ ..+.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~----~~~~~kL~D 185 (370)
T cd05621 114 D--DKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD----KHGHLKLAD 185 (370)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEEe
Confidence 7 57899999999999999999754 378889999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCc---cCCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS---HMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~---y~tse~DI 993 (993)
||+|+...... .....+||+.|||||++.+.. +.+.++||
T Consensus 186 FG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~Di 230 (370)
T cd05621 186 FGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230 (370)
T ss_pred cccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCE
Confidence 99998654322 223567999999999998654 35567775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=257.27 Aligned_cols=183 Identities=21% Similarity=0.283 Sum_probs=151.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+++.+ ++.||||++.+... ........+.+|..++..++|+||+++++++.+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~--~ 73 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-----LKRAETACFREERNVLVNGDCQWITTLHYAFQD--E 73 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc--C
Confidence 47999999999999999999884 56799999875321 122234567889999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+.+|+|.+++.+....+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~----~~~~~kl~DfG~a 149 (331)
T cd05624 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD----MNGHIRLADFGSC 149 (331)
T ss_pred CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc----CCCCEEEEeccce
Confidence 789999999999999999987555688999999999999999999999999999999999998 5678999999999
Q ss_pred cccccccc--cCCCCCCCCccccccccCC----ccCCCCCCC
Q 001940 958 KVKQQTLV--SGGVRGTLPWMAPELLSGK----SHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~--s~s~~GTp~YmAPEVL~Gk----~y~tse~DI 993 (993)
+....... .....||+.|||||++.+. .....++||
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di 191 (331)
T cd05624 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDW 191 (331)
T ss_pred eeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccE
Confidence 86543321 2235699999999999763 234556665
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=253.71 Aligned_cols=181 Identities=29% Similarity=0.451 Sum_probs=149.7
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|+. +++.||||+++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-------TPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-------cchhHHHHHHHHhhCCCCCcCeEEEEEec--
Confidence 46899999999999999999988 47789999987542211 11246689999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...+++||||+ .++|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 149 (303)
T cd07869 75 KETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLIS----DTGELKLADFGL 149 (303)
T ss_pred CCeEEEEEECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECCCCc
Confidence 56799999999 5788888877666688999999999999999999999999999999999998 567899999999
Q ss_pred ccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++..... .......||+.|+|||++.+......++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHH
Confidence 8754322 222345689999999999877666666664
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=261.00 Aligned_cols=183 Identities=30% Similarity=0.513 Sum_probs=153.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg---t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
.+..++|++.+.||+|+||.||+|++++ ..||||++...... .....+.+.+|+.+++.++||||+++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-----KQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 3456789999999999999999998743 46999998754321 122345688999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 101 ~~--~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~ikL~ 173 (340)
T PTZ00426 101 KD--ESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLD----KDGFIKMT 173 (340)
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC----CCCCEEEe
Confidence 88 578999999999999999997654 488999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....||+.|||||++.+..+ +.++||
T Consensus 174 DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di 211 (340)
T PTZ00426 174 DFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGH-GKAADW 211 (340)
T ss_pred cCCCCeecCCC--cceecCChhhcCHHHHhCCCC-Cccccc
Confidence 99999865432 234679999999999987654 456665
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=255.12 Aligned_cols=183 Identities=23% Similarity=0.302 Sum_probs=152.7
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||+||+++. +++.||||+++..... .....+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~--~ 73 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-----AQETVSFFEEERDILSISNSPWIPQLQYAFQD--K 73 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceeeEEec--C
Confidence 4799999999999999999987 4778999999864321 12234568889999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+++++|.+++.+....+++..+..++.||+.||+|||+.+|+||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~----~~~~~kL~Dfg~a 149 (330)
T cd05601 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID----RTGHIKLADFGSA 149 (330)
T ss_pred CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC----CCCCEEeccCCCC
Confidence 679999999999999999987756689999999999999999999999999999999999998 6678999999999
Q ss_pred ccccccc--ccCCCCCCCCccccccccC-----CccCCCCCCC
Q 001940 958 KVKQQTL--VSGGVRGTLPWMAPELLSG-----KSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~--~s~s~~GTp~YmAPEVL~G-----k~y~tse~DI 993 (993)
+...... ......||+.|+|||++.+ ....+.++||
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di 192 (330)
T cd05601 150 ARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192 (330)
T ss_pred eECCCCCceeeecccCCccccCHHHhccccccccCCCCCccee
Confidence 8654332 2233469999999999974 3344566665
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=267.77 Aligned_cols=177 Identities=29% Similarity=0.430 Sum_probs=149.8
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+..+++|.|+||.||+|+.. ++.||||+.-.+... -.+|+.+|++++|||||++.-+|.....+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------------knrEl~im~~l~HpNIV~L~~~f~~~~~~ 92 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------------KNRELQIMRKLDHPNIVRLLYFFSSSTES 92 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------------CcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence 5788899999999999999884 578999987654221 12689999999999999998888764344
Q ss_pred ---cEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 879 ---SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 879 ---~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++.+|||||+ .+|.++++.. +..++...++.++.||++||.|||+.+|+||||||.|||+| +..+.+|||
T Consensus 93 d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKic 168 (364)
T KOG0658|consen 93 DEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKIC 168 (364)
T ss_pred chhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEec
Confidence 6779999994 5899988742 45577788888999999999999999999999999999998 356899999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||.|+.........+..=|-.|+|||.|.|...+++..||
T Consensus 169 DFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDi 209 (364)
T KOG0658|consen 169 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDI 209 (364)
T ss_pred cCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEE
Confidence 99999988776655566668899999999999999999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=280.83 Aligned_cols=181 Identities=25% Similarity=0.407 Sum_probs=153.9
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~ 871 (993)
..+..++|.++++||+|.||+|+++..+ ++.+|||++++.....+.. ++....|..|+.... ||.+++++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~-----Ve~~~~EkrI~~la~~HPFL~~L~~~ 437 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDE-----VESLMCEKRIFELANRHPFLVNLFSC 437 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecccc-----HHHHHHHHHHHHHhccCCeEeecccc
Confidence 4566789999999999999999999885 5669999999987655432 346667777777665 9999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
|++ ..++|+||||+.||++..+++ ...+++..+..++.+|+.||.|||++|||+||||.+|||+| ..|.+||
T Consensus 438 fQT--~~~l~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD----~eGh~ki 509 (694)
T KOG0694|consen 438 FQT--KEHLFFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLD----TEGHVKI 509 (694)
T ss_pred ccc--CCeEEEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEc----ccCcEEe
Confidence 999 678999999999999544433 23489999999999999999999999999999999999999 7789999
Q ss_pred EecCCccccc-cccccCCCCCCCCccccccccCCccCC
Q 001940 952 GDLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 952 iDFGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
+||||+|..- ....+.++|||+.|||||++++..|..
T Consensus 510 ADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~ 547 (694)
T KOG0694|consen 510 ADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTR 547 (694)
T ss_pred cccccccccCCCCCccccccCChhhcChhhhccCcccc
Confidence 9999999653 555677899999999999999887653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=276.47 Aligned_cols=181 Identities=35% Similarity=0.623 Sum_probs=151.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcCc-ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kgt-~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+....+++++.||+|-||.||.|+|++. +||||.++...... +.|.+|+.+|++|+|+|||+++++|..
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---------~~f~~Ea~iMk~L~H~~lV~l~gV~~~- 272 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---------EAFLREAQIMKKLRHEKLVKLYGVCTK- 272 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---------hHHHHHHHHHHhCcccCeEEEEEEEec-
Confidence 3444566678899999999999999876 89999998754321 478899999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHh-ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~-~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.++||||||..|+|.++|+. .+..+...+.+.|+.||++||+||+++++|||||..+||||+ .+..+||+||
T Consensus 273 -~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~----~~~~vKIsDF 347 (468)
T KOG0197|consen 273 -QEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD----EDLVVKISDF 347 (468)
T ss_pred -CCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec----cCceEEEccc
Confidence 3479999999999999999997 556788999999999999999999999999999999999998 6789999999
Q ss_pred CCccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+...+... ...-.-...|.|||.+... ..+++.||
T Consensus 348 GLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~-~FS~kSDV 387 (468)
T KOG0197|consen 348 GLARLIGDDEYTASEGGKFPIKWTAPEALNYG-KFSSKSDV 387 (468)
T ss_pred ccccccCCCceeecCCCCCCceecCHHHHhhC-Ccccccce
Confidence 99996544322 2222346789999999854 45666665
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=251.28 Aligned_cols=181 Identities=28% Similarity=0.454 Sum_probs=149.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.++||+|+||+||+|..+ +..||+|+++...... ....+.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKNLKHANIVTLHDIIHT-- 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-------cchhHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 467999999999999999999874 6789999987542211 11356689999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...+++||||+. ++|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~DfG~ 149 (288)
T cd07871 75 ERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN----EKGELKLADFGL 149 (288)
T ss_pred CCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 567999999996 599999877666688999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ......||+.|+|||++.+....+.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 187 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDM 187 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCCcccCcHHHH
Confidence 97643221 22345689999999999876666666664
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=254.71 Aligned_cols=183 Identities=21% Similarity=0.292 Sum_probs=151.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||.||+++.+ ++.+|+|++.+... ........+.+|+.++..++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-----LKRAETACFREERDVLVNGDNQWITTLHYAFQD--E 73 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-----HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec--C
Confidence 47999999999999999999885 56699999875321 122233457889999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+|+|.+++.+....+++..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~----~~~~~kL~DfG~a 149 (332)
T cd05623 74 NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADFGSC 149 (332)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC----CCCCEEEeecchh
Confidence 789999999999999999987656689999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc--ccCCCCCCCCccccccccC----CccCCCCCCC
Q 001940 958 KVKQQTL--VSGGVRGTLPWMAPELLSG----KSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~--~s~s~~GTp~YmAPEVL~G----k~y~tse~DI 993 (993)
+...... .....+||+.|||||++.+ ......++||
T Consensus 150 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv 191 (332)
T cd05623 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDW 191 (332)
T ss_pred eecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCE
Confidence 7543221 2234579999999999873 4455667775
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=255.55 Aligned_cols=175 Identities=26% Similarity=0.352 Sum_probs=145.5
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.||+|+||.||+++. +++.||||++.+.... .......+.+|+.+++.++||||+++++++.. .+.+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~lv 73 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVII-----AKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT--KDRLCFV 73 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc--CCEEEEE
Confidence 3699999999999987 4778999999864322 12234577889999999999999999999987 5789999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc-
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ- 962 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~- 962 (993)
|||+.+++|.+++.... .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~----~~~~~kL~DfG~~~~~~~~ 148 (328)
T cd05593 74 MEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD----KDGHIKITDFGLCKEGITD 148 (328)
T ss_pred EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEEC----CCCcEEEecCcCCccCCCc
Confidence 99999999999887654 588999999999999999999999999999999999998 567899999999885422
Q ss_pred ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.......+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 178 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 178 (328)
T ss_pred ccccccccCCcCccChhhhcCCCC-CccCCc
Confidence 222345679999999999987654 566775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=249.33 Aligned_cols=182 Identities=31% Similarity=0.455 Sum_probs=147.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEc------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k------------------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~ 859 (993)
..++|++.++||+|+||.||+|.+. +..||||++.... .......+.+|+.+|++
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILSR 75 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHhh
Confidence 4568999999999999999999752 2258999887532 11234578899999999
Q ss_pred cCCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------------------CccCHHHHHHHHHHHHHHHHH
Q 001940 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------RTIDRRKRLIIAMDAAFGMEY 921 (993)
Q Consensus 860 LrHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------------------k~Lse~~~lkIalQIL~GLeY 921 (993)
++||||+++++++.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|
T Consensus 76 l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 153 (304)
T cd05096 76 LKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKY 153 (304)
T ss_pred cCCCCeeEEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999987 467999999999999999986532 235777889999999999999
Q ss_pred HHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 922 LHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+.+|+||||||+|||++ .++.+||+|||+++...... ......++..|||||++.+.. .+.++||
T Consensus 154 lH~~~ivH~dlkp~Nill~----~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 223 (304)
T cd05096 154 LSSLNFVHRDLATRNCLVG----ENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDV 223 (304)
T ss_pred HHHCCccccCcchhheEEc----CCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhh
Confidence 9999999999999999998 56789999999998653321 223345688999999987654 4556665
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=255.04 Aligned_cols=175 Identities=24% Similarity=0.347 Sum_probs=145.2
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.||+|+||.||+++. .+..||+|+++..... .......+.+|+.+++.++||||++++++|.. .+.+|+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 73 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVII-----AKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRLCFV 73 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCcceeeEEec--CCEEEEE
Confidence 3699999999999987 4778999999864321 12234567789999999999999999999987 5789999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc-
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ- 962 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~- 962 (993)
|||+.+++|..++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 ~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~ 148 (323)
T cd05595 74 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISD 148 (323)
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEc----CCCCEEecccHHhccccCC
Confidence 99999999999887654 588999999999999999999999999999999999998 567899999999875322
Q ss_pred ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........||+.|+|||++.+..+ ..++||
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 178 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 178 (323)
T ss_pred CCccccccCCcCcCCcccccCCCC-Cchhch
Confidence 222334679999999999987654 456675
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=258.84 Aligned_cols=185 Identities=22% Similarity=0.358 Sum_probs=153.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+++++ ++.||+|++.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 455689999999999999999999884 677999998753221 1222346788999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~----~~~~ikL~D 185 (371)
T cd05622 114 D--DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (371)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC----CCCCEEEEe
Confidence 7 57899999999999999999754 378888899999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCc---cCCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS---HMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~---y~tse~DI 993 (993)
||+++...... .....+||+.|||||++.+.. ..+.++||
T Consensus 186 fG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~Di 230 (371)
T cd05622 186 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230 (371)
T ss_pred CCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccce
Confidence 99998654322 223567999999999997653 35667775
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=263.35 Aligned_cols=184 Identities=25% Similarity=0.365 Sum_probs=156.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+..++|++.++||.|..++||+|++ +++.||||+++...- ....+.+.+|+..|+.++||||++++..|..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc-------~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKC-------NNDLDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhh-------hhhHHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 4567899999999999999999988 578899999986532 1225688999999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+..+|+||.||.+|++.++++.. ...+++..+..|++++++||.|||.+|.||||||+.||||+ .+|.|||+|
T Consensus 96 --~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~----~dG~VkLad 169 (516)
T KOG0582|consen 96 --DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILID----SDGTVKLAD 169 (516)
T ss_pred --cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEc----CCCcEEEcC
Confidence 57899999999999999999875 34589999999999999999999999999999999999999 778999999
Q ss_pred cCCcccccccc----c-cCCCCCCCCcccccc-ccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL----V-SGGVRGTLPWMAPEL-LSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~----~-s~s~~GTp~YmAPEV-L~Gk~y~tse~DI 993 (993)
||.+-.+.... . .+.++||+.|||||+ +..-.-|..++||
T Consensus 170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDI 215 (516)
T KOG0582|consen 170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADI 215 (516)
T ss_pred ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhh
Confidence 99866432211 1 156789999999999 5555556667776
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=259.20 Aligned_cols=185 Identities=20% Similarity=0.335 Sum_probs=152.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+++.+ ++.||||++.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-----KRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 345678999999999999999999884 678999999754221 1122345778999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+|+|.+++.+. .+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|
T Consensus 114 ~--~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~----~~~~~kL~D 185 (370)
T cd05596 114 D--DKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 185 (370)
T ss_pred c--CCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEc----CCCCEEEEe
Confidence 7 56799999999999999998764 378888889999999999999999999999999999998 667999999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCc---cCCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS---HMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~---y~tse~DI 993 (993)
||+++...... .....+||+.|||||++.+.. ..+.++||
T Consensus 186 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di 230 (370)
T cd05596 186 FGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 230 (370)
T ss_pred ccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceee
Confidence 99998654322 223467999999999997653 35566665
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=252.14 Aligned_cols=175 Identities=26% Similarity=0.356 Sum_probs=144.5
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.||+|+||.||+++. +++.||+|+++...... ......+.+|+.+++.++||||+++++++.. .+.+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~--~~~~~lv 73 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRLCFV 73 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhCCCCCCCceEEEEEc--CCEEEEE
Confidence 3699999999999987 47789999998643221 2234567789999999999999999999987 5789999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
|||+.+++|.+++.... .+++..+..|+.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 ~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~----~~~~~kL~Dfg~~~~~~~ 148 (325)
T cd05594 74 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKITDFGLCKEGIK 148 (325)
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEEC----CCCCEEEecCCCCeecCC
Confidence 99999999999887654 58899999999999999999997 7999999999999998 66789999999987532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.........||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179 (325)
T ss_pred CCcccccccCCcccCCHHHHccCCC-CCcccc
Confidence 2222334579999999999987654 456775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=264.48 Aligned_cols=185 Identities=32% Similarity=0.429 Sum_probs=160.5
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~ 875 (993)
...|++.+.||.|.||.||+++. +++.+|+|++.+....... ..+.+.+|+.+|++|. |||||.++++|++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-----~~~~v~~Ev~il~~l~~hpniv~l~~~~e~- 107 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-----DREDVRREVAILQQLSGHPNIVQLKDAFED- 107 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-----cHHHHHHHHHHHHhccCCCCEEEEEEEEEc-
Confidence 35689999999999999999988 4788999999987655432 2357889999999999 9999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+++|||++.||.|++.|... . +++..+..++.||+.+++|||+.||+||||||+|+|+.......+.+|++|||
T Consensus 108 -~~~~~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 108 -PDSVYLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred -CCeEEEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 56899999999999999999877 3 89999999999999999999999999999999999998665445689999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|............+||+.|+|||++.+.. ++.++||
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~-y~~~~Di 221 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRP-YGDEVDV 221 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcCCC-CCcccch
Confidence 999887766677889999999999998654 4455554
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=251.70 Aligned_cols=173 Identities=24% Similarity=0.354 Sum_probs=144.0
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||+|+||.||+|+.. ++.||||+++..... .......+.+|+.++++++||||+++++++.+ .+.+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-----SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS--PEKLYLVLA 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCcEeceeeEEec--CCeEEEEEc
Confidence 799999999999884 667999998754321 12234567889999999999999999999987 578999999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc-cc
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-TL 964 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~-~~ 964 (993)
|+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++.... ..
T Consensus 74 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~~~~ 148 (312)
T cd05585 74 FINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLD----YQGHIALCDFGLCKLNMKDDD 148 (312)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEEC----CCCcEEEEECcccccCccCCC
Confidence 999999999997654 488999999999999999999999999999999999998 667899999999985422 22
Q ss_pred ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 ~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.....+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 176 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGY-TKAVDW 176 (312)
T ss_pred ccccccCCcccCCHHHHcCCCC-CCccce
Confidence 3345679999999999987654 456675
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=251.12 Aligned_cols=180 Identities=22% Similarity=0.315 Sum_probs=146.7
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC-CcceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP-NIVrL~G~f~d~s~ 877 (993)
+|++++.||+|+||.||+|+.+ ++.||||++.+..... ....+.+..|..++..+.|+ +|+++++++.+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--M 73 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--C
Confidence 5889999999999999999885 5679999998653221 22235677889999999765 58888888887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~~ 148 (324)
T cd05587 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----AEGHIKIADFGMC 148 (324)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc----CCCCEEEeecCcc
Confidence 67999999999999999987654 478899999999999999999999999999999999998 5678999999998
Q ss_pred cccc-cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+... ........+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 184 (324)
T cd05587 149 KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184 (324)
T ss_pred eecCCCCCceeeecCCccccChhhhcCCCC-Ccccch
Confidence 7532 2222334579999999999987764 456665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-27 Score=251.86 Aligned_cols=176 Identities=26% Similarity=0.407 Sum_probs=144.2
Q ss_pred EEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+.||+|+||.||+++. .++.||||+++...... .......+.+|+.+|+.++||||++++++|.. .+.+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~----~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR----NQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKL 75 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHh----hhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeE
Confidence 6799999999999976 36679999998643211 11223467789999999999999999999987 5689
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
|+||||+.+++|.+++.... .+.+..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD----AQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEeeCcCCeec
Confidence 99999999999999997654 477888888999999999999999999999999999998 6678999999998753
Q ss_pred c-cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 961 Q-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 961 ~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
. .........||+.|+|||++.+..+ ..++||
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 183 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDW 183 (323)
T ss_pred ccCCCcccccCCCccccChhhccCCCC-CCccee
Confidence 2 2222344679999999999987654 456675
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=249.92 Aligned_cols=180 Identities=22% Similarity=0.322 Sum_probs=147.1
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~ 877 (993)
+|++++.||+|+||.||+|+.+ ++.||||++++..... ....+.+..|..++..+ +|++|+++++++.+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-----DDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--M 73 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--C
Confidence 5889999999999999999885 5679999998653221 12234566677777776 58999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+|+|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kL~DfG~~ 148 (323)
T cd05616 74 DRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC----CCCcEEEccCCCc
Confidence 68999999999999999987654 488999999999999999999999999999999999998 6678999999999
Q ss_pred cccc-cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+... ........+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 184 (323)
T cd05616 149 KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184 (323)
T ss_pred eecCCCCCccccCCCChhhcCHHHhcCCCC-CCccch
Confidence 8543 2223345679999999999987764 466675
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=269.84 Aligned_cols=184 Identities=29% Similarity=0.451 Sum_probs=164.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.....|.++.+||+|.|++|.+|+. +++.||||++++..... ...+.+.+|+.+|+.|.|||||++|.+...
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~------~~~~k~~rev~imk~l~HPnIvkl~~v~~t 126 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP------SKRQKLGREVDIMKSLNHPNIVKLFSVIET 126 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh------HHHHHHHHHHHHHHhcCCcceeeeeeeeee
Confidence 3456799999999999999999987 68899999999865432 122348899999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...+|+||||+.+|.++++|.+.++. .+..+..++.|++.|++|||+++|+|||||.+||||+ .+..+||+||
T Consensus 127 --~~~lylV~eya~~ge~~~yl~~~gr~-~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~----~~mnikIaDf 199 (596)
T KOG0586|consen 127 --EATLYLVMEYASGGELFDYLVKHGRM-KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD----ENMNIKIADF 199 (596)
T ss_pred --cceeEEEEEeccCchhHHHHHhcccc-hhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc----cccceeeecc
Confidence 57899999999999999999988774 4477788889999999999999999999999999998 7778999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++...........++|++.|+|||++.|++|...++||
T Consensus 200 gfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~ 238 (596)
T KOG0586|consen 200 GFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDI 238 (596)
T ss_pred ccceeecccccccccCCCCCccChHhhcCcccCCcceeh
Confidence 999998887788899999999999999999999999996
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=249.17 Aligned_cols=174 Identities=26% Similarity=0.381 Sum_probs=144.8
Q ss_pred EEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 806 RELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+.||+|+||.||+++. .++.||||+++..... ......+.+|+.+|++++||||+++++++.+ .+.+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~ 73 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK------VRDRVRTKMERDILAEVNHPFIVKLHYAFQT--EGKL 73 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh------hhhHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCEE
Confidence 5799999999999875 4678999999864321 1122456789999999999999999999987 5789
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
|+||||+.+++|.+++.+.. .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 74 YLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLTDFGLSKES 148 (318)
T ss_pred EEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEEC----CCCcEEEeeccCCccc
Confidence 99999999999999997653 489999999999999999999999999999999999998 5678999999999865
Q ss_pred ccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 961 QQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 961 ~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... .......||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di 181 (318)
T cd05582 149 IDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADW 181 (318)
T ss_pred CCCCCceecccCChhhcCHHHHcCCCC-CCccce
Confidence 433 23345679999999999987654 456665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=268.43 Aligned_cols=189 Identities=34% Similarity=0.554 Sum_probs=156.5
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEcC-----cc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRG-----SD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~kg-----t~-VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
...++.-++..+.++||+|+||.||+|+++- .. ||||..+..... .+..+++|.+|.++|+.++|||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~-----~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSEL-----TKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccc-----cHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3445566777788999999999999998841 13 899988753221 234467899999999999999999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
++||++.. ...+++|||+|.||+|.++|++....++..+++.++.+.+.||+|||++++|||||..+|+|++ .+
T Consensus 225 r~yGVa~~--~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~----~~ 298 (474)
T KOG0194|consen 225 RFYGVAVL--EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS----KK 298 (474)
T ss_pred EEEEEEcC--CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----CC
Confidence 99999988 5679999999999999999998877799999999999999999999999999999999999998 55
Q ss_pred CeEEEEecCCccccccccccC-CCCCCCCccccccccCCccCCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~s~-s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+||+|||||+......... ...-...|+|||.+... .++.+.||
T Consensus 299 ~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV 345 (474)
T KOG0194|consen 299 GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDV 345 (474)
T ss_pred CeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccch
Confidence 678999999998765332222 22356789999999866 77777776
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=249.78 Aligned_cols=178 Identities=25% Similarity=0.412 Sum_probs=144.1
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHH---HhhcCCCCcceEEEEEEcCC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL---LSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~I---Lr~LrHPNIVrL~G~f~d~s 876 (993)
|++++.||+|+||.||+|.++ ++.||||+++...... ....+.+.+|+.+ ++.++||||+++++++.+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-----RDEVESLMCEKRIFETANSERHPFLVNLFACFQT-- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--
Confidence 678999999999999999884 6789999998653221 1123345555554 467789999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|+||||+.+++|..++... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 74 ~~~~~lv~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~----~~~~~kL~Dfg~ 147 (324)
T cd05589 74 EDHVCFVMEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD----TEGFVKIADFGL 147 (324)
T ss_pred CCEEEEEEcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC----CCCcEEeCcccC
Confidence 56899999999999999888643 489999999999999999999999999999999999998 667999999999
Q ss_pred cccccc-ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++.... .......+||+.|||||++.+..+ ..++||
T Consensus 148 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di 184 (324)
T cd05589 148 CKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDW 184 (324)
T ss_pred CccCCCCCCcccccccCccccCHhHhcCCCC-Ccccch
Confidence 875322 222345679999999999987654 456675
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=248.33 Aligned_cols=181 Identities=26% Similarity=0.330 Sum_probs=145.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC--
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s-- 876 (993)
+|++.++||+|+||.||+|+. ++..||||+++..... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH------VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc------chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 588999999999999999987 4678999998743211 112246789999999999999999999886532
Q ss_pred -CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 -~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+|+||||+ +++|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kL~Dfg 148 (338)
T cd07859 75 EFKDIYVVFELM-ESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN----ADCKLKICDFG 148 (338)
T ss_pred CCceEEEEEecC-CCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEccCc
Confidence 23589999999 578999887654 488999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc----ccCCCCCCCCccccccccCC-ccCCCCCCC
Q 001940 956 LSKVKQQTL----VSGGVRGTLPWMAPELLSGK-SHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk-~y~tse~DI 993 (993)
+++...... ......||+.|+|||++.+. ...+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~Dv 191 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 191 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHH
Confidence 998543221 12345799999999998753 345556664
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=243.10 Aligned_cols=181 Identities=26% Similarity=0.338 Sum_probs=149.7
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|++.++||+|+||.||++.. +++.||||++....... ......+.+|+.+++.++|+||+++++.+.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhh-----hhhHHHHHHHHHHHHhcCCCCEeeeeeeecC--CC
Confidence 378899999999999999987 47789999987543211 1123456789999999999999999999887 46
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.++|+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05605 74 ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLD----DYGHIRISDLGLA 149 (285)
T ss_pred eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 799999999999999988654 34589999999999999999999999999999999999998 5678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.............||+.|+|||++.+.. .+.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 184 (285)
T cd05605 150 VEIPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDW 184 (285)
T ss_pred eecCCCCccccccCCCCccCcHHhcCCC-CCccccc
Confidence 8754433334557999999999998765 4456675
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=240.94 Aligned_cols=182 Identities=29% Similarity=0.418 Sum_probs=143.3
Q ss_pred CCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc---CCCCcceEEEEEE
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVR 873 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L---rHPNIVrL~G~f~ 873 (993)
.+|++++.||+|+||+||+|++. ++.||||+++....... . ...+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~--~----~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG--M----PLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC--c----hHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 36899999999999999999873 56799999875432211 1 12344566666554 6999999999986
Q ss_pred c---CCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 874 D---GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 874 d---~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
. .....+++||||+. ++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~----~~~~~ 149 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 149 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc----CCCCE
Confidence 3 12456899999995 6899988754 34588999999999999999999999999999999999998 56789
Q ss_pred EEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++............||+.|+|||++.+.. ...++||
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 192 (290)
T cd07862 150 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDL 192 (290)
T ss_pred EEccccceEeccCCcccccccccccccChHHHhCCC-CCCccch
Confidence 999999998765444445567999999999997664 4456675
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=250.78 Aligned_cols=175 Identities=23% Similarity=0.358 Sum_probs=144.3
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||.||++++. ++.||||++++..... ....+.+.+|..++..+ +||||++++++|.+ .+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~-----~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~l 73 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-----DEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFF 73 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEE
Confidence 36999999999999884 6779999998643221 22345677899999888 69999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc-c
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-Q 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~-~ 961 (993)
||||+++++|.+++.+.. .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++.. .
T Consensus 74 v~e~~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg~~~~~~~ 148 (329)
T cd05588 74 VIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLTDYGMCKEGIR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEECcCcccccccc
Confidence 999999999999887653 589999999999999999999999999999999999998 5678999999998753 2
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCC-CCccce
Confidence 2223345679999999999987654 456675
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.53 Aligned_cols=180 Identities=25% Similarity=0.326 Sum_probs=147.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+++ ++.||||+++..... ....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN------EEVKETTLRELKMLRTLKQENIVELKEAFRR--R 72 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc------ccchhhHHHHHHHHHhCCCccccchhhhEec--C
Confidence 46999999999999999999985 667999998754221 1223467789999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.++.|..+. .....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~----~~~~~kl~Dfg~~ 147 (287)
T cd07848 73 GKLYLVFEYVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS----HNDVLKLCDFGFA 147 (287)
T ss_pred CEEEEEEecCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeeccCc
Confidence 7899999999887766554 3344588999999999999999999999999999999999998 5678999999999
Q ss_pred ccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......||+.|+|||++.+..+ +.++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 184 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDM 184 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCC-CCchhH
Confidence 8754322 2234568999999999987764 556665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=253.28 Aligned_cols=175 Identities=25% Similarity=0.384 Sum_probs=146.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
....+|++++.||+|+||.||+|+.. +..||+|+.... ....|+.++++++|+||+++++++..
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~ 128 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVS 128 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEe
Confidence 34457999999999999999999985 457899975432 23468899999999999999999988
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
....++||||+ .++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ ..+.+||+||
T Consensus 129 --~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~----~~~~~kl~Df 201 (357)
T PHA03209 129 --GAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN----DVDQVCIGDL 201 (357)
T ss_pred --CCeeEEEEEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEecC
Confidence 46789999999 5789998887767799999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++............||+.|+|||++.+..+ ..++||
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 239 (357)
T PHA03209 202 GAAQFPVVAPAFLGLAGTVETNAPEVLARDKY-NSKADI 239 (357)
T ss_pred ccccccccCcccccccccccccCCeecCCCCC-CchhhH
Confidence 99986544333345679999999999987654 456664
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=248.38 Aligned_cols=175 Identities=25% Similarity=0.361 Sum_probs=140.8
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~-ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+. +++.||||++....... ....+.+..|.. +++.++||||+++++++.+ .+.+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~--~~~~~l 73 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-----KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--ADKLYF 73 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe--CCEEEE
Confidence 3699999999999988 47789999997643221 112234444444 5688999999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (323)
T cd05575 74 VLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGIE 148 (323)
T ss_pred EEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeccCCCccccc
Confidence 999999999999987654 588899999999999999999999999999999999998 567899999999875322
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.......+||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 179 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQPY-DRTVDW 179 (323)
T ss_pred CCCccccccCChhhcChhhhcCCCC-Cccccc
Confidence 223345679999999999987654 456775
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=245.79 Aligned_cols=178 Identities=29% Similarity=0.421 Sum_probs=144.2
Q ss_pred EEEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 805 VRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
.++||+|+||+||+|+.+ ++.||||++..... ...+.+|+.+|++++||||+++++++.......+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 357999999999999863 45699998864321 1245689999999999999999999976556778
Q ss_pred EEEEeeccCCcHHHHHHhc--------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 881 ATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~--------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++..+...+.+||+
T Consensus 76 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 9999998 56888887532 12478889999999999999999999999999999999996544466789999
Q ss_pred ecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++...... ......||+.|||||++.+...++.++||
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 199 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 199 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhH
Confidence 999998654321 22346789999999999987777777886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=247.12 Aligned_cols=181 Identities=30% Similarity=0.477 Sum_probs=151.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+..++|++++.||+|+||.||++++. +..+|+|++.... .....+.+.+|+.+|++++|+||+++++++..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 45678999999999999999999985 6678999887531 12234578899999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~----~~~~~kl~D 147 (331)
T cd06649 75 --DGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN----SRGEIKLCD 147 (331)
T ss_pred --CCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc----CCCcEEEcc
Confidence 568999999999999999997654 488999999999999999999986 699999999999998 567899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++..... ......||+.|+|||++.+.. .+.++||
T Consensus 148 fg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~Di 185 (331)
T cd06649 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDI 185 (331)
T ss_pred Cccccccccc-ccccCCCCcCcCCHhHhcCCC-CCchHhH
Confidence 9998865433 234567999999999998765 3455664
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=246.77 Aligned_cols=175 Identities=26% Similarity=0.370 Sum_probs=140.4
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHH-HHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEA-LLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi-~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||.||+|+.. ++.||||++.+.... .......+.+|. .+++.++|+||+++++++.+ .+.+|+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~--~~~~~l 73 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL-----KKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT--AEKLYF 73 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHH-----HhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999884 677999999764321 112223444454 46789999999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
||||+++++|...+.+.. .+.+..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~~~~~ 148 (321)
T cd05603 74 VLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLD----SQGHVVLTDFGLCKEGVE 148 (321)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEccCCCCccCCC
Confidence 999999999999887643 478888899999999999999999999999999999998 66789999999987532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........+||+.|+|||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEPY-DRTVDW 179 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCCC-CCcCcc
Confidence 2223345679999999999987654 456775
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=247.38 Aligned_cols=174 Identities=26% Similarity=0.365 Sum_probs=141.8
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc---CCCCcceEEEEEEcCCCCcEEE
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L---rHPNIVrL~G~f~d~s~~~L~L 882 (993)
||+|+||+||+|+.+ ++.||||++.+.... .......+..|..++.++ +||||+++++++.+ ...+|+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~l 73 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-----AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYL 73 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-----hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEE
Confidence 799999999999884 778999998754321 122233455666666655 69999999999988 567999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
||||+.+++|.+++.+.. .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~a~~~~~ 148 (330)
T cd05586 74 VTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD----ATGHIALCDFGLSKANLT 148 (330)
T ss_pred EEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC----CCCCEEEecCCcCcCCCC
Confidence 999999999999987654 488999999999999999999999999999999999998 56789999999987532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........+||+.|||||++.+......++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dv 180 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCCCCCCccce
Confidence 22233456799999999999877667777886
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=247.46 Aligned_cols=175 Identities=24% Similarity=0.347 Sum_probs=139.1
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHH-HHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rE-i~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|++. ++.||+|++.+..... ......+..| ..+++.++|+||+++++++.. .+.+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~--~~~~~l 73 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-----KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADKLYF 73 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-----hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc--CCeEEE
Confidence 36999999999999884 5679999997643211 1112233334 445788999999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
||||+.+++|.+++.... .+.+..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~----~~~~~kl~DfG~a~~~~~ 148 (325)
T cd05602 74 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTDFGLCKENIE 148 (325)
T ss_pred EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEEccCCCCccccc
Confidence 999999999999997654 477888888999999999999999999999999999998 56789999999997532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........+||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQPY-DRTVDW 179 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCCC-CCcccc
Confidence 2223345679999999999987654 456675
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=247.33 Aligned_cols=175 Identities=25% Similarity=0.351 Sum_probs=140.9
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~-ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+. +++.||||++.+..... ......+.+|.. +++.++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~--~~~~~l 73 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-----RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT--TEKLYF 73 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhHHHHHHHHHHHHHHhCCCCCCccEEEEEec--CCEEEE
Confidence 3699999999999987 47789999997643221 112234445544 5778999999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|..++.... .+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~----~~~~~kL~DfG~~~~~~~ 148 (325)
T cd05604 74 VLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD----SQGHVVLTDFGLCKEGIA 148 (325)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEEeecCCcccCCC
Confidence 999999999999887554 588999999999999999999999999999999999998 667899999999875322
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.......+||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 179 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQPY-DNTVDW 179 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCCC-CCcCcc
Confidence 223345679999999999987765 456775
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=247.39 Aligned_cols=175 Identities=25% Similarity=0.388 Sum_probs=140.6
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh-cCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~-LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
++||+|+||.||+|+++ ++.||||+++...... ....+.+..|..++.. ++||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~l 73 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLE-----DDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----hhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999884 5679999998643221 1122344556666654 589999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~----~~~~~kL~Dfg~a~~~~~ 148 (316)
T cd05592 74 VMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD----KDGHIKIADFGMCKENMN 148 (316)
T ss_pred EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEEC----CCCCEEEccCcCCeECCC
Confidence 999999999999987654 488999999999999999999999999999999999998 567899999999985422
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.......+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 179 (316)
T cd05592 149 GEGKASTFCGTPDYIAPEILKGQKY-NESVDW 179 (316)
T ss_pred CCCccccccCCccccCHHHHcCCCC-CCcccc
Confidence 223345679999999999987754 566775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=255.18 Aligned_cols=176 Identities=22% Similarity=0.285 Sum_probs=146.0
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+...+|+++++||+|+||.||++.+. ++.||||+... ..+.+|+.+|++|+||||++++++|
T Consensus 87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------------~~~~~E~~il~~l~HpnIv~~~~~~ 152 (391)
T PHA03212 87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------------GGTATEAHILRAINHPSIIQLKGTF 152 (391)
T ss_pred cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------------hhhHHHHHHHHhCCCCCCCCEeEEE
Confidence 3455678999999999999999999884 67799996432 2456899999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. ....++|||++ .++|..++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ ..+.+||+
T Consensus 153 ~~--~~~~~lv~e~~-~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~----~~~~vkL~ 224 (391)
T PHA03212 153 TY--NKFTCLILPRY-KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN----HPGDVCLG 224 (391)
T ss_pred EE--CCeeEEEEecC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc----CCCCEEEE
Confidence 87 56789999999 578988887654 478999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccc--cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~--~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+..... .......||+.|+|||++.+..+ +.++||
T Consensus 225 DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 266 (391)
T PHA03212 225 DFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDI 266 (391)
T ss_pred eCCcccccccccccccccccCccCCCChhhhcCCCC-CcHHHH
Confidence 99999754322 12234679999999999987654 455664
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=248.14 Aligned_cols=175 Identities=22% Similarity=0.354 Sum_probs=143.2
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+.+ ++.||+|++++..... ....+.+.+|+.++.++ +||||+++++++.. .+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 73 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFF 73 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcc-----hhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEE
Confidence 36999999999999884 6679999998653221 12234577888888776 79999999999988 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|..++.... .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~----~~~~~kL~DfG~~~~~~~ 148 (329)
T cd05618 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLTDYGMCKEGLR 148 (329)
T ss_pred EEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCCEEEeeCCccccccC
Confidence 999999999999887654 588999999999999999999999999999999999998 667899999999875322
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........||+.|+|||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDW 179 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCC-CCccce
Confidence 222345679999999999987755 446665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=270.07 Aligned_cols=183 Identities=32% Similarity=0.555 Sum_probs=152.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
+...++.+.+.||+|.||+||+|+|.|. ||||+++..... ....+.|..|+.++++-+|.||+-+.|+|..+
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt------~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p- 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPT------PEQLQAFKNEVAVLKKTRHENILLFMGACMNP- 460 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc-eEEEEEecCCCC------HHHHHHHHHHHHHHhhcchhhheeeehhhcCC-
Confidence 3445567788999999999999999875 999999876432 12567899999999999999999999999974
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.||+.||+|-+|+.+|+-...+++..+.+.|++||+.|+.|||.++|||||||..||++. ++++|||+|||+
T Consensus 461 --~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~----~~~kVkIgDFGL 534 (678)
T KOG0193|consen 461 --PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLH----EDLKVKIGDFGL 534 (678)
T ss_pred --ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEc----cCCcEEEecccc
Confidence 35999999999999999988777899999999999999999999999999999999999998 668999999999
Q ss_pred cccccccc---ccCCCCCCCCccccccccCC--ccCCCCCCC
Q 001940 957 SKVKQQTL---VSGGVRGTLPWMAPELLSGK--SHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~---~s~s~~GTp~YmAPEVL~Gk--~y~tse~DI 993 (993)
+....... ......|.+.|||||+++.+ .-++...||
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDV 576 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDV 576 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccch
Confidence 88654432 22334588899999999733 333444443
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-26 Score=246.87 Aligned_cols=175 Identities=22% Similarity=0.369 Sum_probs=142.4
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~L 882 (993)
++||+|+||.||+|+++ ++.||||+++..... .....+.+..|..++..+ +||||+++++++.+ .+.+|+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~l 73 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVIL-----QDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFF 73 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhh-----hhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEE
Confidence 36999999999999885 567999999864322 122234566788888765 79999999999987 567999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|..++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~----~~~~~kL~Dfg~~~~~~~ 148 (321)
T cd05591 74 VMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD----AEGHCKLADFGMCKEGIL 148 (321)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeecccceeccc
Confidence 999999999999987654 488899999999999999999999999999999999998 667899999999875422
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........||+.|+|||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 179 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELEY-GPSVDW 179 (321)
T ss_pred CCccccccccCccccCHHHHcCCCC-CCccce
Confidence 222345679999999999987654 456665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=256.70 Aligned_cols=182 Identities=28% Similarity=0.381 Sum_probs=154.8
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc---
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--- 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d--- 874 (993)
..|..++.||+|+||.|+.|.+ +++.||||++... + ......++..+|+.+|+.++|+||+.+++++..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F-----~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-F-----ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-h-----hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 4455679999999999999988 4788999988742 1 223345678899999999999999999999876
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
..-..+|+|+|+| +.+|..+|+... .++...+.++++||++||+|+|+.+|+||||||+|+|++ .+..+||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n----~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLN----ADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhheeec----cCCCEEeccc
Confidence 2345689999999 889999997654 489999999999999999999999999999999999998 7788999999
Q ss_pred CCcccccc---ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQ---TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~---~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|+.... ....+..+-|.||+|||++.....++..+||
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDi 211 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDI 211 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhh
Confidence 99998753 3334567789999999999999899998886
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=238.56 Aligned_cols=183 Identities=27% Similarity=0.477 Sum_probs=148.6
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+...+|++.+.||+|+||.||+|+++ +..||+|+++.... ....+.+.+|+.++++++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-------DKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-------HHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 34567999999999999999999763 45689998875421 1223568899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.. .+.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+++||||||+|||++ .++.+||
T Consensus 75 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~----~~~~~~l 148 (266)
T cd05064 75 ITR--GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN----SDLVCKI 148 (266)
T ss_pred Eec--CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc----CCCcEEE
Confidence 987 5679999999999999999987656689999999999999999999999999999999999998 5678999
Q ss_pred EecCCcccccccccc--CCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s--~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||.+......... ....++..|+|||++.+..+ +.++||
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 191 (266)
T cd05064 149 SGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF-SSASDV 191 (266)
T ss_pred CCCcccccccccchhcccCCCCceeecCHHHHhhCCc-cchhHH
Confidence 999987654322111 12335678999999976543 445554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=259.38 Aligned_cols=182 Identities=23% Similarity=0.315 Sum_probs=146.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.....+|++.+.||+|+||.||+|.. .++.||||++.... ....+|+.+|+.++|+||+++++++.
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~ 129 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYY 129 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEe
Confidence 44567899999999999999999987 46789999886431 12346899999999999999998875
Q ss_pred cC------CCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC
Q 001940 874 DG------PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 874 d~------s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~ 944 (993)
.. ....+++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||+.+|+||||||+|||++.
T Consensus 130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~--- 205 (440)
T PTZ00036 130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP--- 205 (440)
T ss_pred ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC---
Confidence 32 1224779999996 577776653 3456889999999999999999999999999999999999972
Q ss_pred CCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 945 QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+.+||+|||+|+............||+.|||||++.+...++.++||
T Consensus 206 ~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 254 (440)
T PTZ00036 206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDL 254 (440)
T ss_pred CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHH
Confidence 2347999999999876544444456789999999999887777777775
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=269.85 Aligned_cols=178 Identities=30% Similarity=0.489 Sum_probs=153.9
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
+..++..+.+..++-||.|+-|.||+|+++++.||||+++.- -..+|+-|++|+|+|||.|.|+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------------hhhhHHHHHhccCcceeeEeeee
Confidence 444555556667788999999999999999999999977631 12467889999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. ..++|||||||..|-|..+|+... .+.......|..+|+.|+.|||...|||||||.-||||+. +..|||+
T Consensus 182 tq--sPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~----~d~VKIs 254 (904)
T KOG4721|consen 182 TQ--SPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISY----DDVVKIS 254 (904)
T ss_pred cC--CceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeec----cceEEec
Confidence 98 568999999999999999997664 5888888999999999999999999999999999999994 4589999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||-++......+...++||..|||||+|+++ -...++||
T Consensus 255 DFGTS~e~~~~STkMSFaGTVaWMAPEvIrne-PcsEKVDI 294 (904)
T KOG4721|consen 255 DFGTSKELSDKSTKMSFAGTVAWMAPEVIRNE-PCSEKVDI 294 (904)
T ss_pred cccchHhhhhhhhhhhhhhhHhhhCHHHhhcC-Ccccccce
Confidence 99999988777777789999999999999866 45667776
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=233.00 Aligned_cols=178 Identities=34% Similarity=0.505 Sum_probs=146.8
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|++.+.||+|+||+||+++.. ++.+|+|++..... .........+|+.++++++|+||+++++++.. ...
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~ 72 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI------EEEEREENIREIKILRRLRHPNIVQILDVFQD--DNY 72 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH------HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc------cccccchhhhhhhccccccccccccccccccc--ccc
Confidence 788999999999999999995 44699999986521 12222344569999999999999999999988 578
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++||||+.+++|.+++... ..+++..++.++.||+.||.+||+.+|+|+||||+|||++ .++.++|+|||++..
T Consensus 73 ~~~v~~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~----~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 73 LYIVMEYCPGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD----ENGEVKLIDFGSSVK 147 (260)
T ss_dssp EEEEEEEETTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES----TTSEEEESSGTTTEE
T ss_pred cccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 99999999999999999833 4589999999999999999999999999999999999998 667899999999875
Q ss_pred c-ccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 960 K-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 960 ~-~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
. ..........+|..|+|||++......+.+.|
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 181 (260)
T PF00069_consen 148 LSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSD 181 (260)
T ss_dssp STSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHH
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 3 22334456678999999999984444444444
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=247.03 Aligned_cols=175 Identities=26% Similarity=0.406 Sum_probs=142.4
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+.+ ++.||||++++.... .....+.+..|..++..+ +||||+++++++.+ .+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~i 73 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVIL-----QDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFF 73 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-----hccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEE
Confidence 36999999999999884 677999999864321 112234667788888776 69999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~----~~~~~kL~DfG~~~~~~~ 148 (320)
T cd05590 74 VMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLADFGMCKEGIF 148 (320)
T ss_pred EEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC----CCCcEEEeeCCCCeecCc
Confidence 999999999999987654 488999999999999999999999999999999999998 66789999999987532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.........||+.|||||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEMLY-GPSVDW 179 (320)
T ss_pred CCCcccccccCccccCHHHHcCCCC-CCccch
Confidence 2223345679999999999987644 455665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=245.94 Aligned_cols=180 Identities=21% Similarity=0.324 Sum_probs=146.5
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~ 877 (993)
+|++.+.||+|+||+||+|+.+ ++.||||++.+.... .....+.+..|..+++.+. |++|+++++++.+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~ 73 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVI-----QDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--V 73 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhccCCCchhheeeEEec--C
Confidence 4788899999999999999884 678999999864321 1222346677888888876 5778889988887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+++++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~----~~~~ikL~Dfg~~ 148 (323)
T cd05615 74 DRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD----SEGHIKIADFGMC 148 (323)
T ss_pred CEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEeccccc
Confidence 67999999999999999987654 488999999999999999999999999999999999998 5678999999998
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 184 (323)
T cd05615 149 KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184 (323)
T ss_pred cccCCCCccccCccCCccccCHHHHcCCCC-CCccch
Confidence 854322 22345679999999999987654 456775
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=246.36 Aligned_cols=175 Identities=22% Similarity=0.328 Sum_probs=144.2
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+.+ ++.||||++++.... .....+.+.+|..++.++ +|+||+++++++.+ .+.+|+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 73 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVH-----DDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFL 73 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEE
Confidence 36999999999999874 567999999864321 223345678899998888 59999999999987 567999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
||||+.+++|..++.... .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~----~~~~~kl~Dfg~~~~~~~ 148 (327)
T cd05617 74 VIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD----ADGHIKLTDYGMCKEGLG 148 (327)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe----CCCCEEEeccccceeccC
Confidence 999999999999887654 489999999999999999999999999999999999998 56789999999987532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGEEY-GFSVDW 179 (327)
T ss_pred CCCceecccCCcccCCHHHHCCCCC-Cchhee
Confidence 2223345679999999999987655 456665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=241.85 Aligned_cols=181 Identities=30% Similarity=0.462 Sum_probs=148.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||.||+|+.+ ++.||||+++...... ....+.+|+.++++++|+||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIVHT-- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-------cchhHHHHHHHHHhCCCCCcceEEEEEee--
Confidence 467999999999999999999874 6679999987543211 11246689999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+. ++|.+++......+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~ 150 (309)
T cd07872 76 DKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN----ERGELKLADFGL 150 (309)
T ss_pred CCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECcccc
Confidence 567999999996 588888877666688999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ......+|+.|+|||++.+......++||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (309)
T cd07872 151 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDM 188 (309)
T ss_pred ceecCCCccccccccccccccCCHHHhCCCCCCcHHHH
Confidence 87543322 22345689999999999876666666664
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=270.13 Aligned_cols=177 Identities=28% Similarity=0.508 Sum_probs=152.0
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|.-++.||.|+||.||.|++ +.+.||||++.- .++... ....++.+|+..|++|+|||+|.+.|+|-. +..
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsy---SGKQs~--EKWqDIlKEVrFL~~l~HPntieYkgCyLr--e~T 100 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY---SGKQSN--EKWQDILKEVRFLRQLRHPNTIEYKGCYLR--EHT 100 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccc---cccccH--HHHHHHHHHHHHHHhccCCCcccccceeec--cch
Confidence 55567899999999999988 456799998864 333322 234688999999999999999999999987 567
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.||||||| -|+-.|+|.-..+.+.+..+..|+.+.+.||.|||+.+.||||||..|||++ ..+.|||+|||.|.+
T Consensus 101 aWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs----e~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS----EPGLVKLADFGSASI 175 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec----CCCeeeeccccchhh
Confidence 89999999 6688888877777899999999999999999999999999999999999998 778999999999987
Q ss_pred cccccccCCCCCCCCcccccccc--CCccCCCCCCC
Q 001940 960 KQQTLVSGGVRGTLPWMAPELLS--GKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~~s~s~~GTp~YmAPEVL~--Gk~y~tse~DI 993 (993)
... .++++|||.|||||+|+ ....|..++||
T Consensus 176 ~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDv 208 (948)
T KOG0577|consen 176 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 208 (948)
T ss_pred cCc---hhcccCCccccchhHheeccccccCCccce
Confidence 655 35789999999999986 67788888886
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=266.18 Aligned_cols=181 Identities=27% Similarity=0.424 Sum_probs=156.1
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
....|+.+++||+|+||.||+|.+. ++.||||++..... +..++++.+|+.+|.+++++||.++|+.|..
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~-------~deIediqqei~~Ls~~~~~~it~yygsyl~- 82 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA-------EDEIEDIQQEISVLSQCDSPNITEYYGSYLK- 82 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhc-------chhhHHHHHHHHHHHhcCcchHHhhhhheee-
Confidence 3456888899999999999999884 67799999987632 3346788899999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+|++||||.||++.++|+... .+.+.....|+++++.||.|||..+.+|||||+.|||+. ..+.+||+|||
T Consensus 83 -g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s----~~g~vkl~Dfg 156 (467)
T KOG0201|consen 83 -GTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS----ESGDVKLADFG 156 (467)
T ss_pred -cccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEe----ccCcEEEEecc
Confidence 567999999999999999997654 357788888999999999999999999999999999998 66899999999
Q ss_pred Cccccccccc-cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~-s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+-++..... ...++||+.|||||+++ ...|..++||
T Consensus 157 Va~ql~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADI 194 (467)
T KOG0201|consen 157 VAGQLTNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADI 194 (467)
T ss_pred eeeeeechhhccccccccccccchhhhc-cccccchhhh
Confidence 9988765543 36789999999999999 4466778886
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=242.90 Aligned_cols=183 Identities=28% Similarity=0.519 Sum_probs=147.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.+...+|++++.||+|+||.||+|++. ++ .||||+++... .....+++.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~ 75 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRLL 75 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 355678999999999999999999873 33 38999886421 112235688899999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.. ...++|+||+.+|+|.+++......+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+
T Consensus 76 g~~~~---~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~----~~~~~ 148 (316)
T cd05108 76 GICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK----TPQHV 148 (316)
T ss_pred EEEcC---CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec----CCCcE
Confidence 99886 347899999999999999987666688999999999999999999999999999999999998 56789
Q ss_pred EEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++....... .....++..|+|||++.+..+ +.++||
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di 194 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY-THQSDV 194 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCC-Cchhhh
Confidence 9999999986543322 122334678999999976543 455664
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=251.06 Aligned_cols=176 Identities=31% Similarity=0.475 Sum_probs=142.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|+++++||+|+||.||+|++. ++.||||++.... .....+.+.+|+.+++.++|+||+++++++.. .
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 144 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-------EDTVRRQICREIEILRDVNHPNVVKCHDMFDH--N 144 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-------cHHHHHHHHHHHHHHHhCCCCCcceeeeEecc--C
Confidence 45677889999999999999884 7889999986431 12234578899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+.. ...+..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 145 ~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DfG~~ 215 (353)
T PLN00034 145 GEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN----SAKNVKIADFGVS 215 (353)
T ss_pred CeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEcccccc
Confidence 7899999999999986532 356777888999999999999999999999999999998 5678999999999
Q ss_pred ccccccc-ccCCCCCCCCccccccccCC----ccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGK----SHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk----~y~tse~DI 993 (993)
+...... ......||..|+|||++... .+...++||
T Consensus 216 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dv 256 (353)
T PLN00034 216 RILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256 (353)
T ss_pred eecccccccccccccCccccCccccccccccCcCCCcchhH
Confidence 8654332 22345799999999998542 233446665
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-27 Score=263.77 Aligned_cols=182 Identities=27% Similarity=0.478 Sum_probs=157.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
-++|..+++||+|+||.++..+.+ ++.+|+|++.......+. .+...+|+.++++++|||||.+++.|..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~------r~~A~~E~~lis~~~hP~iv~y~ds~~~-- 74 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE------RRSAIQEMDLLSKLLHPNIVEYKDSFEE-- 74 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh------hHHHHHHHHHHHhccCCCeeeeccchhc--
Confidence 357899999999999999987764 677999999876544321 1256789999999999999999999998
Q ss_pred CCc-EEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 877 DGS-LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 877 ~~~-L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+++ ++|||+||+||+|.+.|.+.+ ..++++.+..++.||+.||.|||++.|+|||||+.||+++ .+..|||.||
T Consensus 75 ~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt----k~~~VkLgDf 150 (426)
T KOG0589|consen 75 DGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT----KDKKVKLGDF 150 (426)
T ss_pred CCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc----ccCceeecch
Confidence 566 999999999999999998765 6789999999999999999999999999999999999998 6668899999
Q ss_pred CCcccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|+...... ...+.+||+.||+||++.+.+|. .+.||
T Consensus 151 GlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn-~KSDi 189 (426)
T KOG0589|consen 151 GLAKILNPEDSLASTVVGTPYYMCPEILSDIPYN-EKSDI 189 (426)
T ss_pred hhhhhcCCchhhhheecCCCcccCHHHhCCCCCC-ccCcc
Confidence 9999887765 66778999999999999988765 44444
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-26 Score=245.69 Aligned_cols=181 Identities=31% Similarity=0.495 Sum_probs=149.9
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+..++|++.++||+|+||.||++.++ +..+|+|++.... .......+.+|+.++++++|+||++++++|.+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 45678999999999999999999885 6678999887531 11223568899999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~----~~~~~kL~D 147 (333)
T cd06650 75 --DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCD 147 (333)
T ss_pred --CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc----CCCCEEEee
Confidence 578999999999999999997654 478889999999999999999975 799999999999998 567899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||++...... ......||..|+|||++.+.. .+.+.||
T Consensus 148 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 185 (333)
T cd06650 148 FGVSGQLIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDI 185 (333)
T ss_pred CCcchhhhhh-ccccCCCCccccCHHHhcCCC-CCcHHHH
Confidence 9998765332 223457999999999998764 3344553
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=235.76 Aligned_cols=180 Identities=27% Similarity=0.352 Sum_probs=148.4
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|+..+.||+|+||+||++.+. ++.||+|++...... .......+.+|+.+|++++|+||+.+++.+.. .+.
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~ 74 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-----KRKGESMALNEKQILEKVNSQFVVNLAYAYET--KDA 74 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-----hhhHHHHHHHHHHHHHHcCCcCceeEEEEEec--CCE
Confidence 778899999999999999884 678999998754321 12223457789999999999999999999887 567
Q ss_pred EEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~----~~~~~kl~Dfg~~~ 150 (285)
T cd05632 75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD----DYGHIRISDLGLAV 150 (285)
T ss_pred EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC----CCCCEEEecCCcce
Confidence 999999999999998886543 4589999999999999999999999999999999999998 55789999999987
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
............||..|+|||++.+..+ ..+.||
T Consensus 151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Di 184 (285)
T cd05632 151 KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDY 184 (285)
T ss_pred ecCCCCcccCCCCCcCccChHHhcCCCC-Ccccch
Confidence 6543333344579999999999987654 455665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=239.90 Aligned_cols=178 Identities=28% Similarity=0.411 Sum_probs=142.8
Q ss_pred EEEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 805 VRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
..+||+|+||+||+|+.+ +..||+|.+..... ...+.+|+.+++.++||||+++++++.......+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----------SMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 368999999999999864 35699998864321 1246689999999999999999999976556789
Q ss_pred EEEEeeccCCcHHHHHHhc--------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 881 ATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~--------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++||||+. ++|.+++... ...+++..+..|+.||+.||.|||+.+|+||||||+|||+...+...+.+||+
T Consensus 76 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 99999985 5788777531 22478888999999999999999999999999999999996444466799999
Q ss_pred ecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++...... ......||+.|+|||++.+....+.++||
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 199 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 199 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHH
Confidence 999998654322 12345689999999999887766777775
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=245.76 Aligned_cols=180 Identities=23% Similarity=0.330 Sum_probs=145.6
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||++.. .+..||||++...... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN------QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc------hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 46899999999999999999987 4778999998754211 122346778999999999999999999987532
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+|+||||+. ++|.+.+.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~----~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMD-ANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCC-cCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 135799999995 466666643 378888899999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++............||+.|+|||++.+..+ ..++||
T Consensus 166 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di 205 (359)
T cd07876 166 DFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY-KENVDI 205 (359)
T ss_pred cCCCccccccCccCCCCcccCCCCCchhccCCCC-Ccchhh
Confidence 9999986544444445678999999999987755 445665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=244.16 Aligned_cols=175 Identities=25% Similarity=0.387 Sum_probs=141.0
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh-cCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~-LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||.||+|+++ ++.||||+++...... ....+.+..|..++.. ++|+||+++++++.+ .+.+|+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 73 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLI-----DDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFF 73 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-----cchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEE
Confidence 36999999999999884 6789999998643211 1122345667777765 489999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05620 74 VMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLD----RDGHIKIADFGMCKENVF 148 (316)
T ss_pred EECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEC----CCCCEEeCccCCCeeccc
Confidence 999999999999987654 478899999999999999999999999999999999998 567899999999874321
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.......+||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 179 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLKY-TFSVDW 179 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCCC-Ccccch
Confidence 122345679999999999987654 456775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=258.04 Aligned_cols=179 Identities=20% Similarity=0.303 Sum_probs=146.8
Q ss_pred CCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..|.+.+.||+|+||.||+|... +..||+|.+.... ......+.+|+.+|+.++|||||+++++|..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--------~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--------ERQAAYARSELHCLAACDHFGIVKHFDDFKS-- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--
Confidence 34999999999999999999763 4568888764321 1223467789999999999999999999988
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+||||||+.+|+|.++|... ...+++..+..++.||+.||.|||+.+|+||||||+|||++ ..+.+||+|
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~~kL~D 212 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM----PTGIIKLGD 212 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC----CCCcEEEEe
Confidence 57899999999999999988642 33578889999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++...... .....+||+.|||||++.+..+ +.++||
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 254 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY-SKKADM 254 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCC-CcHHhH
Confidence 99998654332 2345679999999999987644 455564
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=260.11 Aligned_cols=182 Identities=23% Similarity=0.352 Sum_probs=164.1
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
-|.+.+.||+|-|..|-+|++ +|..||||++.+..+. ......+.+|+..|+.++|||||++|.+... ..
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD------~~st~hlfqEVRCMKLVQHpNiVRLYEViDT--QT 90 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD------TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT--QT 90 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc------hhhhhHHHHHHHHHHHhcCcCeeeeeehhcc--cc
Confidence 377778999999999999976 8999999999876542 2233578899999999999999999999877 67
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
++|||+|+-++|+|+++|-+....+.+..+.+++.||+.|+.|+|+..+|||||||+|+.+.. .-|.|||+|||++.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE---KlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE---KLGLVKLTDFGFSN 167 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---ecCceEeeeccccc
Confidence 899999999999999999988888999999999999999999999999999999999998872 56899999999999
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...........||++.|.|||+++|..|....+||
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDi 202 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDI 202 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccCCcchhh
Confidence 88888777889999999999999999999999997
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=240.13 Aligned_cols=176 Identities=20% Similarity=0.253 Sum_probs=147.4
Q ss_pred EEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc--CCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--GPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d--~s~~~L~LV 883 (993)
..||+|+++.||+|+++++.||||+++.... ......+.+.+|+.+|++++||||+++++++.+ .....+++|
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-----GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEecccccc-----ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 5799999999999999999999999875421 122335678899999999999999999999876 434578999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
|||+.+|+|.+++.+.. .+++...+.++.+++.||.|||+. +++||||||+|||++ .++.+||+|||+++....
T Consensus 101 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~----~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 101 LEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT----ENYKLKIICHGLEKILSS 175 (283)
T ss_pred EEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC----CCCcEEEcccchHhhhcc
Confidence 99999999999997654 588899999999999999999984 999999999999998 667899999999986543
Q ss_pred ccccCCCCCCCCccccccccCC-ccCCCCCCC
Q 001940 963 TLVSGGVRGTLPWMAPELLSGK-SHMVTEKEL 993 (993)
Q Consensus 963 ~~~s~s~~GTp~YmAPEVL~Gk-~y~tse~DI 993 (993)
.. ....||..|+|||++.+. ..++.++||
T Consensus 176 ~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di 205 (283)
T PHA02988 176 PP--FKNVNFMVYFSYKMLNDIFSEYTIKDDI 205 (283)
T ss_pred cc--ccccCcccccCHHHhhhccccccchhhh
Confidence 32 234689999999999763 456677775
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=236.85 Aligned_cols=174 Identities=25% Similarity=0.352 Sum_probs=142.1
Q ss_pred ecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||+|+||+||++.+ +++.||||++...... .....+.+..|+.+++.++|+||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-----KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT--KTDLCLVMT 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-----hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC--CCeEEEEEe
Confidence 79999999999987 4678999998754321 11223467789999999999999999999887 567999999
Q ss_pred eccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 886 FMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 886 Ym~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.....
T Consensus 74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD----NDGNVRISDLGLAVELKD 149 (280)
T ss_pred CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEeeCccceecCC
Confidence 9999999988753 234588999999999999999999999999999999999998 567899999999976533
Q ss_pred cc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.. ......||+.|+|||++.+..+. .++||
T Consensus 150 ~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv 180 (280)
T cd05608 150 GQSKTKGYAGTPGFMAPELLQGEEYD-FSVDY 180 (280)
T ss_pred CCccccccCCCcCccCHHHhcCCCCC-ccccH
Confidence 22 23345799999999999877543 45664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=235.99 Aligned_cols=181 Identities=25% Similarity=0.344 Sum_probs=148.8
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|++.+.||+|+||.||++.+. ++.||||.+....... ....+.+.+|+.++++++|+||+.+++.+.+ .+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~ 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGESMALNEKQILEKVNSRFVVSLAYAYET--KD 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-----hHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CC
Confidence 3778899999999999999884 6789999987543221 1222456789999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+|+||||||+|||++ ..+.++|+|||++
T Consensus 74 ~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~----~~~~~~l~Dfg~~ 149 (285)
T cd05630 74 ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD----DHGHIRISDLGLA 149 (285)
T ss_pred EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC----CCCCEEEeeccce
Confidence 7999999999999999886533 3588999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.............||..|+|||++.+.. .+.+.||
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di 184 (285)
T cd05630 150 VHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDW 184 (285)
T ss_pred eecCCCccccCCCCCccccChHHHcCCC-CCCcccc
Confidence 7654333333457999999999998765 4456675
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-26 Score=257.40 Aligned_cols=175 Identities=31% Similarity=0.492 Sum_probs=152.3
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
++||+|.||+||-|+. +|+.||||+|.+..+..+.+ ..++.|+.||..++||.||.+-..|+. .+++++|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET--~ervFVV 641 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFET--PERVFVV 641 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecC--CceEEEE
Confidence 6799999999999987 58999999999887765433 367899999999999999999999888 5789999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccc
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~ 963 (993)
||-+.|.=|.-+|......+++...+.+..||+.||+|||-++|+|+||||+|||+...+ .-..+||||||+|+.+...
T Consensus 642 MEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~-~FPQvKlCDFGfARiIgEk 720 (888)
T KOG4236|consen 642 MEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS-PFPQVKLCDFGFARIIGEK 720 (888)
T ss_pred ehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC-CCCceeeccccceeecchh
Confidence 999955445555665556699999999999999999999999999999999999997554 5678999999999999888
Q ss_pred cccCCCCCCCCccccccccCCccCCC
Q 001940 964 LVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 964 ~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
....+.+||+.|+|||+++.+.|..+
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrS 746 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRS 746 (888)
T ss_pred hhhhhhcCCccccCHHHHhhcccccc
Confidence 87888999999999999999988654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=243.42 Aligned_cols=175 Identities=27% Similarity=0.392 Sum_probs=140.8
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh-cCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~-LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+++ ++.||||+++....... ...+.+..|..++.. ++||||+++++++.+ .+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~l 73 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFF 73 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhc-----chHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEE
Confidence 36999999999999884 56799999986532111 112345567777765 589999999999988 567999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 74 v~ey~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~----~~~~~kl~Dfg~~~~~~~ 148 (316)
T cd05619 74 VMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD----TDGHIKIADFGMCKENML 148 (316)
T ss_pred EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC----CCCCEEEccCCcceECCC
Confidence 999999999999997653 478889999999999999999999999999999999998 567899999999875321
Q ss_pred -ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 -TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 -~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........||+.|+|||++.+..+ +.++||
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 179 (316)
T cd05619 149 GDAKTCTFCGTPDYIAPEILLGQKY-NTSVDW 179 (316)
T ss_pred CCCceeeecCCccccCHHHHcCCCC-Cchhhh
Confidence 122334679999999999987654 566775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=250.75 Aligned_cols=183 Identities=30% Similarity=0.454 Sum_probs=146.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.++||+|+||+||+|++. +..||||+++..... ...+.+.+|+.+|+.+ +||||+++
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-------~~~~~~~~Ei~il~~l~~HpnIv~l 104 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-------TEREALMSELKVLSYLGNHINIVNL 104 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-------HHHHHHHHHHHHHHHhcCCcceeee
Confidence 34567999999999999999999752 446999998743211 1234678899999999 89999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------------------------------------------------
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------------------------------------ 900 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------------------------------------------------ 900 (993)
+++|.+ .+..++||||+++|+|.+++....
T Consensus 105 ~~~~~~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 182 (375)
T cd05104 105 LGACTV--GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTK 182 (375)
T ss_pred eeeecc--CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccc
Confidence 999988 567899999999999999986532
Q ss_pred --------------------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 901 --------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 901 --------------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~----~~~~~kl~Df 258 (375)
T cd05104 183 ADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT----HGRITKICDF 258 (375)
T ss_pred cccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE----CCCcEEEecC
Confidence 1367788899999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++...... ......++..|+|||++.+.. .+.++||
T Consensus 259 G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi 299 (375)
T cd05104 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDV 299 (375)
T ss_pred ccceeccCcccccccCCCCCCcceeChhHhcCCC-CCCCCCH
Confidence 9998654322 112234567899999998765 4456665
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=245.57 Aligned_cols=180 Identities=23% Similarity=0.329 Sum_probs=146.2
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||++.. .++.||||++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 89 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 89 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc------ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc
Confidence 46899999999999999999987 477899998875321 1122356778999999999999999999986532
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+++||||+. ++|.+.+.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~----~~~~~kl~ 161 (355)
T cd07874 90 SLEEFQDVYLVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 161 (355)
T ss_pred cccccceeEEEhhhhc-ccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEC----CCCCEEEe
Confidence 235799999995 467776653 378888899999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++............||..|+|||++.+..+ ..++||
T Consensus 162 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di 201 (355)
T cd07874 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDI 201 (355)
T ss_pred eCcccccCCCccccCCccccCCccCHHHHcCCCC-CchhhH
Confidence 9999987655544455679999999999987754 345664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=230.81 Aligned_cols=179 Identities=33% Similarity=0.588 Sum_probs=146.4
Q ss_pred CCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.++|++++.||+|+||.||+++++. ..+|+|.+...... .+.+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---------EEDFIEEAKVMMKLSHPKLVQLYGVCTQ--Q 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---------HHHHHHHHHHHHHCCCCCceeEEEEEcc--C
Confidence 3568999999999999999998854 57999987643211 2367889999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+++++|.+++......+++..++.++.|++.||+|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~d~g~~ 147 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS----STGVVKVSDFGMT 147 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc----CCCeEEECCCCCc
Confidence 679999999999999999976555688999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... .....++..|+|||++.+..+ +.++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 184 (256)
T cd05114 148 RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY-SSKSDV 184 (256)
T ss_pred cccCCCceeccCCCCCchhhCChhhcccCcc-chhhhh
Confidence 86533221 122345678999999986643 345554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=233.07 Aligned_cols=181 Identities=28% Similarity=0.403 Sum_probs=142.1
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh---cCCCCcceEEEEEEcC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS---LHHPNVVSFYGIVRDG 875 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~---LrHPNIVrL~G~f~d~ 875 (993)
+|++.+.||+|+||+||+|+.+ ++.||||+++........ ...+.+|+.+++. ++|+||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGL------PLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCC------chHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 4889999999999999999884 677999998754322111 0123455555554 4799999999998653
Q ss_pred ---CCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 876 ---PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 876 ---s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~kl 149 (288)
T cd07863 75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGGQVKL 149 (288)
T ss_pred cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEE
Confidence 1345899999996 58988887643 3488999999999999999999999999999999999998 5678999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++............||..|+|||++.+.. ...++||
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 190 (288)
T cd07863 150 ADFGLARIYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDM 190 (288)
T ss_pred CccCccccccCcccCCCccccccccCchHhhCCC-CCCcchh
Confidence 9999998765444444567899999999998664 4556665
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=235.24 Aligned_cols=174 Identities=24% Similarity=0.333 Sum_probs=142.5
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||+|+||.||+++.+ ++.+|+|++........ .....+..|+.++++++||||+++++++.. ...+++|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-----~~~~~~~~E~~il~~l~hp~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-----SGEKMALLEKEILEKVNSPFIVNLAYAFES--KTHLCLVMS 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-----hhhHHHHHHHHHHHhcCCCcEEEEEEEEec--CCeEEEEEe
Confidence 799999999999874 78899999875432211 112345569999999999999999999987 567999999
Q ss_pred eccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc
Q 001940 886 FMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~ 964 (993)
|+.+++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~----~~~~~~l~Dfg~~~~~~~~~ 149 (277)
T cd05607 74 LMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD----DQGNCRLSDLGLAVELKDGK 149 (277)
T ss_pred cCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc----CCCCEEEeeceeeeecCCCc
Confidence 999999998886543 3588888999999999999999999999999999999998 56789999999988665443
Q ss_pred ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 ~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......||..|+|||++.+.. .+.++||
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 177 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEP-YSYPVDW 177 (277)
T ss_pred eeeccCCCCCccCHHHHccCC-CCCchhH
Confidence 334457899999999998776 5566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=244.06 Aligned_cols=180 Identities=23% Similarity=0.347 Sum_probs=148.8
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|.. .++.||||++..... .....+.+.+|+.+|++++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ------SLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh------hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 36799999999999999999987 466799998875321 1122346778999999999999999999886421
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...++++||++ +++|.+++... .+++..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~----~~~~~kl~ 160 (343)
T cd07878 88 SIENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN----EDCELRIL 160 (343)
T ss_pred cccccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC----CCCCEEEc
Confidence 13578999988 88999888643 488999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....||+.|+|||++.+....+.++||
T Consensus 161 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 199 (343)
T cd07878 161 DFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDI 199 (343)
T ss_pred CCccceecCCC--cCCccccccccCchHhcCCccCCchhhh
Confidence 99999865443 2346799999999999887777788886
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=249.85 Aligned_cols=184 Identities=30% Similarity=0.468 Sum_probs=147.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
.+..++|++.+.||+|+||.||+|++. ...||||+++.... ......+.+|+.+++.+ +|+||++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~il~~l~~h~nIv~ 106 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-------TDEREALMSELKILSHLGQHKNIVN 106 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-------HHHHHHHHHHHHHHHhhccCCceee
Confidence 345568999999999999999999862 23699999875421 11235678999999999 8999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------------------------------
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------------------------------------------- 900 (993)
++++|.. .+.+++||||+.+|+|.+++....
T Consensus 107 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (374)
T cd05106 107 LLGACTH--GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEM 184 (374)
T ss_pred EeeEecC--CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccccccc
Confidence 9999987 567999999999999999986431
Q ss_pred ----------------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 901 ----------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 901 ----------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
..+++..+++|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~----~~~~~kL~DfGla~ 260 (374)
T cd05106 185 RPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT----DGRVAKICDFGLAR 260 (374)
T ss_pred CCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe----CCCeEEEeeceeee
Confidence 1367788899999999999999999999999999999998 56789999999998
Q ss_pred cccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......++..|||||++.+.. ++.++||
T Consensus 261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 297 (374)
T cd05106 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDV 297 (374)
T ss_pred eccCCcceeeccCCCCccceeCHHHhcCCC-CCccccH
Confidence 653322 112234567899999997654 5567775
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=247.90 Aligned_cols=181 Identities=28% Similarity=0.390 Sum_probs=147.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC-
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD- 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~- 877 (993)
+|++++.||+|+||.||++.. +++.||||++..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ------NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc------chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 478889999999999999987 478899998864311 11223567899999999999999999999886321
Q ss_pred --CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 878 --GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 878 --~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..+|+||||+. ++|.+++... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~----~~~~~kL~Dfg 148 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFG 148 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEEC----CCCCEEecccc
Confidence 26899999995 6888887654 3588999999999999999999999999999999999998 66799999999
Q ss_pred Ccccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...... ......+|..|+|||++.+...++.+.||
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDI 188 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHH
Confidence 998653321 22344689999999999987777777775
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=244.35 Aligned_cols=183 Identities=29% Similarity=0.419 Sum_probs=157.1
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
..++..++|++.+.||+|.||.||.|+.+ +..||+|++.+..+. .......+.+|++|-..|+||||+++|++
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~-----~~~v~~qlrREiEIqs~L~hpnilrlY~~ 90 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQIL-----KTQVEHQLRREIEIQSHLRHPNILRLYGY 90 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHH-----HhcchhhhhheeEeecccCCccHHhhhhh
Confidence 34566789999999999999999999885 456899999876432 23344678899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
|.+ ....||++||...|+|+..|... ...+++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+|
T Consensus 91 fhd--~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg----~~~~lk 164 (281)
T KOG0580|consen 91 FHD--SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG----SAGELK 164 (281)
T ss_pred eec--cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC----CCCCee
Confidence 999 67899999999999999999843 34588888899999999999999999999999999999998 667899
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
|+|||.+-... .......|||..|.+||++.+..++.
T Consensus 165 iAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~ 201 (281)
T KOG0580|consen 165 IADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDK 201 (281)
T ss_pred ccCCCceeecC-CCCceeeecccccCCHhhcCCCCccc
Confidence 99999987654 33445689999999999999987764
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=242.10 Aligned_cols=175 Identities=23% Similarity=0.375 Sum_probs=143.0
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+++ ++.||||++++..... ......+.+|..+++.+ +||||+++++++.+ .+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~l 73 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQ-----DDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFF 73 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-----hhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEE
Confidence 36999999999999884 5679999998653221 12234567788888877 69999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ- 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~- 961 (993)
||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++...
T Consensus 74 v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~ 148 (318)
T cd05570 74 VMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLD----SEGHIKIADFGMCKEGIL 148 (318)
T ss_pred EEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEEC----CCCcEEecccCCCeecCc
Confidence 999999999999987654 489999999999999999999999999999999999998 66789999999987532
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........+||+.|+|||++.+..+ ..++||
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di 179 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179 (318)
T ss_pred CCCcccceecCccccCHHHhcCCCC-Ccchhh
Confidence 2222334579999999999987655 356665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=232.00 Aligned_cols=182 Identities=35% Similarity=0.551 Sum_probs=147.1
Q ss_pred CCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+|++++.||+|+||.||++.. .+..||||++.... ....+.+.+|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--------AEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 35789999999999999999975 35679999876431 12245788999999999999999999988
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.......+++||||+++++|.+++.+....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----~~~~~~l~ 150 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----SENRVKIG 150 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC----CCCeEEEC
Confidence 76545678999999999999999987655689999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++....... .....++..|+|||++.+..+ ..++||
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 194 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF-SVASDV 194 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHH
Confidence 9999986543221 111223456999999976543 445554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=228.36 Aligned_cols=181 Identities=31% Similarity=0.561 Sum_probs=147.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.++|++.+.||+|+||.||+|+++ ...||||+++.... ......+.+|+.++++++|+||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-------DKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-------hHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 457899999999999999999884 23589998864321 122346888999999999999999999988
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. .+.+++||||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~----~~~~~~l~d 149 (266)
T cd05033 76 K--SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSD 149 (266)
T ss_pred c--CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCCEEECc
Confidence 7 5679999999999999999987666789999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++..... .......++..|+|||.+.+..+ +.+.||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv 191 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF-TSASDV 191 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCC-ccccch
Confidence 9999876421 11122335678999999986653 445564
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-26 Score=265.35 Aligned_cols=186 Identities=24% Similarity=0.377 Sum_probs=158.2
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC--
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s-- 876 (993)
-|...+.||+|+||.||+++. .|+.||||.++...... ..+..-+|+++|++|+|+|||+++++=.+..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r-------~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~ 86 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR-------PRERWCREIEILKKLNHPNIVKLFDIEETKFLG 86 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc-------hHHHHHHHHHHHHHcCchhhhhhcccCCccccC
Confidence 356668899999999999987 58899999998754221 1245678999999999999999999865543
Q ss_pred --CCcEEEEEeeccCCcHHHHHHhc--cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 --DGSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 --~~~L~LVmEYm~GGSL~dlL~~~--~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...-.+|||||.+|||+.+|+.. -..+++.+.+.+..++..||.|||++||+||||||.||++-...+..-.-||+
T Consensus 87 ~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 87 LVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred cccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeee
Confidence 34457999999999999999853 34599999999999999999999999999999999999997554456678999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||.||...+.....++.||..|.+||++..+.+++..+|.
T Consensus 167 DfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDL 207 (732)
T KOG4250|consen 167 DFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDL 207 (732)
T ss_pred cccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeeh
Confidence 99999999888888899999999999999987888887773
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-25 Score=231.05 Aligned_cols=179 Identities=30% Similarity=0.468 Sum_probs=150.6
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||++.+ .++.||||++...... .....+.+.+|+.++++++||||+++++++.+ .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV-----KLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD--D 73 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHHhCCCCCccceeeEEEc--C
Confidence 4689999999999999999988 4678999998754221 12234578899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~dfg~~ 148 (290)
T cd05580 74 SNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD----SDGYIKITDFGFA 148 (290)
T ss_pred CeEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEeeCCCc
Confidence 67999999999999999997664 588999999999999999999999999999999999998 5678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .....|++.|+|||.+.+.. ...+.||
T Consensus 149 ~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di 181 (290)
T cd05580 149 KRVKGR--TYTLCGTPEYLAPEIILSKG-YGKAVDW 181 (290)
T ss_pred cccCCC--CCCCCCCccccChhhhcCCC-CCccccH
Confidence 876443 33456899999999997664 3455664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-26 Score=262.34 Aligned_cols=187 Identities=32% Similarity=0.467 Sum_probs=153.4
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
...++..+.+.+.++||+|.||.|.++...+ ..||||+++...- ....++|.+|+++|.+|+|||||+++|+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-------~~~r~~F~kEIkiLsqLkhPNIveLvGV 603 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-------KNARNDFLKEIKILSRLKHPNIVELLGV 603 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-------hhHHHHHHHHHHHHhccCCCCeeEEEee
Confidence 3445556677888999999999999999876 8899999986532 2234689999999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCc-cCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~-Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
|.. ++.++||||||++|+|.++|.+.... +.......|+.||+.||+||.+.++|||||.+.|+|++ .+.++|
T Consensus 604 C~~--DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~----~e~~iK 677 (807)
T KOG1094|consen 604 CVQ--DDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVD----GEFTIK 677 (807)
T ss_pred eec--CCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeec----CcccEE
Confidence 998 57799999999999999999887433 35566778999999999999999999999999999999 789999
Q ss_pred EEecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++.+... ...+..+-.+.|||||.|.-. +.+++.|+
T Consensus 678 iadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDv 722 (807)
T KOG1094|consen 678 IADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDV 722 (807)
T ss_pred ecCcccccccccCCceeeecceeeeeeehhHHHHHhc-cccchhhh
Confidence 9999999965333 223445667899999977633 34455553
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=229.48 Aligned_cols=180 Identities=26% Similarity=0.397 Sum_probs=152.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||+|++ .++.||||++....... ...+.+.+|+.++++++|+||+++++++.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG------GIPNQALREIKALQACQHPYVVKLLDVFPH--GS 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc------hhhHHHHHHHHHHHhCCCCCCcceeeEEec--CC
Confidence 588999999999999999987 47789999987643211 223468899999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.++|+|||++.
T Consensus 73 ~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~----~~~~~~l~dfg~~~ 147 (286)
T cd07832 73 GFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS----ADGVLKIADFGLAR 147 (286)
T ss_pred eeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc----CCCcEEEeeeeecc
Confidence 799999999 9999999987667789999999999999999999999999999999999998 56789999999988
Q ss_pred cccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......|+..|+|||++.+......+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 184 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDL 184 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHH
Confidence 654332 22345689999999999877666666664
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=242.75 Aligned_cols=180 Identities=22% Similarity=0.324 Sum_probs=145.7
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||++.. .++.||||++...... ......+.+|+.+++.++|+||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN------QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccC------chhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 46899999999999999999987 4677999998753211 122346778999999999999999999886521
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+|+||||+. ++|.+++.. .+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCC-CCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEEC----CCCcEEEE
Confidence 235799999995 577777753 377888899999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++............||..|+|||++.+..+ ..++||
T Consensus 169 DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di 208 (364)
T cd07875 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDI 208 (364)
T ss_pred eCCCccccCCCCcccCCcccCCcCCHHHHhCCCC-CchhhH
Confidence 9999987655444455679999999999987654 345564
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=229.20 Aligned_cols=179 Identities=34% Similarity=0.587 Sum_probs=146.7
Q ss_pred CCCceEEEEecccCceEEEEEEEcCc-ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kgt-~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.++|++++.||+|+||.||++++.+. .+|||.++..... ...+.+|+.++++++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMKLSHEKLVQLYGVCTK--Q 71 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---------HHHHHHHHHHHhcCCCCCeeeEEEEEcc--C
Confidence 45799999999999999999988654 5999988743211 2367889999999999999999999887 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~----~~~~~kl~d~g~~ 147 (256)
T cd05113 72 RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD----DQGCVKVSDFGLS 147 (256)
T ss_pred CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCCEEECCCccc
Confidence 678999999999999999987555689999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... .....++..|+|||++.+.. ...+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di 184 (256)
T cd05113 148 RYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDV 184 (256)
T ss_pred eecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHH
Confidence 85533221 11233567899999997654 3345554
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=222.51 Aligned_cols=180 Identities=27% Similarity=0.459 Sum_probs=150.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||+|.+ +++.|++|++...... ....+.+.+|+.+++.++|+||+++++++.+ .+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN------RREREEAIDEARVLAKLDSSYIIRYYESFLD--KG 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC------HHHHHHHHHHHHHHHhcCCCCeehheeeecc--CC
Confidence 588899999999999999988 4788999998754221 2234578899999999999999999999987 57
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~----~~~~~~l~df~~~ 148 (256)
T cd08529 73 KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD----AYDNVKIGDLGVA 148 (256)
T ss_pred EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe----CCCCEEEcccccc
Confidence 899999999999999999764 45688999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......|++.|+|||++.+.. ...++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 184 (256)
T cd08529 149 KLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDV 184 (256)
T ss_pred eeccCccchhhccccCccccCHHHhcCCC-CCCccch
Confidence 8654332 223456899999999998765 3455664
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=233.90 Aligned_cols=182 Identities=30% Similarity=0.479 Sum_probs=149.8
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+.++|++++.||+|+||.||+|+.+ ++.||+|.++...... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~nI~~~~~~~~~- 75 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHT- 75 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-------chhHHHHHHHHHHhcCCCCcceEEEEEec-
Confidence 3467999999999999999999874 6779999987543211 11246689999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+. ++|.+++......+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||
T Consensus 76 -~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~dfg 149 (301)
T cd07873 76 -EKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN----ERGELKLADFG 149 (301)
T ss_pred -CCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC----CCCcEEECcCc
Confidence 567999999996 689998887666688999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++....... ......+++.|+|||++.+....+.+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 188 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDM 188 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhCCCCCccHHHH
Confidence 987643221 22334578999999999876666666664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=225.93 Aligned_cols=185 Identities=29% Similarity=0.434 Sum_probs=149.8
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|++.+.||+|+||.||++++ ++..||||++....... ......+.+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP---ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc---ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 4789999999999999999987 46789999886432111 112334678899999999999999999999877545
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+++++|.+++.+.. .+++..++.++.|++.||.|||+.+|+|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~Dfg~~ 153 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD----SVGNVKLGDFGAS 153 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----CCCCEEECcCccc
Confidence 67899999999999999987654 478888999999999999999999999999999999998 5678999999998
Q ss_pred cccccc----cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~----~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......||..|+|||++.+.. .+.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 192 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADI 192 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCC-CCcchhH
Confidence 754321 1123356899999999998754 3455664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=248.22 Aligned_cols=184 Identities=30% Similarity=0.444 Sum_probs=147.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVr 867 (993)
.+..++|+++++||+|+||.||+|.+.+ ..||||+++.... ....+.+.+|+.+|+++. ||||++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~Ei~~l~~l~~HpnIv~ 105 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-------SSEKQALMSELKIMTHLGPHLNIVN 105 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhcCCCCCeee
Confidence 3456789999999999999999998632 3599999865321 122357889999999996 999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------------------------------
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------------------------------------------- 900 (993)
++++|.+ .+.++||||||.+|+|.++|....
T Consensus 106 l~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (400)
T cd05105 106 LLGACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQA 183 (400)
T ss_pred EEEEEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccc
Confidence 9999987 567999999999999999886431
Q ss_pred ------------------------------------------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 001940 901 ------------------------------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (993)
Q Consensus 901 ------------------------------------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI 932 (993)
..+++..++.++.||+.||.|||+.+|+||||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~di 263 (400)
T cd05105 184 DTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDL 263 (400)
T ss_pred cccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 13667778899999999999999999999999
Q ss_pred CCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 933 KPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||++ .++.+||+|||+++...... ......++..|||||++.+..+ +.++||
T Consensus 264 kp~Nill~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 322 (400)
T cd05105 264 AARNVLLA----QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDV 322 (400)
T ss_pred ChHhEEEe----CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhH
Confidence 99999998 56789999999998653321 1223457788999999987643 456665
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=230.12 Aligned_cols=182 Identities=31% Similarity=0.517 Sum_probs=145.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
.-++|++.+.||+|+||+||+|.+ .+..||+|.+.... .......+.+|+.++++++|+||++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 75 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-------NPQQWGEFQQEASLMAELHHPNIVCLLGV 75 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCCeeeEEEE
Confidence 346789999999999999999985 24568999886421 11223568889999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhcc----------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPe 935 (993)
+.. ....|+||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 76 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 76 VTQ--EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred Eec--CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 887 467899999999999999985321 24778889999999999999999999999999999
Q ss_pred CEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++ ..+.+||+|||+++...... ......++..|+|||++.+.. .+.+.||
T Consensus 154 nili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 209 (283)
T cd05090 154 NILIG----EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDI 209 (283)
T ss_pred eEEEc----CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhh
Confidence 99998 56789999999998653221 223345677899999997654 4556664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=230.14 Aligned_cols=183 Identities=28% Similarity=0.506 Sum_probs=146.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.+...+|++++.||+|+||+||+|++. +. .||||+++.... ....+.+.+|+.+++.++|+||++++
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-------PKANKEILDEAYVMAGVGSPYVCRLL 75 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-------HHHHHHHHHHHHHHHhcCCCCCceEE
Confidence 345678999999999999999999873 33 379998864321 12234678899999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.. ...+++|||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ ..+.+
T Consensus 76 ~~~~~---~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~----~~~~~ 148 (279)
T cd05109 76 GICLT---STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK----SPNHV 148 (279)
T ss_pred EEEcC---CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc----CCCcE
Confidence 99875 347899999999999999987656689999999999999999999999999999999999997 55689
Q ss_pred EEEecCCcccccccccc---CCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLVS---GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s---~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++........ ....++..|+|||++.+..+ +.++||
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di 194 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF-THQSDV 194 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCCC-CchhHH
Confidence 99999999865432221 12235678999999976643 345554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-25 Score=254.80 Aligned_cols=186 Identities=23% Similarity=0.310 Sum_probs=150.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
....+|++.+.||+|+||+||+|+. +++.||||++...... ......+.+|+.++..++|+||++++..+..
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~------~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS------EADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 3457899999999999999999987 5788999998764321 2233567889999999999999999887764
Q ss_pred CCC------CcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCC
Q 001940 875 GPD------GSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (993)
Q Consensus 875 ~s~------~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e 945 (993)
... ..+++||||+.+|+|.++|... ...+++..+..|+.||+.||.|||+.+|+||||||+|||++ .
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~----~ 178 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC----S 178 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe----C
Confidence 221 1378999999999999998753 34588999999999999999999999999999999999998 5
Q ss_pred CCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 946 RPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 946 ~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++.+||+|||+++..... ......+||+.|||||++.+..+ +.++||
T Consensus 179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DV 228 (496)
T PTZ00283 179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADM 228 (496)
T ss_pred CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHH
Confidence 678999999999865432 12235679999999999987654 455554
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-25 Score=230.37 Aligned_cols=182 Identities=32% Similarity=0.555 Sum_probs=148.7
Q ss_pred CCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.-|+++++||+|+||.||++++ .+..||+|.++... .......+.+|+.++++++|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-------cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 4478899999999999999975 35679999886431 1122357889999999999999999999988
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.......++||||+++++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~----~~~~~~l~d 152 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQVKIGD 152 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----CCCCEEECC
Confidence 7544678999999999999999977655689999999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++...... ......|+..|+|||++.+.. .+.+.||
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di 195 (284)
T cd05079 153 FGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDV 195 (284)
T ss_pred CccccccccCccceeecCCCCCCccccCHHHhccCC-CCccccc
Confidence 99998653321 122345778899999987664 4456665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=230.74 Aligned_cols=181 Identities=33% Similarity=0.561 Sum_probs=146.2
Q ss_pred CCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
..+|++++.||+|+||.||+|...+ ..||+|.++... .......+.+|+.++++++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-------EPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-------CHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 4578899999999999999998743 358999886431 11233568899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeN 936 (993)
+.. .+..+++|||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 154 (283)
T cd05048 77 CTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154 (283)
T ss_pred EcC--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccce
Confidence 887 467899999999999999997532 347788899999999999999999999999999999
Q ss_pred EEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 937 ILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||++ .++.+||+|||+++...... ......+|+.|+|||.+.+..+ +.++||
T Consensus 155 il~~----~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv 209 (283)
T cd05048 155 CLVG----EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDI 209 (283)
T ss_pred EEEc----CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhH
Confidence 9998 56789999999997543221 1233457889999999876543 455664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-24 Score=227.05 Aligned_cols=181 Identities=25% Similarity=0.361 Sum_probs=149.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+++ ++.||+|++....... ...+.+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 72 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP------VIKKIALREIRMLKQLKHPNLVNLIEVFRR--K 72 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc------cccHHHHHHHHHHHhCCCCCEeeeeeEEee--C
Confidence 46899999999999999999884 6789999887542111 112356789999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||++++.|..++... ..+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~ 147 (286)
T cd07847 73 RKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT----KQGQIKLCDFGFA 147 (286)
T ss_pred CEEEEEEeccCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc----CCCcEEECccccc
Confidence 6799999999998888877544 3589999999999999999999999999999999999998 5678999999999
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ......++..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 184 (286)
T cd07847 148 RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDV 184 (286)
T ss_pred eecCCCcccccCcccccccCCHHHHhCCCCcCchhhh
Confidence 8654432 22345688999999999876666667775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=248.85 Aligned_cols=152 Identities=28% Similarity=0.395 Sum_probs=134.8
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC--cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg--t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..+.|++++.||.|.-|+||+++.++ ..+|+|++.+..+.. ...+.+..-|.+||+.++||.++.||..|+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~-----rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLAS-----RKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhh-----hhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 3455678899999999999999999976 568999999876543 344567788999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. +..+|+|||||+||+|..++++. ++.+++..++.++.+++.||+|||-.|||+|||||+||||. ++|+|.|+
T Consensus 148 t--~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvr----edGHIMLs 221 (459)
T KOG0610|consen 148 T--DKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVR----EDGHIMLS 221 (459)
T ss_pred c--cceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEe----cCCcEEee
Confidence 8 67899999999999999998764 46699999999999999999999999999999999999998 78999999
Q ss_pred ecCCcc
Q 001940 953 DLGLSK 958 (993)
Q Consensus 953 DFGLAk 958 (993)
||.|+.
T Consensus 222 DFDLS~ 227 (459)
T KOG0610|consen 222 DFDLSL 227 (459)
T ss_pred eccccc
Confidence 999874
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-26 Score=243.16 Aligned_cols=179 Identities=26% Similarity=0.341 Sum_probs=155.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~ 877 (993)
.|...+.||.|..+.|.++.. ++.++|+|++...........-....+...+|+.||+++. ||+|+++.++|+. +
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes--~ 95 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES--D 95 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--c
Confidence 355557799999999988866 5788999999865544333345566778889999999985 9999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++|+|.|+.|.|+|+|...- ++++....+|++|++.|++|||.++|+||||||+|||++ .+..+||+|||+|
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld----dn~~i~isDFGFa 170 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD----DNMNIKISDFGFA 170 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec----cccceEEecccee
Confidence 78999999999999999997664 589999999999999999999999999999999999999 7789999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCcc
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+.+.........||||+|+|||.++..-+
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtikC~m~ 199 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIKCSMY 199 (411)
T ss_pred eccCCchhHHHhcCCCcccChhheeeecc
Confidence 99988888888999999999999975543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-26 Score=262.98 Aligned_cols=180 Identities=29% Similarity=0.500 Sum_probs=153.3
Q ss_pred eEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+...+||+|+|-+||||.+. |.+||--.++...+... ....++|..|+.+|+.|+|+|||++|.+|.+..+.++
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~----~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQS----PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcC----hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 44568999999999999874 66677665555544432 3345689999999999999999999999999777889
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~--gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+|+|.+..|+|..|+++.++ ++.+.++.|++||++||.|||+. .|||||||.+||+|+ +..|.|||+|+|||.
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIGDLGLAt 194 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIGDLGLAT 194 (632)
T ss_pred eeeeecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeecchhHHH
Confidence 999999999999999988765 88999999999999999999987 799999999999997 356899999999999
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+...... .+.|||.|||||++. +.|...+||
T Consensus 195 l~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDV 226 (632)
T KOG0584|consen 195 LLRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDV 226 (632)
T ss_pred Hhhccccc-eeccCccccChHHHh--hhcchhhhh
Confidence 88777654 488999999999996 566666765
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=223.43 Aligned_cols=183 Identities=31% Similarity=0.478 Sum_probs=149.5
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+.|++.+.||+|+||.||++.. .+..||||++...... .......+.+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--D 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--C
Confidence 4688899999999999999977 4788999998754321 1122334578899999999999999999999988 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~----~~~~~~l~dfg~~ 151 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 151 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 68999999999999999987654 478889999999999999999999999999999999998 5678999999998
Q ss_pred cccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... .....|+..|+|||++.+.. ...+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 190 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADV 190 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC-CCchhhh
Confidence 75432211 12356888999999998765 4455554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=228.66 Aligned_cols=180 Identities=29% Similarity=0.470 Sum_probs=146.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||+|+. ++..||||+++..... +...+.+.+|+.+++.++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE------EGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ES 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc------CCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CC
Confidence 588999999999999999988 4778999998753211 1122456789999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 147 (285)
T cd07861 73 RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID----NKGVIKLADFGL 147 (285)
T ss_pred eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc----CCCcEEECcccc
Confidence 8999999996 68988886532 4588999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......+++.|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 185 (285)
T cd07861 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDI 185 (285)
T ss_pred eeecCCCcccccCCcccccccChHHhcCCCCcCcHHHH
Confidence 87543221 22334578999999999876655556664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-27 Score=247.53 Aligned_cols=185 Identities=23% Similarity=0.331 Sum_probs=157.7
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+.|++.++||+|.|+.||++.. +|+.+|+|+++...+... ..+.+.+|+.|.+.|+|||||++.+.+..
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~------~~e~l~rEarIC~~LqHP~IvrL~~ti~~- 81 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR------DFQKLEREARICRKLQHPNIVRLHDSIQE- 81 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc------cHHHHHHHHHHHHhcCCCcEeehhhhhcc-
Confidence 446678888999999999999866 588899999987766543 23578899999999999999999998877
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+..|||+|+|.|++|..-|-.+ ..+++..+-.+++||+.+|.|+|.++|||||+||+|+|+-.++ ...-+||+|||
T Consensus 82 -~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~-~~A~vKL~~FG 158 (355)
T KOG0033|consen 82 -ESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKA-KGAAVKLADFG 158 (355)
T ss_pred -cceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeecc-CCCceeecccc
Confidence 68899999999999998766544 3478888889999999999999999999999999999998665 55679999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+..........+.|||.|||||+++..+|. ..+||
T Consensus 159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDi 195 (355)
T KOG0033|consen 159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDI 195 (355)
T ss_pred eEEEeCCccccccccCCCcccCHHHhhcCCCC-Ccchh
Confidence 99988877777788999999999999877654 44443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=226.82 Aligned_cols=181 Identities=25% Similarity=0.396 Sum_probs=147.5
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|+. +++.||+|++..... .....+.+|+.++++++|+||+++++++..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~- 77 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--------DDFSLIQQEIFMVKECKHCNIVAYFGSYLS- 77 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--------chHHHHHHHHHHHHhcCCCCeeeeeEEEEe-
Confidence 456799999999999999999987 467799999874321 112357789999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 78 -~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg 151 (267)
T cd06646 78 -REKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT----DNGDVKLADFG 151 (267)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCCEEECcCc
Confidence 578999999999999999987553 588999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCC--ccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGK--SHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk--~y~tse~DI 993 (993)
+++...... ......|+..|+|||++.+. ...+.+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dv 192 (267)
T cd06646 152 VAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192 (267)
T ss_pred cceeecccccccCccccCccccCHhHcccccCCCCcchhhH
Confidence 998653322 12345689999999998532 223445554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.8e-25 Score=229.38 Aligned_cols=182 Identities=29% Similarity=0.465 Sum_probs=144.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
..++|++.+.||+|+||.||+|.++ ++.||||++..... . .....+.+|+.+++.++|+||+++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-----~--~~~~~~~~e~~~l~~l~~~~iv~~~~ 76 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-----M--RERIEFLNEASVMKEFNCHHVVRLLG 76 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-----H--HHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 4567999999999999999999864 24599998764211 1 12346889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
++.. .+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++||||||+|||++
T Consensus 77 ~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~- 153 (277)
T cd05062 77 VVSQ--GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA- 153 (277)
T ss_pred EEcC--CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc-
Confidence 9876 567899999999999999997532 1256778889999999999999999999999999999998
Q ss_pred CCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 942 RDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 942 ~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++....... .....+++.|||||++.+.. .+.++||
T Consensus 154 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 204 (277)
T cd05062 154 ---EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDV 204 (277)
T ss_pred ---CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHH
Confidence 567899999999875432211 11234578899999998654 3455554
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=231.19 Aligned_cols=180 Identities=27% Similarity=0.427 Sum_probs=148.0
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||+|++ +++.||+|+++...... .....+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~------~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLYDVLHS--DK 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc------cCccchhHHHHHHHhcCCCCeeeHHHHhcc--CC
Confidence 488999999999999999988 47789999987542211 112356789999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++|+||+. ++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++
T Consensus 73 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~----~~~~~~l~dfg~~~ 147 (284)
T cd07839 73 KLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN----KNGELKLADFGLAR 147 (284)
T ss_pred ceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc----CCCcEEECccchhh
Confidence 7999999995 688888876555689999999999999999999999999999999999998 56789999999988
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......++..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 183 (284)
T cd07839 148 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 183 (284)
T ss_pred ccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHH
Confidence 653321 12234578999999999887666666665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=230.39 Aligned_cols=182 Identities=27% Similarity=0.471 Sum_probs=145.6
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcc----eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~----VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
+..++|++++.||+|+||+||+|.+ .+.. +++|.+... .......++..|+.+++++.||||+++++
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~~~~~l~~l~h~~iv~~~~ 76 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-------SGRQTFQEITDHMLAMGSLDHAYIVRLLG 76 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-------cchHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 3456889999999999999999988 3443 666665422 11123356778888999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++.. ...++|+||+.+|+|.+++......+++..++.|+.||+.||.|||+.+++||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~----~~~~~k 149 (279)
T cd05111 77 ICPG---ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK----SDSIVQ 149 (279)
T ss_pred EECC---CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEE
Confidence 8754 457899999999999999987766789999999999999999999999999999999999998 667899
Q ss_pred EEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++...... ......++..|+|||++.+.. .+.++||
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv 194 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDV 194 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhH
Confidence 99999998643221 223345778899999997654 3455664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=224.62 Aligned_cols=178 Identities=34% Similarity=0.587 Sum_probs=147.2
Q ss_pred cCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..++|++.+.||+|+||.||++..++..||+|.++... ..+.+.+|+.++++++|+||+++++++... .
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 72 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-K 72 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcC-C
Confidence 34679999999999999999999999999999886431 124678899999999999999999987543 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccC-ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k-~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+..++||||+.+++|.+++.+... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~ 148 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS----EDNVAKVSDFGL 148 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc----CCCcEEecCCcc
Confidence 578999999999999999976543 478899999999999999999999999999999999998 667899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ....++..|+|||++.+..+ +.+.||
T Consensus 149 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~Dv 182 (256)
T cd05082 149 TKEASSTQ--DTGKLPVKWTAPEALREKKF-STKSDV 182 (256)
T ss_pred ceeccccC--CCCccceeecCHHHHccCCC-Cchhhh
Confidence 88653322 23345678999999876643 345564
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=244.72 Aligned_cols=174 Identities=20% Similarity=0.301 Sum_probs=143.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
...+|++++.||+|+||.||++... +..||||.+... ..+.+|+.+|++|+|+||+++++++.
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~~ 156 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAYR 156 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeEe
Confidence 3467999999999999999999763 356899987642 13457999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. ...+++|||++ +++|.+++... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ ..+.+||+|
T Consensus 157 ~--~~~~~lv~e~~-~~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~----~~~~~~l~D 228 (392)
T PHA03207 157 W--KSTVCMVMPKY-KCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD----EPENAVLGD 228 (392)
T ss_pred e--CCEEEEEehhc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcc
Confidence 7 56799999999 57899888543 4589999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++...... ......||+.|+|||++.+..+ ..++||
T Consensus 229 fG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv 270 (392)
T PHA03207 229 FGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY-CAKTDI 270 (392)
T ss_pred CccccccCcccccccccccccccCccCHhHhcCCCC-CchhhH
Confidence 99997654322 1234679999999999987654 445664
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=221.90 Aligned_cols=179 Identities=24% Similarity=0.409 Sum_probs=147.8
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||++++ .+..+|+|.++.... ....+.+.+|+.+++.++|+||+++++.+.+ .+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-------SSAVEDSRKEAVLLAKMKHPNIVAFKESFEA--DG 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-------hHHHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 588999999999999999987 467799999874321 1123567789999999999999999999987 57
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+|+|+||||+|||++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~----~~~~~~l~dfg~~ 147 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT----QNGKVKLGDFGSA 147 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC----CCCcEEEcccCcc
Confidence 899999999999999988653 34578899999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ......|++.|+|||++.+.. .+.++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv 183 (255)
T cd08219 148 RLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDI 183 (255)
T ss_pred eeecccccccccccCCccccCHHHHccCC-cCchhhh
Confidence 7654322 223456899999999997764 4445554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=229.19 Aligned_cols=182 Identities=33% Similarity=0.471 Sum_probs=148.4
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC------------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG------------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg------------------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~ 859 (993)
...+|++.++||+|+||.||+|+... ..||+|++..... ....+.+.+|+.++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-------DNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-------HHHHHHHHHHHHHHHh
Confidence 34679999999999999999987642 3479998875421 1234578899999999
Q ss_pred cCCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc----------CccCHHHHHHHHHHHHHHHHHHHhCCcee
Q 001940 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (993)
Q Consensus 860 LrHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------k~Lse~~~lkIalQIL~GLeYLHs~gIIH 929 (993)
++|+||+++++++.. .+.+++||||+.+++|.+++.+.. ..+++..++.++.||+.||.|||+.+|+|
T Consensus 76 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H 153 (296)
T cd05051 76 LSDPNIARLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVH 153 (296)
T ss_pred cCCCCEeEEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 999999999999987 467999999999999999997643 25889999999999999999999999999
Q ss_pred cCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 930 RDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||||+|||++ ..+.+||+|||+++...... ......+|..|||||++.+.. .+.++||
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 215 (296)
T cd05051 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDV 215 (296)
T ss_pred cccchhceeec----CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchh
Confidence 99999999998 55799999999988643321 223445678999999987653 5566665
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=231.44 Aligned_cols=183 Identities=29% Similarity=0.406 Sum_probs=151.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+++ ++.+|||.++..... ......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 46888999999999999999985 677999998754322 1122356789999999999999999999887544
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+. ++|.+++......+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~~~l~d~g~~ 153 (293)
T cd07843 79 DKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN----NRGILKICDFGLA 153 (293)
T ss_pred CcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCcEEEeecCce
Confidence 78999999996 599999887666689999999999999999999999999999999999998 5678999999998
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......+++.|+|||++.+....+.+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 190 (293)
T cd07843 154 REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDM 190 (293)
T ss_pred eeccCCccccccccccccccCchhhcCCccccchhhH
Confidence 865443 222345578899999999877666677775
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=228.38 Aligned_cols=175 Identities=23% Similarity=0.425 Sum_probs=140.5
Q ss_pred EEecccCceEEEEEEEc--------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 806 RELGSGTYGSVYHGKWR--------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--------------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+.||+|+||.||+|++. ...||+|++... .......+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--------HRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--------hhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 36899999999999853 124788876542 12234578889999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC---CCCe
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP---QRPV 948 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~---e~g~ 948 (993)
+.. +...++||||+.+++|..++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++. ....
T Consensus 73 ~~~--~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 73 CVR--DVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred Eec--CCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCce
Confidence 987 46689999999999999998876666899999999999999999999999999999999999974321 1224
Q ss_pred EEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+||+|||++..... .....||..|||||++.+....+.++||
T Consensus 151 ~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (262)
T cd05077 151 IKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADK 192 (262)
T ss_pred eEeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHH
Confidence 89999999875432 2235688899999999866666777775
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=252.07 Aligned_cols=174 Identities=26% Similarity=0.353 Sum_probs=145.1
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
....|.+.+.||+|+||.||+|.+. ++.||||.... ..+.+|+.+|++|+|+|||++++++..
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~- 231 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVV- 231 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEE-
Confidence 3457999999999999999999884 56799995331 135579999999999999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+..++|||++ .++|.+++......+++..++.|+.||+.||.|||+++||||||||+||||+ ..+.+||+|||
T Consensus 232 -~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~----~~~~vkL~DFG 305 (461)
T PHA03211 232 -GGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN----GPEDICLGDFG 305 (461)
T ss_pred -CCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC----CCCCEEEcccC
Confidence 56789999999 5789998877656799999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...... ......||+.|||||++.+..+ +.++||
T Consensus 306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDv 345 (461)
T PHA03211 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY-TPSVDI 345 (461)
T ss_pred CceecccccccccccccCCCcCCcCHHHHcCCCC-CchHHH
Confidence 998653321 1234579999999999987754 445554
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=224.85 Aligned_cols=182 Identities=25% Similarity=0.418 Sum_probs=148.4
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.++||+|+||.||+|+. +++.||||+++...... ......+.+|+.+++.++||||+++++++.+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-----AKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--D 74 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC-----HHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--C
Confidence 5799999999999999999987 57889999886532211 2233568889999999999999999999987 4
Q ss_pred CcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+.+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+++++|+||||+|||++ .++.++|+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~----~~~~~~l~d~ 150 (267)
T cd08228 75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc----CCCCEEECcc
Confidence 679999999999999998863 234578899999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++....... ......|++.|+|||.+.+... ..+.||
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di 189 (267)
T cd08228 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDI 189 (267)
T ss_pred ccceeccchhHHHhcCCCCccccChhhhccCCC-CchhhH
Confidence 9988654322 1234568899999999987654 344553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=224.79 Aligned_cols=181 Identities=30% Similarity=0.582 Sum_probs=148.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|+++++||+|+||.||+|... ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---------SVQAFLEEANLMKTLQHDKLVRLYAVVTK- 72 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---------hHHHHHHHHHHHHhCCCCCeeeEEEEEcC-
Confidence 45678999999999999999999874 56699998764311 13478899999999999999999999877
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++||||||+|||++ ..+.+||+||
T Consensus 73 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 147 (261)
T cd05072 73 -EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS----ESLMCKIADF 147 (261)
T ss_pred -CCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec----CCCcEEECCC
Confidence 56789999999999999999753 34578888999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++........ .....++..|+|||++.+.. .+.+.||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 187 (261)
T cd05072 148 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDV 187 (261)
T ss_pred ccceecCCCceeccCCCccceecCCHHHhccCC-CChhhhh
Confidence 99986543321 12334677899999987654 3445665
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=232.72 Aligned_cols=183 Identities=32% Similarity=0.500 Sum_probs=144.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--Ccc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~--VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~ 871 (993)
+.-++|++.+.||+|+||.||+|.++ +.. +|+|.++... .......+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-------CHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 44568999999999999999999874 333 5777665321 112235678899999999 89999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeN 936 (993)
+.. .+.+|+||||+++++|.+++.+.. ..+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 77 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred ECC--CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 987 567999999999999999997542 247888999999999999999999999999999999
Q ss_pred EEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 937 ILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||++ .++.+||+|||+++............++..|+|||++.+.. .+.++||
T Consensus 155 ili~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 206 (303)
T cd05088 155 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDV 206 (303)
T ss_pred EEec----CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-Ccccccc
Confidence 9998 56789999999987433222222223467899999987664 4566775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=228.31 Aligned_cols=181 Identities=28% Similarity=0.458 Sum_probs=148.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|+.+ ++.||||++........ ...+.+|+.++++++|+||+++++++.+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-------PFTAIREASLLKDLKHANIVTLHDIIHT-- 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC-------chhHHHHHHHHhhCCCcceeeEEEEEec--
Confidence 467999999999999999999874 67899999875432111 1245679999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
....++||||+. ++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~ 149 (291)
T cd07844 75 KKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS----ERGELKLADFGL 149 (291)
T ss_pred CCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc----CCCCEEECcccc
Confidence 568999999996 599999887666789999999999999999999999999999999999998 667899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ......++..|+|||++.+....+.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 187 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDM 187 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcCcccCcHHHH
Confidence 87543211 11223478899999999876656666665
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=229.99 Aligned_cols=187 Identities=32% Similarity=0.411 Sum_probs=148.7
Q ss_pred CceEEEEecccCceEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
+|++.++||+|+||.||+|.+ .+..||||++........ ...+.+.+|+.++++++||||+++++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT-----GISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEecccccccc-----CccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 488899999999999999988 357899999886431111 11235678999999999999999999999864
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc----cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~----~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+++||||+. ++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++.++...+.+||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 578999999995 5777766532 22578899999999999999999999999999999999998544447899999
Q ss_pred ecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++...... ......+|..|+|||++.+......+.||
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 199 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDI 199 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHH
Confidence 999988653322 12345688999999999876666666664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=231.37 Aligned_cols=178 Identities=31% Similarity=0.463 Sum_probs=147.7
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||++++. +..+|+|.++... .......+.+|+.++++++||||++++++|.+ .
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--D 71 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 46899999999999999999884 5668888876431 12234567889999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+.+++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+ .+++||||||+|||++ .++.+||+|||+
T Consensus 72 ~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~----~~~~~~l~dfg~ 146 (308)
T cd06615 72 GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGV 146 (308)
T ss_pred CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe----cCCcEEEccCCC
Confidence 7899999999999999999765 448899999999999999999997 5999999999999998 567899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......|+..|+|||++.+.. .+.++||
T Consensus 147 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~-~~~~~Di 181 (308)
T cd06615 147 SGQLIDS-MANSFVGTRSYMSPERLQGTH-YTVQSDI 181 (308)
T ss_pred ccccccc-ccccCCCCcCccChhHhcCCC-CCccchH
Confidence 8765333 224467899999999987765 3445564
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=225.61 Aligned_cols=183 Identities=31% Similarity=0.510 Sum_probs=147.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
+..++|++.+.||+|+||.||+|.+++ ..||+|.+.... .......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~ 75 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRLL 75 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEEE
Confidence 455789999999999999999998753 459999876431 111234678899999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd 940 (993)
+++.. ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++
T Consensus 76 ~~~~~--~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~ 153 (277)
T cd05032 76 GVVST--GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA 153 (277)
T ss_pred EEEcC--CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc
Confidence 99987 467999999999999999997532 2367788899999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 941 MRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 941 ~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++...... ......+|..|+|||++.+.. .+.++||
T Consensus 154 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 204 (277)
T cd05032 154 ----EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDV 204 (277)
T ss_pred ----CCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccch
Confidence 66789999999988543321 122345688999999987654 4556665
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=226.46 Aligned_cols=181 Identities=33% Similarity=0.567 Sum_probs=146.5
Q ss_pred CCCceEEEEecccCceEEEEEEEc--C---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--G---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--g---t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..+|++.+.||+|+||.||+|++. + ..+|+|.++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-------EKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457889999999999999999873 2 2589998864311 122357888999999999999999999988
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. .+..++||||+++++|.+++......+++..++.|+.|++.||.|||+.+++||||||+|||++ .++.+||+|
T Consensus 76 ~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~----~~~~~~l~d 149 (267)
T cd05066 76 K--SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN----SNLVCKVSD 149 (267)
T ss_pred c--CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC----CCCeEEeCC
Confidence 7 5679999999999999999987666689999999999999999999999999999999999998 567899999
Q ss_pred cCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++....... .....++..|+|||++.+.. .+.+.||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv 192 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDV 192 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCc-cCchhhh
Confidence 999986533211 11223456899999998654 3455554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-25 Score=226.39 Aligned_cols=179 Identities=33% Similarity=0.596 Sum_probs=145.5
Q ss_pred CCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..+|++.+.||+|+||.||+++++. ..+|+|++...... ...+.+|+.++++++|+||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS---------EDDFIEEAKVMMKLSHPNLVQLYGVCTK--Q 71 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEEEEEEEEcC--C
Confidence 3468889999999999999998854 46899988643211 1357789999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+++++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~kl~dfg~~ 147 (256)
T cd05059 72 RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG----EDNVVKVSDFGLA 147 (256)
T ss_pred CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC----CCCcEEECCcccc
Confidence 678999999999999999987655689999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccccc--CCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s--~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+........ ....++..|+|||.+.+..+ +.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di 184 (256)
T cd05059 148 RYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF-SSKSDV 184 (256)
T ss_pred eecccccccccCCCCCCccccCHHHhccCCC-CchhhH
Confidence 865432211 12224567999999987654 345554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=226.57 Aligned_cols=178 Identities=29% Similarity=0.488 Sum_probs=143.8
Q ss_pred ceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 802 LEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
|++++.||+|+||+||++.+ .+..||+|+++.... ....+.+.+|+.+|++++|+||+++++++...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-------QQNTSGWKKEINILKTLYHENIVKYKGCCSEQ 78 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 48899999999999988754 356799999875421 11234678899999999999999999998775
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....+++||||+.+++|.+++... .+++..++.|+.|++.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg 152 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD----NDRLVKIGDFG 152 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc----CCCcEEEeecc
Confidence 456789999999999999999764 389999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++....... .....++..|+|||++.+.. .+.+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di 193 (283)
T cd05080 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDV 193 (283)
T ss_pred cccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCccccc
Confidence 9986543221 12234567799999997654 3456665
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=220.77 Aligned_cols=181 Identities=29% Similarity=0.426 Sum_probs=150.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|+.. ++.+|+|++..... ...+.+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 71 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--------DDFEIIQQEISMLKECRHPNIVAYFGSYLR-- 71 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--------hhHHHHHHHHHHHHhCCCCChhceEEEEEe--
Confidence 467999999999999999999874 56799999875421 123578899999999999999999999887
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...++++|||+.+++|.+++......+++..+..++.|++.||.|||+.+|+|+||||+||+++ .++.+||+|||+
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~ 147 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT----EDGDVKLADFGV 147 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC----CCCCEEECcccc
Confidence 5679999999999999999987655689999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCC--ccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGK--SHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk--~y~tse~DI 993 (993)
+....... ......++..|+|||++.+. .....++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di 187 (262)
T cd06613 148 SAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187 (262)
T ss_pred chhhhhhhhccccccCCccccCchhhcccccCCcCchhhh
Confidence 87654322 22345688999999998765 123345554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=223.98 Aligned_cols=174 Identities=29% Similarity=0.539 Sum_probs=140.1
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.||+|+||.||+|++ +++.+|+|.+.... .......+.+|+.++++++|+||+++++++.. ...+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 71 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIV 71 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEE
Confidence 3699999999999987 57789999876321 11223468899999999999999999999987 5679999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccc
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~ 963 (993)
|||+.+++|.+++......+++..++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||++......
T Consensus 72 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 72 MELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT----EKNVLKISDFGMSREEEDG 147 (252)
T ss_pred EeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc----CCCcEEECccccCcccccc
Confidence 999999999999987665688999999999999999999999999999999999998 5678999999998764432
Q ss_pred ccc---CCCCCCCCccccccccCCccCCCCCCC
Q 001940 964 LVS---GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 964 ~~s---~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... ....++..|+|||.+.+.. .+.++||
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 179 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGR-YSSESDV 179 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCC-CChHHHH
Confidence 111 1112345799999987665 3445554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=223.80 Aligned_cols=173 Identities=26% Similarity=0.445 Sum_probs=138.6
Q ss_pred EEecccCceEEEEEEEcCcc------------eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 806 RELGSGTYGSVYHGKWRGSD------------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~------------VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
+.||+|+||.||+|.+.... +++|++.... . ....+.+|+.++++++|+||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-------~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-------R--DSLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-------h--hHHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 36999999999999885433 6777665331 1 1357889999999999999999999987
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC---CCCeEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP---QRPVCK 950 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~---e~g~VK 950 (993)
. ...++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++.++. ....+|
T Consensus 72 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 72 R---DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred c---CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEE
Confidence 6 3478999999999999999876656899999999999999999999999999999999999983320 112799
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCC-ccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK-SHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk-~y~tse~DI 993 (993)
|+|||++..... .....++..|+|||++.+. ...+.+.||
T Consensus 149 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 189 (259)
T cd05037 149 LSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADK 189 (259)
T ss_pred eCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHH
Confidence 999999886543 2234577889999999876 455555664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.2e-26 Score=245.09 Aligned_cols=186 Identities=30% Similarity=0.417 Sum_probs=155.3
Q ss_pred CCceEEEEecccCceEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..|+.+..||+|+||.||+|..+ ...+|||+++........+ ....+|+.+++.|+|+||+.+..+|.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS------~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS------MSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC------HHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 46888999999999999999552 2358999988653222111 24568999999999999999999887
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHh----ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~----~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
.. +.++||++||. .-+|..+|+- +.+.++...++.|+.||+.|+.|||++-|+||||||+||||..++++.|+|
T Consensus 98 ~~-d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 98 SH-DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred cc-CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCee
Confidence 64 67899999998 4588888863 235688889999999999999999999999999999999999888889999
Q ss_pred EEEecCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++....... ....+-|++|+|||+++|..+++..+||
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDv 223 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDV 223 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhh
Confidence 9999999998765432 2355679999999999999999999986
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=224.82 Aligned_cols=180 Identities=31% Similarity=0.552 Sum_probs=145.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--C---cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--G---SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--g---t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.+|++.+.||+|+||.||+|.++ + ..||||+++... .....+.|..|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 46889999999999999999874 2 249999886431 12234578899999999999999999999877
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...+++||||+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~----~~~~~kl~df 150 (269)
T cd05065 77 --SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN----SNLVCKVSDF 150 (269)
T ss_pred --CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc----CCCcEEECCC
Confidence 5678999999999999999987666789999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccccc----CCCC--CCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVS----GGVR--GTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s----~s~~--GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++........ .... .+..|+|||++.+..+ +.++||
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv 194 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDV 194 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcc-cchhhh
Confidence 998755332111 1111 2457999999976654 445664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=227.94 Aligned_cols=182 Identities=35% Similarity=0.544 Sum_probs=147.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
...+|.+.+.||+|+||.||+|++. +..||||+++.... ....+.+.+|+.+|+.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 75 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-------NDARKDFEREAELLTNFQHENIVKFYG 75 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-------HHHHHHHHHHHHHHHhcCCCCchheee
Confidence 3456888999999999999999763 35699998874311 112357889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc-------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD-------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENL 937 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNI 937 (993)
++.. ...+++||||+.+++|.+++...+ ..+++..++.++.||+.||.|||+++++||||||+||
T Consensus 76 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~ni 153 (280)
T cd05049 76 VCTE--GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153 (280)
T ss_pred EEec--CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceE
Confidence 9988 467999999999999999997542 3467888999999999999999999999999999999
Q ss_pred EEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 938 LVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 938 LLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++ .++.+||+|||+++...... ......+++.|+|||++.+.. .+.++||
T Consensus 154 li~----~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 207 (280)
T cd05049 154 LVG----YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDV 207 (280)
T ss_pred EEc----CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhH
Confidence 998 56899999999987543221 122344678899999998765 4455665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=265.92 Aligned_cols=184 Identities=34% Similarity=0.540 Sum_probs=151.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
.+...+.+..+.||+|.||+||+|+.. ..-||||.++... .....++|.+|+.+|..|+|||||+|
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-------~~~~~~dF~REaeLla~l~H~nIVrL 554 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-------ENQARQDFRREAELLAELQHPNIVRL 554 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-------cHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 455667788899999999999999873 3349999988642 22345789999999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------C----ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------R----TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------k----~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPe 935 (993)
+|+|.. .+.++||+|||..|||.++|+... . .++..+.+.||.||+.||+||-+..+|||||.++
T Consensus 555 lGVC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATR 632 (774)
T KOG1026|consen 555 LGVCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATR 632 (774)
T ss_pred EEEEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhh
Confidence 999998 567999999999999999997421 1 2788899999999999999999999999999999
Q ss_pred CEEEccCCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+||. ++..|||+||||++....... .....-.++||+||.|.-. .++++.||
T Consensus 633 NCLVg----e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDV 688 (774)
T KOG1026|consen 633 NCLVG----ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDV 688 (774)
T ss_pred hceec----cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhh
Confidence 99998 889999999999996533321 1122346789999998844 56777776
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=230.65 Aligned_cols=170 Identities=32% Similarity=0.600 Sum_probs=138.3
Q ss_pred eEEEEecccCceEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 803 EEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~k------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
++.+.||.|.||.||+|.++ +..|+||+++... .....+.|.+|+.++++++||||++++|++..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-- 72 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-------SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-- 72 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-------SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-------ccccceeeeecccccccccccccccccccccc--
Confidence 56789999999999999997 5669999985421 12234678899999999999999999999995
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+|+|.++|... ...+++..++.|+.||+.||.|||+++++|+||+++|||++ .++.+||+|||
T Consensus 73 ~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~----~~~~~Kl~~f~ 148 (259)
T PF07714_consen 73 NEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD----SNGQVKLSDFG 148 (259)
T ss_dssp SSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE----TTTEEEEESTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccc
Confidence 45699999999999999999887 55689999999999999999999999999999999999999 67899999999
Q ss_pred Cccccccc---cccCCCCCCCCccccccccCCc
Q 001940 956 LSKVKQQT---LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 956 LAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+++..... .......+...|+|||++.+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp TGEETTTSSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred ccccccccccccccccccccccccccccccccc
Confidence 99876221 1223344678899999987654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=220.79 Aligned_cols=182 Identities=27% Similarity=0.428 Sum_probs=149.9
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++++.||.|+||.||++.. +++.||+|++...... ....+.+..|+.++++++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT------EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC------HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 588999999999999999987 4677999988754221 12235678899999999999999999988765566
Q ss_pred cEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLH-----s~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.++++|||+.+++|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||+++ .++.+|
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~----~~~~~k 150 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD----ANNNVK 150 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe----cCCCEE
Confidence 789999999999999998753 456889999999999999999999 88999999999999998 567999
Q ss_pred EEecCCccccccccc-cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~-s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||++........ .....|+..|+|||++.+.. .+.+.||
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv 193 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDI 193 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCC-CCchhHH
Confidence 999999987654332 33456899999999997655 3344553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=229.77 Aligned_cols=174 Identities=26% Similarity=0.434 Sum_probs=139.3
Q ss_pred EecccCceEEEEEEEc--------------------------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc
Q 001940 807 ELGSGTYGSVYHGKWR--------------------------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k--------------------------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L 860 (993)
.||+|+||.||+|.+. ...||+|++... .......+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--------HRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------HHHHHHHHHHHHHHHhcC
Confidence 5999999999998752 123788887642 122345688899999999
Q ss_pred CCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q 001940 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (993)
Q Consensus 861 rHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd 940 (993)
+|+||+++++++.+ ....++||||+++++|..++.+....+++..++.|+.||+.||+|||+++|+||||||+|||++
T Consensus 74 ~h~niv~~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~ 151 (274)
T cd05076 74 SHIHLAFVHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLA 151 (274)
T ss_pred CCCCeeeEEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEe
Confidence 99999999999987 5678999999999999999977656689999999999999999999999999999999999997
Q ss_pred cCC---CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 941 MRD---PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 941 ~~d---~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+ .....+||+|||++...... ....++..|+|||++.+....+.++||
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv 204 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADK 204 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHH
Confidence 432 12346899999987643221 223578899999999876556666664
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=220.77 Aligned_cols=180 Identities=26% Similarity=0.436 Sum_probs=149.2
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++++.||.|+||.||.++. ++..+++|.+...... ......+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS------EKERRDALNEIVILSLLQHPNIIAYYNHFMD--DN 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc------hhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CC
Confidence 488999999999999988877 4778999988754321 1223467899999999999999999999988 57
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~----~~~~~kl~d~~~~ 148 (256)
T cd08221 73 TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT----KAGLIKLGDFGIS 148 (256)
T ss_pred eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe----CCCCEEECcCcce
Confidence 899999999999999999765 44588999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......|++.|+|||++.+.. .+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv 184 (256)
T cd08221 149 KILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDI 184 (256)
T ss_pred EEcccccccccccCCCccccCHhhcCCCC-CCCcchh
Confidence 8654332 234466899999999998765 3445564
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=229.47 Aligned_cols=183 Identities=30% Similarity=0.412 Sum_probs=150.2
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||+|.++ ++.||||+++...... ........+..|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CC
Confidence 4788899999999999999874 6789999998654321 111223456789999999999999999999988 57
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+ +++|.+++......+++..++.++.||+.||.|||+++|+|+||||+|||++ .++.+||+|||+++
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~----~~~~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLAR 150 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc----CCCCEEEccceeee
Confidence 899999999 9999999987654689999999999999999999999999999999999998 56789999999998
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......+++.|+|||++.+......+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 186 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDM 186 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHH
Confidence 654432 22234578899999998766555555554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=230.64 Aligned_cols=185 Identities=28% Similarity=0.405 Sum_probs=150.8
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|.+ +++.||+|+++...... .....+.+|+.++++++|+||+++++++.+.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD------GIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC------CCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 356899999999999999999988 47789999987543211 1112455799999999999999999999875
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..+.+++||||+. ++|.+++......+++..++.++.||+.||.|||+.+++||||||+|||++ ..+.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~kL~dfg 153 (309)
T cd07845 79 HLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT----DKGCLKIADFG 153 (309)
T ss_pred CCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEECccc
Confidence 4567899999995 589998877656689999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++....... ......++..|+|||++.+....+.+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 192 (309)
T cd07845 154 LARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDM 192 (309)
T ss_pred eeeecCCccCCCCcccccccccChhhhcCCCCcCchHHH
Confidence 998654332 12233468889999999877666777775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=254.03 Aligned_cols=175 Identities=27% Similarity=0.307 Sum_probs=148.7
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-C-----CCcceEEEEE
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-H-----PNVVSFYGIV 872 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-H-----PNIVrL~G~f 872 (993)
+|++++.||+|+||.|.+|.+ +++.||||+++... ....+...|+.+|..|+ | -|||+++++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---------~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---------RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---------HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 799999999999999999988 47789999998642 22345567899999987 3 4799999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
.. .+++|||+|.+ ..+|.++|+.. ...++...++.|+.||+.||.+||+.+|||+||||+||||... ....|||
T Consensus 258 ~f--r~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r~~vKV 332 (586)
T KOG0667|consen 258 YF--RNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KRSRIKV 332 (586)
T ss_pred cc--ccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--CcCceeE
Confidence 98 68899999988 88999999865 4568999999999999999999999999999999999999744 4558999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+|||.|....+..- ..+.+..|+|||+|+|-+|.. +.|
T Consensus 333 IDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~-~ID 370 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDT-AID 370 (586)
T ss_pred EecccccccCCcce--eeeeccccccchhhccCCCCC-ccc
Confidence 99999998766543 566788999999999987653 444
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=226.06 Aligned_cols=181 Identities=28% Similarity=0.426 Sum_probs=146.1
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++.+.||+|+||.||+|.. +++.||||++....... ....+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-- 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-------VPFTAIREASLLKGLKHANIVLLHDIIHT-- 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-------CcHHHHHHHHHHHhcCCCCEeEEEEEEec--
Confidence 36799999999999999999987 47789999987543211 11245689999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+..++||||+. ++|.+++......+.+..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~Dfg~ 149 (291)
T cd07870 75 KETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS----YLGELKLADFGL 149 (291)
T ss_pred CCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc----CCCcEEEecccc
Confidence 567999999995 777777765545578888889999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ......+++.|+|||++.+....+.+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 187 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187 (291)
T ss_pred ccccCCCCCCCCCccccccccCCceeecCCCCCcHHHH
Confidence 87543221 22344578999999999876555566664
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=219.54 Aligned_cols=174 Identities=36% Similarity=0.593 Sum_probs=145.9
Q ss_pred EEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 806 RELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+.||+|+||.||+|.+. +..||||+++..... ...+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~ 71 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE-------EERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPL 71 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch-------hHHHHHHHHHHHHhhcCCCChheeeeeecC--CCce
Confidence 36999999999999885 667999998754221 134578899999999999999999999987 6789
Q ss_pred EEEEeeccCCcHHHHHHhc--------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 881 ATVTEFMVNGSLKQFLQKK--------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~--------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++||||+.+++|.+++... ...+++..++.++.||+.||.|||+++|+||||||+||+++ .++.+||+
T Consensus 72 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~----~~~~~~l~ 147 (262)
T cd00192 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG----EDLVVKIS 147 (262)
T ss_pred EEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC----CCCcEEEc
Confidence 9999999999999999876 46689999999999999999999999999999999999998 66899999
Q ss_pred ecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++...... .......++..|+|||.+.+. ..+.+.||
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di 190 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDV 190 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccC-Ccchhhcc
Confidence 99999866443 223345578899999998766 44555664
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=230.23 Aligned_cols=182 Identities=31% Similarity=0.481 Sum_probs=145.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC----------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG----------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg----------------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr 861 (993)
...+|++.+.||+|+||.||+++..+ ..||||+++.... ......+.+|+.++++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-------KTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhCC
Confidence 45689999999999999999987632 2389998874311 122346889999999999
Q ss_pred CCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------CccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 862 HPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-----------k~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
|+||+++++++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||
T Consensus 76 h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~ 153 (295)
T cd05097 76 NPNIIRLLGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHR 153 (295)
T ss_pred CCCcCeEEEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecc
Confidence 9999999999987 567899999999999999986532 136788889999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||||+|||++ .++.+||+|||++....... ......++..|+|||++.+.. .+.++||
T Consensus 154 dlkp~Nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 214 (295)
T cd05097 154 DLATRNCLVG----NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDV 214 (295)
T ss_pred ccChhhEEEc----CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhH
Confidence 9999999998 55689999999987543221 122334677899999987654 4556664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=219.37 Aligned_cols=181 Identities=30% Similarity=0.469 Sum_probs=147.7
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++++.||+|++|.||+++.+ ++.||||++...... ....+.+.+|+.++++++|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~ 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS------RRERKAAEQEAQLLSQLKHPNIVAYRESWEGE-DG 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC-CC
Confidence 4899999999999999999874 677999998754221 12234678899999999999999999887642 45
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+++++|.+++... ...+++.+++.++.+++.||.+||+.+|+||||||+||+++ ..+.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~----~~~~~~l~df~~~ 149 (257)
T cd08223 74 LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT----RTNIIKVGDLGIA 149 (257)
T ss_pred EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe----cCCcEEEecccce
Confidence 689999999999999998764 34589999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......|++.|+|||++.+..+. .++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv 185 (257)
T cd08223 150 RVLENQCDMASTLIGTPYYMSPELFSNKPYN-YKSDV 185 (257)
T ss_pred EEecccCCccccccCCcCccChhHhcCCCCC-chhhh
Confidence 865332 222345689999999999876543 45564
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=221.91 Aligned_cols=185 Identities=26% Similarity=0.471 Sum_probs=150.3
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCC-chhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGK-PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k-~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+|.+...||+|+||.||+|.. .++.+|+|++........ ........+.+.+|+.++++++|+||+++++++.+ .
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--A 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--C
Confidence 367788999999999999987 467899998876543322 22233456788999999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~----~~~~~~l~dfg~~ 153 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD----NKGGIKISDFGIS 153 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc----CCCCEEecccCCC
Confidence 6889999999999999999765 3478889999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......|+..|+|||++.+..+ +.+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv 195 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADI 195 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCC-Cchhhh
Confidence 8654211 1123458899999999987654 345564
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=226.26 Aligned_cols=184 Identities=29% Similarity=0.529 Sum_probs=147.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
.+..++|++.+.||+|+||.||++.+.+ ..+|+|++..... ......+.+|+.+++++ +|+||++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~i~~ 80 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-------EKDLSDLVSEMEMMKMIGKHKNIIN 80 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-------HHHHHHHHHHHHHHHhhcCCCCeee
Confidence 3455679999999999999999998742 4589998874311 12234688899999999 7999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhc---------------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~---------------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI 932 (993)
+++++.. .+.+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+|+||||
T Consensus 81 ~~~~~~~--~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dl 158 (293)
T cd05053 81 LLGVCTQ--EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158 (293)
T ss_pred EEEEEcC--CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999887 56799999999999999999642 245888999999999999999999999999999
Q ss_pred CCCCEEEccCCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 933 KPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||++ .++.+||+|||+++....... .....++..|+|||++.+.. .+.++||
T Consensus 159 kp~Nil~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 217 (293)
T cd05053 159 AARNVLVT----EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDV 217 (293)
T ss_pred ceeeEEEc----CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCcccce
Confidence 99999998 567999999999986543221 12223567899999987654 4456675
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-25 Score=226.50 Aligned_cols=180 Identities=28% Similarity=0.441 Sum_probs=147.2
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|+. +++.||+|+++.... .....+.+|+.+++.++||||+++++.+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--------~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-- 77 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--------EDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-- 77 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--------hHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--
Confidence 35688888999999999999987 467899999875421 112357789999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+|+|+||||+|||++ .++.+||+|||+
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~~~l~dfg~ 152 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT----DNGHVKLADFGV 152 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEECccee
Confidence 578999999999999999987654 588999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCcccccccc--CCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLS--GKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~--Gk~y~tse~DI 993 (993)
+....... ......||..|+|||++. .......++||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv 192 (267)
T cd06645 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192 (267)
T ss_pred eeEccCcccccccccCcccccChhhhccccCCCCCchhhh
Confidence 87543321 223457999999999975 22334456664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=265.35 Aligned_cols=191 Identities=25% Similarity=0.363 Sum_probs=154.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
....+|++++.||+|+||+||+|++. +..||+|++...... ......|..|+.+|+.|+|||||+++++|.+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~------e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK------EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 34578999999999999999999884 566899998754321 1234578899999999999999999999977
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCCEEEccCC-
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGK-------NIVHFDLKCENLLVNMRD- 943 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~-------gIIHRDIKPeNILLd~~d- 943 (993)
.....+||||||+.+++|.++|... ...+++..++.|+.||+.||.|||+. +||||||||+||||+...
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 5567899999999999999999753 24589999999999999999999984 499999999999996321
Q ss_pred ------------CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCC-ccCCCCCCC
Q 001940 944 ------------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK-SHMVTEKEL 993 (993)
Q Consensus 944 ------------~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk-~y~tse~DI 993 (993)
.....+||+|||+++............||+.|+|||++.+. ...+.++||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV 226 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDM 226 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHH
Confidence 12356999999999876554444566799999999999754 345566665
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=222.49 Aligned_cols=181 Identities=30% Similarity=0.599 Sum_probs=146.5
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|++.+.||+|+||.||+|.++ ++.||||.++..... .+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---------PKDFLAEAQIMKKLRHPKLIQLYAVCTL- 72 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---------HHHHHHHHHHHHHCCCCCccceeEEEec-
Confidence 34567999999999999999999874 467999988753211 2357789999999999999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 73 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~df 147 (261)
T cd05068 73 -EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG----ENNICKVADF 147 (261)
T ss_pred -CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc----CCCCEEECCc
Confidence 567899999999999999997643 4588999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccccc--CCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s--~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++........ ....++..|+|||++.+.. .+.+.||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 187 (261)
T cd05068 148 GLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDV 187 (261)
T ss_pred ceEEEccCCcccccCCCcCceeccCccccccCC-CCchhhH
Confidence 999866432211 1122345799999987654 3445554
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=226.81 Aligned_cols=173 Identities=31% Similarity=0.486 Sum_probs=145.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+.|+++++||.|+||.||+|+.. +..+|+|++.... ....+.+.+|+.+++.++|+||+++++.+..
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--------EEELEDYMVEIEILATCNHPYIVKLLGAFYW- 80 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-
Confidence 3466999999999999999999884 6779999886431 1234578889999999999999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|..++.+....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 81 -~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~dfg 155 (292)
T cd06644 81 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT----LDGDIKLADFG 155 (292)
T ss_pred -CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc----CCCCEEEccCc
Confidence 5689999999999999998876666689999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccc-cccCCCCCCCCccccccccCC
Q 001940 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 956 LAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk 984 (993)
++...... .......+++.|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 185 (292)
T cd06644 156 VSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185 (292)
T ss_pred cceeccccccccceecCCccccCceeeccc
Confidence 98754322 122345688999999999643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=228.32 Aligned_cols=180 Identities=32% Similarity=0.470 Sum_probs=142.1
Q ss_pred CCceEEEEecccCceEEEEEEEcC--c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRG--S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kg--t--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d 874 (993)
++|++.+.||+|+||.||+|..+. . .+++|.++... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-------SENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-------CHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 578999999999999999998742 2 36888776321 112235688899999999 79999999999887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILL 939 (993)
.+.+++||||+++++|.+++.... ..+++..++.|+.||+.||+|||+.+|+||||||+|||+
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill 152 (297)
T cd05089 75 --RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV 152 (297)
T ss_pred --CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE
Confidence 567999999999999999996532 247888999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 940 NMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 940 d~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+ .++.+||+|||++..............+..|+|||++.+..+ +.++||
T Consensus 153 ~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 201 (297)
T cd05089 153 G----ENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDV 201 (297)
T ss_pred C----CCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhH
Confidence 8 567899999999875432222222233567999999976653 455664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=237.11 Aligned_cols=184 Identities=28% Similarity=0.458 Sum_probs=144.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~-------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.+.||+|+||+||+|.+ .++.||||+++.... ......+.+|+.++.++ +|+||+++
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~niv~~ 76 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVNL 76 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-------hHHHHHHHHHHHHHHhccCCccHhhh
Confidence 3456899999999999999999974 246799999875321 11234678899999999 68999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------------------------------------------------
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------------------------------------ 900 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------------------------------------------------ 900 (993)
++++... ...+++||||+.+|+|.+++....
T Consensus 77 ~~~~~~~-~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 77 LGACTKP-GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred cceeecC-CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 9988753 457899999999999999986431
Q ss_pred ------------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 901 ------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 901 ------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
..+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~----~~~~~kl~dfg~~~~~~~ 231 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYK 231 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc----CCCcEEEEeccccccccc
Confidence 1256777888999999999999999999999999999998 567899999999886432
Q ss_pred cc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.. ......++..|+|||++.+..+ +.+.||
T Consensus 232 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 264 (343)
T cd05103 232 DPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDV 264 (343)
T ss_pred CcchhhcCCCCCCcceECcHHhcCCCC-CchhhH
Confidence 21 1122345678999999876543 445554
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=225.25 Aligned_cols=174 Identities=29% Similarity=0.413 Sum_probs=144.0
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||.||+|.+ .+..||||++..... ....+.+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 71 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-------VELQKQIMSELEILYKCDSPYIIGFYGAFFV--E 71 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-------hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE--C
Confidence 3678889999999999999987 467799998875321 1123468889999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+..++||||+++++|..+. .+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||++
T Consensus 72 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~----~~~~~~l~dfg~~ 142 (279)
T cd06619 72 NRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN----TRGQVKLCDFGVS 142 (279)
T ss_pred CEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC----CCCCEEEeeCCcc
Confidence 6789999999999996553 367888889999999999999999999999999999998 6678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......||..|+|||++.+.. .+.+.||
T Consensus 143 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 176 (279)
T cd06619 143 TQLVNS-IAKTYVGTNAYMAPERISGEQ-YGIHSDV 176 (279)
T ss_pred eecccc-cccCCCCChhhcCceeecCCC-CCCcchH
Confidence 865433 233467999999999998765 3455664
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.6e-24 Score=224.09 Aligned_cols=174 Identities=30% Similarity=0.415 Sum_probs=137.0
Q ss_pred EecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
.||+|+||.||+|++. ...+|+|.++.... ......+.+|+.++++++||||+++++++.+ ...+++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 72 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-------VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE--VTPYLL 72 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CCCcEE
Confidence 5899999999999864 24589998765321 1122467889999999999999999999887 466899
Q ss_pred EEeeccCCcHHHHHHhcc----CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 883 VTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~----k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
||||+.+++|.+++.... ...++..++.++.|++.||.|||+.+++||||||+|||++ ..+.+||+|||+++
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----~~~~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----ADLTVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc----CCCcEEECCccccc
Confidence 999999999999997532 2356677888999999999999999999999999999998 56789999999987
Q ss_pred cccccc---ccCCCCCCCCccccccccCCcc------CCCCCCC
Q 001940 959 VKQQTL---VSGGVRGTLPWMAPELLSGKSH------MVTEKEL 993 (993)
Q Consensus 959 ~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y------~tse~DI 993 (993)
...... ......|+..|+|||++.+... .+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Di 192 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNV 192 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchh
Confidence 543321 1223457889999999975432 3456665
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=221.29 Aligned_cols=177 Identities=36% Similarity=0.581 Sum_probs=148.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..++|++.+.||.|+||.||+|...++.||||.++.... ..+++.+|+.+++.++|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 72 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---------AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--G 72 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---------HHHHHHHHHHHHHhcCCcceeeeEEEEcC--C
Confidence 456789999999999999999999999999999875421 23578889999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+|||++ .++.+||+|||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~----~~~~~~l~d~g~ 148 (256)
T cd05039 73 NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS----EDLVAKVSDFGL 148 (256)
T ss_pred CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe----CCCCEEEccccc
Confidence 77999999999999999997654 3589999999999999999999999999999999999998 667899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
++....... ...++..|+|||++.+..+ ..+.|
T Consensus 149 ~~~~~~~~~--~~~~~~~~~ape~~~~~~~-~~~~D 181 (256)
T cd05039 149 AKEASQGQD--SGKLPVKWTAPEALREKKF-STKSD 181 (256)
T ss_pred ccccccccc--cCCCcccccCchhhcCCcC-CcHHH
Confidence 987633222 2335678999999875533 33444
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=223.41 Aligned_cols=180 Identities=23% Similarity=0.412 Sum_probs=152.1
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|++.+.||.|+||.||+|+++ ++.||+|++.+.... .....+.+.+|+.++++++||||+++++.+.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCV-----EKGSVRNVLNERRILQELNHPFLVNLWYSFQD--EE 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhc-----chhHHHHHHHHHHHHHhCCCCChHHHHHhhcC--CC
Confidence 4889999999999999999885 788999999864321 11234678899999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++... ..+++..+..|+.||+.||.|||+.+++|+||||+||+++ .++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~----~~~~~~l~d~~~~~ 148 (258)
T cd05578 74 NMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD----EQGHVHITDFNIAT 148 (258)
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc----CCCCEEEeeccccc
Confidence 799999999999999999766 4588999999999999999999999999999999999998 66789999999988
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
............|+..|+|||++.+.. ...+.||
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di 182 (258)
T cd05578 149 KVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDW 182 (258)
T ss_pred ccCCCccccccCCChhhcCHHHHcccC-CCCcccc
Confidence 765443344566899999999997655 5566665
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=223.52 Aligned_cols=179 Identities=23% Similarity=0.306 Sum_probs=146.4
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCC
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~ 878 (993)
|++.++||+|+||.||+|+. +++.||+|+++...... . .....+|+.+++++. |+||+++++++.+...+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~---~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL---E----QVNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc---h----hhhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 67889999999999999987 46789999987542111 1 113456888888886 99999999999985557
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+. ++|.+++......+++..++.++.||+.||+|||+.+++||||||+||+++ . +.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~----~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK----D-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc----C-CCeEEEeccccc
Confidence 8999999996 688888876656689999999999999999999999999999999999998 4 789999999998
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
............+|..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 182 (282)
T cd07831 148 GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDI 182 (282)
T ss_pred ccccCCCcCCCCCCcccCChhHhhcCCCCCcchhH
Confidence 76544333445689999999988766666667775
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=262.92 Aligned_cols=182 Identities=27% Similarity=0.390 Sum_probs=147.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.++||+|+||.||+|.+. ++.||||++...... .....+++.+|+.++++++||||+++++++.+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-----~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d--~ 74 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-----NPLLKKRFLREAKIAADLIHPGIVPVYSICSD--G 74 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-----CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee--C
Confidence 57999999999999999999884 778999998754221 12334578899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhc----------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~----------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
+..++||||++|++|.+++... ...++...++.++.||+.||.|||+.+|+||||||+|||++ ..+
T Consensus 75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd----~dg 150 (932)
T PRK13184 75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG----LFG 150 (932)
T ss_pred CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc----CCC
Confidence 6799999999999999998642 12245667788999999999999999999999999999998 567
Q ss_pred eEEEEecCCccccccc-------------------cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQT-------------------LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~-------------------~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+||+|||+++..... ......+||+.|||||++.+..+ +.++||
T Consensus 151 ~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDI 214 (932)
T PRK13184 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDI 214 (932)
T ss_pred CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHH
Confidence 8999999999865110 01123569999999999987754 455564
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5e-24 Score=218.08 Aligned_cols=181 Identities=29% Similarity=0.466 Sum_probs=150.1
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||++.. .+..+|||++...... ....+.+.+|+.++++++|+||+++++.+.. .+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT------KDERLAAQNECQVLKLLSHPNIIEYYENFLE--DK 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc------cHHHHHHHHHHHHHhhCCCCchhheeeeEec--CC
Confidence 588999999999999999887 4677999998754321 1223578899999999999999999999886 56
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+++++|.+++... ...+++..++.++.+++.||.|||+++|+|+||||+||+++. .+..+||+|||++
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~---~~~~~~l~d~~~~ 149 (256)
T cd08220 73 ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK---HKMVVKIGDFGIS 149 (256)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccCCCc
Confidence 799999999999999999764 345889999999999999999999999999999999999972 3357899999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.............|+..|+|||.+.+.. .+.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 184 (256)
T cd08220 150 KILSSKSKAYTVVGTPCYISPELCEGKP-YNQKSDI 184 (256)
T ss_pred eecCCCccccccccCCcccCchhccCCC-CCcccch
Confidence 8765444444567899999999998654 4456665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=225.18 Aligned_cols=164 Identities=28% Similarity=0.399 Sum_probs=130.1
Q ss_pred EecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+||+|+||.||+|... ...+|+|.+.... .......+.+|+.+++.++|+||+++++.+.. ...+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~--~~~~~l 72 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-------TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE--SIPYLL 72 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-------ChHHHHHHHHHHHHHHhCCCCCcceEEEEECC--CCceEE
Confidence 5999999999999753 2346777665321 11223467889999999999999999999987 567999
Q ss_pred EEeeccCCcHHHHHHhccC----ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 883 VTEFMVNGSLKQFLQKKDR----TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k----~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
||||+.+++|.+++..... ..++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~----~~~~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLT----ADLSVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEec----CCCcEEEecccccc
Confidence 9999999999999976432 245677889999999999999999999999999999998 56789999999987
Q ss_pred cccccc---ccCCCCCCCCccccccccC
Q 001940 959 VKQQTL---VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 959 ~~~~~~---~s~s~~GTp~YmAPEVL~G 983 (993)
...... ......++..|+|||++..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhh
Confidence 542221 1223346778999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=237.32 Aligned_cols=184 Identities=28% Similarity=0.452 Sum_probs=146.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.+.||+|+||.||+|... ++.||+|+++.... ....+.+.+|+.+++++ +|+||+++
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-------~~~~~~~~~E~~~~~~l~~h~niv~~ 76 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-------ASEYKALMTELKILIHIGHHLNVVNL 76 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-------HHHHHHHHHHHHHHHhhccCcchhhe
Confidence 44568999999999999999999653 35699998874321 11234677899999999 79999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------------------------------------------------
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------------------------------------------ 900 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------------------------------------------------ 900 (993)
+++|... ...++++|||+.+++|.++|....
T Consensus 77 ~~~~~~~-~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 77 LGACTKP-GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred eeeEecC-CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 9988753 467899999999999999986421
Q ss_pred ------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---c
Q 001940 901 ------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---V 965 (993)
Q Consensus 901 ------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~ 965 (993)
..+++..+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+++...... .
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~----~~~~vkL~DfG~a~~~~~~~~~~~ 231 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS----ENNVVKICDFGLARDIYKDPDYVR 231 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe----CCCcEEEeccccchhcccCcchhh
Confidence 2478888999999999999999999999999999999998 56789999999998653221 1
Q ss_pred cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 966 SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 966 s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.....++..|||||++.+..+ +.++||
T Consensus 232 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di 258 (337)
T cd05054 232 KGDARLPLKWMAPESIFDKVY-TTQSDV 258 (337)
T ss_pred ccCCCCCccccCcHHhcCCCC-CccccH
Confidence 223456788999999987654 445664
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=219.03 Aligned_cols=183 Identities=30% Similarity=0.492 Sum_probs=150.3
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|+..+.||+|+||.||+|... ++.||+|++........ .....+.+.+|+.+++.++|+||+++++++.+ ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT---GQEAVKQLEQEIALLSKLQHPNIVQYLGTERE--ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccccc---chHHHHHHHHHHHHHHhcCCCCchheeeeEec--CC
Confidence 3677789999999999999884 77899999875432211 22334578899999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+++++|.+++.+.. .+++..+..++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~----~~~~~kl~d~~~~~ 150 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD----TNGVVKLADFGMAK 150 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccce
Confidence 7999999999999999997654 478899999999999999999999999999999999998 56789999999988
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
............|+..|+|||.+........+.||
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~ 185 (258)
T cd06632 151 QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185 (258)
T ss_pred eccccccccccCCCcceeCHHHhcCCCCCCchhhh
Confidence 65443333456689999999998766534555554
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.1e-26 Score=259.41 Aligned_cols=179 Identities=25% Similarity=0.423 Sum_probs=152.3
Q ss_pred CCceEEEEecccCceEEEEEEEcCcc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~--VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+-|+++..||.|+||+||+|..+.+. .|.|+|... .+..++++.-|+.||..++||+||++++.|.. +
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--------seEELEDylVEIeILa~CdHP~ivkLl~ayy~--e 101 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--------SEEELEDYLVEIEILAECDHPVIVKLLSAYYF--E 101 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--------chhHHhhhhhhhhhhhcCCChHHHHHHHHHhc--c
Confidence 44788899999999999999887554 477877643 23346789999999999999999999998877 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+||+.|||.||-...++-.-++.+.+.++..+++|++.||.|||+++|||||||..|||++ .+|.|+|+|||.+
T Consensus 102 nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T----ldGdirLADFGVS 177 (1187)
T KOG0579|consen 102 NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT----LDGDIRLADFGVS 177 (1187)
T ss_pred CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE----ecCcEeeeccccc
Confidence 789999999999999999888888899999999999999999999999999999999999998 7789999999987
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
-..... ....++.||++|||||++.+.......+|
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYD 213 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYD 213 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCch
Confidence 543322 23457889999999999987766655554
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=222.60 Aligned_cols=180 Identities=31% Similarity=0.580 Sum_probs=147.4
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
...+|++.+.||+|+||.||+|.++ ++.||+|++.... ...+.+.+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 73 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 73 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---------hHHHHHHHHHHHHHhCCCCChhheEEEEcC-
Confidence 4456889999999999999999884 6779999886431 113468889999999999999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++... ...+++..++.++.|++.||.|||+++++||||||+|||++ .++.+||+||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~df 148 (263)
T cd05052 74 -EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVADF 148 (263)
T ss_pred -CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCcEEeCCC
Confidence 56789999999999999999754 34588999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccccc--CCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s--~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++......... ....++..|+|||.+.+..+ +.+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 188 (263)
T cd05052 149 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDV 188 (263)
T ss_pred ccccccccceeeccCCCCCccccCCHHHhccCCC-CchhHH
Confidence 999865443221 12234678999999876654 345664
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=225.81 Aligned_cols=185 Identities=30% Similarity=0.538 Sum_probs=145.8
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
..++|++.+.||+|+||.||+|.+.. ..||+|.+..... ......+.+|+.+++.++|+||+++++
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~ 76 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-------EQDESDFLMEALIMSKFNHQNIVRLIG 76 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-------HHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34678999999999999999998854 4578887754311 122346888999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~ 944 (993)
++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+|||++..+
T Consensus 77 ~~~~--~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~- 153 (277)
T cd05036 77 VSFE--RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG- 153 (277)
T ss_pred EEcc--CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-
Confidence 9887 466899999999999999997643 2478899999999999999999999999999999999998433
Q ss_pred CCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 945 QRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....+||+|||+++....... .....++..|+|||++.+.. .+.+.||
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 204 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDV 204 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHH
Confidence 345799999999986533211 11223456899999997655 4455664
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=225.14 Aligned_cols=184 Identities=25% Similarity=0.359 Sum_probs=147.8
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.++||+|+||.||+|+. +++.||||++....... .....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC------CchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 35799999999999999999988 47789999886542211 11124567999999999999999999987632
Q ss_pred ------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 877 ------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
....++||||+. ++|.+++......+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~k 159 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT----KDGILK 159 (310)
T ss_pred ccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC----CCCcEE
Confidence 235699999995 588888877665689999999999999999999999999999999999998 667899
Q ss_pred EEecCCcccccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||++....... ......++..|+|||++.+.....+++||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 207 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDM 207 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhh
Confidence 99999997553321 11234578899999999877666677775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-24 Score=224.35 Aligned_cols=167 Identities=29% Similarity=0.478 Sum_probs=140.6
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|++++.||+|+||.||++.+. +..+|+|.+.... ....+.+.+|+.+++.++|+||+++++++.. .+.
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 76 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--------EEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENN 76 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--------HHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCE
Confidence 677789999999999999885 5567888875431 1224568889999999999999999999987 568
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.++||||+.+++|..++.+....+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++..
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~----~~~~~kl~dfg~~~~ 152 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT----LDGDIKLADFGVSAK 152 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----cCCCEEEcccccccc
Confidence 9999999999999998876556689999999999999999999999999999999999998 567899999999875
Q ss_pred cccc-cccCCCCCCCCcccccccc
Q 001940 960 KQQT-LVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 960 ~~~~-~~s~s~~GTp~YmAPEVL~ 982 (993)
.... .......||..|+|||++.
T Consensus 153 ~~~~~~~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 153 NTRTIQRRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred ccccccccccccccccccCHhhcc
Confidence 4322 1223456899999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=229.01 Aligned_cols=181 Identities=29% Similarity=0.486 Sum_probs=144.0
Q ss_pred CCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
..+|++.++||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+++.++|+||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 345777889999999999999873 3569999987432 11233568889999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhc---------------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~---------------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeN 936 (993)
+.. ...+++++||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|
T Consensus 77 ~~~--~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 77 VTK--EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EcC--CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 987 46789999999999999998532 1247788889999999999999999999999999999
Q ss_pred EEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 937 ILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||++ .++.+||+|||+++...... ......+++.|+|||++.+.. .+.+.||
T Consensus 155 il~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 209 (283)
T cd05091 155 VLVF----DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDI 209 (283)
T ss_pred eEec----CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhH
Confidence 9998 55689999999988653321 123345678999999987655 3455664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=227.05 Aligned_cols=171 Identities=30% Similarity=0.480 Sum_probs=145.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||.|+||.||++.++ +..+|+|++.... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 74 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--------EEELEDFMVEIDILSECKHPNIVGLYEAYFY--E 74 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--------HHHHHHHHHHHHHHHhCCCCceeEEEEEEec--C
Confidence 56889999999999999999884 6779999986431 1233578899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||||+||+++ .++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~----~~~~~~l~d~g~~ 150 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT----LDGDVKLADFGVS 150 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC----CCCCEEEccCccc
Confidence 679999999999999999987666799999999999999999999999999999999999998 6678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk 984 (993)
....... ......||+.|+|||++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 178 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACE 178 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhc
Confidence 7543221 22345689999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=226.68 Aligned_cols=182 Identities=35% Similarity=0.565 Sum_probs=146.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
+...+|.+.+.||+|+||+||++... +..+|+|.+.... ....+.+.+|+.++++++|+||++++
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~ 73 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIVKFY 73 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--------HHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34567999999999999999999752 2348899876431 12345788999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENL 937 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNI 937 (993)
+++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||+|||+.+++||||||+||
T Consensus 74 ~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Ni 151 (288)
T cd05093 74 GVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 151 (288)
T ss_pred EEEec--CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 99987 577999999999999999997532 2488999999999999999999999999999999999
Q ss_pred EEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 938 LVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 938 LLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++ .++.+||+|||+++...... ......++..|+|||++.+.. ...+.||
T Consensus 152 li~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi 205 (288)
T cd05093 152 LVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDV 205 (288)
T ss_pred EEc----cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhH
Confidence 998 66789999999998553221 122334678899999998654 4445664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=221.02 Aligned_cols=183 Identities=26% Similarity=0.419 Sum_probs=149.1
Q ss_pred CceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 801 DLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
+|++.+.||+|+||.||+|.. .++.+|||+++...... ....+..+.+.+|+.++++++|+||+++++++.+ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNV--LAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccch--hhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCe
Confidence 478889999999999999987 56779999987543221 1223345678899999999999999999999987 578
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++||||+.+++|.+++.+.. .+++..+..++.||+.||+|||+.+|+|+||||+||+++ .++.+||+|||++..
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~ 151 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLM----PNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEEC----CCCeEEeccchhhHh
Confidence 999999999999999997654 478888899999999999999999999999999999998 567899999999875
Q ss_pred ccc-------ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQ-------TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~-------~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... ........||..|+|||++.+..+ ..+.||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv 191 (265)
T cd06631 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDI 191 (265)
T ss_pred hhhccccccccccccccCCCccccChhhhcCCCC-cchhhH
Confidence 421 111234568999999999987654 445554
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=226.64 Aligned_cols=180 Identities=29% Similarity=0.443 Sum_probs=147.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||++++. +..||+|.++... .......+.+|+.++++++|+||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFI--E 71 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--C
Confidence 46889999999999999999885 7889999886431 11223578899999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhc--cCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~--~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+.+++||||+++++|..++... ...+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||+||
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~df 147 (286)
T cd06622 72 GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN----GNGQVKLCDF 147 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC----CCCCEEEeec
Confidence 7899999999999999998764 2358999999999999999999996 5999999999999998 5678999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCcc-----CCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH-----MVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y-----~tse~DI 993 (993)
|++....... .....|+..|+|||++.+... .+.+.||
T Consensus 148 g~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di 190 (286)
T cd06622 148 GVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDV 190 (286)
T ss_pred CCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccch
Confidence 9987654332 233468889999999875543 3445554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=223.34 Aligned_cols=172 Identities=31% Similarity=0.524 Sum_probs=138.3
Q ss_pred EecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
.||+|+||.||+|.++ +..||+|++.... .....+.+.+|+.++++++|+||+++++++.. ..+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~---~~~~l 71 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-------EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA---EALML 71 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-------ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC---CCeEE
Confidence 3899999999999774 3458999886431 12233578899999999999999999998864 46899
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++......+++..+++++.||+.||.|||+++++||||||+|||++ .++.+||+|||+++....
T Consensus 72 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~----~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV----NQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc----CCCcEEeccCCccccccC
Confidence 9999999999999986666789999999999999999999999999999999999998 567899999999975432
Q ss_pred ccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... .....++..|+|||++.+.. .+.++||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 181 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDV 181 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCC-CCchhhH
Confidence 211 11122357899999987654 3455664
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=222.15 Aligned_cols=182 Identities=26% Similarity=0.499 Sum_probs=146.6
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|++.++||+|+||.||+|.+.. ..||||.+..... ....+.+.+|+.++++++|+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-------PSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 345678999999999999999998742 3589998764321 1233578889999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.+ ...++||||+.+++|.+++......+++..++.++.||+.||+|||+.+++|+||||+|||++ ..+.+||
T Consensus 76 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l 148 (270)
T cd05056 76 ITE---NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS----SPDCVKL 148 (270)
T ss_pred EcC---CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe----cCCCeEE
Confidence 876 457899999999999999987665689999999999999999999999999999999999998 5678999
Q ss_pred EecCCcccccccccc--CCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s--~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++........ ....++..|+|||.+.+.. .+.+.||
T Consensus 149 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 191 (270)
T cd05056 149 GDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDV 191 (270)
T ss_pred ccCceeeecccccceecCCCCccccccChhhhccCC-CCchhhh
Confidence 999998865433211 1223456899999987664 3455664
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=228.54 Aligned_cols=183 Identities=27% Similarity=0.479 Sum_probs=145.9
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIV 866 (993)
+..++|++.+.||+|+||.||+|++. +..||+|++.... .......+.+|+.+++.+ +|+||+
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-------chHHHHHHHHHHHHHHhhccCCCch
Confidence 45678999999999999999999752 2358999876431 112235688999999999 799999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
++++++.. ...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+|||
T Consensus 85 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 85 NLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred heeEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999987 567899999999999999997632 2467788899999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 932 IKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. .+.++||
T Consensus 163 lkp~Nili~----~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 222 (304)
T cd05101 163 LAARNVLVT----ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDV 222 (304)
T ss_pred cccceEEEc----CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhH
Confidence 999999998 56789999999998653321 122234567899999997754 3455664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-24 Score=229.73 Aligned_cols=182 Identities=29% Similarity=0.497 Sum_probs=144.4
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg---------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
..++|.+.+.||+|+||.||++++.+ ..+|+|+++... .......+.+|+.+++.+ +|+||++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-------ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34679999999999999999997632 358999887431 111234677899999999 7999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI 932 (993)
+++++.. .+.+|+||||+.+++|.+++.... ..+++.+++.|+.||+.||+|||+.+++||||
T Consensus 89 ~~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 166 (307)
T cd05098 89 LLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL 166 (307)
T ss_pred EEEEEec--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 9999987 567999999999999999997642 24788899999999999999999999999999
Q ss_pred CCCCEEEccCCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 933 KPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||++ .++.+||+|||+++....... .....+++.|||||++.+..+ +.+.||
T Consensus 167 kp~Nill~----~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 225 (307)
T cd05098 167 AARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDV 225 (307)
T ss_pred cHHheEEc----CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHH
Confidence 99999998 567899999999876532211 112234578999999976543 445554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-26 Score=272.31 Aligned_cols=185 Identities=23% Similarity=0.309 Sum_probs=158.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|+++++||+|+||.|..++.+ ++.+|+|++++.... +......|+.|-.+|..-..+-|++++.+|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-----Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-----KRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-----hchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 356789999999999999999999885 566899999874332 2233468999999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ +.++|||||||+||+|..+|.+.. .+++..+++++.+|+.||.-||+.|+|||||||+||||| ..|+|||+|
T Consensus 146 D--~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld----~~GHikLAD 218 (1317)
T KOG0612|consen 146 D--ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD----KSGHIKLAD 218 (1317)
T ss_pred C--ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec----ccCcEeecc
Confidence 9 688999999999999999999887 689999988899999999999999999999999999999 778999999
Q ss_pred cCCcccccccc--ccCCCCCCCCcccccccc----CCccCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLS----GKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~----Gk~y~tse~D 992 (993)
||.|-.+.... .+...+|||.|.+||++. ++..+..++|
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecD 263 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECD 263 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccc
Confidence 99877655332 345678999999999996 3355666665
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=223.88 Aligned_cols=179 Identities=31% Similarity=0.568 Sum_probs=144.5
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
...+|++.++||+|+||.||+|++.+ ..||||+++..... .+.+.+|+.++++++|+||+++++.+..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~-- 72 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 72 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC---------HHHHHHHHHHHHhCCCCCcceEEEEECC--
Confidence 44679999999999999999998853 46999998753211 1357889999999999999999998754
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 73 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~----~~~~~~L~dfg 147 (262)
T cd05071 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFG 147 (262)
T ss_pred -CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc----CCCcEEeccCC
Confidence 4579999999999999999763 34578899999999999999999999999999999999998 56789999999
Q ss_pred Cccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++....... .....++..|+|||++.+..+ +...||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv 186 (262)
T cd05071 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDV 186 (262)
T ss_pred ceeeccccccccccCCcccceecCHhHhccCCC-CchhhH
Confidence 9976543321 123346778999998876543 444553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=220.81 Aligned_cols=185 Identities=30% Similarity=0.445 Sum_probs=149.8
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|+..+.||+|+||.||+|.. ++..||+|++....... ...+..+.+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP---ETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCc---hhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 3688899999999999999987 46789999887543211 122344578899999999999999999999887555
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..++++|||+.+++|.+++.+.. .+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~----~~~~~~l~dfg~~ 153 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEccCCCc
Confidence 77899999999999999997654 478889999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......++..|+|||++.+..+ +.+.||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 192 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADV 192 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCC-Cchhhh
Confidence 7543211 1123458899999999987643 445564
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-24 Score=220.06 Aligned_cols=185 Identities=29% Similarity=0.437 Sum_probs=149.8
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|++.+.||+|+||.||+|.+ +++.||+|++....... ........+.+|+.++++++|+||+++++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQ---ETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccc---hhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 4689999999999999999987 47789999875432111 122344678899999999999999999999887655
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~dfg~~ 153 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD----SAGNVKLGDFGAS 153 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECccccc
Confidence 67899999999999999987654 378888999999999999999999999999999999998 5678999999999
Q ss_pred cccccc----cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~----~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......|+..|+|||++.+... ..++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 192 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADV 192 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCC-CccccH
Confidence 865321 11224568999999999987643 445554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.4e-24 Score=218.64 Aligned_cols=182 Identities=25% Similarity=0.414 Sum_probs=149.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|... ++.||+|.++...... ....+.+.+|+.++++++|+||+++++++.+ .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~ 74 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMD-----AKARQDCLKEIDLLKQLDHPNVIKYLASFIE--N 74 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccc-----hhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--C
Confidence 57999999999999999999884 7889999987533221 1223568899999999999999999999987 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+..++||||+.+++|.+++... ...+++..++.++.+|+.||.|||+.+|+||||||+||+++ .++.+||+||
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~----~~~~~~l~d~ 150 (267)
T cd08224 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC----CCCcEEEecc
Confidence 6789999999999999998642 34578999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++...... ......|+..|+|||.+.+..+ ..+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di 189 (267)
T cd08224 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDI 189 (267)
T ss_pred ceeeeccCCCcccceecCCccccCHHHhccCCC-CchhcH
Confidence 9987653322 2233568899999999876654 345553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=220.22 Aligned_cols=184 Identities=26% Similarity=0.458 Sum_probs=148.9
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|+..+.||+|+||.||+++. +++.||+|++...... ........+.+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT--SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE--DS 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC--chhHHHHHHHHHHHHHHHHHcCCCceehhhceecc--CC
Confidence 477889999999999999987 5778999998753211 12223345688999999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++.+.. .+++..++.++.||+.||.|||+++++|+||||+||+++. ....+||+|||++.
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~---~~~~~~l~dfg~~~ 152 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS---TGQRLRIADFGAAA 152 (268)
T ss_pred eEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC---CCCEEEEccccccc
Confidence 7999999999999999997654 5788999999999999999999999999999999999972 22469999999987
Q ss_pred cccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......||..|+|||++.+..+ ..++||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv 191 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDV 191 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCC-Ccccch
Confidence 654321 1223568899999999977654 455665
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=220.16 Aligned_cols=186 Identities=27% Similarity=0.486 Sum_probs=150.4
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCC--CchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAG--KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~--k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
+|.+.+.||+|+||.||+|.. .++.+|||+++...... .........+.+.+|+.+++.++|+||+++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc--
Confidence 477889999999999999976 47789999886532211 111223345678899999999999999999999887
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++.+.. .+++..+..++.||+.||.|||+.+++||||||+||+++ .++.+||+|||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~----~~~~~~l~d~~~ 154 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVD----ADGICKISDFGI 154 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEc----CCCeEEEeeccc
Confidence 567999999999999999997764 588899999999999999999999999999999999998 667999999999
Q ss_pred cccccccc---ccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 957 SKVKQQTL---VSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~---~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
++...... ......|+..|+|||++.+.. ..+.+.||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv 195 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDI 195 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchh
Confidence 87543221 123356889999999988665 34556664
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=220.87 Aligned_cols=180 Identities=31% Similarity=0.452 Sum_probs=141.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHhhcCCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~-ILr~LrHPNIVrL~G~f~d~s 876 (993)
++|++.+.||+|+||.||+++++ ++.||||+++...... . ...+..|+. .++.++|+||+++++++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ------E-QKRLLMDLDISMRSVDCPYTVTFYGALFR-- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH------H-HHHHHHHHHHHHHHcCCCCeeeeeEEEec--
Confidence 47899999999999999999884 7889999987542211 1 123444555 4677889999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+.+++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++ +++||||||+|||++ .++.+||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~----~~~~~kl~ 146 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN----RNGQVKLC 146 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCEEEe
Confidence 567999999995 788888764 234589999999999999999999997 999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCc---cCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS---HMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~---y~tse~DI 993 (993)
|||++.............|+..|+|||++.+.. ..+.++||
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di 190 (283)
T cd06617 147 DFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDV 190 (283)
T ss_pred ecccccccccccccccccCCccccChhhcCCcccccccCccccc
Confidence 999998654433333456899999999987532 23455664
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=244.52 Aligned_cols=181 Identities=20% Similarity=0.293 Sum_probs=139.5
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC------CCCcceEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH------HPNVVSFY 869 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr------HPNIVrL~ 869 (993)
...+|+++++||+|+||+||+|.+ .++.||||+++.... ....+..|+.+++.++ |.+|++++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---------YTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---------hHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 457899999999999999999987 467799999864211 1123345566665554 45689999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCC----
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDP---- 944 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~---- 944 (993)
++|... .+.+|+|||++ +++|.+++.+.. .+++..+..|+.||+.||.|||+ .+||||||||+|||++..+.
T Consensus 198 ~~~~~~-~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 198 RYFQNE-TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EEEEcC-CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 988764 46789999988 888999887653 58899999999999999999998 59999999999999974431
Q ss_pred --------CCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 945 --------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 945 --------e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....+||+|||++..... .....+||+.|||||++.+..+. .++||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~-~~~Di 328 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWM-YSTDM 328 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCC-cHHHH
Confidence 123699999998864332 23356799999999999887653 45554
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.2e-24 Score=222.42 Aligned_cols=182 Identities=31% Similarity=0.533 Sum_probs=146.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
++..+|++.+.||+|+||.||+|.++ +. .+|+|.+..... ......+.+|+.++++++|+||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-------PKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-------HHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 45578999999999999999999873 22 488898765421 123356888999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++.. ...++||||+.+++|.+++......+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+|
T Consensus 77 ~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~----~~~~~k 149 (279)
T cd05057 77 ICLS---SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK----TPQHVK 149 (279)
T ss_pred EEec---CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc----CCCeEE
Confidence 9886 568999999999999999987666689999999999999999999999999999999999998 567899
Q ss_pred EEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++....... .....++..|+|||.+.+..+ ..+.||
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di 194 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY-THKSDV 194 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCc-CchhhH
Confidence 999999986543221 112224678999998865433 344543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=225.93 Aligned_cols=182 Identities=30% Similarity=0.452 Sum_probs=144.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC------------------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG------------------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg------------------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~ 859 (993)
..++|++.+.||+|+||.||++.+.+ ..+|+|++.... .......+.+|+.+++.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-------~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-------NKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHh
Confidence 34679999999999999999986432 248999887431 11223578899999999
Q ss_pred cCCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc----------CccCHHHHHHHHHHHHHHHHHHHhCCcee
Q 001940 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (993)
Q Consensus 860 LrHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------k~Lse~~~lkIalQIL~GLeYLHs~gIIH 929 (993)
++|+||+++++++.. .+.+++||||+.+++|.+++.... ..+++.++..++.||+.||.|||+.+|+|
T Consensus 76 l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 153 (296)
T cd05095 76 LKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVH 153 (296)
T ss_pred CCCCCcceEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 999999999999987 467899999999999999987642 23667789999999999999999999999
Q ss_pred cCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 930 RDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||||+|||++ .++.+||+|||+++...... ......+++.|+|||++.+.. .+.++||
T Consensus 154 ~dlkp~Nili~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di 215 (296)
T cd05095 154 RDLATRNCLVG----KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDV 215 (296)
T ss_pred ccCChheEEEc----CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhh
Confidence 99999999998 56789999999998643321 122234567899999887654 4556665
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=224.62 Aligned_cols=175 Identities=24% Similarity=0.444 Sum_probs=141.1
Q ss_pred EEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 806 RELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
+.||+|+||.||+|..+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-- 70 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--------HRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-- 70 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--------hHHHHHHHHHHHHHHHhCCCCChhheeeEEEe--
Confidence 35999999999999763 234777876532 12234578889999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC----CCCCeEEEE
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD----PQRPVCKIG 952 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d----~e~g~VKLi 952 (993)
....++||||+.+|+|.+++......+++..++.++.||+.||+|||+++|+||||||+|||++.++ .....+||+
T Consensus 71 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 71 GDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred CCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEec
Confidence 4568999999999999999987666789999999999999999999999999999999999997443 122358999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++...... ....++..|+|||++.+....+.+.||
T Consensus 151 d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di 188 (258)
T cd05078 151 DPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADK 188 (258)
T ss_pred ccccccccCCc---hhccccCCccCchhccCCCCCCchhhH
Confidence 99998755332 235688899999999876656666665
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=222.55 Aligned_cols=181 Identities=27% Similarity=0.345 Sum_probs=149.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|.++ ++.||||+++..... ....+.+.+|+.++++++|+||+++++++.. .
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 72 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD------EDVKKTALREVKVLRQLRHENIVNLKEAFRR--K 72 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc------ccchhHHHHHHHHHHhcCCCCeeehhheEEE--C
Confidence 36899999999999999999884 677999988754221 1223568899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.++.|..++.. ...+++..+..++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~iv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~----~~~~~kl~d~g~~ 147 (288)
T cd07833 73 GRLYLVFEYVERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS----ESGVLKLCDFGFA 147 (288)
T ss_pred CEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEEeeecc
Confidence 679999999988777665544 34589999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ......++..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv 185 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDV 185 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhH
Confidence 8654432 33446688999999999887566667775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=218.88 Aligned_cols=179 Identities=31% Similarity=0.588 Sum_probs=146.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..+|++.+.||+|+||.||++.+. +..+|+|++...... ...+.+|+.+++++.|+||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS---------EEDFIEEAQVMMKLSHPKLVQLYGVCTE--R 71 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC---------HHHHHHHHHHHHhCCCCCeeeEEEEEcc--C
Confidence 457899999999999999999885 678999988754221 1357789999999999999999999887 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
...++||||+.+++|.+++......+++..++.++.|++.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 147 (256)
T cd05112 72 SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMT 147 (256)
T ss_pred CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc----CCCeEEECCCcce
Confidence 678999999999999999987656688999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........ .....++..|+|||++.+.. .+.++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv 184 (256)
T cd05112 148 RFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDV 184 (256)
T ss_pred eecccCcccccCCCccchhhcCHhHhccCC-cChHHHH
Confidence 75533211 12233567899999987654 3344553
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=224.67 Aligned_cols=181 Identities=27% Similarity=0.431 Sum_probs=147.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||++... ++.||||.+...... .....+.+.+|+.+++.++|+||+++++.+.. .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 73 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-----LRNQIQQVFVERDILTFAENPFVVSMFCSFET--K 73 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-----hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec--C
Confidence 46899999999999999999884 567999988754221 12234577889999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||||+|||++ ..+.+||+|||++
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~----~~~~~~l~dfg~~ 148 (305)
T cd05609 74 RHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT----SMGHIKLTDFGLS 148 (305)
T ss_pred CEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC----CCCCEEEeeCCCc
Confidence 67999999999999999997654 588899999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc----------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL----------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~----------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......|+..|+|||.+.+.. .+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 199 (305)
T cd05609 149 KIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDW 199 (305)
T ss_pred cccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhH
Confidence 7421110 111245788999999987654 3566664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=228.34 Aligned_cols=183 Identities=28% Similarity=0.494 Sum_probs=145.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIV 866 (993)
+..++|++.++||+|+||.||+++.. ...+|+|+++.... ......+.+|+.+++++ +|+||+
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv 81 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-------DKDLADLISEMELMKLIGKHKNII 81 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-------hHHHHHHHHHHHHHHhccCCCCee
Confidence 34567899999999999999999752 23589998764311 12245688899999999 599999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
++++++.. .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||++||+|||
T Consensus 82 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 82 NLLGVCTQ--EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred eEEEEEcc--CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999887 567999999999999999997532 3478889999999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 932 IKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|||++ .++.+||+|||+++....... .....++..|||||++.+.. .+.++||
T Consensus 160 lkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 219 (314)
T cd05099 160 LAARNVLVT----EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDV 219 (314)
T ss_pred ccceeEEEc----CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchh
Confidence 999999998 567899999999986543211 11223456799999997654 4556675
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=217.26 Aligned_cols=181 Identities=28% Similarity=0.406 Sum_probs=150.7
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||.|+||+||+|.+ ++..+|+|++...... ...+.+.+|+.+++.++|+||+++++.+.. .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ-------TSVDELRKEVQAMSQCNHPNVVKYYTSFVV--G 71 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc-------hHHHHHHHHHHHHHhcCCCCEEEEEEEEee--C
Confidence 4799999999999999999987 4667999998754221 134578899999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||
T Consensus 72 ~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~----~~~~~~l~df~ 147 (267)
T cd06610 72 DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG----EDGSVKIADFG 147 (267)
T ss_pred CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEcccc
Confidence 67999999999999999997642 4588999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccccc-----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLV-----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~-----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++........ .....|+..|+|||++......+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv 190 (267)
T cd06610 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADI 190 (267)
T ss_pred hHHHhccCccccccccccccCChhhcChHHHccccCcCcccch
Confidence 9876543321 2344689999999999876556666664
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=263.75 Aligned_cols=184 Identities=36% Similarity=0.627 Sum_probs=153.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc---Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k---gt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
.+..+..++.+.||+|.||.||+|... +. .||||.++... .+..+.+|.+|..+|+.++|||||++
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-------~~~~~~~Fl~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-------SEQEVSDFLKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCcceeeE
Confidence 355667889999999999999999884 32 28888887542 23445789999999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhc------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~ 942 (993)
+|++.+ .+..+|++|||++|+|..+|++. ...++....+.|+.||++|++||+++++|||||..+|+||+
T Consensus 761 iGv~l~--~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~-- 836 (1025)
T KOG1095|consen 761 IGVCLD--SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD-- 836 (1025)
T ss_pred EEeecC--CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec--
Confidence 999998 56789999999999999999987 66799999999999999999999999999999999999999
Q ss_pred CCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 943 DPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...+|||+|||||+.+..... .....-...|||||.++. ...+++.||
T Consensus 837 --~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDv 887 (1025)
T KOG1095|consen 837 --ERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDV 887 (1025)
T ss_pred --ccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccch
Confidence 668999999999994432211 112233568999999986 577788886
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-26 Score=246.17 Aligned_cols=175 Identities=27% Similarity=0.471 Sum_probs=151.9
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|.++++||+|+||.||+|.+ .|..+|||.+.... .++++.+|+.+|.+++.+++|++||.|.. +..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s----------DLQEIIKEISIMQQC~S~yVVKYYGSYFK--~sD 102 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT----------DLQEIIKEISIMQQCKSKYVVKYYGSYFK--HSD 102 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc----------hHHHHHHHHHHHHHcCCchhhhhhhhhcc--CCc
Confidence 56678899999999999977 47889999876542 13467899999999999999999999887 567
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+|+|||||-.|++.++++.+.+.+++.++..+++..++||+|||...-||||||..|||++ .+|+.||+|||.|.+
T Consensus 103 LWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLN----T~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 103 LWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLN----TDGIAKLADFGVAGQ 178 (502)
T ss_pred eEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEc----ccchhhhhhccccch
Confidence 9999999999999999999999999999999999999999999999999999999999998 668999999999998
Q ss_pred cccccc-cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~~-s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+... .+...||+.|||||++..-.|. +++||
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~-~~ADI 212 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYD-TKADI 212 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhccc-hhhhH
Confidence 876643 3567899999999999865543 34443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=224.37 Aligned_cols=181 Identities=35% Similarity=0.540 Sum_probs=146.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
+..+|.+.+.||+|+||.||++++. +..+++|.+.... ....+.+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--------LAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--------HHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 4567899999999999999999753 2347888876431 122356889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPe 935 (993)
++.. ...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 75 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 75 VCGD--GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEcc--CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 9987 567999999999999999997532 24788999999999999999999999999999999
Q ss_pred CEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++ .++.+||+|||+++...... ......++..|+|||++.+.. ...+.||
T Consensus 153 Nil~~----~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 208 (291)
T cd05094 153 NCLVG----ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDV 208 (291)
T ss_pred eEEEc----cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhH
Confidence 99998 56799999999997543321 123345788999999998754 3445664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=220.72 Aligned_cols=182 Identities=30% Similarity=0.542 Sum_probs=146.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--Cc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt---~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..++|+..+.||+|+||.||+|+.. +. .+|||+++.... ....+.+..|+.++++++|+||+++++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-------EKQRQDFLSEASIMGQFSHHNIIRLEGVV 75 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-------HHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence 4457889999999999999999874 22 589998864311 11235688899999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. .+..++||||+.+++|.+++......+++..+..++.|++.||.|||+.+++||||||+|||++ .++.+||+
T Consensus 76 ~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~----~~~~~kl~ 149 (268)
T cd05063 76 TK--FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN----SNLECKVS 149 (268)
T ss_pred cc--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc----CCCcEEEC
Confidence 87 5678999999999999999987666789999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++........ ......+..|+|||++.+..+ +.++||
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv 193 (268)
T cd05063 150 DFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDV 193 (268)
T ss_pred CCccceecccccccceeccCCCcCceecCHHHhhcCCc-ChHhHH
Confidence 9999875532211 111223457999999976543 555664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=222.10 Aligned_cols=181 Identities=28% Similarity=0.443 Sum_probs=145.1
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s 876 (993)
..|++.+.||+|+||.||+|.+ .++.||||++..... ....+..|+.+++++ +|+||+++++++....
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---------cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 4577888999999999999988 467799999875321 113567888999988 6999999999987532
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
...+|+||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+||+++ .++.+||
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~----~~~~~~l 152 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAEVKL 152 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC----CCCCEEE
Confidence 24689999999999999999864 34588999999999999999999999999999999999998 6678999
Q ss_pred EecCCcccccccc-ccCCCCCCCCccccccccCCc----cCCCCCCC
Q 001940 952 GDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKS----HMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~----y~tse~DI 993 (993)
+|||+++...... ......|+..|+|||++.+.. ..+.++||
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv 199 (272)
T cd06637 153 VDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 199 (272)
T ss_pred ccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhH
Confidence 9999998654321 223456899999999986432 33445554
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-25 Score=243.13 Aligned_cols=182 Identities=27% Similarity=0.373 Sum_probs=156.0
Q ss_pred cccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
..++.-++|..+++||+|+||+|.+++. .++.+|||++++.....+ ..++..+.|..+|+..+||.+..+...
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiak-----dEVAHTlTE~RVL~~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAK-----DEVAHTLTENRVLQNCRHPFLTSLKYS 236 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeeh-----HHhhhhhhHHHHHHhccCcHHHHhhhh
Confidence 3445567899999999999999999977 477899999998766543 234567789999999999999999888
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
|+. ++++|+||||..||.|+..|.+.. .+++.....+..+|+.||.|||+.+||.||||.+|+|+| .+|++||
T Consensus 237 FQt--~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLD----kDGHIKi 309 (516)
T KOG0690|consen 237 FQT--QDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLD----KDGHIKI 309 (516)
T ss_pred hcc--CceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheec----cCCceEe
Confidence 888 788999999999999999997754 477777778888999999999999999999999999999 7789999
Q ss_pred EecCCcccc-ccccccCCCCCCCCccccccccCCccC
Q 001940 952 GDLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 952 iDFGLAk~~-~~~~~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
+|||+++.. ........+|||+.|+|||++....|.
T Consensus 310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYg 346 (516)
T KOG0690|consen 310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYG 346 (516)
T ss_pred eecccchhcccccceeccccCChhhcCchhhcccccc
Confidence 999999953 445566789999999999999866554
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=242.20 Aligned_cols=184 Identities=29% Similarity=0.439 Sum_probs=145.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVr 867 (993)
.+..++|.+.++||+|+||.||+|++.+ ..||||+++.... ....+.+.+|+.+|.++. |+||++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~~E~~~l~~l~~H~niv~ 105 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-------SSEKQALMSELKIMSHLGPHLNIVN 105 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-------hhHHHHHHHHHHHHHhcCCCCCeEE
Confidence 3455678888999999999999998743 4699999975321 112246789999999997 999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------------------------------
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------------------------------- 900 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------------------------------------------- 900 (993)
++++|.. .+.+++||||+.+|+|.++|....
T Consensus 106 ~~~~~~~--~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 106 LLGACTK--GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEcc--CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 9999987 467999999999999999996532
Q ss_pred --------------------------------------------------CccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 901 --------------------------------------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 901 --------------------------------------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
..+++..++.|+.||+.||.|||+.+|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 125666778899999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||||+|||++ ..+.+||+|||+++...... ......++..|||||++.+..+ ..++||
T Consensus 264 dlkp~NiLl~----~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 324 (401)
T cd05107 264 DLAARNVLIC----EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDV 324 (401)
T ss_pred cCCcceEEEe----CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHH
Confidence 9999999998 56789999999998643221 1223457889999999976543 455564
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=224.48 Aligned_cols=181 Identities=28% Similarity=0.385 Sum_probs=149.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||.||+|.++ ++.||+|++...... ....+.+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 72 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD------KMVKKIAMREIRMLKQLRHENLVNLIEVFRR--K 72 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc------chhhHHHHHHHHHHHhcCCcchhhHHHhccc--C
Confidence 46899999999999999999984 678999988654221 1123457789999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|..++.... .+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~----~~~~~~l~dfg~~ 147 (286)
T cd07846 73 KRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS----QSGVVKLCDFGFA 147 (286)
T ss_pred CeEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC----CCCcEEEEeeeee
Confidence 78999999999999888775543 489999999999999999999999999999999999998 5678999999998
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... .......++..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 184 (286)
T cd07846 148 RTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184 (286)
T ss_pred eeccCCccccCcccceeeccCcHHhccccccCchHhH
Confidence 865332 222345688999999999876666666775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-24 Score=225.37 Aligned_cols=182 Identities=25% Similarity=0.423 Sum_probs=149.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|... ++.+|||.+...... .....+.+.+|+.+++.++|+||+++++.+.+ .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 73 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-----KRNKVKRVLTEQEILATLDHPFLPTLYASFQT--E 73 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-----hHHHHHHHHHHHHHHHhCCCCCchhheeeeec--C
Confidence 46899999999999999999884 678999998764322 12234578899999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.++|+|||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~~l~dfg~ 149 (316)
T cd05574 74 TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH----ESGHIMLSDFDL 149 (316)
T ss_pred CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc----CCCCEEEeecch
Confidence 6799999999999999998754 34588999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc------------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL------------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~------------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......||..|+|||++.+..+ +.+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di 215 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDW 215 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHH
Confidence 87532110 1123468999999999987654 445564
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=222.14 Aligned_cols=184 Identities=29% Similarity=0.396 Sum_probs=144.5
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s 876 (993)
++|++.+.||+|+||.||+|.+ +++.||||+++..... ......+.+|+.+++++. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~------~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE------EGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc------cCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 4689999999999999999988 4678999988754211 111235778999999995 699999999987632
Q ss_pred C---CcEEEEEeeccCCcHHHHHHhcc----CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 877 D---GSLATVTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 877 ~---~~L~LVmEYm~GGSL~dlL~~~~----k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
. ..+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+||+++. .++.+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~---~~~~~ 150 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK---QKGLL 150 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec---CCCeE
Confidence 1 238999999975 8888876532 34789999999999999999999999999999999999983 25789
Q ss_pred EEEecCCcccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++...... ......+++.|+|||++.+....+.+.||
T Consensus 151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 195 (295)
T cd07837 151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDI 195 (295)
T ss_pred EEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHH
Confidence 999999988543221 12233578899999999876666667765
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=224.56 Aligned_cols=183 Identities=31% Similarity=0.497 Sum_probs=142.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
+..++|++.+.||+|+||.||+|..+ +..||+|.++... .. .....+.+|+.++++++|+||++++
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~--~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-----SL--RERIEFLNEASVMKGFTCHHVVRLL 75 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-----CH--HHHHHHHHHHHHHHhCCCCCeeeEE
Confidence 34568999999999999999999753 2368999876431 11 1123577899999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd 940 (993)
+++.+ ....++||||+.+|+|.+++.... ...+...++.++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~ 153 (288)
T cd05061 76 GVVSK--GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA 153 (288)
T ss_pred EEEcC--CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc
Confidence 99887 467899999999999999997532 2245667888999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 941 MRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 941 ~~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++....... .....++..|+|||.+.+..+ +.+.||
T Consensus 154 ----~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv 204 (288)
T cd05061 154 ----HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDM 204 (288)
T ss_pred ----CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHH
Confidence 567899999999885432211 122345778999999876543 344553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=228.39 Aligned_cols=183 Identities=28% Similarity=0.448 Sum_probs=147.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.+.||+|+||.||++.+. +..||||+++.... ....+.+.+|+.+++++ +|+||+++
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~iv~~ 104 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-------SSEREALMSELKIMSHLGNHENIVNL 104 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-------hHHHHHHHHHHHHHHhccCCCCcceE
Confidence 44567999999999999999999752 23589998764321 12235788999999999 79999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
++++.. .+.+++||||+.+++|.+++.... ..+++.+++.|+.||+.||.|||+.+|+|+||||+|||++ .++
T Consensus 105 ~~~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~ 178 (302)
T cd05055 105 LGACTI--GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----HGK 178 (302)
T ss_pred EEEEec--CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc----CCC
Confidence 999887 567999999999999999997643 3489999999999999999999999999999999999998 567
Q ss_pred eEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+||+|||+++...... ......++..|+|||++.+.. .+.++||
T Consensus 179 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 226 (302)
T cd05055 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDV 226 (302)
T ss_pred eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHH
Confidence 89999999998553321 122344678899999987665 3445554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=219.60 Aligned_cols=180 Identities=31% Similarity=0.585 Sum_probs=146.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|+++++||+|+||.||+|.. .++.||+|.+...... ...+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 72 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---------PEAFLAEANLMKQLQHPRLVRLYAVVTQ- 72 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---------HHHHHHHHHHHHhcCCcCeeeEEEEEcc-
Confidence 4457899999999999999999987 4677999988754221 2367889999999999999999998754
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+.+++||||+.+++|.+++... ...+++.+++.++.|++.||+|||+.+++||||||+||+++ .++.++|+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~----~~~~~~l~df 146 (260)
T cd05067 73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS----ETLCCKIADF 146 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc----CCCCEEEccC
Confidence 5689999999999999998653 34588899999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++........ .....++..|+|||++.+.. .+.+.||
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di 186 (260)
T cd05067 147 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDV 186 (260)
T ss_pred cceeecCCCCcccccCCcccccccCHHHhccCC-cCcccch
Confidence 99976542221 12344678899999987654 3455664
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=220.11 Aligned_cols=180 Identities=31% Similarity=0.596 Sum_probs=145.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|++.++||+|+||.||+|.+. +..+|+|++...... .+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~---------~~~~~~E~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS---------PESFLEEAQIMKKLRHDKLVQLYAVVSE- 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC---------HHHHHHHHHHHHhcCCCceEEEEeEECC-
Confidence 34567899999999999999999874 567999988754221 1357889999999999999999998754
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...++||||+.+++|.+++... ...+++..++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~----~~~~~~l~df 146 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG----DGLVCKIADF 146 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe----CCceEEeCCc
Confidence 4579999999999999999764 34588999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++........ .....++..|+|||++.+.. .+.+.||
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 186 (260)
T cd05070 147 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDV 186 (260)
T ss_pred eeeeeccCcccccccCCCCCccccChHHHhcCC-Ccchhhh
Confidence 99986543221 12234567899999987654 3455564
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=217.90 Aligned_cols=178 Identities=29% Similarity=0.491 Sum_probs=151.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|++. +..+|+|.+..... .+.+.+|+.++++++|+||+++++++.+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------~~~~~~e~~~~~~l~~~~i~~~~~~~~~-- 69 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------LQEIIKEISILKQCDSPYIVKYYGSYFK-- 69 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----------HHHHHHHHHHHHhCCCCcEeeeeeeeec--
Confidence 367899999999999999999985 57799998864311 3578899999999999999999999988
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...+|++|||+.+++|.+++......+++..++.++.|++.||.|||+.+|+|+||+|+||+++ .++.+||+|||+
T Consensus 70 ~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~----~~~~~~l~dfg~ 145 (256)
T cd06612 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN----EEGQAKLADFGV 145 (256)
T ss_pred CCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC----CCCcEEEccccc
Confidence 4789999999999999999987667789999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......|+..|+|||++.+..+ +.+.||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di 182 (256)
T cd06612 146 SGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADI 182 (256)
T ss_pred chhcccCccccccccCCccccCHHHHhcCCC-CchhhH
Confidence 88764432 2234558899999999987643 445554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=217.20 Aligned_cols=173 Identities=33% Similarity=0.554 Sum_probs=139.9
Q ss_pred EecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 807 ELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
.||+|+||.||+|... +..+|+|+++.... ......+.+|+.+++.++|+||+++++++.. .+..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-------QELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVME 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-------HHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEE
Confidence 6999999999999874 56799998764321 1122368889999999999999999999987 467899999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccc
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~ 965 (993)
|+.+++|.+++......+++..++.++.|++.||.|||+.+++||||||+||+++ .++.+||+|||++........
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~----~~~~~~l~d~g~~~~~~~~~~ 148 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSRQEDDGIY 148 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc----CCCeEEECCCccceecccccc
Confidence 9999999999987666688999999999999999999999999999999999998 567899999999875443321
Q ss_pred c--CCCCCCCCccccccccCCccCCCCCCC
Q 001940 966 S--GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 966 s--~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
. ....++..|+|||++.+.. .+.+.||
T Consensus 149 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 177 (250)
T cd05085 149 SSSGLKQIPIKWTAPEALNYGR-YSSESDV 177 (250)
T ss_pred ccCCCCCCcccccCHHHhccCC-CCchhHH
Confidence 1 1223467799999987653 4445554
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.2e-24 Score=221.37 Aligned_cols=183 Identities=27% Similarity=0.410 Sum_probs=144.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d 874 (993)
..++|++++.||+|+||.||+++. .++.+|+|+++.... ....+..|+.+++.+ +|+||+++++++..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---------IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---------hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 356899999999999999999987 467899998764211 113567889999999 69999999998853
Q ss_pred ---CCCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 875 ---GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 875 ---~s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
...+.+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----~~~~ 162 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----TEGG 162 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC----CCCC
Confidence 124578999999999999998763 234578888999999999999999999999999999999998 5667
Q ss_pred EEEEecCCcccccccc-ccCCCCCCCCccccccccCCc----cCCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKS----HMVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~----y~tse~DI 993 (993)
+||+|||+++...... ......||+.|+|||++.+.. ..+.+.||
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 212 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDV 212 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhh
Confidence 9999999988654322 223456899999999986432 23445554
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=218.34 Aligned_cols=181 Identities=27% Similarity=0.439 Sum_probs=142.4
Q ss_pred ceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
|++.+.||+|+||.||+|+.. +..||||+++.... .......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH------TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC------CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 567889999999999999874 25699999875321 1223457889999999999999999999886532
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhc-----cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~-----~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
. ...++||||+.+++|..++... ...+++..++.++.|++.||.|||+.+|+||||||+|||++ .++
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~----~~~ 150 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLR----EDM 150 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEEC----CCC
Confidence 2 2478999999999999988542 23588899999999999999999999999999999999998 567
Q ss_pred eEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+||+|||+++....... .....++..|+|||++.+.. ...++||
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv 198 (273)
T cd05035 151 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDV 198 (273)
T ss_pred eEEECCccceeeccccccccccccccCCccccCHhhcccCC-CCcccch
Confidence 899999999986533221 11223567899999987554 4456665
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=221.03 Aligned_cols=179 Identities=28% Similarity=0.465 Sum_probs=146.5
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||.|++|.||+|++. ++.||||+++...... ..+.+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG-------TPSTAIREISLMKELKHENIVRLHDVIHT--EN 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc-------chHHHHHHHHHHHhhcCCCEeeeeeeEee--CC
Confidence 5889999999999999999984 7789999987643211 12356689999999999999999999988 56
Q ss_pred cEEEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 879 SLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||+
T Consensus 72 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~----~~~~~~l~d~g~ 146 (284)
T cd07836 72 KLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN----KRGELKLADFGL 146 (284)
T ss_pred cEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC----CCCcEEEeecch
Confidence 7899999997 58888887543 4589999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ......+|..|++||++.+......+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 184 (284)
T cd07836 147 ARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDI 184 (284)
T ss_pred hhhhcCCccccccccccccccChHHhcCCCCCCcHHHH
Confidence 87543321 12234578999999999876655666554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=220.91 Aligned_cols=180 Identities=31% Similarity=0.535 Sum_probs=147.3
Q ss_pred CCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..+|++.++||.|+||.||+|++. +..+|+|++..... .....+.+|+.+++.++|+||+++++++.+ .
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 74 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--------LKQQDFQKEVQALKRLRHKHLISLFAVCSV--G 74 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--------hhHHHHHHHHHHHhcCCCcchhheeeeEec--C
Confidence 356888999999999999999885 57799998875421 123467789999999999999999999887 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
..+++||||+++++|.+++... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~----~~~~~kl~d~g~ 150 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG----EDLVCKVADFGL 150 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc----CCceEEEccccc
Confidence 6799999999999999999763 34588999999999999999999999999999999999998 667899999999
Q ss_pred ccccccccc-cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~-s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+........ .....++..|+|||++.+..+ ..++||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di 187 (261)
T cd05148 151 ARLIKEDVYLSSDKKIPYKWTAPEAASHGTF-STKSDV 187 (261)
T ss_pred hhhcCCccccccCCCCceEecCHHHHccCCC-CchhhH
Confidence 986543321 223346778999999876543 445554
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=218.98 Aligned_cols=183 Identities=28% Similarity=0.510 Sum_probs=149.0
Q ss_pred CCCceEEEEecccCceEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+|++++.||+|+||.||++++. +..+|||+++..... ...+.+.+|+.+++.+.|+||+++++++
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~ei~~l~~l~~~~i~~~~~~~ 75 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-------QHRSDFEREIEILRTLDHENIVKYKGVC 75 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-------HHHHHHHHHHHHHHhCCCCChheEEeee
Confidence 356888899999999999999864 567999998754211 2345788999999999999999999998
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.......+++||||+.+++|.+++......+++..++.++.||+.||.|||+++++|+||||+|||++ .++.+||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~ 151 (284)
T cd05038 76 EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE----SEDLVKIS 151 (284)
T ss_pred ecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc----CCCCEEEc
Confidence 87555679999999999999999987665689999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++........ .....++..|+|||.+.+..+ +.+.||
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di 195 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDV 195 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCC-Ccccch
Confidence 9999987642211 112235667999999876543 344554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=222.97 Aligned_cols=181 Identities=36% Similarity=0.539 Sum_probs=145.7
Q ss_pred cCCCceEEEEecccCceEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~-------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
...+|...++||+|+||.||+++. ++..+|+|.+.... ......+.+|+.+++.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--------HHHHHHHHHHHHHHhcCCCCCCceEEE
Confidence 456788899999999999999964 24468888876431 223457889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc--------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~--------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeN 936 (993)
++.+ ....++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|
T Consensus 75 ~~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~n 152 (280)
T cd05092 75 VCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRN 152 (280)
T ss_pred EEec--CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhh
Confidence 9887 467899999999999999997543 247888999999999999999999999999999999
Q ss_pred EEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 937 ILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||++ .++.+||+|||+++...... ......+++.|+|||++.+.. .+.++||
T Consensus 153 il~~----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 207 (280)
T cd05092 153 CLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDI 207 (280)
T ss_pred EEEc----CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhH
Confidence 9998 56789999999987543221 122334578899999998765 3455664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=220.19 Aligned_cols=174 Identities=32% Similarity=0.577 Sum_probs=144.0
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
.+|++.+.||+|+||.||+++..++.||+|+++... ....+.+|+.++++++|+||+++++++.. +.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----------TAQAFLEETAVMTKLHHKNLVRLLGVILH---NG 72 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc----------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC---CC
Confidence 568999999999999999999999999999886431 12467889999999999999999999875 34
Q ss_pred EEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+|||+++
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~----~~~~~kl~Dfg~~~ 148 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS----EDGVAKVSDFGLAR 148 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc----CCCcEEECCCccce
Confidence 799999999999999997643 3578899999999999999999999999999999999998 56789999999987
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......+..|+|||.+.+..+ +.+.||
T Consensus 149 ~~~~~--~~~~~~~~~y~~pe~~~~~~~-~~~~Dv 180 (254)
T cd05083 149 VGSMG--VDNSKLPVKWTAPEALKHKKF-SSKSDV 180 (254)
T ss_pred ecccc--CCCCCCCceecCHHHhccCCc-CchhhH
Confidence 64332 122334678999999876543 344553
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5e-24 Score=220.40 Aligned_cols=182 Identities=25% Similarity=0.450 Sum_probs=148.6
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||++.+ ++..+|||.+...... .......+.+|+.+++.++|+||+++++++.. .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~ 74 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLM-----DAKARADCIKEIDLLKQLNHPNVIKYYASFIE--D 74 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhh-----hHHHHHHHHHHHHHHHHccCCchhhhhheeEe--C
Confidence 4688889999999999999986 5788999988753221 12234578899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+.+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+||
T Consensus 75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df 150 (267)
T cd08229 75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDL 150 (267)
T ss_pred CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEECcc
Confidence 679999999999999999864 234578999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++....... ......|+..|+|||++.+..+ +.+.||
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv 189 (267)
T cd08229 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDI 189 (267)
T ss_pred hhhhccccCCcccccccCCcCccCHHHhcCCCc-cchhhH
Confidence 9987654322 2234568999999999976643 344553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=221.82 Aligned_cols=182 Identities=23% Similarity=0.374 Sum_probs=146.4
Q ss_pred CceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEc
Q 001940 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d 874 (993)
+|++.+.||+|+||.||+++. ++..||+|+++...... .....+.+.+|+.+++++ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQ----KAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhh----cchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 478899999999999999986 46789999987542211 112234677899999999 59999999999887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+..+++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+++||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~----~~~~~kl~df 149 (290)
T cd05613 77 --DTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVLTDF 149 (290)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC----CCCCEEEeeC
Confidence 567899999999999999997654 478888999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc--ccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
|+++...... ......|+..|+|||.+.+.. ....+.||
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv 191 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW 191 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccH
Confidence 9988653321 223456899999999987543 33445554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=220.35 Aligned_cols=184 Identities=24% Similarity=0.393 Sum_probs=148.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
+..++|++.+.||+|+||.||+|.+.. ..|++|++.... .....+.+.+|+.++++++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-------SEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 456789999999999999999998753 668999876321 1223457889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc-------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD-------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d 943 (993)
++... ....++++||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++||||||+|||++
T Consensus 76 ~~~~~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~--- 151 (280)
T cd05043 76 VCIED-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID--- 151 (280)
T ss_pred EEecC-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---
Confidence 88764 456889999999999999997532 3488999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 944 PQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++...... ......++..|+|||++.+.. .+.++||
T Consensus 152 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di 202 (280)
T cd05043 152 -EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDV 202 (280)
T ss_pred -CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhH
Confidence 56799999999998653221 112344677899999997654 3455564
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=223.98 Aligned_cols=179 Identities=30% Similarity=0.459 Sum_probs=141.5
Q ss_pred CceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
+|++.+.||+|+||.||+|.... ..+|+|++..... ......+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-------SSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-------HHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47788999999999999998742 3588888764321 122357889999999999999999999988
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------CccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~-----------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
. .+..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+|+||
T Consensus 74 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~ 151 (290)
T cd05045 74 Q--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHR 151 (290)
T ss_pred c--CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehh
Confidence 7 567899999999999999986421 236788899999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||||+|||++ .++.+||+|||+++...... ......++..|+|||++.+.. .+.+.||
T Consensus 152 dikp~nill~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di 212 (290)
T cd05045 152 DLAARNVLVA----EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDV 212 (290)
T ss_pred hhhhheEEEc----CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHH
Confidence 9999999998 56789999999987543221 112334677899999987654 3344553
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=219.27 Aligned_cols=172 Identities=30% Similarity=0.478 Sum_probs=137.5
Q ss_pred EecccCceEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+||+|+||.||+|.+ ++..+|||+++... ......+.+.+|+.+++.++|+||+++++++.. ...++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~l 72 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWML 72 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEE
Confidence 589999999999976 35679999886432 112344678899999999999999999998864 45789
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||+++....
T Consensus 73 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~----~~~~~kl~Dfg~~~~~~~ 147 (257)
T cd05116 73 VMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV----TQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc----CCCeEEECCCccccccCC
Confidence 999999999999997653 588999999999999999999999999999999999998 567899999999986533
Q ss_pred ccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... .....++..|+|||++.+.. ...+.||
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 181 (257)
T cd05116 148 DENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDV 181 (257)
T ss_pred CCCeeeecCCCCCCccccCHhHhccCC-cCchhHH
Confidence 221 11223467899999986543 3345553
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=217.77 Aligned_cols=181 Identities=30% Similarity=0.594 Sum_probs=147.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|++.+.||+|+||.||+|.++ +..||||.+...... .+++.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 72 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---------PEAFLQEAQIMKKLRHDKLVQLYAVCSE- 72 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---------HHHHHHHHHHHhhCCCCCEeeeeeeeec-
Confidence 45678999999999999999999875 456899988753211 2467889999999999999999999886
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+++++|+||||+||+++ .++.+||+||
T Consensus 73 -~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~----~~~~~~l~d~ 147 (261)
T cd05034 73 -EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG----ENLVCKIADF 147 (261)
T ss_pred -CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc----CCCCEEECcc
Confidence 467999999999999999997643 4689999999999999999999999999999999999998 5679999999
Q ss_pred CCccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++....... .....++..|+|||.+.+.. .+.++||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di 187 (261)
T cd05034 148 GLARLIEDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDV 187 (261)
T ss_pred ccceeccchhhhhhhccCCCccccCHHHhccCC-cCchhHH
Confidence 99886543211 11223567899999998654 3444553
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=218.99 Aligned_cols=175 Identities=29% Similarity=0.518 Sum_probs=138.4
Q ss_pred EEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 806 RELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+.||+|+||.||+|++. ...||||++.... .....+.+.+|+.+++.++||||+++++++... ++..
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~ 72 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-------DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSP 72 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-------CHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCc
Confidence 35899999999999863 2458999875321 112245778899999999999999999987643 4568
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
++||||+.+++|.+++.+.....++..++.++.||+.||.|||+.+++||||||+|||++ ..+.+||+|||+++..
T Consensus 73 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~----~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 73 LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD----ESFTVKVADFGLARDI 148 (262)
T ss_pred EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCccccccc
Confidence 899999999999999987655577888889999999999999999999999999999998 5678999999998754
Q ss_pred cccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 961 QQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 961 ~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.... ......++..|+|||.+.+.. .+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 185 (262)
T cd05058 149 YDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDV 185 (262)
T ss_pred cCCcceeecccccCcCCccccChhHhccCc-cchHHHH
Confidence 3221 112334677899999987654 3445554
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=230.47 Aligned_cols=180 Identities=23% Similarity=0.342 Sum_probs=146.2
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|+. +++.||||++..... .......+.+|+.++++++|+||++++++|....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ------NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc------ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 46799999999999999999987 477899998864321 1122345678999999999999999999986531
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+|+||||+ .++|.+.+... ++...+..++.||+.||+|||+.+|+||||||+|||++ .++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~----~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELM-DANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEecc-CCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEc
Confidence 13579999999 46888887643 78888999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++............||..|+|||++.+..+ ..++||
T Consensus 161 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 200 (353)
T cd07850 161 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDI 200 (353)
T ss_pred cCccceeCCCCCCCCCCcccccccCHHHHhCCCC-CCchhh
Confidence 9999987654433344568999999999987654 355664
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=229.21 Aligned_cols=178 Identities=20% Similarity=0.313 Sum_probs=141.0
Q ss_pred EEEEeccc--CceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 804 EVRELGSG--TYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 804 ile~LGeG--gFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
++++||+| +|++||++.. +++.||||+++.... .....+.+.+|+.+++.++||||++++++|.. ++.
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~--~~~ 73 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 73 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc------cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE--CCE
Confidence 45789999 7889999987 477899999875422 11233467789999999999999999999988 577
Q ss_pred EEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 880 LATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
+++||||+++++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.++|+||+.+.
T Consensus 74 ~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~----~~~~~~l~~~~~~~ 149 (327)
T cd08227 74 LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe----cCCcEEEcccchhh
Confidence 99999999999999999754 34488999999999999999999999999999999999998 56789999998654
Q ss_pred cccccc--------ccCCCCCCCCccccccccCC-ccCCCCCCC
Q 001940 959 VKQQTL--------VSGGVRGTLPWMAPELLSGK-SHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~--------~s~s~~GTp~YmAPEVL~Gk-~y~tse~DI 993 (993)
...... ......++..|+|||++.+. ..++.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 193 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhH
Confidence 322110 11223467889999999764 335566664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=214.63 Aligned_cols=180 Identities=26% Similarity=0.474 Sum_probs=149.2
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||++.. .+..||+|+++..... ....+.+..|+.++++++|+||+++++.+.. .+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND------PKTIKEIADEMKVLELLKHPNLVKYYGVEVH--RE 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc------hHHHHHHHHHHHHHHhCCCCChhheeeeEec--CC
Confidence 488899999999999999987 4678999998754321 2345678999999999999999999999876 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++|+||+.+++|.+++.... .+++..+..|+.+++.||.|||+.+|+|+||||+||+++ ..+.+||+|||++.
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~----~~~~~kl~d~g~~~ 147 (264)
T cd06626 73 KVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD----HNGVIKLGDFGCAV 147 (264)
T ss_pred EEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccccccc
Confidence 7999999999999999997653 478889999999999999999999999999999999998 56789999999988
Q ss_pred ccccccc-----cCCCCCCCCccccccccCCc--cCCCCCCC
Q 001940 959 VKQQTLV-----SGGVRGTLPWMAPELLSGKS--HMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~-----s~s~~GTp~YmAPEVL~Gk~--y~tse~DI 993 (993)
....... .....++..|+|||++.+.. ....++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv 189 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADI 189 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccch
Confidence 6543221 11346889999999998654 24555664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-25 Score=249.33 Aligned_cols=188 Identities=27% Similarity=0.375 Sum_probs=160.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---CCCcceEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIV 872 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---HPNIVrL~G~f 872 (993)
+..+|+.++.||+|+||.|++|.++ ...|+||.|.+.....+.-.|.+.+-.+--|+.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999885 456999999887654443344444445667999999998 99999999999
Q ss_pred EcCCCCcEEEEEeecc-CCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 873 RDGPDGSLATVTEFMV-NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~-GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
++ ++.+||+||--. +.+|+++|..+.. +++.++..|++|++.|+++||+.||||||||-+|++++ .+|.+||
T Consensus 639 Ed--dd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd----~~g~~kl 711 (772)
T KOG1152|consen 639 ED--DDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVD----SNGFVKL 711 (772)
T ss_pred ec--CCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhccccccccCceecccccccEEEe----cCCeEEE
Confidence 99 688999999753 4599999987654 89999999999999999999999999999999999999 7889999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||.|...+.. ....++||..|+|||++.|.+|...+.||
T Consensus 712 idfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdi 752 (772)
T KOG1152|consen 712 IDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDI 752 (772)
T ss_pred eeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchh
Confidence 999998766544 34568899999999999999999999887
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=219.15 Aligned_cols=180 Identities=28% Similarity=0.423 Sum_probs=139.9
Q ss_pred eEEEEecccCceEEEEEEEcCc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC--
Q 001940 803 EEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~kgt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s-- 876 (993)
.+.+.||+|+||.||+|+++.. .+|||.++.... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVES 75 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcc
Confidence 4568899999999999988532 489998875321 1223467889999999999999999999875421
Q ss_pred --CCcEEEEEeeccCCcHHHHHHh-----ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 877 --DGSLATVTEFMVNGSLKQFLQK-----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 877 --~~~L~LVmEYm~GGSL~dlL~~-----~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
....++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 76 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~ 151 (272)
T cd05075 76 EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN----ENMNV 151 (272)
T ss_pred cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEc----CCCCE
Confidence 2357899999999999988743 223478999999999999999999999999999999999998 56789
Q ss_pred EEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++....... .....+++.|+|||++.+.. .+.+.||
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di 197 (272)
T cd05075 152 CVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDV 197 (272)
T ss_pred EECCCCcccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHH
Confidence 9999999986543221 12234677899999997654 3445553
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.5e-24 Score=221.22 Aligned_cols=174 Identities=26% Similarity=0.331 Sum_probs=143.2
Q ss_pred ecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||+|+||+||++.. +++.||+|++...... .......+..|+.+|++++||||+++++++.. .+.+|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-----KRKGEQMALNEKKILEKVSSRFIVSLAYAFET--KDDLCLVMT 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-----hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec--CCeEEEEEe
Confidence 68999999999977 4778999998754321 11223456789999999999999999999987 567999999
Q ss_pred eccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc
Q 001940 886 FMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~ 964 (993)
|+.+++|.+++.+.. ..+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~----~~~~~~l~dfg~~~~~~~~~ 149 (277)
T cd05577 74 LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLD----DHGNVRISDLGLAVELKGGK 149 (277)
T ss_pred cCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEccCcchhhhccCC
Confidence 999999999987654 3588999999999999999999999999999999999998 56789999999987654433
Q ss_pred ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 ~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......++..|+|||++.+.. .+.+.||
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~-~~~~~Di 177 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEV-YDFSVDW 177 (277)
T ss_pred ccccccCCCCcCCHHHhcCCC-CCchhhh
Confidence 334456888999999998766 4555664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=214.75 Aligned_cols=178 Identities=35% Similarity=0.602 Sum_probs=144.5
Q ss_pred ceEEEEecccCceEEEEEEEcC------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 802 LEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kg------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+++.+.||.|+||.||++++.. ..||+|+++.... ....+.+..|+.+++.++|+||+++++++.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-------EQQIEEFLREARIMRKLDHPNIVKLLGVCTE- 72 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-------hHHHHHHHHHHHHHHhcCCCchheEEEEEcC-
Confidence 3567889999999999998864 6799999865421 1134578899999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCc-cCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~-Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+..+++|||+.+++|.+++...... +++..+..++.||+.||.|||+.+++|+||||+||+++ ..+.+||+||
T Consensus 73 -~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~----~~~~~~l~df 147 (258)
T smart00219 73 -EEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG----ENLVVKISDF 147 (258)
T ss_pred -CCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc----cCCeEEEccc
Confidence 46799999999999999999765444 89999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccccccC--CCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSG--GVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~--s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++......... ...+++.|+|||.+.+. ....+.||
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di 187 (258)
T smart00219 148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG-KFTSKSDV 187 (258)
T ss_pred CCceecccccccccccCCCcccccChHHhccC-CCCcchhH
Confidence 9998654332111 23377899999998543 34445554
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=222.98 Aligned_cols=182 Identities=31% Similarity=0.525 Sum_probs=145.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
..++|++.+.||+|+||.||+|++. +..||||++.... .......+.+|+.+++++.|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 4567999999999999999999863 4668999886432 1122356888999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------------CccCHHHHHHHHHHHHHHHHHHHhCCcee
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------------k~Lse~~~lkIalQIL~GLeYLHs~gIIH 929 (993)
++.+ ...+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+++|
T Consensus 76 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H 153 (288)
T cd05050 76 VCAV--GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVH 153 (288)
T ss_pred EEcC--CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 9887 467899999999999999997432 23677888999999999999999999999
Q ss_pred cCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 930 RDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||||+|||++ .++.+||+|||++....... .......+..|+|||++.+.. .+.++||
T Consensus 154 ~dl~p~nil~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 215 (288)
T cd05050 154 RDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDV 215 (288)
T ss_pred ccccHhheEec----CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHH
Confidence 99999999998 66789999999987543221 112233567899999987765 3445554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=216.73 Aligned_cols=180 Identities=31% Similarity=0.443 Sum_probs=143.1
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.+.....||+|+||.||+|++. +..||+|.+.... ....+.+.+|+.++++++|+||+++++++.. .+
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 78 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--------SRYVQPLHEEIALHSYLKHRNIVQYLGSDSE--NG 78 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--------HHHHHHHHHHHHHHHhcCCCCeeeeeeeecc--CC
Confidence 3344468999999999999874 5669999876432 1123578899999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCcc--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~L--se~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+++||||+.+++|.+++......+ ++..+..++.||+.||.|||+.+|+||||||+||+++. ..+.+||+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~---~~~~~~l~dfg~ 155 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT---YSGVVKISDFGT 155 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC---CCCeEEEecchh
Confidence 8999999999999999998654444 78888899999999999999999999999999999973 246899999999
Q ss_pred ccccccc-cccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~-~~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
+...... .......|+..|+|||++.+.. ....+.||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv 194 (268)
T cd06624 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194 (268)
T ss_pred heecccCCCccccCCCCccccChhhhccccccCCchhhh
Confidence 8754322 1223346899999999986543 34455564
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=218.63 Aligned_cols=181 Identities=30% Similarity=0.452 Sum_probs=148.7
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|++.+.||+|+||.||+|.+. ++.+|+|++..... .......+.+|+.++++++|+||+++++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE------KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc------cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999885 57899999986531 1112246778999999999999999999998743378
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++||||+. ++|.+++......+++..++.++.||+.||+|||+.+++|+||||+|||++ .++.+||+|||++..
T Consensus 75 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~----~~~~~~l~d~g~~~~ 149 (287)
T cd07840 75 IYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN----NDGVLKLADFGLARP 149 (287)
T ss_pred EEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc----CCCCEEEccccceee
Confidence 999999996 589999877655689999999999999999999999999999999999998 667899999999986
Q ss_pred ccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......++..|+|||.+.+....+.+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 185 (287)
T cd07840 150 YTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDM 185 (287)
T ss_pred ccCCCcccccccccccccCCceeeEccccCChHHHH
Confidence 64432 12334578899999988776555666664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=224.15 Aligned_cols=180 Identities=29% Similarity=0.467 Sum_probs=148.8
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||+||++.+. ++.||+|++.... .....+.+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 74 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLN- 74 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEec-
Confidence 4467889999999999999999885 7789999886431 12234578899999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++...+ .+++..+..++.+++.||.|||+ .+++||||||+||+++ .++.++|+||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~----~~~~~~l~d~ 148 (284)
T cd06620 75 -ENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN----SRGQIKLCDF 148 (284)
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC----CCCcEEEccC
Confidence 478999999999999999987653 48899999999999999999997 5999999999999998 5678999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++...... ......||..|+|||++.+. ..+.+.||
T Consensus 149 gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di 185 (284)
T cd06620 149 GVSGELINS-IADTFVGTSTYMSPERIQGG-KYTVKSDV 185 (284)
T ss_pred Ccccchhhh-ccCccccCcccCCHHHHccC-CCCccchH
Confidence 998754322 22345789999999998765 34445664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-24 Score=226.35 Aligned_cols=182 Identities=30% Similarity=0.549 Sum_probs=144.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.+...+|+.++.||+|+||.||+|.+. +. .||+|++..... ......+.+|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~h~niv~~~ 75 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-------PKANVEFMDEALIMASMDHPHLVRLL 75 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCcccEE
Confidence 355678999999999999999999873 33 368887764311 12223578899999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.. ...++|+||+.+|+|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 76 ~~~~~---~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~----~~~~~ 148 (303)
T cd05110 76 GVCLS---PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK----SPNHV 148 (303)
T ss_pred EEEcC---CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec----CCCce
Confidence 99875 346799999999999999987666688999999999999999999999999999999999997 55689
Q ss_pred EEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+|||+++....... .....++..|+|||++.+..+ +.++|
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~D 193 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF-THQSD 193 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCCC-ChHHH
Confidence 9999999986543221 122345778999999876543 34444
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=216.80 Aligned_cols=173 Identities=25% Similarity=0.373 Sum_probs=144.3
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||.|+||.||+++.+ ++.||+|++....... ....+.+.+|+.+++.++|+||+++++.+.+ ...+++|||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-----TGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLME 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-----hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEe
Confidence 699999999999996 7889999997643221 1223578899999999999999999999887 567999999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccc
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~ 965 (993)
|+++++|.+++.+.. .+++..+..++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||+++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~----~~~~~~l~df~~~~~~~~~~~ 148 (262)
T cd05572 74 YCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD----SNGYVKLVDFGFAKKLKSGQK 148 (262)
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc----CCCCEEEeeCCcccccCcccc
Confidence 999999999997653 488999999999999999999999999999999999998 567899999999987654433
Q ss_pred cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 966 SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 966 s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.....|+..|+|||++.+..+ ..+.||
T Consensus 149 ~~~~~~~~~~~~PE~~~~~~~-~~~~Di 175 (262)
T cd05572 149 TWTFCGTPEYVAPEIILNKGY-DFSVDY 175 (262)
T ss_pred cccccCCcCccChhHhcCCCC-CChhhh
Confidence 344578999999999876543 455564
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=218.32 Aligned_cols=183 Identities=30% Similarity=0.451 Sum_probs=147.2
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d 874 (993)
..++|++.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +|+||+++++++..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---------DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---------cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 357899999999999999999988 46789999886421 1123566888899988 79999999999875
Q ss_pred CC---CCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 875 GP---DGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 875 ~s---~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
.. .+.+++||||+.+++|.++++. ....+++..++.++.|++.||+|||+.+|+||||||+||+++ .++.
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~----~~~~ 166 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT----TEGG 166 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCC
Confidence 32 2468999999999999998864 334588999999999999999999999999999999999998 5668
Q ss_pred EEEEecCCcccccccc-ccCCCCCCCCccccccccCCcc----CCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSH----MVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y----~tse~DI 993 (993)
+||+|||++....... ......|+..|+|||++.+... .+.+.||
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di 216 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDV 216 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccch
Confidence 9999999988654322 2234568999999999865432 3566665
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-23 Score=220.27 Aligned_cols=182 Identities=28% Similarity=0.414 Sum_probs=145.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+++ ++.||||++...... ....+.+.+|+.++++++|+||+++++++.+ .
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 73 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED------EGVPSTAIREISLLKEMQHGNIVRLQDVVHS--E 73 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc------ccchHHHHHHHHHHHhccCCCEeeEEEEEec--C
Confidence 57999999999999999999874 678999988654221 1122457789999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||+++. .++.+||+|||+
T Consensus 74 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~---~~~~~kl~dfg~ 149 (294)
T PLN00009 74 KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR---RTNALKLADFGL 149 (294)
T ss_pred CeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC---CCCEEEEccccc
Confidence 68999999995 58888775543 33678888899999999999999999999999999999973 235799999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......+++.|+|||++.+......++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv 187 (294)
T PLN00009 150 ARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDI 187 (294)
T ss_pred ccccCCCccccccCceeecccCHHHHhCCCCCCcHHHH
Confidence 97543221 22334678999999999876666666664
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=218.78 Aligned_cols=181 Identities=28% Similarity=0.456 Sum_probs=145.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
.++|++++.||+|+||.||+|+.+ ...||+|.+.... .....+.+.+|+.++++++|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 76 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-------DENLQSEFRRELDMFRKLSHKNVVRLLGL 76 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-------chHHHHHHHHHHHHHHhcCCcceeeeEEE
Confidence 467899999999999999999873 3458888775421 12234578899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhcc--------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKD--------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~--------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d 943 (993)
+.+ .+..++||||+++++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 77 ~~~--~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~--- 151 (275)
T cd05046 77 CRE--AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS--- 151 (275)
T ss_pred ECC--CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---
Confidence 877 567899999999999999997543 1478999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 944 PQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++...... ......++..|+|||.+.+... ..+.||
T Consensus 152 -~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di 201 (275)
T cd05046 152 -SQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDV 201 (275)
T ss_pred -CCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCC-CchhhH
Confidence 56789999999987543221 1223456778999999876653 344554
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=217.84 Aligned_cols=178 Identities=31% Similarity=0.577 Sum_probs=142.9
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..++|++.+.||+|+||.||+|.+.+ ..+|+|++..... ..+.+.+|+.++++++|+||+++++++..
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 72 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---------MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-- 72 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---------cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 34578999999999999999998854 4689998764321 12367789999999999999999998754
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
+..++||||+.+++|.+++... ...+++..+..++.||+.||.|||+.+|+|+||||+|||++ .++.+||+|||
T Consensus 73 -~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~----~~~~~~l~dfg 147 (260)
T cd05069 73 -EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG----DNLVCKIADFG 147 (260)
T ss_pred -CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc----CCCeEEECCCc
Confidence 4578999999999999999764 34478899999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc--ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++...... ......++..|+|||.+.+.. .+.+.|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~D 185 (260)
T cd05069 148 LARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSD 185 (260)
T ss_pred cceEccCCcccccCCCccchhhCCHHHhccCC-cChHHH
Confidence 997653322 112334677899999887554 333444
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=219.65 Aligned_cols=178 Identities=27% Similarity=0.420 Sum_probs=149.4
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||.|+||.||+|++ .++.||+|++..... ......+.+|+.+++.++|+||+++++++.+ .
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 71 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-------EDEIEDIQQEIQFLSQCRSPYITKYYGSFLK--G 71 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-------chHHHHHHHHHHHHHHcCCCCeeeeeEEEEE--C
Confidence 3688889999999999999988 467899999875321 1123467789999999999999999999987 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++|+||+.+++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++
T Consensus 72 ~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~g~~ 145 (274)
T cd06609 72 SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS----EEGDVKLADFGVS 145 (274)
T ss_pred CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC----CCCCEEEcccccc
Confidence 7899999999999999999765 588999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......|+..|+|||++.+.. .+.+.||
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv 181 (274)
T cd06609 146 GQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADI 181 (274)
T ss_pred eeecccccccccccCCccccChhhhccCC-CCchhhH
Confidence 876543 2233456889999999998766 5555664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=221.87 Aligned_cols=184 Identities=27% Similarity=0.417 Sum_probs=147.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|.++ ++.||||+++...... .....+.+|+.+++.++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE------GFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc------CchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 467899999999999999999984 6789999987542211 11235678999999999999999999987642
Q ss_pred --------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 877 --------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 877 --------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
.+.+++||||+.+ +|..++......+++..++.|+.||+.||.|||+.+|+|+||||+||+++ .++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~----~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLN----NKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCc
Confidence 2479999999965 77777776555689999999999999999999999999999999999998 6678
Q ss_pred EEEEecCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+||+|||++....... ......++..|+|||++.+....+.+.||
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 155 IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred EEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHH
Confidence 9999999988654322 11233467889999998766555666665
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=209.68 Aligned_cols=181 Identities=33% Similarity=0.523 Sum_probs=152.3
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|++|.||+|... ++.|++|++...... ....+.+.+|+.++++++|+||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 4788899999999999999985 778999998765321 23346788999999999999999999999874337
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++.+.. .+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.+||+|||.+.
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 149 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD----SDGVVKLADFGCAK 149 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc----CCCCEEEcccccEE
Confidence 8999999999999999998765 689999999999999999999999999999999999998 56789999999988
Q ss_pred ccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... .....++..|+|||.+.+.. ...+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv 186 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADI 186 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCC-CCchhhH
Confidence 7655432 34456899999999987664 4555554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=219.81 Aligned_cols=179 Identities=33% Similarity=0.506 Sum_probs=149.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||.|+||.||++.++ ++.+|+|++..... ....+.+.+|+.++++++|+||+++++.+.. .
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~ 71 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-------EAIQKQILRELDILHKCNSPYIVGFYGAFYN--N 71 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-------hHHHHHHHHHHHHHHHCCCCchhhhheeeec--C
Confidence 35778889999999999999885 67799998875421 1233567889999999999999999999988 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+.+++||||+.+++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++ .++.+||+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~----~~~~~~l~d~g~ 147 (265)
T cd06605 72 GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN----SRGQIKLCDFGV 147 (265)
T ss_pred CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC----CCCCEEEeeccc
Confidence 78999999999999999998765668899999999999999999999 9999999999999998 567899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+......... ...|+..|+|||.+.+.. ...+.||
T Consensus 148 ~~~~~~~~~~-~~~~~~~y~~PE~~~~~~-~~~~~Dv 182 (265)
T cd06605 148 SGQLVNSLAK-TFVGTSSYMAPERIQGND-YSVKSDI 182 (265)
T ss_pred chhhHHHHhh-cccCChhccCHHHHcCCC-CCchhhH
Confidence 8765433222 267899999999998763 3445554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=219.19 Aligned_cols=173 Identities=34% Similarity=0.513 Sum_probs=135.9
Q ss_pred EecccCceEEEEEEEcC--c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEE
Q 001940 807 ELGSGTYGSVYHGKWRG--S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~kg--t--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~ 881 (993)
.||+|+||.||+|++.+ . .+|+|.++... .....+.+.+|+.++.++ +||||+++++++.. .+.++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~ 72 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLY 72 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-------CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCce
Confidence 58999999999998843 2 36888776321 112234678899999999 79999999999987 56789
Q ss_pred EEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 882 TVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
+||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+++||||||+|||++ .+
T Consensus 73 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~----~~ 148 (270)
T cd05047 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----EN 148 (270)
T ss_pred EEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEc----CC
Confidence 9999999999999997532 2478889999999999999999999999999999999998 66
Q ss_pred CeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+||+|||+++.............+..|+|||++.+.. .+.+.||
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di 194 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDV 194 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccCC-CCchhhH
Confidence 799999999986433221112223466799999987654 4455664
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=221.70 Aligned_cols=184 Identities=28% Similarity=0.433 Sum_probs=147.0
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.++||+|+||.||+|.++ ++.+|||++........ ....+.+|+.++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG------FPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC------cchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 478999999999999999999884 67899999875432111 1124568999999999999999999876532
Q ss_pred ------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 877 ------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
...+++||||+. ++|...+......+++..++.++.||+.||.|||+.+|+|+||||+|||++ .++.+|
T Consensus 81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~----~~~~~~ 155 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILID----NQGILK 155 (311)
T ss_pred ccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEE
Confidence 235799999995 578777766555699999999999999999999999999999999999998 667899
Q ss_pred EEecCCccccccccc------------cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLV------------SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~------------s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++....... .....||+.|+|||++.+......+.||
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 210 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI 210 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHh
Confidence 999999875432211 1234578899999998876666667775
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=208.46 Aligned_cols=178 Identities=32% Similarity=0.540 Sum_probs=151.0
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|+..+.||+|++|.||++.++ +..+++|++..... ...+.+.+|+.+++.++|+||+++++.+.. ..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLK--KD 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CC
Confidence 5888999999999999999985 77899999875421 233578899999999999999999999887 46
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
..++++||+.+++|.+++......+++..+..++.|++.||.+||+.+++|+||+|+||+++ .++.+||+|||++.
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~----~~~~~~l~d~~~~~ 146 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT----SDGEVKLIDFGLSA 146 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc----cCCeEEEeeccccc
Confidence 78999999999999999987656689999999999999999999999999999999999998 56789999999988
Q ss_pred ccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
............|+..|+|||++.+.. .+.+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv 180 (253)
T cd05122 147 QLSDTKARNTMVGTPYWMAPEVINGKP-YDYKADI 180 (253)
T ss_pred cccccccccceecCCcccCHHHHcCCC-CCccccH
Confidence 765443234567899999999997654 4455554
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=218.69 Aligned_cols=164 Identities=25% Similarity=0.402 Sum_probs=129.9
Q ss_pred EecccCceEEEEEEEc-Ccc---eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGTYGSVYHGKWR-GSD---VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k-gt~---VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
.||+|+||.||+++.. +.. +++|.+..... ....+.+.+|+.+++.++||||+++++.+.+ ...+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~l 72 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-------SKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLL 72 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-------hHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEE
Confidence 5999999999999763 333 45555543211 1224578899999999999999999999987 467899
Q ss_pred EEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 883 VTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
||||+.+++|.+++.+.. ...+...++.++.||+.||.|||+.+++||||||+|||++ .++.+||+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~----~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLT----SDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEc----CCccEEecccccccc
Confidence 999999999999997642 3356667788999999999999999999999999999998 567899999999864
Q ss_pred cccc---cccCCCCCCCCccccccccC
Q 001940 960 KQQT---LVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 960 ~~~~---~~s~s~~GTp~YmAPEVL~G 983 (993)
.... .......|+..|+|||++.+
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhccc
Confidence 3211 12234568899999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=221.72 Aligned_cols=180 Identities=26% Similarity=0.427 Sum_probs=152.5
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|..+++||+|+||+||+|+.+ ++.||+|.++....... .-....+|+.+|+.|+|.|||+++++... +.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg------vpssalreicllkelkhknivrl~dvlhs--dk 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG------VPSSALREICLLKELKHKNIVRLHDVLHS--DK 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC------CcHHHHHHHHHHHHhhhcceeehhhhhcc--Cc
Confidence 4667789999999999999874 67799999986532211 11246789999999999999999999876 67
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+-+|+||| ..+|..+...-+..++.+.+..++.|+++||.|+|+.+++||||||.|+||+ .+|.+||+|||+++
T Consensus 75 kltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin----~ngelkladfglar 149 (292)
T KOG0662|consen 75 KLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLIN----RNGELKLADFGLAR 149 (292)
T ss_pred eeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEec----cCCcEEecccchhh
Confidence 899999999 6799999988777899999999999999999999999999999999999998 77899999999998
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
-..-.. -....+-|++|++|.++.|.+-+++..|+
T Consensus 150 afgipvrcysaevvtlwyrppdvlfgakly~tsidm 185 (292)
T KOG0662|consen 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_pred hcCCceEeeeceeeeeeccCcceeeeeehhccchHh
Confidence 655443 22334579999999999999999888774
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=219.77 Aligned_cols=177 Identities=24% Similarity=0.313 Sum_probs=137.7
Q ss_pred EecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEE
Q 001940 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVm 884 (993)
.||+|+||.||+|+. .++.||||++........... ...........+++...|++|+++++++.. .+.+++||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~ 76 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE--TLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFIL 76 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhH--HHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEE
Confidence 389999999999987 467899999876533221111 111111223344555689999999999887 56799999
Q ss_pred eeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc
Q 001940 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (993)
Q Consensus 885 EYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~ 964 (993)
||+.+++|.+++.... .+++..++.|+.|++.||.|||+.+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 77 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~----~~~~~kl~dfg~~~~~~~~- 150 (278)
T cd05606 77 DLMNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKK- 150 (278)
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC----CCCCEEEccCcCccccCcc-
Confidence 9999999999887653 589999999999999999999999999999999999998 5678999999998754332
Q ss_pred ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 ~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......||..|+|||++.+....+.++||
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 179 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADW 179 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccch
Confidence 22345799999999999865555677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=227.57 Aligned_cols=183 Identities=26% Similarity=0.465 Sum_probs=144.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIV 866 (993)
+...+|++.+.||+|+||.||+|++. ...||+|+++... .....+.+.+|+.+++++ +|+||+
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-------TDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 44567999999999999999999752 1258999876431 112245788999999999 799999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
++++++.. .+.+++||||+.+++|.++|.... ..+++..++.++.||+.||.|||+++|+|||
T Consensus 82 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 82 NLLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred eeeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 99999987 567999999999999999997532 2467888899999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 932 IKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|||++ .++.+||+|||+++....... .....++..|||||++.+..+ +.++||
T Consensus 160 lkp~Nill~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 219 (334)
T cd05100 160 LAARNVLVT----EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDV 219 (334)
T ss_pred cccceEEEc----CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-Cchhhh
Confidence 999999998 567899999999986543211 112234567999999976644 445664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=220.29 Aligned_cols=174 Identities=24% Similarity=0.344 Sum_probs=136.3
Q ss_pred EecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHH---HHhhcCCCCcceEEEEEEcCCCCcEE
Q 001940 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL---LLSSLHHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~---ILr~LrHPNIVrL~G~f~d~s~~~L~ 881 (993)
.||+|+||.||++... ++.+|||++........... ..+.+|.. ++...+|+||+.+++++.. .+.++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 73 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-----TLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLC 73 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHH-----HHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEE
Confidence 3899999999999874 67899999876533221111 12233433 3444579999999999887 46799
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+||||+.+++|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++....
T Consensus 74 lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~----~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 74 FILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFS 148 (279)
T ss_pred EEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEEC----CCCCEEEccCCcceecc
Confidence 9999999999999987654 489999999999999999999999999999999999998 56789999999987543
Q ss_pred cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... .....||..|+|||++.+......++||
T Consensus 149 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di 179 (279)
T cd05633 149 KKK-PHASVGTHGYMAPEVLQKGTAYDSSADW 179 (279)
T ss_pred ccC-ccCcCCCcCccCHHHhcCCCCCCchhhh
Confidence 322 2234689999999998754455566675
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=214.50 Aligned_cols=180 Identities=29% Similarity=0.530 Sum_probs=145.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|++.++||+|+||.||++.+. +..+|+|++.... ...+.+.+|+.++++++|+||+++++.+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---------hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 45678999999999999999999874 5669999876431 113468889999999999999999999876
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.+||+||
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~ 146 (260)
T cd05073 73 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIADF 146 (260)
T ss_pred --CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc----CCCcEEECCC
Confidence 5689999999999999999763 34578888999999999999999999999999999999998 6679999999
Q ss_pred CCccccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++........ .....++..|+|||++.+.. .+.+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di 186 (260)
T cd05073 147 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDV 186 (260)
T ss_pred cceeeccCCCcccccCCcccccccCHhHhccCC-cCccccc
Confidence 99876533211 12234567899999997653 4445564
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=214.30 Aligned_cols=182 Identities=28% Similarity=0.444 Sum_probs=147.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
.++|++.+.||+|+||.||+|..+ ++.+++|++..... ..+.+.+|+.+++++ .|+||+++++++.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---------EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---------hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 478999999999999999999984 56799998875321 124688999999999 699999999999763
Q ss_pred C----CCcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 876 P----DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 876 s----~~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
. ...+++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~----~~~~ 151 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT----KNAE 151 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc----cCCe
Confidence 2 34589999999999999998753 35688999999999999999999999999999999999998 5678
Q ss_pred EEEEecCCcccccccc-ccCCCCCCCCccccccccCCc----cCCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKS----HMVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~----y~tse~DI 993 (993)
+||+|||++....... ......|+..|+|||++.+.. ....+.||
T Consensus 152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999999987543322 223456899999999986543 33445564
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-23 Score=218.36 Aligned_cols=181 Identities=29% Similarity=0.442 Sum_probs=147.8
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+..+.||.|++|.||++.. .++.+|+|++..... ......+.+|+.++++++|+||++++++|.+...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-------PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-------hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 4689999999999999999988 467799998875421 1223568899999999999999999999987656
Q ss_pred CcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+.+++||||+++++|.+++.. ....+++..+..|+.||+.||.|||+.+++|+||+|+||+++ ..+.+||+||
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~----~~~~~~l~df 149 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT----RKGQVKLCDF 149 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe----cCCeEEEeec
Confidence 789999999999999988753 334578889999999999999999999999999999999998 5568999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|++....... .....++..|+|||.+.+..+ +.+.||
T Consensus 150 g~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~-~~~~Dv 186 (287)
T cd06621 150 GVSGELVNSL-AGTFTGTSFYMAPERIQGKPY-SITSDV 186 (287)
T ss_pred cccccccccc-cccccCCccccCHHHhcCCCC-CchhhH
Confidence 9987554322 123467889999999876644 334553
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=215.36 Aligned_cols=173 Identities=32% Similarity=0.539 Sum_probs=141.6
Q ss_pred EEecccCceEEEEEEEcC---c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 806 RELGSGTYGSVYHGKWRG---S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kg---t--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+.||+|+||.||+|.+.. + .||||++...... ...+.+.+|+.++++++|+||+++++++.+ ..+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-------DIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPL 70 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-------HHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeE
Confidence 368999999999998732 2 5899988764321 345678899999999999999999999886 678
Q ss_pred EEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
++||||+.+++|.+++.+.. ..+++..+..++.|++.||.|||+++++|+||||+|||++ .++.+||+|||+++.
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~----~~~~~kl~dfg~~~~ 146 (257)
T cd05040 71 MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA----SDDKVKIGDFGLMRA 146 (257)
T ss_pred EEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe----cCCEEEecccccccc
Confidence 99999999999999997754 4688999999999999999999999999999999999998 567999999999986
Q ss_pred ccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......++..|+|||++.+..+ +.+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Di 183 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTF-SHASDV 183 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhcccCc-Cchhhh
Confidence 54321 1123457789999999876543 444554
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=218.92 Aligned_cols=178 Identities=28% Similarity=0.486 Sum_probs=147.3
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---CCCcceEEEEEEcC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDG 875 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---HPNIVrL~G~f~d~ 875 (993)
.|++++.||+|+||.||+|.+ .++.||||+++.... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~- 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-------DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK- 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-------chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-
Confidence 477788999999999999987 467899998875321 112346778999999987 9999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....++||||+.+++|.++++.. .+++..++.++.||+.||.|||+.+|+|+||+|+||+++ ..+.++|+|||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~----~~~~~~l~dfg 146 (277)
T cd06917 74 -GPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT----NTGNVKLCDFG 146 (277)
T ss_pred -CCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc----CCCCEEEccCC
Confidence 56799999999999999998654 588999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++....... ......|+..|+|||.+.+....+.++||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 185 (277)
T cd06917 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185 (277)
T ss_pred ceeecCCCccccccccCCcceeCHHHhccCCccccchhH
Confidence 987654332 22345689999999999776556666664
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=222.28 Aligned_cols=178 Identities=22% Similarity=0.410 Sum_probs=147.4
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++.+.||+|+||.||+|.. .+..||+|.+...... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--------~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-- 88 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV-- 88 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEEe--
Confidence 35899999999999999999987 4678999988754221 12467789999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...+++||||+.+++|.+++.+. .+++.+++.++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~----~~~~~kl~dfg~ 162 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCCCEEECcccc
Confidence 56899999999999999998653 378889999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......|++.|+|||.+.+..+ +.++||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 199 (296)
T cd06654 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDI 199 (296)
T ss_pred chhccccccccCcccCCccccCHHHHcCCCC-CccchH
Confidence 87643322 2233568999999999986543 455664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=219.24 Aligned_cols=180 Identities=28% Similarity=0.433 Sum_probs=146.3
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++++.||+|+||.||+|+. +++.||||+++...... .....+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~ 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNIVKLLDVIHT--EN 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc------ccchHHHHHHHHHHhcCCCCCcchhhhccc--CC
Confidence 488999999999999999988 47789999887543211 112467789999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++||||+. ++|..++... ...+++..++.++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||++
T Consensus 73 ~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~----~~~~~~l~dfg~~ 147 (284)
T cd07860 73 KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 147 (284)
T ss_pred cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEeeccch
Confidence 8999999995 6898888653 34588999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......++..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 184 (284)
T cd07860 148 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 184 (284)
T ss_pred hhcccCccccccccccccccCCeEEecCCCCCcHHHH
Confidence 7553321 12234578899999999876655666664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=227.85 Aligned_cols=181 Identities=23% Similarity=0.370 Sum_probs=145.7
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.++||+|+||.||+|.+ +++.||||+++... .......+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-------HQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 46899999999999999999987 47789999986421 1122346778999999999999999999876532
Q ss_pred ---CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 ---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ---~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
...+++||||+. ++|.+++... .+++..+..++.||+.||.|||+.+|+||||||+|||++ ..+.+||+|
T Consensus 77 ~~~~~~~~lv~e~~~-~~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~----~~~~~kl~d 149 (336)
T cd07849 77 FESFNDVYIVQELME-TDLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICD 149 (336)
T ss_pred ccccceEEEEehhcc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC----CCCCEEECc
Confidence 235899999995 5888887543 488999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++...... ......||..|+|||++.+....+.++||
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 193 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDI 193 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHH
Confidence 99987653321 11235689999999998766556666665
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=247.96 Aligned_cols=174 Identities=33% Similarity=0.489 Sum_probs=148.1
Q ss_pred EecccCceEEEEEEEcCcc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEE
Q 001940 807 ELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~kgt~--VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVm 884 (993)
+||+|+||+||-|++..++ .|||.+.... .+..+-+.+|+.+.+.|+|.|||+++|.+.+ ++.+-|.|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd--------sr~~QPLhEEIaLH~~LrHkNIVrYLGs~se--nGf~kIFM 651 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD--------SREVQPLHEEIALHSTLRHKNIVRYLGSVSE--NGFFKIFM 651 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc--------chhhccHHHHHHHHHHHhhHhHHHHhhccCC--CCeEEEEe
Confidence 6999999999999986555 5999886542 1233567889999999999999999999876 68899999
Q ss_pred eeccCCcHHHHHHhccCcc--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 885 EFMVNGSLKQFLQKKDRTI--DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 885 EYm~GGSL~dlL~~~~k~L--se~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
|-++||+|.++|+.+...+ .+.++-++.+||++||+|||++.|||||||-+|+||+.- .|.+||+|||-++....
T Consensus 652 EqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy---SGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 652 EQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY---SGVLKISDFGTSKRLAG 728 (1226)
T ss_pred ecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec---cceEEecccccchhhcc
Confidence 9999999999999887777 788889999999999999999999999999999999843 48999999999987643
Q ss_pred c-cccCCCCCCCCcccccccc-CCccCCCCCCC
Q 001940 963 T-LVSGGVRGTLPWMAPELLS-GKSHMVTEKEL 993 (993)
Q Consensus 963 ~-~~s~s~~GTp~YmAPEVL~-Gk~y~tse~DI 993 (993)
- ..+..+.||+.|||||+|- |..-+...+||
T Consensus 729 inP~TETFTGTLQYMAPEvIDqG~RGYG~aADI 761 (1226)
T KOG4279|consen 729 INPCTETFTGTLQYMAPEVIDQGPRGYGKAADI 761 (1226)
T ss_pred CCccccccccchhhhChHhhccCCcCCCchhhh
Confidence 2 3445788999999999995 66667777776
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=212.84 Aligned_cols=180 Identities=22% Similarity=0.434 Sum_probs=148.0
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||+++. .++.||||++...... ....+.+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS------PKEREESRKEVAVLSNMKHPNIVQYQESFEE--NG 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC------hHHHHHHHHHHHHHHhCCCCCeeeeEeeecC--CC
Confidence 588999999999999999987 4678999998754221 1123467889999999999999999999887 57
Q ss_pred cEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..++||||+.+++|.+++.... ..+++.+++.++.|++.||.|||+.+++|+||+|+|||++ .++.++|+|||++
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~----~~~~~~l~d~~~~ 148 (256)
T cd08218 73 NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTIKLGDFGIA 148 (256)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEEeeccce
Confidence 8999999999999999987643 3578899999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ......|++.|+|||++.+.. .+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv 184 (256)
T cd08218 149 RVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDI 184 (256)
T ss_pred eecCcchhhhhhccCCccccCHHHhCCCC-CCCccch
Confidence 7654332 122346889999999987664 4455664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=209.34 Aligned_cols=180 Identities=28% Similarity=0.536 Sum_probs=150.0
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||.|+||.||++.+. +..+|+|++...... ....+.+.+|+.+++.++|+|++++++.+.. .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~--~~ 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS------EKEREDALNEVKILKKLNHPNIIKYYESFEE--KG 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC------hHHHHHHHHHHHHHHhcCCCChhheEEEEec--CC
Confidence 5889999999999999999985 788999998754321 1233467889999999999999999999887 47
Q ss_pred cEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..++||||+++++|.+++.+. ...+++..+..++.+|+.||.|||+.+++|+||+|+||+++ .++.+||+|||
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~----~~~~~~l~d~~ 148 (258)
T cd08215 73 KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFG 148 (258)
T ss_pred EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc----CCCcEEECCcc
Confidence 899999999999999999875 36689999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++....... ......|++.|+|||.+.+.. .+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv 186 (258)
T cd08215 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDI 186 (258)
T ss_pred ceeecccCcceecceeeeecccChhHhccCC-CCccccH
Confidence 988654432 233456899999999987665 3445554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.3e-24 Score=244.24 Aligned_cols=187 Identities=21% Similarity=0.334 Sum_probs=137.4
Q ss_pred CCCceEEEEecccCceEEEEEEEcC---cceEEEEeeccc---------cCCCchhHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRG---SDVAIKRIKASC---------FAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kg---t~VAVKvIkk~~---------~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
.++|+++++||+|+||+||++..+. ..+++|.+.... ..............+.+|+.+|++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 3679999999999999999987642 122222111000 0000001122345688999999999999999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc----CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~ 942 (993)
++++++.. .+..|+|||++ +++|.+++.... .......++.|+.||+.||+|||+++||||||||+|||++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~-- 301 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN-- 301 (501)
T ss_pred cEeEEEEE--CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--
Confidence 99999988 56789999998 567777765422 1233556778999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 943 DPQRPVCKIGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++...... ......||..|+|||++.+..+ ..++||
T Consensus 302 --~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 351 (501)
T PHA03210 302 --CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDI 351 (501)
T ss_pred --CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHH
Confidence 56789999999998664332 2234679999999999987754 445554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=211.85 Aligned_cols=179 Identities=34% Similarity=0.534 Sum_probs=150.1
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|++|.||+|+.. ++.||||++...... .....+.+|+.++.+++|+||+++++++.. .
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 71 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-------EFRKQLLRELKTLRSCESPYVVKCYGAFYK--E 71 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--C
Confidence 36889999999999999999884 778999998754211 223578899999999999999999999987 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+.+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+ .+++|+||+|+||+++ .++.++|+|||+
T Consensus 72 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~----~~~~~~l~df~~ 146 (264)
T cd06623 72 GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN----SKGEVKIADFGI 146 (264)
T ss_pred CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC----CCCCEEEccCcc
Confidence 7899999999999999999765 458999999999999999999999 9999999999999998 567899999999
Q ss_pred cccccccccc-CCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVS-GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s-~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+......... ....++..|+|||.+.+. ..+.+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv 183 (264)
T cd06623 147 SKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADI 183 (264)
T ss_pred ceecccCCCcccceeecccccCHhhhCCC-CCCchhhH
Confidence 8865433222 245688999999998766 44455664
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=245.64 Aligned_cols=182 Identities=28% Similarity=0.436 Sum_probs=152.8
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
..+-|+++++||.|.+|.||+++. .++.+|||++...... .+++..|..+|+.+. |||++.+||+|.-
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---------deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---------EEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---------cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 456799999999999999999876 5788999988754211 124556788888774 9999999999864
Q ss_pred ---CCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 875 ---GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 875 ---~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+..+.+|||||||.+|+..|++++. +..+.|..+.+|+++++.||.+||++.+||||||-.|||++ .++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT----~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT----ENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe----ccCcEE
Confidence 3356899999999999999999864 45689999999999999999999999999999999999998 778999
Q ss_pred EEecCCcccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 951 IGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 951 LiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+|||.+.+.+.+. ..+..+||+.|||||++...+...+..|
T Consensus 164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd 206 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYD 206 (953)
T ss_pred EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcc
Confidence 99999999887654 3456789999999999988776666555
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=247.18 Aligned_cols=172 Identities=23% Similarity=0.366 Sum_probs=145.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|.+. ++.||||+++..... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-- 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-----NKNMVHQVQAERDALALSKSPFIVHLYYSLQS-- 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-----CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE--
Confidence 367999999999999999999986 788999999764322 12334578889999999999999999999887
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...+||||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+||||||||+||||+ .++.+||+|||+
T Consensus 76 ~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~----~~g~vkL~DFGl 150 (669)
T cd05610 76 ANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS----NEGHIKLTDFGL 150 (669)
T ss_pred CCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc----CCCCEEEEeCCC
Confidence 568999999999999999997654 478889999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCcccccccc
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~ 982 (993)
++...... ......+|+.|++||...
T Consensus 151 s~~~~~~~~~~~~~~~t~~~~~pe~~~ 177 (669)
T cd05610 151 SKVTLNRELNMMDILTTPSMAKPKNDY 177 (669)
T ss_pred CccccCCcccccccccCccccCccccc
Confidence 98754332 233567899999999654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=208.36 Aligned_cols=179 Identities=30% Similarity=0.496 Sum_probs=149.8
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|++|.||+++.. +..||+|.+...... +...+.+.+|+.++++++|+||+++++++.+ .+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK------EEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SD 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC------HHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CC
Confidence 4788999999999999999874 678999998765321 2334678899999999999999999999887 47
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
..++||||+.+++|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.+||+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~----~~~~~~l~d~~~~~ 147 (254)
T cd06627 73 SLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT----KDGVVKLADFGVAT 147 (254)
T ss_pred EEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC----CCCCEEEeccccce
Confidence 899999999999999999766 4589999999999999999999999999999999999998 56789999999998
Q ss_pred ccccccc-cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLV-SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~-s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... .....++..|+|||.+.+.. ...+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv 182 (254)
T cd06627 148 KLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDI 182 (254)
T ss_pred ecCCCcccccccccchhhcCHhhhcCCC-CCcchhH
Confidence 6544322 23456889999999987665 4555654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=221.91 Aligned_cols=177 Identities=23% Similarity=0.405 Sum_probs=146.6
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++.+.||+|+||.||++.. .++.||||.+...... ..+.+.+|+.+++.++|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-- 87 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV-- 87 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--------hHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 36799999999999999999987 4788999998753211 12457789999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+++++|.+++.+. .+++..+..++.|++.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~----~~~~~~l~Dfg~ 161 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 161 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEECcCcc
Confidence 56899999999999999998653 478889999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+....... ......|++.|+|||.+.+..+ +.+.|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 197 (297)
T cd06656 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVD 197 (297)
T ss_pred ceEccCCccCcCcccCCccccCHHHHcCCCC-CcHHH
Confidence 87653322 2234568999999999987544 33444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=213.58 Aligned_cols=172 Identities=31% Similarity=0.500 Sum_probs=138.4
Q ss_pred EEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 806 RELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
++||+|+||.||+|++.. ..+|+|.+...... ...+.+.+|+.+++.+.|+||+++++++.. ...
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~ 70 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-------AGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPL 70 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---Cce
Confidence 369999999999998732 56999988754321 233578889999999999999999998764 457
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+++|+||||+|||++ .++.+||+|||+++..
T Consensus 71 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~----~~~~~kl~df~~~~~~ 145 (257)
T cd05060 71 MLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV----NRHQAKISDFGMSRAL 145 (257)
T ss_pred EEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc----CCCcEEecccccccee
Confidence 99999999999999997665 589999999999999999999999999999999999998 5678999999999865
Q ss_pred cccccc----CCCCCCCCccccccccCCccCCCCCCC
Q 001940 961 QQTLVS----GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 961 ~~~~~s----~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ....++..|+|||.+.+.. ...++||
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di 181 (257)
T cd05060 146 GAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDV 181 (257)
T ss_pred ecCCcccccccCccccccccCHHHhcCCC-CCccchH
Confidence 332211 1122456899999997654 4456664
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=216.08 Aligned_cols=186 Identities=26% Similarity=0.453 Sum_probs=148.2
Q ss_pred CceEEEEecccCceEEEEEEEcC---cceEEEEeeccccCCC--chhHHHHHHHHHHHHHHHhh-cCCCCcceEEEEEEc
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRG---SDVAIKRIKASCFAGK--PSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRD 874 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kg---t~VAVKvIkk~~~~~k--~~ere~~ie~f~rEi~ILr~-LrHPNIVrL~G~f~d 874 (993)
.|++.+.||+|+||.||++.+++ +.+|||++........ ...+.....++..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999854 6699998875432211 11233445667788888865 799999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEE
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.+.+++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+|||++ .++.+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~----~~~~~~ 154 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG----EDDKVT 154 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC----CCCcEE
Confidence 5789999999999999998753 34458899999999999999999996 6899999999999998 667899
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||++.............|+..|+|||++.+.. .+.+.||
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv 196 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADV 196 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHH
Confidence 99999998765443344567899999999998654 3445553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.1e-23 Score=219.63 Aligned_cols=177 Identities=24% Similarity=0.426 Sum_probs=147.1
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+|++.+.||.|+||.||+|.. .++.||||.+...... ..+.+.+|+.+++.++|+||+++++++.. .
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 88 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--------KKELIINEILVMKELKNPNIVNFLDSFLV--G 88 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--------hHHHHHHHHHHHHhcCCCceeeeeeeEec--C
Confidence 5699999999999999999986 5788999988653211 12467789999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|..++... .+++.+++.++.|++.||.|||+.+++||||||+||+++ .++.+||+|||++
T Consensus 89 ~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~----~~~~~kl~dfg~~ 162 (296)
T cd06655 89 DELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG----MDGSVKLTDFGFC 162 (296)
T ss_pred ceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEccCccc
Confidence 6799999999999999998654 478999999999999999999999999999999999998 5678999999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ......|+..|+|||.+.+..+ +.++||
T Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 198 (296)
T cd06655 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDI 198 (296)
T ss_pred hhcccccccCCCcCCCccccCcchhcCCCC-CchhhH
Confidence 7653322 2234568999999999876543 445553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=211.39 Aligned_cols=174 Identities=34% Similarity=0.584 Sum_probs=142.0
Q ss_pred EEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEE
Q 001940 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVm 884 (993)
++||+|+||.||++.+. ++.||+|++...... ...+.+.+|+.++++++|+||+++++++.+ ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 71 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-------DLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVM 71 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-------HHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEE
Confidence 36999999999999885 788999988754221 223568899999999999999999999887 56799999
Q ss_pred eeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc
Q 001940 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (993)
Q Consensus 885 EYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~ 964 (993)
||+.+++|.+++......+++..++.++.+++.||.|||+++++||||||+|||++ .++.+||+|||+++......
T Consensus 72 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~----~~~~~~l~d~g~~~~~~~~~ 147 (251)
T cd05041 72 ELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG----ENNVLKISDFGMSREEEGGI 147 (251)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEc----CCCcEEEeeccccccccCCc
Confidence 99999999999977655688999999999999999999999999999999999998 56789999999998654221
Q ss_pred cc---CCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 VS---GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 ~s---~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.. ....++..|+|||++.+.. .+.+.||
T Consensus 148 ~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di 178 (251)
T cd05041 148 YTVSDGLKQIPIKWTAPEALNYGR-YTSESDV 178 (251)
T ss_pred ceeccccCcceeccCChHhhccCC-CCcchhH
Confidence 11 1223466799999987654 4455664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=216.79 Aligned_cols=178 Identities=29% Similarity=0.441 Sum_probs=147.2
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~ 878 (993)
|++.+.||.|+||+||+|+.. ++.||||++....... . .....+|+..+++++ |+||+++++++.+ .+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~----~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW----E---ECMNLREVKSLRKLNEHPNIVKLKEVFRE--ND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch----h---HHHHHHHHHHHHhccCCCCchhHHHHhhc--CC
Confidence 678899999999999999984 6779999887542210 1 123456889999999 9999999999987 57
Q ss_pred cEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..++||||+ +++|.+++.... ..+++..++.++.|++.+|.|||+++++|+||||+||+++ .++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~----~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS----GPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCCEEEeecccc
Confidence 899999999 889999887654 4689999999999999999999999999999999999998 6779999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+............|+..|+|||++.+....+.+.||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 182 (283)
T cd07830 147 REIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDI 182 (283)
T ss_pred eeccCCCCcCCCCCcccccCceeeecCcCcCCccch
Confidence 876544333456689999999998766555666665
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=226.56 Aligned_cols=182 Identities=25% Similarity=0.407 Sum_probs=147.9
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
.++|++.+.||+|+||.||+|.+. ++.+|||++...... ......+.+|+.+++++ +|+||++++++|...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN------ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc------chhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 457888999999999999999874 678999988643211 11124567899999999 999999999998765
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....+++||||+. ++|..++... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~----~~~~~kl~d~g 152 (337)
T cd07852 80 NDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN----SDCRVKLADFG 152 (337)
T ss_pred CCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEEeecc
Confidence 4557899999996 6999988764 578889999999999999999999999999999999998 67799999999
Q ss_pred Ccccccccc------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...... ......||..|+|||++.+......+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi 196 (337)
T cd07852 153 LARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDM 196 (337)
T ss_pred chhccccccccccCcchhcccccccccCceeeeccccccccchH
Confidence 988553321 22345689999999998876666677775
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=218.71 Aligned_cols=179 Identities=26% Similarity=0.459 Sum_probs=146.1
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..|++.+.||+|+||.||+|+. .++.||+|++....... ....+.+.+|+.+++.++|+||++++++|.+ .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~ 87 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-----NEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--E 87 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCc-----HHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--C
Confidence 4588899999999999999987 47789999886432111 1223567899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+..++||||+. |+|.+++......+++..+..++.||+.||.|||+.+|+||||+|+||+++ .++.+||+|||++
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~----~~~~~kL~dfg~~ 162 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT----EPGTVKLADFGSA 162 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC----CCCCEEEeecCcc
Confidence 67899999995 678787766555689999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccccCCCCCCCCccccccccC--CccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSG--KSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~G--k~y~tse~DI 993 (993)
...... ....|+..|+|||++.+ ....+.+.||
T Consensus 163 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv 197 (307)
T cd06607 163 SLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (307)
T ss_pred eecCCC---CCccCCccccCceeeeccCCCCCCcccch
Confidence 765432 23568899999999853 3344556664
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=218.51 Aligned_cols=180 Identities=24% Similarity=0.397 Sum_probs=142.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s 876 (993)
++|+..+.||+|+||.||++++. ++.||||++...... .....+.+|+.++.++. |+||+++++++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-------~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-- 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-- 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-------HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--
Confidence 45666788999999999999884 678999988754211 22356788999999996 9999999999887
Q ss_pred CCcEEEEEeeccCCcHHHHHH---h-ccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEE
Q 001940 877 DGSLATVTEFMVNGSLKQFLQ---K-KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~---~-~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
.+..+++|||+. ++|.++.. . ....+++..+..++.+++.||+|||+. +|+||||||+|||++ .++.+||
T Consensus 75 ~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~~kl 149 (288)
T cd06616 75 EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD----RNGNIKL 149 (288)
T ss_pred CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc----cCCcEEE
Confidence 467899999985 45555432 2 235588999999999999999999975 999999999999998 5678999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCC--ccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK--SHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk--~y~tse~DI 993 (993)
+|||+++............||..|+|||++.+. ...+.++||
T Consensus 150 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di 193 (288)
T cd06616 150 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193 (288)
T ss_pred eecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhh
Confidence 999999765444333445689999999999876 456667775
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=214.85 Aligned_cols=182 Identities=27% Similarity=0.424 Sum_probs=144.9
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
...|++.+.||.|+||.||+|++ .++.+|+|++.... .....+..|+.+++++ +|+||+++++++...
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---------DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---------HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 45788899999999999999988 46779999876431 1124577888899888 699999999998642
Q ss_pred ----CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 876 ----PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 876 ----s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
....+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~----~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT----ENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEE
Confidence 245789999999999999999764 34478888899999999999999999999999999999998 567899
Q ss_pred EEecCCccccccc-cccCCCCCCCCccccccccCC----ccCCCCCCC
Q 001940 951 IGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK----SHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk----~y~tse~DI 993 (993)
|+|||++...... .......|+..|+|||++..+ ...+.+.||
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dv 209 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDI 209 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccch
Confidence 9999998755322 122345689999999998642 233445564
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=241.97 Aligned_cols=182 Identities=20% Similarity=0.316 Sum_probs=148.5
Q ss_pred cccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
..++.+.-|..++.||-|+||+|.++.. +...+|+|.+++..... ...+.....|..||.....+-||+||..
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~-----rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLM-----RNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHh-----hhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 3445666799999999999999999865 34458999988764432 2334577889999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
|++ +++||+||||++||++..+|.+.+- +.+..++.++.++..|+++.|+.|+|||||||+||||| .+|.|||
T Consensus 698 FQD--kdnLYFVMdYIPGGDmMSLLIrmgI-FeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILID----rdGHIKL 770 (1034)
T KOG0608|consen 698 FQD--KDNLYFVMDYIPGGDMMSLLIRMGI-FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID----RDGHIKL 770 (1034)
T ss_pred ecc--CCceEEEEeccCCccHHHHHHHhcc-CHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEc----cCCceee
Confidence 999 6889999999999999999988765 66776666677999999999999999999999999999 7789999
Q ss_pred EecCCcccc---------c------c----------------------------ccccCCCCCCCCccccccccCCccC
Q 001940 952 GDLGLSKVK---------Q------Q----------------------------TLVSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 952 iDFGLAk~~---------~------~----------------------------~~~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
+|||||.-. . + .......+||+.|+|||+|....|.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~ 849 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT 849 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence 999998510 0 0 0011345799999999999877654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=224.92 Aligned_cols=183 Identities=27% Similarity=0.351 Sum_probs=147.7
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++++.||+|+||+||+|+. +++.||||+++..... ......+.+|+.+++.++|+||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~ 77 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN------RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH 77 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc------cchhHHHHHHHHHHHhcCCCCccchHHheeccc
Confidence 35799999999999999999987 4778999998753211 111235668999999999999999999886532
Q ss_pred C---CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 D---GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ~---~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. ..+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+++||||||+|||++ .++.+||+|
T Consensus 78 ~~~~~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----~~~~~kL~D 151 (337)
T cd07858 78 REAFNDVYIVYELM-DTDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICD 151 (337)
T ss_pred ccccCcEEEEEeCC-CCCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----CCCCEEECc
Confidence 1 3589999999 578998887653 589999999999999999999999999999999999998 567899999
Q ss_pred cCCccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++..... .......+|..|+|||++.+......++||
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 192 (337)
T cd07858 152 FGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192 (337)
T ss_pred CccccccCCCcccccccccccCccChHHHhcCCCCCCcccH
Confidence 9999865433 222345688999999998765556677775
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-25 Score=247.88 Aligned_cols=189 Identities=25% Similarity=0.340 Sum_probs=165.8
Q ss_pred HHHhccccccCCCceEEEEecccCceEEEEEEEcCcc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 789 AIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 789 ~ia~~i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~--VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
.+.+....+...+++++..||-|+||.|=+++.+++. +|+|++++..... .+..+.+..|-.+|..++.+.||
T Consensus 409 ~~~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVd-----tkQqeHv~sEr~Im~~~~s~fIv 483 (732)
T KOG0614|consen 409 DFAEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVD-----TKQQEHVFSERNIMMECRSDFIV 483 (732)
T ss_pred HHHhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccc-----hhHHHHHHhHHHHHHhcCchHHH
Confidence 3344555667778899999999999999999887655 7999998765543 23346788899999999999999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
++|..|.+ ..++||+||-|-||.|...|+.++. ++..+...++..+++|++|||++|||+|||||+|+|++ .+
T Consensus 484 rLYrTfrd--~kyvYmLmEaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd----~~ 556 (732)
T KOG0614|consen 484 RLYRTFRD--SKYVYMLMEACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLD----NR 556 (732)
T ss_pred HHHHHhcc--chhhhhhHHhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeec----cC
Confidence 99999998 6889999999999999999988875 77888888888999999999999999999999999999 67
Q ss_pred CeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
|.+||.|||+|+.+.....+..+|||+.|.|||+++++.+..+
T Consensus 557 Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~a 599 (732)
T KOG0614|consen 557 GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRA 599 (732)
T ss_pred CceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchh
Confidence 8999999999999999888899999999999999999988754
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=215.77 Aligned_cols=179 Identities=28% Similarity=0.448 Sum_probs=144.8
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|+++++||.|++|.||+|.+ +++.||||++....... .....+.+|+.+++.++|+||+++++++.+ .+.
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~--~~~ 72 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE------GVPSTAIREISLLKELNHPNIVRLLDVVHS--ENK 72 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc------cchhHHHHHHHHHHhcCCCCccCHhheecc--CCe
Confidence 56789999999999999987 47889999987543211 112356789999999999999999999987 578
Q ss_pred EEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+++||||+|+|||++ .++.+||+|||+++
T Consensus 73 ~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df~~~~ 147 (283)
T cd07835 73 LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID----REGALKLADFGLAR 147 (283)
T ss_pred EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCcEEEeeccccc
Confidence 99999999 578999987654 3589999999999999999999999999999999999998 56789999999997
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......++..|+|||++.+......+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di 183 (283)
T cd07835 148 AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDI 183 (283)
T ss_pred ccCCCccccCccccccCCCCCceeecCcccCcHHHH
Confidence 543221 12233568899999998776555555553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.3e-23 Score=211.39 Aligned_cols=172 Identities=26% Similarity=0.379 Sum_probs=137.8
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~-ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||.||+|.. .++.||||++.+..... . .....+..|.. +...++|+||+++++++.. .+.+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~----~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~l 74 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA----K-NQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYL 74 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH----H-HHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEE
Confidence 5699999999999988 46789999987542211 1 11223344444 4456689999999999987 568999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++.... .+++..+..|+.||+.||.|||+.+++|+||||+|||++ .++.+||+|||+++....
T Consensus 75 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~----~~~~~~l~dfg~~~~~~~ 149 (260)
T cd05611 75 VMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID----QTGHLKLTDFGLSRNGLE 149 (260)
T ss_pred EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCcEEEeecccceeccc
Confidence 999999999999997654 488999999999999999999999999999999999998 567899999999876433
Q ss_pred ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 963 TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 963 ~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.....|+..|+|||.+.+.. .+.+.||
T Consensus 150 ---~~~~~~~~~y~~pe~~~~~~-~~~~~Dv 176 (260)
T cd05611 150 ---NKKFVGTPDYLAPETILGVG-DDKMSDW 176 (260)
T ss_pred ---cccCCCCcCccChhhhcCCC-Ccchhhh
Confidence 23456889999999998776 5566665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.8e-23 Score=215.90 Aligned_cols=176 Identities=26% Similarity=0.419 Sum_probs=145.2
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+.++.||+|+||.||+|.++ +..||||++..... ......+.+|+.+++++.|+||+++++.+.+ ..
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GT 75 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CC
Confidence 4677789999999999999874 67899998875321 1234578899999999999999999999988 57
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~----~~~~~~l~dfg~~~ 149 (277)
T cd06640 76 KLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred EEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc----CCCCEEEcccccce
Confidence 899999999999999998653 478888999999999999999999999999999999998 56789999999997
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
...... ......++..|+|||++.+... +.+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~D 183 (277)
T cd06640 150 QLTDTQIKRNTFVGTPFWMAPEVIQQSAY-DSKAD 183 (277)
T ss_pred eccCCccccccccCcccccCHhHhccCCC-ccHHH
Confidence 654322 2233468889999999876643 34444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=223.87 Aligned_cols=180 Identities=26% Similarity=0.407 Sum_probs=146.0
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||++.. ++..||||++..... .......+.+|+.+|++++|+||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 56799999999999999999987 477899998864311 1222346778999999999999999999987632
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ..+++||||+ +++|.+++... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~----~~~~~kl~ 160 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN----EDCELKIL 160 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEe
Confidence 1 2468999999 88999888643 488999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++...... .....+++.|+|||++.+....+.+.||
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di 199 (343)
T cd07880 161 DFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDI 199 (343)
T ss_pred ecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHH
Confidence 99999865432 2345678999999999765555555553
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=223.58 Aligned_cols=182 Identities=25% Similarity=0.385 Sum_probs=148.0
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC--
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG-- 875 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~-- 875 (993)
++|++.+.||+|+||.||+|.. +++.||+|++...... ....+.+.+|+.+|++++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV------PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc------ccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 6799999999999999999987 4788999998753211 11234667899999999999999999987642
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....+++||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 79 ~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLM-ESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN----EDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehh-hhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCcEEecccc
Confidence 235689999999 468999886554 489999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...... ......|+..|+|||++.+......++||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 195 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDM 195 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccch
Confidence 987653221 11245789999999998776556777775
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=210.19 Aligned_cols=173 Identities=29% Similarity=0.468 Sum_probs=142.9
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||+|+||.||++++. ++.+|+|++...... .....+.+.+|+.++++++|+||+++++.+.. ...+|+|||
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~-----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMI-----RKNQVDQVLTERDILSQAQSPYVVKLYYSFQG--KKNLYLVME 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhh-----hhhHHHHHHHHHHHHHhCCCcchhHHHHheec--CcEEEEEEe
Confidence 689999999999985 788999998754321 22345678899999999999999999998887 567999999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc-
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL- 964 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~- 964 (993)
|+.+++|.+++.+.. .+++..+..++.||+.||.|||+.+++|+||+|+||+++ .++.+||+|||++.......
T Consensus 74 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~----~~~~~~l~dfg~~~~~~~~~~ 148 (265)
T cd05579 74 YLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID----SNGHLKLTDFGLSKVGLVRRQ 148 (265)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc----CCCCEEEEecccchhcccCcc
Confidence 999999999998755 589999999999999999999999999999999999998 56789999999987543221
Q ss_pred --------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 --------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 --------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......++..|+|||++.+.. .+.+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv 184 (265)
T cd05579 149 INLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDW 184 (265)
T ss_pred cccccccccccCcccCccccCHHHhcCCC-CCcchhh
Confidence 223456888999999987665 4445554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.6e-23 Score=214.74 Aligned_cols=182 Identities=23% Similarity=0.363 Sum_probs=145.9
Q ss_pred CceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEc
Q 001940 801 DLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d 874 (993)
+|++.+.||+|+||.||+++. +++.||||++++.... .+....+.+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~----~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIV----QKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHH----hhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 478899999999999999875 3567999998754221 1223345678899999999 59999999999887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...+++||||+.+++|.+++.... .+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~----~~~~~~l~df 149 (288)
T cd05583 77 --DTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD----SEGHVVLTDF 149 (288)
T ss_pred --CCEEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC----CCCCEEEEEC
Confidence 567899999999999999987643 478889999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc--ccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
|+++...... ......|+..|+|||.+.+.. ....+.||
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv 191 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW 191 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhh
Confidence 9987643322 122356899999999987654 23444553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=219.07 Aligned_cols=177 Identities=26% Similarity=0.421 Sum_probs=144.2
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+..+.||+|+||.||+|.+. +..||||++.... .....+.+.+|+.++++++|+||+++++.+.. ..
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GT 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhccccc--CC
Confidence 3556677999999999999873 6679999886431 11234578899999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++... .+++..+..++.||+.||.|||+.+++|+||||+||+++ .++.+||+|||+++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKPG--PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS----EQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe----CCCCEEEccccccc
Confidence 799999999999999998653 478899999999999999999999999999999999998 56789999999987
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......|+..|+|||++.+..+ ..+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 184 (277)
T cd06642 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DFKADI 184 (277)
T ss_pred cccCcchhhhcccCcccccCHHHhCcCCC-chhhhH
Confidence 654322 2223468899999999987653 344553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-23 Score=246.23 Aligned_cols=187 Identities=32% Similarity=0.549 Sum_probs=156.0
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
...++.....++.++||.|.||.||+|+++ ...||||.++... .++...+|+.|+.||.++.||||++
T Consensus 622 FakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-------tekqrrdFL~EAsIMGQFdHPNIIr 694 (996)
T KOG0196|consen 622 FAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIR 694 (996)
T ss_pred hhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-------cHHHHhhhhhhhhhcccCCCCcEEE
Confidence 334556677889999999999999999884 3459999998652 2344568999999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
|-|+... ....+||+|||++|+|+.+|+++...++..++..|++.|+.|++||-+.++|||||..+||||+ .+.
T Consensus 695 LEGVVTk--s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVN----snL 768 (996)
T KOG0196|consen 695 LEGVVTK--SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVN----SNL 768 (996)
T ss_pred EEEEEec--CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeec----cce
Confidence 9999887 4568999999999999999999888899999999999999999999999999999999999998 889
Q ss_pred eEEEEecCCccccccccc-c-CCCCC--CCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQTLV-S-GGVRG--TLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~-s-~s~~G--Tp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+|++|||+++.++++.. . ....| .+.|.|||.|.-. +.++..||
T Consensus 769 vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDV 817 (996)
T KOG0196|consen 769 VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDV 817 (996)
T ss_pred EEEeccccceeecccCCCccccccCCccceeecChhHhhhc-ccCchhhc
Confidence 999999999998865541 1 11112 4689999999754 34455554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-24 Score=237.60 Aligned_cols=170 Identities=32% Similarity=0.462 Sum_probs=140.2
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHh--hcCCCCcceEEEEEEcCC-
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS--SLHHPNVVSFYGIVRDGP- 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr--~LrHPNIVrL~G~f~d~s- 876 (993)
+..+++++||+|.||.||||+++++.||||++.... .+.|..|-.|.+ .|+|+||++++++-...+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~-----------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE-----------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred CchhhHHHhhcCccceeehhhccCceeEEEecCHHH-----------HHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 345566889999999999999999999999987432 134555555554 668999999998865433
Q ss_pred -CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEEccCCCCC
Q 001940 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---------NIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 877 -~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~---------gIIHRDIKPeNILLd~~d~e~ 946 (993)
...+|||+||.+.|+|.++|+.. .++|....+|+..|++||.|||+. .|+|||||.+||||. .+
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK----~D 352 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK----ND 352 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc----cC
Confidence 34699999999999999999876 489999999999999999999963 699999999999998 67
Q ss_pred CeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 947 PVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
++..|+|||+|....... .....+||.+|||||++.|.-.
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgain 395 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAIN 395 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcc
Confidence 899999999998765443 2234789999999999987643
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=213.57 Aligned_cols=176 Identities=27% Similarity=0.439 Sum_probs=144.0
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
-|++++.||+|+||.||+|.+ .++.||||++..... ....+.+.+|+.++++++|+||+++++++.+ ..
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~ 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DT 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-------hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CC
Confidence 367788999999999999987 467899998764321 1223578899999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++... .+++..+..++.|++.||.|||+.+++|+||||+||+++ .++.++|+|||+++
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~----~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC----CCCCEEEeecccce
Confidence 799999999999999998653 478999999999999999999999999999999999998 56789999999987
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
...... ......|+..|+|||.+.+... ..+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~D 183 (277)
T cd06641 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DSKAD 183 (277)
T ss_pred ecccchhhhccccCCccccChhhhccCCC-Cchhh
Confidence 653321 2233568899999999876533 33444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-23 Score=246.74 Aligned_cols=186 Identities=22% Similarity=0.322 Sum_probs=144.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-C-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-G-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-g-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f 872 (993)
++...++++.+.|.+|||+.||+|+.. + .+||+|++-.. .+...+.+.+|+.+|+.|+ |+|||.+++..
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 455567899999999999999999984 3 78999988643 2334567889999999998 99999999932
Q ss_pred -EcC-CC---CcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCCC
Q 001940 873 -RDG-PD---GSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 873 -~d~-s~---~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d~ 944 (993)
... .+ -.++|+||||.||.|.++++++ ...|++.++++|+.|+++|+.+||... |||||||-+||||+
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---- 180 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---- 180 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc----
Confidence 221 11 2467999999999999999854 234999999999999999999999875 99999999999998
Q ss_pred CCCeEEEEecCCcccccccc-ccC---------CCCCCCCcccccccc--CCccCCCCCCC
Q 001940 945 QRPVCKIGDLGLSKVKQQTL-VSG---------GVRGTLPWMAPELLS--GKSHMVTEKEL 993 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~~~~-~s~---------s~~GTp~YmAPEVL~--Gk~y~tse~DI 993 (993)
.++..||||||.+.-.-... ... ..-.|+.|+|||+|- ...-..++.||
T Consensus 181 ~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDI 241 (738)
T KOG1989|consen 181 ADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDI 241 (738)
T ss_pred CCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHH
Confidence 66789999999886432111 110 112689999999883 33344555554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-24 Score=237.33 Aligned_cols=191 Identities=24% Similarity=0.354 Sum_probs=158.8
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|-++.+||+|+|+.||+|.+ ..+.||||+-..... .+.+.++...+...+|..|.+.|.||.||++|++|.-.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~-WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKN-WRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccc-hhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-
Confidence 45688889999999999999976 466799998776543 33445666778888999999999999999999999864
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~--gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
...+|-|+|||+|-+|..+|+... .+++.++..|+.||+.||.||.+. .|||-||||.|||+.... ..|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt-acGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT-ACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc-ccceeEeeec
Confidence 567999999999999999998764 589999999999999999999975 899999999999997443 6789999999
Q ss_pred CCcccccccc--------ccCCCCCCCCcccccccc-C--CccCCCCCCC
Q 001940 955 GLSKVKQQTL--------VSGGVRGTLPWMAPELLS-G--KSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~--------~s~s~~GTp~YmAPEVL~-G--k~y~tse~DI 993 (993)
|+++.++... .+....||.||++||.|. + .+..+.++||
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDV 667 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDV 667 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceee
Confidence 9999876543 234557999999999774 4 5667777775
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.5e-23 Score=216.42 Aligned_cols=184 Identities=22% Similarity=0.361 Sum_probs=145.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f 872 (993)
.+..++|++.+.||+|+||.||+|+++ ++.||||+++..... .....+.+|+.++.++. |+||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~~i~~~~~~~ 83 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-------EENKRILMDLDVVLKSHDCPYIVKCYGYF 83 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-------HHHHHHHHHHHHHHhccCCCchHhhheee
Confidence 345678999999999999999999996 788999998754211 11234556776666665 99999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
.+ ...+++||||+ +++|.+++......+++..+..++.||+.||.|||+ .+|+||||||+|||++ .++.+||
T Consensus 84 ~~--~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~----~~~~~kL 156 (296)
T cd06618 84 IT--DSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLD----ASGNVKL 156 (296)
T ss_pred ec--CCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEc----CCCCEEE
Confidence 87 56799999998 557888877655678999999999999999999997 5999999999999998 5678999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCc---cCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS---HMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~---y~tse~DI 993 (993)
+|||++.............++..|+|||++.+.. ..+.+.||
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di 201 (296)
T cd06618 157 CDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADV 201 (296)
T ss_pred CccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhH
Confidence 9999988654433333445888999999997653 23445553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-24 Score=237.09 Aligned_cols=184 Identities=26% Similarity=0.357 Sum_probs=155.9
Q ss_pred ccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+..+.|+.-++||+|+||.||-++. +|+-+|.|++.+..+..+ .-....+.|-.||.+++.+.||.+-.+|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr-----~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKR-----KGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHh-----hhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 345667899999999999999998755 688899998876533221 1123466789999999999999998888
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
++ .+.+|+||..|.||+|.-+|.+.+ ..+++..++.++.+|+.||++||+.+||.|||||+|||+| +.|.|+|
T Consensus 255 eT--kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLD----d~GhvRI 328 (591)
T KOG0986|consen 255 ET--KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLD----DHGHVRI 328 (591)
T ss_pred cC--CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeec----cCCCeEe
Confidence 87 678999999999999999888764 4589999999999999999999999999999999999999 7789999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
+|+|+|..+.........+||.+|||||++.+..|..+
T Consensus 329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s 366 (591)
T KOG0986|consen 329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFS 366 (591)
T ss_pred eccceEEecCCCCccccccCcccccCHHHHcCCcccCC
Confidence 99999998776665566689999999999998885544
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=221.41 Aligned_cols=181 Identities=24% Similarity=0.356 Sum_probs=146.4
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||++.. +++.||||+++.... .....+.+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch------hhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 347899999999999999999986 477899998875311 111234677899999999999999999988642
Q ss_pred C----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 876 P----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 876 s----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
. ...++++++++ +++|.+++... .+++..+..++.||+.||.|||+.+|+||||||+||+++ .++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~----~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc----CCCCEEE
Confidence 1 23578888887 88999888653 488999999999999999999999999999999999998 5678999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++..... .....||..|+|||++.+......++||
T Consensus 162 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 201 (345)
T cd07877 162 LDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDI 201 (345)
T ss_pred eccccccccccc--ccccccCCCccCHHHHhCccCCCchhhH
Confidence 999998865432 2345689999999998775556666664
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.8e-23 Score=216.80 Aligned_cols=178 Identities=24% Similarity=0.416 Sum_probs=146.4
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||++.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-- 87 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--------PKKELIINEILVMRENKHPNIVNYLDSYLV-- 87 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--------hHHHHHHHHHHHHhhcCCCCeeehhheeee--
Confidence 36799999999999999999976 467799998864311 112467889999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
....|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+.+++|+||||+||+++ .++.+||+|||+
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~----~~~~~kL~dfg~ 161 (293)
T cd06647 88 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 161 (293)
T ss_pred CCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc----CCCCEEEccCcc
Confidence 46789999999999999998754 378888999999999999999999999999999999998 567899999998
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......|++.|+|||.+.+..+ +.+.||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv 198 (293)
T cd06647 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDI 198 (293)
T ss_pred eecccccccccccccCChhhcCchhhccCCC-CchhhH
Confidence 87543322 2234568899999999877543 455664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=220.13 Aligned_cols=175 Identities=24% Similarity=0.444 Sum_probs=142.3
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|.....||+|+||.||++.. ++..||||++.... ....+.+.+|+.+++.++|+||+++++.+.. .+.
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~ 93 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--------QQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDE 93 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--------HHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCe
Confidence 44456799999999999987 47789999886431 1223467899999999999999999999887 567
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.++||||+.+++|.+++... .+++..++.++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++..
T Consensus 94 ~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~----~~~~~kL~dfg~~~~ 167 (292)
T cd06658 94 LWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT----SDGRIKLSDFGFCAQ 167 (292)
T ss_pred EEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc----CCCCEEEccCcchhh
Confidence 99999999999999988643 478899999999999999999999999999999999998 567899999999875
Q ss_pred ccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......||..|+|||++.+..+ +.+.||
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 201 (292)
T cd06658 168 VSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDI 201 (292)
T ss_pred cccccccCceeecCccccCHHHHccCCC-CchhhH
Confidence 43221 2234568999999999876543 345554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.2e-23 Score=212.87 Aligned_cols=181 Identities=30% Similarity=0.467 Sum_probs=148.7
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s 876 (993)
++|++.+.||+|+||.||+++. .+..||||++...... .....+.+.+|+.+++++. |+||+++++++..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-----~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-- 73 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI-----KEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-- 73 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhcc-----chHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--
Confidence 4789999999999999999988 4788999998764322 1222356788999999999 9999999999877
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++.+.. .+++..++.|+.|++.||.|||+.+++|+||||+||+++ .++.++|+|||+
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~----~~~~~~l~df~~ 148 (280)
T cd05581 74 EENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD----KDMHIKITDFGT 148 (280)
T ss_pred CceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC----CCCCEEecCCcc
Confidence 567999999999999999997764 589999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc---------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL---------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~---------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......|+..|+|||++.+.. .+.+.||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di 205 (280)
T cd05581 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDL 205 (280)
T ss_pred ccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhH
Confidence 87543321 122345789999999887654 4444553
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=220.79 Aligned_cols=175 Identities=23% Similarity=0.404 Sum_probs=143.2
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|+....||+|+||.||++.. .++.||||++...... ..+.+.+|+.+++.++||||+++++.+.. .+.
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--------~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~ 92 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--------RRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEE 92 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--------hHHHHHHHHHHHHhCCCCchhhhhhheee--CCe
Confidence 44556799999999999987 4788999998643211 12357789999999999999999999887 577
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++||||+++++|..++... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++..
T Consensus 93 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~----~~~~~kL~dfg~~~~ 166 (297)
T cd06659 93 LWVLMEFLQGGALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT----LDGRVKLSDFGFCAQ 166 (297)
T ss_pred EEEEEecCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc----cCCcEEEeechhHhh
Confidence 99999999999999988653 478999999999999999999999999999999999998 667899999999875
Q ss_pred ccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......|+..|+|||++.+..+ +.+.||
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv 200 (297)
T cd06659 167 ISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDI 200 (297)
T ss_pred cccccccccceecCccccCHHHHccCCC-CchhhH
Confidence 43321 2234568999999999987653 455554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=212.50 Aligned_cols=177 Identities=31% Similarity=0.492 Sum_probs=137.7
Q ss_pred EecccCceEEEEEEEcC--------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 807 ELGSGTYGSVYHGKWRG--------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~kg--------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.||+|+||.||+|++.. ..+|||.+..... ......+.+|+.+++.++||||+++++++.. .+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 72 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-------DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NE 72 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-------hhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CC
Confidence 58999999999998743 4589998764311 1123467889999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhc------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEE
Q 001940 879 SLATVTEFMVNGSLKQFLQKK------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKL 951 (993)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||+.+++|+||||+|||++.++ .....+||
T Consensus 73 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 73 PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred CeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEE
Confidence 799999999999999999753 23367888999999999999999999999999999999998322 11238999
Q ss_pred EecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++...... ......++..|+|||++.+.. .+.+.||
T Consensus 153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 196 (269)
T cd05044 153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDV 196 (269)
T ss_pred CCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhH
Confidence 9999987543221 112334678899999997654 3556664
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-23 Score=220.71 Aligned_cols=181 Identities=28% Similarity=0.359 Sum_probs=149.3
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC--
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP-- 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s-- 876 (993)
+|++.+.||.|+||.||+|+.. ++.||||++..... .....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD------DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc------cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 5889999999999999999984 67899998875321 1122356888999999999999999999988742
Q ss_pred -CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 -DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 -~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+|+||||+. ++|.+++.+.. .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.++|+|||
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~----~~~~~~L~dfg 148 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN----SNCDLKICDFG 148 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEcccC
Confidence 236899999996 58999887654 689999999999999999999999999999999999998 66899999999
Q ss_pred Ccccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++....... ......+|..|+|||++.+......++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi 190 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDI 190 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhH
Confidence 998765432 23345689999999999887666666664
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=207.98 Aligned_cols=181 Identities=23% Similarity=0.483 Sum_probs=145.6
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.+.||+|+||.||++..+ +..+|+|.+....... ...+.+.+|+.+++.++|+||+++++.+.. .+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~--~~ 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV------KEKEASKKEVILLAKMKHPNIVTFFASFQE--NG 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc------hhhHHHHHHHHHHHhCCCCChhhhhheecc--CC
Confidence 4889999999999999999884 6789999987543211 122467789999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.+++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||||+|||++.+ ...+||+|||.+
T Consensus 73 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~---~~~~~l~d~~~~ 149 (257)
T cd08225 73 RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN---GMVAKLGDFGIA 149 (257)
T ss_pred eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC---CCeEEecccccc
Confidence 8999999999999999987643 347899999999999999999999999999999999999732 246799999998
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ......|++.|+|||++.+.. .+.+.||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv 185 (257)
T cd08225 150 RQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDI 185 (257)
T ss_pred hhccCCcccccccCCCccccCHHHHcCCC-CCchhhH
Confidence 7654332 122346899999999987654 3344553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=208.53 Aligned_cols=180 Identities=29% Similarity=0.416 Sum_probs=141.9
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc---CCCCcceEEEEEEcCC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIVRDGP 876 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L---rHPNIVrL~G~f~d~s 876 (993)
|++.+.||+|+||.||+|+++ ++.+|||+++...... .....+.+|+.+++++ .|+||+++++++....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE------GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc------hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 678899999999999999984 6889999997542211 1112455676666555 6999999999998732
Q ss_pred C---CcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 D---GSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~---~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ..++++|||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+++|+||||+|||++ .++.+||+
T Consensus 75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~----~~~~~~l~ 149 (287)
T cd07838 75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT----SDGQVKIA 149 (287)
T ss_pred CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc----cCCCEEEe
Confidence 1 13899999996 58999887643 3589999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++.............++..|+|||++.+.. ...+.||
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di 189 (287)
T cd07838 150 DFGLARIYSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDM 189 (287)
T ss_pred ccCcceeccCCcccccccccccccChHHhccCC-CCCcchh
Confidence 999998765443334456889999999998765 4455664
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=212.37 Aligned_cols=179 Identities=31% Similarity=0.447 Sum_probs=147.6
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|++.+.||.|++|.||++.. .++.+|+|+++...... .....+.+|+.++++++|+||+++++++.. ...
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 72 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE------GIPKTALREIKLLKELNHPNIIKLLDVFRH--KGD 72 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc------hhHHHHHHHHHHHHHhcCCCcchHHHhhcc--CCC
Confidence 56778999999999999987 47779999887543211 223467789999999999999999999887 478
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++||||+. ++|.+++......+++..+..++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||.+..
T Consensus 73 ~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~----~~~~~~l~df~~~~~ 147 (283)
T cd05118 73 LYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN----TEGVLKLADFGLARS 147 (283)
T ss_pred EEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC----CCCcEEEeeeeeeEe
Confidence 999999996 589988887656789999999999999999999999999999999999998 567899999999876
Q ss_pred ccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......++..|+|||.+.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di 182 (283)
T cd05118 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDI 182 (283)
T ss_pred cCCCcccccCccCcccccCcHHHhcCCCCCchhHH
Confidence 64432 22335688899999999876556666664
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=220.30 Aligned_cols=186 Identities=24% Similarity=0.349 Sum_probs=144.3
Q ss_pred CCce-EEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHH------HHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 800 DDLE-EVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERE------RLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 800 ddYe-ile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere------~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
++|. +.+.||.|+||+||+|.+ .++.||||+++............ .....+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4454 446799999999999987 47789999987543221100000 01124678999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++.. .+.+++||||+. ++|.+++.... .+++..++.++.||+.||.|||+.+|+|+||||+|||++ .++.+|
T Consensus 88 ~~~~--~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~----~~~~~k 159 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN----SKGICK 159 (335)
T ss_pred EEec--CCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC----CCCCEE
Confidence 9987 568999999995 69999987643 488999999999999999999999999999999999998 567899
Q ss_pred EEecCCccccccc---------------cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQT---------------LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~---------------~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||++...... .......++..|+|||++.+....+.+.||
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 217 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDM 217 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHH
Confidence 9999998754311 111233468899999999877666666664
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=206.35 Aligned_cols=179 Identities=31% Similarity=0.503 Sum_probs=147.4
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|++.++||+|+||.||+++.+ +..+|||++...... ......+.+|+.++++++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS------QKEREDAVNEIRILASVNHPNIISYKEAFLD--GN 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc------HHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CC
Confidence 4889999999999999999874 667999998754321 1223467789999999999999999999887 47
Q ss_pred cEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 879 SLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..++||||+++++|.+++.+. ...+++..+..++.|++.||.|||+.+++|+||||+||+++ ..+.+||+|||
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~----~~~~~kl~d~g 148 (256)
T cd08530 73 KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV----ANDLVKIGDLG 148 (256)
T ss_pred EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe----cCCcEEEeecc
Confidence 899999999999999998662 24588899999999999999999999999999999999998 56789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++..... ......|+..|+|||.+.+..+. .+.||
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~ 184 (256)
T cd08530 149 ISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYS-YKSDI 184 (256)
T ss_pred chhhhccC-CcccccCCccccCHHHHCCCCCC-chhhH
Confidence 99876554 22335688999999999876543 34553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.38 Aligned_cols=181 Identities=26% Similarity=0.328 Sum_probs=142.2
Q ss_pred CceEEEEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
+|++.+.||+|+||.||+++.. +..||||++...... ....+.+.+|+.+++++ +|+||+++++.+...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK------KILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc------chhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 4889999999999999999985 457999988643211 11234677899999999 499999999875432
Q ss_pred --CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 876 --s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
....++++|||+ +++|.+++... ..+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+|
T Consensus 75 ~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~----~~~~~kl~D 148 (332)
T cd07857 75 PGNFNELYLYEELM-EADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN----ADCELKICD 148 (332)
T ss_pred cccCCcEEEEEecc-cCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----CCCCEEeCc
Confidence 224578899988 57899988654 3588999999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++...... ......||..|+|||++.+......++||
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di 193 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDV 193 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHH
Confidence 99998543221 12345789999999998765555566664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=210.75 Aligned_cols=179 Identities=32% Similarity=0.482 Sum_probs=147.7
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|++.+.||+|+||.||+|+.. ++.+|+|++..... .....+.+..|+.++++++|+||+++++++.+ .+.
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~ 72 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE------EEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERK 72 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc------cccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCc
Confidence 567789999999999999884 68899999886531 11123456789999999999999999999887 478
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++||||+. ++|.+++.+....+++..++.++.|++.||.|||+.+|+||||+|+||+++ .++.+||+|||+++.
T Consensus 73 ~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~----~~~~~~l~d~g~~~~ 147 (282)
T cd07829 73 LYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN----RDGVLKLADFGLARA 147 (282)
T ss_pred eEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc----CCCCEEEecCCcccc
Confidence 999999996 699999987655689999999999999999999999999999999999998 567899999999886
Q ss_pred ccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ......++..|+|||++.+....+.+.||
T Consensus 148 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv 182 (282)
T cd07829 148 FGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDI 182 (282)
T ss_pred cCCCccccCccccCcCcCChHHhcCCcCCCccccH
Confidence 54332 22234567889999999877566666775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-24 Score=233.86 Aligned_cols=182 Identities=24% Similarity=0.348 Sum_probs=150.8
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+...+|.++.+||+|+||+|.+|..+++ .+|||++++......... +.-..|-.+|... +-|.++++...|
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDv-----ectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDV-----ECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcc-----cceehhhhheecCCCCchHHHHHHHh
Confidence 44567899999999999999999988754 489999998765543322 2233455566554 478999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+. -+++|+||||+.||+|...|++.++ +.+..+..++.+|+.||-|||++|||.||||.+|||++ .+|.|||+
T Consensus 420 QT--mDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd----~eGHiKi~ 492 (683)
T KOG0696|consen 420 QT--MDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD----SEGHIKIA 492 (683)
T ss_pred hh--hhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEec----cCCceEee
Confidence 98 5789999999999999999988776 77778888899999999999999999999999999999 77899999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccccccccCCccCCC
Q 001940 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 953 DFGLAk~~-~~~~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
|||+++.. ....++..++||+.|+|||++.-++|..+
T Consensus 493 DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgks 530 (683)
T KOG0696|consen 493 DFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKS 530 (683)
T ss_pred ecccccccccCCcceeeecCCCcccccceEEecccccc
Confidence 99999954 34445678999999999999987777543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=215.60 Aligned_cols=179 Identities=26% Similarity=0.472 Sum_probs=144.9
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..|+..+.||+|+||.||++++ .+..||||++...... .....+.+.+|+.++++++|+||+++++++.+ .
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~ 97 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-----SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--E 97 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-----chHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--C
Confidence 3477888999999999999987 4678999988754221 12234578889999999999999999999987 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
...++||||+. |+|.+++......+++..+..++.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++
T Consensus 98 ~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~----~~~~~kl~dfg~~ 172 (317)
T cd06635 98 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSA 172 (317)
T ss_pred CeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC----CCCCEEEecCCCc
Confidence 67899999996 588888776666689999999999999999999999999999999999998 5678999999998
Q ss_pred cccccccccCCCCCCCCccccccccC--CccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSG--KSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~G--k~y~tse~DI 993 (993)
...... ....|+..|+|||++.+ ......+.||
T Consensus 173 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv 207 (317)
T cd06635 173 SIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDV 207 (317)
T ss_pred cccCCc---ccccCCccccChhhhhcCCCCCCCccccH
Confidence 754332 23568899999999853 2334555554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=254.04 Aligned_cols=183 Identities=30% Similarity=0.488 Sum_probs=147.2
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc---
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD--- 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d--- 874 (993)
.+|++++.||+||||.||+++. +|+.+|||+|.... .......+.+|+.+|.+|+|||||++|..|.+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~ 551 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTA 551 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCC
Confidence 4677788999999999999987 59999999998653 12233468899999999999999999876400
Q ss_pred ---------------------------------------------------------------------------C----
Q 001940 875 ---------------------------------------------------------------------------G---- 875 (993)
Q Consensus 875 ---------------------------------------------------------------------------~---- 875 (993)
+
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ---------------------------CC--------CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHH
Q 001940 876 ---------------------------PD--------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920 (993)
Q Consensus 876 ---------------------------s~--------~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLe 920 (993)
.+ -.+||=||||+...|.++++++...-.....++++++|+.||.
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHH
Confidence 00 1368889999999999988776432257778899999999999
Q ss_pred HHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc-------------------cccccCCCCCCCCccccccc
Q 001940 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ-------------------QTLVSGGVRGTLPWMAPELL 981 (993)
Q Consensus 921 YLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~-------------------~~~~s~s~~GTp~YmAPEVL 981 (993)
|+|+.|||||||||.||+++ ....|||+|||+|+... .....++.+||.-|+|||++
T Consensus 712 YIH~~giIHRDLKP~NIFLd----~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 712 YIHDQGIIHRDLKPRNIFLD----SRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHhCceeeccCCcceeEEc----CCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999999999999999999 66789999999998511 00122456799999999999
Q ss_pred cCCc--cCCCCCCC
Q 001940 982 SGKS--HMVTEKEL 993 (993)
Q Consensus 982 ~Gk~--y~tse~DI 993 (993)
.+.. .+..++|+
T Consensus 788 ~~~~~~~Yn~KiDm 801 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDM 801 (1351)
T ss_pred cccccccccchhhh
Confidence 9887 68888885
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=238.03 Aligned_cols=177 Identities=26% Similarity=0.524 Sum_probs=146.1
Q ss_pred ceEEEEecccCceEEEEEEEc----Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR----GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k----gt--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.++.+.||+|-||.||+|.+. |+ -||||..+.++...+ .+.|..|..+|+.++|||||+++|+|.+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-------tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-------TEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-------HHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 344468999999999999873 22 389999987653321 3579999999999999999999999997
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...|||||+++-|.|..+|+.....++......++.||+.||.|||++.+|||||..+|||+. ....|||+|||
T Consensus 463 --~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs----Sp~CVKLaDFG 536 (974)
T KOG4257|consen 463 --QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS----SPQCVKLADFG 536 (974)
T ss_pred --cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec----Ccceeeecccc
Confidence 458999999999999999998888899999999999999999999999999999999999998 55699999999
Q ss_pred CccccccccccCC--CCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGG--VRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s--~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++..++...... ..-.+.|||||.+.-. ..++..||
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfR-rFTtASDV 575 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFR-RFTTASDV 575 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchh-cccchhhH
Confidence 9998766543222 2235679999998643 34444443
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=211.67 Aligned_cols=176 Identities=23% Similarity=0.431 Sum_probs=144.1
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|...+.||+|++|.||++.. .++.+|||+++.... ...+.+.+|+.+++.++|+||+++++++.. .+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--------~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--------QRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--------hHHHHHHHHHHHHHHcCCCChheEEEEEEc--CC
Confidence 455668999999999999987 467799998864311 112457789999999999999999999887 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
..++|+||+.+++|.+++.. ..+++..+..|+.||+.||.|||+.+|+||||||+||+++ .++.+||+|||++.
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d~g~~~ 163 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT----SDGRVKLSDFGFCA 163 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc----CCCcEEEcccccch
Confidence 78999999999999999877 3488899999999999999999999999999999999998 56789999999887
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......|+..|+|||++.+.. ...+.||
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv 198 (285)
T cd06648 164 QVSKEVPRRKSLVGTPYWMAPEVISRLP-YGTEVDI 198 (285)
T ss_pred hhccCCcccccccCCccccCHHHhcCCC-CCCcccH
Confidence 543221 223356899999999998765 3455664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=213.94 Aligned_cols=188 Identities=19% Similarity=0.172 Sum_probs=133.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCc-----ceEEEEeeccccCCCchhHHH------HHHHHHHHHHHHhhcCCCC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERER------LIADFWKEALLLSSLHHPN 864 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt-----~VAVKvIkk~~~~~k~~ere~------~ie~f~rEi~ILr~LrHPN 864 (993)
.+...+|++.++||+|+||+||+|++.+. .+|+|+...... ....+. .......+...+..+.|+|
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~---~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~ 84 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE---TIVMETLVYNNIYDIDKIALWKNIHNIDHLG 84 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC---chhhHHHHHHhhhhHHHHHHHHHhccCCCCC
Confidence 34557899999999999999999988543 466665432211 111110 0112233445567788999
Q ss_pred cceEEEEEEcCCC--CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC
Q 001940 865 VVSFYGIVRDGPD--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (993)
Q Consensus 865 IVrL~G~f~d~s~--~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~ 942 (993)
|+++++.+..... ...+++||++ ..++.+++.... ..++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~-- 160 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD-- 160 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--
Confidence 9999987654321 1346788877 456777765532 357788889999999999999999999999999999998
Q ss_pred CCCCCeEEEEecCCccccccc--------cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 943 DPQRPVCKIGDLGLSKVKQQT--------LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~--------~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+|+..... .......||+.|+|||++.+..+ +.++||
T Consensus 161 --~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~Di 216 (294)
T PHA02882 161 --GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDL 216 (294)
T ss_pred --CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHH
Confidence 5578999999999754221 11123469999999999987764 555664
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=209.27 Aligned_cols=180 Identities=27% Similarity=0.474 Sum_probs=150.4
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+.|++.+.||+|+||.||++.+. +..+|+|++..... ..+.+.+|+.+++.++|+||+++++.+..
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 86 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLV- 86 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-
Confidence 3456888899999999999999985 77899999875421 23467889999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+..++|+||+.+++|.+++......+++..+..++.||+.||.|||+.||+|+||||+||+++ .++.+||+|||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~----~~~~~~l~d~~ 161 (286)
T cd06614 87 -GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS----KDGSVKLADFG 161 (286)
T ss_pred -CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc----CCCCEEECccc
Confidence 4789999999999999999987654689999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++....... ......++..|+|||++.+..+ ..+.||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv 199 (286)
T cd06614 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GPKVDI 199 (286)
T ss_pred hhhhhccchhhhccccCCcccCCHhHhcCCCC-CCcccc
Confidence 887543321 1233458889999999887653 456665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=209.02 Aligned_cols=181 Identities=29% Similarity=0.435 Sum_probs=140.2
Q ss_pred ceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
|++.+.||+|+||.||+|.++ +..||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS------SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC------hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 567789999999999999863 467999998754211 122456888999999999999999999886532
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhc-----cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKK-----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~-----~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
. ...++++||+.+++|.+++... ...++...++.++.||+.||.|||+.+|+||||||+|||++ .++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~----~~~ 150 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN----ENM 150 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc----CCC
Confidence 2 1347889999999999887532 12478888999999999999999999999999999999998 567
Q ss_pred eEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+||+|||+++...... ......++..|++||.+.+..+ +.++||
T Consensus 151 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi 198 (273)
T cd05074 151 TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDV 198 (273)
T ss_pred CEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhh
Confidence 89999999988653221 1122345678999999876643 445664
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-23 Score=230.15 Aligned_cols=167 Identities=32% Similarity=0.555 Sum_probs=138.1
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHh--hcCCCCcceEEEEEEc--C
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS--SLHHPNVVSFYGIVRD--G 875 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr--~LrHPNIVrL~G~f~d--~ 875 (993)
.+..+.+.||+|.||.||+|+|+|+.||||++.... + +...+|.+|.. .|+|+||+.+++.=.. +
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd------E-----~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD------E-----RSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred heeEEEEEecCccccceeeccccCCceEEEEecccc------h-----hhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 456788999999999999999999999999987431 1 24556666664 6799999999876332 2
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEccCCCCCC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~--------gIIHRDIKPeNILLd~~d~e~g 947 (993)
.-..+|||++|.+.|+|+|+|.+ .+++.+..+++++.++.||.+||.. .|.|||||..||||. .++
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK----kn~ 353 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNG 353 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc----cCC
Confidence 22369999999999999999987 3589999999999999999999953 699999999999998 778
Q ss_pred eEEEEecCCccccccc-----cccCCCCCCCCccccccccC
Q 001940 948 VCKIGDLGLSKVKQQT-----LVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~-----~~s~s~~GTp~YmAPEVL~G 983 (993)
.+.|+|+|||-..... ...+..+||..|||||+|..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9999999999765433 12356689999999999953
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=217.72 Aligned_cols=180 Identities=26% Similarity=0.399 Sum_probs=145.2
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||.|+||.||+|.. +++.||||++.+..... ...+.+.+|+.+++.++||||++++++|...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------VLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc------chhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 456799999999999999999987 46779999886532211 1224677899999999999999999998753
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....++||||+ +++|.++++.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 82 -~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~----~~~~~~l~dfg 153 (328)
T cd07856 82 -LEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILIN----ENCDLKICDFG 153 (328)
T ss_pred -CCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeEC----CCCCEEeCccc
Confidence 35689999998 67899888643 367888888999999999999999999999999999998 56789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... .....++..|+|||++.+....+.+.||
T Consensus 154 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 189 (328)
T cd07856 154 LARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDI 189 (328)
T ss_pred cccccCCC--cCCCcccccccCceeeeccCCcCcHHHH
Confidence 98754332 2335678899999998765555555654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=212.20 Aligned_cols=177 Identities=26% Similarity=0.460 Sum_probs=143.6
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|..+++||+|+||+||+|+. .+..||||++....... ....+.+.+|+.+++.++|+||+++++++.+ ...
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~ 95 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT-----NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHT 95 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc-----hHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCE
Confidence 66678899999999999987 47789999987542211 1233567889999999999999999999988 567
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.|+||||+. ++|.+++......+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++..
T Consensus 96 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~----~~~~~kL~dfg~~~~ 170 (313)
T cd06633 96 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT----EPGQVKLADFGSASK 170 (313)
T ss_pred EEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC----CCCCEEEeecCCCcc
Confidence 899999994 688888876666789999999999999999999999999999999999998 567899999999865
Q ss_pred cccccccCCCCCCCCccccccccC--CccCCCCCCC
Q 001940 960 KQQTLVSGGVRGTLPWMAPELLSG--KSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~~s~s~~GTp~YmAPEVL~G--k~y~tse~DI 993 (993)
... .....|+..|+|||++.+ ......+.||
T Consensus 171 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv 203 (313)
T cd06633 171 SSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDV 203 (313)
T ss_pred cCC---CCCccccccccChhhccccCCCCCCchhhH
Confidence 332 234568999999999853 2334445554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-23 Score=233.52 Aligned_cols=181 Identities=24% Similarity=0.318 Sum_probs=151.6
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYG 870 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G 870 (993)
.+..++...|+++++||+||-+.||++... .+.+|+|++.... .....+.-|..|+.+|.+|+ |.+||++|+
T Consensus 354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~------~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D 427 (677)
T KOG0596|consen 354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE------ADNQTLDGYRNEIALLNKLKGHDKIIQLYD 427 (677)
T ss_pred eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh------cCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence 455677888999999999999999999885 4557888765432 23455678999999999997 999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
|-.. ++.+||||||- ..+|..+|+++........++.+..||+.++.++|..||||.||||.|+|+- .|.+|
T Consensus 428 YEv~--d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LK 499 (677)
T KOG0596|consen 428 YEVT--DGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLK 499 (677)
T ss_pred eecc--CceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEE
Confidence 9776 78999999975 7899999998876666457778889999999999999999999999999994 68999
Q ss_pred EEecCCccccccccc---cCCCCCCCCccccccccCCccC
Q 001940 951 IGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 951 LiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
|+|||+|+.+..... ..+.+||+.||+||.+....+.
T Consensus 500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~ 539 (677)
T KOG0596|consen 500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSS 539 (677)
T ss_pred eeeechhcccCccccceeeccccCcccccCHHHHhhcccc
Confidence 999999998765532 3467899999999999765554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-23 Score=222.58 Aligned_cols=175 Identities=27% Similarity=0.302 Sum_probs=144.3
Q ss_pred CCceEE-EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 800 DDLEEV-RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 800 ddYeil-e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
++|++- ++||-|-.|+|..+.. +++++|+|++... ...++|+++.-+. .|+|||.++++|++.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------------~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------------PKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------------HHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 445443 5799999999998866 4788999988643 1344677765444 599999999998763
Q ss_pred --CCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 --PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 --s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...++.+|||.|+||.|+..++.++ ..+++.++..|+.||..|+.|||+.+|.||||||+|+|..... .+..+||+
T Consensus 128 ~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~-~na~lKLt 206 (400)
T KOG0604|consen 128 YQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTS-PNAPLKLT 206 (400)
T ss_pred ccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCC-CCcceEec
Confidence 2457899999999999999998765 4689999999999999999999999999999999999998655 67899999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
|||+|+...........+-|+.|.|||++..++|..
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydk 242 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDK 242 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCchhcCC
Confidence 999999877555556678899999999997666543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-23 Score=242.36 Aligned_cols=176 Identities=30% Similarity=0.482 Sum_probs=144.4
Q ss_pred eEEEEecccCceEEEEEEE--c----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 803 EEVRELGSGTYGSVYHGKW--R----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~--k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
+..++||+|+||+||+|.| + +-+||||++....... ...++++|+.+|.+|+||||+++++++...
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~-------~s~e~LdeAl~masldHpnl~RLLgvc~~s- 770 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPK-------ASIELLDEALRMASLDHPNLLRLLGVCMLS- 770 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCch-------hhHHHHHHHHHHhcCCCchHHHHhhhcccc-
Confidence 3457899999999999988 3 3458999987653221 224788999999999999999999999973
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.||++||+.|+|.++++..+..+..+..+.|+.||++||.|||.+.++||||..+|+||. .-..+||+|||+
T Consensus 771 --~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk----sP~hvkitdfgl 844 (1177)
T KOG1025|consen 771 --TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK----SPNHVKITDFGL 844 (1177)
T ss_pred --hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec----CCCeEEEEecch
Confidence 48899999999999999998888899999999999999999999999999999999999998 456899999999
Q ss_pred cccccccccc---CCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVS---GGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s---~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++........ ....-.+.|||-|.+... .++.+.||
T Consensus 845 a~ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDV 883 (1177)
T KOG1025|consen 845 AKLLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDV 883 (1177)
T ss_pred hhccCcccccccccccccCcHHHHHHHhhcc-CCCchhhh
Confidence 9977544321 222345779999998744 44555554
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=213.05 Aligned_cols=179 Identities=18% Similarity=0.261 Sum_probs=141.6
Q ss_pred eEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEE
Q 001940 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~L 882 (993)
.+.+.+|.|+++.||+++.+++.||||+++..... ....+.+.+|+.+++.++|+||+++++++.+ ....++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~ 76 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCS------KEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYV 76 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccc------hhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEE
Confidence 34455677777777777778899999998754211 1234578899999999999999999999987 567899
Q ss_pred EEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 883 VTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+|||+.+++|.+++... ...+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||.+....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~----~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS----GDGKVVLSGLRYSVSMI 152 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe----cCCceEEecCccceeec
Confidence 99999999999999864 34578889999999999999999999999999999999998 56789999999886442
Q ss_pred ccc--------ccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 962 QTL--------VSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 962 ~~~--------~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
... ......++..|+|||++.+.. ....+.||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (314)
T cd08216 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193 (314)
T ss_pred cccccccccccccccccccccccCHHHhcCCCCCCCcchhH
Confidence 211 112345788899999997642 34455664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=216.31 Aligned_cols=176 Identities=21% Similarity=0.341 Sum_probs=137.6
Q ss_pred EEeccc--CceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEE
Q 001940 806 RELGSG--TYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 806 e~LGeG--gFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~ 881 (993)
..||+| +||+||++++ .++.||||++...... ....+.+.+|+.+++.++|+||++++++|.. .+.++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~ 75 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT------EEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLW 75 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceE
Confidence 346666 9999999988 5788999998753211 1234678899999999999999999999998 56799
Q ss_pred EEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 882 TVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
+||||+.+++|.+++.+.. ..+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+|++||+.+...
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~----~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS----GDGLVSLSGLSHLYSL 151 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe----CCCcEEEechHHHhhh
Confidence 9999999999999987643 3488899999999999999999999999999999999998 5678999999864422
Q ss_pred ccccc--------cCCCCCCCCccccccccCCcc-CCCCCCC
Q 001940 961 QQTLV--------SGGVRGTLPWMAPELLSGKSH-MVTEKEL 993 (993)
Q Consensus 961 ~~~~~--------s~s~~GTp~YmAPEVL~Gk~y-~tse~DI 993 (993)
..... .....++..|||||++.+... .+.++||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di 193 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDI 193 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhH
Confidence 11100 011235677999999986533 4555664
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=216.33 Aligned_cols=179 Identities=26% Similarity=0.399 Sum_probs=143.6
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|.+.+.||+|+||.||+|.+ +++.||||++...... +.....+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS------EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc------ccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 35799999999999999999987 4788999988753211 112245778999999999999999999987532
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ..+++||||+. .+|..++. ..+++..+..++.|++.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~----~~~~~kL~ 159 (342)
T cd07879 88 SGDEFQDFYLVMPYMQ-TDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN----EDCELKIL 159 (342)
T ss_pred cCCCCceEEEEecccc-cCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEe
Confidence 1 34699999995 57776652 3478899999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....+|..|+|||++.+......++||
T Consensus 160 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 198 (342)
T cd07879 160 DFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDI 198 (342)
T ss_pred eCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHH
Confidence 99998865332 2345688999999999875556666664
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.6e-22 Score=207.78 Aligned_cols=169 Identities=25% Similarity=0.343 Sum_probs=133.3
Q ss_pred CceEEEE--ecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHh-hcCCCCcceEEEEEEcC
Q 001940 801 DLEEVRE--LGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS-SLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 801 dYeile~--LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr-~LrHPNIVrL~G~f~d~ 875 (993)
+|++.+. ||+|+||.||++.. .+..+|+|++....... .|+.... ..+|+||+++++.|..
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------------~e~~~~~~~~~h~~iv~~~~~~~~- 80 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------------IEPMVHQLMKDNPNFIKLYYSVTT- 80 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------------hhHHHHHHhhcCCCEEEEEEEEec-
Confidence 4455555 59999999999987 46778999887542211 0111222 1269999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC-eEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g-~VKLiDF 954 (993)
.+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+++||||||+||+++ ..+ .++|+||
T Consensus 81 -~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~----~~~~~~~l~df 154 (267)
T PHA03390 81 -LKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD----RAKDRIYLCDY 154 (267)
T ss_pred -CCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe----CCCCeEEEecC
Confidence 468999999999999999997764 689999999999999999999999999999999999998 444 8999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++..... ....||..|+|||++.+..+ ..+.||
T Consensus 155 g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~Dv 189 (267)
T PHA03390 155 GLCKIIGTP---SCYDGTLDYFSPEKIKGHNY-DVSFDW 189 (267)
T ss_pred ccceecCCC---ccCCCCCcccChhhhcCCCC-CchhhH
Confidence 998765433 23468999999999987654 445564
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-23 Score=253.72 Aligned_cols=172 Identities=28% Similarity=0.431 Sum_probs=143.5
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|....+||.|.||.||.|.. +|.-.|+|.++..... ...+....+|..+|..|+|||||++||+=.. ..
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH--Re 1307 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH--RE 1307 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeec--HH
Confidence 455667899999999999977 5777899998865322 3345677899999999999999999999776 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
..+|.||||++|+|.+++... +..++.....+..|++.||.|||+.|||||||||+|||++ .+|.+|+.|||.|.
T Consensus 1308 kv~IFMEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld----~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1308 KVYIFMEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLD----FNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeee----cCCcEEeeccccee
Confidence 789999999999999999654 3366666677888999999999999999999999999999 66799999999998
Q ss_pred ccccc-----cccCCCCCCCCccccccccCCc
Q 001940 959 VKQQT-----LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 959 ~~~~~-----~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
..... ...+...||+.|||||+|.|..
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 65433 2235678999999999998764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=216.59 Aligned_cols=181 Identities=24% Similarity=0.388 Sum_probs=144.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++.+.||.|+||.||+|..+ ++.||+|++..... ...+.+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~ 75 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPSG 75 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhcccc
Confidence 368999999999999999999884 67899999875422 12346778999999999999999998776532
Q ss_pred C------------CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC
Q 001940 877 D------------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 877 ~------------~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~ 944 (993)
. ..+++||||+. ++|.+++... .+++..++.++.||+.||.|||+.+|+||||||+|||++.
T Consensus 76 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--- 149 (342)
T cd07854 76 SDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--- 149 (342)
T ss_pred cccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---
Confidence 1 35789999996 6898888643 4789999999999999999999999999999999999973
Q ss_pred CCCeEEEEecCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 945 QRPVCKIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++....... .....||..|+|||++.+......++||
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 202 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM 202 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhH
Confidence 345799999999976532211 1223578899999988766666667775
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=205.15 Aligned_cols=182 Identities=25% Similarity=0.393 Sum_probs=141.6
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
+|.+.+.||+|+||.||++++. +..+++|+++........ ......+.+|+.++++++||||+++++++.+ ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELN---PNETVQANQEAQLLSKLDHPAIVKFHASFLE--RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccC---cchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CC
Confidence 4888999999999999999885 344667766543321111 1112346678999999999999999999887 45
Q ss_pred cEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 879 SLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+.+++|+||||+||+++ . +.+||+|||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~-~~~~l~d~g 150 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----N-NLLKIGDFG 150 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----c-CCEeecccC
Confidence 78999999999999998864 334689999999999999999999999999999999999996 2 469999999
Q ss_pred Cccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++..... .......|+..|+|||.+.+..+. .+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv 188 (260)
T cd08222 151 VSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD-SKSDI 188 (260)
T ss_pred ceeecCCCcccccCCCCCcCccCHHHHccCCCC-chhhH
Confidence 98765332 222345688999999998765443 34553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=200.62 Aligned_cols=173 Identities=27% Similarity=0.397 Sum_probs=142.7
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||.|+||.||++... ++.+|+|++....... ......+..|+.++++++|+||+++++.+.. ....++|||
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 73 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-----RKEVEHTLTERNILSRINHPFIVKLHYAFQT--EEKLYLVLE 73 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-----hHHHHHHHHHHHHHHHcCCCcHHHHHHHeec--CCeeEEEEe
Confidence 689999999999884 6789999987653221 1234578889999999999999999999887 577999999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccc-c
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT-L 964 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~-~ 964 (993)
|+.+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++ ..+.++|+|||++...... .
T Consensus 74 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~----~~~~~~l~d~~~~~~~~~~~~ 148 (250)
T cd05123 74 YAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD----ADGHIKLTDFGLAKELSSEGS 148 (250)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc----CCCcEEEeecCcceecccCCC
Confidence 999999999997664 488999999999999999999999999999999999998 5678999999998865433 2
Q ss_pred ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 ~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......++..|+|||.+.+.. .+.+.||
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~ 176 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKG-YGKAVDW 176 (250)
T ss_pred cccCCcCCccccChHHhCCCC-CCchhhH
Confidence 234456889999999987654 3334443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=210.60 Aligned_cols=178 Identities=27% Similarity=0.491 Sum_probs=143.8
Q ss_pred CceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+..+.||+|+||.||+|+. .+..+|||.+....... .....++.+|+.+++.++|+||+++++++.. ..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 88 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-----NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EH 88 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccC-----hHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CC
Confidence 467778899999999999988 46779999886432211 1223467789999999999999999999987 46
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
..++||||+. ++|.+++......+++..++.++.|++.||.|||+.+++||||||+|||++ .++.+||+|||++.
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~----~~~~~kl~dfg~~~ 163 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (308)
T ss_pred eeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC----CCCcEEECCcccce
Confidence 7899999995 688888766555688999999999999999999999999999999999998 56789999999987
Q ss_pred ccccccccCCCCCCCCccccccccC--CccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSG--KSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~G--k~y~tse~DI 993 (993)
..... ....|+..|+|||++.+ ......+.||
T Consensus 164 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di 197 (308)
T cd06634 164 IMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (308)
T ss_pred eecCc---ccccCCccccCHHHHhhcccCCCCcccch
Confidence 65432 24568899999999853 2334556665
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=216.55 Aligned_cols=180 Identities=24% Similarity=0.379 Sum_probs=146.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|++. +..||||++..... .....+.+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ------SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc------hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 467999999999999999999884 67799998864311 1122345778999999999999999998876532
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ..+++|+||+ +++|.+++... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~----~~~~~kL~ 160 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN----EDCELKIL 160 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC----CCCCEEEc
Confidence 1 3489999998 77999998753 489999999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||++...... .....+|..|+|||++.+....+.++||
T Consensus 161 dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 199 (343)
T cd07851 161 DFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDI 199 (343)
T ss_pred ccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhH
Confidence 99999865433 2345688999999998766566666665
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.2e-22 Score=211.29 Aligned_cols=171 Identities=23% Similarity=0.408 Sum_probs=139.9
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
.+||+|+||.||++.. ++..||||++.... ......+.+|+.+++.++|+||+++++.+.. .+..++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 95 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--------QQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVV 95 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--------hhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEE
Confidence 5699999999999987 46789999875321 1123468889999999999999999999987 5689999
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccc
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~ 963 (993)
|||+++++|.+++... .+++..++.++.|++.||+|||+.+++|+||||+||+++ .++.++|+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~----~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 96 MEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred EecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCCEEEcccccceecccc
Confidence 9999999999987543 478889999999999999999999999999999999998 5678999999998754332
Q ss_pred c-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 964 L-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 964 ~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
. ......||..|+|||++.+..+ +.+.||
T Consensus 170 ~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv 199 (292)
T cd06657 170 VPRRKSLVGTPYWMAPELISRLPY-GPEVDI 199 (292)
T ss_pred cccccccccCccccCHHHhcCCCC-CchhhH
Confidence 2 2234568999999999876543 345554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.8e-22 Score=215.71 Aligned_cols=165 Identities=27% Similarity=0.350 Sum_probs=137.1
Q ss_pred EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+|+.|-.+.. ++.++|||++.+..- -...++.+|++++..++ |+||++++++|++ +.++||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--------HsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYL 153 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--------HSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYL 153 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCc--------hHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEE
Confidence 5699999999988765 688999999987521 12357889999999997 9999999999998 678999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
|||-|.||.|...|.+... +++.++.++..+|+.||.|||.+||.||||||+|||....+ .-.-||||||.+..-...
T Consensus 154 VfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn-~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN-KVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC-CcCceeeecccccccccc
Confidence 9999999999999987654 89999999999999999999999999999999999997444 556799999998764321
Q ss_pred c--------cccCCCCCCCCcccccccc
Q 001940 963 T--------LVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 963 ~--------~~s~s~~GTp~YmAPEVL~ 982 (993)
. ....+.+|+..|||||++.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHh
Confidence 1 1123457899999999763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=220.23 Aligned_cols=170 Identities=18% Similarity=0.104 Sum_probs=127.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
...++|++.+.||+|+||+||+|.++ ++.||||++....... ......+.|.+|+.+|++|+|+||+..+..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~---~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWW---SKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccc---ccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34578999999999999999999873 5567999875321100 011234568899999999999999853322
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL-KCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI-KPeNILLd~~d~e~g~VKLi 952 (993)
.+..||||||++|++|... .. .. ...++.+++.||.|||+.||+|||| ||+|||++ .++.+||+
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~----~~~~ikLi 154 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG----PDGEAAVI 154 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc----CCCCEEEE
Confidence 1347999999999999632 11 11 1457789999999999999999999 99999997 55689999
Q ss_pred ecCCccccccccc---------cCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTLV---------SGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~~---------s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+|+....... .....+++.|+|||.+.-+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~ 197 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRER 197 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhh
Confidence 9999986543321 124568899999999975443
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-22 Score=218.22 Aligned_cols=182 Identities=21% Similarity=0.346 Sum_probs=153.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+...+|.++++||.|+|.+|..++.+ .+.+|+|++++..+...+. +.-...|-.+..+. +||.+|-+...|
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndded-----idwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDED-----IDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCccc-----chhHHhhHHHHHhccCCCeEEehhhhh
Confidence 355678999999999999999999884 5568999999876654332 23444555555544 699999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+. +.++++|.||+.||+|.-.+++.. +++++.+..+..+|+.||.|||+.|||.||||.+|+|+| ..+.+||+
T Consensus 321 qt--esrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld----aeghiklt 393 (593)
T KOG0695|consen 321 QT--ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD----AEGHIKLT 393 (593)
T ss_pred cc--cceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc----cCCceeec
Confidence 98 678999999999999998887654 488999888999999999999999999999999999999 77899999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccccccccCCccCCC
Q 001940 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 953 DFGLAk~~-~~~~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
|+|+++.. .....+..++||+.|.|||+++|..|..+
T Consensus 394 dygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfs 431 (593)
T KOG0695|consen 394 DYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFS 431 (593)
T ss_pred ccchhhcCCCCCcccccccCCCcccchhhhcccccCce
Confidence 99999964 45556778999999999999999988764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-22 Score=230.36 Aligned_cols=180 Identities=31% Similarity=0.596 Sum_probs=149.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+...+++.-.+||-|.||.||.|.|+ ...||||.++.+. ..+++|++|..+|+.++|||+|+|+|+|..
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---------MeveEFLkEAAvMKeikHpNLVqLLGVCT~ 334 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH 334 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---------hhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence 34455667789999999999999996 4568999888543 235789999999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccC-ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k-~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+..+|||+|||..|+|.++|++..+ .++...+++|+.||..|++||..+++|||||..+|+|+. ++..||++|
T Consensus 335 --EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg----EnhiVKvAD 408 (1157)
T KOG4278|consen 335 --EPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHIVKVAD 408 (1157)
T ss_pred --CCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc----ccceEEeec
Confidence 5679999999999999999987653 466677889999999999999999999999999999998 778999999
Q ss_pred cCCcccccccccc--CCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~~s--~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||++.+..+..+ ....-.+.|.|||-+.-.. .+.+.|
T Consensus 409 FGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNt-FSiKSD 448 (1157)
T KOG4278|consen 409 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNT-FSIKSD 448 (1157)
T ss_pred cchhhhhcCCceecccCccCcccccCcccccccc-cccchh
Confidence 9999988665432 2334467899999886443 334444
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-22 Score=214.59 Aligned_cols=169 Identities=24% Similarity=0.398 Sum_probs=141.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s 876 (993)
++++.+..||.|+.|.|++++.+ +...|||.+..... ....++++..+.++.+.+ +|+||+.||+|..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~N-------kee~kRILmDldvv~~s~dcpyIV~c~GyFi~-- 162 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-- 162 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCC-------HHHHHHHHHhhhHHhhccCCCeeeeeeeEEee--
Confidence 45566788999999999999885 47789999986421 122345666677666555 9999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
+...++.||.| ...+..+|++-...+++..+-++...+++||.||-.+ +|||||+||+|||+| ..|.+||||||
T Consensus 163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlD----e~GniKlCDFG 237 (391)
T KOG0983|consen 163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGNIKLCDFG 237 (391)
T ss_pred CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEc----cCCCEEeeccc
Confidence 45688999988 6778888888777899999999999999999999865 999999999999999 77899999999
Q ss_pred CccccccccccCCCCCCCCcccccccc
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
++..+.+......-.|.+.|||||.|.
T Consensus 238 IsGrlvdSkAhtrsAGC~~YMaPERid 264 (391)
T KOG0983|consen 238 ISGRLVDSKAHTRSAGCAAYMAPERID 264 (391)
T ss_pred ccceeecccccccccCCccccCccccC
Confidence 999887776666677999999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-24 Score=224.25 Aligned_cols=184 Identities=24% Similarity=0.394 Sum_probs=148.6
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc--
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD-- 874 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d-- 874 (993)
...|+.+.+||+|.||.||+|+. .++.||+|++--.. +++-.-....+|+.+|..|+|+|++.++.+|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen------eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN------EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc------cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 34577778999999999999977 46678888654211 111112356789999999999999999888753
Q ss_pred ----CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 875 ----GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 875 ----~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+....+|||+++| ..+|..+|.+....++..++.+++.+++.||.|+|+..|+|||+|++|+||+ .++++|
T Consensus 90 Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt----~dgilk 164 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFC-EHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT----KDGILK 164 (376)
T ss_pred CCcccccceeeeeHHHh-hhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc----CCceEE
Confidence 2234599999999 5699999998877799999999999999999999999999999999999998 678999
Q ss_pred EEecCCcccccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++...... .....+-|++|++||.++|..-++...||
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDi 212 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDI 212 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchh
Confidence 99999997543221 12334569999999999999999999886
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=222.76 Aligned_cols=185 Identities=22% Similarity=0.228 Sum_probs=133.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEE------------------cCcceEEEEeeccccCCCchh-H-----HHHHHHHH
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW------------------RGSDVAIKRIKASCFAGKPSE-R-----ERLIADFW 851 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~------------------kgt~VAVKvIkk~~~~~k~~e-r-----e~~ie~f~ 851 (993)
.+..++|++.++||+|+||+||+|.+ .++.||||+++.......... + ....+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 35678999999999999999999964 245699999864321100000 0 00112344
Q ss_pred HHHHHHhhcCCCCc-----ceEEEEEEcC------CCCcEEEEEeeccCCcHHHHHHhcc--------------------
Q 001940 852 KEALLLSSLHHPNV-----VSFYGIVRDG------PDGSLATVTEFMVNGSLKQFLQKKD-------------------- 900 (993)
Q Consensus 852 rEi~ILr~LrHPNI-----VrL~G~f~d~------s~~~L~LVmEYm~GGSL~dlL~~~~-------------------- 900 (993)
.|+.++.+++|.++ ++++++|... ..+..||||||+.+++|.++|....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 57777888876654 6777776531 1356899999999999999986431
Q ss_pred ---CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCC--CCCCCCc
Q 001940 901 ---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--VRGTLPW 975 (993)
Q Consensus 901 ---k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s--~~GTp~Y 975 (993)
..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++.......... ..+|+.|
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~----~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT----VDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC----CCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 1234567888999999999999999999999999999998 557899999999975533222222 2347899
Q ss_pred cccccccCC
Q 001940 976 MAPELLSGK 984 (993)
Q Consensus 976 mAPEVL~Gk 984 (993)
+|||++...
T Consensus 377 ~aPE~l~~~ 385 (507)
T PLN03224 377 SPPEELVMP 385 (507)
T ss_pred eChhhhcCC
Confidence 999998643
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.5e-21 Score=197.81 Aligned_cols=160 Identities=18% Similarity=0.180 Sum_probs=129.0
Q ss_pred cCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEeecc
Q 001940 811 GTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888 (993)
Q Consensus 811 GgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmEYm~ 888 (993)
|.||.||++++ +++.+|+|++.... .+.+|...+....||||+++++++.+ ....++||||+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAE 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCC
Confidence 89999999988 47789999987542 12234445556679999999999887 567999999999
Q ss_pred CCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCC
Q 001940 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968 (993)
Q Consensus 889 GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s 968 (993)
+++|.+++.+.. .+++..+..++.|++.||.|||+.+|+||||||+||+++ .++.++|+|||++...... ...
T Consensus 69 ~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~df~~~~~~~~~--~~~ 141 (237)
T cd05576 69 GGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD----DRGHIQLTYFSRWSEVEDS--CDG 141 (237)
T ss_pred CCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc----CCCCEEEecccchhccccc--ccc
Confidence 999999987654 488999999999999999999999999999999999998 5678999999987655433 223
Q ss_pred CCCCCCccccccccCCccCCCCCCC
Q 001940 969 VRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 969 ~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..++..|+|||++.+..+ +.+.||
T Consensus 142 ~~~~~~y~aPE~~~~~~~-~~~~Dv 165 (237)
T cd05576 142 EAVENMYCAPEVGGISEE-TEACDW 165 (237)
T ss_pred CCcCccccCCcccCCCCC-CchhhH
Confidence 456778999999876544 345554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-22 Score=204.00 Aligned_cols=173 Identities=31% Similarity=0.482 Sum_probs=139.8
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHh-hcCCCCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS-SLHHPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr-~LrHPNIVrL~G~f~d 874 (993)
..+++..+..||+|++|.|=+-++ .|+..|+|.+..... .+..++++.|+.+.. ...+|.+|.+||.+.+
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r 116 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR 116 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhhc
Confidence 344556667899999998755544 688899999986422 233456777887655 4469999999998887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEE
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.+..|+.||.| ..+|..+.++ ++..+++..+-+|+..++.||.|||++ .+||||+||+||||+ ..|+||
T Consensus 117 --egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn----~~GqVK 189 (282)
T KOG0984|consen 117 --EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN----YDGQVK 189 (282)
T ss_pred --cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc----cCCcEE
Confidence 67899999999 6788777653 456789999999999999999999976 999999999999999 667999
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
|||||+|..+.++...+.-.|...|||||.+...
T Consensus 190 iCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e 223 (282)
T KOG0984|consen 190 ICDFGISGYLVDSIAKTMDAGCKPYMAPERINPE 223 (282)
T ss_pred EcccccceeehhhhHHHHhcCCCccCChhhcCcc
Confidence 9999999988776555556688899999998643
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-22 Score=233.99 Aligned_cols=180 Identities=27% Similarity=0.427 Sum_probs=151.3
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|+.+..+|.|+||.|||+++ +++..|||+++...-. .+.-+.+|+.+++.++|+|||.++|.|..
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--------d~~~iqqei~~~~dc~h~nivay~gsylr- 83 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--------DFSGIQQEIGMLRDCRHPNIVAYFGSYLR- 83 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--------cccccccceeeeecCCCcChHHHHhhhhh-
Confidence 467899999999999999999988 4778999999875322 12356789999999999999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+|++||||.+|+|.+...-.+ .+++.++.+.+++.++||+|||+.|-+|||||-.|||++ ..+.+||+|||
T Consensus 84 -~dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt----d~gDvklaDfg 157 (829)
T KOG0576|consen 84 -RDKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT----DEGDVKLADFG 157 (829)
T ss_pred -hcCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcCCcccccccccceeec----ccCceeecccC
Confidence 578999999999999999775544 589999999999999999999999999999999999998 67899999999
Q ss_pred Ccccccccc-ccCCCCCCCCcccccccc--CCccCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLS--GKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~--Gk~y~tse~D 992 (993)
.+-.+.... ....+.||+.|||||+-. .+.-+....|
T Consensus 158 vsaqitati~KrksfiGtpywmapEvaaverkggynqlcd 197 (829)
T KOG0576|consen 158 VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCD 197 (829)
T ss_pred chhhhhhhhhhhhcccCCccccchhHHHHHhccccccccc
Confidence 988776553 345788999999999763 3444444444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-23 Score=219.04 Aligned_cols=178 Identities=28% Similarity=0.398 Sum_probs=145.2
Q ss_pred EEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC---
Q 001940 804 EVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG--- 878 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~--- 878 (993)
-.+.||-|+||.||.+.+ +++.||+|++... ..+....+++.+|+++|..++|.|++..+++.+-..-+
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv------fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV------FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchH------HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence 346799999999999887 5888999987642 12334457899999999999999999998887643211
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+|+|+|+| ..+|..+|-.. ..++...++-+.+||++||+|||+.+|+||||||.|+|++ .+..+||||||+++
T Consensus 131 EiYV~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVN----SNCvLKICDFGLAR 204 (449)
T KOG0664|consen 131 ELYVLTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVN----SNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEec----cCceEEeccccccc
Confidence 367888888 56787776543 4588888888999999999999999999999999999998 88999999999999
Q ss_pred ccccccc--cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTLV--SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+.... .+..+-|..|+|||++.|..+++..+||
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDi 241 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDI 241 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccce
Confidence 7654432 2334468899999999999999999997
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=185.82 Aligned_cols=177 Identities=33% Similarity=0.526 Sum_probs=145.5
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
|++.+.||.|++|.||++... +..+|||.+...... ...+.+.+|+..++.++|+||+++++++.. ...
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFED--PEP 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeec--CCc
Confidence 567889999999999999885 578999998864321 234578899999999999999999999887 467
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.++++||+.+++|.+++......+++..+..++.+++.+|.+||+.+++|+||++.||+++ ..+.++|+|||++..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~----~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG----MDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeeCceeeE
Confidence 8999999999999999976543378889999999999999999999999999999999998 557899999999887
Q ss_pred ccccc--ccCCCCCCCCcccccccc-CCccCCCCCC
Q 001940 960 KQQTL--VSGGVRGTLPWMAPELLS-GKSHMVTEKE 992 (993)
Q Consensus 960 ~~~~~--~s~s~~GTp~YmAPEVL~-Gk~y~tse~D 992 (993)
..... ......++..|++||.+. ...+.. +.|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~~D 182 (225)
T smart00221 148 IHRDLAALLKTVKGTPFYLAPEVLLGGKGYGE-AVD 182 (225)
T ss_pred ecCcccccccceeccCCcCCHhHhcCCCCCCc-hhh
Confidence 65432 233456888999999983 333332 555
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.6e-22 Score=213.99 Aligned_cols=175 Identities=26% Similarity=0.440 Sum_probs=141.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHH-HhhcCCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL-LSSLHHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~I-Lr~LrHPNIVrL~G~f 872 (993)
++..++++-+..||.|+||+|+|-.++ ++..|||+|+.... +...++++.|... ++.-++||||++||++
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 344556666788999999999998774 77899999986532 2334567777775 4556799999999998
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHh----ccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCC
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~----~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g 947 (993)
.. ++..||.||+| ..+|..+.+. ....+++..+-.|+..++.||.||-. ..||||||||+|||++ ..|
T Consensus 133 F~--EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILld----r~G 205 (361)
T KOG1006|consen 133 FS--EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLD----RHG 205 (361)
T ss_pred hc--CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEe----cCC
Confidence 87 67799999999 6777766543 23458888888999999999999986 5999999999999999 667
Q ss_pred eEEEEecCCccccccccccCCCCCCCCccccccccCC
Q 001940 948 VCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
.|||||||++..+..+...+.-.|...|||||.|.-.
T Consensus 206 ~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 206 DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred CEeeecccchHhHHHHHHhhhccCCccccChhccCCc
Confidence 9999999999988776655566788999999999643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=232.81 Aligned_cols=165 Identities=22% Similarity=0.351 Sum_probs=131.7
Q ss_pred ceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
++..+.||+|+||.||+|++ .+..||||+++.... ....|+.++++++|||||+++++|.+ ...
T Consensus 692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~l~~l~HpnIv~~~~~~~~--~~~ 757 (968)
T PLN00113 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------------IPSSEIADMGKLQHPNIVKLIGLCRS--EKG 757 (968)
T ss_pred CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------------ccHHHHHHHhhCCCCCcceEEEEEEc--CCC
Confidence 44557899999999999987 477899998864321 11245778999999999999999987 467
Q ss_pred EEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 880 LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH---GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLH---s~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.++||||+++|+|.++++. +++..+.+|+.||+.||+||| +.+|+||||||+|||++ .++..++. ||.
T Consensus 758 ~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~----~~~~~~~~-~~~ 828 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID----GKDEPHLR-LSL 828 (968)
T ss_pred CEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC----CCCceEEE-ecc
Confidence 8999999999999999953 789999999999999999999 66999999999999998 44455554 665
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
....... ....||+.|||||++.+.. ++.++||
T Consensus 829 ~~~~~~~---~~~~~t~~y~aPE~~~~~~-~~~~sDv 861 (968)
T PLN00113 829 PGLLCTD---TKCFISSAYVAPETRETKD-ITEKSDI 861 (968)
T ss_pred ccccccC---CCccccccccCcccccCCC-CCcccch
Confidence 5433221 2336899999999998765 4567786
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=222.32 Aligned_cols=174 Identities=20% Similarity=0.234 Sum_probs=120.5
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
+..++|++.++||+|+||.||+|++. +..||||++.... ..+ ....| .++...+.++..++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~e----~~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AVE----IWMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hhH----HHHHH--HHHhhchhhHHHHHH
Confidence 45678999999999999999999884 5679999876421 111 01111 112222222222221
Q ss_pred EE----EcCCCCcEEEEEeeccCCcHHHHHHhccCc-------------------cCHHHHHHHHHHHHHHHHHHHhCCc
Q 001940 871 IV----RDGPDGSLATVTEFMVNGSLKQFLQKKDRT-------------------IDRRKRLIIAMDAAFGMEYLHGKNI 927 (993)
Q Consensus 871 ~f----~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~-------------------Lse~~~lkIalQIL~GLeYLHs~gI 927 (993)
.+ .......+++||||+.+++|.+++...... .....+..|+.||+.||.|||+.+|
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 11 112256799999999999999998754211 1123456789999999999999999
Q ss_pred eecCCCCCCEEEccCCCCCCeEEEEecCCccccccc--cccCCCCCCCCccccccccCCc
Q 001940 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 928 IHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~--~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+||||||+|||++. ..+.+||+|||+|+..... .......||+.|||||++....
T Consensus 277 iHRDLKP~NILl~~---~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 277 VHRDVKPQNIIFSE---GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred EeCcCCHHHEEEeC---CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence 99999999999972 2468999999999865332 2234567999999999775443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=226.74 Aligned_cols=178 Identities=30% Similarity=0.490 Sum_probs=142.7
Q ss_pred CCceEEEEecccCceEEEEEEEc---Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k---gt--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+++++.++||+|.||.|++|.|+ ++ .||||+++...... +..+|++|+.+|.+|+|+|+|+|||+..+
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-------~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-------IMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-------hHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 34556688999999999999995 33 48999998654321 45689999999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHh-ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~-~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
..+.||||+++.|+|.+.|++ ....+--..+..++.||+.||.||.++++|||||..+|||+- ....|||+|
T Consensus 183 ---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla----sprtVKI~D 255 (1039)
T KOG0199|consen 183 ---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA----SPRTVKICD 255 (1039)
T ss_pred ---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec----ccceeeeec
Confidence 357899999999999999987 334455666778999999999999999999999999999998 456899999
Q ss_pred cCCccccccccccC----CCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTLVSG----GVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~~s~----s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||.+.+....... ...-...|+|||.|+..++ +.+.|
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSD 297 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASD 297 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccc-cccch
Confidence 99999765433221 2223567999999985543 44444
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.3e-21 Score=202.52 Aligned_cols=189 Identities=25% Similarity=0.299 Sum_probs=149.6
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
+...+.+++|++.+.||+|||+.||+++. ++..+|+|++.... .+.++...+|+...++++||||+++++
T Consensus 14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~d 85 (302)
T KOG2345|consen 14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVD 85 (302)
T ss_pred CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHH
Confidence 34456788999999999999999999985 57779999987542 122456789999999999999999988
Q ss_pred EEEcC---CCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccC
Q 001940 871 IVRDG---PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMR 942 (993)
Q Consensus 871 ~f~d~---s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~ 942 (993)
+.... .....||++.|+..|+|.+.+++ ++..+++.+.++|+.+|++||++||+.. ++||||||.|||++
T Consensus 86 h~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-- 163 (302)
T KOG2345|consen 86 HQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-- 163 (302)
T ss_pred HHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec--
Confidence 75432 13458999999999999998875 3457999999999999999999999997 99999999999998
Q ss_pred CCCCCeEEEEecCCccccccccc----------cCCCCCCCCccccccccCCccC--CCCCCC
Q 001940 943 DPQRPVCKIGDLGLSKVKQQTLV----------SGGVRGTLPWMAPELLSGKSHM--VTEKEL 993 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~~~----------s~s~~GTp~YmAPEVL~Gk~y~--tse~DI 993 (993)
..+.++|.|||.+....-... .....=|..|+|||.+.-+.+. ++++||
T Consensus 164 --~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDI 224 (302)
T KOG2345|consen 164 --DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDI 224 (302)
T ss_pred --CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccch
Confidence 567899999999875321100 0112247899999999766554 344554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.6e-20 Score=176.94 Aligned_cols=173 Identities=36% Similarity=0.613 Sum_probs=142.8
Q ss_pred ecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 808 LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
||+|.+|.||++... ++.++||++....... ..+.+.+|+..++.++|++|+++++++.. ....+++||
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEe
Confidence 689999999999996 7889999988543211 23578899999999999999999999987 477999999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCC-CCeEEEEecCCcccccccc
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIGDLGLSKVKQQTL 964 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e-~g~VKLiDFGLAk~~~~~~ 964 (993)
|+.+++|.+++......++...+..++.+++.+|.+||+.+++|+||+|.||+++ . .+.++|+|||++.......
T Consensus 72 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~----~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD----SDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe----CCCCcEEEecCCceEEccCCc
Confidence 9999999999987644588999999999999999999999999999999999998 4 5789999999988654432
Q ss_pred -ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 965 -VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 965 -~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
......++..|++||.+......+.+.||
T Consensus 148 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~ 177 (215)
T cd00180 148 SLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177 (215)
T ss_pred chhhcccCCCCccChhHhcccCCCCchhhh
Confidence 12234578899999999765344455553
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=219.92 Aligned_cols=182 Identities=31% Similarity=0.481 Sum_probs=147.2
Q ss_pred cCCCceEEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcce
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVS 867 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVr 867 (993)
..++.++.+.||+|.||.|++|..+ ...||||.++..... ...+.+..|+.+|+.+. |+||+.
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-------~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-------SEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-------HHHHHHHHHHHHHHHhcCCcchhh
Confidence 3344456669999999999999753 335899988865321 23457889999999986 999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI 932 (993)
++|+|.. .+.+++|+||+..|+|.++|+... ..+.....+.++.||+.|++||.+..+|||||
T Consensus 367 llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 367 LLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred heeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 9999998 678999999999999999998776 34888899999999999999999999999999
Q ss_pred CCCCEEEccCCCCCCeEEEEecCCcccccccccc--CCCCC--CCCccccccccCCccCCCCCCC
Q 001940 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS--GGVRG--TLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 933 KPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s--~s~~G--Tp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+|||+. .+..+||+|||+|+........ ..-.| ...|||||.+.. ..++.+.||
T Consensus 445 AaRNVLi~----~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDV 504 (609)
T KOG0200|consen 445 AARNVLIT----KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDV 504 (609)
T ss_pred hhhhEEec----CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Ccccccchh
Confidence 99999998 6689999999999954332211 11222 345999999998 667777776
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8.9e-21 Score=224.12 Aligned_cols=173 Identities=30% Similarity=0.449 Sum_probs=136.4
Q ss_pred EEecccCceE-EEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGS-VYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGt-VYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.+|.|+.|+ ||+|.+.++.||||++-..++ ....+|+.+|+..+ |||||++|+.-++ ...+||+
T Consensus 515 eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~-----------~~A~rEi~lL~eSD~H~NviRyyc~E~d--~qF~YIa 581 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYEGREVAVKRLLEEFF-----------DFAQREIQLLQESDEHPNVIRYYCSEQD--RQFLYIA 581 (903)
T ss_pred HHcccCCCCcEEEEEeeCCceehHHHHhhHhH-----------HHHHHHHHHHHhccCCCceEEEEeeccC--CceEEEE
Confidence 5689999985 799999999999998765432 34568999998886 9999999876544 6789999
Q ss_pred EeeccCCcHHHHHHhccCccCH---HHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC-CCCeEEEEecCCccc
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDR---RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP-QRPVCKIGDLGLSKV 959 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse---~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~-e~g~VKLiDFGLAk~ 959 (993)
.|.| ..+|.++++........ ...+.++.|++.||.+||+.+||||||||.||||+..+. ...+++|+|||+|+.
T Consensus 582 lELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred ehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 9999 78999999874211111 234667889999999999999999999999999986432 347899999999997
Q ss_pred ccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 960 KQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 960 ~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... ...+..||-+|+|||++..... ...+||
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDi 697 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDI 697 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhcccc-Ccccch
Confidence 65432 2345679999999999986654 336665
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-20 Score=183.03 Aligned_cols=167 Identities=32% Similarity=0.498 Sum_probs=139.5
Q ss_pred CceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEeeccC
Q 001940 812 TYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVN 889 (993)
Q Consensus 812 gFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmEYm~G 889 (993)
+||.||+|++. ++.+|+|++........ .+.+.+|+.++++++|+||+++++.+.. ....+++|||+.+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-------RERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-------HHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCC
Confidence 58999999985 58899999875432110 3578899999999999999999999887 4679999999999
Q ss_pred CcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCC
Q 001940 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969 (993)
Q Consensus 890 GSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~ 969 (993)
++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|+||+++ .++.++|+|||++............
T Consensus 72 ~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~----~~~~~~l~d~~~~~~~~~~~~~~~~ 146 (244)
T smart00220 72 GDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD----EDGHVKLADFGLARQLDPGGLLTTF 146 (244)
T ss_pred CCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC----CCCcEEEccccceeeeccccccccc
Confidence 999999976544 78899999999999999999999999999999999998 5578999999999876654344456
Q ss_pred CCCCCccccccccCCccCCCCCCC
Q 001940 970 RGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 970 ~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++..|++||++.+..... +.||
T Consensus 147 ~~~~~~~~pE~~~~~~~~~-~~Di 169 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGK-AVDV 169 (244)
T ss_pred cCCcCCCCHHHHccCCCCc-hhhH
Confidence 7899999999997655433 6664
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-18 Score=172.79 Aligned_cols=179 Identities=34% Similarity=0.550 Sum_probs=146.8
Q ss_pred ceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC-CcceEEEEEEcCCCCcE
Q 001940 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP-NVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP-NIVrL~G~f~d~s~~~L 880 (993)
|++.+.||.|+|+.||++.+. ..+|+|.+........ .....+.+|+.+++.+.|+ +|+++++.+.. ....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~-----~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKS-----KEVERFLREIQILASLNHPPNIVKLYDFFQD--EGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccch-----hHHHHHHHHHHHHHHccCCcceeeEEEEEec--CCEE
Confidence 778899999999999999988 7789999886533221 2345788999999999988 79999999965 4558
Q ss_pred EEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC-eEEEEecCCc
Q 001940 881 ATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLS 957 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g-~VKLiDFGLA 957 (993)
+++++|+.+++|.+++.... ..+.......++.|++.+|.|+|+.+++||||||+|||++ ... .++++|||++
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~----~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD----RDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec----CCCCeEEEeccCcc
Confidence 99999999999997776654 2588899999999999999999999999999999999998 444 7999999999
Q ss_pred ccccccc-------ccCCCCCCCCccccccccCC--ccCCCCCC
Q 001940 958 KVKQQTL-------VSGGVRGTLPWMAPELLSGK--SHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~-------~s~s~~GTp~YmAPEVL~Gk--~y~tse~D 992 (993)
+...... ......||..|+|||++.+. .......|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D 193 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSD 193 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHh
Confidence 8544332 23566799999999999885 45555555
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=199.92 Aligned_cols=177 Identities=23% Similarity=0.270 Sum_probs=145.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--C----CcceEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--P----NVVSFY 869 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--P----NIVrL~ 869 (993)
...+|++..+||+|+||.|-.+.++ +..||||+++... +..+...-|+.+|.+|.+ | -+|++.
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---------kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---------KYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---------HHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 4678999999999999999999774 5679999998542 223455678899999842 2 278888
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-----
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD----- 943 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d----- 943 (993)
+||.. .++.|||+|.+ |-+++++|.+. ...++..++..|+.||+.+++|||+.+++|-||||+|||+...+
T Consensus 158 ~wFdy--rghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 158 DWFDY--RGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred hhhhc--cCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 88887 78899999988 88999999874 46689999999999999999999999999999999999985332
Q ss_pred -----------CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCC
Q 001940 944 -----------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 944 -----------~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
.....|||+|||.|....+.. ..++.|--|+|||+|+|.++..
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~ 288 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQ 288 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCC
Confidence 224579999999998766554 4567899999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=181.88 Aligned_cols=146 Identities=24% Similarity=0.167 Sum_probs=108.7
Q ss_pred EEecccCceEEEEEEE-cCcceEEEEeeccccCCCch------------------hHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS------------------ERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~------------------ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
..||+|+||.||+|.. +++.||||+++......... .+........+|+.++.++.+++|.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 5799999999999987 58899999998653211110 0011122345699999999887764
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCCEEEccCCCC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL-HGKNIVHFDLKCENLLVNMRDPQ 945 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYL-Hs~gIIHRDIKPeNILLd~~d~e 945 (993)
....+... ..+|||||+.+++|...+.+. ..++...++.++.||+.+|.+| |+.||+||||||+|||++ .
T Consensus 83 ~p~~~~~~----~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~----~ 153 (190)
T cd05147 83 CPEPILLK----SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH----D 153 (190)
T ss_pred CCcEEEec----CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----C
Confidence 43333222 238999999888776553332 3578889999999999999999 799999999999999997 2
Q ss_pred CCeEEEEecCCccccc
Q 001940 946 RPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 946 ~g~VKLiDFGLAk~~~ 961 (993)
+.++|+|||+|....
T Consensus 154 -~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 -GKLYIIDVSQSVEHD 168 (190)
T ss_pred -CcEEEEEccccccCC
Confidence 479999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.3e-19 Score=205.55 Aligned_cols=180 Identities=21% Similarity=0.287 Sum_probs=149.1
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC------CCC
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH------HPN 864 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr------HPN 864 (993)
.+.++...+|.+....|+|-|++|.+|.+ .+..||||+|.... .+-+.-++|+.+|++|. --+
T Consensus 425 ~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---------~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 425 RIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---------VMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---------HHhhhhhHHHHHHHHhhccCchhhhH
Confidence 34456678899999999999999999988 47789999998653 23346678999999996 357
Q ss_pred cceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccC--ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC
Q 001940 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (993)
Q Consensus 865 IVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k--~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~ 942 (993)
+++|+..|.. .++||||+|-+ ..+|.++|++.+. .+...++..++.|+..||..|-..||+|.||||+|||++.
T Consensus 496 clrl~r~F~h--knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE- 571 (752)
T KOG0670|consen 496 CLRLFRHFKH--KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNE- 571 (752)
T ss_pred HHHHHHHhhh--cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEecc-
Confidence 8999998888 67899999988 7899999998654 3777888999999999999999999999999999999972
Q ss_pred CCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCC
Q 001940 943 DPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
...++||||||.|........+ .+.-+-.|.|||+|+|.+|..
T Consensus 572 --~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~ 614 (752)
T KOG0670|consen 572 --SKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDY 614 (752)
T ss_pred --CcceeeeccCcccccccccccc-HHHHHHhccCcceeecCcccC
Confidence 5679999999998866544332 223355799999999998875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-20 Score=195.29 Aligned_cols=172 Identities=23% Similarity=0.346 Sum_probs=145.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
..++|++.+++|.|.++.||.|.. ++++++||+++... -+.+.+|+.||..|. ||||++++++..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----------kkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----------KKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----------HHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 457899999999999999999985 67889999998542 136779999999998 9999999999999
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
+......||+||+.+.+...+.. +++...+.+++.++++||.|+|+.||+|||+||.|++||. ....++|+|+
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh---~~rkLrlIDW 177 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH---ELRKLRLIDW 177 (338)
T ss_pred ccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech---hhceeeeeec
Confidence 87778899999999988887764 3667778889999999999999999999999999999983 5568999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
|+|.........+-.+.+-.|--||++-.-..+
T Consensus 178 GLAEFYHp~~eYnVRVASRyfKGPELLVdy~~Y 210 (338)
T KOG0668|consen 178 GLAEFYHPGKEYNVRVASRYFKGPELLVDYQMY 210 (338)
T ss_pred chHhhcCCCceeeeeeehhhcCCchheeechhc
Confidence 999988776655556677788899988654433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-18 Score=174.14 Aligned_cols=147 Identities=22% Similarity=0.153 Sum_probs=110.9
Q ss_pred EEEecccCceEEEEEEEc-CcceEEEEeeccccCCC------------------chhHHHHHHHHHHHHHHHhhcCCCCc
Q 001940 805 VRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGK------------------PSERERLIADFWKEALLLSSLHHPNV 865 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k------------------~~ere~~ie~f~rEi~ILr~LrHPNI 865 (993)
.+.||+|+||.||+|... ++.||||+++....... ..........+.+|...+.++.+++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999999874 89999999986532100 00111122345689999999999988
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHH-HHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCC
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQF-LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dl-L~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d 943 (993)
.....+... ..+|||||+.++++... +.. ..++......++.|++.+|.+||+ .||+||||||+|||++
T Consensus 82 ~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~--- 152 (190)
T cd05145 82 PVPEPILLK----KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH--- 152 (190)
T ss_pred CCceEEEec----CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE---
Confidence 554444332 13899999988755443 433 346778889999999999999999 9999999999999996
Q ss_pred CCCCeEEEEecCCcccccc
Q 001940 944 PQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~ 962 (993)
++.++|+|||+++....
T Consensus 153 --~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 --DGKPYIIDVSQAVELDH 169 (190)
T ss_pred --CCCEEEEEcccceecCC
Confidence 25799999999986644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.6e-19 Score=193.00 Aligned_cols=179 Identities=24% Similarity=0.346 Sum_probs=146.6
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|.-+..+|.|.- .|.-|-+ .+++||+|++... +...... ++..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~a-----kra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHA-----KRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccc-----hhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 456778888999987 6655654 5889999988765 3333333 35678999999999999999999986421
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
....|+||||| ..+|..++.. .++-+.+.+|.+|++.|++|||+.+|+||||||+||++. ..+.+||.
T Consensus 89 ~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~----~~~~lKi~ 160 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVN----SDCTLKIL 160 (369)
T ss_pred cHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceec----chhheeec
Confidence 12479999999 7789888863 377888999999999999999999999999999999998 77899999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+........+.++.|-.|.|||++.|.. +...+||
T Consensus 161 dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdi 200 (369)
T KOG0665|consen 161 DFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDI 200 (369)
T ss_pred cchhhcccCcccccCchhheeeccCchheeccC-Ccccchh
Confidence 999999877665566778899999999999988 6666765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=202.01 Aligned_cols=173 Identities=23% Similarity=0.287 Sum_probs=138.4
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHh-hcCCCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS-SLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr-~LrHPNIVrL~G~f~d~ 875 (993)
.++|++...||.|+|+.|-++.. +++..++|++.+... +..+|+.++. .-+|+||+++.+.+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------------~~~~e~~~~~~~~~h~niv~~~~v~~~- 387 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------------DNQDEIPISLLVRDHPNIVKSHDVYED- 387 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc------------ccccccchhhhhcCCCcceeecceecC-
Confidence 46788888899999999999877 467789999986521 2234664544 4469999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....|+|||++.|+.|.+.+..... +. ..+..|+.+|+.|+.|||++|||||||||+|||++ ...+.++|+|||
T Consensus 388 -~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG 461 (612)
T KOG0603|consen 388 -GKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFG 461 (612)
T ss_pred -CceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEec
Confidence 5779999999999998888766543 22 66778999999999999999999999999999995 156789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++..... ....+-|..|.|||++... -++..+||
T Consensus 462 ~a~~~~~~--~~tp~~t~~y~APEvl~~~-~yt~acD~ 496 (612)
T KOG0603|consen 462 FWSELERS--CDTPALTLQYVAPEVLAIQ-EYTEACDW 496 (612)
T ss_pred hhhhCchh--hcccchhhcccChhhhccC-CCCcchhh
Confidence 99987766 2334568899999999854 44455554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=179.09 Aligned_cols=175 Identities=22% Similarity=0.306 Sum_probs=139.6
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC-CCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH-PNIVrL~G~f~ 873 (993)
+....|+++++||.|+||.+|.|.. .|..||||+-....... .+..|..+.+.|++ ..|..+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----------qL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----------QLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----------chhHHHHHHHHhccCCCCchhhhhcc
Confidence 4567899999999999999999987 68999999876543211 45678888888874 56666666655
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ ...-.||||.+ |.+|.++++-..+.++..+++-++-|++.-++|+|.+++|||||||+|+|..-.. ....+.|+|
T Consensus 82 e--~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LID 157 (341)
T KOG1163|consen 82 E--KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLID 157 (341)
T ss_pred c--cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEEe
Confidence 5 45678999988 9999999987777899999999999999999999999999999999999997443 456899999
Q ss_pred cCCcccccccc--------ccCCCCCCCCccccccccCCc
Q 001940 954 LGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 954 FGLAk~~~~~~--------~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+|+...+.. ......||..|++=-...|.+
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e 197 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE 197 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhh
Confidence 99999654332 224567999998866555443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=169.29 Aligned_cols=143 Identities=18% Similarity=0.240 Sum_probs=115.7
Q ss_pred EEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
+.||+|++|.||+|.+.+..|+||+...................+.+|+.++..+.|++|.....++.+ ....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD--PENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe--CCCCEEEEE
Confidence 579999999999999999999999876543322222222234568899999999999998777666665 356789999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
|++|++|.+++.... . .+..++.+++.+|.+||+.+++|+||+|+|||++ .+.++|+|||+++..
T Consensus 80 ~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-----~~~~~liDf~~a~~~ 144 (211)
T PRK14879 80 YIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-----GGKIYLIDFGLAEFS 144 (211)
T ss_pred EeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-----CCCEEEEECCcccCC
Confidence 999999999986532 2 7788899999999999999999999999999997 357999999998854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-17 Score=181.94 Aligned_cols=178 Identities=21% Similarity=0.246 Sum_probs=136.7
Q ss_pred CceEEEEecccCceEEEEEEEcCc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC----CCCcceEEEEEE
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH----HPNVVSFYGIVR 873 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt---~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr----HPNIVrL~G~f~ 873 (993)
.|++.++||+|+||.||++..... .+|+|+.......... .+..|..++..+. ..++..+++...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--------~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--------VLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--------cchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 899999999999999999998543 5888887654222110 3445777777776 357888888774
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKL 951 (993)
......||||+.+ |.+|.++..... +.++..+++.|+.|++.+|++||+.|+|||||||+|+++...+ .....+.|
T Consensus 91 -~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 91 -STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred -CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEE
Confidence 1256789999987 999999987654 6799999999999999999999999999999999999998543 12257999
Q ss_pred EecCCcc--cccccc--------c-cCCCCCCCCccccccccCCccCC
Q 001940 952 GDLGLSK--VKQQTL--------V-SGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 952 iDFGLAk--~~~~~~--------~-s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
.|||+|+ ...... . ...+.||..|+++.+..+.+...
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r 216 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGR 216 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCC
Confidence 9999998 321110 1 23456999999999887776543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.7e-18 Score=175.55 Aligned_cols=143 Identities=19% Similarity=0.247 Sum_probs=106.5
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-----CCCCcceEEEEEEcCC-C
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-----HHPNVVSFYGIVRDGP-D 877 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-----rHPNIVrL~G~f~d~s-~ 877 (993)
-.+.||+|+||.||.-..... .+||++...... ..+.+.+|+.+++.+ .||||++++|++.+.. .
T Consensus 6 ~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~--------~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~ 76 (210)
T PRK10345 6 EQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG--------GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT 76 (210)
T ss_pred CcceecCCCceEEEECCCCcC-eEEEEEeccccc--------hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence 347899999999996222333 368887653211 124678999999999 5799999999998842 1
Q ss_pred Cc-EEEEEee--ccCCcHHHHHHhccCccCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 878 GS-LATVTEF--MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 878 ~~-L~LVmEY--m~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GL-eYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+. +.+|||| +.+++|.+++++. .+++. ..++.+++.++ +|||+.+|+||||||+|||++..+.....++|+|
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 34 3478999 5579999999763 25554 34567888887 8999999999999999999986544456899999
Q ss_pred -cCCccc
Q 001940 954 -LGLSKV 959 (993)
Q Consensus 954 -FGLAk~ 959 (993)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 555443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-18 Score=192.55 Aligned_cols=176 Identities=22% Similarity=0.322 Sum_probs=144.2
Q ss_pred CCCceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f 872 (993)
...|...++||+|+|++||++.+ +...||+|.+...... .++..|+++|..+. +.||+++.+.+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----------~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----------SRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----------hHHHHHHHHHHHhccchhhhcchhhh
Confidence 35688899999999999999976 3456999988754322 25778999999886 99999999998
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. ++...+||||++..+..+++.. ++-..+..+++.++.||.++|.+|||||||||.|+|.+.. .+.-.|+
T Consensus 105 rn--nd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~---t~rg~Lv 175 (418)
T KOG1167|consen 105 RN--NDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRR---TQRGVLV 175 (418)
T ss_pred cc--CCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccc---cCCceEE
Confidence 87 6789999999999999998864 5677888899999999999999999999999999999844 4567899
Q ss_pred ecCCccccc-----------------c--c-------c-------------------ccCCCCCCCCccccccccCCccC
Q 001940 953 DLGLSKVKQ-----------------Q--T-------L-------------------VSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 953 DFGLAk~~~-----------------~--~-------~-------------------~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
|||+|...+ . . . ......||++|+|||++.+.+..
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999986110 0 0 0 00123499999999999999999
Q ss_pred CCCCCC
Q 001940 988 VTEKEL 993 (993)
Q Consensus 988 tse~DI 993 (993)
++++||
T Consensus 256 ttaiDi 261 (418)
T KOG1167|consen 256 TTAIDI 261 (418)
T ss_pred CCccce
Confidence 999997
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.4e-17 Score=166.11 Aligned_cols=140 Identities=21% Similarity=0.237 Sum_probs=109.9
Q ss_pred EecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEee
Q 001940 807 ELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmEY 886 (993)
.||+|+||.||+|.+.+..|++|+..................++.+|+.+++.+.|++|.....++.. ....++||||
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD--PDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE--CCCCEEEEEE
Confidence 38999999999999999999999876543332222233334678899999999998875544444444 3456899999
Q ss_pred ccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 887 MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 887 m~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
++|++|.+++..... .++.+++.+|.+||+.+++|+||||+|||++ .+.++|+|||+++...
T Consensus 79 ~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-----~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 79 IEGKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-----DDKLYLIDFGLGKYSD 140 (199)
T ss_pred ECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-----CCcEEEEECCCCcCCC
Confidence 999999998754321 6788999999999999999999999999997 3579999999988643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=181.35 Aligned_cols=178 Identities=20% Similarity=0.293 Sum_probs=144.0
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~ 873 (993)
+..-.|++.++||+|+||.+|.|+. +++.||||.-....-+ -.+..|....+.|. .++|..+|-+-+
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----------PQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----------PQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCc----------chHHHHHHHHHHHcCCCCCCceeeecc
Confidence 4566799999999999999999976 7999999965432211 24556777777775 789999876655
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCC-CCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ-RPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e-~g~VKLi 952 (993)
+ .-+-.||||++ |-+|.|++.-.++.++-.+++-||.|++.-++|+|++.+|.|||||+|+||...+.. ...|.|+
T Consensus 95 e--G~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 95 E--GKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred c--cchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEE
Confidence 5 34567899988 999999999888889999999999999999999999999999999999999866532 3578999
Q ss_pred ecCCccccccccc--------cCCCCCCCCccccccccCCccC
Q 001940 953 DLGLSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 953 DFGLAk~~~~~~~--------s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
|||+|+.+.+..+ ..+..||..||+=-.-+|.+.+
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS 214 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS 214 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhh
Confidence 9999998765533 2456799999997776666543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=189.05 Aligned_cols=144 Identities=22% Similarity=0.209 Sum_probs=115.1
Q ss_pred ceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEE
Q 001940 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~ 881 (993)
|...+.||+|+||+||++.+.+..+++|+........+........+++.+|+.+++.++|++|+....++.+ ....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--PEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe--CCCCE
Confidence 3556889999999999999988777777654332222222222334678899999999999999887776665 34578
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+||||+++++|.+++. ....++.+++.+|.+||+.+|+||||||+|||++ ++.++|+|||+++...
T Consensus 413 lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-----~~~~~liDFGla~~~~ 478 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-----DDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-----CCcEEEEeCcccccCC
Confidence 9999999999999885 3457889999999999999999999999999994 3479999999998654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.8e-18 Score=180.39 Aligned_cols=169 Identities=24% Similarity=0.347 Sum_probs=133.0
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s 876 (993)
+.|.+.+.||+|-||.+-+++++ ++.+|+|.+.... ..+++|.+|...--.|. |.||+.-|++-...
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---------tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt- 93 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---------TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT- 93 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---------hhHHHHHHHhccceeeccchhhhHHHHHHhhc-
Confidence 56888899999999999999996 5668999776432 23568889987655554 89999988764443
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++++||++-|+|..-+...+ +.+...++++.|++.||+|||++++||||||.+||||-.. ...+|||||||+
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--df~rvKlcDFG~ 169 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--DFYRVKLCDFGL 169 (378)
T ss_pred CceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC--CccEEEeeeccc
Confidence 467889999999999998776643 7888899999999999999999999999999999999744 456999999999
Q ss_pred ccccccccccCCCCCCCCccccccccCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
++...... ....-+..|.+||+....
T Consensus 170 t~k~g~tV--~~~~~~~~y~~pe~~~~~ 195 (378)
T KOG1345|consen 170 TRKVGTTV--KYLEYVNNYHAPELCDTV 195 (378)
T ss_pred ccccCcee--hhhhhhcccCCcHHHhhc
Confidence 87543321 122245678999976533
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=169.70 Aligned_cols=151 Identities=21% Similarity=0.113 Sum_probs=112.5
Q ss_pred CceEEEEecccCceEEEEEE-E--cCcceEEEEeeccccCCC----------------chhHHHHHHHHHHHHHHHhhcC
Q 001940 801 DLEEVRELGSGTYGSVYHGK-W--RGSDVAIKRIKASCFAGK----------------PSERERLIADFWKEALLLSSLH 861 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk-~--kgt~VAVKvIkk~~~~~k----------------~~ere~~ie~f~rEi~ILr~Lr 861 (993)
.|++.+.||+|+||.||+|. . +++.||||+++....... ...+......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48888999999999999998 3 688999999986432110 0111222345678999999997
Q ss_pred CCC--cceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCCEE
Q 001940 862 HPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN-IVHFDLKCENLL 938 (993)
Q Consensus 862 HPN--IVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g-IIHRDIKPeNIL 938 (993)
+.. +.+++++ ...++||||+.+.+|..++... ..+....+..++.||+.+|.+||+.| |+||||||+|||
T Consensus 109 ~~~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe------cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 632 3444432 1248999999998887654332 23556667889999999999999999 999999999999
Q ss_pred EccCCCCCCeEEEEecCCccccccc
Q 001940 939 VNMRDPQRPVCKIGDLGLSKVKQQT 963 (993)
Q Consensus 939 Ld~~d~e~g~VKLiDFGLAk~~~~~ 963 (993)
++ .+.++|+|||++......
T Consensus 182 i~-----~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 182 VH-----DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred EE-----CCCEEEEEChhhhccCCc
Confidence 97 247999999998865443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-16 Score=166.41 Aligned_cols=148 Identities=12% Similarity=0.117 Sum_probs=117.9
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHH------HHHHHHHHhhcCCCCcce
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIAD------FWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~------f~rEi~ILr~LrHPNIVr 867 (993)
...+...+|++++.||.|+||.||++..++..+|||+++..... .+..+.. +.+|+..+.++.|++|..
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 33456789999999999999999998777788999999765321 1222223 678999999999999999
Q ss_pred EEEEEEcCC------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 868 FYGIVRDGP------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 868 L~G~f~d~s------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
+..++.... .+..+|||||++|.+|.++.. +++ ....+++.+|..||+.|++||||||+|||++
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~- 169 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS- 169 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe-
Confidence 998876432 235799999999999988742 222 2355899999999999999999999999997
Q ss_pred CCCCCCeEEEEecCCcccc
Q 001940 942 RDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 942 ~d~e~g~VKLiDFGLAk~~ 960 (993)
.++ ++|+|||.++..
T Consensus 170 ---~~g-i~liDfg~~~~~ 184 (232)
T PRK10359 170 ---KNG-LRIIDLSGKRCT 184 (232)
T ss_pred ---CCC-EEEEECCCcccc
Confidence 445 999999988755
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.3e-16 Score=162.86 Aligned_cols=136 Identities=19% Similarity=0.129 Sum_probs=106.2
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcEEE
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L~L 882 (993)
+...|++|+||+||.+...+.+++.+.+...... .+......+.+|+.+|++|. +++|++++++ +..++
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~----~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~------~~~~l 75 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWW----LRGVAWWLARREALALRQLDGLPRTPRLLHW------DGRHL 75 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhh----hhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE------cCEEE
Confidence 4578999999999988888888887777654321 11122235789999999995 5889999886 23699
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL-KCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI-KPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+|||+.|.+|...+.. ....++.|++.+|++||+.||+|||| ||+|||++ .++.++|+|||+|....
T Consensus 76 vmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~----~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 76 DRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ----EDGSPAVIDFQLAVRGN 143 (218)
T ss_pred EEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc----CCCCEEEEECCCceecC
Confidence 9999999998765421 11346779999999999999999999 79999997 55689999999998543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.1e-16 Score=158.76 Aligned_cols=144 Identities=18% Similarity=0.025 Sum_probs=107.9
Q ss_pred ceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCch--------------hHHHHHHHHHHHHHHHhhcCCCC--
Q 001940 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPS--------------ERERLIADFWKEALLLSSLHHPN-- 864 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~--------------ere~~ie~f~rEi~ILr~LrHPN-- 864 (993)
|.+.+.||+|+||.||++.. +++.||||++.......... ........+.+|+.++..+.+.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 67778999999999999988 58899999987542110000 00111234678899999998874
Q ss_pred cceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC
Q 001940 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 865 IVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~ 944 (993)
+...++. ...++||||+.+++|..+... .....++.+|+.++.+||+.+|+||||||+|||++
T Consensus 97 v~~~~~~------~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---- 159 (198)
T cd05144 97 VPKPIDW------NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---- 159 (198)
T ss_pred CCceeec------CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc----
Confidence 4444432 345899999999998775431 23456788999999999999999999999999998
Q ss_pred CCCeEEEEecCCcccccc
Q 001940 945 QRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~~ 962 (993)
.++.++|+|||++.....
T Consensus 160 ~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 160 DDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcEEEEECCccccCCC
Confidence 567899999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-16 Score=191.36 Aligned_cols=133 Identities=20% Similarity=0.246 Sum_probs=99.3
Q ss_pred hcCC-CCcceEEEEEEcC-----CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 001940 859 SLHH-PNVVSFYGIVRDG-----PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (993)
Q Consensus 859 ~LrH-PNIVrL~G~f~d~-----s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI 932 (993)
.+.| .||.+++++|... ....++++|||+ +++|.++|......+++..++.|+.||+.||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4445 5788888877221 124678889987 77999999866666899999999999999999999999999999
Q ss_pred CCCCEEEccCC---------------CCCCeEEEEecCCccccccc-----------------cccCCCCCCCCcccccc
Q 001940 933 KCENLLVNMRD---------------PQRPVCKIGDLGLSKVKQQT-----------------LVSGGVRGTLPWMAPEL 980 (993)
Q Consensus 933 KPeNILLd~~d---------------~e~g~VKLiDFGLAk~~~~~-----------------~~s~s~~GTp~YmAPEV 980 (993)
||+||||+..+ ...+.+||+|||+++..... ......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 99999996311 13456788888887642110 00112458999999999
Q ss_pred ccCCccCCCCCCC
Q 001940 981 LSGKSHMVTEKEL 993 (993)
Q Consensus 981 L~Gk~y~tse~DI 993 (993)
+.+..+ ..++||
T Consensus 187 ~~~~~~-~~~sDV 198 (793)
T PLN00181 187 DNGSSS-NCASDV 198 (793)
T ss_pred hccCCC-Cchhhh
Confidence 988765 667776
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-15 Score=168.79 Aligned_cols=136 Identities=24% Similarity=0.320 Sum_probs=113.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-----C---CCcc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----H---PNVV 866 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-----H---PNIV 866 (993)
+...+|.+.++||-|-|++||+|.++ .+.||+|+.+... ...+....||.+|++++ | ..||
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---------hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---------HYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---------HHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 45589999999999999999999885 5669999988542 23346678999999884 2 4599
Q ss_pred eEEEEEEcC-C-CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccC
Q 001940 867 SFYGIVRDG-P-DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMR 942 (993)
Q Consensus 867 rL~G~f~d~-s-~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~ 942 (993)
+|++.|... . ..++|||+|++ |.+|..+|... .+.++...++.|++||+.||.|||+. ||||-||||+|||+...
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 999999752 2 34789999999 88999999865 35689999999999999999999975 99999999999999743
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.1e-15 Score=165.51 Aligned_cols=186 Identities=24% Similarity=0.387 Sum_probs=144.8
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
.++...+++...++-+|+||.||+|.|+. +.|-+|.++.. ..+..+..++.|..++..+.|||+..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-------AS~iQv~~~L~es~lly~~sH~nll~ 351 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-------ASQIQVNLLLQESMLLYGASHPNLLS 351 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-------ccHHHHHHHHHHHHHHhcCcCCCccc
Confidence 34556678888899999999999998743 23566665532 23344568899999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHh-------ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~-------~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd 940 (993)
+.+++.+. ....+.++.++.-|+|..+|.. ..+.++..+...++.|++.|++|||+.+|||.||..+|.+|+
T Consensus 352 V~~V~ie~-~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 352 VLGVSIED-YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVID 430 (563)
T ss_pred eeEEEeec-cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceeh
Confidence 99998874 4567788999988999999972 224577778889999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 941 MRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 941 ~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...|||+|-.+++..-... .....-....||+||.+.++.| ++..|+
T Consensus 431 ----d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDv 481 (563)
T KOG1024|consen 431 ----DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDV 481 (563)
T ss_pred ----hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhh
Confidence 67899999999998653321 1122224678999999986644 445553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=135.52 Aligned_cols=134 Identities=22% Similarity=0.157 Sum_probs=109.8
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--CCcceEEEEEEcCCCCcEE
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--PNIVrL~G~f~d~s~~~L~ 881 (993)
+.+.||+|.++.||++...+..++||+...... ...+.+|+.+++.+++ ..+++++.++.. .+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGES--DGWSY 69 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccE
Confidence 357899999999999999888899998865321 2367789999999986 589999888765 46789
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~---gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
++|||+.+..+..+ +......++.+++.+|.+||.. +++|+||||+|||++ ..+.++|+|||+++
T Consensus 70 ~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~----~~~~~~l~Df~~~~ 137 (155)
T cd05120 70 LLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD----DGKILGIIDWEYAG 137 (155)
T ss_pred EEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE----CCcEEEEEeccccc
Confidence 99999988877654 4455566788999999999985 799999999999998 45789999999987
Q ss_pred ccc
Q 001940 959 VKQ 961 (993)
Q Consensus 959 ~~~ 961 (993)
...
T Consensus 138 ~~~ 140 (155)
T cd05120 138 YGP 140 (155)
T ss_pred CCC
Confidence 543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.3e-14 Score=144.76 Aligned_cols=144 Identities=21% Similarity=0.083 Sum_probs=98.0
Q ss_pred EEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhH----------------HHHHHHHHHHHHHHhhcCCC--Cc
Q 001940 805 VRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSER----------------ERLIADFWKEALLLSSLHHP--NV 865 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~er----------------e~~ie~f~rEi~ILr~LrHP--NI 865 (993)
.+.||+|+||+||+|... ++.||||+++........... .........|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999886 888999998754321111000 00001123566666666543 34
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHH-HHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCC
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQ-FLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~d-lL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d 943 (993)
.+.++. ...++||||+.++.+.. .+.... . ......++.+++.++.+||. .+|+||||||+||+++
T Consensus 82 ~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~--- 149 (187)
T cd05119 82 PKPIDL------NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD--- 149 (187)
T ss_pred CceEec------CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE---
Confidence 555543 23589999999854321 121111 1 15567889999999999999 9999999999999997
Q ss_pred CCCCeEEEEecCCcccccc
Q 001940 944 PQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~ 962 (993)
++.++|+|||++.....
T Consensus 150 --~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 --DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred --CCcEEEEECcccccccC
Confidence 35799999999975544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-14 Score=152.01 Aligned_cols=146 Identities=15% Similarity=0.139 Sum_probs=107.4
Q ss_pred EEec-ccCceEEEEEEEcCcceEEEEeeccccCCCch-----hHHHHHHHHHHHHHHHhhcCCCCc--ceEEEEEEcCCC
Q 001940 806 RELG-SGTYGSVYHGKWRGSDVAIKRIKASCFAGKPS-----ERERLIADFWKEALLLSSLHHPNV--VSFYGIVRDGPD 877 (993)
Q Consensus 806 e~LG-eGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~-----ere~~ie~f~rEi~ILr~LrHPNI--VrL~G~f~d~s~ 877 (993)
..|| .|+.|+||+++..+..+|||.+.......+-. .......++.+|+.++..|.|++| ++.+++......
T Consensus 37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~ 116 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG 116 (239)
T ss_pred ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence 4577 88899999998888999999986533211100 001123467889999999998875 677776543211
Q ss_pred C--cEEEEEeeccC-CcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 G--SLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~--~L~LVmEYm~G-GSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
. ..++||||+++ .+|.+++... .++.. .+.+|+.+|.+||+.||+||||||+|||++ .++.++|+||
T Consensus 117 ~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~----~~~~v~LIDf 186 (239)
T PRK01723 117 LFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD----PDGKFWLIDF 186 (239)
T ss_pred cceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc----CCCCEEEEEC
Confidence 1 23599999997 6999988653 24433 356899999999999999999999999998 4458999999
Q ss_pred CCccccc
Q 001940 955 GLSKVKQ 961 (993)
Q Consensus 955 GLAk~~~ 961 (993)
|.+....
T Consensus 187 g~~~~~~ 193 (239)
T PRK01723 187 DRGELRT 193 (239)
T ss_pred CCcccCC
Confidence 9987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.8e-15 Score=179.01 Aligned_cols=179 Identities=21% Similarity=0.263 Sum_probs=133.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---CCCcceEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGI 871 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---HPNIVrL~G~ 871 (993)
.+....|.+-+.||+|+||.||+|.. +++.||||+-+..+.-. |.--.+++.+|+ -+-|+.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----------FYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----------eeehHHHHHhhchhhhcchHHHHHH
Confidence 45567899999999999999999977 57889999877543211 111122344444 1234444444
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC---CCCCCe
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPV 948 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~---d~e~g~ 948 (993)
+.. .+.-+||+||.+.|+|.++++ ..+.+++..++.|+.|+++.++.||..+|||+||||+|.||... +....-
T Consensus 763 ~~~--~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 763 HVF--QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred Hcc--CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 333 233478999999999999998 44568999999999999999999999999999999999999633 223567
Q ss_pred EEEEecCCcccc---ccccccCCCCCCCCccccccccCCccCC
Q 001940 949 CKIGDLGLSKVK---QQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 949 VKLiDFGLAk~~---~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
++|+|||.|.-+ .+........+|-.+-.+|+..|.++.+
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtY 882 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTY 882 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCch
Confidence 999999998743 2233445567888999999999998765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.9e-15 Score=176.27 Aligned_cols=181 Identities=28% Similarity=0.381 Sum_probs=137.3
Q ss_pred eEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
...+.+|.|++|.|+..... .+..+.|..... .... .........+..|+.+-..|+|+||+..+..+.+. ...
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~-~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~--~~~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPT-ESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI--DGI 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCc-ccHHHHhhhhhhheeecccccCCchhhhHHHHhhc--ccc
Confidence 44578999999977776552 333455543321 1011 11222233377888888999999998887776663 233
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
.-+||||+. +|+.++.... .+....+-.++.|++.||+|||..||.|||||++|+|+. ..+.+||+|||.+...
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~----~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT----ENGILKIIDFGAASVF 470 (601)
T ss_pred hhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe----cCCceEEeecCcceee
Confidence 444999999 9999997653 477888888999999999999999999999999999998 6779999999998764
Q ss_pred ccc-----cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 961 QQT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 961 ~~~-----~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... .....++|+-.|+|||++.+.+|....+||
T Consensus 471 ~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDi 508 (601)
T KOG0590|consen 471 RYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDV 508 (601)
T ss_pred ccCcchhhhhhcCcccCCcCcCcccccccccCcchhhh
Confidence 322 334577899999999999999999998886
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.6e-14 Score=165.58 Aligned_cols=160 Identities=28% Similarity=0.383 Sum_probs=130.1
Q ss_pred EecccCceEEEEEE-----EcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcE
Q 001940 807 ELGSGTYGSVYHGK-----WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 807 ~LGeGgFGtVYKAk-----~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L 880 (993)
.+|+|+||.|++++ +.+.-+|+|++++.....+... ....|..++..++ ||.+|++...++. ++.+
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~------~t~~er~il~~~~~~~f~v~lhyafqt--~~kl 72 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT------HTKQERIILAFVHNTPFLVKLHYAFQT--DGKL 72 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc------ccccHHHHHhhccCCCceeeeeeeecc--ccch
Confidence 37999999999753 2456689999887655443322 3345677888887 9999999988887 6789
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
+++++|+.+|+|...+.+... +.+.....+..+++.+++++|+.+|++||+|++||+++ .+|.+|+.|||+++..
T Consensus 73 ~l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld----~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 73 YLILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLL----LEGHIKLTDFGLSKEA 147 (612)
T ss_pred hHhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeec----ccCccccCCchhhhHh
Confidence 999999999999999877655 44555555556899999999999999999999999999 7889999999999976
Q ss_pred ccccccCCCCCCCCcccccccc
Q 001940 961 QQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 961 ~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
-..... |||..|||||++.
T Consensus 148 v~~~~~---cgt~eymApEI~~ 166 (612)
T KOG0603|consen 148 VKEKIA---CGTYEYRAPEIIN 166 (612)
T ss_pred Hhhhhc---ccchhhhhhHhhh
Confidence 554433 8999999999998
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.2e-12 Score=144.32 Aligned_cols=184 Identities=22% Similarity=0.303 Sum_probs=128.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------------------------------------cceEEEEeeccccCC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------------------------------------SDVAIKRIKASCFAG 838 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------------------------------------t~VAVKvIkk~~~~~ 838 (993)
.+..++|++.+.||+|....||.|+... .+.|||.+..-...
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~- 231 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD- 231 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC-
Confidence 3456789999999999999999875421 01466765432211
Q ss_pred CchhHHHHHHHHHHHHH--------------HHhh--------cCCCCcceEEEEEEcC---------------------
Q 001940 839 KPSERERLIADFWKEAL--------------LLSS--------LHHPNVVSFYGIVRDG--------------------- 875 (993)
Q Consensus 839 k~~ere~~ie~f~rEi~--------------ILr~--------LrHPNIVrL~G~f~d~--------------------- 875 (993)
+....+.+...+|.. ..+. -+|||||+++++|.+.
T Consensus 232 --s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 --SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred --CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 223334444444421 1112 2599999999987431
Q ss_pred ----CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 876 ----PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 876 ----s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
....+|+||.-+ ..+|.+++-... .+.....-|+.|+++|+.|||+.||.|||+|.+||||..++..-..+.|
T Consensus 310 ~g~g~~~tlylvMkrY-~~tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRY-RQTLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred cccCCCceEEEehhcc-hhhHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEE
Confidence 123589999988 679999987553 4666777788899999999999999999999999999887767788999
Q ss_pred EecCCccccccc-------cccCCCCCCCCccccccccCCc
Q 001940 952 GDLGLSKVKQQT-------LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 952 iDFGLAk~~~~~-------~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+|||++--.+.. .-.-...|.-.-||||+....+
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999987532221 0111334788899999986443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.2e-11 Score=142.47 Aligned_cols=148 Identities=18% Similarity=0.151 Sum_probs=99.0
Q ss_pred EEecccCceEEEEEEE-cCcceEEEEeeccccCCCc--------------------------h----hHHH--HHHHHHH
Q 001940 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP--------------------------S----ERER--LIADFWK 852 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~--------------------------~----ere~--~ie~f~r 852 (993)
+.||.|++|.||+|+. +|+.||||+.+......-. . .... ..-+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5699999999999998 5889999998654210000 0 0000 0013556
Q ss_pred HHHHHhhcC----CCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHH-HHHHHHhCCc
Q 001940 853 EALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF-GMEYLHGKNI 927 (993)
Q Consensus 853 Ei~ILr~Lr----HPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~-GLeYLHs~gI 927 (993)
|...+.+++ +.+-+.+-.++.+. .+..+|||||++|++|.+++.......+ ...++..++. .+..+|..|+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 666666663 33333333333332 2346899999999999987654322222 3345556655 4788999999
Q ss_pred eecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 928 IHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+|+|+||.||+++ .++.++|+|||++....
T Consensus 279 ~H~D~hPgNilv~----~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVL----KDGKIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEEC----CCCcEEEEeCCCeeECC
Confidence 9999999999997 55789999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.1e-11 Score=119.22 Aligned_cols=130 Identities=15% Similarity=0.058 Sum_probs=95.5
Q ss_pred EEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc-eEEEEEEcCCCCcEEEE
Q 001940 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDGPDGSLATV 883 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV-rL~G~f~d~s~~~L~LV 883 (993)
++.|+.|.++.||+++..+..+++|+....... ...+.+|+.+++.+...+++ +++.... ...++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~---------~~~~~~E~~~l~~l~~~~~~P~~~~~~~----~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL---------LINRENEAENSKLAAEAGIGPKLYYFDP----ETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCccc---------ccCHHHHHHHHHHHHHhCCCCceEEEeC----CCCeEE
Confidence 467899999999999998899999987643210 11345788888888655544 4554432 224799
Q ss_pred EeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 884 TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI-----VHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 884 mEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gI-----IHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
|||++|.++.... . ....++.+++++|..||+.++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-----~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-----DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-----CCeEEEEeccccc
Confidence 9999998876530 1 112346789999999999875 9999999999997 2368999999987
Q ss_pred ccc
Q 001940 959 VKQ 961 (993)
Q Consensus 959 ~~~ 961 (993)
...
T Consensus 136 ~~~ 138 (170)
T cd05151 136 MND 138 (170)
T ss_pred CCC
Confidence 543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.2e-10 Score=120.72 Aligned_cols=154 Identities=19% Similarity=0.178 Sum_probs=116.6
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEE
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LV 883 (993)
.+..|-+|+-+.|+++.+.|+.++||.-.......+........++..+|+.+|.+++--.|.--.-+|.+. ..-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~--~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT--YGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec--CCCeEE
Confidence 457899999999999999999999997665555555445555567888999999998755554443345552 345789
Q ss_pred EeeccC-CcHHHHHHhccCccCHH-HHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 884 TEFMVN-GSLKQFLQKKDRTIDRR-KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 884 mEYm~G-GSL~dlL~~~~k~Lse~-~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
|||++| -++.+++......-... ....++..|-..|.-||..+|||+||.++|||+..++ ....+.|+|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~-~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG-NQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-CcCceEEEeecchhcc
Confidence 999976 37888876543322333 3367888999999999999999999999999998665 5556789999998753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.5e-11 Score=141.94 Aligned_cols=152 Identities=18% Similarity=0.245 Sum_probs=96.2
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccC---------------------C----C-chhHHHHH-----
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA---------------------G----K-PSERERLI----- 847 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~---------------------~----k-~~ere~~i----- 847 (993)
+|+. +.||+|++|.||+|+.+ |+.||||+++..... . + ...-....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 68999999999999984 789999999754210 0 0 00000111
Q ss_pred -HHHHHHHHHHhhcC----CCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHH--HHhccC---ccCHHHHHHHHHHHHH
Q 001940 848 -ADFWKEALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF--LQKKDR---TIDRRKRLIIAMDAAF 917 (993)
Q Consensus 848 -e~f~rEi~ILr~Lr----HPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dl--L~~~~k---~Lse~~~lkIalQIL~ 917 (993)
-++.+|...+.+++ +.+.+.+-.++.+- .+..+|||||+.|+.|.++ +...+. .+.+..+..++
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~----- 273 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF----- 273 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence 13455555555553 44445444444432 2346899999999999875 332221 12222222233
Q ss_pred HHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 918 GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..+...|++|+|+||.||+++.++...+.++++|||++....
T Consensus 274 --~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 --TQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred --HHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 334568999999999999998554455699999999987653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=3e-11 Score=118.74 Aligned_cols=87 Identities=22% Similarity=0.334 Sum_probs=73.7
Q ss_pred CcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCC
Q 001940 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969 (993)
Q Consensus 890 GSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~ 969 (993)
|+|.+++...+..+++..++.|+.||+.||.|||+.+ ||+|||++ .++.+|+ ||+++...... .
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~----~~~~~~~--fG~~~~~~~~~----~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT----WDGLLKL--DGSVAFKTPEQ----S 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc----Cccceee--ccceEeecccc----C
Confidence 6899999876667999999999999999999999988 99999998 5678888 99988764432 2
Q ss_pred CCCCCccccccccCCccCCCCCCC
Q 001940 970 RGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 970 ~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.||+.|||||++.+..+ ..++||
T Consensus 65 ~g~~~y~aPE~~~~~~~-~~~~Di 87 (176)
T smart00750 65 RVDPYFMAPEVIQGQSY-TEKADI 87 (176)
T ss_pred CCcccccChHHhcCCCC-cchhhH
Confidence 58999999999988765 457775
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.9e-10 Score=119.39 Aligned_cols=140 Identities=19% Similarity=0.171 Sum_probs=104.8
Q ss_pred EEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEe
Q 001940 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTE 885 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmE 885 (993)
..|++|+-+.+|.+.+.+..+++|.--......+.........+..+|+.++.+++--.|..-+=+..+ .+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCEEEEE
Confidence 358899999999999988888888655555554444444445678899999998874444332223334 234578999
Q ss_pred eccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 886 FMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 886 Ym~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
|++|-.|.++|... ...++..+-.-+.-||..||+|+||.++||++. .+.+.++||||++..
T Consensus 80 ~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~-----~~~i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILS-----GGRIYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEe-----CCcEEEEECCccccc
Confidence 99999999898765 234667777788899999999999999999997 234999999999853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.6e-10 Score=119.28 Aligned_cols=143 Identities=18% Similarity=0.088 Sum_probs=100.1
Q ss_pred EEecccCceEEEEEEEc--------CcceEEEEeeccccCCC------------------chhHHHHHHHHHHHHHHHhh
Q 001940 806 RELGSGTYGSVYHGKWR--------GSDVAIKRIKASCFAGK------------------PSERERLIADFWKEALLLSS 859 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--------gt~VAVKvIkk~~~~~k------------------~~ere~~ie~f~rEi~ILr~ 859 (993)
..||.|.-+.||.|... +..+|||+++......+ ...+........+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999764 36899999875432111 01122222234489999999
Q ss_pred cCC--CCcceEEEEEEcCCCCcEEEEEeeccCCcHH-HHHHhccCccCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCC
Q 001940 860 LHH--PNVVSFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYL-HGKNIVHFDLKCE 935 (993)
Q Consensus 860 LrH--PNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~-dlL~~~~k~Lse~~~lkIalQIL~GLeYL-Hs~gIIHRDIKPe 935 (993)
|.- -++.+.+++ ...+|||||+.+..+. ..|++. .++......+..+++.+|..| |+.+|||+||++.
T Consensus 83 l~~~Gv~vP~pi~~------~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL------KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe------cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 863 466677664 2358999999765442 223222 244555667788999999998 8999999999999
Q ss_pred CEEEccCCCCCCeEEEEecCCccccc
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
|||++ ++.++|+|||.+-...
T Consensus 155 NIL~~-----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-----CCcEEEEECCCceeCC
Confidence 99996 2469999999886554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-11 Score=150.92 Aligned_cols=171 Identities=19% Similarity=0.162 Sum_probs=126.4
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+|...+.||.+.|=+|.+|+++...|+||++-+....-. .+..++..+|++ .+.+++||++.+..+-.. +...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~s----L~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t--~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTIS----LRPFKQRLEEIK-FALMKAPNCLPFQKVLVT--DKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCC----chHHHHHHHHHH-HHhhcCCcccchHHHHHh--hHHH
Confidence 677889999999999999999877799999876542211 122233445555 677889999998766444 4556
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
|||=+|+ .-+|+|.|..+. .+...+.+.|+.||+.||..+|+.||+|+|||.+||||+ .-.-+.|+||..=|-.
T Consensus 97 ylvRqyv-khnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT----SWNW~~LtDFAsFKPt 170 (1431)
T KOG1240|consen 97 YLVRQYV-KHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT----SWNWLYLTDFASFKPT 170 (1431)
T ss_pred HHHHHHH-hhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe----eechhhhhcccccCCc
Confidence 7888887 569999997654 578888899999999999999999999999999999998 5567899999765421
Q ss_pred ----ccccccCCCC----CCCCccccccccCC
Q 001940 961 ----QQTLVSGGVR----GTLPWMAPELLSGK 984 (993)
Q Consensus 961 ----~~~~~s~s~~----GTp~YmAPEVL~Gk 984 (993)
+......-+. .-..|.|||.+-..
T Consensus 171 YLPeDNPadf~fFFDTSrRRtCYiAPERFv~~ 202 (1431)
T KOG1240|consen 171 YLPEDNPADFTFFFDTSRRRTCYIAPERFVSA 202 (1431)
T ss_pred cCCCCCcccceEEEecCCceeeecChHhhhcc
Confidence 1111111111 22469999988643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.7e-10 Score=122.13 Aligned_cols=169 Identities=20% Similarity=0.255 Sum_probs=104.4
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC----------CCcceEE
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH----------PNVVSFY 869 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH----------PNIVrL~ 869 (993)
+...+.||.|+|+.||.+++. ++++|||+........ ....+.+.+|......+.+ -.++--+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~-----~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADAS-----ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTH-----TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccc-----hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 466789999999999999994 6889999987654221 1224456666544444322 1122222
Q ss_pred EEEE---------cCC-CC-----cEEEEEeeccCCcHHHHHHh---ccC---ccCHHHHHHHHHHHHHHHHHHHhCCce
Q 001940 870 GIVR---------DGP-DG-----SLATVTEFMVNGSLKQFLQK---KDR---TIDRRKRLIIAMDAAFGMEYLHGKNIV 928 (993)
Q Consensus 870 G~f~---------d~s-~~-----~L~LVmEYm~GGSL~dlL~~---~~k---~Lse~~~lkIalQIL~GLeYLHs~gII 928 (993)
+... ... .. ..+++|+-+ .++|.+++.. ... .+....++.+..|+++.+.+||+.||+
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV 167 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLV 167 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceE
Confidence 2211 111 01 246777776 7788887652 221 244456677889999999999999999
Q ss_pred ecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCcccccccc
Q 001940 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 929 HRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
|+||||+|+|++ .+|.++|+||+........... ...+..|.+||...
T Consensus 168 Hgdi~~~nfll~----~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 168 HGDIKPENFLLD----QDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELES 215 (288)
T ss_dssp EST-SGGGEEE-----TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHH
T ss_pred ecccceeeEEEc----CCCCEEEcChHHHeecCceeec--cCCCcccCChhhhh
Confidence 999999999999 7789999999876654433222 23457799999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=7.6e-11 Score=143.93 Aligned_cols=137 Identities=29% Similarity=0.482 Sum_probs=96.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|..+++|..|+||.||..+++ .+.+|+|+ ++..+ |++ ||..+ .+
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-------------------ilR-----nilt~----a~-- 130 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-------------------ILR-----NILTF----AG-- 130 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-------------------hhh-----ccccc----cC--
Confidence 467899999999999999999875 77789854 33211 111 12222 11
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
..+.| ||-..+++.-+. ++ .+++.+++|||+.+|+|||+||+|+||+ .-|++|++|||+
T Consensus 131 --npfvv------gDc~tllk~~g~-lP--------vdmvla~Eylh~ygivhrdlkpdnllIT----~mGhiKlTDfgL 189 (1205)
T KOG0606|consen 131 --NPFVV------GDCATLLKNIGP-LP--------VDMVLAVEYLHSYGIVHRDLKPDNLLIT----SMGHIKLTDFGL 189 (1205)
T ss_pred --Cccee------chhhhhcccCCC-Cc--------chhhHHhHhhccCCeecCCCCCCcceee----ecccccccchhh
Confidence 12222 555566655332 22 1347899999999999999999999998 778999999999
Q ss_pred cccccc----------------ccccCCCCCCCCccccccccCCccC
Q 001940 957 SKVKQQ----------------TLVSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 957 Ak~~~~----------------~~~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
++..-. .......+||+.|.|||++..+.|.
T Consensus 190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg 236 (1205)
T KOG0606|consen 190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG 236 (1205)
T ss_pred hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccC
Confidence 885311 1123456899999999999877654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.8e-11 Score=129.52 Aligned_cols=170 Identities=26% Similarity=0.481 Sum_probs=130.2
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~ 879 (993)
.++.++-+|.+.-.|..|+|+|.+..+++|+++..... .++-++|.+|.-.|+-+.||||+.+++.|..+ ..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t------~risrdfneefp~lrifshpnilpvlgacnsp--pn 261 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVT------ARISRDFNEEFPALRIFSHPNILPVLGACNSP--PN 261 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcc------hhhcchhhhhCcceeeecCCchhhhhhhccCC--CC
Confidence 34455667888999999999999999999998865322 23445899999999999999999999999985 56
Q ss_pred EEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhC-C-ceecCCCCCCEEEccCCCCCCeEEE--Eec
Q 001940 880 LATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGK-N-IVHFDLKCENLLVNMRDPQRPVCKI--GDL 954 (993)
Q Consensus 880 L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~-g-IIHRDIKPeNILLd~~d~e~g~VKL--iDF 954 (993)
+.++..||+-|+|+.+|.... -.++..++.+++++|++|+.|||+. . |.---|....++|| ++.+.+| +|-
T Consensus 262 lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid----edltarismad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID----EDLTARISMADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec----chhhhheecccc
Confidence 899999999999999998653 3467788999999999999999987 3 34446888899998 4444444 343
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
-++.+. ....-.+.||+||.++.++..
T Consensus 338 kfsfqe------~gr~y~pawmspealqrkped 364 (448)
T KOG0195|consen 338 KFSFQE------VGRAYSPAWMSPEALQRKPED 364 (448)
T ss_pred eeeeec------cccccCcccCCHHHHhcCchh
Confidence 222211 112346789999999877654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=5.4e-11 Score=142.11 Aligned_cols=183 Identities=23% Similarity=0.252 Sum_probs=140.9
Q ss_pred CCCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
...|.+.+.||+|+|+.|-..... ...+|+|.+...... ....+....|..+-+.+. |.|++.+++...+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~------~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~ 92 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKS------EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS 92 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCc------cchhhhcCccccccccccccccccccCCccCC
Confidence 456778888999999999877552 334677766544311 112234556777777777 9999999998777
Q ss_pred CCCCcEEEEEeeccCCcHHHHH-HhccCccCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEccCCCCCC-eEEE
Q 001940 875 GPDGSLATVTEFMVNGSLKQFL-QKKDRTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDPQRP-VCKI 951 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL-~~~~k~Lse~~~lkIalQIL~GLeYLH-s~gIIHRDIKPeNILLd~~d~e~g-~VKL 951 (993)
....+++++|..++++.+.+ .......+...+-.++.|+..+|.|+| ..++.||||||+|.+++ ..+ .+|+
T Consensus 93 --~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~----~s~~~l~~ 166 (601)
T KOG0590|consen 93 --PRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD----ESGSALKI 166 (601)
T ss_pred --CcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc----cCCCcccC
Confidence 45688999999999999988 443324566667778899999999999 99999999999999998 445 8999
Q ss_pred EecCCcccccc-c---cccCCCCC-CCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQ-T---LVSGGVRG-TLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~-~---~~s~s~~G-Tp~YmAPEVL~Gk~y~tse~DI 993 (993)
.|||+|..... . ......+| ++.|+|||...+..|.....|+
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~ 213 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDV 213 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccc
Confidence 99999986544 2 22345578 9999999999998887777764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-09 Score=106.23 Aligned_cols=145 Identities=21% Similarity=0.220 Sum_probs=100.6
Q ss_pred EEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--CCcceEEEEEEcCC-CCcEE
Q 001940 806 RELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGP-DGSLA 881 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--PNIVrL~G~f~d~s-~~~L~ 881 (993)
+.|+.|.++.||++...+ +.+++|+....... .....+.+|..+++.+.+ .++.+++.+..... .+..+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF 76 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence 678999999999998865 78999987653211 012356788999999875 44677777655421 13568
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG------------------------------------- 924 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs------------------------------------- 924 (993)
+||||++|.+|.+.+.. ..++......++.+++++|..||+
T Consensus 77 ~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 77 YVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99999999887665421 124455555555666666666653
Q ss_pred -------------------CCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 925 -------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 925 -------------------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..++|+|+++.|||++.+ ..+.+.|+||+.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~--~~~~~~iID~e~~~~g~ 208 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD--EPRVVAVLDWELATLGD 208 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC--CCcEEEEEeccccccCC
Confidence 246999999999999832 14578999999887543
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >smart00666 PB1 PB1 domain | Back alignment and domain information |
|---|
Probab=98.95 E-value=4.8e-09 Score=93.73 Aligned_cols=75 Identities=49% Similarity=0.848 Sum_probs=66.0
Q ss_pred CCeeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCe
Q 001940 41 GKLRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTR 117 (993)
Q Consensus 41 ~~l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r 117 (993)
.+++| ||++|.+.|+++++|.+|+.++++.++. .+.|||+ +||-| +|++++|+||..||+.+.+.. ...
T Consensus 4 vK~~~-~~~~~~~~~~~~~s~~dL~~~i~~~~~~~~~~~~l~Y~--Dedgd-~v~l~sd~Dl~~a~~~~~~~~----~~~ 75 (81)
T smart00666 4 VKLRY-GGETRRLSVPRDISFEDLRSKVAKRFGLDNQSFTLKYQ--DEDGD-LVSLTSDEDLEEAIEEYDSLG----SKK 75 (81)
T ss_pred EEEEE-CCEEEEEEECCCCCHHHHHHHHHHHhCCCCCCeEEEEE--CCCCC-EEEecCHHHHHHHHHHHHHcC----Cce
Confidence 46778 8999999999999999999999999986 5999999 77766 999999999999999997753 356
Q ss_pred EEEEEe
Q 001940 118 LRIFLF 123 (993)
Q Consensus 118 lR~flf 123 (993)
|||++|
T Consensus 76 l~l~v~ 81 (81)
T smart00666 76 LRLHVF 81 (81)
T ss_pred EEEEeC
Confidence 899886
|
Phox and Bem1p domain, present in many eukaryotic cytoplasmic signalling proteins. The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-10 Score=130.62 Aligned_cols=107 Identities=25% Similarity=0.369 Sum_probs=87.1
Q ss_pred cEEEEEeeccCCcHHHHHHhc--cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 879 SLATVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~--~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
++||.|++|...+|.++|..+ ....++...+.++.|++.|++| ++.+|||+||.||++. .+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~----~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS----DDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc----cchhhhhhhhhh
Confidence 589999999999999999643 3456777888999999999999 9999999999999997 455899999999
Q ss_pred cccccccc-------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
........ .....+||.+||+||+|.|+.| ..++||
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdI 445 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDI 445 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcch
Confidence 77554333 2345679999999999998744 445554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.1e-08 Score=104.22 Aligned_cols=133 Identities=24% Similarity=0.160 Sum_probs=84.5
Q ss_pred EEEEEEE-cCcceEEEEeeccccCC------------------CchhHHHHHHHHHHHHHHHhhcCCC--CcceEEEEEE
Q 001940 815 SVYHGKW-RGSDVAIKRIKASCFAG------------------KPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR 873 (993)
Q Consensus 815 tVYKAk~-kgt~VAVKvIkk~~~~~------------------k~~ere~~ie~f~rEi~ILr~LrHP--NIVrL~G~f~ 873 (993)
.||.|.. .+..+|||+.+...... ....+........+|..+|.++.-- ++.+.+.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 57889999987642111 1112333456788999999999865 567776552
Q ss_pred cCCCCcEEEEEeecc--CCcHHHHHHhccCccCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 874 DGPDGSLATVTEFMV--NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY-LHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 874 d~s~~~L~LVmEYm~--GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeY-LHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
..+|||||+. |..|..+.... ++......++.+++..+.. +|+.||+|+||.+.|||++ . +.+.
T Consensus 80 -----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~-~~~~ 146 (188)
T PF01163_consen 80 -----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----D-GKVY 146 (188)
T ss_dssp -----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----T-TCEE
T ss_pred -----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----c-ceEE
Confidence 2379999998 66665544322 1133445667778875555 6799999999999999997 3 3799
Q ss_pred EEecCCccccc
Q 001940 951 IGDLGLSKVKQ 961 (993)
Q Consensus 951 LiDFGLAk~~~ 961 (993)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=9e-08 Score=104.44 Aligned_cols=144 Identities=14% Similarity=0.114 Sum_probs=97.5
Q ss_pred eEEEEEEEcCcceEEEEeeccccCCCchhHH-----HHHHHHHHHHHHHhhcCCCC--cceEEEEEEcCC---CCcEEEE
Q 001940 814 GSVYHGKWRGSDVAIKRIKASCFAGKPSERE-----RLIADFWKEALLLSSLHHPN--VVSFYGIVRDGP---DGSLATV 883 (993)
Q Consensus 814 GtVYKAk~kgt~VAVKvIkk~~~~~k~~ere-----~~ie~f~rEi~ILr~LrHPN--IVrL~G~f~d~s---~~~L~LV 883 (993)
..|++..+.|+.+.||........ ...+. .-...+.+|...+.+|..-+ .....++..... ...-+||
T Consensus 36 rrvvr~~~~g~~~~vKr~~~~~~~--~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFELAGKSYFLKWHRGTGWG--EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEEECCEEEEEEEecCCcHH--HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 446678888888999977432210 00000 00013668888887775333 334444443221 2346899
Q ss_pred EeeccCC-cHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC---CCCCCeEEEEecCCcc
Q 001940 884 TEFMVNG-SLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---DPQRPVCKIGDLGLSK 958 (993)
Q Consensus 884 mEYm~GG-SL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~---d~e~g~VKLiDFGLAk 958 (993)
||++++. +|.+++... ....+...+..++.+++..+.-||..||+|+|+++.|||++.+ +.+...+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999876 899998642 2334566777899999999999999999999999999999842 1245789999999886
Q ss_pred c
Q 001940 959 V 959 (993)
Q Consensus 959 ~ 959 (993)
.
T Consensus 194 ~ 194 (268)
T PRK15123 194 I 194 (268)
T ss_pred c
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5e-09 Score=122.17 Aligned_cols=124 Identities=35% Similarity=0.505 Sum_probs=103.1
Q ss_pred HhhcCCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCC
Q 001940 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNI-VHFDLKCE 935 (993)
Q Consensus 857 Lr~LrHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gI-IHRDIKPe 935 (993)
|+.+.|.|+.+++|.+.++ ..+++|.+||..|+|.+.+.+....+++.-...++++|+.||.|||...| .|+.++..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4678899999999999985 77999999999999999999877778888888999999999999998766 99999999
Q ss_pred CEEEccCCCCCCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCcc
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|.+++ ....+||+|||+....... .......-..-|.|||.+.+...
T Consensus 79 nClvd----~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~ 128 (484)
T KOG1023|consen 79 NCLVD----SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALS 128 (484)
T ss_pred cceee----eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccc
Confidence 99999 7889999999998766421 00111113356999999987533
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=3e-07 Score=95.80 Aligned_cols=111 Identities=21% Similarity=0.136 Sum_probs=83.2
Q ss_pred HHHHHHHHHhhcCC--CCcceEEEEEEcCC--CCcEEEEEeeccCC-cHHHHHHhccCccCHHHHHHHHHHHHHHHHHHH
Q 001940 849 DFWKEALLLSSLHH--PNVVSFYGIVRDGP--DGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH 923 (993)
Q Consensus 849 ~f~rEi~ILr~LrH--PNIVrL~G~f~d~s--~~~L~LVmEYm~GG-SL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLH 923 (993)
+..+|...+..|.. -.+.+.+++..... ...-+||||++++. +|.+++..... .+......++.+++..+.-||
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHH
Confidence 56677777777653 23455555554421 12458999999885 89999876433 556677788999999999999
Q ss_pred hCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 924 s~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..||+|+|+++.|||++.++ ....+.|+||+.++...
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HCcCCCCCCCcccEEEeCCC-CceeEEEEcchhceeCC
Confidence 99999999999999998544 45689999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=9e-08 Score=112.30 Aligned_cols=171 Identities=26% Similarity=0.269 Sum_probs=129.6
Q ss_pred ceEEEEecc--cCceEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 802 LEEVRELGS--GTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 802 Yeile~LGe--GgFGtVYKAk~----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
+-+...+|. |.+|.||.+.. ....+|+|.-+......... .+-.+|+...++++ |+|.++.+..+..
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~------~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS------KRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc------ccccchhhcccccCccccccccCccccc
Confidence 445567899 99999999877 35668888754332111111 12335666666776 9999998888887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCCEEEccCCCCC-CeE
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQR-PVC 949 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~----GLeYLHs~gIIHRDIKPeNILLd~~d~e~-g~V 949 (993)
.+.+++=+|++ +.+|..+.......++...+..+..++.. ||.++|+.+++|-|+||+||++. .+ ...
T Consensus 190 --~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~----~~~~s~ 262 (524)
T KOG0601|consen 190 --SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT----SDWTSC 262 (524)
T ss_pred --CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc----ccccee
Confidence 57799999988 68898888877666888888888888888 99999999999999999999997 44 789
Q ss_pred EEEecCCcccccccccc------CCCCCCCCccccccccCCc
Q 001940 950 KIGDLGLSKVKQQTLVS------GGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s------~s~~GTp~YmAPEVL~Gk~ 985 (993)
+++|||+...+...... ....|...|++||++.+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~ 304 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA 304 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcccc
Confidence 99999998766544322 1224777899999997653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.2e-07 Score=111.35 Aligned_cols=183 Identities=21% Similarity=0.190 Sum_probs=128.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGI 871 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~ 871 (993)
.....+|.++..||.|.|+.|++...+ +..+++|.+........ .. + .-..|+.+...+. |.+++.++..
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~d----i-~sl~ev~l~~~l~~~~~~~g~~~~ 334 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SD----I-FSLGEVILEAILGSHLPSVGKNSS 334 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hh----h-cchhhhhHhhHhhcccccCCCCCC
Confidence 345678999999999999999987653 56688887765432211 11 1 1234555555554 8888888777
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
|.. ....++=.|||+++++...+. ....+++..++++..|++.++.++|+..++|+|+||+||++.+++ +..++
T Consensus 335 W~~--~r~~~ip~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~---~~~~~ 408 (524)
T KOG0601|consen 335 WSQ--LRQGYIPLEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG---FFSKL 408 (524)
T ss_pred ccc--cccccCchhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch---hhhhc
Confidence 766 345678999999998877663 233478888899999999999999999999999999999998433 67899
Q ss_pred EecCCccccccccccCCCCCCCCcc-ccccccCCccCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWM-APELLSGKSHMVTEKE 992 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~Ym-APEVL~Gk~y~tse~D 992 (993)
.|||+.....-. ......+-+++ ..|++......-.++|
T Consensus 409 ~~~~~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~ 448 (524)
T KOG0601|consen 409 GDFGCWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKAD 448 (524)
T ss_pred ccccccccccee--cccccccccccccchhhccccccccccc
Confidence 999987642111 11222344455 3666665555555554
|
|
| >PF00564 PB1: PB1 domain; InterPro: IPR000270 The Phox and Bem1p domain, is present in many eukaryotic cytoplasmic signalling proteins | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.6e-07 Score=79.77 Aligned_cols=75 Identities=39% Similarity=0.692 Sum_probs=61.3
Q ss_pred eeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001940 43 LRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (993)
Q Consensus 43 l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR 119 (993)
++|.|+..|++.++++++|.+|+.++++.++. .+.|+|+ +|| +.+|+|++|+||..|++.+.+. +..+||
T Consensus 6 ~~~~~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~Y~--D~d-gD~V~i~sd~Dl~~a~~~~~~~----~~~~lr 78 (84)
T PF00564_consen 6 VRYGGDIRRIISLPSDVSFDDLRSKIREKFGLLDEDFQLKYK--DED-GDLVTISSDEDLQEAIEQAKES----GSKTLR 78 (84)
T ss_dssp EEETTEEEEEEEECSTSHHHHHHHHHHHHHTTSTSSEEEEEE--ETT-SSEEEESSHHHHHHHHHHHHHC----TTSCEE
T ss_pred EEECCeeEEEEEcCCCCCHHHHHHHHHHHhCCCCccEEEEee--CCC-CCEEEeCCHHHHHHHHHHHHhc----CCCcEE
Confidence 34444334569999999999999999999986 5899998 555 4899999999999999999986 334799
Q ss_pred EEEec
Q 001940 120 IFLFS 124 (993)
Q Consensus 120 ~flf~ 124 (993)
||+..
T Consensus 79 l~v~~ 83 (84)
T PF00564_consen 79 LFVQD 83 (84)
T ss_dssp EEEEE
T ss_pred EEEEe
Confidence 99863
|
The domain adopts a beta-grasp fold, similar to that found in ubiquitin and Ras-binding domains. A motif, variously termed OPR, PC and AID, represents the most conserved region of the majority of PB1 domains, and is necessary for PB1 domain function. This function is the formation of PB1 domain heterodimers, although not all PB1 domain pairs associate.; GO: 0005515 protein binding; PDB: 1IPG_A 1IP9_A 2KFK_A 1WMH_A 1VD2_A 1WI0_A 1OEY_C 1PQS_A 1Q1O_A 1TZ1_A .... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1e-06 Score=96.52 Aligned_cols=142 Identities=20% Similarity=0.048 Sum_probs=100.8
Q ss_pred ceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCC------------c--hhHHHHHHHHHHHHHHHhhcCCC--C
Q 001940 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGK------------P--SERERLIADFWKEALLLSSLHHP--N 864 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k------------~--~ere~~ie~f~rEi~ILr~LrHP--N 864 (993)
..+...||-|.-+.||.|.. ++.++|||.-+......+ . +.-........+|..+|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34568899999999999988 589999997654321100 0 01112234567899999999855 7
Q ss_pred cceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC
Q 001940 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 865 IVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~ 944 (993)
|.+-+++ +..++||||++|-.|...- ++....-.|+..|+.-+.-+-..||||+|+.+=|||++
T Consensus 173 VP~P~~~------nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---- 236 (304)
T COG0478 173 VPKPIAW------NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---- 236 (304)
T ss_pred CCCcccc------ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe----
Confidence 7777764 5679999999887765542 12233334555556556655589999999999999998
Q ss_pred CCCeEEEEecCCccc
Q 001940 945 QRPVCKIGDLGLSKV 959 (993)
Q Consensus 945 e~g~VKLiDFGLAk~ 959 (993)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 667899999976543
|
|
| >cd05992 PB1 The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.2e-06 Score=74.50 Aligned_cols=74 Identities=36% Similarity=0.657 Sum_probs=58.9
Q ss_pred CeeeecCceeEEEcc-CCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCe
Q 001940 42 KLRYVGGETRIVSLP-RDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTR 117 (993)
Q Consensus 42 ~l~YvGG~tri~~v~-r~~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~r 117 (993)
+++|- |++|.+.|+ ++++|.+|+++|.+.++. .+.|||. .||- .+|++++|+||..|++.+.+ ....+
T Consensus 4 K~~~~-~~~~~~~~~~~~~s~~~L~~~i~~~~~~~~~~~~l~y~--D~e~-d~v~l~sd~Dl~~a~~~~~~----~~~~~ 75 (81)
T cd05992 4 KVKYG-GEIRRFVVVSRSISFEDLRSKIAEKFGLDAVSFKLKYP--DEDG-DLVTISSDEDLEEAIEEARR----SGSKK 75 (81)
T ss_pred EEEec-CCCEEEEEecCCCCHHHHHHHHHHHhCCCCCcEEEEee--CCCC-CEEEeCCHHHHHHHHHHHhh----cCCcc
Confidence 34555 566777777 999999999999999986 4677777 5553 78999999999999999977 34467
Q ss_pred EEEEEe
Q 001940 118 LRIFLF 123 (993)
Q Consensus 118 lR~flf 123 (993)
+|++++
T Consensus 76 l~l~v~ 81 (81)
T cd05992 76 LRLFVF 81 (81)
T ss_pred EEEEeC
Confidence 888875
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as a noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.6e-05 Score=84.67 Aligned_cols=146 Identities=16% Similarity=0.164 Sum_probs=102.3
Q ss_pred ecccCceEEEEEEEcCcceEEEEeeccccCC-C-chhHHHHHHHHHHHHHHHhhcCCCC--cceEE--EEEEcCCCCcEE
Q 001940 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAG-K-PSERERLIADFWKEALLLSSLHHPN--VVSFY--GIVRDGPDGSLA 881 (993)
Q Consensus 808 LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~-k-~~ere~~ie~f~rEi~ILr~LrHPN--IVrL~--G~f~d~s~~~L~ 881 (993)
-|.||-+-|++....|..+=+|......... . +.- ...|.+|+..|.+|..-+ +.+.. +.-..+..-.-+
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g----~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFG----RPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCC----chHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEE
Confidence 4569999999998888878888764211100 0 111 247889999988886322 34443 211222233468
Q ss_pred EEEeeccC-CcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 882 TVTEFMVN-GSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 882 LVmEYm~G-GSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
||+|-+.+ .+|.+++.+.. ...+...+..+..+|+..|.-||+.|+.|+|+-+.|||++..+ +..++++||.-++.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g--~~~v~lIDlEk~r~ 179 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG--KAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC--CeeEEEEEhhccch
Confidence 99998854 48999886532 2356777778999999999999999999999999999997432 34699999987764
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.1e-06 Score=98.63 Aligned_cols=119 Identities=23% Similarity=0.314 Sum_probs=94.7
Q ss_pred cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccC
Q 001940 822 RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901 (993)
Q Consensus 822 kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k 901 (993)
.+.+|.|+.++...- .......+-+..|+.|+||||++++..+.. .+.+|||+|-+ ..|..++++.+
T Consensus 36 ~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~--~~~~ylvTErV--~Pl~~~lk~l~- 102 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEE--EGTLYLVTERV--RPLETVLKELG- 102 (690)
T ss_pred cCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcc--cCceEEEeecc--ccHHHHHHHhH-
Confidence 567788887775421 112234566778999999999999999887 67899999987 36777776543
Q ss_pred ccCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 902 TIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 902 ~Lse~~~lkIalQIL~GLeYLH-s~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
...+...+.||+.||.||| +.+++|++|.-+-|+|+ ..|..||.+|.++...
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn----~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN----ESGEWKLGGLELVSKA 155 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc----CCCcEEEeeeEEEecc
Confidence 5666777889999999998 56999999999999998 7789999999887543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.4e-05 Score=84.02 Aligned_cols=148 Identities=16% Similarity=0.105 Sum_probs=98.0
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHH------HHHHHHHhhc---CCC
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADF------WKEALLLSSL---HHP 863 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f------~rEi~ILr~L---rHP 863 (993)
-...+...+|++.+.+-......|.+...+++.+++|..+..... .++.+..| .+++..+.++ ..-
T Consensus 24 l~~~i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r-----~er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 24 LGEKILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR-----PERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHHHHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh-----HHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 344566788999999999988999998889999999987654211 11112211 2223323333 333
Q ss_pred CcceEEEEEEcCC---CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q 001940 864 NVVSFYGIVRDGP---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (993)
Q Consensus 864 NIVrL~G~f~d~s---~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd 940 (993)
.+..++.+..-.. -...+|||||++|..|.++.. +++ .++..|+.+|.-||+.|++|+|+.|.|++++
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 3334333322210 124578999999998877642 222 2345677789999999999999999999997
Q ss_pred cCCCCCCeEEEEecCCccc
Q 001940 941 MRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 941 ~~d~e~g~VKLiDFGLAk~ 959 (993)
++.++++||+..+.
T Consensus 170 -----~~~i~iID~~~k~~ 183 (229)
T PF06176_consen 170 -----NNGIRIIDTQGKRM 183 (229)
T ss_pred -----CCcEEEEECccccc
Confidence 23599999987664
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=95.09 Aligned_cols=148 Identities=18% Similarity=0.170 Sum_probs=93.6
Q ss_pred EEecccCceEEEEEEEc-CcceEEEEeeccccC---------------------C----C-chh------HHHHHHHHHH
Q 001940 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA---------------------G----K-PSE------RERLIADFWK 852 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~---------------------~----k-~~e------re~~ie~f~r 852 (993)
+.|+.++-|.||+|+++ |+.||||+.+..... . + ... +-...-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 56999999999999996 899999997653210 0 0 000 0011123555
Q ss_pred HHHHHhhcC----CCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHH-HHHHHhCCc
Q 001940 853 EALLLSSLH----HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG-MEYLHGKNI 927 (993)
Q Consensus 853 Ei~ILr~Lr----HPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~G-LeYLHs~gI 927 (993)
|...+.+++ ...-+.+=.+|.+- .+.-.|+|||++|..+.++...+...++... |+..++++ ++.+-..|+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dgf 286 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcCc
Confidence 666665553 22223333334332 2345899999999999888533333355333 33333332 344455899
Q ss_pred eecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 928 IHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+|.|..|.||+++ .++.+.+.|||+.....
T Consensus 287 fHaDpHpGNi~v~----~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 287 FHADPHPGNILVR----SDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cccCCCccceEEe----cCCcEEEEcCcceecCC
Confidence 9999999999998 66899999999987543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.7e-05 Score=80.34 Aligned_cols=137 Identities=16% Similarity=0.173 Sum_probs=81.1
Q ss_pred EEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC--cceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN--VVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN--IVrL~G~f~d~s~~~L~LV 883 (993)
..||+|..+.||+. .+..+++|....... .....+|..+++.+..-. +.+.+.+... .+...+|
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~----------~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD----------KETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCCC----------HHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeee
Confidence 67999999999984 355678898764220 123567888888886433 4666776655 4557899
Q ss_pred EeeccCCc-HHHHH---------------------Hhcc-CccCHHHH-HHHHH----------HHHH-HHHHHHh----
Q 001940 884 TEFMVNGS-LKQFL---------------------QKKD-RTIDRRKR-LIIAM----------DAAF-GMEYLHG---- 924 (993)
Q Consensus 884 mEYm~GGS-L~dlL---------------------~~~~-k~Lse~~~-lkIal----------QIL~-GLeYLHs---- 924 (993)
||+++|.+ +...+ +... ........ ..+.. .+.. ...+|..
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99998863 21111 0000 00010000 00000 1111 1223331
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..++|+|+.|.||+++ ..+ +.|+||+.+....
T Consensus 153 ~~~~HgD~~~~Nii~~----~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 153 STCLHGDFQIGNLITS----GKG-TYWIDLGDFGYGN 184 (226)
T ss_pred CceEecCCCCCcEEEc----CCC-cEEEechhcCcCC
Confidence 2578999999999997 444 8999999887543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.6e-05 Score=82.90 Aligned_cols=132 Identities=27% Similarity=0.287 Sum_probs=95.2
Q ss_pred eEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc-eEEEEEEcCCCCcEE
Q 001940 803 EEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDGPDGSLA 881 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV-rL~G~f~d~s~~~L~ 881 (993)
.+.+.|++|++|.||++.|++..+|+|+-+.+.. ...+..|.++|..+.-.++. ++|.+-. .+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~----------r~~l~kEakiLeil~g~~~~p~vy~yg~------~~ 88 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP----------RRNLEKEAKILEILAGEGVTPEVYFYGE------DF 88 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCcc----------hhhHHHHHHHHHHhhhcCCCceEEEech------hh
Confidence 3456799999999999999999999998775432 23678899999999877664 4555422 35
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCC--CCEEEccCCCCCCeEEEEecCCccc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKC--ENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKP--eNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+.|||+.|-.|.++-... +..+++ .+++.-.-|-..||-|..|.- .||++. ...+.|+||..|+.
T Consensus 89 i~me~i~G~~L~~~~~~~----~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~-----~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG----DRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVN-----DRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc----cHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEec-----CCcEEEEEccchhh
Confidence 679999988888765421 223322 444554456678999999985 566664 34799999999986
Q ss_pred cccc
Q 001940 960 KQQT 963 (993)
Q Consensus 960 ~~~~ 963 (993)
...+
T Consensus 156 k~~p 159 (201)
T COG2112 156 KKKP 159 (201)
T ss_pred ccCC
Confidence 5444
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.7e-05 Score=79.16 Aligned_cols=135 Identities=23% Similarity=0.233 Sum_probs=95.2
Q ss_pred CCceEEEEecccCc-eEEEEEEEcCcceEEEEeeccccCCCch-------------hHHHHHHHHHHHHHHHhhcC---C
Q 001940 800 DDLEEVRELGSGTY-GSVYHGKWRGSDVAIKRIKASCFAGKPS-------------ERERLIADFWKEALLLSSLH---H 862 (993)
Q Consensus 800 ddYeile~LGeGgF-GtVYKAk~kgt~VAVKvIkk~~~~~k~~-------------ere~~ie~f~rEi~ILr~Lr---H 862 (993)
.+++.++.||.|.- |.||+++..+..+|+|+++.-.+..... .......-|..|.....+|+ +
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~ 116 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR 116 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence 68999999999999 9999999999999999943211111100 01123456888888877775 4
Q ss_pred CCc--ceEEEEEEcC----------------CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh
Q 001940 863 PNV--VSFYGIVRDG----------------PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924 (993)
Q Consensus 863 PNI--VrL~G~f~d~----------------s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs 924 (993)
..+ |+++||..-. ......||-||+.... .++... +.+|++-|..||.
T Consensus 117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~~k 182 (207)
T PF13095_consen 117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKILHK 182 (207)
T ss_pred cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHHHH
Confidence 556 9999997321 1123467888876543 122222 4567778899999
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
.||+=+|+|+.|..=. ||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~~G---------~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYRGG---------KLVDFSSS 206 (207)
T ss_pred CCeeeccCccccccCC---------EEEecccC
Confidence 9999999999999632 89999965
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5.1e-05 Score=89.00 Aligned_cols=136 Identities=17% Similarity=0.156 Sum_probs=103.3
Q ss_pred eEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC--CCCcEEEEEeeccC
Q 001940 814 GSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PDGSLATVTEFMVN 889 (993)
Q Consensus 814 GtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~--s~~~L~LVmEYm~G 889 (993)
.+.||+.. +|..+++|+++........ ..-.-+++++++.|.|||++.++|... .+..+++|++|+++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n--------k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTN--------KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPS 361 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcc--------cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCC
Confidence 47788866 5888999999544332221 111335689999999999999988732 24578999999986
Q ss_pred -CcHHHHHHh--------------ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 890 -GSLKQFLQK--------------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 890 -GSL~dlL~~--------------~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
++|.++.-. .+...++..++.++.|+..||.++|+.|+..+-|.+.+||++ ++.+++|..-
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~----G~~RIriS~C 437 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT----GKMRIRISGC 437 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee----CcceEEEecc
Confidence 478776421 123467788999999999999999999999999999999998 5668888877
Q ss_pred CCccccc
Q 001940 955 GLSKVKQ 961 (993)
Q Consensus 955 GLAk~~~ 961 (993)
|+.....
T Consensus 438 ~i~Dvl~ 444 (655)
T KOG3741|consen 438 GIMDVLQ 444 (655)
T ss_pred cceeeec
Confidence 7766543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.8e-05 Score=81.73 Aligned_cols=143 Identities=22% Similarity=0.132 Sum_probs=96.3
Q ss_pred EEecccCceEEEEEEE-cCcceEEEEeeccccCCCc----------------hhHHHHHHHHHHHHHHHhhcC--CCCcc
Q 001940 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP----------------SERERLIADFWKEALLLSSLH--HPNVV 866 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~----------------~ere~~ie~f~rEi~ILr~Lr--HPNIV 866 (993)
..|..|.-+.||+|.. .+..+|||+++......+. ..+.....-..+|+..|+++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 4788888899999876 5788999998765432211 112223334567888888885 45556
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcH-HHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSL-KQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL-~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~ 944 (993)
+-+.+... .|||||+....+ .=.|+... +.......+..++++.+.-|-. .++||+||+.=|||+.
T Consensus 134 ~Pi~~~~n------VLvMEfIg~~g~pAP~LkDv~--~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~---- 201 (268)
T COG1718 134 EPIAFRNN------VLVMEFIGDDGLPAPRLKDVP--LELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH---- 201 (268)
T ss_pred CceeecCC------eEEEEeccCCCCCCCCcccCC--cCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----
Confidence 66665333 789999944310 01122211 2233566677788888888776 8999999999999996
Q ss_pred CCCeEEEEecCCccccc
Q 001940 945 QRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~ 961 (993)
++.+.|+|||-|-...
T Consensus 202 -~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CCeEEEEECccccccC
Confidence 3579999999876544
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00017 Score=73.12 Aligned_cols=143 Identities=17% Similarity=0.136 Sum_probs=82.8
Q ss_pred EEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC--CcceEEEEEEcC-CCCcEE
Q 001940 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVRDG-PDGSLA 881 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP--NIVrL~G~f~d~-s~~~L~ 881 (993)
++.|+.|..+.||+....+..+++|+.... .....+.+|..+++.|... .+.+++...... .....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----------~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----------DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----------HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----------CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 478999999999999998888999986532 1223566788887777533 356666644332 234579
Q ss_pred EEEeeccCCcHHH----------------HHH---hc---cCccCHHH---------HHHH------------HHHHHH-
Q 001940 882 TVTEFMVNGSLKQ----------------FLQ---KK---DRTIDRRK---------RLII------------AMDAAF- 917 (993)
Q Consensus 882 LVmEYm~GGSL~d----------------lL~---~~---~k~Lse~~---------~lkI------------alQIL~- 917 (993)
++|++++|..+.. .+. .. ........ .... ...+..
T Consensus 72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (239)
T PF01636_consen 72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER 151 (239)
T ss_dssp EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence 9999999987777 111 11 00011000 0000 111222
Q ss_pred HHHHHHh-------CCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 918 GMEYLHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 918 GLeYLHs-------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
.+..+.+ ..++|+|+.+.|||++ ..++.+.|+||+.+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~---~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 152 LLQELEALLPKPLPPVLIHGDLHPGNILVD---PSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHHHHHHHCCSCEEEE-SS-SGGGEEEE---SSTTEEEE--GTT-EEE
T ss_pred HHHHHHhhhccCCCcEEEEeccccccceee---eccceeEEEecccceEC
Confidence 3333332 3699999999999998 13456689999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd06407 PB1_NLP A PB1 domain is present in NIN like proteins (NLP), a key enzyme in a process of establishment of symbiosis betweeen legumes and nitrogen fixing bacteria (Rhizobium) | Back alignment and domain information |
|---|
Probab=97.91 E-value=7.6e-05 Score=68.56 Aligned_cols=71 Identities=25% Similarity=0.419 Sum_probs=60.6
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEE
Q 001940 46 VGGETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIF 121 (993)
Q Consensus 46 vGG~tri~~v~r~~~f~~l~~kl~~~~~~----~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~f 121 (993)
.||+++.+.++.+++|.+|+.++++.++. .++|||. .|| .-.|+++||+||+.-++-|... +..++|||
T Consensus 7 ~~~d~~r~~l~~~~~~~~L~~~i~~r~~~~~~~~f~LkY~--Dde-gd~v~ltsd~DL~eai~i~~~~----~~~~v~l~ 79 (82)
T cd06407 7 YGEEKIRFRLPPSWGFTELKQEIAKRFKLDDMSAFDLKYL--DDD-EEWVLLTCDADLEECIDVYRSS----GSHTIRLL 79 (82)
T ss_pred eCCeEEEEEcCCCCCHHHHHHHHHHHhCCCCCCeeEEEEE--CCC-CCeEEeecHHHHHHHHHHHHHC----CCCeEEEE
Confidence 38899999999999999999999999974 5999999 666 8899999999998887766553 45778988
Q ss_pred Ee
Q 001940 122 LF 123 (993)
Q Consensus 122 lf 123 (993)
+.
T Consensus 80 v~ 81 (82)
T cd06407 80 VH 81 (82)
T ss_pred ee
Confidence 74
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes like osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-inte |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00016 Score=76.11 Aligned_cols=77 Identities=17% Similarity=0.110 Sum_probs=51.9
Q ss_pred EEecccCc-eEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcEEEE
Q 001940 806 RELGSGTY-GSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 806 e~LGeGgF-GtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L~LV 883 (993)
+.|..|.. ..||+....+..+.||+..... ...+.+|+.+++.+. +--+.+++++... .+..++|
T Consensus 4 ~~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv 70 (244)
T cd05150 4 ERVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----------TYELEREAERLRWLAGKLPVPEVIDYGSD--DGRAWLL 70 (244)
T ss_pred eecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----------ccchHHHHHHHHHHHhcCCCCeEEEEEec--CCccEEE
Confidence 34555665 7899998777778888765331 113456777777774 3446677777665 3567899
Q ss_pred EeeccCCcHHHH
Q 001940 884 TEFMVNGSLKQF 895 (993)
Q Consensus 884 mEYm~GGSL~dl 895 (993)
||+++|.+|...
T Consensus 71 ~e~i~G~~l~~~ 82 (244)
T cd05150 71 TSAVPGVPAAAL 82 (244)
T ss_pred EEeeCCccHhHh
Confidence 999998877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.72 E-value=3.6e-05 Score=86.21 Aligned_cols=94 Identities=29% Similarity=0.464 Sum_probs=77.7
Q ss_pred HHHhhcCCCCcceEEEEEEcC---CCCcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhC--C
Q 001940 855 LLLSSLHHPNVVSFYGIVRDG---PDGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGK--N 926 (993)
Q Consensus 855 ~ILr~LrHPNIVrL~G~f~d~---s~~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~--g 926 (993)
..|..+-|-|||++..||.+. +.....+++|||..|+|..+|++. ...+......+|+-||+.||.|||+. .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 345666799999999998763 234678999999999999999864 34477778889999999999999986 7
Q ss_pred ceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 927 IVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 927 IIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
|+|+++..+-|++. .++.+|+.
T Consensus 199 iihgnlTc~tifiq----~ngLIkig 220 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQ----HNGLIKIG 220 (458)
T ss_pred cccCCcchhheeec----CCceEEec
Confidence 99999999999998 66777764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00012 Score=87.32 Aligned_cols=152 Identities=17% Similarity=0.108 Sum_probs=92.6
Q ss_pred EEecccCceEEEEEEEc-CcceEEEEeeccccCC---------------------Cc------hhHH--HHHHHHHHHHH
Q 001940 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAG---------------------KP------SERE--RLIADFWKEAL 855 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~---------------------k~------~ere--~~ie~f~rEi~ 855 (993)
+.|+.-+.|.||+|+.+ |+.||||+.+...... .. +..+ ...-+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999985 7779999976532100 00 0000 00113555555
Q ss_pred HHhhc----CCCCc---ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHH-HHHHHhCCc
Q 001940 856 LLSSL----HHPNV---VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG-MEYLHGKNI 927 (993)
Q Consensus 856 ILr~L----rHPNI---VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~G-LeYLHs~gI 927 (993)
...++ +|-++ |.+=.++.+- ...-.|+||||+|..+.++..-....++...+ +..+.++ ++-|-..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHhcCC
Confidence 44433 35551 1222333332 23468999999998776654322233555533 3333333 334456799
Q ss_pred eecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 928 IHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+|+|=.|.|||+..+...+..+.|.|||+...+.
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 9999999999998544356789999999987543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00072 Score=84.47 Aligned_cols=81 Identities=15% Similarity=0.238 Sum_probs=55.9
Q ss_pred EEEEecccCceEEEEEEEcC----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCc--ceEEEEEEcCC
Q 001940 804 EVRELGSGTYGSVYHGKWRG----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNV--VSFYGIVRDGP 876 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kg----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNI--VrL~G~f~d~s 876 (993)
.++.|+.|.++.+|+....+ ..+++|+......... ...+.+|+.+|+.|. |.+| .+++.++.+..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~-------~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~ 114 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS-------AHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS 114 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc-------HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC
Confidence 35788999999999987754 3577776543221110 125678999999986 6654 78888876531
Q ss_pred -CCcEEEEEeeccCCc
Q 001940 877 -DGSLATVTEFMVNGS 891 (993)
Q Consensus 877 -~~~L~LVmEYm~GGS 891 (993)
.+..|+||||++|..
T Consensus 115 v~G~~flVME~v~G~~ 130 (822)
T PLN02876 115 VIGTAFYIMEYLEGRI 130 (822)
T ss_pred cCCCceEEEEecCCcc
Confidence 246789999998764
|
|
| >cd06408 PB1_NoxR The PB1 domain is present in the Epichloe festucae NoxR protein (NADPH oxidase regulator), a key regulator of NADPH oxidase isoform, NoxA | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00028 Score=65.57 Aligned_cols=72 Identities=15% Similarity=0.391 Sum_probs=59.2
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCC--ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcC--CCCCCeEEEEE
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEG--AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGS--GDGFTRLRIFL 122 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~--~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~--~~~~~rlR~fl 122 (993)
+|++|++.|+.+|+|.+|..|+.+.|+. .++|||+ .| ...|++++++||+-.|.-+-...+ .+.-+|+-+.+
T Consensus 10 ~~Dv~~i~v~~~i~f~dL~~kIrdkf~~~~~~~iKyk--DE--GD~iti~sq~DLd~Ai~~a~~~~~~~~~~~~~~e~w~ 85 (86)
T cd06408 10 QDDTRYIMIGPDTGFADFEDKIRDKFGFKRRLKIKMK--DD--GDMITMGDQDDLDMAIDTARSEARKQGSDMGKLEIWV 85 (86)
T ss_pred cCcEEEEEcCCCCCHHHHHHHHHHHhCCCCceEEEEE--cC--CCCccccCHHHHHHHHHHHHHHHHhhcccccceeeec
Confidence 7899999999999999999999999985 5999999 54 789999999999999988865433 22336666554
|
NoxA is essential for growth control of the fungal endophyte in plant tissue in the process of symbiotic interaction between a fungi and its plant host. The Epichloe festucae p67(phox)-like regulator, NoxR, dispensable in culture but essential in plants for the symbiotic interaction. Plants infected with a noxR deletion mutant show severe stunting and premature senescence, whereas hyphae in the meristematic tissues show increased branching leading to increased fungal colonization of pseudostem and leaf blade tissue. The PB1 domain is a modular domain mediating specific protein-protein interactions which a play role in many critical cell processes such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=1.7e-05 Score=98.48 Aligned_cols=180 Identities=21% Similarity=0.213 Sum_probs=123.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+++.+++-+-.|.|+.++.++-. +...++|+..+.....++.. +....+-.++...++|.++..+--+..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~-----~s~r~~s~~~i~p~~P~v~~~~~s~~~- 875 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDY-----ESIRSKSNILITPRSPAVVRSFPSFPC- 875 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccc-----cccCCccCccccCCCCceecccCCCCC-
Confidence 4567788888999999999987663 33345555544332222111 123344445555566777766544333
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...++||++|+.+++|...|++.+. .+.+........+..+++|||...++|||+||.|+|+. ..+..+++|||
T Consensus 876 -rsP~~L~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~----~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 876 -RSPLPLVGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA----YDGHRPLTDFG 949 (1205)
T ss_pred -CCCcchhhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccccchhhcccccccchhhc----ccCCcccCccc
Confidence 4568999999999999999988764 44444445556788999999999999999999999997 66789999998
Q ss_pred Ccc-ccc-----------------------------c--ccccCCCCCCCCccccccccCCccCCC
Q 001940 956 LSK-VKQ-----------------------------Q--TLVSGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 956 LAk-~~~-----------------------------~--~~~s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
..+ ... . ........||+.|.+||.+.|..+...
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 322 100 0 011234569999999999998876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0012 Score=69.72 Aligned_cols=144 Identities=19% Similarity=0.229 Sum_probs=94.4
Q ss_pred EEecccCceEEEEEEEcCcceEEEEeeccccCCCc--------hhHHHHHHHHHHHHHHHhhcC------CCCcceEEEE
Q 001940 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKP--------SERERLIADFWKEALLLSSLH------HPNVVSFYGI 871 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~--------~ere~~ie~f~rEi~ILr~Lr------HPNIVrL~G~ 871 (993)
..||+|+.=.||.--. .....||++......... .......+...+|+.....+. +..|.+++|+
T Consensus 7 ~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 5699999999986433 334688988765410000 000111234556666555554 8889999999
Q ss_pred EEcCCCCcEEEEEeeccC------CcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCC
Q 001940 872 VRDGPDGSLATVTEFMVN------GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~G------GSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e 945 (993)
.+++ --+.+|+|.+.+ -+|.+++.+.. ++. .... .+-.-.+||-+..|+.+||+|.||++...+..
T Consensus 86 veT~--~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 86 VETN--LGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EecC--CceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9883 446889998754 37888885543 444 2222 33344568889999999999999999877644
Q ss_pred CCeEEEEe-cCCcc
Q 001940 946 RPVCKIGD-LGLSK 958 (993)
Q Consensus 946 ~g~VKLiD-FGLAk 958 (993)
...+.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 44788888 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00042 Score=72.19 Aligned_cols=99 Identities=25% Similarity=0.165 Sum_probs=78.6
Q ss_pred HHHHHHHhhcCC-CCcceEEEEEEcCCCCcEEEEEeeccCCcHHHH---HHhccCccCHHHHHHHHHHHHHHHHHHHh--
Q 001940 851 WKEALLLSSLHH-PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-- 924 (993)
Q Consensus 851 ~rEi~ILr~LrH-PNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dl---L~~~~k~Lse~~~lkIalQIL~GLeYLHs-- 924 (993)
..|..+|+.+.+ +++.+++|+|-. ++|+||...+++... +.. ....+|..+++||.+++..+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 357888888886 699999999865 679999987766421 111 1236899999999999999999997
Q ss_pred -CCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 925 -KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 925 -~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
..+.-.|++++|+-++ .++.+|++|.......
T Consensus 80 ~~~~~lcDv~~~nfgv~----~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVN----DDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEe----CCCcEEEEechhcchh
Confidence 3588899999999998 6678999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00074 Score=71.26 Aligned_cols=74 Identities=18% Similarity=0.153 Sum_probs=43.7
Q ss_pred EEecccCce-EEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC---CcceEEEEEEcCC-CCcE
Q 001940 806 RELGSGTYG-SVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP---NVVSFYGIVRDGP-DGSL 880 (993)
Q Consensus 806 e~LGeGgFG-tVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP---NIVrL~G~f~d~s-~~~L 880 (993)
+.|+.|+.. .||+. +..+++|+.+... ....+.+|..+|+.|... -+.++++...... .+..
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----------~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----------YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----------hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 567777776 58875 3457778654311 113567788888777532 3445444333211 1235
Q ss_pred EEEEeeccCCcH
Q 001940 881 ATVTEFMVNGSL 892 (993)
Q Consensus 881 ~LVmEYm~GGSL 892 (993)
++||++++|.+|
T Consensus 70 ~~l~~~i~G~~l 81 (235)
T cd05155 70 WSVYRWLEGETA 81 (235)
T ss_pred eEEEEeecCCCC
Confidence 889999988665
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.37 E-value=5.1e-05 Score=90.70 Aligned_cols=162 Identities=16% Similarity=0.127 Sum_probs=113.3
Q ss_pred ceEEEEecccCceEEEEEEEcCcc-eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC-cceEEEEEEcCCCCc
Q 001940 802 LEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGPDGS 879 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kgt~-VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN-IVrL~G~f~d~s~~~ 879 (993)
+.....++++++++++|.+...+. ...|.+... ....-++++|.+++||| .+..++-++. +..
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~--E~~ 308 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDG--EDY 308 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCc--ccc
Confidence 444456889999999988775433 234433321 12334677999999999 5555554444 678
Q ss_pred EEEEEeeccCC-cHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 880 LATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 880 L~LVmEYm~GG-SL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++|+++.++ +-..........+..-+..++++.-+++|++||+..-+||| |||.. ....|+.||+...
T Consensus 309 ~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-----~~~~~~~~~~v~~ 379 (829)
T KOG0576|consen 309 LWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-----EEEVKLLDFAVPP 379 (829)
T ss_pred cchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-----ccccccccccCCc
Confidence 99999999777 22222222222244445566777788999999998889999 88885 3578999999988
Q ss_pred ccccccccCCCCCCCCccccccccCCccC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHM 987 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~ 987 (993)
.+..........+|+.|+|||++.+..+.
T Consensus 380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~ 408 (829)
T KOG0576|consen 380 QLTRTMKPRTAIGTPEPLAPEVIQENTID 408 (829)
T ss_pred ccCcccccccCCCCCCCCCchhhcccccc
Confidence 87776566677899999999988766543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0023 Score=66.83 Aligned_cols=73 Identities=12% Similarity=0.138 Sum_probs=46.2
Q ss_pred EEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC-cceEEEEEEcCCCCcE
Q 001940 805 VRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDGPDGSL 880 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN-IVrL~G~f~d~s~~~L 880 (993)
++.|..|-...+|+.... +..+++|+........ ....+|+.+++.+.... ..++++.+..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~---------~d~~~E~~~~~~l~~~gl~P~v~~~~~~------ 67 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI---------IDRERELRIHKLLSKHGLAPKLYATFQN------ 67 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce---------ecHHHHHHHHHHHHhCCCCCeEEEEeCC------
Confidence 467888888999998875 4678899766431110 01235777777775333 4455543321
Q ss_pred EEEEeeccCCcH
Q 001940 881 ATVTEFMVNGSL 892 (993)
Q Consensus 881 ~LVmEYm~GGSL 892 (993)
.+||||++|.+|
T Consensus 68 ~~l~e~i~G~~l 79 (235)
T cd05157 68 GLIYEFIPGRTL 79 (235)
T ss_pred cEEEEeeCCCcC
Confidence 479999988665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd06405 PB1_Mekk2_3 The PB1 domain is present in the two mitogen-activated protein kinase kinases MEKK2 and MEKK3 which are two members of the signaling kinase cascade involved in angiogenesis and early cardiovascular development | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0011 Score=59.91 Aligned_cols=70 Identities=26% Similarity=0.542 Sum_probs=60.1
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
-||-||+.++|.+.|.||..|+.+.||..+.+-|-.=. -||-+.|.|||+.-|+-.|+ ++ ....||+.|-
T Consensus 8 ~gEKRIi~f~RPvkf~dl~~kv~~afGq~mdl~ytn~e----L~iPl~~Q~DLDkAie~ld~-s~--~~ksLRilL~ 77 (79)
T cd06405 8 NGEKRIIQFPRPVKFKDLQQKVTTAFGQPMDLHYTNNE----LLIPLKNQEDLDRAIELLDR-SP--HMKSLRILLS 77 (79)
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEeccc----EEEeccCHHHHHHHHHHHcc-Cc--cccceeEeEe
Confidence 48999999999999999999999999999999887322 79999999999999999999 22 2244888774
|
The PB1 domain of MEKK2 (and/or MEKK3) interacts with the PB1 domain of another member of the kinase cascade Map2k5. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, f |
| >cd06401 PB1_TFG The PB1 domain found in TFG protein, an oncogenic gene product and fusion partner to nerve growth factor tyrosine kinase receptor TrkA and to the tyrosine kinase ALK | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0022 Score=59.00 Aligned_cols=53 Identities=30% Similarity=0.670 Sum_probs=44.8
Q ss_pred cCceeEEEccC-CCChHHHHHHHHHHhC------CceEEEeeCCCCCCCceeeecChhhHHHH
Q 001940 47 GGETRIVSLPR-DVTYEELMSRMRELYE------GAVVLKYQQPDEDLDALVSVVNDDDVINM 102 (993)
Q Consensus 47 GG~tri~~v~r-~~~f~~l~~kl~~~~~------~~~~lkyqLp~edld~LisV~~deDl~~m 102 (993)
|||.|.+.++. .++|.+|+..+..++. .+|.|||. .|| ..||+||+++||.--
T Consensus 8 g~DiR~~~~~~~~~t~~~L~~~v~~~F~~~~~~~~~flIKYk--D~d-GDlVTIts~~dL~~A 67 (81)
T cd06401 8 GDDIRRIPIHNEDITYDELLLMMQRVFRGKLGSSDDVLIKYK--DED-GDLITIFDSSDLSFA 67 (81)
T ss_pred CCeEEEEeccCccccHHHHHHHHHHHhccccCCcccEEEEEE--CCC-CCEEEeccHHHHHHH
Confidence 99999999998 5899999999987776 26899999 333 569999999999754
|
The PB1 domain is a modular domain mediating specific protein-protein interaction in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The PB1 domains of TFG represent a type I/II PB1 domain. The physiological function of TFG remains unknown. |
| >cd06398 PB1_Joka2 The PB1 domain is present in the Nicotiana plumbaginifolia Joka2 protein which interacts with sulfur stress inducible UP9 protein | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0043 Score=58.29 Aligned_cols=74 Identities=30% Similarity=0.599 Sum_probs=57.8
Q ss_pred eeeecCceeEEEccC-----CCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCC
Q 001940 43 LRYVGGETRIVSLPR-----DVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGD 113 (993)
Q Consensus 43 l~YvGG~tri~~v~r-----~~~f~~l~~kl~~~~~~----~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~ 113 (993)
..| ||++|-++++. +++|.+|..|+++++.. .+.|||. .|| ..+|.++||+||..-|+..-+ .+
T Consensus 5 v~y-~~~~rRf~l~~~~~~~d~~~~~L~~kI~~~f~l~~~~~~~l~Y~--Ded-gd~V~l~~D~DL~~a~~~~~~---~~ 77 (91)
T cd06398 5 VKY-GGTLRRFTFPVAENQLDLNMDGLREKVEELFSLSPDADLSLTYT--DED-GDVVTLVDDNDLTDAIQYFCS---GS 77 (91)
T ss_pred EEe-CCEEEEEEeccccccCCCCHHHHHHHHHHHhCCCCCCcEEEEEE--CCC-CCEEEEccHHHHHHHHHHHhc---cC
Confidence 344 88899999995 79999999999999874 5899998 543 589999999999987765423 34
Q ss_pred CCCeEEEEEe
Q 001940 114 GFTRLRIFLF 123 (993)
Q Consensus 114 ~~~rlR~flf 123 (993)
+..-|||++-
T Consensus 78 ~~~~lrl~v~ 87 (91)
T cd06398 78 RLNPLRIDVT 87 (91)
T ss_pred CCceEEEEEE
Confidence 4455888764
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.004 Score=66.48 Aligned_cols=135 Identities=13% Similarity=0.094 Sum_probs=75.7
Q ss_pred ecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc-ceEEEEEEcCCCCcEEEEEee
Q 001940 808 LGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDGPDGSLATVTEF 886 (993)
Q Consensus 808 LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI-VrL~G~f~d~s~~~L~LVmEY 886 (993)
+..|-.+.+|+....+..+++|+......... -...+|..+++.+..-.+ .+++.... -++||||
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~--------~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~ 69 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALG--------VDRQREYQILQALSALGLAPKPILVNE------HWLLVEW 69 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCccccccc--------CcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEe
Confidence 55677889999887788899997653311100 023467777777764333 34444322 2689999
Q ss_pred ccCCcHHH--------------HHHh---c---cCccCHHH-HHHHH---------HHHHHHHHHHHh--------CCce
Q 001940 887 MVNGSLKQ--------------FLQK---K---DRTIDRRK-RLIIA---------MDAAFGMEYLHG--------KNIV 928 (993)
Q Consensus 887 m~GGSL~d--------------lL~~---~---~k~Lse~~-~lkIa---------lQIL~GLeYLHs--------~gII 928 (993)
++|..+.. .|.+ . ...++... ...+. ..+...++.+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 98865431 1111 1 11111111 11111 111122222221 2589
Q ss_pred ecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 929 HFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 929 HRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
|+|+.+.|||++ .++ ++|+||..|....
T Consensus 150 H~Dl~~~Nil~~----~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 150 HMDVHAYNLVVT----PQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCCCCcCcEEEe----CCC-CEEEeccccCcCC
Confidence 999999999997 333 7899999887543
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.00097 Score=75.42 Aligned_cols=139 Identities=16% Similarity=0.042 Sum_probs=94.9
Q ss_pred ceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCc--------------hhHHHHHHHHHHHHHHHhhcCC--CC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKP--------------SERERLIADFWKEALLLSSLHH--PN 864 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~--------------~ere~~ie~f~rEi~ILr~LrH--PN 864 (993)
+.+.+.||-|.-+.||.+-+. |++.++|.-+........ ..-....-...+|...|+.|.- --
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 667889999999999999874 888999975443211100 0111112235678888888862 23
Q ss_pred cceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC
Q 001940 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 865 IVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~ 944 (993)
|.+.++ .++.++|||++.+-.|..+-+- .+.. .+...++.-+.-|-..|+||+|+.-=||+++
T Consensus 174 VPkpiD------~~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---- 236 (465)
T KOG2268|consen 174 VPKPID------HNRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---- 236 (465)
T ss_pred CCCccc------ccceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHHHcCceecccchheeEEe----
Confidence 445544 3567999999988887665321 1222 2344555566778899999999999999998
Q ss_pred CCCeEEEEecCCc
Q 001940 945 QRPVCKIGDLGLS 957 (993)
Q Consensus 945 e~g~VKLiDFGLA 957 (993)
....++++||--+
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 5678999999643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0071 Score=65.94 Aligned_cols=74 Identities=22% Similarity=0.336 Sum_probs=45.4
Q ss_pred EEEecccCceEEEEEEEc--------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC-cceEEEEEEcC
Q 001940 805 VRELGSGTYGSVYHGKWR--------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIVRDG 875 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k--------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN-IVrL~G~f~d~ 875 (993)
++.|..|-...+|+.... ++.+++|+....... .....+|..+++.+.... ..++++.+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---------~~~r~~E~~~~~~l~~~g~~P~~~~~~~~- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---------LIDRERELVVFARLSERNLGPKLYGIFPN- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---------eechHHHHHHHHHHHhCCCCCceEEEeCC-
Confidence 356666777899998765 367899987653211 013346666776665322 3455555432
Q ss_pred CCCcEEEEEeeccCCcHH
Q 001940 876 PDGSLATVTEFMVNGSLK 893 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~ 893 (993)
.+|+||++|..+.
T Consensus 73 -----~~v~e~i~G~~l~ 85 (302)
T cd05156 73 -----GRIEEFIPSRTLT 85 (302)
T ss_pred -----CchhheeCCCcCC
Confidence 3589999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.014 Score=64.14 Aligned_cols=145 Identities=16% Similarity=0.130 Sum_probs=80.9
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--CCcceEEEEEE----c
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVR----D 874 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--PNIVrL~G~f~----d 874 (993)
....++.|+.|....+|+.+..+..+++|+.+... . . +.+..|..++..|.. -.+.+++.... .
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~---~-~------~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRV---K-A------EELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred CceeccccCCccccceEEEEeCCCcEEEEEecCCC---C-H------HHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 34456778888888999988766678889765421 0 0 123345555555532 12444443211 1
Q ss_pred CCCCcEEEEEeeccCCcHH-----------HHH---HhccCcc-----------CHHHHH------------HHHHHHHH
Q 001940 875 GPDGSLATVTEFMVNGSLK-----------QFL---QKKDRTI-----------DRRKRL------------IIAMDAAF 917 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~-----------dlL---~~~~k~L-----------se~~~l------------kIalQIL~ 917 (993)
...+..++||||++|..+. ..| +.....+ .|.... .....+..
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~ 172 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK 172 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence 1135678999999885321 111 1100000 011000 00112334
Q ss_pred HHHHHHh-------CCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 918 GMEYLHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 918 GLeYLHs-------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.+++|.. .+++|+|+.+.||+++ .++.+.|+||+.+..
T Consensus 173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~----~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFD----GDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHhhhhhcCCCccCCCCCCcCcEEEE----CCceEEEeecccccC
Confidence 4555542 5899999999999998 445678999998853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.011 Score=64.04 Aligned_cols=143 Identities=15% Similarity=0.114 Sum_probs=81.8
Q ss_pred ceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC--CcceEEEEEE----cC
Q 001940 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP--NVVSFYGIVR----DG 875 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP--NIVrL~G~f~----d~ 875 (993)
..-++.|..|....+|+....+..+++|+.... . ...+..|+.++..|..- .+.+++.... ..
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~--------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~ 84 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTDSGRYVLTLFEKV---S--------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSE 84 (296)
T ss_pred hhheecccCccccceEEEEeCCCcEEEEEcCCC---C--------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeee
Confidence 334567888888899998877778999987631 1 01344566666666432 2444433210 01
Q ss_pred CCCcEEEEEeeccCCcHHH-----------HH---HhccC----------ccCHHHHH----------HHHHHHHHHHHH
Q 001940 876 PDGSLATVTEFMVNGSLKQ-----------FL---QKKDR----------TIDRRKRL----------IIAMDAAFGMEY 921 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~d-----------lL---~~~~k----------~Lse~~~l----------kIalQIL~GLeY 921 (993)
-.+..++|++|++|..+.. .| +.... ...+.... .....+..++.+
T Consensus 85 ~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 164 (296)
T cd05153 85 LAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELAR 164 (296)
T ss_pred eCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHH
Confidence 1345789999998865421 11 11000 00111100 011112334445
Q ss_pred HHh-------CCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 922 LHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 922 LHs-------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+-+ .+++|+|+.|.|||++ .+..+.|+||+.+..
T Consensus 165 l~~~~~~~~~~~l~HgD~~~~Nil~~----~~~~~~iIDfe~a~~ 205 (296)
T cd05153 165 QDAFDPSDLPRGVIHADLFRDNVLFD----GDELSGVIDFYFACT 205 (296)
T ss_pred HHhhhhhcCCCcCCccCcCcccEEEe----CCceEEEeehhhhcC
Confidence 443 3799999999999998 445678999998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd06404 PB1_aPKC PB1 domain is an essential modular domain of the atypical protein kinase C (aPKC) which in complex with Par6 and Par3 proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.014 Score=54.09 Aligned_cols=72 Identities=22% Similarity=0.366 Sum_probs=58.2
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEE
Q 001940 46 VGGETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIF 121 (993)
Q Consensus 46 vGG~tri~~v~r~~~f~~l~~kl~~~~~~----~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~f 121 (993)
-+|+-+|..++.+++|.+|..|+.++|.. .+++||- +|| .-+|++++|++|+.-+..|..- +..-|-+-
T Consensus 7 y~gdi~it~~d~~~s~e~L~~~v~~~c~~~~~q~ft~kw~--DEE-GDp~tiSS~~EL~EA~rl~~~n----~~~~l~ih 79 (83)
T cd06404 7 YNGDIMITSIDPSISLEELCNEVRDMCRFHNDQPFTLKWI--DEE-GDPCTISSQMELEEAFRLYELN----KDSELNIH 79 (83)
T ss_pred ecCcEEEEEcCCCcCHHHHHHHHHHHhCCCCCCcEEEEEE--CCC-CCceeecCHHHHHHHHHHHHhc----CcccEEEE
Confidence 46777899999999999999999999973 6999998 544 4589999999998777776543 33457777
Q ss_pred Eec
Q 001940 122 LFS 124 (993)
Q Consensus 122 lf~ 124 (993)
+||
T Consensus 80 vfp 82 (83)
T cd06404 80 VFP 82 (83)
T ss_pred ecC
Confidence 886
|
PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, |
| >cd06396 PB1_NBR1 The PB1 domain is an essential part of NBR1 protein, next to BRCA1, a scaffold protein mediating specific protein-protein interaction with both titin protein kinase and with another scaffold protein p62 | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.014 Score=53.97 Aligned_cols=69 Identities=16% Similarity=0.282 Sum_probs=56.4
Q ss_pred cCceeEEEccC--CCChHHHHHHHHHHhCC-ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 47 GGETRIVSLPR--DVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 47 GG~tri~~v~r--~~~f~~l~~kl~~~~~~-~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
||+++.+.++. +.+|.+|.+.+++.|+- .+.|||= +|| .--|+++||.||+.-++-|.|- .-.||+++.
T Consensus 8 ~~d~~rf~~~~~~~~~~~~L~~ev~~rf~l~~f~lKYl--Dde-~e~v~lssd~eLeE~~rl~~~~-----~~~l~~~v~ 79 (81)
T cd06396 8 NGESQSFLVSDSENTTWASVEAMVKVSFGLNDIQIKYV--DEE-NEEVSVNSQGEYEEALKSAVRQ-----GNLLQMNVY 79 (81)
T ss_pred CCeEEEEEecCCCCCCHHHHHHHHHHHhCCCcceeEEE--cCC-CCEEEEEchhhHHHHHHHHHhC-----CCEEEEEEe
Confidence 67888999998 78999999999999995 5899997 544 5789999999998777766652 256888874
|
A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. The NBR1 protein contains a type I PB1 domain. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.04 Score=64.15 Aligned_cols=82 Identities=21% Similarity=0.113 Sum_probs=51.4
Q ss_pred EEEEecccCceEEEEEEEcCc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---CCCcceEEEEEEcCCCC
Q 001940 804 EVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---HPNIVrL~G~f~d~s~~ 878 (993)
..+.||.|.+..||++...+. .++||.-........... ....+++..|...|+.+. ...+.+++.+ + ..
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~w-pl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D--~~ 104 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESW-PLTLDRARIEAEALKIQAKYVPDLVPKVYHY--D--EE 104 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccc-cccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--C--CC
Confidence 457899999999999988643 799997532111000000 011235556777777653 3567788776 2 24
Q ss_pred cEEEEEeeccCC
Q 001940 879 SLATVTEFMVNG 890 (993)
Q Consensus 879 ~L~LVmEYm~GG 890 (993)
..++||||+++.
T Consensus 105 ~~~lVME~L~~~ 116 (401)
T PRK09550 105 LAVTVMEDLSDH 116 (401)
T ss_pred CCEEEEecCCCc
Confidence 468999999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.047 Score=60.08 Aligned_cols=31 Identities=19% Similarity=0.275 Sum_probs=25.7
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
.++||+|+.+.|||++ .+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~----~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE----GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE----CCceEEEEecccccC
Confidence 3899999999999997 334568999998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.012 Score=67.70 Aligned_cols=144 Identities=24% Similarity=0.173 Sum_probs=94.4
Q ss_pred EEecccCceEEEEEEE-cCcceEEEEeeccccCCCchh------------------HHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 806 RELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSE------------------RERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~e------------------re~~ie~f~rEi~ILr~LrHPNIV 866 (993)
..|..|.-+.||.|.. .|..+|||+++...+..+..+ |....--..+|+..|++|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 5688899999999977 578899999886543322211 122222345678888888755543
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHH-HHHHhccCccCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCCEEEccCCC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLK-QFLQKKDRTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~-dlL~~~~k~Lse~~~lkIalQIL~GLeYLH-s~gIIHRDIKPeNILLd~~d~ 944 (993)
.---+.. ....|||+|+-..... -.|+. ..++...+..+-++++.-+.-|- ..++||.||.-=|+|+.
T Consensus 230 ~PePIlL----k~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh---- 299 (520)
T KOG2270|consen 230 CPEPILL----KNHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH---- 299 (520)
T ss_pred CCCceee----ecceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE----
Confidence 2211111 1257999999432211 12222 23555566677778888887775 56999999999999995
Q ss_pred CCCeEEEEecCCcccc
Q 001940 945 QRPVCKIGDLGLSKVK 960 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~ 960 (993)
.|.+.|+|-+-|-..
T Consensus 300 -dG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVEH 314 (520)
T ss_pred -CCEEEEEEccccccC
Confidence 578999999877543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.033 Score=61.76 Aligned_cols=83 Identities=16% Similarity=0.119 Sum_probs=59.3
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC---CCcceEEEEEEcC-C
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH---PNVVSFYGIVRDG-P 876 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH---PNIVrL~G~f~d~-s 876 (993)
.....+.||+|..+.||+....+..+.+|..+.... ...+..|...|+.|.- ..+.++++++... .
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~----------~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGNPMPLMARSFST----------PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCCEEEEEeccccc----------chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 445567899999999999887666677787543100 0257788888888853 4678888887653 2
Q ss_pred CCcEEEEEeeccCCcHH
Q 001940 877 DGSLATVTEFMVNGSLK 893 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~ 893 (993)
.+.-+||||++++.++.
T Consensus 85 ~g~~~LVmE~i~G~~~~ 101 (297)
T PRK10593 85 PGPDVLLLERLRGVSVE 101 (297)
T ss_pred CCCeEEEEeccCCEecC
Confidence 35689999999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.045 Score=63.93 Aligned_cols=163 Identities=16% Similarity=0.103 Sum_probs=103.2
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE----EcCCCC
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV----RDGPDG 878 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f----~d~s~~ 878 (993)
..+.||+|+-+.+|-.-.-+. .+.|++.+...... . +.+..|... .||-+-.-+.|= .....+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~----a-------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQ----A-------QKVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred CCccccCCccceeeecchhhc-hhheeecCCCchHH----H-------HHHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 446799999999996543333 34588876533211 1 112223222 355432211110 111122
Q ss_pred -cEEEEEeeccCC-cHHHHHHh-----ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 879 -SLATVTEFMVNG-SLKQFLQK-----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 879 -~L~LVmEYm~GG-SL~dlL~~-----~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
.+-++|..+.+. -+..+++. ......|.-.++.++.|+.+...||..|.+-+|+.++|+|++ ..+.|.|
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs----d~~~V~L 158 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS----DDSKVVL 158 (637)
T ss_pred ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee----cCceEEE
Confidence 367788887665 23333321 223478889999999999999999999999999999999998 5678999
Q ss_pred EecCCccccccccccCCCCCCCCcccccccc
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
.|-..-............+|...|.+||.-.
T Consensus 159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 159 VDSDSFQINANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred EcccceeeccCCceEecccCccccCCHHHhc
Confidence 9855333333344444567999999999754
|
|
| >cd06397 PB1_UP1 Uncharacterized protein 1 | Back alignment and domain information |
|---|
Probab=95.95 E-value=0.026 Score=52.03 Aligned_cols=57 Identities=25% Similarity=0.434 Sum_probs=47.0
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHH
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEY 106 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~ey 106 (993)
||+||=+++++.-+|++|++||..++.. ++.|+|- .|| .-+|++++|+||+..+.-.
T Consensus 8 ~g~~RRf~~~~~pt~~~L~~kl~~Lf~lp~~~~~vtYi--DeD-~D~ITlssd~eL~d~~~~~ 67 (82)
T cd06397 8 LGDTRRIVFPDIPTWEALASKLENLYNLPEIKVGVTYI--DND-NDEITLSSNKELQDFYRLS 67 (82)
T ss_pred CCceEEEecCCCccHHHHHHHHHHHhCCChhHeEEEEE--cCC-CCEEEecchHHHHHHHHhc
Confidence 5667777799999999999999999984 5899997 443 3799999999998766533
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play a role in many critical cell processes, such as osteoclastogenesis, angiogenesis, early cardiovascular development, and cell polarity. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domain, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. |
| >cd06402 PB1_p62 The PB1 domain is an essential part of p62 scaffold protein (alias sequestosome 1,SQSTM) involved in cell signaling, receptor internalization, and protein turnover | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.042 Score=51.50 Aligned_cols=64 Identities=20% Similarity=0.457 Sum_probs=50.4
Q ss_pred ceeEEEccC--CCChHHHHHHHHHHhC----CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEE
Q 001940 49 ETRIVSLPR--DVTYEELMSRMRELYE----GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFL 122 (993)
Q Consensus 49 ~tri~~v~r--~~~f~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~fl 122 (993)
|-|-.++++ +++|.+|+.++.++|. ..|+|||. +|| .-||+++|||||.--+.... .+-||||+
T Consensus 15 EIRRf~l~~~~~~s~~~L~~~V~~~f~~l~~~~ftlky~--Dee-GDlvtIssdeEL~~A~~~~~-------~~~~RlyI 84 (87)
T cd06402 15 EIRRFAIDEDVSTSYEYLVEKVAAVFPSLRGKNFQLFWK--DEE-GDLVAFSSDEELVMALGSLN-------DDTFRIYI 84 (87)
T ss_pred ceEEEEecCCCCcCHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEeecCHHHHHHHHHcCC-------CCcEEEEE
Confidence 668888865 5699999999999984 36999999 444 46999999999987665432 25599987
|
The PB1 domain is a modular domain mediating specific protein-protein interaction which play roles in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.1 Score=59.14 Aligned_cols=140 Identities=17% Similarity=0.216 Sum_probs=77.7
Q ss_pred EEEEecccCceEEEEEEEc------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc-eEEEEEEcCC
Q 001940 804 EVRELGSGTYGSVYHGKWR------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV-SFYGIVRDGP 876 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~k------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV-rL~G~f~d~s 876 (993)
.+..|..|-...+|+..+. ++.|++|+....... .+ +...|..+++.+.--++. ++++.+..
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~--------~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-- 108 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL--------FF-DRDDEIRTFECMSRHGQGPRLLGRFPN-- 108 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe--------ee-chHHHHHHHHHHHHcCCCCceEEEECC--
Confidence 3456666888899998753 256889987653211 11 124577777777644443 45555433
Q ss_pred CCcEEEEEeeccCCcHHHH--------------HH---hcc----C-ccCHHHHHHHHHH-----------------HHH
Q 001940 877 DGSLATVTEFMVNGSLKQF--------------LQ---KKD----R-TIDRRKRLIIAMD-----------------AAF 917 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dl--------------L~---~~~----k-~Lse~~~lkIalQ-----------------IL~ 917 (993)
+ .|+||+++.+|... |. ... . ..-+..+.++..+ +..
T Consensus 109 -g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 109 -G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred -c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 2 58999977665311 11 111 0 0111112122111 111
Q ss_pred HHHHH----H----hCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 918 GMEYL----H----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 918 GLeYL----H----s~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
.++.| . ...++|+|+++.|||++. .++.++|+||..|....
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~---~~~~~~lID~Eya~~~~ 233 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDE---ETRAITIIDYEYASYNP 233 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeC---CCCcEEEEeehhccccc
Confidence 12222 1 236899999999999972 23579999999987543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.17 Score=55.07 Aligned_cols=29 Identities=17% Similarity=0.306 Sum_probs=24.5
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++|+|+.+.|||++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~----~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK----D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe----C-CcEEEEECcccc
Confidence 4789999999999997 3 357899999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.12 Score=57.07 Aligned_cols=33 Identities=27% Similarity=0.290 Sum_probs=26.0
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
.++|+|+.+.|||++. .....-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~---~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDE---DARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeC---CCCEEEEECcHhcccCC
Confidence 5899999999999982 12356799999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.15 Score=57.36 Aligned_cols=33 Identities=21% Similarity=0.169 Sum_probs=26.7
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
-++|.|+.+.|||++. +++.++|+||..|....
T Consensus 183 v~CHnDl~~~NiL~~~---~~~~l~lID~EYag~nd 215 (330)
T PLN02421 183 VFAHNDLLSGNLMLNE---DEGKLYFIDFEYGSYSY 215 (330)
T ss_pred EEEECCCCcccEEEeC---CCCcEEEEcccccCCCc
Confidence 3799999999999962 23579999999987543
|
|
| >cd06406 PB1_P67 A PB1 domain is present in p67 proteins which forms a signaling complex with p40, a crucial step for activation of NADPH oxidase during phagocytosis | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.094 Score=48.49 Aligned_cols=59 Identities=19% Similarity=0.360 Sum_probs=47.9
Q ss_pred CeeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHH
Q 001940 42 KLRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEE 105 (993)
Q Consensus 42 ~l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~e 105 (993)
+++|-+ |-+|.|+++++|++|..|+++-.+- .+.|.|. .|+=..++.+ +|+||+.++.-
T Consensus 6 KV~f~~--tIaIrvp~~~~y~~L~~ki~~kLkl~~e~i~LsYk--de~s~~~v~l-~d~dle~aws~ 67 (80)
T cd06406 6 KVHFKY--TVAIQVARGLSYATLLQKISSKLELPAEHITLSYK--SEASGEDVIL-SDTNMEDVWSQ 67 (80)
T ss_pred EEEEEE--EEEEEcCCCCCHHHHHHHHHHHhCCCchhcEEEec--cCCCCCccCc-ChHHHHHHHHh
Confidence 456665 9999999999999999999997764 4889998 4444567778 89999988754
|
PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes . A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. The p67 proteins contain |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.52 E-value=0.34 Score=55.13 Aligned_cols=152 Identities=18% Similarity=0.176 Sum_probs=84.9
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--CCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--PNIVrL~G~f~d~s~~ 878 (993)
...+.+.+..|.-..+|....+++++++. ....... . .......+|+.+|+.+.- .-+...+++|.+...+
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~---~---~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g 98 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDP---V---ESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLG 98 (321)
T ss_pred CCceeeeccCCcccceEEEecCCceEEEe-cCCcccc---c---hhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCC
Confidence 34455666455445666666667777777 2210000 0 112345577777777753 3345667777765345
Q ss_pred cEEEEEeeccCC------------------cHHHHHHhc-----------cC--ccCHHHHHHHH--------------H
Q 001940 879 SLATVTEFMVNG------------------SLKQFLQKK-----------DR--TIDRRKRLIIA--------------M 913 (993)
Q Consensus 879 ~L~LVmEYm~GG------------------SL~dlL~~~-----------~k--~Lse~~~lkIa--------------l 913 (993)
..|.||+|++|. +|.++|..- ++ .....++..+. -
T Consensus 99 ~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p 178 (321)
T COG3173 99 TPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP 178 (321)
T ss_pred CceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence 779999999872 222222210 00 00001111111 1
Q ss_pred HHHHHHHHHHhC--------CceecCCCCCCEEEccCCCCCCeEEEEecCCccccccc
Q 001940 914 DAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963 (993)
Q Consensus 914 QIL~GLeYLHs~--------gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~ 963 (993)
.+..-..||..+ .++|+|+.+.|||++ ...-+-++||+++...+..
T Consensus 179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~----~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID----PGRPTGVLDWELATLGDPL 232 (321)
T ss_pred hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe----CCCeeEEEeccccccCCcH
Confidence 123335566543 589999999999998 3344889999999876543
|
|
| >cd06403 PB1_Par6 The PB1 domain is an essential part of Par6 protein which in complex with Par3 and aPKC proteins is crucial for establishment of apical-basal polarity of animal cells | Back alignment and domain information |
|---|
Probab=94.43 E-value=0.16 Score=46.82 Aligned_cols=67 Identities=27% Similarity=0.478 Sum_probs=53.2
Q ss_pred eecCceeEEEccCC--CChHHHHHHHHHHhC---CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001940 45 YVGGETRIVSLPRD--VTYEELMSRMRELYE---GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (993)
Q Consensus 45 YvGG~tri~~v~r~--~~f~~l~~kl~~~~~---~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR 119 (993)
+-++|+|=.+++|+ .+|.||.+.|..+.. .++.|+|.=|..| |+.|+|||.+..-+. + ..+-||
T Consensus 6 kfdaEfRRFsl~r~~~~~f~ef~~ll~~lH~l~~~~f~i~Y~D~~gD---LLPInNDdNf~kAls-------s-a~plLR 74 (80)
T cd06403 6 KFDAEFRRFSLDRNKPGKFEDFYKLLEHLHHIPNVDFLIGYTDPHGD---LLPINNDDNFLKALS-------S-ANPLLR 74 (80)
T ss_pred ccCCeEEEEEeccccCcCHHHHHHHHHHHhCCCCCcEEEEEeCCCCC---EecccCcHHHHHHHH-------c-CCCceE
Confidence 46899999999998 899999999988864 4799999977544 899999998764332 2 246689
Q ss_pred EEE
Q 001940 120 IFL 122 (993)
Q Consensus 120 ~fl 122 (993)
||+
T Consensus 75 l~i 77 (80)
T cd06403 75 IFI 77 (80)
T ss_pred EEE
Confidence 887
|
The PB1 domain is a modular domain mediating specific protein-protein interactions which play a role in many critical cell processes. A canonical PB1-PB1 interaction, which involves heterodimerization of two PB1 domains, is required for the formation of macromolecular signaling complexes ensuring specificity and fidelity during cellular signaling. The interaction between two PB1 domain depends on the type of PB1. There are three types of PB1 domains: type I which contains an OPCA motif, acidic aminoacid cluster, type II which contains a basic cluster, and type I/II which contains both an OPCA motif and a basic cluster. Interactions of PB1 domains with other protein domains have been described as noncanonical PB1-interactions. The PB1 domain module is conserved in amoebas, fungi, animals, and plants. The |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.048 Score=66.63 Aligned_cols=75 Identities=21% Similarity=0.359 Sum_probs=55.4
Q ss_pred HHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc----------ccCCCCCCCCcccccccc
Q 001940 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL----------VSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 914 QIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~----------~s~s~~GTp~YmAPEVL~ 982 (993)
+++.||.|+|+. ++||++|.|++|.++ ..+..||+.|+++-...... ..-...-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~n----a~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVN----ANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheeec----cCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 455899999965 999999999999998 77899999999876443210 111123456899999998
Q ss_pred CCccCCCCCCC
Q 001940 983 GKSHMVTEKEL 993 (993)
Q Consensus 983 Gk~y~tse~DI 993 (993)
+ ..-+.+.|+
T Consensus 183 ~-~~~~~~sd~ 192 (700)
T KOG2137|consen 183 G-TTNTPASDV 192 (700)
T ss_pred c-ccccccccc
Confidence 7 566666553
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=93.48 E-value=0.37 Score=55.77 Aligned_cols=76 Identities=20% Similarity=0.167 Sum_probs=45.9
Q ss_pred EecccCceEEEEEEEcC--cceEEEEeeccccC---CCchhHHHHHHHHHHHHHHHhhcC--CC-CcceEEEEEEcCCCC
Q 001940 807 ELGSGTYGSVYHGKWRG--SDVAIKRIKASCFA---GKPSERERLIADFWKEALLLSSLH--HP-NVVSFYGIVRDGPDG 878 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~kg--t~VAVKvIkk~~~~---~k~~ere~~ie~f~rEi~ILr~Lr--HP-NIVrL~G~f~d~s~~ 878 (993)
.||.|....||++...+ +.|+||.-..-... ..+.. ..+..-|...|+... .| .+.++|.+ + ..
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~----~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D--~e 73 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLT----LDRARIESSALIRQGEHVPHLVPRIFHF--D--TE 73 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCC----ccHHHHHHHHHHHhhccCccccCeEEEE--c--cc
Confidence 58999999999998864 47999975422111 11111 123345666666553 33 56667655 2 24
Q ss_pred cEEEEEeeccCC
Q 001940 879 SLATVTEFMVNG 890 (993)
Q Consensus 879 ~L~LVmEYm~GG 890 (993)
...+|||+++..
T Consensus 74 ~~~~vMEdL~~~ 85 (370)
T TIGR01767 74 MAVTVMEDLSHH 85 (370)
T ss_pred cceehHhhCccc
Confidence 457999999643
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.91 Score=50.30 Aligned_cols=30 Identities=13% Similarity=0.099 Sum_probs=26.1
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+++|+|+.+.|||++ .++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~----~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD----ETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEc----CCCCEEEEEhhhccc
Confidence 799999999999997 455789999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 993 | ||||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-20 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 8e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-17 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-12 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-12 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-10 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-10 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-10 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-10 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-10 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-10 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-10 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 8e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 9e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 7e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-04 |
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 6e-74
Identities = 67/213 (31%), Positives = 109/213 (51%), Gaps = 12/213 (5%)
Query: 784 IAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS 841
+ +E L T+ ++++E +++G G +G V+ G+ S VAIK + G+
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
E+ +F +E ++S+L+HPN+V YG++ + P V EF+ G L L K
Sbjct: 63 MIEKF-QEFQREVFIMSNLNHPNIVKLYGLMHNPP----RMVMEFVPCGDLYHRLLDKAH 117
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSK 958
I +L + +D A G+EY+ +N IVH DL+ N+ + D PVC K+ D GLS+
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 959 VKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
+ G+ G WMAPE + + TEK
Sbjct: 178 QSVHS--VSGLLGNFQWMAPETIGAEEESYTEK 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 8e-71
Identities = 58/202 (28%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I +L +G G +G VY W G +VA+K + + + I + +EA L
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAAR----HDPDEDISQTIENVRQEAKL 59
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ L HPN+++ G+ P+ L V EF G L + L K I + A+ A
Sbjct: 60 FAMLKHPNIIALRGVCLKEPN--LCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIA 115
Query: 917 FGMEYLHGKN---IVHFDLKCENLLVNMR----DPQRPVCKIGDLGLSKVKQQTLVSGGV 969
GM YLH + I+H DLK N+L+ + D + KI D GL++ +T
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 970 RGTLPWMAPELLSGKSHMVTEK 991
G WMAPE++ ++
Sbjct: 176 -GAYAWMAPEVIRASM--FSKG 194
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-70
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 18/199 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I L + +L G ++ G+W+G+D+ +K +K ++ R DF +E
Sbjct: 7 IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS------TRKSRDFNEECPR 60
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDA 915
L HPNV+ G + P +T +M GSL L + + +D+ + + A+D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 916 AFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
A GM +LH I L +++++ +I + Q G
Sbjct: 121 ARGMAFLHTLEPLIPRHALNSRSVMIDEDM----TARISMADVKFSFQSP----GRMYAP 172
Query: 974 PWMAPELLSGK-SHMVTEK 991
W+APE L K
Sbjct: 173 AWVAPEALQKKPEDTNRRS 191
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 5e-70
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 18/199 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + + + +GSG++G+VY GKW G DVA+K + + + + F E +
Sbjct: 21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN------VTAPTPQQLQAFKNEVGV 73
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L H N++ F G LA VT++ SL L + + +K + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTA 130
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS---GGVRGTL 973
GM+YLH K+I+H DLK N+ ++ + KIGD GL+ K + S + G++
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
Query: 974 PWMAPELLSGKSH-MVTEK 991
WMAPE++ + + +
Sbjct: 187 LWMAPEVIRMQDSNPYSFQ 205
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 5e-70
Identities = 81/234 (34%), Positives = 120/234 (51%), Gaps = 25/234 (10%)
Query: 763 HGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR 822
H DYD T + L + + + I DL ++G+G++G+V+ +W
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDD------MDIPWCDLNIKEKIGAGSFGTVHRAEWH 59
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
GSDVA+K + F + +F +E ++ L HPN+V F G V P+ L+
Sbjct: 60 GSDVAVKILMEQDFH------AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN--LSI 111
Query: 883 VTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLL 938
VTE++ GSL + L K +D R+RL +A D A GM YLH +N IVH +LK NLL
Sbjct: 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLL 171
Query: 939 VNMRDPQRPVCKIGDLGLSKVKQQTLVSG-GVRGTLPWMAPELLSGKSHMVTEK 991
V+ ++ K+ D GLS++K T +S GT WMAPE+L + EK
Sbjct: 172 VD----KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP--SNEK 219
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 5e-66
Identities = 58/204 (28%), Positives = 83/204 (40%), Gaps = 20/204 (9%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + LE +G G +G VYHG+W G +VAI+ I + E + F +E +
Sbjct: 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLID------IERDNEDQLKAFKREVM 81
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
H NVV F G P LA +T +L ++ +D K IA +
Sbjct: 82 AYRQTRHENVVLFMGACMSPPH--LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI 139
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG------GV 969
GM YLH K I+H DLK +N+ + I D GL +
Sbjct: 140 VKGMGYLHAKGILHKDLKSKNVFYDNG-----KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 970 RGTLPWMAPELLSGKSHMVTEKEL 993
G L +APE++ S E +L
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKL 218
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 4e-65
Identities = 60/203 (29%), Positives = 90/203 (44%), Gaps = 26/203 (12%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
L I ++E +G G +G V KWR DVAIK+I++ E F E
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----------ESERKAFIVE 51
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRKRLII 911
LS ++HPN+V YG + + V E+ GSL L + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLN----PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 912 AMDAAFGMEYLHG---KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
+ + G+ YLH K ++H DLK NLL+ V KI D G + Q + +
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGG---TVLKICDFGTACDIQTHMTNN- 163
Query: 969 VRGTLPWMAPELLSGKSHMVTEK 991
+G+ WMAPE+ G ++ +EK
Sbjct: 164 -KGSAAWMAPEVFEGSNY--SEK 183
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 8e-59
Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 30/209 (14%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+Q ++ V+++G G YG V+ GKWRG VA+K + A E E
Sbjct: 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE---------TE 81
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+ H N++ F G L +T++ NGSL +L+ T+D + L +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKL 139
Query: 912 AMDAAFGMEYLHGKN--------IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
A + G+ +LH + I H DLK +N+LV + C I DLGL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVKFISD 195
Query: 964 -----LVSGGVRGTLPWMAPELLSGKSHM 987
+ GT +M PE+L +
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNR 224
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-56
Identities = 56/212 (26%), Positives = 89/212 (41%), Gaps = 33/212 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
+ DL LG G +G R + + +K + + E + F KE
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI------RFDEETQ--RTFLKEV 58
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HPNV+ F G++ L +TE++ G+L+ ++ D +R+ A D
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKR--LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----------- 963
A GM YLH NI+H DL N LV + + D GL+++
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 964 ----LVSGGVRGTLPWMAPELLSGKSHMVTEK 991
V G WMAPE+++G+S+ EK
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSY--DEK 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-50
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 34/210 (16%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
Q + +G G +G V+ GKWRG +VA+K R +++EA
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF-----------SSREERSWFREA 85
Query: 855 --LLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L H N++ F L V+++ +GSL +L + T+ +
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIK 143
Query: 911 IAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+A+ A G+ +LH + I H DLK +N+LV + C I DLGL+
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTCCIADLGLAVRHDS 199
Query: 963 T-----LVSGGVRGTLPWMAPELLSGKSHM 987
+ GT +MAPE+L +M
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPEVLDDSINM 229
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-50
Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 34/208 (16%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+Q D+ + +G G YG V+ G W+G +VA+K R +++E
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIF-----------SSRDEKSWFRE 50
Query: 854 A--LLLSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
L H N++ F S L +T + GSL +LQ T+D L
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCL 108
Query: 910 IIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
I + A G+ +LH + I H DLK +N+LV C I DLGL+ +
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG----QCCIADLGLAVMHS 164
Query: 962 QT-----LVSGGVRGTLPWMAPELLSGK 984
Q+ + + GT +MAPE+L
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDET 192
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-44
Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 18/188 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
+ ++DL ++G G +G V+ G+ R VA+K + + + A F +EA
Sbjct: 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-----PPDLK--AKFLQEA 163
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L HPN+V G+ + V E + G FL+ + + + L + D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGD 221
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTL 973
AA GMEYL K +H DL N LV ++ V KI D G+S+ + G +
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKN----VLKISDFGMSREEADGVYAASGGLRQV 277
Query: 974 P--WMAPE 979
P W APE
Sbjct: 278 PVKWTAPE 285
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-43
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 21/190 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I +D+ R LG G +G VY G + VA+K K C + + F
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-----TLDNK--EKFM 61
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
EA+++ +L HP++V GI+ + P + E G L +L++ ++ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLY 118
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
++ M YL N VH D+ N+LV + K+GD GLS+ +
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPE----CVKLGDFGLSRYIEDEDYYKASVT 174
Query: 972 TLP--WMAPE 979
LP WM+PE
Sbjct: 175 RLPIKWMSPE 184
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 21/190 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K S+ R F
Sbjct: 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-----SDSVR--EKFL 64
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 121
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
A + + YL K VH D+ N+LV+ D K+GD GLS+ + + +G
Sbjct: 122 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 177
Query: 972 TLP--WMAPE 979
LP WMAPE
Sbjct: 178 KLPIKWMAPE 187
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+K +++ ++ELGSG +G V GKW+G DVA+K IK + +F++EA
Sbjct: 5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-----MSED----EFFQEAQ 55
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+ L HP +V FYG+ ++ P + VTE++ NG L +L+ + ++ + L + D
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYP---IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
GM +L +H DL N LV+ K+ D G+++ V P
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDL----CVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 975 --WMAPE 979
W APE
Sbjct: 169 VKWSAPE 175
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-42
Identities = 52/211 (24%), Positives = 76/211 (36%), Gaps = 40/211 (18%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
++ D+L+ + +G G YG+VY G VA+K + +E K
Sbjct: 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINE---------KNIY 59
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGS---LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
+ + H N+ F V E+ NGSL ++L T D +A
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLA 117
Query: 913 MDAAFGMEYLHG---------KNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVKQ 961
G+ YLH I H DL N+LV + C I D GLS
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT------CVISDFGLSMRLT 171
Query: 962 QTLVSG---------GVRGTLPWMAPELLSG 983
+ GT+ +MAPE+L G
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-42
Identities = 62/187 (33%), Positives = 90/187 (48%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWRG DVAIK IK + +F +EA
Sbjct: 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSED----EFIEEAK 71
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ +L H +V YG+ + P + +TE+M NG L +L++ ++ L + D
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRP---IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
MEYL K +H DL N LVN + V K+ D GLS+ + V P
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQG----VVKVSDFGLSRYVLDDEYTSSVGSKFP 184
Query: 975 --WMAPE 979
W PE
Sbjct: 185 VRWSPPE 191
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 50/204 (24%), Positives = 78/204 (38%), Gaps = 34/204 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++ L+ + G +G V+ + VA+K + E E
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW--QNE-------YEVYS 71
Query: 857 LSSLHHPNVVSFYGIVRDGPDGS--LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L + H N++ F G + G L +T F GSL FL+ + + IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAET 129
Query: 915 AAFGMEYLHGK----------NIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKVK-- 960
A G+ YLH I H D+K +N+L+ N+ I D GL+
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL------TACIADFGLALKFEA 183
Query: 961 -QQTLVSGGVRGTLPWMAPELLSG 983
+ + G GT +MAPE+L G
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEG 207
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 26/195 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ +++LG G +GSV ++ VA+K+++ DF
Sbjct: 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH----STEEHLR----DF 58
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L SL H N+V + G+ +L + E++ GSL+ +LQK ID K L
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVS 966
GMEYL K +H DL N+LV + KIGD GL+KV K+ V
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENEN----RVKIGDFGLTKVLPQDKEFFKVK 174
Query: 967 GGVRGTLP--WMAPE 979
G P W APE
Sbjct: 175 EP--GESPIFWYAPE 187
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKAN-- 61
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI + +T+ M G L ++++ I +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 965 VSGGVRGTLPWMAPE 979
+ G + + WMA E
Sbjct: 175 HAEGGKVPIKWMALE 189
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 56/187 (29%), Positives = 83/187 (44%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ E DF +EA
Sbjct: 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEE----DFIEEAE 55
Query: 856 LLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++ L HP +V YG+ P + VTEFM +G L +L+ + L + +D
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAP---ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
GM YL ++H DL N LV + V K+ D G+++ + P
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 975 --WMAPE 979
W +PE
Sbjct: 169 VKWASPE 175
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 57/195 (29%), Positives = 88/195 (45%), Gaps = 25/195 (12%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ +R+LG G +G V ++ VA+K +K AD
Sbjct: 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-----GGNHI--ADL 70
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
KE +L +L+H N+V + GI + + + EF+ +GSLK++L K I+ +++L
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVS 966
A+ GM+YL + VH DL N+LV KIGD GL+K + V
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTVK 186
Query: 967 GGVRGTLP--WMAPE 979
P W APE
Sbjct: 187 DD--RDSPVFWYAPE 199
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 780 IEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGK 839
+ ++A + R + +L+ ++ +G G +G V G +RG+ VA+K IK
Sbjct: 1 MGGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----- 55
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
+ + F EA +++ L H N+V G++ + G L VTE+M GSL +L+ +
Sbjct: 56 -ATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYIVTEYMAKGSLVDYLRSR 109
Query: 900 DRTIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R++ L+ ++D MEYL G N VH DL N+LV+ + V K+ D GL+
Sbjct: 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT- 164
Query: 959 VKQQTLVSGGVRGTLP--WMAPE 979
K+ + G LP W APE
Sbjct: 165 -KEASSTQDT--GKLPVKWTAPE 184
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 68/233 (29%), Positives = 99/233 (42%), Gaps = 27/233 (11%)
Query: 759 LVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYH 818
+ H DYD T + L + + A Q + L+ +++LG G +GSV
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQ-FEERHLKFLQQLGKGNFGSVEM 59
Query: 819 GKWRGSD------VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872
++ VA+K+++ DF +E +L SL H N+V + G+
Sbjct: 60 CRYDPLQDNTGEVVAVKKLQH----STEEHLR----DFEREIEILKSLQHDNIVKYKGVC 111
Query: 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932
+L + E++ GSL+ +LQK ID K L GMEYL K +H DL
Sbjct: 112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171
Query: 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVSGGVRGTLP--WMAPE 979
N+LV + KIGD GL+KV Q V G P W APE
Sbjct: 172 ATRNILVENEN----RVKIGDFGLTKVLPQDKEYYKVKEP--GESPIFWYAPE 218
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 58/192 (30%), Positives = 82/192 (42%), Gaps = 21/192 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I DL + +LG G++G V G+W VA+K +K + + DF
Sbjct: 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFI 69
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E + SL H N++ YG+V P + VTE GSL L+K
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
A+ A GM YL K +H DL NLL+ RD + KIGD GL + ++
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 182
Query: 968 GVRGTLPWMAPE 979
+ W APE
Sbjct: 183 HRKVPFAWCAPE 194
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 48/196 (24%), Positives = 86/196 (43%), Gaps = 26/196 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
I+N+DL LG GT+ ++ G R V +K + + E
Sbjct: 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK----AHRNYSE--- 57
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
F++ A ++S L H ++V YG+ G V EF+ GSL +L+K I+
Sbjct: 58 -SFFEAASMMSKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKNKNCINILW 114
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR----PVCKIGDLGLSKVKQQT 963
+L +A A M +L ++H ++ +N+L+ + ++ P K+ D G+S
Sbjct: 115 KLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP- 173
Query: 964 LVSGGVRGTLPWMAPE 979
++ +PW+ PE
Sbjct: 174 --KDILQERIPWVPPE 187
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 22/193 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
+ + +G G +G VYHG +D A+K + E + F
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 74
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +++ HPNV+S GI +GS V +M +G L+ F++ + + +
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGG 968
+ A GM+YL K VH DL N +++ ++ K+ D GL++ V
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 969 VRGTLP--WMAPE 979
LP WMA E
Sbjct: 190 TGAKLPVKWMALE 202
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-41
Identities = 59/189 (31%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E E +F KEA
Sbjct: 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVE----EFLKEA 60
Query: 855 LLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IA 912
++ + HPN+V G+ R+ P +TEFM G+L +L++ +R L+ +A
Sbjct: 61 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ MEYL KN +H DL N LV + K+ D GLS++ +
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 973 LP--WMAPE 979
P W APE
Sbjct: 174 FPIKWTAPE 182
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 26/195 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
+ L+ + +LG G +GSV ++ VA+K+++ S +++R DF
Sbjct: 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-----PDQQR---DF 71
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +LH +V + G+ SL V E++ +G L+ FLQ+ +D + L+
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT----LVS 966
+ GMEYL + VH DL N+LV KI D GL+K+ +V
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEA----HVKIADFGLAKLLPLDKDYYVVR 187
Query: 967 GGVRGTLP--WMAPE 979
G P W APE
Sbjct: 188 EP--GQSPIFWYAPE 200
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 8e-41
Identities = 55/187 (29%), Positives = 87/187 (46%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V LG+G +G V+ G + G VA+K +K + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPD----AFLAEAN 60
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
L+ L H +V Y +V P + +TE+M NGSL FL+ +L+ +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM ++ +N +H DL+ N+LV+ CKI D GL+++ + + P
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 975 --WMAPE 979
W APE
Sbjct: 174 IKWTAPE 180
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-41
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 780 IEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIK 832
EP E A + I+ + + +GSG G V +G+ R VAIK +K
Sbjct: 27 AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL 892
A +ER+R DF EA ++ HPN++ G+V G VTE+M NGSL
Sbjct: 87 AGY-----TERQR--RDFLSEASIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSL 137
Query: 893 KQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
FL+ D + + + GM YL VH DL N+LV+ VCK+
Sbjct: 138 DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVCKVS 193
Query: 953 DLGLSKV--KQQTLVSGGVRGTLP--WMAPE 979
D GLS+V G +P W APE
Sbjct: 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 59/192 (30%), Positives = 82/192 (42%), Gaps = 23/192 (11%)
Query: 797 IKNDDLEEVR-ELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFW 851
+K D+L ELG G +GSV G +R DVAIK +K + + +
Sbjct: 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-----EKADT--EEMM 58
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EA ++ L +P +V G+ + L V E G L +FL K I +
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
+ GM+YL KN VH DL N+L+ R KI D GLSK + +
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH----YAKISDFGLSKALGADDSYYTARS 171
Query: 970 RGTLP--WMAPE 979
G P W APE
Sbjct: 172 AGKWPLKWYAPE 183
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 769 DYDNDTVKTLKIEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGS-- 824
DYD T + L + + +A+ + I + + +G+G +G VY G + S
Sbjct: 11 DYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG 70
Query: 825 ----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880
VAIK +KA +E++R DF EA ++ H N++ G++ +
Sbjct: 71 KKEVPVAIKTLKAGY-----TEKQR--VDFLGEAGIMGQFSHHNIIRLEGVISKYK--PM 121
Query: 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940
+TE+M NG+L +FL++KD + + + A GM+YL N VH DL N+LVN
Sbjct: 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 941 MRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--GTLP--WMAPE 979
VCK+ D GLS+V + + G +P W APE
Sbjct: 182 ----SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 50/190 (26%), Positives = 82/190 (43%), Gaps = 22/190 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEA 854
R +G G +G VYHG++ AIK + ++ F +E
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-----EMQQV--EAFLREG 73
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
LL+ L+HPNV++ GI+ +G + +M +G L QF++ R + + +
Sbjct: 74 LLMRGLNHPNVLALIGIMLPP-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVRG 971
A GMEYL + VH DL N +++ + K+ D GL++ ++ V
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 972 TLP--WMAPE 979
LP W A E
Sbjct: 189 RLPVKWTALE 198
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-40
Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 22/193 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
+ + +G G +G VYHG +D A+K + E + F
Sbjct: 86 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-----DIGEV--SQFL 138
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +++ HPNV+S GI +GS V +M +G L+ F++ + + +
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGG 968
+ A GM++L K VH DL N +++ ++ K+ D GL++ V
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 969 VRGTLP--WMAPE 979
LP WMA E
Sbjct: 254 TGAKLPVKWMALE 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-39
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 25/217 (11%)
Query: 774 TVKTLKIEPTIAEA--EAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----V 826
++T ++P E + + + + ++ + +G+G +G V G+ + V
Sbjct: 18 GLRTF-VDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 827 AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEF 886
AIK +K +E++R DF EA ++ HPN++ G+V + VTE+
Sbjct: 77 AIKTLKVGY-----TEKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTEY 127
Query: 887 MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
M NGSL FL+K D + + + A GM+YL VH DL N+L+N
Sbjct: 128 MENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL--- 184
Query: 947 PVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE 979
VCK+ D GL +V G +P W +PE
Sbjct: 185 -VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 27/195 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
L+++R+LG G +G V + ++ VA+K +KA + R + +
Sbjct: 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-----GPQHR--SGW 80
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +L+H +++ + G D SL V E++ GSL+ +L + +I + L+
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLL 138
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL----VS 966
A GM YLH ++ +H DL N+L++ + KIGD GL+K + V
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR----LVKIGDFGLAKAVPEGHEYYRVR 194
Query: 967 GGVRGTLP--WMAPE 979
G P W APE
Sbjct: 195 ED--GDSPVFWYAPE 207
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-39
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 29/214 (13%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKP 840
E T+A + R + +L+ ++ +G G +G V G +RG+ VA+K IK
Sbjct: 174 EGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDAT 229
Query: 841 SERERLIADFWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK 899
++ F EA +++ L H N+V G++ + L VTE+M GSL +L+ +
Sbjct: 230 AQ------AFLAEASVMTQLRHSNLVQLLGVIVEEKGG--LYIVTEYMAKGSLVDYLRSR 281
Query: 900 DRTIDRRKRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R++ L+ ++D MEYL G N VH DL N+LV+ + V K+ D GL+
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLT- 336
Query: 959 VKQQTLVSGGVRGTLP--WMAPELL-----SGKS 985
K+ + + LP W APE L S KS
Sbjct: 337 -KEASSTQDTGK--LPVKWTAPEALREKKFSTKS 367
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 29/206 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ ++ +R LG G +G VY G+ G VA+K + C SE++ D
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 79
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK------KDRTI 903
F EAL++S +H N+V G+ + E M G LK FL++ + ++
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQS--LPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQ 961
L +A D A G +YL + +H D+ N L+ P R V KIGD G+++ +
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYRA 196
Query: 962 QTLVSGGVRGTLP--WMAPE-LLSGK 984
GG LP WM PE + G
Sbjct: 197 SYYRKGG-CAMLPVKWMPPEAFMEGI 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-39
Identities = 60/190 (31%), Positives = 88/190 (46%), Gaps = 20/190 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K E F +EA
Sbjct: 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPE----AFLQEAQ 231
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM Y+ N VH DL+ N+LV VCK+ D GL+++ + + P
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 975 --WMAPELLS 982
W APE
Sbjct: 345 IKWTAPEAAL 354
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 23/195 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + S +
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-----SPKAN-- 61
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI + +T+ M G L ++++ I +
Sbjct: 62 KEILDEAYVMASVDNPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQY 118
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 119 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ----HVKITDFGLAKLLGAEEKEY 174
Query: 965 VSGGVRGTLPWMAPE 979
+ G + + WMA E
Sbjct: 175 HAEGGKVPIKWMALE 189
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-39
Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 30/202 (14%)
Query: 794 LQTIKNDDLE--------EVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPS 841
L+ I+ ++ E +ELGSG +G+V G ++ VA+K +K A P+
Sbjct: 3 LEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPA 60
Query: 842 ERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR 901
++ + EA ++ L +P +V GI V E G L ++LQ+ +R
Sbjct: 61 LKD----ELLAEANVMQQLDNPYIVRMIGICEAES---WMLVMEMAELGPLNKYLQQ-NR 112
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV-- 959
+ + + + + GM+YL N VH DL N+L+ + KI D GLSK
Sbjct: 113 HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALR 168
Query: 960 KQQTLVSGGVRGTLP--WMAPE 979
+ G P W APE
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPE 190
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-39
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ ++ +R LG G +G VY G+ G VA+K + C SE++ D
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-----SEQDE--LD 120
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK------KDRT 902
F EAL++S +H N+V G+ + P + E M G LK FL++ + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--K 960
+ L +A D A G +YL + +H D+ N L+ P R V KIGD G+++ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGR-VAKIGDFGMARDIYR 236
Query: 961 QQTLVSGGVRGTLP--WMAPE-LLSGK 984
GG LP WM PE + G
Sbjct: 237 AGYYRKGG-CAMLPVKWMPPEAFMEGI 262
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-39
Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 23/192 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
K +L +++ LGSG +G+V+ G W V IK I+ +
Sbjct: 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-----SGRQSF--QAV 62
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + SL H ++V G+ L VT+++ GSL +++ + + L
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLN 119
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSG 967
+ A GM YL +VH +L N+L+ ++ D G++ + + L+
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS----QVQVADFGVADLLPPDDKQLLYS 175
Query: 968 GVRGTLPWMAPE 979
+ + WMA E
Sbjct: 176 EAKTPIKWMALE 187
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 1e-38
Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 21/190 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K S+ R F
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-----SDSVR--EKFL 439
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKFSLDLASLILY 496
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
A + + YL K VH D+ N+LV+ D K+GD GLS+ + + +G
Sbjct: 497 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 552
Query: 972 TLP--WMAPE 979
LP WMAPE
Sbjct: 553 KLPIKWMAPE 562
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 55/199 (27%), Positives = 79/199 (39%), Gaps = 26/199 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I + L + LG G +GSV G + D VA+K +K S+RE +F
Sbjct: 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS----SQREI--EEFL 84
Query: 852 KEALLLSSLHHPNVVSFYGIV-RDGPDGSLAT--VTEFMVNGSLKQFLQK-----KDRTI 903
EA + HPNV+ G+ G + FM G L +L + I
Sbjct: 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQ 962
+ L +D A GMEYL +N +H DL N ++ + D GLSK +
Sbjct: 145 PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR----DDMTVCVADFGLSKKIYSG 200
Query: 963 TLVSGGVRGTLP--WMAPE 979
G +P W+A E
Sbjct: 201 DYYRQGRIAKMPVKWIAIE 219
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 53/200 (26%), Positives = 79/200 (39%), Gaps = 27/200 (13%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I R LG G +GSV + + D VA+K +KA + + +F
Sbjct: 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII----ASSDI--EEFL 73
Query: 852 KEALLLSSLHHPNVVSFYGIV-RDGPDGSLAT---VTEFMVNGSLKQFLQK-----KDRT 902
+EA + HP+V G+ R G L + FM +G L FL
Sbjct: 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQ 961
+ + + +D A GMEYL +N +H DL N ++ + + D GLS K+
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA----EDMTVCVADFGLSRKIYS 189
Query: 962 QTLVSGGVRGTLP--WMAPE 979
G LP W+A E
Sbjct: 190 GDYYRQGCASKLPVKWLALE 209
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-38
Identities = 59/192 (30%), Positives = 90/192 (46%), Gaps = 22/192 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS--DVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E E +F KEA
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVE----EFLKEA 267
Query: 855 LLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IA 912
++ + HPN+V G+ R+ P +TEFM G+L +L++ +R L+ +A
Sbjct: 268 AVMKEIKHPNLVQLLGVCTREPP---FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 324
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ MEYL KN +H +L N LV + K+ D GLS++ +
Sbjct: 325 TQISSAMEYLEKKNFIHRNLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 973 LP--WMAPELLS 982
P W APE L+
Sbjct: 381 FPIKWTAPESLA 392
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-38
Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 20/187 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L+ ++LG+G +G V+ + VA+K +K E F EA
Sbjct: 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVE----AFLAEAN 235
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ +L H +V + +V P + +TEFM GSL FL+ + + +LI +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM ++ +N +H DL+ N+LV+ VCKI D GL++V + + P
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASL----VCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 975 --WMAPE 979
W APE
Sbjct: 349 IKWTAPE 355
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 6e-38
Identities = 60/190 (31%), Positives = 88/190 (46%), Gaps = 20/190 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-DVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K E F +EA
Sbjct: 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPE----AFLQEAQ 314
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI-IAMD 914
++ L H +V Y +V + P + VTE+M GSL FL+ + R +L+ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A GM Y+ N VH DL+ N+LV VCK+ D GL+++ + + P
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENL----VCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 975 --WMAPELLS 982
W APE
Sbjct: 428 IKWTAPEAAL 437
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 61/215 (28%), Positives = 89/215 (41%), Gaps = 23/215 (10%)
Query: 774 TVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVR-ELGSGTYGSVYHGKWRGS----DVAI 828
+ T E ++ E + +K D+L ELG G +GSV G +R DVAI
Sbjct: 309 PMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 829 KRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV 888
K +K + + + +EA ++ L +P +V G+ + L V E
Sbjct: 369 KVLKQGT-----EKADT--EEMMREAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAG 418
Query: 889 NGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
G L +FL K I + + GM+YL KN VH +L N+L+ R
Sbjct: 419 GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH----Y 474
Query: 949 CKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE 979
KI D GLSK + + G P W APE
Sbjct: 475 AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 63/216 (29%), Positives = 89/216 (41%), Gaps = 43/216 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
I + + ELG +G VY G G VAIK +K R +
Sbjct: 6 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-----EGPLR--EE 58
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
F EA+L + L HPNVV G+V +D P L+ + + +G L +FL +
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGST 115
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
++ + + A GMEYL ++VH DL N+LV + KI D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY----DKLNVKISD 171
Query: 954 LGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGK 984
LGL + G LP WMAPE ++ GK
Sbjct: 172 LGLFREVYAADYYKLLG-NSLLPIRWMAPEAIMYGK 206
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ + + RELG G++G VY G +G VAIK + + S RER +
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-----SMRER--IE 74
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------D 900
F EA ++ + +VV G+V G + E M G LK +L+
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQG--QPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 901 RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KV 959
K + +A + A GM YL+ VH DL N +V + KIGD G++ +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 188
Query: 960 KQQTLVSGGVRGTLP--WMAPE-LLSGK 984
+ G +G LP WM+PE L G
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLKDGV 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 57/184 (30%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 807 ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
E+G G++ +VY G +VA ++ SER+R +EA +L L HPN
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT--KSERQRFK----EEAEMLKGLQHPN 86
Query: 865 VVSFYGIVRDGP--DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+V FY + VTE M +G+LK +L K+ + + + G+++L
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 923 HGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
H + I+H DLKC+N+ + KIGDLGL+ +K+ + V GT +MAPE+
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASFAK-AVIGTPEFMAPEM 201
Query: 981 LSGK 984
K
Sbjct: 202 YEEK 205
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 66/215 (30%), Positives = 92/215 (42%), Gaps = 42/215 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
IK D+ RELG G +G V+ + VA+K +K + R D
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------TLAAR--KD 63
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK---------- 898
F +EA LL++L H ++V FYG+ P L V E+M +G L +FL+
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVD 120
Query: 899 -----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + L IA A GM YL ++ VH DL N LV + KIGD
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG----ANLLVKIGD 176
Query: 954 LGLSK-VKQQTLVSGGVRGTLP--WMAPE-LLSGK 984
G+S+ V G LP WM PE ++ K
Sbjct: 177 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 211
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-36
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 39/206 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD----VAIKRIKASCFAGKPSERERLIADFWK 852
+ +D++ +G G +G V + + AIKR+K S+ + DF
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-----SKDDH--RDFAG 74
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +L L HHPN+++ G G L E+ +G+L FL+K
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGY---LYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 900 ----DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
T+ ++ L A D A GM+YL K +H DL N+LV + V KI D G
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFG 187
Query: 956 LSKVKQQTLVSGGVRGTLP--WMAPE 979
LS+ ++ + G LP WMA E
Sbjct: 188 LSRGQEVYVKKTM--GRLPVRWMAIE 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 69/214 (32%), Positives = 94/214 (43%), Gaps = 41/214 (19%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
IK D+ ELG G +G V+ + VA+K +K + SE R D
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------SESAR--QD 89
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR-- 906
F +EA LL+ L H ++V F+G+ P L V E+M +G L +FL+
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP---LLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146
Query: 907 -----------KRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+L+ +A A GM YL G + VH DL N LV Q V KIGD
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG----QGLVVKIGDF 202
Query: 955 GLSK-VKQQTLVSGGVRGTLP--WMAPE-LLSGK 984
G+S+ + G R LP WM PE +L K
Sbjct: 203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 236
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-35
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 51/224 (22%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+++E VR++G G +G V+ + G VA+K +K S + AD
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-----SADMQ--AD 96
Query: 850 FWKEALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQK---------- 898
F +EA L++ +PN+V G+ P + + E+M G L +FL+
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKP---MCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153
Query: 899 -------------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQ 945
+ ++L IA A GM YL + VH DL N LV +
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----E 209
Query: 946 RPVCKIGDLGLSKV--KQQTLVSGGVRGTLP--WMAPE-LLSGK 984
V KI D GLS+ + G +P WM PE + +
Sbjct: 210 NMVVKIADFGLSRNIYSADYYKADG-NDAIPIRWMPPESIFYNR 252
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-34
Identities = 54/205 (26%), Positives = 87/205 (42%), Gaps = 39/205 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
++L+ + LG+G +G V G VA+K +K++ E+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-----HADEK--EALMS 98
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR---- 906
E ++S L H N+V+ G GP + +TE+ G L FL++K R ++
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGP---VLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 907 --------KRLI-IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+ L+ + A GM +L KN +H D+ N+L+ V KIGD GL+
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT----NGHVAKIGDFGLA 211
Query: 958 -KVKQQTLVSGGVRGTLP--WMAPE 979
+ + LP WMAPE
Sbjct: 212 RDIMNDSNYIVKGNARLPVKWMAPE 236
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-34
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K +E++ +D
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDL 87
Query: 851 WKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E ++ + H N+++ G +DGP L + E+ G+L+++L+ +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 200
Query: 954 LGLS-KVKQQTLVSGGVRGTLP--WMAPE 979
GL+ + G LP WMAPE
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPE 229
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 56/214 (26%), Positives = 85/214 (39%), Gaps = 48/214 (22%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWK 852
+L + LG G +G V VA+K +K + S E D
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-----SPSEL--RDLLS 75
Query: 853 EALLLSSLHHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK------------ 899
E +L ++HP+V+ YG +DGP L + E+ GSL+ FL++
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 900 -----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+R + + A + GM+YL +VH DL N+LV +
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA----EGRK 188
Query: 949 CKIGDLGLS-KVKQQTLVSGGVRGTLP--WMAPE 979
KI D GLS V ++ +G +P WMA E
Sbjct: 189 MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 33/204 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D +E+ +GSG +G V+ K R G IKR+K E+ +E L
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAE----REVKAL 58
Query: 858 SSLHHPNVVSFYG--------------IVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRT 902
+ L H N+V + G L EF G+L+Q+++K +
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+D+ L + G++Y+H K +++ DLK N+ + KIGD GL +
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK----QVKIGDFGLVTSLKN 174
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
+GTL +M+PE +S + +
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDY 198
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 41/215 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D EE+ LG G +G V + AIK+I+ + + ++ E +LL
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTIL----SEVMLL 56
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLAT-----------VTEFMVNGSLKQFLQKKDRTIDRR 906
+SL+H VV +Y + + E+ NG+L + ++ R
Sbjct: 57 ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
+ + + Y+H + I+H DLK N+ + D R V KIGD GL+K ++L
Sbjct: 117 EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNV-KIGDFGLAKNVHRSLDI 172
Query: 967 GGVR---------------GTLPWMAPELLSGKSH 986
+ GT ++A E+L G H
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 54/209 (25%), Positives = 81/209 (38%), Gaps = 38/209 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L+ + LG G +G V G D VA+K +K + E
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-----THSEH--RA 76
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E +L + HH NVV+ G P G L + EF G+L +L+ K
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + A GME+L + +H DL N+L++ ++ V KI D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICD 191
Query: 954 LGLS-KVKQQTLVSGGVRGTLP--WMAPE 979
GL+ + + LP WMAPE
Sbjct: 192 FGLARDIYKDPDYVRKGDARLPLKWMAPE 220
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 43/209 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLIADF 850
D L + LG G +G V + G D VA+K +K +E++ +D
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-----TEKDL--SDL 133
Query: 851 WKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E ++ + H N+++ G +DGP L + E+ G+L+++L+ +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ + + + A GMEYL + +H DL N+LV + V KI D
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT----ENNVMKIAD 246
Query: 954 LGLSKVKQQTLV-SGGVRGTLP--WMAPE 979
GL++ G LP WMAPE
Sbjct: 247 FGLARDINNIDYYKKTTNGRLPVKWMAPE 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 38/214 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E ++ LG G +G V+ K + + AIKRI+ + RE+++ +E L
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVM----REVKAL 57
Query: 858 SSLHHPNVVSFYG----------IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ L HP +V ++ + P L + +LK ++ + +R +
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 908 RLI--IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
+ I + A +E+LH K ++H DLK N+ M D V K+GD GL Q
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEE 173
Query: 966 SGGVR-------------GTLPWMAPELLSGKSH 986
V GT +M+PE + G S+
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 56/211 (26%), Positives = 82/211 (38%), Gaps = 43/211 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
+ L + LG+G +G V G VA+K +K S ER
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-----HLTER--EALMS 75
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +LS L +H N+V+ G GP +TE+ G L FL++K
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP---TLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 900 ------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
+ +D L + A GM +L KN +H DL N+L+ + KI D
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR----ITKICD 188
Query: 954 LGLSKVKQQTLV-SGGVRGTLP--WMAPELL 981
GL++ + LP WMAPE +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESI 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 16/188 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + LG G+YG V+ + + G A+KR + P +R R + E
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSP--FRGPKDRARKL----AEVGSH 110
Query: 858 SSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ HP V + G L TE SL+Q + ++ + D
Sbjct: 111 EKVGQHPCCVRLEQAWEE--GGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTL 167
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
+ +LH + +VH D+K N+ + R CK+GD GL G +M
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRG----RCKLGDFGLLVELGTAGAGEVQEGDPRYM 223
Query: 977 APELLSGK 984
APELL G
Sbjct: 224 APELLQGS 231
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAG 838
P +A+ + + +++G G + VY G VA+K+++
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQ---IFD 69
Query: 839 KPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ- 897
+ R AD KE LL L+HPNV+ +Y + D L V E G L + ++
Sbjct: 70 LMDAKAR--ADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNIVLELADAGDLSRMIKH 125
Query: 898 --KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
K+ R I R + +E++H + ++H D+K N+ + V K+GDLG
Sbjct: 126 FKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG----VVKLGDLG 181
Query: 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSH 986
L + + + GT +M+PE + +
Sbjct: 182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-33
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G + VA+K +K+ +E++
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-----TEKDL-- 118
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK------ 899
+D E ++ + H N+++ G +DGP L + E+ G+L+++LQ +
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGP---LYVIVEYASKGNLREYLQARRPPGLE 175
Query: 900 ---------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
+ + + + A A GMEYL K +H DL N+LV + V K
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT----EDNVMK 231
Query: 951 IGDLGLS-KVKQQTLVSGGVRGTLP--WMAPE 979
I D GL+ + G LP WMAPE
Sbjct: 232 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPE 263
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 13/205 (6%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIAD 849
G Q+ N LG G +V+ G+ + G AIK S +P + +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQM---- 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRK 907
+E +L L+H N+V + I + + EF GSL L++ + +
Sbjct: 56 --REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
LI+ D GM +L IVH ++K N++ + + + V K+ D G ++ +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKE 992
+ GT ++ P++ ++
Sbjct: 174 SLYGTEEYLHPDMYERAVLRKDHQK 198
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 56/177 (31%), Positives = 77/177 (43%), Gaps = 18/177 (10%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG GTYG VY G +AIK I P R +E L L H N+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI--------PERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI--IAMDAAFGMEYLH 923
V + G + +G + E + GSL L+ K + ++ I G++YLH
Sbjct: 82 VQYLGSFSE--NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWMAPE 979
IVH D+K +N+L+N V KI D G SK + + GTL +MAPE
Sbjct: 140 DNQIVHRDIKGDNVLINTYS---GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPE 193
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 57/216 (26%), Positives = 81/216 (37%), Gaps = 48/216 (22%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWK 852
++LE + LGSG +G V + G VA+K +K ER
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-----DSSER--EALMS 97
Query: 853 EALLLSSL-HHPNVVSFYGIV-RDGPDGSLATVTEFMVNGSLKQFLQKK----------- 899
E +++ L H N+V+ G GP + + E+ G L +L+ K
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 900 -----------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948
+ L A A GME+L K+ VH DL N+LV V
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HGKV 210
Query: 949 CKIGDLGLS-KVKQQTLVSGGVRGTLP--WMAPELL 981
KI D GL+ + + LP WMAPE L
Sbjct: 211 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL 246
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 64/199 (32%), Positives = 96/199 (48%), Gaps = 23/199 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
++ + +G G +G VY G R G+ VA+KR G E F E LS
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEE-----FETEIETLS 90
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---RKRLIIAMDA 915
HP++VS G + + + ++M NG+LK+ L D +RL I + A
Sbjct: 91 FCRHPHLVSLIGFCDER--NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGT 972
A G+ YLH + I+H D+K N+L++ + V KI D G+SK QT +S V+GT
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 973 LPWMAPELLSGKSHMVTEK 991
L ++ PE +TEK
Sbjct: 205 LGYIDPEYFI--KGRLTEK 221
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 41/196 (20%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ++++G G++G K G IK I S ERE +E +L
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESR----REVAVL 77
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
+++ HPN+V + + +GSL V ++ G L + + K + L +
Sbjct: 78 ANMKHPNIVQYRESFEE--NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLVSGGVR 970
++++H + I+H D+K +N+ + ++GD G+++V + +
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG----TVQLGDFGIARVLNSTVELARACI----- 186
Query: 971 GTLPWMAPELLSGKSH 986
GT +++PE+ K +
Sbjct: 187 GTPYYLSPEICENKPY 202
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 32/215 (14%)
Query: 791 ARGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIA 848
A G+++ + E+ ++GSG +GSV+ R G AIKR K + + +
Sbjct: 2 AMGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP--LAGSVDEQNAL- 58
Query: 849 DFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---ID 904
+E + L H +VV ++ + D + E+ GSL + + R
Sbjct: 59 ---REVYAHAVLGQHSHVVRYFSAWAE--DDHMLIQNEYCNGGSLADAISENYRIMSYFK 113
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR---------------DPQRPVC 949
+ + + G+ Y+H ++VH D+K N+ ++ + +
Sbjct: 114 EAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984
KIGDLG V G ++A E+L
Sbjct: 174 KIGDLGHVTRISSPQV---EEGDSRFLANEVLQEN 205
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYH-GKWRGSDVAIKRIKASCFAGKPSERERLIADFW 851
+ + LG G G++ + G + DVA+KRI CF ++RE
Sbjct: 17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADRE------- 67
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
LL S HPNV+ ++ +D E +L++++++KD + + +
Sbjct: 68 -VQLLRESDEHPNVIRYFCTEKD--RQFQYIAIEL-CAATLQEYVEQKDFAHLGLEPITL 123
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVSGGVR 970
G+ +LH NIVH DLK N+L++M + + I D GL K S R
Sbjct: 124 LQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 971 ----GTLPWMAPELLSGKSH 986
GT W+APE+LS
Sbjct: 184 SGVPGTEGWIAPEMLSEDCK 203
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 31/203 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E + +G+G+YG + + G + K + +E++ L+ E LL
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLV----SEVNLL 59
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMD 914
L HPN+V +Y + D + +L V E+ G L + K + + +D L +
Sbjct: 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 915 AAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QT 963
++ H ++ ++H DLK N+ ++ + K+GD GL+++ +T
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ----NVKLGDFGLARILNHDTSFAKT 175
Query: 964 LVSGGVRGTLPWMAPELLSGKSH 986
V GT +M+PE ++ S+
Sbjct: 176 FV-----GTPYYMSPEQMNRMSY 193
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 24/192 (12%)
Query: 808 LGSGTYGSVYHGKWRGSDVAIKRIKASC-FAGKPSERERLIADFWKEALLLSSLHHPNVV 866
+G G +G VY G + VA+K++ A + +++ F +E +++ H N+V
Sbjct: 39 MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQ-----FDQEIKVMAKCQHENLV 93
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFL--QKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
G DG D L V +M NGSL L + R IA AA G+ +LH
Sbjct: 94 ELLGFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE 151
Query: 925 KNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSK---VKQQTLVSGGVRGTLPWMAPE 979
+ +H D+K N+L+ KI D GL++ QT+++ + GT +MAPE
Sbjct: 152 NHHIHRDIKSANILLDEAFT-A-----KISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 980 LLSGKSHMVTEK 991
L G+ +T K
Sbjct: 206 ALRGE---ITPK 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 45/197 (22%), Positives = 82/197 (41%), Gaps = 13/197 (6%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIAD 849
G Q+ N LG G +V+ G+ + G AIK S +P + +
Sbjct: 2 GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQM---- 55
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT--IDRRK 907
+E +L L+H N+V + I + + EF GSL L++ + +
Sbjct: 56 --REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE 113
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
LI+ D GM +L IVH ++K N++ + + + V K+ D G ++ +
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173
Query: 968 GVRGTLPWMAPELLSGK 984
+ GT ++ P++
Sbjct: 174 SLYGTEEYLHPDMYERA 190
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 28/195 (14%)
Query: 808 LGSGTYGSVYHGK-WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866
LG G +G VY G+ G+ VA+KR+K G E + F E ++S H N++
Sbjct: 38 LGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQ-----FQTEVEMISMAVHRNLL 90
Query: 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMDAAFGMEYLH 923
G + L V +M NGS+ L+++ +D KR IA+ +A G+ YLH
Sbjct: 91 RLRGFCMTPTERLL--VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH 148
Query: 924 GK---NIVHFDLKCENLLVNMR-DPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTLPWMA 977
I+H D+K N+L++ + +GD GL+K+ + T V+ VRGT+ +A
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEA-----VVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 978 PE-LLSGKSHMVTEK 991
PE L +GKS +EK
Sbjct: 204 PEYLSTGKS---SEK 215
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 27/188 (14%)
Query: 807 ELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+G G++G V+ K G A+K++ RL +E + + L P
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKV-------------RLEVFRVEELVACAGLSSPR 111
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
+V YG VR+GP + E + GSL Q + K+ + + L A G+EYLH
Sbjct: 112 IVPLYGAVREGP--WVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG------VRGTLPWMAP 978
+ I+H D+K +N+L+ + D G + Q + + GT MAP
Sbjct: 169 RRILHGDVKADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 979 ELLSGKSH 986
E++ GK
Sbjct: 226 EVVMGKPC 233
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 63/193 (32%), Positives = 95/193 (49%), Gaps = 18/193 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
+K+DD E++ ELG+G G V+ K G +A K I KP+ R ++I +E
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQII----REL 82
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + P +V FYG DG ++ E M GSL Q L KK I + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIA 139
Query: 915 AAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+ YL K I+H D+K N+LVN R K+ D G+S ++ + V GT
Sbjct: 140 VIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLCDFGVSGQLIDSMANSFV-GTR 194
Query: 974 PWMAPELLSGKSH 986
+M+PE L G +
Sbjct: 195 SYMSPERLQGTHY 207
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 46/214 (21%), Positives = 80/214 (37%), Gaps = 30/214 (14%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE 853
I N +++LG G + V + G A+KRI + +RE +E
Sbjct: 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQ----RE 76
Query: 854 ALLLSSLHHPNVVSFYG--IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR---RKR 908
A + +HPN++ + G + F G+L +++ + +
Sbjct: 77 ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQI 136
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS-- 966
L + + G+E +H K H DLK N+L+ + DLG +
Sbjct: 137 LWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQPVLMDLGSMNQACIHVEGSR 192
Query: 967 --------GGVRGTLPWMAPELLSGKSHM-VTEK 991
R T+ + APEL S +SH + E+
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDER 226
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 34/207 (16%)
Query: 806 RELGSGTYGSVYH-GKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN 864
+ LG G+ G+V G ++G VA+KR+ + E LL S HPN
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC--DIALME--------IKLLTESDDHPN 70
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI------IAMDAAFG 918
V+ +Y D L E N +L+ ++ K+ + + K + A G
Sbjct: 71 VIRYYCSETT--DRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC---------KIGDLGLSKVKQQTLVSGGV 969
+ +LH I+H DLK +N+LV+ I D GL K S
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 970 R-----GTLPWMAPELLSGKSHMVTEK 991
GT W APELL +++ T++
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKR 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-27
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 16/188 (8%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG+G +G V + G VAIK+ + P RER E ++ L+HP
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWC----LEIQIMKKLNHP 72
Query: 864 NVVSFYGIVRDGPDGSLAT----VTEFMVNGSLKQFLQKKDRT--IDRRKRLIIAMDAAF 917
NVVS + + E+ G L+++L + + + + D +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH I+H DLK EN+++ + KI DLG +K Q + GTL ++A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 978 PELLSGKS 985
PELL K
Sbjct: 192 PELLEQKK 199
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 58/189 (30%), Positives = 92/189 (48%), Gaps = 19/189 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
+K DDLE + ELG G YG V G +A+KRI+A+ E++RL+ D
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDL---D 57
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ---KKDRTIDRRKRLII 911
+ + ++ P V+FYG + +G + E M + SL +F + K +TI I
Sbjct: 58 ISMRTVDCPFTVTFYGALFR--EGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 912 AMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A+ +E+LH K +++H D+K N+L+N K+ D G+S +
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 971 GTLPWMAPE 979
G P+MAPE
Sbjct: 171 GCKPYMAPE 179
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 53/198 (26%), Positives = 84/198 (42%), Gaps = 11/198 (5%)
Query: 795 QTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIA 848
Q++ L + + LGSG G V R VAI+ I FA +
Sbjct: 126 QSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL 185
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKR 908
+ E +L L+HP ++ D D + V E M G L + R + +
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFF-DAEDYYI--VLELMEGGELFDKVVGNKRLKEATCK 242
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
L ++YLH I+H DLK EN+L++ ++ + KI D G SK+ +T +
Sbjct: 243 LYF-YQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRT 300
Query: 969 VRGTLPWMAPELLSGKSH 986
+ GT ++APE+L
Sbjct: 301 LCGTPTYLAPEVLVSVGT 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 23/198 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 58
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 115
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 116 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 168
Query: 969 VRGTLPWMAPELLSGKSH 986
GT+ +M PE + S
Sbjct: 169 QVGTVNYMPPEAIKDMSS 186
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 25/206 (12%)
Query: 793 GLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
G++T K +E+ ELGSG + V + + G + A K IK + S R
Sbjct: 1 GMETFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVC 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ +E +L + HPN+++ + + + + + E + G L F D +
Sbjct: 59 REEIEREVSILRQVLHPNIITLHDVYEN--RTDVVLILELVSGGEL--F----DFLAQKE 110
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ +A G+ YLH K I HFDLK EN+++ ++ P K+ D GL+
Sbjct: 111 S--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKS 985
+ + + GT ++APE+++ +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEP 194
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 39/207 (18%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+++ ++ + LGSG + V+ K R G A+K IK K +
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK------KSPAFRD--SS 52
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-- 907
E +L + H N+V+ I V + + G L F DR ++R
Sbjct: 53 LENEIAVLKKIKHENIVTLEDIYES--TTHYYLVMQLVSGGEL--F----DRILERGVYT 104
Query: 908 -RLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ DA+ ++YLH IVH DLK ENLL + + I D GLSK+
Sbjct: 105 EK-----DASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKI-MITDFGLSKM 158
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+Q ++S GT ++APE+L+ K +
Sbjct: 159 EQNGIMSTAC-GTPGYVAPEVLAQKPY 184
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 50/207 (24%), Positives = 91/207 (43%), Gaps = 25/207 (12%)
Query: 793 GLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
G++ K +E+ ELGSG + V + + G + A K IK + S R
Sbjct: 1 GMEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKR--QSRASRRGVS 58
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ +E +L + H NV++ + + + + + E + G L F D +
Sbjct: 59 REEIEREVSILRQVLHHNVITLHDVYEN--RTDVVLILELVSGGEL--F----DFLAQKE 110
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ +A G+ YLH K I HFDLK EN+++ ++ P K+ D GL+
Sbjct: 111 S--LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ + + GT ++APE+++ +
Sbjct: 169 IEDGVEFKNIFGTPEFVAPEIVNYEPL 195
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 56/190 (29%), Positives = 82/190 (43%), Gaps = 21/190 (11%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ LGSG G V R VAIK I FA + + E +L L+HP
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------ 917
++ D D + V E M G L F D+ + KRL A
Sbjct: 76 CIIKIKNFF-DAEDYYI--VLELMEGGEL--F----DK-VVGNKRLKEA-TCKLYFYQML 124
Query: 918 -GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH I+H DLK EN+L++ ++ + KI D G SK+ +T + + GT ++
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 977 APELLSGKSH 986
APE+L
Sbjct: 184 APEVLVSVGT 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 43/198 (21%), Positives = 71/198 (35%), Gaps = 23/198 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 77
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 78 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 134
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 135 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 187
Query: 969 VRGTLPWMAPELLSGKSH 986
GT+ +M PE + S
Sbjct: 188 QVGTVNYMPPEAIKDMSS 205
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 40/202 (19%), Positives = 74/202 (36%), Gaps = 24/202 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL--- 856
+D +R L G + + + A+K+ + S K + ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 857 ------LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
++ + + ++ GI+ + + + E+M N S+ +F + I
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 911 IAMDAAF-------GMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
Y+H KNI H D+K N+L+ D V K+ D G S+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRV-KLSDFGESEYMVD 204
Query: 963 TLVSGGVRGTLPWMAPELLSGK 984
+ G RGT +M PE S +
Sbjct: 205 KKIK-GSRGTYEFMPPEFFSNE 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 31/197 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
+D E R LG G +G+VY + + S +A+K + KA RE I
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI------ 62
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
S L HPN++ YG D + + E+ G++ + LQK + ++R I
Sbjct: 63 ---QSHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGV 969
A + Y H K ++H D+K ENLL+ KI D G S ++ L
Sbjct: 118 LAN-ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSRRTDLC---- 168
Query: 970 RGTLPWMAPELLSGKSH 986
GTL ++ PE++ G+ H
Sbjct: 169 -GTLDYLPPEMIEGRMH 184
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-25
Identities = 42/198 (21%), Positives = 70/198 (35%), Gaps = 23/198 (11%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++K ++++GSG V+ AIK + + + + E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN------LEEADNQTLDSYRNEI 105
Query: 855 LLLSSLHHPN--VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLII 911
L+ L + ++ Y D + V E N L +L+KK RK
Sbjct: 106 AYLNKLQQHSDKIIRLYDYEIT--DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWK 162
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG--- 968
M + +H IVH DLK N L+ + K+ D G++ Q S
Sbjct: 163 NM--LEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDS 215
Query: 969 VRGTLPWMAPELLSGKSH 986
G + +M PE + S
Sbjct: 216 QVGAVNYMPPEAIKDMSS 233
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 49/191 (25%), Positives = 84/191 (43%), Gaps = 20/191 (10%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+DL+++ E+G G YGSV K G +A+KRI+++ E+++L+ D
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDL--- 71
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL----KQFLQKKDRTIDRRKRL 909
+++ S P +V FYG + +G E M + S K D I
Sbjct: 72 DVVMRSSDCPYIVQFYGALFR--EGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG 128
Query: 910 IIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGG 968
I + + +L I+H D+K N+L++ + K+ D G+S ++
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLD----RSGNIKLCDFGISGQLVDSIAKTR 184
Query: 969 VRGTLPWMAPE 979
G P+MAPE
Sbjct: 185 DAGCRPYMAPE 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 45/187 (24%), Positives = 82/187 (43%), Gaps = 16/187 (8%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ +DLE + E+GSGT G V+ + G +A+K+++ S G E +R++ D
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDL--- 74
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
++L S P +V +G + + E M ++ ++ I R + +
Sbjct: 75 DVVLKSHDCPYIVQCFGTFIT--NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTV 131
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
+ YL K ++H D+K N+L++ +R K+ D G+S G
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDFGISGRLVDDKAKDRSAGC 187
Query: 973 LPWMAPE 979
+MAPE
Sbjct: 188 AAYMAPE 194
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 52/189 (27%), Positives = 84/189 (44%), Gaps = 27/189 (14%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
N+ E V ELG G +G VY K G+ A K I ++ E + D+ E +
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--------ETKSEEELEDYIVEIEI 69
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L++ HP +V G DG L + EF G++ + + DR + + ++
Sbjct: 70 LATCDHPYIVKLLGAYYH--DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+ +LH K I+H DLK N+L+ + ++ D G+S K+ + +
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEG----DIRLADFGVSAKNLKTLQKRDSFI----- 178
Query: 971 GTLPWMAPE 979
GT WMAPE
Sbjct: 179 GTPYWMAPE 187
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+ +++++ ELGSG + V + + G A K IK R D
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSS--RRGVSRED 60
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-- 907
+E +L + HPNV++ + + + + + E + G L F D ++
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYEN--KTDVILILELVAGGEL--F----DFLAEKESLT 112
Query: 908 -RLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+A G+ YLH I HFDLK EN+++ R+ +P KI D GL+
Sbjct: 113 EE-----EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 167
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ GT ++APE+++ +
Sbjct: 168 IDFGNEFKNIFGTPEFVAPEIVNYEPL 194
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 26/194 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G G + V R G A+K + + F P D +EA + L HP
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKHP 86
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA---MDAAFGM- 919
++V DG L V EFM L I +R A+ M
Sbjct: 87 HIVELLETYSS--DGMLYMVFEFMDGADL--C----FE-IVKRADAGFVYSEAVASHYMR 137
Query: 920 ------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGT 972
Y H NI+H D+K +L+ ++ PV K+G G++ + + LV+GG GT
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV-KLGGFGVAIQLGESGLVAGGRVGT 196
Query: 973 LPWMAPELLSGKSH 986
+MAPE++ + +
Sbjct: 197 PHFMAPEVVKREPY 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 31/197 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
DD + R LG G +G+VY + + + +A+K + K+ RE I
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEI------ 67
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
S L HPN++ Y D + + EF G L + LQK R ++R +
Sbjct: 68 ---QSHLRHPNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK----VKQQTLVSGGV 969
A + Y H + ++H D+K ENLL+ + KI D G S ++++T+
Sbjct: 123 LAD-ALHYCHERKVIHRDIKPENLLMGYKG----ELKIADFGWSVHAPSLRRRTMC---- 173
Query: 970 RGTLPWMAPELLSGKSH 986
GTL ++ PE++ GK+H
Sbjct: 174 -GTLDYLPPEMIEGKTH 189
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 3e-24
Identities = 35/212 (16%), Positives = 67/212 (31%), Gaps = 31/212 (14%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIA 848
+ + + LG G + VY + +K K + E I
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK------PANPWEFYIG 114
Query: 849 DFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK----DRTID 904
+ L + FY V E G+L + ++ +
Sbjct: 115 T--QLMERLKPSMQHMFMKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 905 RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC-------KIGDLGLS 957
+ + AM + +E +H I+H D+K +N ++ ++ + DLG S
Sbjct: 171 QGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS 230
Query: 958 ---KVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
K+ + + T + E+LS K
Sbjct: 231 IDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 38/196 (19%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELG G + V + G + A K I R +EA + L HP
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIIN------TKKLSARDFQKLEREARICRKLQHP 65
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM------DAAF 917
N+V + +++ + V + + G L F + I+A DA+
Sbjct: 66 NIVRLHDSIQE--ESFHYLVFDLVTGGEL--F--------ED----IVAREFYSEADASH 109
Query: 918 -------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ Y H IVH +LK ENLL+ + V K+ D GL+ + G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAIEVNDSEAWHGFA 168
Query: 971 GTLPWMAPELLSGKSH 986
GT +++PE+L +
Sbjct: 169 GTPGYLSPEVLKKDPY 184
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-24
Identities = 47/210 (22%), Positives = 78/210 (37%), Gaps = 37/210 (17%)
Query: 794 LQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLI 847
+ TI E ELG G + V G + A I R
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIIN------TKKLSARDH 54
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+EA + L HPN+V + + + +G + + + G L F + + R
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISE--EGHHYLIFDLVTGGEL--F----EDIVAREY 106
Query: 908 ---RLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
DA+ + + H +VH +LK ENLL+ + V K+ D GL+
Sbjct: 107 YSEA-----DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLA 160
Query: 958 K-VKQQTLVSGGVRGTLPWMAPELLSGKSH 986
V+ + G GT +++PE+L +
Sbjct: 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/213 (25%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 785 AEAEAIARGLQTIKND---DLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGK 839
+ ++ G+Q +K D ++ ++G G++G V+ G VAIK I +
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-----E 58
Query: 840 PSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK 899
+E E I D +E +LS P V +YG L + E++ GS L +
Sbjct: 59 EAEDE--IEDIQQEITVLSQCDSPYVTKYYGSYLKDTK--LWIIMEYLGGGSALDLL--E 112
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-- 957
+D + I + G++YLH + +H D+K N+L++ K+ D G++
Sbjct: 113 PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE----HGEVKLADFGVAGQ 168
Query: 958 ----KVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
++K+ T V GT WMAPE++ ++
Sbjct: 169 LTDTQIKRNTFV-----GTPFWMAPEVIKQSAY 196
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 61/270 (22%), Positives = 101/270 (37%), Gaps = 34/270 (12%)
Query: 729 AEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAE 788
AE + + + + E V+ G+I TV + +
Sbjct: 84 AENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRG--KGTVSSNYDNYVFDIWK 141
Query: 789 AIARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSE 842
IK+D + + ELG+G +G V+ R G++ A K + S+
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESD 197
Query: 843 RERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+E KE +S L HP +V+ + D D + + EFM G L F ++
Sbjct: 198 KE----TVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGEL--F----EKV 245
Query: 903 IDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
D ++ +A G+ ++H N VH DLK EN++ + K+ D G
Sbjct: 246 ADEHNKMS-EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE--LKLIDFG 302
Query: 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985
L+ GT + APE+ GK
Sbjct: 303 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKP 332
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-24
Identities = 59/193 (30%), Positives = 83/193 (43%), Gaps = 36/193 (18%)
Query: 806 RELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELG G VY K +G+ A+K +K + E +L L HP
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLK----------KTVDKKIVRTEIGVLLRLSHP 108
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N++ I ++ V E + G L F DR +++ R DAA
Sbjct: 109 NIIKLKEIFET--PTEISLVLELVTGGEL--F----DRIVEKGYYSER-----DAADAVK 155
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ YLH IVH DLK ENLL P P+ KI D GLSK+ + ++ V GT
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVLMKTVCGTP 214
Query: 974 PWMAPELLSGKSH 986
+ APE+L G ++
Sbjct: 215 GYCAPEILRGCAY 227
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 29/194 (14%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
ELGSG + V + + G + A K IK + R + +E +L + HP
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSS--RRGVSREEIEREVNILREIRHP 68
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF--- 917
N+++ + I + + + E + G L F D ++ +A
Sbjct: 69 NIITLHDIFEN--KTDVVLILELVSGGEL--F----DFLAEKESLTED-----EATQFLK 115
Query: 918 ----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGT 972
G+ YLH K I HFDLK EN+++ ++ P K+ D G++ ++ GT
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GT 174
Query: 973 LPWMAPELLSGKSH 986
++APE+++ +
Sbjct: 175 PEFVAPEIVNYEPL 188
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 32/220 (14%)
Query: 782 PTIAEAEAIARGLQTI--KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKA 833
++ + + RG + + + + ELG G + V + G + A K I
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 834 SCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK 893
+ + + +EA + L HPN+V + +++ + V + + G L
Sbjct: 65 KKLSARDFQ------KLEREARICRKLQHPNIVRLHDSIQE--ESFHYLVFDLVTGGEL- 115
Query: 894 QFLQKKDRTIDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
F + I R+ A DA+ + Y H IVH +LK ENLL+ +
Sbjct: 116 -F----ED-IVAREFYSEA-DASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGA 168
Query: 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
V K+ D GL+ + G GT +++PE+L +
Sbjct: 169 AV-KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 52/186 (27%), Positives = 85/186 (45%), Gaps = 23/186 (12%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++RE+G G++G+VY VAIK++ ++GK S + D KE
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEK--WQDIIKEVRF 107
Query: 857 LSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L L HPN + + G +R+ + V E+ GS L+ + + + + A
Sbjct: 108 LQKLRHPNTIQYRGCYLREH---TAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS--KVKQQTLVSGGVRGTL 973
G+ YLH N++H D+K N+L++ + K+GD G + + V GT
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPANSFV-----GTP 214
Query: 974 PWMAPE 979
WMAPE
Sbjct: 215 YWMAPE 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 47/194 (24%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 799 NDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++G G G+VY G +VAI+++ + ++ LI E L+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-----QQQPKKELII---NEILV 70
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ +PN+V++ G + L V E++ GSL + + +D + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECL 126
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGGVR 970
+E+LH ++H D+K +N+L+ M K+ D G + K+ T+V
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMV----- 177
Query: 971 GTLPWMAPELLSGK 984
GT WMAPE+++ K
Sbjct: 178 GTPYWMAPEVVTRK 191
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 55/197 (27%), Positives = 82/197 (41%), Gaps = 31/197 (15%)
Query: 808 LGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G GTYG VY K + D A+K+I+ G R E LL L HP
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACR-------EIALLRELKHP 78
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFL--QKKDRTIDRRKRLIIAMDAAF---- 917
NV+S + D + + ++ L + + + + +L M +
Sbjct: 79 NVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 918 --GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-----VKQQTLVSGGVR 970
G+ YLH ++H DLK N+LV P+R KI D+G ++ +K + V
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 971 GTLPWM-APELLSGKSH 986
T W APELL G H
Sbjct: 198 -TF-WYRAPELLLGARH 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 49/228 (21%), Positives = 89/228 (39%), Gaps = 33/228 (14%)
Query: 769 DYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDD----LEEVRELGSGTYGSVYHG--KWR 822
D T + + A + D L+ ++G G+ G V K
Sbjct: 10 GVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHS 69
Query: 823 GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLAT 882
G VA+K + + +R L+ E +++ H NVV Y G + L
Sbjct: 70 GRQVAVKMMDL-----RKQQRRELLF---NEVVIMRDYQHFNVVEMYKSYLVGEE--LWV 119
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
+ EF+ G+L + ++ + + + YLH + ++H D+K +++L+ +
Sbjct: 120 LMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD 177
Query: 943 DPQRPVCKIGDLGLS------KVKQQTLVSGGVRGTLPWMAPELLSGK 984
K+ D G K+++LV GT WMAPE++S
Sbjct: 178 G----RVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPEVISRS 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 62/200 (31%), Positives = 87/200 (43%), Gaps = 30/200 (15%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
K L E+ ++LGSG YG V + + + AIK I+ K S +
Sbjct: 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR------KTSVSTSSNSKLL 84
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---- 907
+E +L L HPN++ Y D + V E G L F D I R K
Sbjct: 85 EEVAVLKLLDHPNIMKLYDFFED--KRNYYLVMECYKGGEL--F----DEIIHRMKFNEV 136
Query: 908 ---RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
+I + + + YLH NIVH DLK ENLL+ ++ + KI D GLS V +
Sbjct: 137 DAAVIIKQVLSG--VTYLHKHNIVHRDLKPENLLLESKEKDALI-KIVDFGLSAVFENQK 193
Query: 965 VSGGVRGTLPWMAPELLSGK 984
GT ++APE+L K
Sbjct: 194 KMKERLGTAYYIAPEVLRKK 213
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 32/200 (16%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
D+ + +G G++G V + A K+I + + F
Sbjct: 3 TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY----FVEDVD----RFK 54
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E ++ SL HPN++ Y D + + V E G L F +R + ++
Sbjct: 55 QEIEIMKSLDHPNIIRLYETFED--NTDIYLVMELCTGGEL--F----ER-VVHKRVFR- 104
Query: 912 AMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
DAA M Y H N+ H DLK EN L P P+ K+ D GL+ +
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPL-KLIDFGLAARFKPGK 163
Query: 965 VSGGVRGTLPWMAPELLSGK 984
+ GT +++P++L G
Sbjct: 164 MMRTKVGTPYYVSPQVLEGL 183
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-23
Identities = 43/204 (21%), Positives = 79/204 (38%), Gaps = 32/204 (15%)
Query: 796 TIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+K + + ELGSG +G V+ + G K I P ++
Sbjct: 43 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKY----T 94
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
E +++ LHHP +++ + D + + EF+ G L F DR ++
Sbjct: 95 VKNEISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGEL--F----DRIAAEDYKM 146
Query: 910 IIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ G++++H +IVH D+K EN++ + KI D GL+
Sbjct: 147 S-EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLATKLNP 203
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
+ T + APE++ +
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPV 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 99.1 bits (248), Expect = 5e-23
Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 24/189 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G++ VY + G +VAIK I K + + K +R+ E + L H
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY--KAGMVQRVQ----NEVKIHCQLKH 70
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEY 921
P+++ Y D + V E NG + ++L+ + + R + GM Y
Sbjct: 71 PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT-GMLY 127
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPWMA 977
LH I+H DL NLL+ KI D GL+ + GT +++
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNM----NIKIADFGLATQLKM---PHEKHYTLCGTPNYIS 180
Query: 978 PELLSGKSH 986
PE+ + +H
Sbjct: 181 PEIATRSAH 189
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 62/188 (32%), Positives = 85/188 (45%), Gaps = 26/188 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V K R + A+K I K S + + + +E LL L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLKKLDHP 81
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
N++ + I+ D S V E G L F D I +RKR DAA +
Sbjct: 82 NIMKLFEILED--SSSFYIVGELYTGGEL--F----DE-IIKRKRFS-EHDAARIIKQVF 131
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
Y+H NIVH DLK EN+L+ ++ + KI D GLS QQ GT ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 977 APELLSGK 984
APE+L G
Sbjct: 191 APEVLRGT 198
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 35/219 (15%)
Query: 779 KIEPTIAEAEAIARGLQTIKNDDLEEVRE----LGSGTYGSVYHG--KWRGSDVAIKRIK 832
++ + + + EEV + LG G+YGSVY K G VAIK++
Sbjct: 4 TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGS 891
E + + KE ++ P+VV +YG ++ L V E+ GS
Sbjct: 64 V----------ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT---DLWIVMEYCGAGS 110
Query: 892 LKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ ++ +++T+ + I G+EYLH +H D+K N+L+N K+
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG----HAKL 166
Query: 952 GDLGLS------KVKQQTLVSGGVRGTLPWMAPELLSGK 984
D G++ K+ T++ GT WMAPE++
Sbjct: 167 ADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEI 200
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 56/200 (28%), Positives = 81/200 (40%), Gaps = 29/200 (14%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
+ R LG G++G V K + G + A+K I K
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLL 74
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---- 907
+E LL L HPN++ Y D G V E G L F D I R++
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFED--KGYFYLVGEVYTGGEL--F----DEIISRKRFSEV 126
Query: 908 ---RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964
R+I + + + Y+H IVH DLK ENLL+ + + +I D GLS + +
Sbjct: 127 DAARIIRQVLSG--ITYMHKNKIVHRDLKPENLLLESKSKDANI-RIIDFGLSTHFEASK 183
Query: 965 VSGGVRGTLPWMAPELLSGK 984
GT ++APE+L G
Sbjct: 184 KMKDKIGTAYYIAPEVLHGT 203
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 53/205 (25%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+I DD E +GSG V + VAIKRI + + + + KE
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-----EKCQTS--MDELLKE 63
Query: 854 ALLLSSLHHPNVVSFYG-IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL--- 909
+S HHPN+VS+Y V L V + + GS+ ++ + + +
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVV---KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 910 ----IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-------- 957
I + G+EYLH +H D+K N+L+ +I D G+S
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG----SVQIADFGVSAFLATGGD 176
Query: 958 ---KVKQQTLVSGGVRGTLPWMAPE 979
++T V GT WMAPE
Sbjct: 177 ITRNKVRKTFV-----GTPCWMAPE 196
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 31/202 (15%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
++++ R+LGSG +G V+ + R G + IK I K + +
Sbjct: 16 FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTIN------KDRSQVP-MEQIE 68
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
E +L SL HPN++ + + D ++ V E G L +R + + R
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVFED--YHNMYIVMETCEGGEL--L----ERIVSAQARGKA 120
Query: 912 A--MDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
A M Y H +++VH DLK EN+L P P+ KI D GL+++ +
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPI-KIIDFGLAELFKS 179
Query: 963 TLVSGGVRGTLPWMAPELLSGK 984
S GT +MAPE+
Sbjct: 180 DEHSTNAAGTALYMAPEVFKRD 201
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 45/209 (21%), Positives = 80/209 (38%), Gaps = 30/209 (14%)
Query: 791 ARGLQTIKNDDLEEV-----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSER 843
L ++ +ELG G + V + G + A K +K K
Sbjct: 15 TENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK------KRRRG 68
Query: 844 ERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+ A+ E +L P V++ + + + + + E+ G + F
Sbjct: 69 QDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEIILILEYAAGGEI--F----SLC 120
Query: 903 IDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955
+ ++ D G+ YLH NIVH DLK +N+L++ P + KI D G
Sbjct: 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI-KIVDFG 179
Query: 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGK 984
+S+ + GT ++APE+L+
Sbjct: 180 MSRKIGHACELREIMGTPEYLAPEILNYD 208
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 35/191 (18%), Positives = 67/191 (35%), Gaps = 31/191 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+LG G +G V+ K +K K +++ KE +L+ H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQV----LVKKEISILNIARHR 61
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF------ 917
N++ + L + EF+ + F +R L +
Sbjct: 62 NILHLHESFES--MEELVMIFEFISGLDI--F----ERINTSAFELN-EREIVSYVHQVC 112
Query: 918 -GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPW 975
+++LH NI HFD++ EN++ + + KI + G + ++K +
Sbjct: 113 EALQFLHSHNIGHFDIRPENII--YQTRRSSTIKIIEFGQARQLKPGDNFRLLF-TAPEY 169
Query: 976 MAPELLSGKSH 986
APE+
Sbjct: 170 YAPEVHQHDVV 180
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 65/205 (31%), Positives = 92/205 (44%), Gaps = 29/205 (14%)
Query: 798 KNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIK-----ASCFAGKPSERERL 846
K + E R+LGSG YG V K + S+ AIK IK ++ E+
Sbjct: 30 KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
+ + E LL SL HPN++ + + D VTEF G L F ++ I R
Sbjct: 90 HEEIYNEISLLKSLDHPNIIKLFDVFED--KKYFYLVTEFYEGGEL--F----EQ-IINR 140
Query: 907 KRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ DAA G+ YLH NIVH D+K EN+L+ ++ + KI D GLS
Sbjct: 141 HKFD-ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI-KIVDFGLSSF 198
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGK 984
+ GT ++APE+L K
Sbjct: 199 FSKDYKLRDRLGTAYYIAPEVLKKK 223
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 53/189 (28%), Positives = 80/189 (42%), Gaps = 25/189 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
R LG G + + A K + K+ KP +RE++ E + SL H
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMS----MEISIHRSLAH 74
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+VV F+G D + + V E SL + +++ + R + G +YL
Sbjct: 75 QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYL 131
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMA 977
H ++H DLK NL +N KIGD GL+ + G R GT ++A
Sbjct: 132 HRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIA 183
Query: 978 PELLSGKSH 986
PE+LS K H
Sbjct: 184 PEVLSKKGH 192
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 53/189 (28%), Positives = 80/189 (42%), Gaps = 25/189 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
R LG G + + A K + K+ KP +RE++ E + SL H
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSL--LLKPHQREKMS----MEISIHRSLAH 100
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+VV F+G D + + V E SL + +++ + R + G +YL
Sbjct: 101 QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL-GCQYL 157
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMA 977
H ++H DLK NL +N KIGD GL+ + G R GT ++A
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDL----EVKIGDFGLATK----VEYDGERKKVLCGTPNYIA 209
Query: 978 PELLSGKSH 986
PE+LS K H
Sbjct: 210 PEVLSKKGH 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-22
Identities = 62/188 (32%), Positives = 85/188 (45%), Gaps = 26/188 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V K R + A+K I K S + + + +E LL L HP
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVIN------KASAKNKDTSTILREVELLKKLDHP 81
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
N++ + I+ D S V E G L F D I +RKR DAA +
Sbjct: 82 NIMKLFEILED--SSSFYIVGELYTGGEL--F----DE-IIKRKRFS-EHDAARIIKQVF 131
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
Y+H NIVH DLK EN+L+ ++ + KI D GLS QQ GT ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDI-KIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 977 APELLSGK 984
APE+L G
Sbjct: 191 APEVLRGT 198
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 1e-21
Identities = 41/207 (19%), Positives = 73/207 (35%), Gaps = 29/207 (14%)
Query: 800 DDLEEVRELGSG--TYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
E + +G G +V K G V ++RI + ++ E
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE------ACSNEMVTFLQGELH 78
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM-- 913
+ +HPN+V + + L VT FM GS K + +D L IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNE--LWVVTSFMAYGSAKDLI--CTHFMDGMNELAIAYIL 134
Query: 914 -DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVS 966
++Y+H VH +K ++L+++ + L + +Q+ +
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISV----DGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 967 GGVR--GTLPWMAPELLSGKSHMVTEK 991
LPW++PE+L K
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAK 217
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 45/190 (23%), Positives = 72/190 (37%), Gaps = 31/190 (16%)
Query: 808 LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865
LG G G V R G A+K + S + +E + P++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQE--------VDHHWQASGGPHI 84
Query: 866 VSFYGIVRDGPDGSLAT--VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM---- 919
V + + G + E M G L F R +R + +AA M
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGEL--F----SRIQERGDQAFTEREAAEIMRDIG 138
Query: 920 ---EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++LH NI H D+K ENLL ++ + K+ D G +K Q + T ++
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVL-KLTDFGFAKETTQNALQTPC-YTPYYV 196
Query: 977 APELLSGKSH 986
APE+L + +
Sbjct: 197 APEVLGPEKY 206
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 57/192 (29%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK---EALLLSS 859
V+ LG G YG V R VA+K + + +R + E +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV----------DMKRAVDCPENIKKEICINKM 61
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L+H NVV FYG R+G E+ G L ++ + +R ++A
Sbjct: 62 LNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GT 972
G+ YLHG I H D+K ENLL+ D + + KI D GL+ V + + GT
Sbjct: 117 --GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGT 170
Query: 973 LPWMAPELLSGK 984
LP++APELL +
Sbjct: 171 LPYVAPELLKRR 182
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 51/231 (22%), Positives = 82/231 (35%), Gaps = 36/231 (15%)
Query: 772 NDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEV----RELGSGTYGSVYHG--KWRGSD 825
+ + P + GLQ KN +++ + LG G G V K
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK 89
Query: 826 VAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT-- 882
A+K ++ +E L + P++V + + G
Sbjct: 90 FALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGM-------EYLHGKNIVHFDLKCE 935
V E + G L F R DR + +A+ M +YLH NI H D+K E
Sbjct: 137 VMECLDGGEL--F----SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190
Query: 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
NLL + P + K+ D G +K T ++APE+L + +
Sbjct: 191 NLLYTSKRPNAIL-KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 54/191 (28%), Positives = 81/191 (42%), Gaps = 32/191 (16%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E V +G+GTYG VY G G AIK + E E + +E +L
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIK----QEINMLKKY 77
Query: 861 -HHPNVVSFYG----IVRDGPDGSLATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMD 914
HH N+ ++YG G D L V EF GS+ ++ K T+ I +
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICRE 137
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS------KVKQQTLVSGG 968
G+ +LH ++H D+K +N+L+ K+ D G+S ++ T +
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFI--- 190
Query: 969 VRGTLPWMAPE 979
GT WMAPE
Sbjct: 191 --GTPYWMAPE 199
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 56/268 (20%), Positives = 105/268 (39%), Gaps = 35/268 (13%)
Query: 728 GAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEA 787
+ +K ++ S + + A+ E + + + D + P +
Sbjct: 20 YFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVD----IPAPPAPFDH 75
Query: 788 EAIARGLQTIKND-DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE 844
+ + + + + LG G +G V+ + G +A K IK ++E
Sbjct: 76 RIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKE 131
Query: 845 RLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID 904
+ E +++ L H N++ Y + V E++ G L F DR ID
Sbjct: 132 ----EVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYVDGGEL--F----DRIID 179
Query: 905 RRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
L +D G+ ++H I+H DLK EN+L RD ++ KI D GL+
Sbjct: 180 ESYNLT-ELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQ--IKIIDFGLA 236
Query: 958 K-VKQQTLVSGGVRGTLPWMAPELLSGK 984
+ K + + GT ++APE+++
Sbjct: 237 RRYKPREKLKVNF-GTPEFLAPEVVNYD 263
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 4e-21
Identities = 49/288 (17%), Positives = 89/288 (30%), Gaps = 30/288 (10%)
Query: 720 SVKRAALEGAEEVKAKVEESDDSVKPDTTTKE--APANEAELVNIHGEIEMDYDNDTVKT 777
S E +A+ E + + + + E ND
Sbjct: 8 SSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPK 67
Query: 778 LKIEPTIAEAEAIARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRI 831
+ + +G G V R G + A+K +
Sbjct: 68 GTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIM 127
Query: 832 KASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLATVTEFMVNG 890
+ + P + E + +E +L + HP++++ + V + M G
Sbjct: 128 EVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES--SSFMFLVFDLMRKG 185
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAF-------GMEYLHGKNIVHFDLKCENLLVNMRD 943
L F D + + L + + +LH NIVH DLK EN+L+ D
Sbjct: 186 EL--F----DY-LTEKVALS-EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---D 234
Query: 944 PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
+ ++ D G S + + GT ++APE+L
Sbjct: 235 DNMQI-RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPG 281
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 44/199 (22%), Positives = 74/199 (37%), Gaps = 47/199 (23%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
++G G+Y + + A+K I S E +LL HP
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT---EE--------IEILLRYGQHP 76
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAFGM- 919
N+++ + D + VTE M G L D+ + ++ R +A+ +
Sbjct: 77 NIITLKDVYDD--GKYVYVVTELMKGGEL--L----DKILRQKFFSER-----EASAVLF 123
Query: 920 ------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ------QTLVSG 967
EYLH + +VH DLK N+L +I D G +K + T
Sbjct: 124 TITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-- 181
Query: 968 GVRGTLPWMAPELLSGKSH 986
T ++APE+L + +
Sbjct: 182 ---YTANFVAPEVLERQGY 197
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 44/200 (22%), Positives = 69/200 (34%), Gaps = 31/200 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSL-H 861
LG G V + + A+K I + E + L KE +L +
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK---RLIIAMDAAF- 917
HPN++ + V + M G L F D ++ + +
Sbjct: 83 HPNIIQLKDTYET--NTFFFLVFDLMKKGEL--F----DYLTEKVTLSEK-----ETRKI 129
Query: 918 ------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRG 971
+ LH NIVH DLK EN+L+ D + K+ D G S V G
Sbjct: 130 MRALLEVICALHKLNIVHRDLKPENILL---DDDMNI-KLTDFGFSCQLDPGEKLREVCG 185
Query: 972 TLPWMAPELLSGKSHMVTEK 991
T ++APE++ +
Sbjct: 186 TPSYLAPEIIECSMNDNHPG 205
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 57/192 (29%), Positives = 84/192 (43%), Gaps = 33/192 (17%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK---EALLLSS 859
V+ LG G YG V R VA+K + + +R + E +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV----------DMKRAVDCPENIKKEICINKM 61
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L+H NVV FYG R+G E+ G L ++ + +R ++A
Sbjct: 62 LNHENVVKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--- 116
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GT 972
G+ YLHG I H D+K ENLL+ D + + KI D GL+ V + + GT
Sbjct: 117 --GVVYLHGIGITHRDIKPENLLL---DERDNL-KISDFGLATVFRYNNRERLLNKMCGT 170
Query: 973 LPWMAPELLSGK 984
LP++APELL +
Sbjct: 171 LPYVAPELLKRR 182
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-20
Identities = 45/232 (19%), Positives = 73/232 (31%), Gaps = 53/232 (22%)
Query: 806 RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+G G+YG V + AIK + + + E L+ LHHP
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE---RIKTEVRLMKKLHHP 88
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM---------- 913
N+ Y + D + + V E G L L + + +
Sbjct: 89 NIARLYEVYED--EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 914 ----------------------DAAF-------GMEYLHGKNIVHFDLKCENLLVNMRDP 944
+ + YLH + I H D+K EN L + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS-TNK 205
Query: 945 QRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSHMVTEK 991
+ K+ D GLSK + GT ++APE+L+ + K
Sbjct: 206 SFEI-KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 49/216 (22%), Positives = 81/216 (37%), Gaps = 56/216 (25%)
Query: 797 IKNDDLEEV-------RELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLI 847
+K+ + + LG G++ K A+K I +R+
Sbjct: 1 MKDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-----------KRME 49
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
A+ KE L HPN+V + + D V E + G L F +R ++
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVMELLNGGEL--F----ERIKKKK 101
Query: 907 K---RLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
+A++ M ++H +VH DLK ENLL + + KI D G
Sbjct: 102 HFSET-----EASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI-KIIDFGF 155
Query: 957 SKVKQ------QTLVSGGVRGTLPWMAPELLSGKSH 986
+++K +T TL + APELL+ +
Sbjct: 156 ARLKPPDNQPLKTPC-----FTLHYAAPELLNQNGY 186
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 53/194 (27%), Positives = 82/194 (42%), Gaps = 36/194 (18%)
Query: 803 EEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWK-EALLLSS 859
+ V+++GSG +G K VA+K I ER I + + E + S
Sbjct: 23 DFVKDIGSGNFGVARLMRDKLTKELVAVKYI----------ERGAAIDENVQREIINHRS 72
Query: 860 LHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDA 915
L HPN+V F ++ LA + E+ G L + + R + R + +++
Sbjct: 73 LRHPNIVRFKEVILTPTH--LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS--- 127
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ-----TLVSGGVR 970
G+ Y H I H DLK EN L++ P KI D G SK + V
Sbjct: 128 --GVSYCHSMQICHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV----- 178
Query: 971 GTLPWMAPELLSGK 984
GT ++APE+L +
Sbjct: 179 GTPAYIAPEVLLRQ 192
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 1e-19
Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 32/198 (16%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALL 856
+ E++ ++G G+YG V+ + R G VAIK+ S R E +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-------EIRM 55
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK-RLIIAMDA 915
L L HPN+V+ + R L V E+ + ++ L + R + + I
Sbjct: 56 LKQLKHPNLVNLLEVFRR--KRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGV 969
+ + H N +H D+K EN+L+ V K+ D G V+
Sbjct: 113 Q-AVNFCHKHNCIHRDVKPENILITKHS----VIKLCDFGFARLLTGPSDYYDDEVA--- 164
Query: 970 RGTLPWM-APELLSGKSH 986
T W +PELL G +
Sbjct: 165 --TR-WYRSPELLVGDTQ 179
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 44/187 (23%), Positives = 79/187 (42%), Gaps = 20/187 (10%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LGSG +G V+ + +V +K IK + + E +LS + H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGS-LKQFLQKKDRTID---RRK-RLIIAMDAAFG 918
N++ I + G V E +G L F+ + R + R +++
Sbjct: 90 NIIKVLDIFEN--QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS-----A 142
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMA 977
+ YL K+I+H D+K EN+++ + K+ D G + +++ L GT+ + A
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGSAAYLERGKLFYTFC-GTIEYCA 197
Query: 978 PELLSGK 984
PE+L G
Sbjct: 198 PEVLMGN 204
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 56/206 (27%), Positives = 81/206 (39%), Gaps = 35/206 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI------------------KASCFAGKPSERER 845
E+G G+YG V + A+K + G +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 846 LIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID- 904
I ++E +L L HPNVV ++ D + L V E + G + + K + D
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 905 -RRK-RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--K 960
R + +I G+EYLH + I+H D+K NLLV KI D G+S
Sbjct: 139 ARFYFQDLIK-----GIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEFKG 189
Query: 961 QQTLVSGGVRGTLPWMAPELLSGKSH 986
L+S V GT +MAPE LS
Sbjct: 190 SDALLSNTV-GTPAFMAPESLSETRK 214
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 52/194 (26%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLL 857
+ + ++G GTYG VY + G A+K+I+ G PS R E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-------EISIL 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
L H N+V Y ++ L V E + + LK+ L + ++ K ++ +
Sbjct: 55 KELKHSNIVKLYDVIHT--KKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ Y H + ++H DLK +NLL+N + KI D GL++ + V T
Sbjct: 112 --GIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLARAFGIPVRKYTHEIV--T 163
Query: 973 LPWMAPELLSGKSH 986
L + AP++L G
Sbjct: 164 LWYRAPDVLMGSKK 177
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 25/186 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
+ +G G + V + G +VAIK I + P+ ++L +E ++ L+HP
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLF----REVRIMKILNHP 74
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
N+V + ++ L + E+ G + +L R + R K R I++ +
Sbjct: 75 NIVKLFEVIETEKTLYL--IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AV 127
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS-KVKQQTLVSGGVRGTLPWMAP 978
+Y H K IVH DLK ENLL+ D + KI D G S + + G P+ AP
Sbjct: 128 QYCHQKRIVHRDLKAENLLL---DADMNI-KIADFGFSNEFTVGGKLDAFC-GAPPYAAP 182
Query: 979 ELLSGK 984
EL GK
Sbjct: 183 ELFQGK 188
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 36/197 (18%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE--RLIADFWKEALLLS 858
E + +G G+YG V + + G VAIK+ S + + + IA +E LL
Sbjct: 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES------DDDKMVKKIA--MREIKLLK 79
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDAA 916
L H N+V+ + + V EF+ + ++ L+ +D + ++ + +
Sbjct: 80 QLRHENLVNLLEVCKK--KKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIIN- 135
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQT-LVSGGVR 970
G+ + H NI+H D+K EN+LV+ V K+ D G + + V+
Sbjct: 136 -GIGFCHSHNIIHRDIKPENILVSQSG----VVKLCDFGFARTLAAPGEVYDDEVA---- 186
Query: 971 GTLPWM-APELLSGKSH 986
T W APELL G
Sbjct: 187 -TR-WYRAPELLVGDVK 201
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 44/206 (21%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-------RLIADF 850
D + +LG GTYG VY VAIKRI+ E E R
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE------HEEEGVPGTAIR----- 82
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
E LL L H N++ ++ + L + E+ LK++ +D+ +
Sbjct: 83 --EVSLLKELQHRNIIELKSVIHH--NHRLHLIFEYA-ENDLKKY-------MDKNPDVS 130
Query: 911 IAMDAAF------GMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGDLGLSKVKQ-- 961
+ + +F G+ + H + +H DLK +NLL+++ D + PV KIGD GL++
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 962 -QTLVSGGVRGTLPWMAPELLSGKSH 986
+ + TL + PE+L G H
Sbjct: 191 IRQFTHEII--TLWYRPPEILLGSRH 214
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 26/195 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-GKPSERERLIADFWKEALL 856
E++ ++G GTYG+V+ K R VA+KR++ G PS R E L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-------EICL 54
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMD 914
L L H N+V + ++ D L V EF + LK++ + +D K + +
Sbjct: 55 LKELKHKNIVRLHDVLHS--DKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRG 971
G+ + H +N++H DLK +NLL+N + K+ + GL++ + + V
Sbjct: 112 K--GLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLARAFGIPVRCYSAEVV-- 163
Query: 972 TLPWMAPELLSGKSH 986
TL + P++L G
Sbjct: 164 TLWYRPPDVLFGAKL 178
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 5e-19
Identities = 48/222 (21%), Positives = 84/222 (37%), Gaps = 38/222 (17%)
Query: 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKE 853
+ L R L G + VY + G + A+KR+ + + + +I +E
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL----LSNEEEKNRAII----QE 75
Query: 854 ALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMV-----NGSLKQFLQKKDRT--IDR 905
+ L HPN+V F G + S EF++ G L +FL+K + +
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 906 RKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
L I ++++H + I+H DLK ENLL++ + K+ D G +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG----TIKLCDFGSATTISHY 191
Query: 964 LVSGG-------------VRGTLPWMAPELLSGKSHM-VTEK 991
T + PE++ S+ + EK
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 59/194 (30%), Positives = 89/194 (45%), Gaps = 25/194 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFA-GKPSERERLIADFWKEALLL 857
+ +++ ++G GTYG VY K G VA+KRI+ G PS R E LL
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-------EISLL 73
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
LHHPN+VS ++ + L V EFM LK+ L + + K + +
Sbjct: 74 KELHHPNIVSLIDVIHS--ERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ + H I+H DLK +NLL+N K+ D GL++ ++ V T
Sbjct: 131 --GVAHCHQHRILHRDLKPQNLLIN----SDGALKLADFGLARAFGIPVRSYTHEVV--T 182
Query: 973 LPWMAPELLSGKSH 986
L + AP++L G
Sbjct: 183 LWYRAPDVLMGSKK 196
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 46/189 (24%), Positives = 73/189 (38%), Gaps = 23/189 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G+YG V A+K +K P+ + KE LL L H
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK----KEIQLLRRLRHK 66
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF---LQKKDRTIDRRK--RLIIAMDAAFG 918
NV+ ++ + + V E+ V G + +K+ +I G
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----G 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---GTLPW 975
+EYLH + IVH D+K NLL+ + KI LG+++ R G+ +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLL---TTGGTL-KISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 976 MAPELLSGK 984
PE+ +G
Sbjct: 178 QPPEIANGL 186
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 45/195 (23%), Positives = 71/195 (36%), Gaps = 33/195 (16%)
Query: 808 LGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPN 864
LG G + V + A+K I+ R R+ ++E +L H N
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQ----PGHIRSRV----FREVEMLYQCQGHRN 72
Query: 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR-----RKRLIIAMDAAFGM 919
V+ + + V E M GS+ R + ++ D A +
Sbjct: 73 VLELIEFFEE--EDRFYLVFEKMRGGSI--L----SHIHKRRHFNELEASVVVQDVASAL 124
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--------G 971
++LH K I H DLK EN+L + PV KI D L + + G
Sbjct: 125 DFLHNKGIAHRDLKPENILCEHPNQVSPV-KICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 972 TLPWMAPELLSGKSH 986
+ +MAPE++ S
Sbjct: 184 SAEYMAPEVVEAFSE 198
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 25/217 (11%), Positives = 49/217 (22%), Gaps = 42/217 (19%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
L G V+ + D A+K F + + + L
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALK-----VFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 864 NVVSFYG------------------IVRDGPDGSLATVTEFMV-----NGSLKQFLQKKD 900
+ + P V +++ + L+ D
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 901 RTIDRRK------RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
R I+ L K +VH +NL + +GD+
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR----LMLGDV 238
Query: 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEK 991
+ + + E L+ + T
Sbjct: 239 SALWKVGTRGPASS--VPVTYAPREFLNASTATFTHA 273
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 46/259 (17%), Positives = 78/259 (30%), Gaps = 83/259 (32%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E ++ +G G +G V+ K + + AIKRI+ + RE++ +E L
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKV----MREVKAL 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDR------------ 905
+ L HP +V ++ + P + + +
Sbjct: 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 906 RKRLIIAMDAAFG--------MEY------------------------------------ 921
+ + M+
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 922 -LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---------- 970
LH K ++H DLK N+ M D V K+GD GL Q V
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDD----VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234
Query: 971 ---GTLPWMAPELLSGKSH 986
GT +M+PE + G ++
Sbjct: 235 GQVGTKLYMSPEQIHGNNY 253
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 28/198 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+++ +LG+GTY +VY G + G VA+K +K G PS R E L+
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-------EISLM 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N+V Y ++ + L V EFM + LK+++ + + L + + F
Sbjct: 58 KELKHENIVRLYDVIHT--ENKLTLVFEFM-DNDLKKYM-DSRTVGNTPRGLELNLVKYF 113
Query: 918 ------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGG 968
G+ + H I+H DLK +NLL+N +R K+GD GL++ T S
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 969 VRGTLPWMAPELLSGKSH 986
V TL + AP++L G
Sbjct: 170 V--TLWYRAPDVLMGSRT 185
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 58/191 (30%), Positives = 94/191 (49%), Gaps = 25/191 (13%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ ++ +LG GTY +VY GK + + VA+K I+ G P R E LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR-------EVSLL 54
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR--KRLIIAMDA 915
L H N+V+ + I+ + SL V E++ + LKQ+L I+ K + +
Sbjct: 55 KDLKHANIVTLHDIIHT--EKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL-- 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGT 972
G+ Y H + ++H DLK +NLL+N +R K+ D GL++ K +T + V T
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLARAKSIPTKTYDNEVV--T 163
Query: 973 LPWMAPELLSG 983
L + P++L G
Sbjct: 164 LWYRPPDILLG 174
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 55/264 (20%), Positives = 101/264 (38%), Gaps = 51/264 (19%)
Query: 742 SVKPDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDD 801
S +P TT+ + + G +++ D D K + T +G +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPG------QGPDRPQEVS 55
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-RLIADFWKEALLLS 858
+ + +G+G++G VY K G VAIK++ + + R E ++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNR-------ELQIMR 102
Query: 859 SLHHPNVVS----FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L H N+V FY + L V +++ ++ + R +
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRV-------ARHYSRAKQTLP 154
Query: 915 AAF----------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQ 962
+ + Y+H I H D+K +NLL++ P V K+ D G +K V+ +
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGSAKQLVRGE 211
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
VS + + APEL+ G +
Sbjct: 212 PNVSYIC--SRYYRAPELIFGATD 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 53/242 (21%), Positives = 93/242 (38%), Gaps = 49/242 (20%)
Query: 768 MDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVR-----ELGSGTYGSVYHGKWR 822
N + +K+ P + I K + E+ +G+G++G V+ K
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 823 GSD-VAIKRIKASCFAGKPSERE-RLIADFWKEALLLSSLHHPNVVS----FYGIVRDGP 876
SD VAIK++ + + R E ++ + HPNVV FY
Sbjct: 63 ESDEVAIKKVL------QDKRFKNR-------ELQIMRIVKHPNVVDLKAFFYSNGDKKD 109
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF----------GMEYLHGKN 926
+ L V E++ ++ + +L M + Y+H
Sbjct: 110 EVFLNLVLEYV-PETVYRA-------SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG 161
Query: 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGK 984
I H D+K +NLL++ P V K+ D G +K + + VS + + APEL+ G
Sbjct: 162 ICHRDIKPQNLLLD---PPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRAPELIFGA 216
Query: 985 SH 986
++
Sbjct: 217 TN 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 40/191 (20%), Positives = 68/191 (35%), Gaps = 26/191 (13%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIK-----RIKASCFAGKPSERERLIADFWKEALLLS 858
LG G +G+V+ G VAIK R+ +A W + +
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW---KVGA 93
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGS-LKQFLQKKDR---TIDRRK-RLIIAM 913
HP V+ V E + L ++ +K R ++A
Sbjct: 94 GGGHPGVIRLLDWFET--QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA- 150
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+++ H + +VH D+K EN+L+ D +R K+ D G + + GT
Sbjct: 151 ----AIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGSGALLHDEPYTDFD-GTR 202
Query: 974 PWMAPELLSGK 984
+ PE +S
Sbjct: 203 VYSPPEWISRH 213
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 57/200 (28%), Positives = 84/200 (42%), Gaps = 39/200 (19%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIK----ASCFAGKPSERERLIADFWKE 853
E++ LG G + +VY + + VAIK+IK + G R E
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-------E 62
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
LL L HPN++ G +++ V +FM L+ ++ D L +
Sbjct: 63 IKLLQELSHPNIIGLLDAF--GHKSNISLVFDFM-ETDLEVIIK------DNSLVLTPSH 113
Query: 914 DAAF------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK---VKQQTL 964
A+ G+EYLH I+H DLK NLL++ + V K+ D GL+K +
Sbjct: 114 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAY 169
Query: 965 VSGGVRGTLPWM-APELLSG 983
V T W APELL G
Sbjct: 170 THQVV--TR-WYRAPELLFG 186
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 50/189 (26%), Positives = 82/189 (43%), Gaps = 30/189 (15%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG GT+G V G+ + G VA+K + ++ +E L HP
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIK----REIQNLKLFRHP 71
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
+++ Y ++ D V E++ G L ++ K R + RR + I++ +
Sbjct: 72 HIIKLYQVISTPTD--FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AV 124
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
+Y H +VH DLK EN+L+ D KI D GLS + G G+ +
Sbjct: 125 DYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSD----GEFLRTSCGSPNY 176
Query: 976 MAPELLSGK 984
APE++SG+
Sbjct: 177 AAPEVISGR 185
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 41/204 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSE---RERLIADFWKE 853
+D + + LG G++ +V + + AIK + K RER +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDV------ 83
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA- 912
+S L HP V Y +D D L + NG L ++++K + R A
Sbjct: 84 ---MSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE 138
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLV--NMRDPQRPVCKIGDLGLSKV--------KQQ 962
+ +A EYLHGK I+H DLK EN+L+ +M +I D G +KV +
Sbjct: 139 IVSAL--EYLHGKGIIHRDLKPENILLNEDMH------IQITDFGTAKVLSPESKQARAN 190
Query: 963 TLVSGGVRGTLPWMAPELLSGKSH 986
+ V GT +++PELL+ KS
Sbjct: 191 SFV-----GTAQYVSPELLTEKSA 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 5e-17
Identities = 51/211 (24%), Positives = 80/211 (37%), Gaps = 52/211 (24%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE-------RLIADF 850
E++ ++G GT+G V+ + R G VA+K++ +E+E R
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME------NEKEGFPITALR----- 65
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPD------GSLATVTEFMVNGSLKQFLQKKDRTID 904
E +L L H NVV+ I R GS+ V +F + L L
Sbjct: 66 --EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFT 122
Query: 905 RR--KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
KR++ + G+ Y+H I+H D+K N+L+ + V K+ D GL+
Sbjct: 123 LSEIKRVMQMLLN--GLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLA----- 171
Query: 963 TLVSGGVRGTLPWM----------APELLSG 983
S PELL G
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLG 202
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 44/185 (23%), Positives = 69/185 (37%), Gaps = 36/185 (19%)
Query: 790 IARGLQTIKNDDLEEV----RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSER 843
+ GLQ KN +++ + LG G G V + A+K ++
Sbjct: 4 VKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------- 54
Query: 844 ERLIADFWKE-ALLLSSLHHPNVVSFYGIVRDGPDGSLAT--VTEFMVNGSLKQFLQKKD 900
+E L + P++V + + G V E + G L F
Sbjct: 55 ----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--F----S 104
Query: 901 RTIDRRKRLIIAMDAAFGM-------EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953
R DR + +A+ M +YLH NI H D+K ENLL + P + K+ D
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL-KLTD 163
Query: 954 LGLSK 958
G +K
Sbjct: 164 FGFAK 168
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-16
Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 26/187 (13%)
Query: 805 VRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH 861
+ G G +Y R G V +K + +G + E L+ +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAM----AMAERQFLAEVV 137
Query: 862 HPNVVSFYGIVRDGPDGSLAT---VTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAF 917
HP++V + V V E+ V G SLK+ + + + + ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKG---QKLPVAEAIAYLLEILP 193
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ YLH +V+ DLK EN+++ ++ K+ DLG G + GT + A
Sbjct: 194 ALSYLHSIGLVYNDLKPENIML---TEEQL--KLIDLGAVSRINSF---GYLYGTPGFQA 245
Query: 978 PELLSGK 984
PE++
Sbjct: 246 PEIVRTG 252
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
V +LG G +VY + VAIK I K +R F +E S L H
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKR----FEREVHNSSQLSH 70
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
N+VS + + L V E+ + G +L ++++ + + G+++
Sbjct: 71 QNIVSMIDVDEEDDCYYL--VMEY-IEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKH 126
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTLPWMAPE 979
H IVH D+K +N+L+ D + + KI D G++K +T + + V GT+ + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILI---DSNKTL-KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 980 LLSGKS 985
G++
Sbjct: 183 QAKGEA 188
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 41/205 (20%)
Query: 800 DDLEEVRELGSGTYGSVY---HGKWRGSDVAIKRIKASCFAGKPSERE-------RLIAD 849
E V E+G G YG V+ K G VA+KR++ + E R +A
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV------QTGEEGMPLSTIREVA- 63
Query: 850 FWKEALL--LSSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDR--- 901
+L L + HPNVV + + R + L V E + + L +L K
Sbjct: 64 -----VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGV 117
Query: 902 TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961
+ K ++ + G+++LH +VH DLK +N+LV K+ D GL+++
Sbjct: 118 PTETIKDMMFQLLR--GLDFLHSHRVVHRDLKPQNILVT----SSGQIKLADFGLARIYS 171
Query: 962 --QTLVSGGVRGTLPWMAPELLSGK 984
L S V TL + APE+L
Sbjct: 172 FQMALTSVVV--TLWYRAPEVLLQS 194
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 47/185 (25%), Positives = 73/185 (39%), Gaps = 18/185 (9%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G G VY + R VA+K + + + P R R +EA L
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSET-LSSDPVFRTR----MQREARTAGRLQE 93
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
P+VV + DG L +NG L L+++ + + + I ++
Sbjct: 94 PHVVPIHDFGEI--DGQLYVDMRL-INGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDA 149
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV--SGGVRGTLPWMAPE 979
H H D+K EN+LV+ D + D G++ + G GTL +MAPE
Sbjct: 150 AHAAGATHRDVKPENILVSADD----FAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205
Query: 980 LLSGK 984
S
Sbjct: 206 RFSES 210
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 57/206 (27%), Positives = 85/206 (41%), Gaps = 43/206 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERE----------RLI 847
E V E+G G YG+VY + S VA+K ++ P+ R +
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR------VPNGGGGGGGLPISTVREV 62
Query: 848 ADFWKEALL--LSSLHHPNVVSFYGIV---RDGPDGSLATVTEFMVNGSLKQFLQKKDR- 901
A LL L + HPNVV + R + + V E + + L+ +L K
Sbjct: 63 A------LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPP 115
Query: 902 --TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959
+ K L+ G+++LH IVH DLK EN+LV K+ D GL+++
Sbjct: 116 GLPAETIKDLMRQFLR--GLDFLHANCIVHRDLKPENILVT----SGGTVKLADFGLARI 169
Query: 960 KQ--QTLVSGGVRGTLPWMAPELLSG 983
L V TL + APE+L
Sbjct: 170 YSYQMALTPVVV--TLWYRAPEVLLQ 193
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 35/197 (17%)
Query: 800 DDLEEVRELGSGTYGSVYHG--KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
DD + VR+LG G Y V+ V +K +K P +++++ +E +L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKKIK----REIKIL 84
Query: 858 SSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+L PN+++ IV+D + A V E + N KQ Q + D
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----------LTDYDIR 133
Query: 917 F-------GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
F ++Y H I+H D+K N++++ + ++ D GL++
Sbjct: 134 FYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 970 RGTLPWMAPELLSGKSH 986
+ + PELL
Sbjct: 191 VASRYFKGPELLVDYQM 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 49/197 (24%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWK 852
T + D + ++ LG+G++G V K + S A+K + K + E +
Sbjct: 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLN---- 90
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E +L +++ P +V +D + +L V E++ G + L++ R + R A
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKD--NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA 148
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGV 969
EYLH ++++ DLK ENLL++ Q+ ++ D G +K + TL
Sbjct: 149 -QIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGFAKRVKGRTWTLC---- 199
Query: 970 RGTLPWMAPELLSGKSH 986
GT +APE++ K +
Sbjct: 200 -GTPEALAPEIILSKGY 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 31/189 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP 863
LG G++G V VA+K I ++ + +E L L HP
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-----KKSDMHMRVEREISYLKLLRHP 69
Query: 864 NVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMDAAFGM 919
+++ Y ++ D + V E+ G L ++ +K R + RR + II +
Sbjct: 70 HIIKLYDVITTPTD--IVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC-----AI 121
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR----GTLPW 975
EY H IVH DLK ENLL+ D V KI D GLS + G G+ +
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---DDNLNV-KIADFGLSNIMTD----GNFLKTSCGSPNY 173
Query: 976 MAPELLSGK 984
APE+++GK
Sbjct: 174 AAPEVINGK 182
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 8e-16
Identities = 26/215 (12%), Positives = 62/215 (28%), Gaps = 36/215 (16%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSE----RERLIADFWKEAL---- 855
LG + + G + + + E L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 856 ------------LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQ------ 897
L+ ++ RD S + M +L+ F +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS 197
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
+++ RL + + + LH +VH L+ ++++ D + V +
Sbjct: 198 STHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGFEHL 253
Query: 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992
+VS + + PEL + ++ + ++
Sbjct: 254 VRDGARVVS---SVSRGFEPPELEARRATISYHRD 285
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 40/189 (21%), Positives = 67/189 (35%), Gaps = 24/189 (12%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALLLSSLHH 862
LGSG +GSVY G VAIK + K + E +LL +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP---MEVVLLKKVSS 105
Query: 863 --PNVVSFYGIVRDGPDGSLATVTEFMVN-GSLKQFLQKKDR---TIDRRK-RLIIAMDA 915
V+ S + E L F+ ++ + R ++
Sbjct: 106 GFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE--- 160
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
+ + H ++H D+K EN+L+ D R K+ D G + + T+ + GT +
Sbjct: 161 --AVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYTDFD-GTRVY 214
Query: 976 MAPELLSGK 984
PE +
Sbjct: 215 SPPEWIRYH 223
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 49/196 (25%), Positives = 87/196 (44%), Gaps = 22/196 (11%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
LG G V+ + DVA+K ++A A PS R F +EA ++L+H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLR----FRREAQNAAALNH 71
Query: 863 PNVVSFYGIVRD-GPDGSLA-TVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGM 919
P +V+ Y P G L V E+ V+G +L+ + + + ++ + + DA +
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 129
Query: 920 EYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----GGVRGTLPW 975
+ H I+H D+K N+++ V K+ D G+++ + S V GT +
Sbjct: 130 NFSHQNGIIHRDVKPANIMI---SATNAV-KVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 976 MAPELLSGKSHMVTEK 991
++PE G V +
Sbjct: 186 LSPEQARG--DSVDAR 199
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 3e-15
Identities = 56/194 (28%), Positives = 86/194 (44%), Gaps = 40/194 (20%)
Query: 806 RELGSGTYGSVYHGKWR--GSDVAIK-----RIKASCFAGKPSERERLIADFWKEALLLS 858
LG GT+G V GK G VA+K +I++ GK RE L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQN---------LK 71
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTID---RRK-RLIIAMD 914
HP+++ Y ++ D + V E++ G L ++ K R + RR + I++
Sbjct: 72 LFRHPHIIKLYQVISTPSD--IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-- 127
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR---- 970
G++Y H +VH DLK EN+L+ D KI D GLS + G
Sbjct: 128 ---GVDYCHRHMVVHRDLKPENVLL---DAHMNA-KIADFGLSNMMSD----GEFLRTSC 176
Query: 971 GTLPWMAPELLSGK 984
G+ + APE++SG+
Sbjct: 177 GSPNYAAPEVISGR 190
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-14
Identities = 53/193 (27%), Positives = 93/193 (48%), Gaps = 24/193 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSERERLIADFWKEALL 856
D + +R LG+G++G V+ + R + A+K + K K + E E L+
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK--QVEHTND----ERLM 59
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
LS + HP ++ +G +D + + +++ G L L+K R + + A +
Sbjct: 60 LSIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVC 116
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ---TLVSGGVRGTL 973
+EYLH K+I++ DLK EN+L++ + KI D G +K TL GT
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYTLC-----GTP 167
Query: 974 PWMAPELLSGKSH 986
++APE++S K +
Sbjct: 168 DYIAPEVVSTKPY 180
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 5e-14
Identities = 35/164 (21%), Positives = 56/164 (34%), Gaps = 7/164 (4%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
D L+ + LG G +G V G D + K E +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 860 L-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
+ HH NVV+ G P G L + EF G+L +L+ K R + + A
Sbjct: 82 IGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSK-----RNEFVPYKTKGARF 135
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ + DLK + + + LS V+++
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 73.9 bits (181), Expect = 7e-14
Identities = 26/214 (12%), Positives = 57/214 (26%), Gaps = 33/214 (15%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPS----ERERLIADFWKEA- 854
L LG + + G + + + + E L +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 855 ------------LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFM--VNGSLKQFLQ--- 897
+ P + D D + + + +L+ F +
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 898 ---KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+++ RL + + + LH +VH L+ ++++ D + V +
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGV-FLTGF 255
Query: 955 GLSKVKQQTLVS--GGVRGTLPWMAPELLSGKSH 986
+ VS G A +L H
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQH 289
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 52/207 (25%), Positives = 79/207 (38%), Gaps = 47/207 (22%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKP-SERE-RLIADFWKEALLLS 858
+ R G GT+G+V GK + G VAIK++ RE +++ L+
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQDPRFRNRELQIMQ-------DLA 74
Query: 859 SLHHPNVVSFYGIV-----RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
LHHPN+V RD D L V E++ +L + R +A
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRC-------CRNYYRRQVAP 126
Query: 914 DAAF----------GMEYLHGK--NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--V 959
+ LH N+ H D+K N+LVN K+ D G +K
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN---EADGTLKLCDFGSAKKLS 183
Query: 960 KQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ V+ + + APEL+ G H
Sbjct: 184 PSEPNVAYIC--SRYYRAPELIFGNQH 208
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 45/191 (23%), Positives = 85/191 (44%), Gaps = 22/191 (11%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSE---RERLIADFWKE 853
D E +R +G G++G V + + A+K + K C +E I
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQI------ 68
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ L HP +V+ + +D + + V + ++ G L+ LQ+ + +L I
Sbjct: 69 ---MQGLEHPFLVNLWYSFQD--EEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC- 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ ++YL + I+H D+K +N+L+ D V I D ++ + + + GT
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILL---DEHGHV-HITDFNIAAMLPRETQITTMAGTK 178
Query: 974 PWMAPELLSGK 984
P+MAPE+ S +
Sbjct: 179 PYMAPEMFSSR 189
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 48/244 (19%), Positives = 92/244 (37%), Gaps = 35/244 (14%)
Query: 766 IEMDYDNDTVKTLKIEPTIAE----AEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHG 819
+ + L + +A+ AE I L+ ++ DD E ++ +G G + V
Sbjct: 21 LLGVHQELGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVV 80
Query: 820 KWRGSD--VAIKRIKASCFAGKPSERERL-IADFWKEALLLSSLHHPNVVSFYGIVRDGP 876
K + + A+K + K +R ++ F +E +L + + + +D
Sbjct: 81 KMKQTGQVYAMKIMN------KWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD-- 132
Query: 877 DGSLATVTEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935
+ L V E+ V G L L K I R +A + ++ +H VH D+K +
Sbjct: 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLA-EIVMAIDSVHRLGYVHRDIKPD 191
Query: 936 NLLVNMRDPQRPVCKIGDLGLSK-------VKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988
N+L++ ++ D G V+ V GT +++PE+L
Sbjct: 192 NILLDRCGH----IRLADFGSCLKLRADGTVRSLVAV-----GTPDYLSPEILQAVGGGP 242
Query: 989 TEKE 992
Sbjct: 243 GTGS 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 6e-13
Identities = 48/201 (23%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIAD--- 849
Q + + + R LG G +G V + R + A K+++ ++R+
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE----------KKRIKKRKGE 228
Query: 850 --FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTI--DR 905
E +L ++ VVS +L V M G LK + + +
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEA 286
Query: 906 RKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLV 965
R A + G+E LH + IV+ DLK EN+L+ +I DLGL+ +
Sbjct: 287 RAVFYAA-EICCGLEDLHRERIVYRDLKPENILL----DDHGHIRISDLGLAVHVPEGQT 341
Query: 966 SGGVRGTLPWMAPELLSGKSH 986
G GT+ +MAPE++ + +
Sbjct: 342 IKGRVGTVGYMAPEVVKNERY 362
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 1e-12
Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 22/241 (9%)
Query: 753 PANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGT 812
+E T + +K D + LG G+
Sbjct: 294 EGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGS 353
Query: 813 YGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870
+G V + +G+D A+K +K + E + + K L L P + +
Sbjct: 354 FGKVMLSERKGTDELYAVKILKKDVVIQD-DDVECTMVE--KRVLALPG-KPPFLTQLHS 409
Query: 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930
+ L V E++ G L +Q+ R + A + A G+ +L K I++
Sbjct: 410 CFQ--TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA-EIAIGLFFLQSKGIIYR 466
Query: 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKS 985
DLK +N+++ D + + KI D G+ K + GV GT ++APE+++ +
Sbjct: 467 DLKLDNVML---DSEGHI-KIADFGMCKEN----IWDGVTTKTFCGTPDYIAPEIIAYQP 518
Query: 986 H 986
+
Sbjct: 519 Y 519
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 45/202 (22%), Positives = 72/202 (35%), Gaps = 34/202 (16%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSER-ERLIADFWKEAL--- 855
R + SG+YG+V + G VAIKR+ + G+ K L
Sbjct: 25 TVQRFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSF--LCKRVLREI 80
Query: 856 -LLSSLHHPNVVSFYGIVRDGPDGSLAT---VTEFMVNGSLKQFLQKKDRTI-DRRKRLI 910
LL+ HHPN++ I + ++ VTE M L Q + + I + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 911 IAMDAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTL 964
+ + G+ LH +VH DL N+L+ I D L++
Sbjct: 140 M-----YHILLGLHVLHEAGVVHRDLHPGNILLADN------NDITICDFNLAREDTADA 188
Query: 965 VSGGVRGTLPWMAPELLSGKSH 986
+ APEL+
Sbjct: 189 NKTHYVTHRWYRAPELVMQFKG 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 46/198 (23%), Positives = 84/198 (42%), Gaps = 29/198 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERL-IADFWKE 853
+K +D E V+ +G G +G V + + + A+K + K +R A FW+E
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS------KFEMIKRSDSAFFWEE 119
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+++ + P VV + +D D L V E+M G L + D + +
Sbjct: 120 RDIMAFANSPWVVQLFYAFQD--DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV 177
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-------VKQQTLVS 966
A + +H +H D+K +N+L++ + K+ D G V+ T V
Sbjct: 178 VLAL--DAIHSMGFIHRDVKPDNMLLD----KSGHLKLADFGTCMKMNKEGMVRCDTAV- 230
Query: 967 GGVRGTLPWMAPELLSGK 984
GT +++PE+L +
Sbjct: 231 ----GTPDYISPEVLKSQ 244
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 47/226 (20%), Positives = 98/226 (43%), Gaps = 20/226 (8%)
Query: 769 DYDNDTVKTLK-IEPTIAEAEAIARGLQT--IKNDDLEEVRELGSGTYGSVYHGKWRGSD 825
+ +N ++ K I + A+ ++ + +D E ++ +G G +G V K + +D
Sbjct: 40 ECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNAD 99
Query: 826 --VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATV 883
A+K + K +E F +E +L + + + + +D D +L V
Sbjct: 100 KVFAMKILNKWEML-KRAETAC----FREERDVLVNGDSKWITTLHYAFQD--DNNLYLV 152
Query: 884 TEFMVNGSLKQFLQKKDRTID-RRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942
++ V G L L K + + R +A + ++ +H + VH D+K +N+L+
Sbjct: 153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLA-EMVIAIDSVHQLHYVHRDIKPDNILM--- 208
Query: 943 DPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGKSH 986
D + ++ D G ++ T+ S GT +++PE+L
Sbjct: 209 DMNGHI-RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 2e-12
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 790 IARGLQTIKNDDLEEVRELGSGTYGSVY---HGKWRGSDV--AIKRIKASCFAGKPSERE 844
+ RG + I+ + E +R LG G YG V+ + A+K +K + +
Sbjct: 7 VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66
Query: 845 RLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD 900
A E +L + HP +V +F G L + E++ G L L+++
Sbjct: 67 HTKA----ERNILEEVKHPFIVDLIYAFQ------TGGKLYLILEYLSGGELFMQLEREG 116
Query: 901 RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960
++ +A + + + +LH K I++ DLK EN+++ + Q V K+ D GL K
Sbjct: 117 IFMEDTACFYLA-EISMALGHLHQKGIIYRDLKPENIML---NHQGHV-KLTDFGLCKES 171
Query: 961 QQTLVSGGVR-----GTLPWMAPELLSGKSH 986
+ G GT+ +MAPE+L H
Sbjct: 172 ----IHDGTVTHTFCGTIEYMAPEILMRSGH 198
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 20/192 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSER----ERLIADFWKE 853
+D R +G G +G VY + + A+K + K E ER++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---- 244
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L+S+ P +V L+ + + M G L L + + R A
Sbjct: 245 --LVSTGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAA- 299
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
+ G+E++H + +V+ DLK N+L++ + +I DLGL+ + V GT
Sbjct: 300 EIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKKPHASV-GTH 354
Query: 974 PWMAPELLSGKS 985
+MAPE+L
Sbjct: 355 GYMAPEVLQKGV 366
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 45/205 (21%), Positives = 77/205 (37%), Gaps = 38/205 (18%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+++ LG G G V VAIK+I P + + +E ++
Sbjct: 14 MDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIV---L-TDPQSVKHAL----REIKIIRR 64
Query: 860 LHHPNVVSFYGIVRDGPDGSLAT------------VTEFMVNGSLKQFLQKKDRTIDRRK 907
L H N+V + I+ V E+M L L++ + +
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHAR 123
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLV 965
+ + G++Y+H N++H DLK NL +N D KIGD GL+++
Sbjct: 124 LFMYQL--LRGLKYIHSANVLHRDLKPANLFINTED-----LVLKIGDFGLARIMDPHYS 176
Query: 966 SGGVR----GTLPWMAPELLSGKSH 986
G T + +P LL ++
Sbjct: 177 HKGHLSEGLVTKWYRSPRLLLSPNN 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-12
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 31/198 (15%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + ++ LG GT+G V + + + A+K ++ K E + E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-DEVAHTVT----ESRVL 59
Query: 858 SSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+ HP + +F L V E+ G L L ++ + R R A
Sbjct: 60 QNTRHPFLTALKYAFQ------THDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA- 112
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR--- 970
+ +EYLH +++V+ D+K ENL++ D + KI D GL K +S G
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLML---DKDGHI-KITDFGLCKEG----ISDGATMKT 164
Query: 971 --GTLPWMAPELLSGKSH 986
GT ++APE+L +
Sbjct: 165 FCGTPEYLAPEVLEDNDY 182
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 56/250 (22%), Positives = 99/250 (39%), Gaps = 24/250 (9%)
Query: 745 PDTTTKEAPANEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEE 804
P+ + A + + + + D + ++A+ + ++ E
Sbjct: 93 PEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 805 VRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ LG GT+G V K + + A+K +K K E + E +L + H
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK-DEVAHTLT----ENRVLQNSRH 207
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
P + + + L V E+ G L L ++ + R R A + ++YL
Sbjct: 208 PFLTALKYSFQT--HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYL 264
Query: 923 HG-KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWM 976
H KN+V+ DLK ENL++ D + KI D GL K + G GT ++
Sbjct: 265 HSEKNVVYRDLKLENLML---DKDGHI-KITDFGLCKEG----IKDGATMKTFCGTPEYL 316
Query: 977 APELLSGKSH 986
APE+L +
Sbjct: 317 APEVLEDNDY 326
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 46/247 (18%), Positives = 99/247 (40%), Gaps = 38/247 (15%)
Query: 755 NEAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYG 814
+ +I + + ++ E + ++ D + +R +G G+Y
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 815 SVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERLIADFWKEALLLSSLHHPNVV-- 866
V + + +D A++ + K + + E+ + + +HP +V
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV--------FEQASNHPFLVGL 118
Query: 867 --SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG 924
F + L V E++ G L +Q++ + + R A + + + YLH
Sbjct: 119 HSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYLHE 171
Query: 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPE 979
+ I++ DLK +N+L+ D + + K+ D G+ K + G GT ++APE
Sbjct: 172 RGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG----LRPGDTTSTFCGTPNYIAPE 223
Query: 980 LLSGKSH 986
+L G+ +
Sbjct: 224 ILRGEDY 230
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 7e-12
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 21/200 (10%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRIKASCFAGKPSERERLIADFWK 852
Q + D + R LG G +G V+ + + + A K++ + + +
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR-KGYQGAMV---- 234
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLK----QFLQKKDRTIDRRKR 908
E +L+ +H +VS L V M G ++ + + R
Sbjct: 235 EKKILAKVHSRFIVSLAYAFET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAI 292
Query: 909 LIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVS 966
A G+E+LH +NI++ DLK EN+L++ +I DLGL+ QT
Sbjct: 293 FYTA-QIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNVRISDLGLAVELKAGQTKTK 347
Query: 967 GGVRGTLPWMAPELLSGKSH 986
G GT +MAPELL G+ +
Sbjct: 348 GYA-GTPGFMAPELLLGEEY 366
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 8e-12
Identities = 45/187 (24%), Positives = 84/187 (44%), Gaps = 28/187 (14%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ +GSG G V + +VAIK++ +P + + ++E +L+ ++H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERNVAIKKL------SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 863 PNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
N++ + P SL V E M + +L Q + + + +R L+ M
Sbjct: 84 KNIIGLLNVFT--PQKSLEEFQDVYIVMELM-DANLCQVI-QMELDHERMSYLLYQM--L 137
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V C KI D GL++ + + T
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 975 WMAPELL 981
+ APE++
Sbjct: 192 YRAPEVI 198
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-12
Identities = 52/205 (25%), Positives = 81/205 (39%), Gaps = 40/205 (19%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ LG G YG V H G VAIK+I+ F KP R + +E +L
Sbjct: 14 QLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEP--F-DKPLFALRTL----REIKILKH 65
Query: 860 LHHPNVVSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H N+++ + I R PD + E M L + + + + D + I
Sbjct: 66 FKHENIITIFNIQR--PDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQT- 121
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS-KVKQQTLVSGGVRG 971
++ LHG N++H DLK NLL+N C K+ D GL+ + + + G
Sbjct: 122 -LRAVKVLHGSNVIHRDLKPSNLLINSN------CDLKVCDFGLARIIDESAADNSEPTG 174
Query: 972 TLPWM----------APELLSGKSH 986
M APE++ +
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAK 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 34/226 (15%), Positives = 69/226 (30%), Gaps = 59/226 (26%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ LG+G++G V G A+K++ + +E ++ L
Sbjct: 10 SLGKTLGTGSFGIVCEVFDIESGKRFALKKV--------LQDPRYKN----RELDIMKVL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR-------------- 906
H N++ D + L +
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 907 -------KRLIIAMDAAF-----------------GMEYLHGKNIVHFDLKCENLLVNMR 942
+++ + + + ++H I H D+K +NLLVN
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-- 175
Query: 943 DPQRPVCKIGDLGLSK--VKQQTLVSGGVRGTLPWMAPELLSGKSH 986
+ K+ D G +K + + V+ + + APEL+ G +
Sbjct: 176 -SKDNTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATE 218
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 1e-11
Identities = 35/245 (14%), Positives = 65/245 (26%), Gaps = 60/245 (24%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ + L+ ++G G +G V+ + VAIK I ++ + E ++
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 857 LSSLH---------HPNVVSFYG--IVRDGPDGSLAT----------------------- 882
L + V+ L
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 883 ---VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLL 938
V EF G + ++ K ++ K I + H DL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKS--ILHQLTASLAVAEASLRFEHRDLHWGNVL 194
Query: 939 VNMRDPQRPVCK----------------IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982
+ ++ I D LS+++ G V M +L +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE----RDGIVVFCDVSMDEDLFT 250
Query: 983 GKSHM 987
G
Sbjct: 251 GDGDY 255
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSER---ERLIADF 850
+K +D + LG G++G V+ +++ ++ AIK + K E E+ +
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV--- 70
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
L + HP + + + +L V E++ G L +Q + R
Sbjct: 71 -----LSLAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY 123
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
A + G+++LH K IV+ DLK +N+L+ D + KI D G+ K + G +
Sbjct: 124 AA-EIILGLQFLHSKGIVYRDLKLDNILL---DKDGHI-KIADFGMCKEN----MLGDAK 174
Query: 971 -----GTLPWMAPELLSGKSH 986
GT ++APE+L G+ +
Sbjct: 175 TNTFCGTPDYIAPEILLGQKY 195
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 54/192 (28%), Positives = 85/192 (44%), Gaps = 29/192 (15%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
++ +GSG YG+V G+ VAIK++ +P + E ++E LL + H
Sbjct: 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKL------YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 863 PNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
NV+ + PD +L V FM L + ++ + DR + L+ M
Sbjct: 84 ENVIGLLDVFT--PDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQM--L 138
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+ Y+H I+H DLK NL VN C KI D GL++ + +G V T
Sbjct: 139 KGLRYIHAAGIIHRDLKPGNLAVNED------CELKILDFGLARQADSEM-TGYV-VTRW 190
Query: 975 WMAPELLSGKSH 986
+ APE++
Sbjct: 191 YRAPEVILNWMR 202
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 46/202 (22%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFAGKPSER---ERLIADFWKE 853
D + LG G++G V + +G+D A+K + K E E+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV------ 73
Query: 854 ALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
L P + F L V E++ G L +Q+ R +
Sbjct: 74 --LALPGKPPFLTQLHSCFQ------TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF 125
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
A + A G+ +L K I++ DLK +N+++ D + + KI D G+ K + GV
Sbjct: 126 YAA-EIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHI-KIADFGMCKEN----IWDGV 176
Query: 970 R-----GTLPWMAPELLSGKSH 986
GT ++APE+++ + +
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPY 198
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 3e-11
Identities = 43/187 (22%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V + +VAIK++ +P + + ++E +L+ +
Sbjct: 65 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMKCV 118
Query: 861 HHPNVVSFYGIVRDGPDGS----LATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+H N++S + + V E M + +L Q + + + +R L+ M
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI-QMELDHERMSYLLYQMLC- 175
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLP 974
G+++LH I+H DLK N++V C KI D GL++ + + T
Sbjct: 176 -GIKHLHSAGIIHRDLKPSNIVVKSD------CTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 975 WMAPELL 981
+ APE++
Sbjct: 229 YRAPEVI 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 783 TIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFA 837
IA + G + E ++ LG G++G V+ G A+K +K +
Sbjct: 7 EIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK 66
Query: 838 GKPSER---ERLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNG 890
+ R ER I L ++HP +V +F +G L + +F+ G
Sbjct: 67 VRDRVRTKMERDI---------LVEVNHPFIVKLHYAFQ------TEGKLYLILDFLRGG 111
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
L L K+ + + +A + A +++LH I++ DLK EN+L+ D + + K
Sbjct: 112 DLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHSLGIIYRDLKPENILL---DEEGHI-K 166
Query: 951 IGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSH 986
+ D GLSK + + GT+ +MAPE+++ + H
Sbjct: 167 LTDFGLSKES----IDHEKKAYSFCGTVEYMAPEVVNRRGH 203
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 53/221 (23%), Positives = 87/221 (39%), Gaps = 38/221 (17%)
Query: 781 EPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRI-KASCFA 837
E + + D+ E +R LG G++G V + + + A+K + K
Sbjct: 4 ESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ 63
Query: 838 GKPSER---ERLIADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNG 890
E E+ I L + +HP + F L V EF+ G
Sbjct: 64 DDDVECTMTEKRI--------LSLARNHPFLTQLFCCFQ------TPDRLFFVMEFVNGG 109
Query: 891 SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950
L +QK R + R R A + + +LH K I++ DLK +N+L+ D + K
Sbjct: 110 DLMFHIQKSRRFDEARARFYAA-EIISALMFLHDKGIIYRDLKLDNVLL---DHEGHC-K 164
Query: 951 IGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGKSH 986
+ D G+ K + GV GT ++APE+L +
Sbjct: 165 LADFGMCKEG----ICNGVTTATFCGTPDYIAPEILQEMLY 201
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 5e-11
Identities = 46/205 (22%), Positives = 74/205 (36%), Gaps = 37/205 (18%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERE----RLIADFWKEALL 856
E +G+G+YG V + VAIK+I + E R++ +E +
Sbjct: 56 EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI------LRVFEDLIDCKRIL----REIAI 105
Query: 857 LSSLHHPNVVSFYGIVR---DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
L+ L+H +VV IV L V E + K+ + + + ++
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL-- 162
Query: 914 DAAF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSG 967
+ G++Y+H I+H DLK N LVN C K+ D GL++
Sbjct: 163 ---YNLLVGVKYVHSAGILHRDLKPANCLVNQD------CSVKVCDFGLARTVDYPENGN 213
Query: 968 GVRGTLPWMAPELLSGKSHMVTEKE 992
P L H K
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKR 238
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 54/194 (27%), Positives = 84/194 (43%), Gaps = 29/194 (14%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ + +GSG YGSV G VA+K++ +P + ++E LL +
Sbjct: 32 QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLKHM 85
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H NV+ + P SL VT M L ++ + T D + LI +
Sbjct: 86 KHENVIGLLDVFT--PARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQI- 141
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGT 972
G++Y+H +I+H DLK NL VN C KI D GL++ + +G V T
Sbjct: 142 -LRGLKYIHSADIIHRDLKPSNLAVNED------CELKILDFGLARHTADEM-TGYV-AT 192
Query: 973 LPWMAPELLSGKSH 986
+ APE++ H
Sbjct: 193 RWYRAPEIMLNWMH 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 30/194 (15%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+GSG YGSV K G VAIK++ +P + E ++E LLL +
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL------SRPFQSEIFAKRAYRELLLLKHM 80
Query: 861 HHPNVVSFYGIVRDGPDGSLAT------VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
H NV+ + P SL V FM L++ + + ++ + L+ M
Sbjct: 81 QHENVIGLLDVFT--PASSLRNFYDFYLVMPFM-QTDLQKIM-GLKFSEEKIQYLVYQM- 135
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGT 972
G++Y+H +VH DLK NL VN C KI D GL++ + +G V T
Sbjct: 136 -LKGLKYIHSAGVVHRDLKPGNLAVNED------CELKILDFGLARHADAEM-TGYV-VT 186
Query: 973 LPWMAPELLSGKSH 986
+ APE++ H
Sbjct: 187 RWYRAPEVILSWMH 200
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-11
Identities = 43/194 (22%), Positives = 81/194 (41%), Gaps = 22/194 (11%)
Query: 803 EEVRELGSGTYGSV---YHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
E V++LG G YG V + G VA+K+I F ++ +R +E ++L+
Sbjct: 12 ELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKI-FDAF-QNSTDAQRTF----REIMILTE 64
Query: 860 LH-HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L H N+V+ ++R D + V ++M L ++ ++ ++ +
Sbjct: 65 LSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIK--V 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH ++H D+K N+L+N C K+ D GLS+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAE------CHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 977 APELLSGKSHMVTE 990
E ++T+
Sbjct: 176 NTENFDDDQPILTD 189
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 8e-11
Identities = 20/142 (14%), Positives = 37/142 (26%), Gaps = 20/142 (14%)
Query: 805 VRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ G W+ D VA+ + + L LS
Sbjct: 36 LIFHGGVPPLQF----WQALDTALDRQVALTFVDPQ-GVLPDDVLQE----TLSRTLRLS 86
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
+ P V +V V E++ GSL++ D + + A
Sbjct: 87 RIDKPGVARVLDVVHT--RAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAA 141
Query: 919 MEYLHGKNIVHFDLKCENLLVN 940
+ H + + V+
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVS 163
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 50/242 (20%), Positives = 99/242 (40%), Gaps = 26/242 (10%)
Query: 756 EAELVNIHGEIEMDYDNDTVKTLKIEPTIAEAEAIARGLQTIKNDDLEEVRELGSGTYGS 815
E D + + L ++ + A + + ++ E ++ LG+G YG
Sbjct: 11 EGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHA-EKVGIENFELLKVLGTGAYGK 69
Query: 816 VY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKE-ALLLSSLHHPNVVSFY 869
V+ G G A+K +K + K E E +L P +V+ +
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT----ERQVLEHIRQSPFLVTLH 125
Query: 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVH 929
+ + L + +++ G L L +++R + ++ + + +E+LH I++
Sbjct: 126 YAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-EIVLALEHLHKLGIIY 182
Query: 930 FDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-----GTLPWMAPELLSGK 984
D+K EN+L+ D V + D GLSK + + R GT+ +MAP+++ G
Sbjct: 183 RDIKLENILL---DSNGHV-VLTDFGLSK---EFVADETERAYDFCGTIEYMAPDIVRGG 235
Query: 985 SH 986
Sbjct: 236 DS 237
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-10
Identities = 45/209 (21%), Positives = 90/209 (43%), Gaps = 38/209 (18%)
Query: 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERL 846
+ + D + +R +G G+Y V + + +D A+K + K + + E+
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 847 IADFWKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT 902
+ + +HP +V F + L V E++ G L +Q++ +
Sbjct: 62 V--------FEQASNHPFLVGLHSCFQ------TESRLFFVIEYVNGGDLMFHMQRQRKL 107
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
+ R A + + + YLH + I++ DLK +N+L+ D + + K+ D G+ K
Sbjct: 108 PEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLL---DSEGHI-KLTDYGMCKEG-- 160
Query: 963 TLVSGGVR-----GTLPWMAPELLSGKSH 986
+ G GT ++APE+L G+ +
Sbjct: 161 --LRPGDTTSTFCGTPNYIAPEILRGEDY 187
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-10
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 27/195 (13%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G G YG V + VAIK+I F + +R + +E +L
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FE-HQTYCQRTL----REIKILLRF 82
Query: 861 HHPNVVSFYGIVRDGPDGSLAT---VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
H N++ I+R + V + M L + L+ + + D + +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQI--LR 139
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLSKVKQQTLVSGGVR----G 971
G++Y+H N++H DLK NLL+N C KI D GL++V G
Sbjct: 140 GLKYIHSANVLHRDLKPSNLLLNTT------CDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 972 TLPWMAPELLSGKSH 986
T + APE++
Sbjct: 194 TRWYRAPEIMLNSKG 208
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-10
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 38/205 (18%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDV--AIKRI-KASCFAGKPSER---ERLIADF 850
K D ++ +G G++G V + + +V A+K + K + K + ER +
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV--- 91
Query: 851 WKEALLLSSLHHPNVV----SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRR 906
LL ++ HP +V SF L V +++ G L LQ++ ++ R
Sbjct: 92 -----LLKNVKHPFLVGLHFSFQ------TADKLYFVLDYINGGELFYHLQRERCFLEPR 140
Query: 907 KRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS 966
R A + A + YLH NIV+ DLK EN+L+ D Q + + D GL K +
Sbjct: 141 ARFYAA-EIASALGYLHSLNIVYRDLKPENILL---DSQGHI-VLTDFGLCKEN----IE 191
Query: 967 GGVR-----GTLPWMAPELLSGKSH 986
GT ++APE+L + +
Sbjct: 192 HNSTTSTFCGTPEYLAPEVLHKQPY 216
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-10
Identities = 42/202 (20%), Positives = 77/202 (38%), Gaps = 34/202 (16%)
Query: 803 EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+G G+YG VY + K +VAIK++ F + +R++ +E +L+ L
Sbjct: 29 IIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMF-EDLIDCKRIL----REITILNRL 82
Query: 861 HHPNVVSFYGIVRDGPDGSLA-----TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ Y ++ PD L V E + LK+ + + + I+
Sbjct: 83 KSDYIIRLYDLII--PDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTIL---- 135
Query: 916 AF----GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC--KIGDLGLS-KVKQQTLVSGG 968
+ G ++H I+H DLK N L+N +D C K+ D GL+ + + +
Sbjct: 136 -YNLLLGENFIHESGIIHRDLKPANCLLN-QD-----CSVKVCDFGLARTINSEKDTNIV 188
Query: 969 VRGTLPWMAPELLSGKSHMVTE 990
+T
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTS 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 32/169 (18%), Positives = 62/169 (36%), Gaps = 23/169 (13%)
Query: 806 RELGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLI-----------ADFWKE 853
+G G +G +Y V +PS+ L + ++
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKV--EPSDNGPLFTELKFYQRAAKPEQIQK 98
Query: 854 ALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMV----NGSLKQFLQKKDRTIDRRKRL 909
+ L + V ++G G FM+ L++ + + R+ L
Sbjct: 99 WIRTRKLKYLGVPKYWGS---GLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+++ +EY+H VH D+K NLL+N ++P + + D GL+
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ--VYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 2e-07
Identities = 91/679 (13%), Positives = 180/679 (26%), Gaps = 238/679 (35%)
Query: 132 NHYVDGDDRESERRYVDALNNMNDGNDFRK---LQH-PDSP--VISS--IDDI------- 176
+H++D + E + +Y D L+ D F + D P ++S ID I
Sbjct: 4 HHHMDFETGEHQYQYKDILSVFED--AFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAV 61
Query: 177 ---------------HMAERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRY 221
M ++F + + Y L P +Q +++ Y
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEV-------LRINYKF--LMSPIKTEQRQPSMMTRMY 112
Query: 222 NEMEGPWSPAYYSPRHYGHHDPPRP---------LPEFPSSPSSARFRMP-FGEERVPEE 271
E Y + + ++ R L E + + + G+ V +
Sbjct: 113 IEQR---DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD 169
Query: 272 YARQHVNHHPTYEPQPQFSENLIWMPPGNVSGDKSGFPGNLFHGHNVFDGNGLCEHCRLT 331
Y+ Q + + W+ N + ++ + E +
Sbjct: 170 VCLS-------YKVQCKMDFKIFWLNLKNCNSPET-----------------VLEMLQKL 205
Query: 332 YHRNQLHLDQPNIGNGLPQVPLSCAECRQNRENLVLNAEAKLPGMYPK-----DNDSRSV 386
+ Q+ + + + + L + L+ + Y N V
Sbjct: 206 LY--QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK------PYENCLLVLLN----V 253
Query: 387 YNESHCHERGWVLQHQLNPRIEEARTHMSGAGRL---NDHYLVDGPGMNIPPGHGNLVDG 443
N N + L + D
Sbjct: 254 QNA-------KAWNA-FNLS---CKI-------LLTTRFKQVTDFLSAATT--------- 286
Query: 444 HHVSPNHAHHRTGPEMGNELFHDPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYP---- 499
H+S +H P+ L L + P T P
Sbjct: 287 THISLDHHSMTLTPDEVKSLL----LKY---LDCRPQDL--------PREVLTTNPRRLS 331
Query: 500 -----VSHGHATAQNLWRNVQNPIHVTPLEASGPVINGSITPAYLRGAVEGNPRIAV--- 551
+ G AT N W++V T +E+S +N + PA R + R++V
Sbjct: 332 IIAESIRDGLATWDN-WKHVNCDKLTTIIESS---LN-VLEPAEYRKMFD---RLSVFPP 383
Query: 552 GVDSPNS-----WIDPSQRVP----------------GFKGTATPPEYYYSQTQKMN--- 587
P W D + + T + P Y K+
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 588 ------------PQSYNQQNQLPDPV----------H--------QSDSFSALVQD---- 613
P++++ + +P + H + F + D
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFL 503
Query: 614 --KLVSSTTDCNLGLRVNNVSEAVRT-----DENCNLGQE----------KAANHVVKVE 656
K+ +T N + N + ++ +N + K +++ +
Sbjct: 504 EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 657 ETDVKRSCLEQNMIPEKPI 675
TD+ R L M ++ I
Sbjct: 564 YTDLLRIAL---MAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 5e-07
Identities = 56/341 (16%), Positives = 107/341 (31%), Gaps = 96/341 (28%)
Query: 19 DDVPRVKFLCSF-LG-RILPRPQDGKL-RYVGGETR----IVSLPRDVTYEELMSRMREL 71
+V K +F L +IL + ++ ++ T + +T +E+ L
Sbjct: 251 LNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK----SL 306
Query: 72 YEGAVVLKYQQ-PDEDLDA---LVSVV--NDDDVINMMEEYEKLGSGDGFTR-LRIFLFS 124
+ + Q P E L +S++ + D + + ++ + D T + L
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC-DKLTTIIESSLNV 365
Query: 125 HSDQDGSNHYVD--------------------GDDRESERRYVDALNNMNDGNDFRKL-- 162
+ + + V+ L+ L
Sbjct: 366 LEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK-------YSLVE 418
Query: 163 QHPDSPVISSIDDIHMAERFFNTMSLEGGIHNQPQYNLHQLTVPHMNSGQQQQPVSQRYN 222
+ P IS I I++ + + + +Y LH+ V H N P + +
Sbjct: 419 KQPKESTIS-IPSIYLELK----------VKLENEYALHRSIVDHYNI-----PKTFDSD 462
Query: 223 EMEGPWSPAY-YSPRHYGHH----DPPRPLPEFPSSPSSARF-----RMPFGEERVP--- 269
++ P+ Y YS H GHH + P + F RF R
Sbjct: 463 DLIPPYLDQYFYS--HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSI 520
Query: 270 -------EEYARQHV-NHHPTYEPQ--------PQFSENLI 294
+ Y + ++ ++ P YE P+ ENLI
Sbjct: 521 LNTLQQLKFY-KPYICDNDPKYERLVNAILDFLPKIEENLI 560
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 1e-06
Identities = 80/573 (13%), Positives = 159/573 (27%), Gaps = 183/573 (31%)
Query: 449 NHAHHRTGPEMGNELFH--DPAAAVVPHLHTPSAEERVVRYGNFPYGADTIYPVSHGHAT 506
+H HH E G + D ++ E+ V + D
Sbjct: 1 HHHHHHMDFETGEHQYQYKD----ILSVF-----EDAFVDNFDCKDVQDMP--------- 42
Query: 507 AQNLWRNVQNPIHVTPLEASGPVINGSITPAYLRGAVEGNPRIAV-----GVDSPN-SWI 560
+++ + + + S ++G++ L + V V N ++
Sbjct: 43 -----KSILSKEEIDHIIMSKDAVSGTL---RLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 561 -DPSQRVPGFKGTATPPEYYYSQTQKM--NPQSYNQQN-QLPDPVHQSDSFSALVQDKLV 616
P + + + Y Q ++ + Q + + N P + ++ L
Sbjct: 95 MSPIKTEQ--RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLK-------LRQAL- 144
Query: 617 SSTTDCNLGLRVNN---------------VSEAVRTDENCNLGQEKAANHV--VKVEETD 659
L LR + + + Q K + + ++ +
Sbjct: 145 -------LELRPAKNVLIDGVLGSGKTWVALDVCLSYKV----QCKMDFKIFWLNLKNCN 193
Query: 660 VKRSCLE--QNMIPEKPIGSTSLLAMEVSGNIEKPGEKSPSDRPEDSKLLAHN-----LS 712
+ LE Q ++ + I + S NI+ S + E +LL L
Sbjct: 194 SPETVLEMLQKLLYQ--IDPNWTSRSDHSSNIKLRIH---SIQAELRRLLKSKPYENCLL 248
Query: 713 ILPELIASVKRAALEGAEEVKAKVEESDDSVKPDTTTKEAPANEAELVNIHGEIEMDYDN 772
+L V+ A A + K+ TT+ + I +D
Sbjct: 249 VLLN----VQNAKAWNAFNLSCKIL---------LTTRFKQVTDFLSAATTTHISLD--- 292
Query: 773 DTVKTLKIEPTIAEAEAI-ARGLQTIKNDDL-EEVRELGSGTYGSVYHGKWRGSDVAIKR 830
TL T E +++ + L + DL EV + +
Sbjct: 293 HHSMTL----TPDEVKSLLLKYL-DCRPQDLPREVL---------------TTNPRRLSI 332
Query: 831 IKASCFAGKPSERERLI-ADFWK-------EALLLSSLHH--PNVV-SFY---GIVRDG- 875
I S R+ L D WK ++ SSL+ P + +
Sbjct: 333 IAESI-------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 876 --PDGSLATV--------TEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK 925
P L+ + +VN K L +K K I +
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ-----PKESTI---------SIPS- 430
Query: 926 NIVHFDLKCENL--------LVNMRDPQRPVCK 950
++ +LK + +V+ + +
Sbjct: 431 --IYLELKVKLENEYALHRSIVDHYNIPKTFDS 461
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 8e-04
Identities = 49/317 (15%), Positives = 89/317 (28%), Gaps = 87/317 (27%)
Query: 702 EDSKLLAHNLSILPELIASVK------------RAALEGAEEVKAKVEESDDSVKPD--- 746
E + IL + ++ L EE+ + D
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILS-KEEIDHIIMSKDAVSGTLRLF 68
Query: 747 TTTKEAPANEAELVNIHGEIEMDYD--NDTVKTLKIEPT------IAEAEAIARGLQTIK 798
T + + + ++Y +KT + +P+ I + + + Q
Sbjct: 69 WTLLSKQEEMVQKF-VEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 799 NDD------LEEVR----ELGSGTYGSVY----HGK-WRGSDVAIKRIKASCFAGKPSER 843
+ ++R EL + GK W DV + K
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFK---- 183
Query: 844 ERLIADFW--------KEALL--LSSLHH---PNVVSFYGIVRDGPDGSLATVTEF-MVN 889
I FW E +L L L + PN S D S +
Sbjct: 184 ---I--FWLNLKNCNSPETVLEMLQKLLYQIDPNWTS-------RSDHSSNIKLRIHSIQ 231
Query: 890 GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
L++ L+ K L++ + + K F+L C+ +L+ R Q
Sbjct: 232 AELRRLLKSKPY----ENCLLV-LL-----NVQNAKAWNAFNLSCK-ILLTTRFKQ---- 276
Query: 950 KIGD-LGLSKVKQQTLV 965
+ D L + +L
Sbjct: 277 -VTDFLSAATTTHISLD 292
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 39/158 (24%), Positives = 67/158 (42%), Gaps = 19/158 (12%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R++GSG++G +Y G G +VAIK ++ +L E+ + +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK------TKHPQLH----IESKIYKMMQG 63
Query: 863 -PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+ + +G V E + G SL+ R + L++A +E
Sbjct: 64 GVGIPTIRWCGAEG--DYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 119
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
Y+H KN +H D+K +N L+ + V I D GL+K
Sbjct: 120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAK 156
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 39/167 (23%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
VR+LG G + +V+ K + VA+K ++ + +E E + + + +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLL----QRVNDADNTK 79
Query: 863 PNVVSFYGIVR-------DGPDGS-LATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAM 913
+ + I++ GP+G + V E + +L ++K + R I I+
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 914 DAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQ--RPVCKIGDLGLS 957
G++Y+H + I+H D+K EN+L+ + D KI DLG +
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 19/158 (12%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH- 861
R++GSG++G +Y G +VAIK ++ +L+ E+ + L
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLL----YESKIYRILQG 61
Query: 862 HPNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
+ + +G V + + G SL+ R + + L++A +E
Sbjct: 62 GTGIPNVRWFGVEG--DYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
++H K+ +H D+K +N L+ + V I D GL+K
Sbjct: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 39/179 (21%), Positives = 58/179 (32%), Gaps = 46/179 (25%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERE-----RL----IADFWKEA 854
+++GSG +G +Y + A +K P E R+ W E
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 855 LLLSSLHHPNVVSFYGIVRD-------------GPDGSLATVTEFMVNG--SLKQFLQKK 899
L L P G+ G L + NG LQ
Sbjct: 103 KQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERLGI--DLQKI--SGQNGTFKKSTVLQLG 157
Query: 900 DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
R +D +EY+H VH D+K NLL+ ++P + + D GLS
Sbjct: 158 IRMLDV-------------LEYIHENEYVHGDIKAANLLLGYKNPDQ--VYLADYGLSY 201
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 42/160 (26%), Positives = 64/160 (40%), Gaps = 23/160 (14%)
Query: 806 RELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH- 862
+++G G +G + GK + VAIK S +L E L
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQL----HLEYRFYKQLGSG 64
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEY 921
+ Y G A V E + G SL+ DRT + L+IA+ MEY
Sbjct: 65 DGIPQVYYFGPCG--KYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 922 LHGKNIVHFDLKCENLLVNMRDPQRPVCKIG---DLGLSK 958
+H KN+++ D+K EN L + P ++ D L+K
Sbjct: 121 VHSKNLIYRDVKPENFL--IGRPGNKTQQVIHIIDFALAK 158
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 35/161 (21%), Positives = 63/161 (39%), Gaps = 23/161 (14%)
Query: 805 VRELGSGTYGSVYHGK--WRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G++G ++ G VAIK S+ +L ++ LL
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR------SDAPQLRDEYRTYKLLAGCTGI 68
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMV----NGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
PNV F G +G +V SL+ L R + + A
Sbjct: 69 PNVYYF------GQEGLHN----VLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLAR 118
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLGLSK 958
++ +H K++V+ D+K +N L+ + + + + D G+ K
Sbjct: 119 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 9e-06
Identities = 27/181 (14%), Positives = 50/181 (27%), Gaps = 47/181 (25%)
Query: 806 RELGSGTYGSVYHG----------KWRGSDVAIK--RIKASCFAGKPSERERLIADFWKE 853
G +Y + ++K F + + +
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 854 ALLLSSLHHPNVVSFYG----------IVRD--GPDGSLATVTEFMVNG----SLKQFLQ 897
L S + + G +V G SL + V+ S + LQ
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR--SLQSA--LDVSPKHVLSERSVLQ 163
Query: 898 KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957
R +D +E+LH VH ++ EN+ V+ D + + G +
Sbjct: 164 VACRLLDA-------------LEFLHENEYVHGNVTAENIFVDPEDQSQ--VTLAGYGFA 208
Query: 958 K 958
Sbjct: 209 F 209
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 34/150 (22%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 805 VRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
+R+LG G + +V+ VA+K +K++ + + E + +++ S +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLL----KSVRNSDPND 97
Query: 863 PN---VVSFYGIVR-DGPDGS-LATVTEFMVNGSLKQFLQK-KDRTIDRRKRLIIAMDAA 916
PN VV + G +G+ + V E + L +++ K + + I
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 917 FGMEYLHGK-NIVHFDLKCENLLVNMRDPQ 945
G++YLH K I+H D+K EN+L+++ +
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQY 186
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 33/182 (18%), Positives = 70/182 (38%), Gaps = 23/182 (12%)
Query: 794 LQTIKNDDL----EEVRELGSGTYGSVY--HGKWRGSDVAIKRIKASCFAGKPSERERLI 847
+ +D + E ++ +G G++G V + VA+K ++ + +
Sbjct: 87 YVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAA 141
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVR--DGPD--GSLATVTEFMVNGSLKQFLQK-KDRT 902
+E +L L + + ++ + + E + + +L + ++K K +
Sbjct: 142 ----EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQG 196
Query: 903 IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962
A ++ LH I+H DLK EN+L+ R K+ D G S + Q
Sbjct: 197 FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK--QQGRSGIKVIDFGSSCYEHQ 254
Query: 963 TL 964
+
Sbjct: 255 RV 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 993 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.96 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.96 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.96 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.96 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.96 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.96 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.95 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.95 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.95 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.95 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.95 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.95 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.95 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.95 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.95 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.95 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.95 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.95 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.95 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.95 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.95 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.95 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.94 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.94 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.94 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.94 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.94 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.94 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.94 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.94 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.94 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.94 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.94 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.93 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.93 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.93 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.93 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.93 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.93 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 2cu1_A | 103 | Mitogen-activated protein kinase kinase kinase 2; | 99.39 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.37 | |
| 1vd2_A | 89 | Protein kinase C, IOTA type; PB1 domain, OPCA moti | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.2 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.02 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.68 | |
| 2jrh_A | 94 | Mitogen-activated protein kinase kinase kinase 3; | 97.35 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.29 | |
| 2c60_A | 111 | Human mitogen-activated protein kinase kinase kina | 97.2 | |
| 2npt_B | 100 | Mitogen-activated protein kinase kinase kinase 2; | 97.19 | |
| 1q1o_A | 98 | Cell division control protein 24; PB1 domain, PCCR | 97.07 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.02 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.97 | |
| 1pqs_A | 77 | Cell division control protein 24; alpha and beta p | 96.92 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.82 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.77 | |
| 2kkc_A | 102 | Sequestosome-1; P62, PB1, autophagy, ubiquitin-pro | 96.63 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.46 | |
| 2ktr_A | 117 | Sequestosome-1; autophagy, NF-KB signaling, HOMO-o | 96.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.34 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.13 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.84 | |
| 1wj6_A | 101 | KIAA0049 protein, RSGI RUH-024; PB1 domain, protei | 95.74 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 95.54 | |
| 1oey_A | 83 | P67-PHOX, neutrophil cytosol factor 2; immune syst | 95.49 | |
| 2bkf_A | 87 | Zinc-finger protein NBR1 (NEXT to breast cancer 1; | 95.06 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.39 | |
| 1wmh_B | 86 | Partitioning defective-6 homolog alpha; kinase, PB | 94.34 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.19 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.97 | |
| 1ip9_A | 85 | BEM1 protein; ubiquitin alpha/beta roll, signaling | 91.69 | |
| 1oey_J | 107 | P40-PHOX, neutrophil cytosol factor 4; immune syst | 90.69 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.56 Aligned_cols=181 Identities=27% Similarity=0.450 Sum_probs=143.3
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|++ +++.||||++++..... ....+.+.+|+.+|++++|||||++++++.+ .
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 85 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-----SDMQGRIEREISYLRLLRHPHIIKLYDVIKS--K 85 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-----HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--C
Confidence 6899999999999999999988 47889999998654322 1223578899999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+||||||+ +|+|.++|.+.+ .+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+|
T Consensus 86 ~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~----~~~~vkl~DFGla 159 (275)
T 3hyh_A 86 DEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD----EHLNVKIADFGLS 159 (275)
T ss_dssp SEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTCCEEECCSSCC
T ss_pred CEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC----CCCCEEEeecCCC
Confidence 7899999999 789999997765 499999999999999999999999999999999999998 6678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...........+||+.|||||++.++.|+..++||
T Consensus 160 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~Di 195 (275)
T 3hyh_A 160 NIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDV 195 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHH
T ss_pred eecCCCCccCCeeECcccCChhhhcCCCCCCChhhh
Confidence 977665555678899999999999999988888775
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=340.76 Aligned_cols=182 Identities=29% Similarity=0.430 Sum_probs=156.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|+.+ ++.||||++.+..... ....+.+.+|+.+|++|+|||||+++++|++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-- 103 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-----ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-- 103 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--
Confidence 467999999999999999999984 7789999998653221 1224578899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||+||+|.++|.+.+ .+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~----~~g~vKl~DFGl 178 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGT 178 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc----CCCCEEEEEcCC
Confidence 678999999999999999998764 489999999999999999999999999999999999998 667999999999
Q ss_pred ccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+..... ......+||+.|||||++.++.| ..++||
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~Di 217 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDL 217 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB-CHHHHH
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCC-CcHHHH
Confidence 9976432 23456789999999999998766 345553
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.28 Aligned_cols=182 Identities=21% Similarity=0.426 Sum_probs=150.5
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
-++|+++++||+|+||+||+|+++ ++.||||++++.... ....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-- 94 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS------SKEREESRREVAVLANMKHPNIVQYRESFEE-- 94 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC------HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--
Confidence 368999999999999999999984 788999999865321 2234678999999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+|||||||+||+|.++|.... ..+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||
T Consensus 95 ~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFG 170 (350)
T 4b9d_A 95 NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT----KDGTVQLGDFG 170 (350)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEEC----TTCCEEECSTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC----CCCCEEEcccc
Confidence 678999999999999999997643 4578999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+...... .....+||+.|||||++.++.|. .++||
T Consensus 171 la~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~-~~~Di 208 (350)
T 4b9d_A 171 IARVLNSTVELARACIGTPYYLSPEICENKPYN-NKSDI 208 (350)
T ss_dssp EESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCC-HHHHH
T ss_pred cceeecCCcccccccCCCccccCHHHHCCCCCC-cHHHH
Confidence 999765432 33456899999999999987664 45554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=334.65 Aligned_cols=186 Identities=32% Similarity=0.545 Sum_probs=153.5
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..++..+++++.++||+|+||+||+|++++ .||||+++.... .....+.|.+|+.+|++|+|||||++++++.
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~------~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 102 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDP------TPEQFQAFRNEVAVLRKTRHVNILLFMGYMT 102 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 345677899999999999999999999875 599999875321 1233468999999999999999999999886
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ +.++||||||++|+|.++|......+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||+|
T Consensus 103 ~---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~----~~~~~Ki~D 175 (307)
T 3omv_A 103 K---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH----EGLTVKIGD 175 (307)
T ss_dssp S---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE----TTEEEEECC
T ss_pred C---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC----CCCcEEEee
Confidence 4 468999999999999999987766799999999999999999999999999999999999998 678999999
Q ss_pred cCCccccccc---cccCCCCCCCCccccccccCCc--cCCCCCCC
Q 001940 954 LGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKS--HMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~--y~tse~DI 993 (993)
||+|+..... ......+||+.|||||++.+.. .++.++||
T Consensus 176 FGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDV 220 (307)
T 3omv_A 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDV 220 (307)
T ss_dssp CSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHH
T ss_pred ccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHh
Confidence 9999875432 2334568999999999997653 34555664
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=338.39 Aligned_cols=177 Identities=23% Similarity=0.399 Sum_probs=154.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..|+++++||+|+||+||+|+++ ++.||||+++...... .+.+.+|+.+|++|+|||||+++++|.+ .
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~ 143 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLV--G 143 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------GGGGHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------HHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 56999999999999999999984 7889999998653221 1357789999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|||||||++|+|.+++.+. .+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+|
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~DFGla 217 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 217 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEC----CCCCEEEecCcCc
Confidence 7899999999999999999764 489999999999999999999999999999999999998 6679999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... ......+||+.|||||++.+..| +.++||
T Consensus 218 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~Di 253 (346)
T 4fih_A 218 AQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDI 253 (346)
T ss_dssp EECCSSSCCBCCCCSCGGGCCHHHHTTCCB-CTHHHH
T ss_pred eecCCCCCcccccccCcCcCCHHHHCCCCC-CcHHHH
Confidence 976543 34557889999999999988776 556664
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=341.23 Aligned_cols=177 Identities=23% Similarity=0.399 Sum_probs=154.0
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
..|+++++||+|+||+||+|+++ ++.||||+++...... .+.+.+|+.+|++|+|||||+++++|.+ .
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--------~~~~~~Ei~il~~l~HpnIV~l~~~~~~--~ 220 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--------RELLFNEVVIMRDYQHENVVEMYNSYLV--G 220 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------GGGHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------HHHHHHHHHHHHhCCCCCCCceEEEEEE--C
Confidence 56999999999999999999984 7889999998653221 1357789999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|||||||+||+|.++++.. .+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+|
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~----~~g~vKl~DFGla 294 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT----HDGRVKLSDFGFC 294 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEecCccc
Confidence 7899999999999999999754 489999999999999999999999999999999999998 6679999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... ......+||+.|||||++.++.| ..++||
T Consensus 295 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~Di 330 (423)
T 4fie_A 295 AQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDI 330 (423)
T ss_dssp EECCSSCCCBCCCEECTTTCCHHHHTTCCB-CTHHHH
T ss_pred eECCCCCccccccccCcCcCCHHHHCCCCC-CcHHHH
Confidence 976443 34457889999999999998876 456664
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=322.53 Aligned_cols=181 Identities=29% Similarity=0.486 Sum_probs=150.7
Q ss_pred CCc-eEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC-
Q 001940 800 DDL-EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (993)
Q Consensus 800 ddY-eile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~- 875 (993)
.+| ++.++||+|+||+||+|.++ +..||||++...... ....+.|.+|+.+|++|+|||||+++++|.+.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 98 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc
Confidence 444 77788999999999999985 677999999865322 12345789999999999999999999998752
Q ss_pred -CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 -PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 -s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
....+|||||||++|+|.++|.+.. .+++..++.|+.||+.||.|||+++ ||||||||+||||+. .++.+||+
T Consensus 99 ~~~~~~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~---~~g~vKl~ 174 (290)
T 3fpq_A 99 KGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIG 174 (290)
T ss_dssp TTEEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS---TTSCEEEC
T ss_pred CCCcEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC---CCCCEEEE
Confidence 2356899999999999999998754 5899999999999999999999998 999999999999972 35789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+..... .....+||+.|||||++.++ +..++||
T Consensus 175 DFGla~~~~~~-~~~~~~GTp~YmAPE~~~~~--y~~~~Di 212 (290)
T 3fpq_A 175 DLGLATLKRAS-FAKAVIGTPEFMAPEMYEEK--YDESVDV 212 (290)
T ss_dssp CTTGGGGCCTT-SBEESCSSCCCCCGGGGGTC--CCTHHHH
T ss_pred eCcCCEeCCCC-ccCCcccCccccCHHHcCCC--CCcHHHH
Confidence 99999865443 33457899999999999763 5566664
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.05 Aligned_cols=184 Identities=35% Similarity=0.561 Sum_probs=152.8
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
..+..++|.+.++||+|+||+||+|++. ++.||||+++... ....+.|.+|+.+|++|+|||||+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--------DNARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC--------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC--------hHHHHHHHHHHHHHHhCCCCCCcc
Confidence 4566678999999999999999999873 4569999997431 123467999999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPe 935 (993)
++|+|.+ .+.++||||||++|+|.++|...+ ..+++..++.|+.||+.||.|||+++||||||||+
T Consensus 80 l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~ 157 (299)
T 4asz_A 80 FYGVCVE--GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 157 (299)
T ss_dssp EEEEECS--SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEEee--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHh
Confidence 9999998 567999999999999999997642 45899999999999999999999999999999999
Q ss_pred CEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||||+ .++.+||+|||+|+...... ......||+.|||||++.+..| +.++||
T Consensus 158 NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DV 213 (299)
T 4asz_A 158 NCLVG----ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDV 213 (299)
T ss_dssp GEEEC----GGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHH
T ss_pred hEEEC----CCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhH
Confidence 99998 66799999999998654332 2334569999999999987754 455554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=332.93 Aligned_cols=182 Identities=25% Similarity=0.361 Sum_probs=148.4
Q ss_pred cCCCceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..++|++++.||+|+||+||+|+. .++.||||++++........ ..+.+|+.+|++|+|||||+++++|
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR------VRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEEC------C------CCCCCCCCTTEECEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHH------HHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 346799999999999999999987 25669999998654322111 2567899999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+|||||||+||+|.++|.+.+ .+++..++.|+.||+.||+|||+++||||||||+|||++ .++.+||+
T Consensus 96 ~~--~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~vKl~ 168 (304)
T 3ubd_A 96 QT--EGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD----EEGHIKLT 168 (304)
T ss_dssp EE--TTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTSCEEEE
T ss_pred EE--CCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEc----CCCCEEec
Confidence 98 678999999999999999998765 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCcccccc-ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+.... .......+||+.|||||++.++.|. .++||
T Consensus 169 DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~Di 209 (304)
T 3ubd_A 169 DFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADW 209 (304)
T ss_dssp SSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCC-THHHH
T ss_pred ccccceeccCCCccccccccCcccCCHHHhccCCCC-CCCcc
Confidence 9999986533 3344567899999999999988765 45554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=328.81 Aligned_cols=184 Identities=35% Similarity=0.545 Sum_probs=148.0
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
..+..++|.+.++||+|+||+||+|+++ ++.||||+++... ....++|.+|+.+|++|+|||||+
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--------~~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--------ESARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS--------HHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC--------HHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3455678999999999999999999874 4679999997431 223467999999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc--------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD--------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLK 933 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~--------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIK 933 (993)
++|+|.+ .+.++||||||++|+|.++|++.. ..+++..++.|+.||+.||.|||+.+|||||||
T Consensus 108 l~g~~~~--~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK 185 (329)
T 4aoj_A 108 FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLA 185 (329)
T ss_dssp EEEEECS--SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred EEEEEEE--CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccccc
Confidence 9999988 567999999999999999997542 348899999999999999999999999999999
Q ss_pred CCCEEEccCCCCCCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 934 CENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 934 PeNILLd~~d~e~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+||||+ .++.+||+|||+|+..... ......+||+.|||||++.+..| +.++||
T Consensus 186 p~NILl~----~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDv 243 (329)
T 4aoj_A 186 TRNCLVG----QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDV 243 (329)
T ss_dssp GGGEEEE----TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHH
T ss_pred HhhEEEC----CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-Cccccc
Confidence 9999998 6789999999999865332 22345679999999999988765 445553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=323.26 Aligned_cols=181 Identities=29% Similarity=0.448 Sum_probs=141.4
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC-
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD- 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~- 877 (993)
+|++++.||+|+||+||+|+++ ++.||||+++... .+...+.+.+|+.+|++|+|||||+++++|.+...
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 5999999999999999999984 7889999997542 12234578899999999999999999999976322
Q ss_pred ---------CcEEEEEeeccCCcHHHHHHhccC--ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 878 ---------GSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 878 ---------~~L~LVmEYm~GGSL~dlL~~~~k--~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
..+|||||||.+|+|.+++..... ..++..++.|+.||+.||+|||+++||||||||+||||+ .+
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~----~~ 154 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 154 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TT
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC----CC
Confidence 247999999999999999986543 245667889999999999999999999999999999998 66
Q ss_pred CeEEEEecCCccccccccc-------------cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLV-------------SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~-------------s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+||+|||+|+....... ....+||+.|||||++.++.| +.++||
T Consensus 155 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~Di 213 (299)
T 4g31_A 155 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDI 213 (299)
T ss_dssp CCEEECCCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHH
T ss_pred CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHH
Confidence 7899999999987543221 234579999999999998765 456664
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=330.66 Aligned_cols=174 Identities=26% Similarity=0.422 Sum_probs=147.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.+.|++.++||+|+||+||+|+++ ++.||||+++...+ +.+|+.+|++|+|||||+++++|.+
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~E~~il~~l~HpnIV~l~~~~~~-- 121 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------------RVEELVACAGLSSPRIVPLYGAVRE-- 121 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------------CTHHHHTTTTCCCTTBCCEEEEEEE--
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------------HHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 356899999999999999999984 78899999986432 2368999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC-eEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP-VCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g-~VKLiDFG 955 (993)
.+.+|||||||+||+|.++|++.+ .+++..++.|+.||+.||+|||+++||||||||+||||+ .++ .+||+|||
T Consensus 122 ~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~----~~g~~vKl~DFG 196 (336)
T 4g3f_A 122 GPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS----SDGSRAALCDFG 196 (336)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC----TTSCCEEECCCT
T ss_pred CCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe----CCCCEEEEeeCC
Confidence 578999999999999999998765 489999999999999999999999999999999999998 444 69999999
Q ss_pred Ccccccccc------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+...... ....++||+.|||||++.++.|. .++||
T Consensus 197 la~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~Di 239 (336)
T 4g3f_A 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDI 239 (336)
T ss_dssp TCEEC------------CCCCCCGGGCCHHHHTTCCCC-THHHH
T ss_pred CCeEccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHH
Confidence 999764322 22346899999999999987654 45664
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=325.30 Aligned_cols=186 Identities=31% Similarity=0.506 Sum_probs=153.8
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
..++...+++++++||+|+||+||+|++. ++.||||+++..... ...+.|.+|+.+|++|+|||||
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~-------~~~~~f~~E~~il~~l~HpNIV 92 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG-------PLREEFRHEAMLRARLQHPNVV 92 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC--------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh-------HHHHHHHHHHHHHHhCCCCCCC
Confidence 33455677899999999999999999873 467999999754211 1235789999999999999999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhc---------------cCccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~---------------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
+++|+|.+ .+.++||||||++|+|.++|... ...+++..++.|+.||+.||.|||+++|||||
T Consensus 93 ~l~g~~~~--~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRD 170 (308)
T 4gt4_A 93 CLLGVVTK--DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 170 (308)
T ss_dssp CEEEEECS--SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred CcceEEEE--CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999987 56799999999999999999643 23589999999999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 932 IKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+||||+ .++.+||+|||+|+..... ......+||+.|||||++.+..| +.++||
T Consensus 171 LK~~NILl~----~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDV 230 (308)
T 4gt4_A 171 LATRNVLVY----DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDI 230 (308)
T ss_dssp CSGGGEEEC----GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHH
T ss_pred ccccceEEC----CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-Cccchh
Confidence 999999998 6679999999999865433 23345679999999999987654 455554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=315.79 Aligned_cols=171 Identities=30% Similarity=0.467 Sum_probs=140.1
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC--
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD-- 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~-- 877 (993)
.+|.+.++||+|+||+||+|+++++.||||+++... .+ ...+..|+..+.+++|||||++++++.+...
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~------~~---~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~ 73 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ER---SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG------HH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------hh---hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCc
Confidence 458889999999999999999999999999987431 11 1123456767788999999999999986422
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEccCCCCCCeE
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~--------gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
..+|||||||++|+|.++|++. .+++..+++|+.|++.||.|||+. +||||||||+||||+ .++.+
T Consensus 74 ~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~----~~~~~ 147 (303)
T 3hmm_A 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEEC----CCCCE
Confidence 2589999999999999999765 488999999999999999999986 999999999999998 67899
Q ss_pred EEEecCCcccccccc-----ccCCCCCCCCccccccccCCc
Q 001940 950 KIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 950 KLiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+|||+|+...... .....+||+.|||||++.+..
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~ 188 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCS
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccc
Confidence 999999998654332 123467999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=324.04 Aligned_cols=183 Identities=26% Similarity=0.388 Sum_probs=154.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC-
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~- 875 (993)
.++|+++++||+|+||+||+|+++ ++.||||+++.... .....+.+.+|+.+|+.|+|||||++++++...
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD------VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc------chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 467999999999999999999984 78899999975421 122345788999999999999999999998652
Q ss_pred ---CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 ---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 ---s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
..+.+||||||| +|+|.++|.+.+ .+++..++.|+.||+.||.|||++|||||||||+|||++ .++.+||+
T Consensus 127 ~~~~~~~~~ivmE~~-~g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~----~~~~~Ki~ 200 (398)
T 4b99_A 127 PYGEFKSVYVVLDLM-ESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVN----ENCELKIG 200 (398)
T ss_dssp CTTTCCCEEEEEECC-SEEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCCEEEEEEeCC-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccC----CCCCEEEe
Confidence 246799999999 578999997654 599999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccccc-----cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~-----~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+..... ......+||+.|||||++.+..+++.++||
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~Di 246 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 246 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhhe
Confidence 99999865322 233467899999999999999888888875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-35 Score=321.02 Aligned_cols=185 Identities=28% Similarity=0.453 Sum_probs=152.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC-CCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH-PNIVr 867 (993)
++..++|++.++||+|+||+||+|++.+ +.||||+++.... ....+.|.+|+.+|+++.| ||||+
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-------~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------hHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 4566789999999999999999999854 3589999875421 1224578999999999965 99999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDL 932 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDI 932 (993)
++|+|.+. .+.++||||||++|+|.++|++.. ..+++..++.|+.||+.||+|||+++||||||
T Consensus 133 l~g~~~~~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDL 211 (353)
T 4ase_A 133 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 211 (353)
T ss_dssp EEEEECCT-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEEec-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCcc
Confidence 99998763 356899999999999999997532 34889999999999999999999999999999
Q ss_pred CCCCEEEccCCCCCCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 933 KCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 933 KPeNILLd~~d~e~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||++ .++.+||+|||+|+..... ......+||+.|||||++.+..| +.++||
T Consensus 212 K~~NILl~----~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDV 270 (353)
T 4ase_A 212 AARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDV 270 (353)
T ss_dssp SGGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHH
T ss_pred CccceeeC----CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccE
Confidence 99999998 6679999999999865432 23345679999999999987654 455554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=311.47 Aligned_cols=176 Identities=20% Similarity=0.261 Sum_probs=147.5
Q ss_pred CCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.++|+++++||+|+||+||+|+.+ ++.||||++..... ..++.+|+.+|+.+ +|||||+++++|
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----------PIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----------HHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----------HHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 467999999999999999999863 45799998865321 12567899999988 699999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+|||||||++|+|.++++ .+++..++.|+.||+.||+|||++|||||||||+|||++. ..+.+||+
T Consensus 90 ~~--~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~---~~~~~kl~ 160 (361)
T 4f9c_A 90 RK--NDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR---RLKKYALV 160 (361)
T ss_dssp EE--TTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEEC
T ss_pred EE--CCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC---CCCeEEEC
Confidence 98 678999999999999999984 3889999999999999999999999999999999999982 23689999
Q ss_pred ecCCcccccccc-----------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL-----------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~-----------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+...... .....+||+.|||||++.+..+++.++||
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di 230 (361)
T 4f9c_A 161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230 (361)
T ss_dssp CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccch
Confidence 999998543211 12345799999999999998888887775
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=333.88 Aligned_cols=188 Identities=23% Similarity=0.310 Sum_probs=156.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|+++++||+|+||+||+|+.+ ++.||||++++........ .........++.+++.++|||||+++++|+
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~--~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--ETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC--HHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh--HHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 456689999999999999999999984 7789999998654322211 122233445577788889999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+|||||||.||+|.++|.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|
T Consensus 263 ~--~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld----~~G~vKL~D 335 (689)
T 3v5w_A 263 T--PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISD 335 (689)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred E--CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEe----CCCCEEecc
Confidence 8 578999999999999999998765 489999999999999999999999999999999999998 678999999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|+...... ....+||+.|||||++.+...+..++||
T Consensus 336 FGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDi 374 (689)
T 3v5w_A 336 LGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADW 374 (689)
T ss_dssp CTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHH
T ss_pred cceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHH
Confidence 99998765543 3467899999999999866566666664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=326.68 Aligned_cols=180 Identities=26% Similarity=0.366 Sum_probs=156.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+.+ ++.||||++.... ....+.+.+|+.+|+.|+|||||+++++|.+ .
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~--~ 226 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--D 226 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC--S
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE--C
Confidence 57999999999999999999984 7889999987532 1123467899999999999999999999998 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|||||||.||+|.++|.+....+++..++.|+.||+.||+|||+++|+||||||+|||++.+ ..+.+||+|||+|
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~--~~~~vKl~DFG~a 304 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 304 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCSSC
T ss_pred CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC--CCCCEEEeeccce
Confidence 78999999999999999997766679999999999999999999999999999999999999743 3468999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+...........+||+.|||||++.++.| ..++|
T Consensus 305 ~~~~~~~~~~~~~GT~~y~APEv~~~~~y-~~~~D 338 (573)
T 3uto_A 305 AHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTD 338 (573)
T ss_dssp EECCTTSEEEEECSSGGGCCHHHHTTCCB-CHHHH
T ss_pred eEccCCCceeeeEECccccCHHHhCCCCC-CcHHH
Confidence 98776655566789999999999998876 33444
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=285.86 Aligned_cols=183 Identities=25% Similarity=0.428 Sum_probs=159.6
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||.||+|++ +++.||||++...... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 85 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN------PTSLQKLFREVRIMKILNHPNIVKLFEVIET- 85 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-
Confidence 456899999999999999999998 5788999999865321 2234578899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 86 -~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~----~~~~~kl~DFG 159 (328)
T 3fe3_A 86 -EKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD----ADMNIKIADFG 159 (328)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTT
T ss_pred -CCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc----CCCCEEEeecc
Confidence 578999999999999999997764 489999999999999999999999999999999999998 66789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...........+||+.|+|||++.+..+.+.++||
T Consensus 160 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 197 (328)
T 3fe3_A 160 FSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197 (328)
T ss_dssp CCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHH
T ss_pred CceecCCCCccccccCCcceeCcccccCCCcCCchhhh
Confidence 99876655555667899999999999998877666664
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=271.28 Aligned_cols=181 Identities=31% Similarity=0.517 Sum_probs=152.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+..++|++.++||+|+||+||+|++. ++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--------DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 45678999999999999999999984 778999988532 12234578899999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Df 152 (310)
T 3s95_A 79 --DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR----ENKNVVVADF 152 (310)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEC----TTSCEEECCC
T ss_pred --CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEEC----CCCCEEEeec
Confidence 5789999999999999999988767799999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccccc---------------CCCCCCCCccccccccCCccCCCCCC
Q 001940 955 GLSKVKQQTLVS---------------GGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 955 GLAk~~~~~~~s---------------~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+++........ ....||+.|+|||++.+..+ +.++|
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 204 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVD 204 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCC-CTHHH
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHH
Confidence 999865332211 14579999999999987654 33444
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=281.28 Aligned_cols=182 Identities=24% Similarity=0.359 Sum_probs=153.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||+||+|+.+ ++.||||++++..... ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~- 76 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-----KDEVAHTVTESRVLQNTRHPFLTALKYAFQT- 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-----hhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-
Confidence 4578999999999999999999884 7789999998643211 1123467889999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 77 -~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~DFG 150 (337)
T 1o6l_A 77 -HDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFG 150 (337)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCT
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC----CCCCEEEeecc
Confidence 578999999999999999997654 489999999999999999999999999999999999998 66799999999
Q ss_pred Cccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++... ........+||+.|+|||++.+..+ +.++|
T Consensus 151 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 187 (337)
T 1o6l_A 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187 (337)
T ss_dssp TCBCSCCTTCCBCCCEECGGGCCGGGGSSSCB-CTTHH
T ss_pred chhhcccCCCcccccccChhhCChhhhcCCCC-Cchhh
Confidence 998643 2333456789999999999987755 44555
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=271.99 Aligned_cols=180 Identities=23% Similarity=0.344 Sum_probs=153.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
....++|++.++||+|+||+||+|++. ++.||||+++....... .+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEE 77 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCcceEEEEee
Confidence 345678999999999999999999985 78899999986433221 245678999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccC--ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k--~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
......+++||||+.+++|.+++..... .+++..++.|+.||+.||.|||+.+|+||||||+|||+...+...+.+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp CTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred cCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence 8656688999999999999999986543 38999999999999999999999999999999999998333226678999
Q ss_pred EecCCccccccccccCCCCCCCCcccccccc
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
+|||+++............||+.|+|||++.
T Consensus 158 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred ccCCCceecCCCCceeecccCCCccCHHHhh
Confidence 9999999776655555677999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-30 Score=266.67 Aligned_cols=181 Identities=27% Similarity=0.407 Sum_probs=152.7
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||+||+|+++ ++.||||+++...... ...+.+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 73 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST------THHHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC------CcchHHHHHHHHHhcCCCCCEeeEEeEEEe--C
Confidence 57999999999999999999984 6789999998653221 123467789999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+. ++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 74 ~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~----~~~~~kl~Dfg~~ 148 (292)
T 3o0g_A 74 KKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp TEEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CEEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEeecccc
Confidence 78999999996 577777766556799999999999999999999999999999999999998 6678999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......||+.|+|||++.+...++.++||
T Consensus 149 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 185 (292)
T 3o0g_A 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred eecCCccccccCCccccCCcChHHHcCCCCcCchHHH
Confidence 866433 233456789999999999888767777664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=277.88 Aligned_cols=184 Identities=22% Similarity=0.352 Sum_probs=155.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|++++.||+|+||.||+|+++ ++.||||++++..... ....+.+.+|..+++++ +||||+++++++
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 79 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVND-----DEDIDWVQTEKHVFEQASNHPFLVGLHSCF 79 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCS-----HHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcc-----hHHHHHHHHHHHHHHhcCCCCccCeEEEEE
Confidence 445678999999999999999999985 6779999998754322 22345678899999987 899999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+|+||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 80 ~~--~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~ 152 (345)
T 3a8x_A 80 QT--ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLT 152 (345)
T ss_dssp EC--SSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEE
Confidence 88 578999999999999999997654 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+++... ........+||+.|+|||++.+..+ +.++|
T Consensus 153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 192 (345)
T 3a8x_A 153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVD 192 (345)
T ss_dssp CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHH
T ss_pred eccccccccCCCCcccccCCCccccCccccCCCCC-ChHHh
Confidence 999998642 2333456789999999999988765 44444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=286.68 Aligned_cols=184 Identities=21% Similarity=0.355 Sum_probs=153.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|+++++||+|+||+||+|+.+ ++.||||++++...... ...+.+.+|..+|+++ +||||++++++|
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~-----~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 122 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD-----EDIDWVQTEKHVFEQASNHPFLVGLHSCF 122 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC---------CCHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----HHHHHHHHHHHHHHhcCCCCCcCeeEEEE
Confidence 455678999999999999999999985 66799999987543321 1224577888888877 899999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.++|||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++|+||||||+||||+ .++.+||+
T Consensus 123 ~~--~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~ 195 (396)
T 4dc2_A 123 QT--ESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD----SEGHIKLT 195 (396)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred EE--CCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC----CCCCEEEe
Confidence 98 578999999999999999998754 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCcccc-ccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVK-QQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~-~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+|+.. .........+||+.|+|||++.+..+ +.++|
T Consensus 196 DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~D 235 (396)
T 4dc2_A 196 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVD 235 (396)
T ss_dssp CCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCB-CTHHH
T ss_pred ecceeeecccCCCccccccCCcccCCchhhcCCCC-ChHHH
Confidence 99999863 33344556789999999999998765 34444
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=268.82 Aligned_cols=181 Identities=27% Similarity=0.439 Sum_probs=146.1
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+|+++ ++.||||+++.... ....+.+.+|+.+|++++||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-------ELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-------TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-------hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 46999999999999999999984 78899999975421 1123578899999999999999999999876422
Q ss_pred -------------------------------------------------------CcEEEEEeeccCCcHHHHHHhccC-
Q 001940 878 -------------------------------------------------------GSLATVTEFMVNGSLKQFLQKKDR- 901 (993)
Q Consensus 878 -------------------------------------------------------~~L~LVmEYm~GGSL~dlL~~~~k- 901 (993)
..+++||||+.+++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 238999999999999999987532
Q ss_pred -ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc-------------ccC
Q 001940 902 -TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-------------VSG 967 (993)
Q Consensus 902 -~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~-------------~s~ 967 (993)
..++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++...... ...
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCTTCEECSCC--------------CCC
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe----CCCCEEEeecCcccccccchhhcccccccccccccc
Confidence 345667889999999999999999999999999999998 56799999999998764431 223
Q ss_pred CCCCCCCccccccccCCccCCCCCC
Q 001940 968 GVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 968 s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
...||+.|+|||++.+..+ +.++|
T Consensus 235 ~~~gt~~y~aPE~~~~~~~-~~~~D 258 (332)
T 3qd2_B 235 GQVGTKLYMSPEQIHGNNY-SHKVD 258 (332)
T ss_dssp SCC-CGGGSCHHHHHCCCC-CTHHH
T ss_pred ccCCCcCccChHHhcCCCC-cchhh
Confidence 4579999999999987654 44444
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=271.01 Aligned_cols=185 Identities=30% Similarity=0.430 Sum_probs=153.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+...++|+++++||+|+||+||+|++ +++.||||++..... .....+.+.+|+.++++++||||+++++++.+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 90 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE------DEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc------cchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence 34567899999999999999999998 577899999975422 11223567899999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+. ++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 91 --~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Df 163 (311)
T 3niz_A 91 --ERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLIN----SDGALKLADF 163 (311)
T ss_dssp --SSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred --CCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEEC----CCCCEEEccC
Confidence 568999999996 589998887766799999999999999999999999999999999999998 5678999999
Q ss_pred CCccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++..... .......||+.|+|||++.+...++.++||
T Consensus 164 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 203 (311)
T 3niz_A 164 GLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDI 203 (311)
T ss_dssp TTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHH
T ss_pred cCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHh
Confidence 999876433 223445789999999999887666666664
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=267.84 Aligned_cols=186 Identities=25% Similarity=0.368 Sum_probs=151.1
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+..++|++++.||+|+||.||+|++. ++.||||++...... .....+.+.+|+.++++++||||+++++++
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 80 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPRE-----KEETLKRFEREVHNSSQLSHQNIVSMIDVD 80 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSC-----CHHHHHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccc-----cHHHHHHHHHHHHHHhcCCCCCCceEEEee
Confidence 3455678999999999999999999874 778999998754221 233456789999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 81 ~~--~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~ 153 (294)
T 4eqm_A 81 EE--DDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID----SNKTLKIF 153 (294)
T ss_dssp EC--SSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred ee--CCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCCEEEE
Confidence 87 578999999999999999997664 589999999999999999999999999999999999998 56789999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++...... ......||+.|+|||++.+..+ +.++||
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 195 (294)
T 4eqm_A 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDI 195 (294)
T ss_dssp CCSSSTTC-------------CCSSCCHHHHHTCCC-CTTHHH
T ss_pred eCCCccccccccccccCccccCccccCHhHhcCCCC-CchHhH
Confidence 999998664432 2334679999999999988654 344453
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=276.40 Aligned_cols=184 Identities=19% Similarity=0.226 Sum_probs=150.1
Q ss_pred cccCCCceEEEEecccCceEEEEEE-----E--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---CCCc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGK-----W--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNV 865 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk-----~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---HPNI 865 (993)
.+..++|++.++||+|+||+||+|. . .++.||||+++... ...+.+|+.+++.++ |+||
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~l~~~~~~~i 129 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----------PWEFYIGTQLMERLKPSMQHMF 129 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----------HHHHHHHHHHHHHSCGGGGGGB
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----------hhHHHHHHHHHHHhhhhhhhhh
Confidence 4556789999999999999999994 2 57789999987531 125667777888787 9999
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHh----ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~----~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
+++++++.. .+..+||||||.+|+|.+++.. ....+++..++.|+.||+.||+|||+.+||||||||+||||+.
T Consensus 130 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 130 MKFYSAHLF--QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp CCEEEEEEC--SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred hhhheeeec--CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 999999988 5678999999999999999975 2456999999999999999999999999999999999999984
Q ss_pred C-------CCCCCeEEEEecCCccccc---cccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 942 R-------DPQRPVCKIGDLGLSKVKQ---QTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 942 ~-------d~e~g~VKLiDFGLAk~~~---~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+ +...+.+||+|||+|+... ........+||+.|||||++.+..+ +.++||
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 268 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDY 268 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHH
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccH
Confidence 1 1126899999999997543 2333456789999999999998764 455553
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=278.65 Aligned_cols=183 Identities=25% Similarity=0.380 Sum_probs=156.8
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||+||+|.+ +++.||||++....... ......+.+|+.+++.++||||+++++++.+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~- 80 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-----SDMHMRVEREISYLKLLRHPHIIKLYDVITT- 80 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-----hhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-
Confidence 457899999999999999999998 57789999997542211 1112467899999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+ +|+|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 81 -~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~DFG 153 (336)
T 3h4j_B 81 -PTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD----DNLNVKIADFG 153 (336)
T ss_dssp -SSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC----TTCCEEECCSS
T ss_pred -CCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc----CCCCEEEEEec
Confidence 56799999999 789999887654 489999999999999999999999999999999999998 66789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...........+||+.|+|||++.+..+.+.++||
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 191 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHH
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccch
Confidence 99877666555667899999999999998877666664
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=272.25 Aligned_cols=188 Identities=38% Similarity=0.664 Sum_probs=147.9
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
....+...+|++.+.||+|+||+||+|+++++.||||++..... .....+.+.+|+.++++++||||+++++++
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF------HAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC------CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 34456678899999999999999999999999999999875432 122345788999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCCCCCCe
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d~e~g~ 948 (993)
.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.
T Consensus 104 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~----~~~~ 177 (309)
T 3p86_A 104 TQ--PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD----KKYT 177 (309)
T ss_dssp CS--TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEEC----TTCC
T ss_pred EE--CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEe----CCCc
Confidence 87 567899999999999999997653 23889999999999999999999999 99999999999998 6679
Q ss_pred EEEEecCCcccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+||+|||+++...... ......||+.|+|||++.+..+ +.++||
T Consensus 178 ~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 222 (309)
T 3p86_A 178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDV 222 (309)
T ss_dssp EEECCCC-----------------CCTTSCHHHHTTCCC-CTTHHH
T ss_pred EEECCCCCCccccccccccccCCCCccccChhhhcCCCC-CchhhH
Confidence 9999999998654332 2345679999999999987755 445553
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8e-30 Score=283.36 Aligned_cols=187 Identities=21% Similarity=0.409 Sum_probs=157.6
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+..++|++++.||+|+||.||+|+.+ ++.||||++.+..... ....+.+.+|+.+|+.++||||++++++|
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 84 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE-----RNEVRNVFKELQIMQGLEHPFLVNLWYSF 84 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc-----HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3455678999999999999999999884 6679999997643211 11235688999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+|+||||+.+|+|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+||||+ .++.+||+
T Consensus 85 ~~--~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~ 157 (384)
T 4fr4_A 85 QD--EEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD----EHGHVHIT 157 (384)
T ss_dssp EC--SSEEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEEC
T ss_pred Ee--CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEC----CCCCEEEe
Confidence 98 578999999999999999998654 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCc--cCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS--HMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~--y~tse~DI 993 (993)
|||+++...........+||+.|+|||++.+.. .++.++||
T Consensus 158 DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~Di 200 (384)
T 4fr4_A 158 DFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200 (384)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHH
T ss_pred ccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCcccee
Confidence 999999776655566788999999999997532 34445553
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=272.44 Aligned_cols=186 Identities=26% Similarity=0.402 Sum_probs=144.5
Q ss_pred ccccCCCceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
..+..++|++++.||+|+||.||+++. .++.||||++++...... ......+.+|+.+|+.++||||++++
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~ 87 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN----AKDTAHTKAERNILEEVKHPFIVDLI 87 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh----hhHHHHHHHHHHHHHhCCCCCcccee
Confidence 345667899999999999999999987 467799999986533211 12234677899999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.. .+.+|+||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 88 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~----~~~~~ 160 (327)
T 3a62_A 88 YAFQT--GGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN----HQGHV 160 (327)
T ss_dssp EEEEC--SSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC----TTSCE
T ss_pred EEEEc--CCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEEC----CCCcE
Confidence 99988 578999999999999999997654 488999999999999999999999999999999999998 56789
Q ss_pred EEEecCCcccccc-ccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 950 KIGDLGLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 950 KLiDFGLAk~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+|||+++.... .......+||+.|+|||++.+..+ +.++|
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 203 (327)
T 3a62_A 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVD 203 (327)
T ss_dssp EECCCSCC----------CTTSSCCTTSCHHHHTTSCC-CTHHH
T ss_pred EEEeCCcccccccCCccccccCCCcCccCHhhCcCCCC-CCccc
Confidence 9999999986432 223445679999999999987654 34444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=291.35 Aligned_cols=186 Identities=22% Similarity=0.303 Sum_probs=154.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+..++|+++++||+|+||+||+|+++ ++.||||++++..... ....+.+.+|..++..++||||++++++|.+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~-----~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK-----RAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-----TTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-----HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 45678999999999999999999985 5679999997632211 1112347789999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+|||||||.+|+|.++|.+....+++..++.|+.||+.||.|||+.+||||||||+||||+ .++.+||+||
T Consensus 146 --~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~----~~g~vkL~DF 219 (437)
T 4aw2_A 146 --DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD----MNGHIRLADF 219 (437)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEc----CCCCEEEcch
Confidence 5789999999999999999987666799999999999999999999999999999999999998 6679999999
Q ss_pred CCcccccccc--ccCCCCCCCCcccccccc----CCccCCCCCCC
Q 001940 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLS----GKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~--~s~s~~GTp~YmAPEVL~----Gk~y~tse~DI 993 (993)
|+|+...... .....+||+.|||||++. +...++.++||
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~Dv 264 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCee
Confidence 9998654332 234568999999999997 23444555553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=277.82 Aligned_cols=184 Identities=26% Similarity=0.401 Sum_probs=147.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|+++++||+|+||+||+|+.+ ++.||||++++... ......+.+.+|..+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-----LQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-----cchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 355688999999999999999999984 67899999986422 1222345678899999988 699999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+|+||||+.+|+|.+++.+.. .+++..++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+
T Consensus 94 ~~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~----~~g~ikL~ 166 (353)
T 3txo_A 94 QT--PDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD----HEGHCKLA 166 (353)
T ss_dssp EC--SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEEC----CCCCEEEc
Confidence 98 578999999999999999997764 489999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+|+... ........+||+.|+|||++.+..+ +.++|
T Consensus 167 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 206 (353)
T 3txo_A 167 DFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVD 206 (353)
T ss_dssp CCTTCBCSCC---------CCGGGCCHHHHHHHHC-TTHHH
T ss_pred cccceeecccCCccccccCCCcCeEChhhcCCCCc-CCccC
Confidence 999998643 2233456789999999999986654 33444
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=278.21 Aligned_cols=188 Identities=25% Similarity=0.372 Sum_probs=155.9
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.+.|++++.||+|+||+||+|+.+ ++.||||++++........ ....+.+.+|+.+|+.++||||++++++|.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVCREEIEREVSILRQVLHPNIITLHDVYEN-- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc--hhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe--
Confidence 467999999999999999999984 7789999998754322111 0112467899999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+|+|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++.++.....+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 578999999999999999997654 5899999999999999999999999999999999999984432234899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
++...........+||+.|+|||++.+..+ +.++|
T Consensus 166 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 200 (361)
T 2yab_A 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEAD 200 (361)
T ss_dssp CEECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHH
T ss_pred ceEcCCCCccccCCCCccEECchHHcCCCC-Ccccc
Confidence 987766555556789999999999987654 34444
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=287.12 Aligned_cols=178 Identities=21% Similarity=0.283 Sum_probs=152.1
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+..++|++++.||+|+||+||+|+.+ ++.||||++++... ......+.+.+|..++..++|+||++++++|
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-----~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-----LKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-----HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-----hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 3456788999999999999999999984 78899999975321 1112234578899999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++ .+.+||||||+.+|+|.++|.+.+..+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+
T Consensus 131 ~~--~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld----~~g~vkL~ 204 (412)
T 2vd5_A 131 QD--ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD----RCGHIRLA 204 (412)
T ss_dssp EC--SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEEC
T ss_pred ee--CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeec----CCCCEEEe
Confidence 98 5789999999999999999987666799999999999999999999999999999999999998 66799999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccC
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~G 983 (993)
|||+++...... .....+||+.|||||++.+
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHH
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhh
Confidence 999998764432 2335689999999999973
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=272.80 Aligned_cols=180 Identities=28% Similarity=0.454 Sum_probs=152.8
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||+||+|+.+ ++.||||++++.... +....+.+.+|..+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~- 77 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD- 77 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-----hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-
Confidence 4568999999999999999999984 778999999864321 11123467789999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+|+||||+.+|+|.+++.+.. .+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 78 -~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~Dfg 151 (318)
T 1fot_A 78 -AQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFG 151 (318)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCS
T ss_pred -CCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc----CCCCEEEeecC
Confidence 578999999999999999998654 489999999999999999999999999999999999998 66799999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++..... ....+||+.|+|||++.+..+ +.++|
T Consensus 152 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~D 185 (318)
T 1fot_A 152 FAKYVPDV--TYTLCGTPDYIAPEVVSTKPY-NKSID 185 (318)
T ss_dssp SCEECSSC--BCCCCSCTTTCCHHHHTTCCB-CTTHH
T ss_pred cceecCCc--cccccCCccccCHhHhcCCCC-Ccccc
Confidence 99875443 345689999999999987764 34455
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=274.84 Aligned_cols=187 Identities=25% Similarity=0.351 Sum_probs=152.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||+||+|.++ ++.||||++........... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGL---STEDLKREASICHMLKHPHIVELLETYSS-- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSC---CHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccc---hHHHHHHHHHHHHhCCCCCCCcEEEEEEe--
Confidence 356999999999999999999884 78899999975432211110 12468899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+|+||||+.+++|.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++.++ ....+||+|
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-~~~~vkl~D 176 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-NSAPVKLGG 176 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS-TTCCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC-CCCcEEEec
Confidence 57899999999999999887653 23489999999999999999999999999999999999998543 446799999
Q ss_pred cCCcccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+++...... .....+||+.|+|||++.+..+ +.++|
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 215 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVD 215 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCCC-CchHh
Confidence 99998765432 2345679999999999987754 44444
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-30 Score=265.67 Aligned_cols=181 Identities=26% Similarity=0.411 Sum_probs=149.0
Q ss_pred CCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
++|++++.||+|+||+||+|+.. ++.||||++....... ...+.+.+|+.++++++||||+++++++.+ .+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~ 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SS
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc------ccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CC
Confidence 57999999999999999999985 7789999987543211 112357789999999999999999999987 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+. ++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 74 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg~~~ 148 (288)
T 1ob3_A 74 RLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (288)
T ss_dssp CEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred eEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEeECcccc
Confidence 7999999996 599999987666789999999999999999999999999999999999998 66789999999998
Q ss_pred ccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..... .......||+.|+|||++.+...++.++||
T Consensus 149 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 184 (288)
T 1ob3_A 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184 (288)
T ss_dssp HHCC---------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred ccCccccccccccccccccCchheeCCCCCCcHHHH
Confidence 65432 223345789999999999877666666664
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=274.98 Aligned_cols=183 Identities=23% Similarity=0.352 Sum_probs=155.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|.++ ++.||||++...... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~ 100 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQE--E 100 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC------HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--C
Confidence 56999999999999999999884 778999999864321 1234578899999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++.++ ..+.+||+|||++
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~DfG~a 178 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFGLA 178 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS-TTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEeecCcc
Confidence 78999999999999999997654 589999999999999999999999999999999999998543 4467999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+............||+.|+|||++.+..+ +.++||
T Consensus 179 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 213 (362)
T 2bdw_A 179 IEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDI 213 (362)
T ss_dssp BCCTTCCSCCCSCSCTTTCCHHHHTTCCC-CTHHHH
T ss_pred eEecCCcccccCCCCccccCHHHHccCCC-CchhhH
Confidence 87765554556789999999999987654 344443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-30 Score=277.52 Aligned_cols=183 Identities=26% Similarity=0.345 Sum_probs=145.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
...++|++++.||+|+||+||+++.+ ++.||||++....... +.+.+|+.+++.++||||+++++++.+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~E~~~l~~l~hpniv~~~~~~~~ 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---------ENVQREIINHRSLRHPNIVRFKEVILT 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---------HHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---------HHHHHHHHHHHhCCCCCCCcEEEEEee
Confidence 34578999999999999999999984 7789999997543211 356789999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.+ ..+.+||+||
T Consensus 88 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~--~~~~~kl~Df 162 (361)
T 3uc3_A 88 --PTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS--PAPRLKICDF 162 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS--SSCCEEECCC
T ss_pred --CCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC--CCceEEEeec
Confidence 578999999999999999997654 48999999999999999999999999999999999999732 2346999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++............||+.|+|||++.+..+....+||
T Consensus 163 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 201 (361)
T 3uc3_A 163 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADV 201 (361)
T ss_dssp CCC---------------CTTSCHHHHHCSSCCHHHHHH
T ss_pred CccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeee
Confidence 999865444444556799999999999888776554553
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=276.95 Aligned_cols=184 Identities=26% Similarity=0.399 Sum_probs=151.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|++++.||+|+||+||+|+++ ++.||||++++..... ....+.+..|..+++.+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-----DDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-----hhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 356689999999999999999999984 6779999998643211 11234567888888876 899999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+
T Consensus 88 ~~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~vkL~ 160 (345)
T 1xjd_A 88 QT--KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIA 160 (345)
T ss_dssp EC--SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred Ee--CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC----CCCCEEEe
Confidence 98 578999999999999999998654 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCcccccc-ccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+++.... .......+||+.|+|||++.+..+ +.++|
T Consensus 161 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 200 (345)
T 1xjd_A 161 DFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVD 200 (345)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHH
T ss_pred EChhhhhcccCCCcccCCCCCcccCChhhhcCCCC-CChhh
Confidence 9999986432 223456789999999999988754 34444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=266.31 Aligned_cols=178 Identities=22% Similarity=0.405 Sum_probs=151.2
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||+||+|++ +++.||||++....... .+.+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLV- 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--------HHHHHHHHHHHhcCCCCCCCeEeEEEEE-
Confidence 346799999999999999999987 47789999987543221 1357789999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.+. .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~Dfg 161 (297)
T 3fxz_A 89 -GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFG 161 (297)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCT
T ss_pred -CCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEC----CCCCEEEeeCC
Confidence 56799999999999999999765 488999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++...... ......||+.|+|||++.+..+ +.++|
T Consensus 162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 198 (297)
T 3fxz_A 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVD 198 (297)
T ss_dssp TCEECCSTTCCBCCCCSCGGGCCHHHHHCSCB-CTHHH
T ss_pred CceecCCcccccCCccCCcCccChhhhcCCCC-CcHHH
Confidence 998654432 3345679999999999988765 34444
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-30 Score=284.82 Aligned_cols=183 Identities=26% Similarity=0.307 Sum_probs=141.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|+++ ++.||||++.... ......+++.+|+.+|+.++|+||+++++++....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF------EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh------cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 468999999999999999999874 7789999986532 11233467889999999999999999999986432
Q ss_pred ---CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 ---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ---~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
...+|+||||+ +++|.+++... ..+++..++.|+.||+.||+|||+.+||||||||+||||+ .++.+||+|
T Consensus 126 ~~~~~~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~----~~~~~kl~D 199 (458)
T 3rp9_A 126 VEKFDELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVN----QDCSVKVCD 199 (458)
T ss_dssp TTTCCCEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEEC----CCCCEeecc
Confidence 25799999998 68999999765 3589999999999999999999999999999999999998 667999999
Q ss_pred cCCcccccccc----------------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL----------------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~----------------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|+...... .....+||++|+|||++.+...++.++||
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di 267 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHH
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHH
Confidence 99998653211 12345789999999998766667776664
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=277.36 Aligned_cols=184 Identities=21% Similarity=0.313 Sum_probs=152.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|++++.||+|+||+||+|+.+ ++.||||++++..... ....+.+..|..+|..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-----~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc-----chHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 356689999999999999999999985 5679999998643211 11234677899999888 799999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++ .+.+|+||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+.||+||||||+|||++ .++.+||+
T Consensus 91 ~~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~vkL~ 163 (353)
T 2i0e_A 91 QT--MDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIA 163 (353)
T ss_dssp EC--SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEEC
T ss_pred Ec--CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEc----CCCcEEEE
Confidence 98 578999999999999999998754 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+++... ........+||+.|+|||++.+..+ +.++|
T Consensus 164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 203 (353)
T 2i0e_A 164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVD 203 (353)
T ss_dssp CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCB-STHHH
T ss_pred eCCcccccccCCcccccccCCccccChhhhcCCCc-CCccc
Confidence 999998643 2334456789999999999987765 34444
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=286.70 Aligned_cols=177 Identities=22% Similarity=0.377 Sum_probs=150.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|+++++||+|+||+||+|+.+ ++.||||++++...... ...+.+.+|+.+++.++||||++++++|.
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 139 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----SDSAFFWEERDIMAFANSPWVVQLFYAFQ 139 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----CCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhh-----HHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 456678999999999999999999984 67799999976322111 01124778999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+||||||+.+|+|.+++.+. .+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+|
T Consensus 140 ~--~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~----~~g~ikL~D 211 (410)
T 3v8s_A 140 D--DRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD----KSGHLKLAD 211 (410)
T ss_dssp C--SSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECC
T ss_pred E--CCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeEC----CCCCEEEec
Confidence 8 57899999999999999999764 488999999999999999999999999999999999998 667999999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCc
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+|+...... .....+||+.|||||++.+..
T Consensus 212 FG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 212 FGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp CTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTT
T ss_pred cceeEeeccCCcccccCCcCCccccCHHHhhccC
Confidence 99998764432 234678999999999998765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=264.15 Aligned_cols=180 Identities=34% Similarity=0.546 Sum_probs=148.0
Q ss_pred ccccCCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
.++..++|++++.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.++++++||||+++
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~ 76 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVKY 76 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC--------HHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC--------HHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 345678899999999999999999985 46779999987431 2234578899999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
++++.......+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.
T Consensus 77 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~ 152 (295)
T 3ugc_A 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NENR 152 (295)
T ss_dssp EEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTE
T ss_pred EEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc----CCCe
Confidence 999876444668999999999999999988766799999999999999999999999999999999999998 5679
Q ss_pred EEEEecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 949 CKIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+||+|||+++...... ......||..|+|||++.+..+
T Consensus 153 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (295)
T 3ugc_A 153 VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194 (295)
T ss_dssp EEECCCCSCC-------------CTTCGGGGCCHHHHHHCCC
T ss_pred EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCC
Confidence 9999999998754332 2233457888999999986653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=267.21 Aligned_cols=183 Identities=27% Similarity=0.392 Sum_probs=146.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCch------------------hHHHHHHHHHHHHHH
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPS------------------ERERLIADFWKEALL 856 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~------------------ere~~ie~f~rEi~I 856 (993)
+..++|++.+.||+|+||.||+|+. +++.||||++.......... ......+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 4457899999999999999999987 46789999997654321110 011224568899999
Q ss_pred HhhcCCCCcceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 001940 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (993)
Q Consensus 857 Lr~LrHPNIVrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeN 936 (993)
|++++||||+++++++.+...+.+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||+.+|+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999987656789999999999999887543 358999999999999999999999999999999999
Q ss_pred EEEccCCCCCCeEEEEecCCccccccc-cccCCCCCCCCccccccccCCc
Q 001940 937 LLVNMRDPQRPVCKIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 937 ILLd~~d~e~g~VKLiDFGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||++ .++.+||+|||+++..... .......||+.|+|||++.+..
T Consensus 168 il~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 168 LLVG----EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp EEEC----TTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC
T ss_pred EEEC----CCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC
Confidence 9998 5678999999999865433 2234567999999999998765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=264.76 Aligned_cols=186 Identities=25% Similarity=0.427 Sum_probs=152.6
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV 865 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~kg---------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI 865 (993)
.++..++|++.+.||+|+||+||+|+++. ..||+|++..... ...+.+.+|+.++++++||||
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i 74 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--------NYSESFFEAASMMSKLSHKHL 74 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--------GGHHHHHHHHHHHHTSCCTTB
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--------HHHHHHHHHHHHHHhCCCCCE
Confidence 34567889999999999999999998742 4599999865321 123468899999999999999
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC-
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP- 944 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~- 944 (993)
+++++++.+ .+..++||||+.+++|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||++.++.
T Consensus 75 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~ 152 (289)
T 4fvq_A 75 VLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDR 152 (289)
T ss_dssp CCEEEEECC--TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBG
T ss_pred eEEEEEEEe--CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcc
Confidence 999999987 56789999999999999999887666999999999999999999999999999999999999984431
Q ss_pred ---CCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 945 ---QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 945 ---e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
..+.+||+|||+++...... ...||+.|+|||++.+....+.++||
T Consensus 153 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di 201 (289)
T 4fvq_A 153 KTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIENPKNLNLATDK 201 (289)
T ss_dssp GGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHCGGGCCHHHHH
T ss_pred cccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCCCCCCCchhHH
Confidence 11239999999997654332 24588999999999875556655553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-30 Score=273.55 Aligned_cols=181 Identities=30% Similarity=0.420 Sum_probs=151.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|++. ++.||||++...... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE-- 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-------chHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 468999999999999999999884 778999998754221 112467889999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kl~Dfg~ 151 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 151 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCeEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe----CCCCEEEEEeec
Confidence 578999999999999999986553 489999999999999999999999999999999999998 667899999999
Q ss_pred ccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++..... .......||+.|+|||++.+..+.+.++||
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 191 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHH
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccH
Confidence 9865322 223456799999999999888776555553
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=275.01 Aligned_cols=182 Identities=25% Similarity=0.400 Sum_probs=142.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~ 875 (993)
.++|++++.||+|+||.||+|.++ ++.||||++..... .....+.+.+|+.+|+.+. |+||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~------~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~ 81 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ------NSTDAQRTFREIMILTELSGHENIVNLLNVLRAD 81 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc------ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence 468999999999999999999884 78899999864321 1223456789999999998 99999999999875
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....+|+|||||. ++|.+++... .+++..+..|+.||+.||+|||+.||+||||||+|||++ .++.+||+|||
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~DFG 154 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN----AECHVKVADFG 154 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred CCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc----CCCCEEecCCc
Confidence 5567999999996 6999999763 488999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccc----------------------ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQ----------------------TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~----------------------~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+.... .......+||++|+|||++.+...++.++||
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 214 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDM 214 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHH
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhH
Confidence 9986432 1122346799999999999987677776664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-29 Score=256.00 Aligned_cols=184 Identities=23% Similarity=0.340 Sum_probs=155.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|.++ ++.||||++...... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 76 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQE- 76 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC------HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-
Confidence 3578999999999999999999884 778999999865321 2234578899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+..++||||+.+++|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++ ..+.+||+|||
T Consensus 77 -~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~~~kl~Dfg 153 (284)
T 3kk8_A 77 -ESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-KGAAVKLADFG 153 (284)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-TTCCEEECCCT
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-CCCcEEEeece
Confidence 577899999999999999887654 489999999999999999999999999999999999998544 45679999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
++.............||+.|+|||++.+..+ +.+.|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 189 (284)
T 3kk8_A 154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVD 189 (284)
T ss_dssp TCEECCSSCBCCCSCSCGGGCCHHHHTTCCB-CTHHH
T ss_pred eeEEcccCccccCCCCCcCCcCchhhcCCCC-Ccccc
Confidence 9987766555556789999999999987654 33444
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-29 Score=267.04 Aligned_cols=174 Identities=18% Similarity=0.220 Sum_probs=150.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||+||+|+++ ++.||+|++.... .....+.+|+.+|+.++||||+++++++.+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 72 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFES-- 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---------ccHHHHHHHHHHHHhCCCCCCCeEeEEEec--
Confidence 468999999999999999999984 6779999987431 112467899999999999999999999988
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++.+ .++.+||+|||+
T Consensus 73 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~--~~~~~kl~Dfg~ 150 (321)
T 1tki_A 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC--CCCCEEEEECCC
Confidence 578999999999999999998766679999999999999999999999999999999999999832 257899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCc
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
++............||+.|+|||++.+..
T Consensus 151 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (321)
T 1tki_A 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDV 179 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCE
T ss_pred CeECCCCCccccccCChhhcCcHHhcCCC
Confidence 98775554444567999999999998764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=277.32 Aligned_cols=182 Identities=18% Similarity=0.186 Sum_probs=142.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---------CCCcceE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---------HPNVVSF 868 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---------HPNIVrL 868 (993)
..++|++++.||+|+||+||+|+++++.||||++................+.+.+|+.+|+.++ |+||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3456888999999999999999999999999999875432110011112246778888888885 8888888
Q ss_pred EEEEEcC----------------------------CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHH
Q 001940 869 YGIVRDG----------------------------PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920 (993)
Q Consensus 869 ~G~f~d~----------------------------s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLe 920 (993)
++++... ..+.+||||||+.+|+|.+.+.+ ..+++..++.|+.||+.||.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 8775311 14689999999999977666644 35899999999999999999
Q ss_pred HHH-hCCceecCCCCCCEEEccCCC----------------CCCeEEEEecCCccccccccccCCCCCCCCccccccccC
Q 001940 921 YLH-GKNIVHFDLKCENLLVNMRDP----------------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 921 YLH-s~gIIHRDIKPeNILLd~~d~----------------e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
||| +.+|+||||||+||||+.++. ....+||+|||+|+..... ..+||+.|||||++.+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence 999 999999999999999984321 1128999999999876543 3479999999999987
Q ss_pred Cc
Q 001940 984 KS 985 (993)
Q Consensus 984 k~ 985 (993)
..
T Consensus 252 ~~ 253 (336)
T 2vuw_A 252 DG 253 (336)
T ss_dssp CS
T ss_pred CC
Confidence 75
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-30 Score=271.71 Aligned_cols=173 Identities=28% Similarity=0.400 Sum_probs=147.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
+..++|+++++||+|+||+||+|+++++.||||++.... .....+.+|+.++++++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---------KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred cchhhchhhheecccCceEEEEEEECCCEEEEEEeecCc---------hHHHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 556789999999999999999999999999999986531 11234556899999999999999999998743
Q ss_pred --CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCCEEEccCCC
Q 001940 877 --DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK----------NIVHFDLKCENLLVNMRDP 944 (993)
Q Consensus 877 --~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~----------gIIHRDIKPeNILLd~~d~ 944 (993)
...+++||||+++|+|.++++.. .+++..++.|+.||+.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~---- 165 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK---- 165 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC----
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC----
Confidence 23579999999999999999764 389999999999999999999999 999999999999998
Q ss_pred CCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCC
Q 001940 945 QRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 945 e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk 984 (993)
.++.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccc
Confidence 66799999999998654332 22346799999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-29 Score=279.30 Aligned_cols=183 Identities=23% Similarity=0.302 Sum_probs=150.0
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|+++ ++.||||+++... ......+++.+|+.+|+.++|+||+++++++....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF------EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT------TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh------cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 578999999999999999999884 6779999997531 12233457889999999999999999999987642
Q ss_pred C---CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 D---GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ~---~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. ..+|+||||+. ++|.+++... ..+++..++.|+.||+.||+|||+.+|+||||||+||||+ .++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~----~~~~~kL~D 172 (432)
T 3n9x_A 99 LLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN----QDCSVKVCD 172 (432)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred CCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC----CCCCEEEcc
Confidence 2 57999999984 6999999765 3589999999999999999999999999999999999998 667899999
Q ss_pred cCCcccccccc-----------------------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL-----------------------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~-----------------------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|+...... .....+||++|+|||++.+...++.++||
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Di 235 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI 235 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccccc
Confidence 99998654321 12456799999999998766666766664
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=264.87 Aligned_cols=179 Identities=26% Similarity=0.363 Sum_probs=143.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s 876 (993)
++|+++++||+|+||+||+|++. ++.||||++...... ... ...+..|+..+.++ +|+||++++++|.+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-- 128 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-----PKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEE-- 128 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-----HHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-----hHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEe--
Confidence 56999999999999999999984 788999987653211 111 22344555555444 89999999999988
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+ +++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~DFG~ 203 (311)
T 3p1a_A 129 GGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG----PRGRCKLGDFGL 203 (311)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----GGGCEEECCCTT
T ss_pred CCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC----CCCCEEEcccee
Confidence 57899999999 7899999988777799999999999999999999999999999999999998 567899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++............||+.|+|||++.+. .+.++||
T Consensus 204 a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di 238 (311)
T 3p1a_A 204 LVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAADV 238 (311)
T ss_dssp CEECC------CCCCCGGGCCGGGGGTC--CSTHHHH
T ss_pred eeecccCCCCcccCCCccccCHhHhcCC--CCchhhH
Confidence 9877655555566799999999999873 4455553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=263.63 Aligned_cols=187 Identities=27% Similarity=0.372 Sum_probs=154.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+.|++.+.||+|+||.||+|+.+ ++.||||+++......... ....+.+.+|+.+|++++||||+++++++.+ .
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe--C
Confidence 46999999999999999999984 7789999998654322110 0112468899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.....+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 7899999999999999999765 358999999999999999999999999999999999999844333448999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+............||+.|+|||++.+..+ +.++|
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 199 (326)
T 2y0a_A 166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEAD 199 (326)
T ss_dssp EECCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHH
T ss_pred eECCCCCccccccCCcCcCCceeecCCCC-CcHHH
Confidence 87755444456779999999999987654 34444
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=265.76 Aligned_cols=181 Identities=29% Similarity=0.490 Sum_probs=137.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|+++ ++.||||+++....... .+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 74 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-------PSTAIREISLMKELKHENIVRLYDVIHT-- 74 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCS-------CHHHHHHHHHHTTCCBTTBCCEEEEECC--
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc-------HHHHHHHHHHHHhcCCCCcceEEEEEEE--
Confidence 467999999999999999999874 77899999976432111 1356789999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhcc-----CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKD-----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~-----k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
.+.+++||||+. ++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||
T Consensus 75 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl 149 (317)
T 2pmi_A 75 ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN----KRGQLKL 149 (317)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEE
T ss_pred CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEc----CCCCEEE
Confidence 578999999997 69999987542 3488999999999999999999999999999999999998 6678999
Q ss_pred EecCCccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++..... .......||+.|+|||++.+...++.++||
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 192 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDI 192 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHH
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHH
Confidence 999999875432 223456799999999999876666666664
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=281.96 Aligned_cols=180 Identities=27% Similarity=0.359 Sum_probs=140.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||+||+|.++ ++.||||++..................+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 468999999999999999999884 6789999998765433222222233457899999999999999999999865
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ....+||+|||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGH 288 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-SSCCEEECCSST
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-CcceEEEeeccc
Confidence 45899999999999999886554 589999999999999999999999999999999999997443 456799999999
Q ss_pred ccccccccccCCCCCCCCccccccccC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
++...........+||+.|+|||++.+
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC-
T ss_pred ceecCCCccccccCCCCCccCceeeec
Confidence 998766555566789999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.5e-30 Score=276.38 Aligned_cols=187 Identities=24% Similarity=0.328 Sum_probs=155.7
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|++ +++.||||+++...............+.+.+|+.+|++++||||++++++|.+ .
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~--~ 101 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN--Q 101 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--C
Confidence 5799999999999999999987 47789999998754322110000112346679999999999999999999987 5
Q ss_pred CcEEEEEeeccCC-cHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 878 GSLATVTEFMVNG-SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 878 ~~L~LVmEYm~GG-SL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
+.+++||||+.+| +|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA----EDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc----CCCcEEEeeccc
Confidence 7899999999777 9999997654 489999999999999999999999999999999999998 567899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++............||+.|+|||++.+..+.+.++||
T Consensus 177 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 213 (335)
T 3dls_A 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213 (335)
T ss_dssp CEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHH
T ss_pred ceECCCCCceeccCCCccccChhhhcCCCCCCCcccc
Confidence 9877665555567799999999999988776666664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=260.89 Aligned_cols=181 Identities=25% Similarity=0.388 Sum_probs=147.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.++++++||||+++++++.+ .
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 74 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--K 74 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeec--C
Confidence 67999999999999999999984 7789999886542 122334578899999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++... ..+++..+..|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 75 ~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 75 RRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT----KHSVIKLCDFGFA 149 (311)
T ss_dssp TEEEEEEECCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CeEEEEEEeCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc----CCCCEEEeeCCCc
Confidence 7899999999999999988654 4489999999999999999999999999999999999998 6679999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......||+.|+|||++.+....+.++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 186 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDV 186 (311)
T ss_dssp EECC------------GGGCCHHHHHTCSCCCTHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhcCCCCCcchhh
Confidence 876533 223456799999999999886666666664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=274.91 Aligned_cols=183 Identities=24% Similarity=0.339 Sum_probs=145.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHH-HhhcCCCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL-LSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~I-Lr~LrHPNIVrL~G~f~ 873 (993)
+..++|++++.||+|+||+||+|+.+ ++.||||++++...... ...+.+.+|..+ ++.++||||++++++|.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~-----~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~ 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK-----KEEKHIMSERNVLLKNVKHPFLVGLHFSFQ 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhh-----HHHHHHHHHHHHHHHhCCCCCCCCEEEEEE
Confidence 44578999999999999999999985 56799999987654322 122345666666 57789999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+|+||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 110 ~--~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~----~~g~ikL~D 182 (373)
T 2r5t_A 110 T--ADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD----SQGHIVLTD 182 (373)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECC
T ss_pred e--CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEC----CCCCEEEee
Confidence 8 578999999999999999998754 488899999999999999999999999999999999998 667999999
Q ss_pred cCCccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+++... ........+||+.|+|||++.+..+ +.++|
T Consensus 183 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 221 (373)
T 2r5t_A 183 FGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVD 221 (373)
T ss_dssp CCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCC-CTHHH
T ss_pred CccccccccCCCccccccCCccccCHHHhCCCCC-Cchhh
Confidence 99998643 3334456789999999999987754 33444
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=256.39 Aligned_cols=176 Identities=31% Similarity=0.599 Sum_probs=150.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.+..++|++++.||+|+||.||+|++++ ..||||+++..... .+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS---------EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc---------HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 4567889999999999999999999864 46999999754321 1357899999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+++++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 75 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~Df 148 (268)
T 3sxs_A 75 --EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD----RDLCVKVSDF 148 (268)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEEC----TTCCEEECCT
T ss_pred --CCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEEC----CCCCEEEccC
Confidence 5679999999999999999988766799999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 955 GLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+++...... ......+|+.|+|||++.+..+
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (268)
T 3sxs_A 149 GMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY 182 (268)
T ss_dssp TCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEE
T ss_pred ccceecchhhhhcccCCCcCcccCCHHHHhccCC
Confidence 9998654432 2234457788999999976554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=267.16 Aligned_cols=177 Identities=25% Similarity=0.310 Sum_probs=148.0
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~ 873 (993)
+..++|++.+.||+|+||+||+|+. +++.||||++...... +.+.+|+.++++| +|+||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----------PQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------CCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------HHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 3467899999999999999999996 5788999998754221 2467899999999 8999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKLi 952 (993)
. .+.+++||||+ +++|.+++......+++..++.|+.||+.||+|||+.+|+||||||+|||++.++ .....+||+
T Consensus 76 ~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 76 C--GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp E--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred c--CCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 8 57799999999 9999999987666799999999999999999999999999999999999998432 112239999
Q ss_pred ecCCccccccccc--------cCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~~--------s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++....... .....||+.|+|||++.+..+
T Consensus 153 DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (330)
T 2izr_A 153 DFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ 194 (330)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred EcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCC
Confidence 9999986543321 245679999999999988654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-29 Score=260.47 Aligned_cols=188 Identities=28% Similarity=0.400 Sum_probs=146.5
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc---CCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L---rHPNIVrL~G~ 871 (993)
+..++|+++++||+|+||+||+|++ +++.||||++............ ...+.+|+.+++.+ +||||++++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~niv~~~~~ 82 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRRLEAFEHPNVVRLMDV 82 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC---CHHHHHHHHHHHHHHHHCCTTBCCEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc---chhHHHHHHHHHHHhhcCCCCeEEeeee
Confidence 4467899999999999999999996 5778999999754322111100 12344566666555 59999999999
Q ss_pred EEcCCCC---cEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 872 VRDGPDG---SLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 872 f~d~s~~---~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
+...... .+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~----~~~ 157 (308)
T 3g33_A 83 CATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT----SGG 157 (308)
T ss_dssp EEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEEC----TTS
T ss_pred eeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc----CCC
Confidence 9874322 5899999995 69999998754 3389999999999999999999999999999999999998 667
Q ss_pred eEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+||+|||+++............||+.|+|||++.+..+ +.++||
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 202 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDM 202 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC-CSTHHH
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCCCC-CchHHH
Confidence 899999999987665555556789999999999987764 445553
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=270.67 Aligned_cols=181 Identities=24% Similarity=0.392 Sum_probs=153.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
...++|++++.||+|+||.||+|+.+ ++.||||++++.... .....+.+.+|+.+|+.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-----cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 45578999999999999999999984 778999999764321 11223568899999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+|+||||+.+|+|.+++.+.. .+++..++.++.||+.||+|||+.+|+||||||+|||++ .++.+||+||
T Consensus 113 --~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~g~~kL~DF 185 (350)
T 1rdq_E 113 --NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDF 185 (350)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCC
T ss_pred --CCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC----CCCCEEEccc
Confidence 578999999999999999998764 489999999999999999999999999999999999998 6679999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+++..... ....+||+.|+|||++.+..+ +.++|
T Consensus 186 g~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~D 220 (350)
T 1rdq_E 186 GFAKRVKGR--TWTLCGTPEALAPEIILSKGY-NKAVD 220 (350)
T ss_dssp TTCEECSSC--BCCCEECGGGCCHHHHTTCCB-CTHHH
T ss_pred ccceeccCC--cccccCCccccCHHHhcCCCC-CCcCC
Confidence 999876543 345679999999999987754 34444
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=255.63 Aligned_cols=179 Identities=26% Similarity=0.439 Sum_probs=152.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.+..++|++.+.||+|+||.||+|+++++.||||+++..... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWS------TRKSRDFNEECPRLRIFSHPNVLPVLGACQSP 79 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCC------HHHHHHHHHHGGGGCCCSCTTEECEEEEECTT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccC------HHHHHHHHHHHHHHHhcCCCchhheEEEEccC
Confidence 455678999999999999999999999999999999864221 12335788999999999999999999999886
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccC-ccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k-~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
..+.+++||||+++++|.+++..... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~----~~~~~~l~ 155 (271)
T 3kmu_A 80 PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID----EDMTARIS 155 (271)
T ss_dssp TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEEC----TTSCEEEE
T ss_pred CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEc----CCcceeEE
Confidence 55789999999999999999987543 4899999999999999999999999 99999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMV 988 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~t 988 (993)
|||++..... ....||+.|+|||++.+..+..
T Consensus 156 ~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~ 187 (271)
T 3kmu_A 156 MADVKFSFQS----PGRMYAPAWVAPEALQKKPEDT 187 (271)
T ss_dssp GGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGS
T ss_pred eccceeeecc----cCccCCccccChhhhccCCCCC
Confidence 9888764322 2456899999999998776544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=267.16 Aligned_cols=177 Identities=31% Similarity=0.535 Sum_probs=148.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
.+..++|++++.||+|+||.||+|++.+ +.||||+++... .....+.+.+|+.++++++||||+++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv~~ 115 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 115 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 4556789999999999999999999864 679999987532 12234578899999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------CccCHHHHHHHHHHHHHHHHHHHhC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLHGK 925 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-----------------------k~Lse~~~lkIalQIL~GLeYLHs~ 925 (993)
++++.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.
T Consensus 116 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 116 LGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEcc--CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999987 567999999999999999997642 4588999999999999999999999
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 194 ~ivH~Dlkp~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 194 KFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp TCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred CeecCCCCcceEEEC----CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC
Confidence 999999999999998 56789999999998653321 223456899999999987654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-29 Score=265.87 Aligned_cols=179 Identities=34% Similarity=0.537 Sum_probs=148.2
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
..+..++|++.+.||+|+||+||+|++. +..||||+++... .....+.+.+|+.++++++||||++++
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 116 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-------TERQRRDFLSEASIMGQFDHPNIIRLE 116 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 3456678999999999999999999983 3349999987532 122345788999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.+ .+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 117 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~ 190 (325)
T 3kul_A 117 GVVTR--GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD----SNLVC 190 (325)
T ss_dssp EEECG--GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCE
T ss_pred EEEEe--CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEC----CCCCE
Confidence 99987 4678999999999999999987766799999999999999999999999999999999999998 66799
Q ss_pred EEEecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 950 KIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 950 KLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||+|||+++...... ......+|+.|+|||++.+..+
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 231 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEE
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCC
Confidence 999999998654321 2223456889999999976543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=252.90 Aligned_cols=180 Identities=24% Similarity=0.314 Sum_probs=152.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|.++ +..||+|++....... .+.+.+|+.++++++||||+++++++.+ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--------~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 78 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--------VDRFKQEIEIMKSLDHPNIIRLYETFED--N 78 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--------HHHHHHHHHHHHhCCCCCEeeEEEEEec--C
Confidence 46999999999999999999985 4578999987643221 2467899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||+..++ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS-PDSPLKLIDFGLA 156 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEECCCTTC
T ss_pred CeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC-CCCcEEEEecccc
Confidence 77999999999999999987654 489999999999999999999999999999999999994332 6678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.............||+.|+|||++.+. .+.++||
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di 190 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDE 190 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHH
T ss_pred eeccCccchhccCCCCCccChHHhccc--CCchhhe
Confidence 877655555567799999999999765 4555553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=260.03 Aligned_cols=173 Identities=32% Similarity=0.510 Sum_probs=143.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh--cCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS--LHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~--LrHPNIVrL~G~f~ 873 (993)
....++|++++.||+|+||+||+|+++++.||||++.... ...+.+|.+++.. ++||||+++++++.
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~niv~~~~~~~ 72 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD-----------EKSWFRETELYNTVMLRHENILGFIASDM 72 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHTCCCCTTBCCEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc-----------chhhHHHHHHHHHhhccCcCeeeEEEeec
Confidence 3456789999999999999999999999999999986431 1234456666655 89999999999876
Q ss_pred cC--CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEccCC
Q 001940 874 DG--PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH--------GKNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 874 d~--s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLH--------s~gIIHRDIKPeNILLd~~d 943 (993)
.. ....+++||||+.+|+|.++++.. .+++..++.|+.||+.||.||| +.+|+||||||+|||++
T Consensus 73 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~--- 147 (301)
T 3q4u_A 73 TSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK--- 147 (301)
T ss_dssp EEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEEC---
T ss_pred cccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEc---
Confidence 52 234689999999999999999653 5899999999999999999999 99999999999999998
Q ss_pred CCCCeEEEEecCCccccccccc-----cCCCCCCCCccccccccCCc
Q 001940 944 PQRPVCKIGDLGLSKVKQQTLV-----SGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~~~~-----s~s~~GTp~YmAPEVL~Gk~ 985 (993)
.++.+||+|||+++....... .....||+.|+|||++.+..
T Consensus 148 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (301)
T 3q4u_A 148 -KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193 (301)
T ss_dssp -TTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC
T ss_pred -CCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcC
Confidence 667999999999976543321 23457999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.6e-29 Score=270.10 Aligned_cols=184 Identities=20% Similarity=0.315 Sum_probs=153.1
Q ss_pred cCCCceEEEEeccc--CceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 798 KNDDLEEVRELGSG--TYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 798 ~~ddYeile~LGeG--gFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..++|+++++||+| +||+||+|+++ ++.||||+++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 96 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC------SNEMVTFLQGELHVSKLFNHPNIVPYRATFI 96 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc------ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE
Confidence 45689999999999 99999999985 78899999986532 1234467889999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.+++|||||.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 97 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~----~~~~~kl~ 170 (389)
T 3gni_B 97 A--DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS----VDGKVYLS 170 (389)
T ss_dssp E--TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEEC
T ss_pred E--CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc----CCCCEEEc
Confidence 8 57899999999999999999764 34589999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccccc--------cccCCCCCCCCccccccccCC-ccCCCCCCC
Q 001940 953 DLGLSKVKQQT--------LVSGGVRGTLPWMAPELLSGK-SHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~--------~~s~s~~GTp~YmAPEVL~Gk-~y~tse~DI 993 (993)
|||++...... .......||+.|+|||++.+. ..++.++||
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 220 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHH
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHH
Confidence 99988643221 112234789999999999874 344455553
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=281.58 Aligned_cols=184 Identities=26% Similarity=0.364 Sum_probs=144.8
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++++.||+|+||.||+|+.. ++.||||+++...... ......+.+|+.+++.++||||++++++|.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC------------------CCCCCSCTTSCCEEEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhh-----hHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 345578999999999999999999884 7789999998653221 122346778999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+ .+|+||||||+||||+ .++.+||+
T Consensus 219 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~----~~~~~kl~ 291 (446)
T 4ejn_A 219 T--HDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD----KDGHIKIT 291 (446)
T ss_dssp E--TTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEEC----SSSCEEEC
T ss_pred e--CCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEEC----CCCCEEEc
Confidence 8 578999999999999999997654 58999999999999999999998 9999999999999998 56789999
Q ss_pred ecCCccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+|+... ........+||+.|+|||++.+..+ +.++|
T Consensus 292 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 331 (446)
T 4ejn_A 292 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 331 (446)
T ss_dssp CCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCC-CTHHH
T ss_pred cCCCceeccCCCcccccccCCccccCHhhcCCCCC-CCccc
Confidence 999998643 2233456789999999999987654 44444
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-29 Score=279.83 Aligned_cols=184 Identities=21% Similarity=0.279 Sum_probs=152.8
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|.. +++.+|+|++..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-- 81 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SARDHQKLEREARICRLLKHPNIVRLHDSISE-- 81 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC--
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE--
Confidence 35799999999999999999987 477899999986532 12234578899999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.+. ..+.+||+|||+
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~-~~~~vkL~DFG~ 159 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL-KGAAVKLADFGL 159 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS-TTCCEEECCCSS
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC-CCCcEEEccCce
Confidence 578999999999999999998764 489999999999999999999999999999999999998543 457899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++...... ......||+.|+|||++.+..+ +.++||
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DI 196 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDL 196 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHH
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCCC-CCcccc
Confidence 98765432 2345689999999999987654 345553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-29 Score=255.14 Aligned_cols=176 Identities=31% Similarity=0.557 Sum_probs=150.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.+..++|++.+.||+|+||.||+|++ +++.||||++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC---------HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 45667899999999999999999998 5677999999854321 1357899999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~Df 150 (269)
T 4hcu_A 77 --QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDF 150 (269)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----GGGCEEECCT
T ss_pred --CCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc----CCCCEEeccc
Confidence 5679999999999999999987777799999999999999999999999999999999999998 5578999999
Q ss_pred CCcccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 955 GLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 955 GLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+++...... ......||+.|+|||++.+..+
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (269)
T 4hcu_A 151 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 184 (269)
T ss_dssp TGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred cccccccccccccccCcccccccCCHHHhcCCCC
Confidence 9998654332 2234557889999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=286.35 Aligned_cols=187 Identities=26% Similarity=0.418 Sum_probs=160.1
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+..++|++.+.||+|+||.||+|++. ++.||||+++..... .....+.+.+|+.+|+.++||||+++++++
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~ 85 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-----SLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-----HTTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3455678999999999999999999984 788999999754321 111235788999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+++||||+.+++|.+++.+.. .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 86 ~~--~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~----~~~~vkL~ 158 (476)
T 2y94_A 86 ST--PSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLD----AHMNAKIA 158 (476)
T ss_dssp EC--SSEEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEC----TTCCEEEC
T ss_pred EE--CCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEe----cCCCeEEE
Confidence 88 567999999999999999997654 589999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++...........+||+.|+|||++.+..+.+.++||
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 199 (476)
T 2y94_A 159 DFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDI 199 (476)
T ss_dssp CCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHH
T ss_pred eccchhhccccccccccCCCcCeEChhhccCCCCCCCccee
Confidence 99999977655555567899999999999988776666664
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=261.09 Aligned_cols=180 Identities=33% Similarity=0.547 Sum_probs=148.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.+....|++++.||+|+||.||+|++ +++.||||+++..... ...+.+.+|+.+++.++|+||++++
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-------NHIADLKKEIEILRNLYHENIVKYK 89 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-------hhHHHHHHHHHHHHhCCCCCeeeee
Confidence 34456799999999999999999985 4677999998754211 1234688999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.......+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 90 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~ 165 (302)
T 4e5w_A 90 GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE----SEHQV 165 (302)
T ss_dssp EEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred eEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc----CCCCE
Confidence 99988555779999999999999999977766799999999999999999999999999999999999998 56799
Q ss_pred EEEecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 950 KIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 950 KLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||+|||+++...... ......||..|+|||++.+..+
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 206 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF 206 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCC
Confidence 999999998664432 2334568899999999876544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-29 Score=254.95 Aligned_cols=184 Identities=23% Similarity=0.383 Sum_probs=150.0
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
.++|++++.||+|+||+||+|++. ++.||||+++...... .....+.+|+.++..+ +||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~- 82 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS------VDEQNALREVYAHAVLGQHSHVVRYFSAWAE- 82 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS------HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc------HHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-
Confidence 357999999999999999999984 7889999988642211 1234677899999999 89999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC---------
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD--------- 943 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d--------- 943 (993)
.+.+++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++
T Consensus 83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 83 -DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred -CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 578999999999999999997642 4589999999999999999999999999999999999997432
Q ss_pred ------CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 944 ------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 944 ------~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.....+||+|||++....... ...||+.|+|||++.+....+.++||
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di 214 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADI 214 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHH
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhH
Confidence 134579999999998765432 34599999999999876555445553
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.6e-29 Score=265.99 Aligned_cols=184 Identities=26% Similarity=0.347 Sum_probs=151.9
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|++ +++.||||++......... ...+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 89 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF------PITALREIKILQLLKHENVVNLIEICRTKA 89 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSS------CHHHHHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccc------hHHHHHHHHHHHhccCCCcccHhheeeccc
Confidence 36799999999999999999998 4778999998765332211 135678999999999999999999998743
Q ss_pred ------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 877 ------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.+.+++||||+. ++|.+.+......+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+|
T Consensus 90 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~----~~~~~k 164 (351)
T 3mi9_A 90 SPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLK 164 (351)
T ss_dssp -------CEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEE
T ss_pred cccccCCceEEEEEeccC-CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc----CCCCEE
Confidence 356899999996 588888877666799999999999999999999999999999999999998 667899
Q ss_pred EEecCCccccccc-----cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQT-----LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~-----~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++..... .......||+.|+|||++.+...++.++||
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 212 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 212 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHH
Confidence 9999999865421 222455789999999999887766766664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=268.92 Aligned_cols=177 Identities=28% Similarity=0.475 Sum_probs=147.9
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVV 866 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIV 866 (993)
+..++|++.+.||+|+||.||+|++. +..||||+++... .....+.+.+|+.+|+++ +||||+
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpnIv 150 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNII 150 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-------BHHHHHHHHHHHHHHHHSCCCTTBC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-------CHHHHHHHHHHHHHHHHhcCCCCEe
Confidence 45578999999999999999999873 2349999987531 123346789999999999 899999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
+++++|.+ .+.+|+||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+++|+|||
T Consensus 151 ~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 228 (370)
T 2psq_A 151 NLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228 (370)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eEEEEEcc--CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999987 567999999999999999998643 2478899999999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 932 IKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 229 lkp~NIll~----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 282 (370)
T 2psq_A 229 LAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282 (370)
T ss_dssp CCGGGEEEC----TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC
T ss_pred cchhhEEEC----CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC
Confidence 999999998 66799999999998654322 2233457889999999987653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=256.10 Aligned_cols=185 Identities=24% Similarity=0.389 Sum_probs=147.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+|+++ ++.||||++...... .....+.+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-----SLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEecccccc-----chhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 455678999999999999999999984 788999998754211 1122357889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 82 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~~l~d 154 (276)
T 2h6d_A 82 T--PTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD----AHMNAKIAD 154 (276)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC----TTSCEEECC
T ss_pred c--CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC----CCCCEEEee
Confidence 7 578999999999999999997654 488999999999999999999999999999999999998 567899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||++.............||+.|+|||++.+..+.+.+.|
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 193 (276)
T 2h6d_A 155 FGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 193 (276)
T ss_dssp CCGGGCCCC-------------CCTGGGTTSCCCHHHHH
T ss_pred cccccccCCCcceecccCCccccCHHHHcCCCCCCccch
Confidence 999987655444445679999999999988766544554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=254.62 Aligned_cols=181 Identities=28% Similarity=0.461 Sum_probs=147.5
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC-
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP- 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s- 876 (993)
++|++++.||+|+||.||+|+. +++.||||++... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---------EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---------HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 4699999999999999999997 4788999998642 122457889999999999999999999986531
Q ss_pred ----------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 877 ----------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 877 ----------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
.+.+++||||+++++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .+
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~----~~ 152 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----ES 152 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TT
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc----CC
Confidence 3578999999999999999987766788899999999999999999999999999999999998 66
Q ss_pred CeEEEEecCCccccccc---------------cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQT---------------LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~---------------~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+||+|||+++..... .......||+.|+|||++.+....+.++||
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHH
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhH
Confidence 78999999999865321 112345699999999999877666666654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=268.24 Aligned_cols=179 Identities=28% Similarity=0.461 Sum_probs=146.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
.+..++|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-------CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 456688999999999999999999853 3569999997532 112235788999999999 7999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccC----------------------------------------------
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---------------------------------------------- 901 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k---------------------------------------------- 901 (993)
+++++.+. ...+++||||+.+|+|.+++.....
T Consensus 91 ~~~~~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 91 LLGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp EEEEECST-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeecC-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999874 3558999999999999999976532
Q ss_pred -------------------ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 902 -------------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 902 -------------------~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
.+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kl~Dfg~a~~~~~ 245 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDFGLARDIYK 245 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECCCGGGSCTTS
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc----CCCcEEEEeccceeeecc
Confidence 188899999999999999999999999999999999998 567899999999986533
Q ss_pred c---cccCCCCCCCCccccccccCCcc
Q 001940 963 T---LVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 963 ~---~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
. .......||+.|+|||++.+..+
T Consensus 246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~ 272 (359)
T 3vhe_A 246 DPDYVRKGDARLPLKWMAPETIFDRVY 272 (359)
T ss_dssp CTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred cccchhccccCCCceeEChhhhcCCCC
Confidence 2 12344568999999999976543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=267.33 Aligned_cols=186 Identities=29% Similarity=0.442 Sum_probs=145.7
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|+++++||+|+||+||+|++ +++.||||+++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 104 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE------EEGVPGTAIREVSLLKELQHRNIIELKSVIHH- 104 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEE-
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc------ccccchhHHHHHHHHHHcCCCCcceEEEEEec-
Confidence 456899999999999999999987 477899999975422 12223467789999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKLiDF 954 (993)
.+.+++||||+. ++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ ...+.+||+||
T Consensus 105 -~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 105 -NHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp -TTEEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred -CCEEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcC
Confidence 578999999996 59999997664 489999999999999999999999999999999999996443 25677999999
Q ss_pred CCccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++..... .......||+.|+|||++.+...++.++||
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 221 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDI 221 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHH
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHH
Confidence 999865432 223445689999999999887767776664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-29 Score=279.24 Aligned_cols=181 Identities=31% Similarity=0.437 Sum_probs=151.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||+||+|+.+ ++.||||++......... ...+.+|+.+|++++||||+++++++.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 93 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD------TSTILREVELLKKLDHPNIMKLFEILED--S 93 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSC------HHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchH------HHHHHHHHHHHHhCCCCCcCeEEEEEEc--C
Confidence 46999999999999999999984 778999999764332211 2467899999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ..+.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLS 171 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-TTCCEEECSCSCT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-CCCCEEEEECCcC
Confidence 78999999999999999987654 489999999999999999999999999999999999997443 5678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+...........+||+.|+|||++.+. ++.++|
T Consensus 172 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~D 204 (486)
T 3mwu_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCD 204 (486)
T ss_dssp TTBCCC----CCTTGGGGCCGGGGGSC--CCHHHH
T ss_pred eECCCCCccCCCcCCCCCCCHHHhCCC--CCchhh
Confidence 876655555567899999999999864 444444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=258.20 Aligned_cols=174 Identities=27% Similarity=0.364 Sum_probs=143.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+.+ +..||||++........ .+.+.+|+.++++++||||+++++++.+ .
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~ 92 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-------MEQIEAEIEVLKSLDHPNIIKIFEVFED--Y 92 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC-------HHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh-------HHHHHHHHHHHHhCCCchHHhHHHheec--C
Confidence 56999999999999999999984 67899999986532211 2467899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
..+++||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ..+.+||+||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~-~~~~~kl~Df 171 (285)
T 3is5_A 93 HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-PHSPIKIIDF 171 (285)
T ss_dssp SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSS-TTCCEEECCC
T ss_pred CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCC-CCCCEEEEee
Confidence 7799999999999999988643 35689999999999999999999999999999999999996433 5678999999
Q ss_pred CCccccccccccCCCCCCCCccccccccC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
|+++............||+.|+|||++.+
T Consensus 172 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 172 GLAELFKSDEHSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp CCCCC----------CTTGGGCCHHHHTT
T ss_pred ecceecCCcccCcCcccccCcCChHHhcc
Confidence 99987655544556779999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=269.16 Aligned_cols=179 Identities=30% Similarity=0.364 Sum_probs=136.3
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||+||+|+++ ++.||||+++... ..+.+.+|+.+|++++||||+++++++.+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~-- 119 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFET-- 119 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEec--
Confidence 467999999999999999999995 5679999997542 11357789999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++..+ .++.+||+|||+
T Consensus 120 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~-~~~~~kl~Dfg~ 197 (349)
T 2w4o_A 120 PTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPA-PDAPLKIADFGL 197 (349)
T ss_dssp SSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSS-TTCCEEECCCC-
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCC-CCCCEEEccCcc
Confidence 567999999999999999997654 489999999999999999999999999999999999997432 467899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
++............||+.|+|||++.+..+ +.++|
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 232 (349)
T 2w4o_A 198 SKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVD 232 (349)
T ss_dssp ---------------CGGGSCHHHHTTCCC-CTHHH
T ss_pred ccccCcccccccccCCCCccCHHHhcCCCC-Ccccc
Confidence 987665544456779999999999987654 44444
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=260.52 Aligned_cols=179 Identities=22% Similarity=0.349 Sum_probs=142.8
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|++ +++.||||+++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-----SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-----CHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 457899999999999999999997 4778999999864321 223445788999999999999999999998763
Q ss_pred CCC--cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 876 PDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 876 s~~--~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
... ..|+||||+++++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D 159 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMD 159 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTSCEEECC
T ss_pred CCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc----CCCCEEEee
Confidence 222 3599999999999999997654 489999999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 954 LGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 954 FGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||+++...... ......||+.|+|||++.+..+
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCC
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCC
Confidence 99998654321 2234569999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=277.65 Aligned_cols=182 Identities=30% Similarity=0.433 Sum_probs=148.8
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||+||+|+++ +..||||++......... ...+.+|+.+|+.++||||++++++|.+ .
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 108 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS------NSKLLEEVAVLKLLDHPNIMKLYDFFED--K 108 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CT------THHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchH------HHHHHHHHHHHHhCCCCCCCeEEEEEEe--C
Confidence 46999999999999999999984 677999999865432211 2467899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++|||||.+|+|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ..+.+||+|||++
T Consensus 109 ~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~DfG~a 186 (494)
T 3lij_A 109 RNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE-KDALIKIVDFGLS 186 (494)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC-CCCcEEEEECCCC
Confidence 78999999999999999887654 489999999999999999999999999999999999997443 4567999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...........+||+.|+|||++.+. ++.++||
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~Di 220 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRKK--YDEKCDV 220 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTTC--BCTHHHH
T ss_pred eECCCCccccccCCCcCeeCHHHHccc--CCCchhH
Confidence 877665555667899999999998643 4455553
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=254.18 Aligned_cols=178 Identities=35% Similarity=0.573 Sum_probs=148.2
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
...+..++|++++.||+|+||.||++++++ ..||||+++..... .+.+.+|+.++++++|+||+++++++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~ 88 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVC 88 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC---------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC---------HHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 345667889999999999999999999864 47999999854321 13578999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ .+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 89 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~----~~~~~kl~ 162 (283)
T 3gen_A 89 TK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVS 162 (283)
T ss_dssp CS--SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTSCEEEC
T ss_pred ec--CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEc----CCCCEEEc
Confidence 87 5679999999999999999987666799999999999999999999999999999999999998 66789999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ......+|+.|+|||++.+..+
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (283)
T 3gen_A 163 DFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 198 (283)
T ss_dssp STTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCC
T ss_pred cccccccccccccccccCCccCcccCCHHHhccCCC
Confidence 999998654332 2234457889999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=258.73 Aligned_cols=178 Identities=23% Similarity=0.324 Sum_probs=152.5
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
..++|++++.||+|+||+||+|+. +++.||||+++... .+.+.+|+.++++++ |+||+++++++.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----------hHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 457899999999999999999987 47789999987431 136789999999997 9999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
......++||||+.+++|.+++.. +++..++.|+.||+.||.|||+.+|+||||||+|||++.+ ...+||+||
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~---~~~~kl~Df 175 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHE---HRKLRLIDW 175 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT---TTEEEECCC
T ss_pred CCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCC---CCEEEEEeC
Confidence 666789999999999999998853 7889999999999999999999999999999999999822 238999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++............||..|+|||++.+....+.++||
T Consensus 176 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (330)
T 3nsz_A 176 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 214 (330)
T ss_dssp TTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHH
T ss_pred CCceEcCCCCccccccccccccChhhhcCCCcCCchhhH
Confidence 999876655555567799999999999886666666664
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=270.79 Aligned_cols=176 Identities=23% Similarity=0.351 Sum_probs=151.0
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|..+ ++.||+|++.... ......+.+|+.+|+.++||||+++++++.+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-- 119 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFED-- 119 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--
Confidence 357999999999999999999884 6779999987532 1112467899999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++.+ ..+.+||+|||+
T Consensus 120 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~~~vkL~DFG~ 197 (387)
T 1kob_A 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGL 197 (387)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC--CCCceEEEeccc
Confidence 578999999999999999998766679999999999999999999999999999999999999733 346799999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCcc
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
++............||+.|+|||++.+..+
T Consensus 198 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 227 (387)
T 1kob_A 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPV 227 (387)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCB
T ss_pred ceecCCCcceeeeccCCCccCchhccCCCC
Confidence 987655444445679999999999987654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=258.42 Aligned_cols=176 Identities=33% Similarity=0.573 Sum_probs=139.4
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
...++..++|++.++||+|+||+||+|++.+ .||||+++.... .....+.+.+|+.++++++|+||+++++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 89 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCC------CHHHHHHHHHHHHHHHhCCCCcEEEEEeec
Confidence 4556778899999999999999999998865 499999875421 123345788999999999999999999975
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. ..+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 90 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~----~~~~~kl~ 162 (289)
T 3og7_A 90 TA---PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH----EDNTVKIG 162 (289)
T ss_dssp CS---SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTTEEEEC
T ss_pred cC---CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC----CCCCEEEc
Confidence 43 568999999999999999987777799999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccccc---cccCCCCCCCCcccccccc
Q 001940 953 DLGLSKVKQQT---LVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 953 DFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~ 982 (993)
|||+++..... .......||+.|+|||++.
T Consensus 163 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp CCC------------------CCCTTCCHHHHC
T ss_pred cceeccccccccccccccccCCCccccCchhhc
Confidence 99999865432 2223457999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=253.82 Aligned_cols=183 Identities=25% Similarity=0.430 Sum_probs=135.5
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|+. +++.||||++...... .....+.+.+|+.++++++||||+++++++.+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 82 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-----KAGMVQRVQNEVKIHCQLKHPSILELYNYFED-- 82 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-----hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--
Confidence 35799999999999999999997 5788999999754221 11223578899999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~dfg~ 158 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT----RNMNIKIADFGL 158 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC----TTCCEEECCCTT
T ss_pred CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc----CCCCEEEEeecc
Confidence 5789999999999999999988767799999999999999999999999999999999999998 567899999999
Q ss_pred cccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+....... ......||+.|+|||++.+..+ +.++||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 195 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDV 195 (278)
T ss_dssp CEECC-----------------------------CTHH
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCCCC-CchhhH
Confidence 98654322 2234579999999999986643 445553
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=264.11 Aligned_cols=188 Identities=27% Similarity=0.356 Sum_probs=146.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|++. ++.||||++..................+.+|+.+|++++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 56999999999999999999884 6789999997654321111122223468899999999999999999999876
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++.++ ....+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 87 EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE-EDCLIKITDFGHS 164 (322)
T ss_dssp SSEEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-SSCCEEECCCTTC
T ss_pred CceEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC-CCCeEEEccCccc
Confidence 3489999999999999998754 3589999999999999999999999999999999999998443 3457999999999
Q ss_pred cccccccccCCCCCCCCcccccccc--CCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLS--GKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~--Gk~y~tse~D 992 (993)
+............||+.|+|||++. +....+.++|
T Consensus 165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 201 (322)
T 2ycf_A 165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 201 (322)
T ss_dssp EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHH
T ss_pred eecccccccccccCCcCccCchhhccCCCCCCCchhh
Confidence 8765544334456999999999984 2333444444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-28 Score=263.49 Aligned_cols=191 Identities=25% Similarity=0.299 Sum_probs=147.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCc---hhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKP---SERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~---~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..++|++.+.||+|+||.||+|.. +++.||||++......... .......+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 457899999999999999999987 4778999998764332211 122334567899999999999999999999986
Q ss_pred cC---CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 874 DG---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 874 d~---s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.. ....+++||||+. ++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~----~~~~~k 174 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA----DNNDIT 174 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEE
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEc----CCCCEE
Confidence 52 2346899999996 789998887766799999999999999999999999999999999999998 667899
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++............||+.|+|||++.+....+.++||
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 217 (362)
T 3pg1_A 175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDM 217 (362)
T ss_dssp ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHH
T ss_pred EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHH
Confidence 9999999866555445566799999999999876666666654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-28 Score=259.27 Aligned_cols=187 Identities=25% Similarity=0.356 Sum_probs=153.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+.+ ++.||||+++......... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 56999999999999999999984 7789999998654322111 0112468899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.++.....+||+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 78999999999999999997653 58999999999999999999999999999999999999844322237999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+............||+.|+|||++.+..+ +.++|
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 200 (321)
T 2a2a_A 167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEAD 200 (321)
T ss_dssp EECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHH
T ss_pred eecCccccccccCCCCCccCcccccCCCC-CCccc
Confidence 87765544556679999999999987654 33444
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-28 Score=271.29 Aligned_cols=183 Identities=34% Similarity=0.582 Sum_probs=152.5
Q ss_pred hccccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 792 ~~i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
.....+..++|++++.||+|+||.||+|+++++.||||+++... ..+.|.+|+.+|++++||||++++++
T Consensus 185 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 185 RSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp HTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEE
Confidence 34456777899999999999999999999999999999997542 12468899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccC-ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k-~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+... .+.+++|||||.+|+|.+++..... .+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+|
T Consensus 255 ~~~~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~k 329 (450)
T 1k9a_A 255 IVEE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAK 329 (450)
T ss_dssp EECT-TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTSCEE
T ss_pred EEcC-CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEC----CCCCEE
Confidence 8763 3479999999999999999987654 368999999999999999999999999999999999998 667999
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+|||+++...... ....+|+.|+|||++.+..+ +.++|
T Consensus 330 l~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~sD 368 (450)
T 1k9a_A 330 VSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF-STKSD 368 (450)
T ss_dssp ECCCTTCEECC--------CCCTTTSCHHHHHSSCC-CHHHH
T ss_pred EeeCCCcccccccc--cCCCCCcceeCHHHhcCCCC-CcHHH
Confidence 99999998654332 22367899999999987653 33444
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=277.98 Aligned_cols=180 Identities=23% Similarity=0.338 Sum_probs=143.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|++. ++.||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG------GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc------cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 478999999999999999999884 7789999997542 12233457889999999999999999999997632
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+||||||+.+ +|.+.+.. .+++..+..|+.||+.||+|||+.+|+||||||+|||++ .++.+||+
T Consensus 135 ~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~----~~~~~kl~ 206 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 206 (464)
T ss_dssp STTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred ccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEe----CCCCEEEE
Confidence 2467999999954 57776643 388999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+...........+||+.|+|||++.+..+ +.++||
T Consensus 207 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 246 (464)
T 3ttj_A 207 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDI 246 (464)
T ss_dssp CCCCC-----CCCC----CCCTTCCHHHHTTCCC-CTTHHH
T ss_pred EEEeeeecCCCcccCCCcccccccCHHHHcCCCC-CHHHHH
Confidence 9999997766555566789999999999998754 455554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=253.17 Aligned_cols=183 Identities=18% Similarity=0.264 Sum_probs=152.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|++.+.||+|+||.||+|+. +++.||||++...... +.+.+|+.+++.+ +|+||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----------HHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 45667899999999999999999996 5788999998754221 2466789999999 799999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKL 951 (993)
.+ ....++||||+ +++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ .....+||
T Consensus 76 ~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 76 QE--GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EE--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred CC--CceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 87 57899999999 9999999987766799999999999999999999999999999999999998543 23456999
Q ss_pred EecCCcccccccc--------ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 952 GDLGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 952 iDFGLAk~~~~~~--------~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+|||+++...... ......||+.|+|||++.+..+ +.++|
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 200 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDD 200 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHH
Confidence 9999998654432 1345679999999999987654 33444
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-29 Score=266.22 Aligned_cols=180 Identities=30% Similarity=0.475 Sum_probs=144.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|++. ++.||||+++...... ....+.+|+.++++++||||+++++++.+ .
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~ 72 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG-------APCTAIREVSLLKDLKHANIVTLHDIIHT--E 72 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--S
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccc-------cchhHHHHHHHHHhcCCCCCCeeeeEEee--C
Confidence 57999999999999999999984 7789999987542111 11134578999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+. ++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 73 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 73 KSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLIN----ERGELKLADFGLA 147 (324)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEEC----TTCCEEECSSSEE
T ss_pred CEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEEC----CCCCEEEccCccc
Confidence 67999999996 699999988777799999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......||+.|+|||++.+...++.++||
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 184 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDM 184 (324)
T ss_dssp ECC------------CGGGCCHHHHTTCCCCCTHHHH
T ss_pred ccccCCccccccccCcccccChhhhcCCCCCCcHHHH
Confidence 865432 223445789999999999887666666664
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.3e-28 Score=263.87 Aligned_cols=177 Identities=23% Similarity=0.356 Sum_probs=152.7
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s 876 (993)
++|++.+.||+|+||.||+|+++ ++.||||++................+.+.+|+.+++++ +||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 46999999999999999999984 78899999986543323333344566788999999999 79999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+|||+
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~----~~~~ikl~DfG~ 246 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD----DNMQIRLSDFGF 246 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC----CCCCEEEEecCc
Confidence 578999999999999999997653 489999999999999999999999999999999999998 667899999999
Q ss_pred ccccccccccCCCCCCCCccccccccC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
+.............||+.|+|||++.+
T Consensus 247 ~~~~~~~~~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 247 SCHLEPGEKLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred ccccCCCcccccCCCCCCccChhhccc
Confidence 987765555556789999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=265.83 Aligned_cols=178 Identities=30% Similarity=0.510 Sum_probs=149.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg---------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNI 865 (993)
.+..++|++.+.||+|+||+||+|++.+ ..||||+++... .....+.+.+|+.+++++ +||||
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hpnI 137 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 137 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-------CHHHHHHHHHHHHHHHHhcCCchh
Confidence 4556789999999999999999998742 459999987541 123345788999999999 89999
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
+++++++.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||
T Consensus 138 v~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 215 (382)
T 3tt0_A 138 INLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 215 (382)
T ss_dssp CCEEEEECS--SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred hhheeeecc--CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 999999987 567999999999999999998653 348999999999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||||+||||+ .++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 216 Dlkp~NIll~----~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 270 (382)
T 3tt0_A 216 DLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270 (382)
T ss_dssp CCCGGGEEEC----TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred CCCcceEEEc----CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence 9999999998 66789999999998654322 2334567899999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-28 Score=267.40 Aligned_cols=180 Identities=23% Similarity=0.340 Sum_probs=152.8
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
...++|++.++||+|+||+||+|++. ++.||||+++....... .+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC-------HHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch-------HHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 45678999999999999999999985 78899999986433221 2456789999999999999999999988
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccC--ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k--~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.....+++||||+.+++|.+++..... .+++..++.|+.||+.||.|||+.+|+||||||+|||+...+...+.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 655688999999999999999976432 389999999999999999999999999999999999983332266789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
|||+++............||+.|+|||++.+
T Consensus 159 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 159 DFGAARELEDDEQFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp CGGGCEECCCGGGSSCSSSCCTTCCHHHHHH
T ss_pred cCCCceEccCCCccccccCCccccCHHHhhc
Confidence 9999997766555556789999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=260.11 Aligned_cols=183 Identities=20% Similarity=0.307 Sum_probs=151.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-----CCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----HPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-----HPNIVrL 868 (993)
.+..++|+++++||+|+||+||+|++ +++.||||+++.. ......+..|+.+++.+. ||||+++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---------KKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---------HHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---------hhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34567899999999999999999998 5778999998742 112345677999999987 9999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC----
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD---- 943 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d---- 943 (993)
++++.. .+.+++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++...
T Consensus 102 ~~~~~~--~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 102 HGKFMY--YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEEE--TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEE
T ss_pred cceeeE--CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccc
Confidence 999998 57899999999 999999998654 3589999999999999999999999999999999999997311
Q ss_pred -----------------CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 944 -----------------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 944 -----------------~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...+.+||+|||+++..... .....||+.|+|||++.+..+ +.++||
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di 242 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGW-DVSSDM 242 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCC-CTTHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCC-CCccch
Confidence 12678999999999865443 345679999999999988764 455554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=250.89 Aligned_cols=182 Identities=30% Similarity=0.501 Sum_probs=140.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.+..++|++.+.||+|+||.||+|+++++.||||+++...... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 77 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDED----ISQTIENVRQEAKLFAMLKHPNIIALRGVCLK- 77 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCccc----HHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3566889999999999999999999999999999987543211 12234578899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCCEEEccCCC----CCCe
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN---IVHFDLKCENLLVNMRDP----QRPV 948 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g---IIHRDIKPeNILLd~~d~----e~g~ 948 (993)
.+.+++||||+.+++|.+++.. ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.... ..+.
T Consensus 78 -~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~ 154 (271)
T 3dtc_A 78 -EPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154 (271)
T ss_dssp -C--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred -CCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence 5678999999999999999864 35899999999999999999999998 999999999999984321 2578
Q ss_pred EEEEecCCccccccccccCCCCCCCCccccccccCCcc
Q 001940 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+||+|||+++....... ....||+.|+|||++.+..+
T Consensus 155 ~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~ 191 (271)
T 3dtc_A 155 LKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRASMF 191 (271)
T ss_dssp EEECCCCC--------------CCGGGSCHHHHHHCCC
T ss_pred eEEccCCcccccccccc-cCCCCccceeCHHHhccCCC
Confidence 99999999986544322 24579999999999976543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=249.83 Aligned_cols=187 Identities=26% Similarity=0.403 Sum_probs=150.1
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|++. ++.||||+++......... ....+.+.+|+.++++++||||+++++++.+ .
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~ 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRR--GVSREEIEREVNILREIRHPNIITLHDIFEN--K 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhcccccccc--chHHHHHHHHHHHHHhCCCCCeeehhheecC--C
Confidence 56999999999999999999985 7789999998654332111 0112468899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++.++.....+||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 67999999999999999997654 48999999999999999999999999999999999999854434458999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
.............||+.|+|||++.+..+ +.++|
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 193 (283)
T 3bhy_A 160 HKIEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEAD 193 (283)
T ss_dssp EECC--------CCCGGGCCHHHHTTCCC-CTHHH
T ss_pred eeccCCCcccccCCCcCccCcceecCCCC-Ccchh
Confidence 87655444455679999999999987653 33444
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=276.87 Aligned_cols=189 Identities=33% Similarity=0.454 Sum_probs=151.5
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCC-----chhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGK-----PSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k-----~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
.++|+++++||+|+||+||+|+.+ ++.||||++........ ....+...+.+.+|+.+|++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999984 67799999986543211 00111224578899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.+ ...+++|||||.+|+|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ ....+||
T Consensus 115 ~~~--~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl 190 (504)
T 3q5i_A 115 FED--KKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN-SLLNIKI 190 (504)
T ss_dssp EEC--SSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-CCSSEEE
T ss_pred EEc--CCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-CCccEEE
Confidence 987 578999999999999999997654 489999999999999999999999999999999999998443 3357999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++...........+||+.|+|||++.+. ++.++||
T Consensus 191 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di 230 (504)
T 3q5i_A 191 VDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK--YNEKCDV 230 (504)
T ss_dssp CCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC--BCTHHHH
T ss_pred EECCCCEEcCCCCccccccCCcCCCCHHHhccC--CCchHHH
Confidence 999999877665555667899999999998753 4555553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=258.09 Aligned_cols=179 Identities=31% Similarity=0.502 Sum_probs=151.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.+..++|++++.||+|+||.||+|++ .++.||||++.... ....+.+.+|+.++++++|+||++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~i~~~~ 90 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--------PDQQRDFQREIQILKALHSDFIVKYR 90 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC--------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC--------HHHHHHHHHHHHHHHhcCCCceeEEE
Confidence 35567899999999999999999985 36679999987531 12235688999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.......+++||||+++++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~----~~~~~ 166 (327)
T 3lxl_A 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE----SEAHV 166 (327)
T ss_dssp EEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred EEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC----CCCCE
Confidence 99986556789999999999999999987666799999999999999999999999999999999999998 56789
Q ss_pred EEEecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 950 KIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 950 KLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||+|||+++...... ......||+.|+|||++.+..+
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 207 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCC
Confidence 999999998654322 2234568899999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=265.75 Aligned_cols=171 Identities=23% Similarity=0.338 Sum_probs=141.8
Q ss_pred eEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 803 EEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
...+.||+|+||.||+|+. +++.||||+++.... ...+.+.+|+.+|++++||||+++++++.+ .+.+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 161 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--------KDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDI 161 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSH--------HHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEE
Confidence 3467899999999999988 477899999985421 123578899999999999999999999988 5789
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
+|||||+++++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||+..+ ..+.+||+|||+++..
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR--DAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET--TTTEEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC--CCCcEEEEeCCCceec
Confidence 99999999999999998766678999999999999999999999999999999999999532 4578999999999977
Q ss_pred ccccccCCCCCCCCccccccccCCc
Q 001940 961 QQTLVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 961 ~~~~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
..........||+.|+|||++.+..
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~ 264 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDF 264 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCB
T ss_pred CCccccccccCCCcEeChhhccCCC
Confidence 6555455567999999999997654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=253.71 Aligned_cols=174 Identities=31% Similarity=0.455 Sum_probs=133.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++++.||+|+||+||+|++ +++.||||+++.... .....+.+.++..+++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN------SQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C------HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC------cHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 34567899999999999999999998 578899999875421 1222334555666788999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+ .+.+++||||+. ++|.+++.. ....+++..++.|+.||+.||.|||++ +|+||||||+|||++ .++.+
T Consensus 77 ~--~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~ 149 (290)
T 3fme_A 77 R--EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN----ALGQV 149 (290)
T ss_dssp C--SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEEC----TTCCE
T ss_pred c--cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC----CCCCE
Confidence 7 567999999996 588887764 345699999999999999999999998 999999999999998 56789
Q ss_pred EEEecCCccccccccccCCCCCCCCcccccccc
Q 001940 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
||+|||+++............||+.|+|||++.
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 150 KMCDFGISGYLVDDVAKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp EBCCC---------------CCCCCCSCHHHHS
T ss_pred EEeecCCcccccccccccccCCCccccChhhcC
Confidence 999999998766554445567999999999973
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=250.59 Aligned_cols=178 Identities=26% Similarity=0.302 Sum_probs=151.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCC-CchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAG-KPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~-k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~ 873 (993)
..++|++.+.||+|+||.||+|+++ ++.||||+++...... .........+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999984 6789999997653211 11223344567889999999996 999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. .+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 95 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~d 167 (298)
T 1phk_A 95 T--NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTD 167 (298)
T ss_dssp C--SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECC
T ss_pred c--CCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEc----CCCcEEEec
Confidence 7 578999999999999999997653 589999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCcccccccc
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
||++.............||+.|+|||++.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 168 FGFSCQLDPGEKLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred ccchhhcCCCcccccccCCccccCHHHhc
Confidence 99998766554455677999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=268.35 Aligned_cols=182 Identities=29% Similarity=0.489 Sum_probs=149.0
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
..+..++|++++.||+|+||+||+|++. +..||||+++... .......+.+|+.++++++||||++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~ 138 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNIVR 138 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-------ChhhHHHHHHHHHHHHhCCCCCCCe
Confidence 4456678999999999999999999863 4469999986431 1122346888999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
+++++.+ .+..++||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++.
T Consensus 139 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 216 (367)
T 3l9p_A 139 CIGVSLQ--SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216 (367)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEec--CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEec
Confidence 9999987 567899999999999999998653 34889999999999999999999999999999999999985
Q ss_pred CCCCCCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCcc
Q 001940 942 RDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 942 ~d~e~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
++ ....+||+|||+++..... .......||+.|+|||++.+..+
T Consensus 217 ~~-~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 263 (367)
T 3l9p_A 217 PG-PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 263 (367)
T ss_dssp SS-TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC
T ss_pred CC-CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC
Confidence 44 4557999999999854322 12234568999999999976543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=264.50 Aligned_cols=180 Identities=22% Similarity=0.280 Sum_probs=148.4
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||+||+|++ +++.||||++..... ...+|+.+|+.++||||++++++|...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheeeec
Confidence 457899999999999999999988 478899999875421 123689999999999999999998542
Q ss_pred ------------------------------------CCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHH
Q 001940 876 ------------------------------------PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAA 916 (993)
Q Consensus 876 ------------------------------------s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL 916 (993)
....+++||||+. ++|.+++.. ....+++..++.|+.||+
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~ 151 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF 151 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence 2345899999996 688877763 345689999999999999
Q ss_pred HHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 917 ~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.||.|||+.||+||||||+|||++. .++.+||+|||+|+............||+.|+|||++.+...++.++||
T Consensus 152 ~aL~~LH~~gi~H~Dikp~Nil~~~---~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (383)
T 3eb0_A 152 RAVGFIHSLGICHRDIKPQNLLVNS---KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDL 225 (383)
T ss_dssp HHHHHHHTTTEECSCCCGGGEEEET---TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred HHHHHHHHCcCccCccCHHHEEEcC---CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence 9999999999999999999999972 3578999999999977655555567799999999999987777777664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=252.44 Aligned_cols=177 Identities=29% Similarity=0.480 Sum_probs=149.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc--
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD-- 874 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d-- 874 (993)
..+|++++.||+|+||.||+|++. ++.||||+++... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 356999999999999999999985 7889999997542 145689999999999999999998864
Q ss_pred ------------CCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 875 ------------GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 875 ------------~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
.....+++||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~- 156 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV- 156 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc-
Confidence 1134589999999999999999764 35689999999999999999999999999999999999998
Q ss_pred CCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 942 RDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 942 ~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
.++.+||+|||+++............||+.|+|||++.+..+ +.++|
T Consensus 157 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 203 (284)
T 2a19_B 157 ---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVD 203 (284)
T ss_dssp ---ETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHH
T ss_pred ---CCCCEEECcchhheeccccccccccCCcccccChhhhccCCC-cchhh
Confidence 567899999999987665544455679999999999987654 33444
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=290.61 Aligned_cols=184 Identities=21% Similarity=0.313 Sum_probs=152.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
.+..++|+++++||+|+||+||+|+++ ++.||||++++..... ....+.+..|..+|..+ +|++|+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~-----~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ-----DDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-----TTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-----HHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 345678999999999999999999985 5679999998643211 11234677888999887 699999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
++ .+.+||||||+.+|+|.++|.... .+++..++.|+.||+.||+|||+.+||||||||+||||+ .++.+||+
T Consensus 412 ~~--~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~----~~g~ikL~ 484 (674)
T 3pfq_A 412 QT--MDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD----SEGHIKIA 484 (674)
T ss_dssp BC--SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEEC----SSSCEEEC
T ss_pred Ee--CCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEc----CCCcEEEe
Confidence 87 578999999999999999998764 489999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccc-cccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQ-QTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~-~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+|+... ........+||+.|||||++.+..+ +.++|
T Consensus 485 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~D 524 (674)
T 3pfq_A 485 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVD 524 (674)
T ss_dssp CCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCB-STHHH
T ss_pred ecceeeccccCCcccccccCCCcccCHhhhcCCCC-Cccce
Confidence 999998642 3334556789999999999988765 44444
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=276.37 Aligned_cols=185 Identities=29% Similarity=0.417 Sum_probs=154.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|+.+ ++.||||++.......... .+.+.+|+.+|++++||||+++++++.+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~- 97 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-----KESLLREVQLLKQLDHPNIMKLYEFFED- 97 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSC-----HHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchH-----HHHHHHHHHHHHhCCCCCCCcEEEEEEe-
Confidence 3457999999999999999999984 7789999997654322111 2468899999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ..+.+||+|||
T Consensus 98 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~~~~kl~Dfg 174 (484)
T 3nyv_A 98 -KGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS-KDANIRIIDFG 174 (484)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCTT
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCC-CCCcEEEEeee
Confidence 578999999999999999997654 489999999999999999999999999999999999996433 56789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++............||+.|+|||++.+. ++.++||
T Consensus 175 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~Di 210 (484)
T 3nyv_A 175 LSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDV 210 (484)
T ss_dssp HHHHBCCCCSHHHHTTGGGTCCHHHHHTC--CCTHHHH
T ss_pred eeEEcccccccccCCCCccccCceeecCC--CCCccee
Confidence 99876554444456799999999999773 4455553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-29 Score=269.23 Aligned_cols=187 Identities=22% Similarity=0.350 Sum_probs=150.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~ 869 (993)
.+..++|++++.||+|+||.||+|+. +++.||||+++.......... .+.+.+|+.+|+.+ +|+||++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~E~~~l~~l~~h~~iv~~~ 125 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT----TEHTRTERQVLEHIRQSPFLVTLH 125 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESS----GGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhH----HHHHHHHHHHHHHccCCCceeEEE
Confidence 34457899999999999999999988 577899999876432111111 12456788999999 699999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.. .+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 126 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~ 198 (355)
T 1vzo_A 126 YAFQT--ETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHV 198 (355)
T ss_dssp EEEEE--TTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCE
T ss_pred EEEee--CceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC----CCCcE
Confidence 99988 578999999999999999998654 489999999999999999999999999999999999998 66789
Q ss_pred EEEecCCccccccc--cccCCCCCCCCccccccccCCc-cCCCCCCC
Q 001940 950 KIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKS-HMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~--~~s~s~~GTp~YmAPEVL~Gk~-y~tse~DI 993 (993)
||+|||+++..... ......+||+.|+|||++.+.. ..+.++||
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dv 245 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 245 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhH
Confidence 99999999865332 2233567999999999998643 34444453
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=251.91 Aligned_cols=183 Identities=27% Similarity=0.445 Sum_probs=149.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||+||+|+++ +..||||++..... ........+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-----chhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 345678999999999999999999885 55799999875421 11222356889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 80 ~--~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~----~~~~~~l~D 152 (279)
T 3fdn_A 80 D--ATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIAD 152 (279)
T ss_dssp C--SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEEC----TTSCEEECS
T ss_pred c--CCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEc----CCCCEEEEe
Confidence 7 577999999999999999997654 489999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||++....... .....||+.|+|||++.+..+ +.+.|
T Consensus 153 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~D 189 (279)
T 3fdn_A 153 FGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMH-DEKVD 189 (279)
T ss_dssp CCEESCC---------CCCCTTCCHHHHTTCCC-CTTHH
T ss_pred ccccccCCccc-ccccCCCCCccCHhHhccCCC-Cccch
Confidence 99987554332 234579999999999987644 34444
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-28 Score=267.06 Aligned_cols=189 Identities=16% Similarity=0.224 Sum_probs=147.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHH------HHHHHHHHHHHHHhhcCCC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERE------RLIADFWKEALLLSSLHHP 863 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere------~~ie~f~rEi~ILr~LrHP 863 (993)
+..++|++.+.||+|+||.||+|.++ ++.||||++..... ...++ .....+.+|+..++.++|+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 45678999999999999999999884 36799999875421 01111 0112345667788899999
Q ss_pred CcceEEEEEEcCCC--CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 864 NVVSFYGIVRDGPD--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 864 NIVrL~G~f~d~s~--~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
||+++++++..... ..++|||||+ +++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++.
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 99999999876322 4589999999 99999999887677999999999999999999999999999999999999973
Q ss_pred CCCCCCeEEEEecCCccccccccc--------cCCCCCCCCccccccccCCccCCCCCC
Q 001940 942 RDPQRPVCKIGDLGLSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 942 ~d~e~g~VKLiDFGLAk~~~~~~~--------s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
. ..+.+||+|||+++....... .....||+.|||||++.+..+ +.++|
T Consensus 188 ~--~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 243 (364)
T 3op5_A 188 K--NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGD 243 (364)
T ss_dssp S--CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHH
T ss_pred C--CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-Cchhh
Confidence 3 357899999999986543321 134459999999999987764 34444
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=269.08 Aligned_cols=177 Identities=31% Similarity=0.527 Sum_probs=149.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+|+++ ++.||||+++... .....+.|.+|+.+|++++||||+++++++.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-------PPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-------CHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-------CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 345678999999999999999999995 7789999987431 1223346889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. .+.+++||||+++|+|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 183 ~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~----~~~~~kl~D 256 (377)
T 3cbl_A 183 Q--KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT----EKNVLKISD 256 (377)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECC
T ss_pred c--CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEc----CCCcEEECc
Confidence 7 5679999999999999999987766789999999999999999999999999999999999998 667999999
Q ss_pred cCCcccccccccc---CCCCCCCCccccccccCCc
Q 001940 954 LGLSKVKQQTLVS---GGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 954 FGLAk~~~~~~~s---~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+++........ ....+|+.|+|||++.+..
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence 9999865433211 1223577899999987554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=265.66 Aligned_cols=185 Identities=26% Similarity=0.377 Sum_probs=146.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|++. ++.||||+++...... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH-- 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcch---hhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee--
Confidence 467999999999999999999884 7789999987543211 111223467799999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+ +|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~----~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGG
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEc----CCCCEEEEeccc
Confidence 5679999999965 89999987766788999999999999999999999999999999999998 667899999999
Q ss_pred ccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++..... .......||+.|+|||++.+...++.++||
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 196 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 196 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHH
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhh
Confidence 9876432 233456799999999999876655555553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=263.25 Aligned_cols=179 Identities=27% Similarity=0.494 Sum_probs=150.1
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+.|++++.||+|+||+||+|+. +++.||||++..... ......+.+.+|+.++++++||||+++++++.+ .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 126 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--E 126 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--C
Confidence 4589999999999999999987 477899999875421 122334678899999999999999999999988 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+. |+|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~kL~DfG~a 201 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSA 201 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTC
T ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----CCCCEEEeeccCc
Confidence 78999999996 789888876666799999999999999999999999999999999999998 6679999999999
Q ss_pred cccccccccCCCCCCCCccccccccC--CccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSG--KSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~G--k~y~tse~DI 993 (993)
+..... ....||+.|+|||++.+ ....+.++||
T Consensus 202 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 236 (348)
T 1u5q_A 202 SIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDV 236 (348)
T ss_dssp BSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHH
T ss_pred eecCCC---CcccCCcceeCHhhhccccCCCCCcHHHH
Confidence 866432 34679999999999863 3334444553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=256.83 Aligned_cols=174 Identities=31% Similarity=0.540 Sum_probs=142.0
Q ss_pred CCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh--cCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS--LHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~--LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|+++++.||||++.... . ..+.+|..++.. ++|+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-------~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-------E----ASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-------H----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-------c----chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3579999999999999999999999999999986431 1 133445555544 48999999999998742
Q ss_pred C--CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCCEEEccCCCCC
Q 001940 877 D--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK--------NIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 877 ~--~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~--------gIIHRDIKPeNILLd~~d~e~ 946 (993)
. ..+++||||+.+++|.++++.. .+++..++.|+.||+.||.|||+. +|+||||||+|||++ .+
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~----~~ 178 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK----KN 178 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC----TT
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC----CC
Confidence 2 6789999999999999999764 489999999999999999999998 999999999999998 56
Q ss_pred CeEEEEecCCccccccccc-----cCCCCCCCCccccccccCCccCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLV-----SGGVRGTLPWMAPELLSGKSHMVT 989 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~-----s~s~~GTp~YmAPEVL~Gk~y~ts 989 (993)
+.+||+|||+++....... .....||+.|+|||++.+..+...
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 226 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNH 226 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCcc
Confidence 7899999999976533221 234579999999999987655443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=262.09 Aligned_cols=178 Identities=25% Similarity=0.432 Sum_probs=143.7
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--Ccc----eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~----VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
..+..++|++++.||+|+||+||+|++. ++. ||+|++........ .+.+.+|+.++++++||||+++
T Consensus 8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~ 80 (325)
T 3kex_A 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQS-------FQAVTDHMLAIGSLDHAHIVRL 80 (325)
T ss_dssp CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSC-------BCSCCHHHHHHHTCCCTTBCCE
T ss_pred hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHH-------HHHHHHHHHHHhcCCCCCcCeE
Confidence 3456789999999999999999999884 444 67777654321111 1246678999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
++++.+ +.+++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.
T Consensus 81 ~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~----~~~~ 153 (325)
T 3kex_A 81 LGLCPG---SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK----SPSQ 153 (325)
T ss_dssp EEEECB---SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEES----SSSC
T ss_pred EEEEcC---CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEEC----CCCe
Confidence 999864 568999999999999999987666789999999999999999999999999999999999998 5678
Q ss_pred EEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 949 CKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 154 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (325)
T 3kex_A 154 VQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194 (325)
T ss_dssp EEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC
T ss_pred EEECCCCcccccCcccccccccCCCCcccccChHHhccCCC
Confidence 9999999998764332 2234568889999999976543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-28 Score=252.74 Aligned_cols=177 Identities=28% Similarity=0.514 Sum_probs=138.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
.+..++|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.++++++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 455678999999999999999999884 2348999876431 1233457889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++.+ +.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 84 ~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~k 156 (281)
T 1mp8_A 84 VITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVK 156 (281)
T ss_dssp EECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEE
T ss_pred EEcc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC----CCCCEE
Confidence 9854 568999999999999999987766799999999999999999999999999999999999998 567999
Q ss_pred EEecCCccccccccc--cCCCCCCCCccccccccCCcc
Q 001940 951 IGDLGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 951 LiDFGLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+|||+++....... .....+|+.|+|||++.+..+
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCC
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCC
Confidence 999999987644322 223457889999999976543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=266.69 Aligned_cols=180 Identities=24% Similarity=0.379 Sum_probs=146.2
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|.+ +++.||||++..... .....+++.+|+.+|+.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc------CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 46899999999999999999998 478899999865321 1233457889999999999999999999998632
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ..+|+||||+ +++|.+++... .+++..+..|+.||+.||.|||+.||+||||||+|||++ .++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~ 170 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 170 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEc----CCCCEEEE
Confidence 1 3579999999 89999999763 488999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....||+.|+|||++.+...++.++||
T Consensus 171 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 209 (367)
T 1cm8_A 171 DFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDI 209 (367)
T ss_dssp CCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHH
T ss_pred eeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhH
Confidence 99999876543 3456799999999999886666666664
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-28 Score=250.37 Aligned_cols=182 Identities=26% Similarity=0.328 Sum_probs=152.4
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||++++. ++.||+|++....... ....+.+.+|+.+++.++|+||+++++++.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-----PHQREKMSMEISIHRSLAHQHVVGFHGFFED- 86 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccC-----HHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-
Confidence 4567999999999999999999985 6779999987653321 2234578899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 87 -~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg 160 (294)
T 2rku_A 87 -NDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFG 160 (294)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCCT
T ss_pred -CCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEc----CCCCEEEEecc
Confidence 578999999999999999987654 589999999999999999999999999999999999998 66789999999
Q ss_pred Cccccccc-cccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++..... .......||+.|+|||++.+..+ +.+.|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 197 (294)
T 2rku_A 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVD 197 (294)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHTTSCB-CTHHH
T ss_pred CceecccCccccccccCCCCcCCcchhccCCC-Cchhh
Confidence 99865432 23345679999999999987654 33444
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-28 Score=267.16 Aligned_cols=179 Identities=23% Similarity=0.288 Sum_probs=138.9
Q ss_pred CCCceEE-EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHH-hhcCCCCcceEEEEEEc
Q 001940 799 NDDLEEV-RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 799 ~ddYeil-e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~IL-r~LrHPNIVrL~G~f~d 874 (993)
.++|.+. +.||+|+||+||+|.++ ++.||||+++.. ..+.+|+.++ +.++||||++++++|..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 3567777 78999999999999884 678999998642 1455777776 45689999999999864
Q ss_pred --CCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 875 --GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 875 --~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
.....+|||||||.+|+|.++|.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ .++.+||
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~~~~kl 205 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKL 205 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-TTCCEEE
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-CCccEEE
Confidence 22457899999999999999998653 4589999999999999999999999999999999999998432 3688999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+|||+++...........+||+.|+|||++.+..+ +.++|
T Consensus 206 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 245 (400)
T 1nxk_A 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCD 245 (400)
T ss_dssp CCCTTCEECC-----------CTTCCGGGSCCCCS-SSHHH
T ss_pred EecccccccCCCCccccCCCCCCccCHhhcCCCCC-CCccc
Confidence 99999987655444456789999999999987654 34444
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=252.93 Aligned_cols=179 Identities=29% Similarity=0.431 Sum_probs=148.9
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
...+..++|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.++++++||||+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-------SPSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-------CHHHHHHHHHHHHHHhhCCCCcee
Confidence 33456778999999999999999999872 3569999987432 122345788999999999999999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------CccCHHHHHHHHHHHHHHHHHHH
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLH 923 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-----------------------k~Lse~~~lkIalQIL~GLeYLH 923 (993)
++++++.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||
T Consensus 90 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 167 (314)
T 2ivs_A 90 KLYGACSQ--DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA 167 (314)
T ss_dssp CEEEEECS--SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEec--CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH
Confidence 99999987 567999999999999999998643 23889999999999999999999
Q ss_pred hCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 924 GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 924 s~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+.+|+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+..
T Consensus 168 ~~~ivH~dikp~NIli~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 168 EMKLVHRDLAARNILVA----EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp HTTEECCCCSGGGEEEE----TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred HCCCcccccchheEEEc----CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 99999999999999998 66789999999998654322 223445788999999987654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.2e-28 Score=257.40 Aligned_cols=182 Identities=26% Similarity=0.328 Sum_probs=152.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
...+|++.+.||+|+||.||++++. ++.||+|++....... ....+.+.+|+.+++.++|+||+++++++.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 112 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-----PHQREKMSMEISIHRSLAHQHVVGFHGFFED- 112 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCS-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcC-----HHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 4567999999999999999999985 6679999988653321 2234578899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 113 -~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~Dfg 186 (335)
T 2owb_A 113 -NDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN----EDLEVKIGDFG 186 (335)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCT
T ss_pred -CCeEEEEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc----CCCCEEEeecc
Confidence 578999999999999999987654 589999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccc-cccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++..... .......||+.|+|||++.+..+ +.+.|
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 223 (335)
T 2owb_A 187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVD 223 (335)
T ss_dssp TCEECCSTTCCBCCCCSCCSSCCHHHHHTSCB-CTHHH
T ss_pred CceecccCcccccccCCCccccCHHHhccCCC-Cchhh
Confidence 99865432 23345679999999999987654 33444
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.6e-28 Score=259.23 Aligned_cols=185 Identities=26% Similarity=0.323 Sum_probs=149.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
....++|++++.||+|+||.||+|++. ++.||||++..... .....+.+.+|+.++++++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 94 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD------DKMVKKIAMREIKLLKQLRHENLVNLLEVCK 94 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC------chHHHHHHHHHHHHHhhCCCCCEeeEEEEee
Confidence 344578999999999999999999985 77899999875421 1223356789999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 95 ~--~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~----~~~~~kl~D 167 (331)
T 4aaa_A 95 K--KKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS----QSGVVKLCD 167 (331)
T ss_dssp E--TTEEEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECC
T ss_pred c--CCEEEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc----CCCcEEEEe
Confidence 8 578999999999999988876543 489999999999999999999999999999999999998 667999999
Q ss_pred cCCccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++..... .......||+.|+|||++.+....+.++||
T Consensus 168 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 208 (331)
T 4aaa_A 168 FGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDV 208 (331)
T ss_dssp CTTC------------CCCCCTTCCHHHHTTCTTCCTHHHH
T ss_pred CCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHH
Confidence 9999865432 233456799999999999887666666664
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=283.86 Aligned_cols=185 Identities=25% Similarity=0.333 Sum_probs=156.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++++.||+|+||.||+|+. +++.||||++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~-----~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-----RKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-----TTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh-----hHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 46677899999999999999999998 47889999997643211 112346788999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.+|+||||+.+|+|.+++.... ..+++..++.|+.||+.||+|||+.+|+||||||+||||+ .++.+||+
T Consensus 255 ~--~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld----~~g~vKL~ 328 (576)
T 2acx_A 255 T--KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLD----DHGHIRIS 328 (576)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEEEC
T ss_pred e--CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEe----CCCCeEEE
Confidence 8 578999999999999999997653 3489999999999999999999999999999999999998 66799999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|||+++...........+||+.|+|||++.+..+. .++|
T Consensus 329 DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~-~~~D 367 (576)
T 2acx_A 329 DLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPD 367 (576)
T ss_dssp CCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEES-SHHH
T ss_pred ecccceecccCccccccCCCccccCHHHHcCCCCC-ccch
Confidence 99999876555444556899999999999876543 4444
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=268.15 Aligned_cols=178 Identities=31% Similarity=0.556 Sum_probs=139.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
.+...+|++.+.||+|+||.||+|+++ +..||||+++... .....+.|.+|+.+|++++||||+++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------TEKQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 455678999999999999999999874 5569999987531 1223457899999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++.+ .+.+++||||+++++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 114 ~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~----~~~~~k 187 (373)
T 2qol_A 114 VVTK--SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN----SNLVCK 187 (373)
T ss_dssp EECS--SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEE
T ss_pred EEee--CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEc----CCCCEE
Confidence 9987 5678999999999999999988776799999999999999999999999999999999999998 667999
Q ss_pred EEecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 951 IGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 951 LiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+|||+++...... ......+|+.|+|||++.+..+
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCC
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCc
Confidence 99999998654322 1122346788999999976543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=258.38 Aligned_cols=177 Identities=31% Similarity=0.436 Sum_probs=145.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
.+..++|++.+.||+|+||.||+|++. +..||||+++.... ....+.+.+|+.+++++ +||||++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~iv~ 113 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHENIVN 113 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC-------HHHHHHHHHHHHHHHhhcCCCCeee
Confidence 455678999999999999999999872 34699999975321 12235788999999999 8999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccC----------------------ccCHHHHHHHHHHHHHHHHHHHhC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----------------------TIDRRKRLIIAMDAAFGMEYLHGK 925 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k----------------------~Lse~~~lkIalQIL~GLeYLHs~ 925 (993)
+++++.. .+.+++||||+++|+|.+++..... .+++..++.|+.||+.||.|||+.
T Consensus 114 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 114 LLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp EEEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEee--CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999987 5679999999999999999986542 278889999999999999999999
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 192 ~ivH~Dikp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 250 (344)
T 1rjb_A 192 SCVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 250 (344)
T ss_dssp TEEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred CcccCCCChhhEEEc----CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC
Confidence 999999999999998 66799999999998654332 223455788999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=251.19 Aligned_cols=184 Identities=32% Similarity=0.585 Sum_probs=150.2
Q ss_pred cccccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
...+..++|++.+.||+|+||+||+|++ +++.||||++........ .......+.+.+|+.++++++||||++++++
T Consensus 13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE-TEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC-HHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 4456778999999999999999999998 477899999876533221 1111112578899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCC-CCCCe
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRD-PQRPV 948 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d-~e~g~ 948 (993)
+.+. .++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++ .....
T Consensus 92 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 92 MHNP----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp ETTT----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred ecCC----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCcee
Confidence 8763 27999999999999999877777999999999999999999999999 99999999999998443 12334
Q ss_pred EEEEecCCccccccccccCCCCCCCCccccccccCC
Q 001940 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
+||+|||+++..... .....||+.|+|||++.+.
T Consensus 168 ~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~ 201 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAE 201 (287)
T ss_dssp EEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCS
T ss_pred EEeCCCCcccccccc--ccccCCCccccCchhhccC
Confidence 999999999865443 3346799999999999543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=252.42 Aligned_cols=177 Identities=30% Similarity=0.456 Sum_probs=148.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~-------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
.+..++|++.+.||+|+||.||+|++ .++.||||+++.... ....+.+.+|+.+++++ +||||++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh-------HHHHHHHHHHHHHHhhcccCCCeee
Confidence 45567899999999999999999986 245799999875421 12235788999999999 8999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccC-----------------ccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-----------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k-----------------~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
+++++.+ .+.+++||||+.+++|.+++..... .+++..++.++.||+.||.|||+.+|+||
T Consensus 92 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 92 LLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred EEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 9999987 5678999999999999999986542 38899999999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 170 dlkp~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 223 (313)
T 1t46_A 170 DLAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (313)
T ss_dssp CCSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred CCccceEEEc----CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC
Confidence 9999999998 66799999999998664432 223455788999999987654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=258.88 Aligned_cols=174 Identities=29% Similarity=0.411 Sum_probs=139.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc-
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD- 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d- 874 (993)
.+..++|++++.||+|+||.||+|+++++.||||++.... ... .....|+..+..++|+||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-------RQN--FINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-------HHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-------hhh--HHHHHHHHHHHhccCcchhhheeccccc
Confidence 4567899999999999999999999999999999987532 111 111234444556899999999986543
Q ss_pred --CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCCEEEccCC
Q 001940 875 --GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK---------NIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 875 --~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~---------gIIHRDIKPeNILLd~~d 943 (993)
.....+++||||+++|+|.+++.... .++..++.|+.||+.||.|||+. +|+||||||+|||++
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~--- 154 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK--- 154 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEEC---
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEc---
Confidence 22346789999999999999997654 58888999999999999999999 999999999999998
Q ss_pred CCCCeEEEEecCCccccccc---------cccCCCCCCCCccccccccCC
Q 001940 944 PQRPVCKIGDLGLSKVKQQT---------LVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~~---------~~s~s~~GTp~YmAPEVL~Gk 984 (993)
.++.+||+|||+++..... .......||+.|+|||++.+.
T Consensus 155 -~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (336)
T 3g2f_A 155 -NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203 (336)
T ss_dssp -TTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred -CCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence 5678999999999865322 122345799999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=259.97 Aligned_cols=187 Identities=25% Similarity=0.279 Sum_probs=145.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|++. +..||||++........ .....+.+.+|+.++++++||||+++++++.+ .
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI---NPKDVERIKTEVRLMKKLHHPNIARLYEVYED--E 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc---CHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--C
Confidence 56999999999999999999884 66799999976532111 11234578899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhc---------------------------------------cCccCHHHHHHHHHHHHHH
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK---------------------------------------DRTIDRRKRLIIAMDAAFG 918 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~---------------------------------------~k~Lse~~~lkIalQIL~G 918 (993)
+.+++||||+++++|.+++... ...+++..++.|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 7899999999999999998521 1124577788899999999
Q ss_pred HHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc-----ccCCCCCCCCccccccccCC-ccCCCCCC
Q 001940 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGK-SHMVTEKE 992 (993)
Q Consensus 919 LeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk-~y~tse~D 992 (993)
|.|||+.+|+||||||+|||++.+ ....+||+|||+++...... ......||+.|+|||++.+. ...+.++|
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTN--KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCS--SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHCCccccCCChhhEEEecC--CCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999999732 23489999999998653311 12356799999999999753 34444555
Q ss_pred C
Q 001940 993 L 993 (993)
Q Consensus 993 I 993 (993)
|
T Consensus 259 i 259 (345)
T 3hko_A 259 A 259 (345)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=249.11 Aligned_cols=180 Identities=31% Similarity=0.428 Sum_probs=151.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+|+++ ++.||||++...... ...+.+.+|+.+++.++||||+++++++.+ .
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 77 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE--G 77 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-------THHHHHHHHHHHHHTCCCTTBCCEEEEEEE--T
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-------hhhHHHHHHHHHHHhcCCCCceeeeeEEEc--C
Confidence 46999999999999999999884 778999999754321 123467899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+..++||||+.+++|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||++
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~dfg~~ 152 (276)
T 2yex_A 78 NIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGLA 152 (276)
T ss_dssp TEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred CEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc----cCCCEEEeeCCCc
Confidence 7899999999999999998654 3589999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... .......||+.|+|||++.+..+.+.++||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 191 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 191 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHH
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchH
Confidence 865322 223456799999999999887765555553
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=250.27 Aligned_cols=183 Identities=28% Similarity=0.453 Sum_probs=152.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+|+.. ++.||||++...... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-----KEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-----hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 345578999999999999999999985 567999998754221 1112346889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+ .+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 85 ~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~D 157 (284)
T 2vgo_A 85 D--RKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMG----YKGELKIAD 157 (284)
T ss_dssp C--SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEEC----TTCCEEECC
T ss_pred c--CCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEc----CCCCEEEec
Confidence 7 578999999999999999997664 489999999999999999999999999999999999998 567899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||++...... ......||+.|+|||++.+..+ +.++|
T Consensus 158 fg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~D 194 (284)
T 2vgo_A 158 FGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTH-DEKVD 194 (284)
T ss_dssp CTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCB-CTTHH
T ss_pred ccccccCccc-ccccccCCCCcCCHHHhccCCC-Ccccc
Confidence 9998765433 2345679999999999987654 34444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=254.06 Aligned_cols=175 Identities=23% Similarity=0.391 Sum_probs=148.0
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|+..+.||+|+||.||+|+.. ++.||||++...... ..+.+.+|+.++++++||||+++++++.. .+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--------RRELLFNEVVIMRDYQHFNVVEMYKSYLV--GE 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------SHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TT
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCcceEEEEEEE--CC
Confidence 3788889999999999999884 788999999754211 12467899999999999999999999998 56
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+++||||+.+++|.+++.+. .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~----~~~~~kl~Dfg~~~ 189 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT----LDGRVKLSDFGFCA 189 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTCE
T ss_pred EEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC----CCCcEEEeeeeeee
Confidence 799999999999999998754 489999999999999999999999999999999999998 56789999999998
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
...... ......||+.|+|||++.+..+ +.++|
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 223 (321)
T 2c30_A 190 QISKDVPKRKSLVGTPYWMAPEVISRSLY-ATEVD 223 (321)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCB-CTHHH
T ss_pred ecccCccccccccCCccccCHhhhcCCCC-Cchhh
Confidence 654432 2345679999999999987644 33444
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=260.65 Aligned_cols=173 Identities=24% Similarity=0.328 Sum_probs=142.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--CCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--PNIVrL~G~f 872 (993)
.+..+.|++++.||+|+||.||++... ++.||||++..... .....+.+.+|+.+|++++| +||+++++++
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc------chHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 456778999999999999999999884 66799999875421 12334678899999999986 9999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+ ...+++|||+ .+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ ++.+||+
T Consensus 79 ~~--~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-----~~~~kl~ 149 (343)
T 3dbq_A 79 IT--DQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLI 149 (343)
T ss_dssp EC--SSEEEEEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEEEEC
T ss_pred ee--CCEEEEEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-----CCcEEEe
Confidence 87 5789999995 5899999998754 588999999999999999999999999999999999996 3579999
Q ss_pred ecCCcccccccc---ccCCCCCCCCccccccccC
Q 001940 953 DLGLSKVKQQTL---VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 953 DFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~G 983 (993)
|||+++...... .....+||+.|+|||++.+
T Consensus 150 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 150 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp CCSSSCCC------------CCCCSSCCHHHHHH
T ss_pred ecccccccCcccccccCCCCcCCcCcCCHHHHhh
Confidence 999998764332 2235679999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=257.74 Aligned_cols=175 Identities=30% Similarity=0.505 Sum_probs=146.1
Q ss_pred CCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
...|++++.||+|+||+||++.+ +++.||||+++... .....+.+.+|+.+|++++||||+++++++
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 102 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-------GPQHRSGWKQEIDILRTLYHEHIIKYKGCC 102 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence 33359999999999999999876 46679999997541 122345788999999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+.....+++||||+++++|.+++.... +++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~----~~~~~kl~ 176 (318)
T 3lxp_A 103 EDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLD----NDRLVKIG 176 (318)
T ss_dssp EETTTTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEEC
T ss_pred ecCCCceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEc----CCCCEEEC
Confidence 9865678999999999999999997653 88999999999999999999999999999999999998 66789999
Q ss_pred ecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ......||..|+|||++.+..+
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 214 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF 214 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEE
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCC
Confidence 999998764432 2234568889999999976544
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-28 Score=263.54 Aligned_cols=171 Identities=25% Similarity=0.336 Sum_probs=143.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s 876 (993)
++|++++.||+|+||+||+|+.+ ++.||||++++... .+.+|+.++.++ +||||+++++++.+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~~~-- 87 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVYDD-- 87 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEEEC--
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEEEc--
Confidence 56999999999999999999985 67899999976431 123577778777 79999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|+||||+.+|+|.+++.+.. .+++..+..++.||+.||.|||+.||+||||||+|||+...+...+.+||+|||+
T Consensus 88 ~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 88 GKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 578999999999999999997654 4899999999999999999999999999999999999964433345799999999
Q ss_pred ccccccc-cccCCCCCCCCccccccccCCc
Q 001940 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 957 Ak~~~~~-~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
++..... ......+||+.|+|||++.+..
T Consensus 167 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 196 (342)
T 2qr7_A 167 AKQLRAENGLLMTPCYTANFVAPEVLERQG 196 (342)
T ss_dssp CEECBCTTCCBCCSSCCSSCCCHHHHHHHH
T ss_pred cccCcCCCCceeccCCCccccCHHHhcCCC
Confidence 9865433 2344567999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=278.81 Aligned_cols=186 Identities=26% Similarity=0.371 Sum_probs=155.9
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
..+..++|++++.||+|+||+||+|+.+ ++.||||++.+.... .....+.+.+|+.+|++++||||++++++|
T Consensus 180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-----~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~ 254 (543)
T 3c4z_A 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-----KRKGYQGAMVEKKILAKVHSRFIVSLAYAF 254 (543)
T ss_dssp SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-----hhHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3456688999999999999999999984 788999999764321 111235688899999999999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
.+ .+.+|+||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 255 ~~--~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~----~~g~v 328 (543)
T 3c4z_A 255 ET--KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD----DDGNV 328 (543)
T ss_dssp EC--SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCE
T ss_pred ee--CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEe----CCCCE
Confidence 88 578999999999999999997642 3589999999999999999999999999999999999998 66799
Q ss_pred EEEecCCcccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 950 KIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 950 KLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+|||+++...... .....+||+.|||||++.+..+. .++|
T Consensus 329 kL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~D 371 (543)
T 3c4z_A 329 RISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD-FSVD 371 (543)
T ss_dssp EECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBC-THHH
T ss_pred EEeecceeeeccCCCcccccccCCccccChhhhcCCCCC-hHHh
Confidence 999999998765433 23456899999999999886543 4444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=270.01 Aligned_cols=182 Identities=28% Similarity=0.402 Sum_probs=136.6
Q ss_pred CceE-EEEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 801 DLEE-VRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 801 dYei-le~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.|++ .++||+|+||+||+|+++ +..||||++...... ..+.+|+.+|++|+||||++++++|...
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----------MSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----------HHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----------HHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3554 357999999999999964 567999998754221 2567899999999999999999999765
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc--------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD--------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~--------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
....+++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+||||...+...+
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 5678999999995 68888876321 23889999999999999999999999999999999999964434678
Q ss_pred eEEEEecCCccccccc----cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 948 VCKIGDLGLSKVKQQT----LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~----~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+||+|||+|+..... ......+||+.|+|||++.+...++.++||
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 219 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDI 219 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHH
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhh
Confidence 9999999999865432 223456799999999999987766666664
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=248.84 Aligned_cols=177 Identities=26% Similarity=0.466 Sum_probs=145.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f 872 (993)
....|++.+.||+|+||+||+|++.. ..||||+++... .....+.+.+|+.++++++||||+++++++
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 95 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 95 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-------CHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence 34569999999999999999998732 237899886421 122345788999999999999999999997
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
... .+..++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 96 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~ 170 (298)
T 3f66_A 96 LRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD----EKFTVKVA 170 (298)
T ss_dssp CCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEEC
T ss_pred EcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEC----CCCCEEEC
Confidence 653 4678999999999999999987777789999999999999999999999999999999999998 66799999
Q ss_pred ecCCcccccccc-----ccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ......||+.|+|||++.+..+
T Consensus 171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (298)
T 3f66_A 171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209 (298)
T ss_dssp SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCC
T ss_pred cccccccccccchhccccccCCCCCccccChHHhcCCCC
Confidence 999998654322 1234567889999999976543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=257.58 Aligned_cols=180 Identities=31% Similarity=0.486 Sum_probs=151.8
Q ss_pred hccccccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 792 ~~i~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.....+..++|++++.||+|+||.||+|++. +..||+|++.... .....+.+.+|+.+++.++||||++++
T Consensus 25 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 97 (360)
T 3eqc_A 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFY 97 (360)
T ss_dssp HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-------CHHHHHHHHHHHGGGGGCCCTTBCCEE
T ss_pred hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-------CHHHHHHHHHHHHHHHHCCCCCEEEEe
Confidence 3455677789999999999999999999995 7789999987542 122345788999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCe
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
+++.+ .+.+++||||+++++|.+++.... .+++..+..|+.||+.||.|||+. +|+||||||+|||++ .++.
T Consensus 98 ~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~----~~~~ 170 (360)
T 3eqc_A 98 GAFYS--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGE 170 (360)
T ss_dssp EEEEE--TTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCC
T ss_pred EEEEE--CCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC----CCCC
Confidence 99998 578999999999999999997764 488999999999999999999996 999999999999998 5678
Q ss_pred EEEEecCCccccccccccCCCCCCCCccccccccCCcc
Q 001940 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+||+|||+++..... ......||+.|+|||++.+..+
T Consensus 171 ~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 207 (360)
T 3eqc_A 171 IKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY 207 (360)
T ss_dssp EEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCC
T ss_pred EEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCC
Confidence 999999999765333 2335679999999999987643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=259.78 Aligned_cols=181 Identities=23% Similarity=0.326 Sum_probs=150.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..+|++++.||+|+||.||+|++. ++.||||++.... .....+.+.+|+.+|++++||||+++++++....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 98 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 98 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-------CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence 468999999999999999999884 6779999987421 1223457889999999999999999999997632
Q ss_pred ---CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 ---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ---~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
...+++||||+. ++|.+++... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 99 ~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~~~kl~D 171 (364)
T 3qyz_A 99 IEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICD 171 (364)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECC
T ss_pred ccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEEC----CCCCEEEEe
Confidence 246899999995 6999999764 489999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccccc----cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++....... .....||+.|+|||++.+....+.++||
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 215 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHH
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhH
Confidence 999986643321 2345799999999998777666666664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-28 Score=258.36 Aligned_cols=178 Identities=29% Similarity=0.528 Sum_probs=142.5
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEc--Ccc----eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSD----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~----VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
..+..++|++++.||+|+||+||+|++. ++. ||+|+++... .....+.+.+|+.++++++||||+++
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~ 82 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-------SPKANKEILDEAYVMASVDNPHVCRL 82 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCE
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-------CHHHHHHHHHHHHHHHhCCCCCEeEE
Confidence 3456778999999999999999999873 444 4777765321 11223578899999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
++++.+ +..++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.
T Consensus 83 ~~~~~~---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~----~~~~ 155 (327)
T 3poz_A 83 LGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQH 155 (327)
T ss_dssp EEEEES---SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTE
T ss_pred EEEEec---CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC----CCCC
Confidence 999987 347899999999999999988777799999999999999999999999999999999999998 5678
Q ss_pred EEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 949 CKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3poz_A 156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC
T ss_pred EEEccCcceeEccCCcccccccCCCccccccChHHhccCCC
Confidence 9999999998654332 1223457889999999986544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.6e-28 Score=245.46 Aligned_cols=175 Identities=32% Similarity=0.569 Sum_probs=149.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|++.+.||+|+||.||+|++ .+..||||++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 74 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLE- 74 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---------HHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred EchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence 4567899999999999999999998 4667999999864321 1367889999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+++++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~----~~~~~kl~dfg 149 (267)
T 3t9t_A 75 -QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 149 (267)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----GGGCEEECCTT
T ss_pred -CCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC----CCCCEEEcccc
Confidence 5679999999999999999987766789999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 956 LAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+++...... ......||..|+|||++.+..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 182 (267)
T 3t9t_A 150 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 182 (267)
T ss_dssp GGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred cccccccccccccccccccccccChhhhcCCCc
Confidence 998654322 2234567889999999976543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=254.46 Aligned_cols=173 Identities=24% Similarity=0.304 Sum_probs=139.1
Q ss_pred CCCceEE-EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEc
Q 001940 799 NDDLEEV-RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRD 874 (993)
Q Consensus 799 ~ddYeil-e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d 874 (993)
.+.|++. +.||+|+||+||+|+. +++.||||++...... ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~ 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--------IRSRVFREVEMLYQCQGHRNVLELIEFFEE 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--------CHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--------hHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4578885 7899999999999987 4788999999754211 123678899999885 79999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ ....+||+||
T Consensus 83 --~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~~~kl~Df 158 (316)
T 2ac3_A 83 --EDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN-QVSPVKICDF 158 (316)
T ss_dssp --TTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS-SSCSEEECCT
T ss_pred --CCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC-CcCceEEEEc
Confidence 578999999999999999997754 489999999999999999999999999999999999998443 3345999999
Q ss_pred CCcccccccc--------ccCCCCCCCCccccccccC
Q 001940 955 GLSKVKQQTL--------VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 955 GLAk~~~~~~--------~s~s~~GTp~YmAPEVL~G 983 (993)
|+++...... .....+||+.|+|||++.+
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHH
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhc
Confidence 9987543211 1223469999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=266.64 Aligned_cols=179 Identities=21% Similarity=0.293 Sum_probs=145.6
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC-
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~- 875 (993)
..+|++++.||+|+||.||+|++ +++.||||++..... .+.+|+.+|+.|+|+||++++++|...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~E~~il~~l~hpniv~l~~~~~~~~ 120 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSG 120 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------------hHHHHHHHHHHcCCCCccceeeEEeccC
Confidence 34699999999999999999998 478899999875321 123689999999999999999998542
Q ss_pred ---CCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 876 ---PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 876 ---s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
....+++||||+.+ +|.+++.. ....+++..++.|+.||+.||.|||+.+|+||||||+||||+. ..+.+
T Consensus 121 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---~~~~~ 196 (420)
T 1j1b_A 121 EKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---DTAVL 196 (420)
T ss_dssp TTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET---TTTEE
T ss_pred CCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC---CCCeE
Confidence 12347899999965 67666543 3456899999999999999999999999999999999999983 23579
Q ss_pred EEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++............||+.|+|||++.+...++.++||
T Consensus 197 kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 240 (420)
T 1j1b_A 197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 240 (420)
T ss_dssp EECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHH
T ss_pred EeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhh
Confidence 99999999976554444567899999999999887666666664
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=249.79 Aligned_cols=181 Identities=30% Similarity=0.422 Sum_probs=151.4
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||.||+|+. +++.||||++........ ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 93 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK------DTSTILREVELLKKLDHPNIMKLFEILED--S 93 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSS------CHHHHHHHHHHHHTCCCTTBCCEEEEEEC--S
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchH------HHHHHHHHHHHHHhccCCCccEEEEEEeC--C
Confidence 5799999999999999999998 477899999976543221 12467899999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ..+.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~-~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 94 SSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE-KDCDIKIIDFGLS 171 (287)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS-TTCCEEECSTTGG
T ss_pred CeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC-CcccEEEeccCcc
Confidence 78999999999999999887654 489999999999999999999999999999999999997443 4568999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+............||+.|+|||++.+. .+.+.|
T Consensus 172 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~D 204 (287)
T 2wei_A 172 TCFQQNTKMKDRIGTAYYIAPEVLRGT--YDEKCD 204 (287)
T ss_dssp GTBCCCSSCSCHHHHHTTCCHHHHTTC--CCTHHH
T ss_pred eeecCCCccccccCcccccChHHhcCC--CCCchh
Confidence 876554444445689999999999764 344444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=251.64 Aligned_cols=183 Identities=22% Similarity=0.293 Sum_probs=143.9
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|++. ++.||||++...... .....+.+.+|+.++++++||||+++++++..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~- 105 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-----DPVFRTRMQREARTAGRLQEPHVVPIHDFGEI- 105 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG-----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc-----CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-
Confidence 3478999999999999999999974 778999998754321 22334678899999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~----~~~~~kl~Dfg 179 (309)
T 2h34_A 106 -DGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS----ADDFAYLVDFG 179 (309)
T ss_dssp -TTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSCC
T ss_pred -CCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc----CCCCEEEecCc
Confidence 578999999999999999998654 489999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+++...... ......||+.|+|||++.+..+ +.++||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di 218 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHA-TYRADI 218 (309)
T ss_dssp C----------------CCGGGCCGGGTCC-----CCCHH
T ss_pred cCccccccccccccccCCCcCccCHHHHcCCCC-CchHhH
Confidence 998654432 2234579999999999987644 445554
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=247.77 Aligned_cols=181 Identities=21% Similarity=0.301 Sum_probs=148.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|++ +++.||||++...... +.+.+|+.+++.++|++++..+..+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----------CHHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----------hHHHHHHHHHHHhhcCCCCCccccccCC
Confidence 457899999999999999999996 5788999998754321 2577899999999999988777776543
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+++||||+ +++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ .++.+||+|||
T Consensus 77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~~~~kl~Dfg 153 (296)
T 3uzp_A 77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 153 (296)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCT
T ss_pred -CCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCC-CCCeEEEeeCC
Confidence 56789999999 9999999986666799999999999999999999999999999999999995322 45789999999
Q ss_pred Cccccccccc--------cCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~~--------s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++....... .....||+.|+|||++.+..+ +.++|
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 197 (296)
T 3uzp_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDD 197 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHH
T ss_pred CcccccccccccccccccccccccccccCChhhhcCCCC-Ccchh
Confidence 9986544322 245679999999999987653 33444
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=253.51 Aligned_cols=185 Identities=23% Similarity=0.285 Sum_probs=148.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++++.||+|+||.||+++. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE--------QQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC--------HHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 45667899999999999999999997 57889999986431 123457889999999999999999999987
Q ss_pred cC--CCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 874 DG--PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 874 d~--s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
.. ....+++||||+.+++|.+++.. ....+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~----~~~~ 172 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG----DEGQ 172 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc----CCCC
Confidence 32 23578999999999999999976 345689999999999999999999999999999999999998 5678
Q ss_pred EEEEecCCccccccccc----------cCCCCCCCCccccccccCCcc--CCCCCC
Q 001940 949 CKIGDLGLSKVKQQTLV----------SGGVRGTLPWMAPELLSGKSH--MVTEKE 992 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~----------s~s~~GTp~YmAPEVL~Gk~y--~tse~D 992 (993)
+||+|||+++....... .....||+.|+|||++.+... .+.++|
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D 228 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD 228 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence 99999999876432111 122357999999999986643 344444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=250.11 Aligned_cols=179 Identities=28% Similarity=0.466 Sum_probs=146.6
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
...++|++++.||+|+||.||+|.++ ++.||||++..... .+.+.+|+.+++.++||||+++++++..
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 95 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----------LQEIIKEISIMQQCDSPHVVKYYGSYFK 95 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----------CHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----------HHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence 34578999999999999999999985 78899999875421 1367889999999999999999999987
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+|+||||+|||++ .++.+||+||
T Consensus 96 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~df 169 (314)
T 3com_A 96 --NTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN----TEGHAKLADF 169 (314)
T ss_dssp --TTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCC
T ss_pred --CCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC----CCCCEEEeec
Confidence 5789999999999999999986666799999999999999999999999999999999999998 5678999999
Q ss_pred CCcccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 955 GLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 955 GLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|++....... ......||+.|+|||++.+..+ +.++|
T Consensus 170 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 207 (314)
T 3com_A 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NCVAD 207 (314)
T ss_dssp TTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCB-CTTHH
T ss_pred ccchhhhhhccccCccCCCCCccChhhcCCCCC-Ccccc
Confidence 9998654432 2345679999999999987653 34444
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=252.05 Aligned_cols=173 Identities=31% Similarity=0.484 Sum_probs=145.1
Q ss_pred ceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEE
Q 001940 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~ 881 (993)
|...+.||+|+||.||+|+++++.||||++........ ....+.+.+|+.++++++||||+++++++.+ .+.++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITT----EELKQQFDQEIKVMAKCQHENLVELLGFSSD--GDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCT----TTHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCE
T ss_pred cccCCccccCCCeEEEEEEECCceEEEEEEecccCcch----HHHHHHHHHHHHHHHhcCCCCeEEEEEEEec--CCceE
Confidence 44458899999999999999999999999875432221 1223578899999999999999999999987 46789
Q ss_pred EEEeeccCCcHHHHHHhc--cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 882 TVTEFMVNGSLKQFLQKK--DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~--~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
+||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl~Dfg~~~~ 182 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD----EAFTAKISDFGLARA 182 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc----CCCcEEEeecccccc
Confidence 999999999999999753 34589999999999999999999999999999999999998 667999999999986
Q ss_pred cccc---cccCCCCCCCCccccccccCC
Q 001940 960 KQQT---LVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 960 ~~~~---~~s~s~~GTp~YmAPEVL~Gk 984 (993)
.... .......||+.|+|||++.+.
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 210 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRGE 210 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTTE
T ss_pred cccccccccccccCCCcCcCChHHhcCC
Confidence 5432 123346799999999998764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=254.68 Aligned_cols=180 Identities=33% Similarity=0.560 Sum_probs=144.8
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEcCc------ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGS------DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~kgt------~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
...+...+|++.+.||+|+||+||+|+++.. .||||+++... .......+.+|+.++++++||||++
T Consensus 38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~ 110 (333)
T 1mqb_A 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIR 110 (333)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3456778999999999999999999987532 49999987532 1122347889999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
+++++.+ .+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++
T Consensus 111 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~ 184 (333)
T 1mqb_A 111 LEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNL 184 (333)
T ss_dssp EEEEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTC
T ss_pred EEEEEec--CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEEC----CCC
Confidence 9999987 5679999999999999999987766799999999999999999999999999999999999998 667
Q ss_pred eEEEEecCCcccccccc----ccCCCCCCCCccccccccCCcc
Q 001940 948 VCKIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
.+||+|||+++...... ......+|+.|+|||++.+..+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 185 VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp CEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 99999999998654321 1123346889999999976643
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=252.40 Aligned_cols=178 Identities=29% Similarity=0.469 Sum_probs=147.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
.+..++|++.+.||+|+||.||+|+++ ++.||||++.... .......+.+|+.+++.++|+||+++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-------CHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 345678999999999999999999864 4679999987431 11223468899999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILL 939 (993)
++++.+ .+..++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+|||+
T Consensus 94 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 94 LGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred EEEEcc--CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 999987 467899999999999999997632 346889999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 940 NMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 940 d~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+ .++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 172 ~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (322)
T 1p4o_A 172 A----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217 (322)
T ss_dssp C----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred c----CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC
Confidence 8 56789999999998654332 2233457899999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=259.95 Aligned_cols=180 Identities=22% Similarity=0.328 Sum_probs=138.9
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|... ++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 97 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 97 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS------SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC------ChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence 468999999999999999999874 77899999975321 1223457889999999999999999999997632
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+++||||+. ++|.+++.. .+++..+..++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 98 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~----~~~~~kl~ 169 (371)
T 2xrw_A 98 SLEEFQDVYIVMELMD-ANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKIL 169 (371)
T ss_dssp STTTCCEEEEEEECCS-EEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEEC
T ss_pred ccccccceEEEEEcCC-CCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc----CCCCEEEE
Confidence 136899999995 588888853 388999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++............||+.|+|||++.+..+ +.++||
T Consensus 170 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 209 (371)
T 2xrw_A 170 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDI 209 (371)
T ss_dssp CCCC----------------CTTCCHHHHTTCCC-CTTHHH
T ss_pred EeecccccccccccCCceecCCccCHHHhcCCCC-CchHhH
Confidence 9999987655444455679999999999988654 445553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=259.55 Aligned_cols=177 Identities=33% Similarity=0.533 Sum_probs=147.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|++.+.||+|+||.||+|+. +++.||||++........ ...+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 98 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG-------ELQFQTEVEMISMAVHRNLLRLRGFCMT- 98 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C-------CCHHHHHHHGGGTCCCTTBCCCCEEECC-
T ss_pred HHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH-------HHHHHHHHHHHHhccCCCccceEEEEec-
Confidence 4567899999999999999999987 478899999876432211 1257889999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCCEEEccCCCCCCeE
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGK---NIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~---gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
.+..++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+|||++ .++.+
T Consensus 99 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~----~~~~~ 173 (326)
T 3uim_A 99 -PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD----EEFEA 173 (326)
T ss_dssp -SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC----TTCCE
T ss_pred -CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC----CCCCE
Confidence 467899999999999999998643 3489999999999999999999999 999999999999998 66789
Q ss_pred EEEecCCccccccc--cccCCCCCCCCccccccccCCcc
Q 001940 950 KIGDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 950 KLiDFGLAk~~~~~--~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||+|||+++..... .......||+.|+|||++.+..+
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 212 (326)
T 3uim_A 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 212 (326)
T ss_dssp EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE
T ss_pred EeccCccccccCcccccccccccCCcCccCHHHhccCCC
Confidence 99999999865432 23345569999999999976543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=247.40 Aligned_cols=177 Identities=28% Similarity=0.510 Sum_probs=145.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCc-----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt-----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
.+..++|++.+.||+|+||+||+|++.+. .||||++.... .....+.+.+|+.++++++||||+++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-------TLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-------CHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-------CchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 34567899999999999999999987432 39999987542 1122357889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++.+ +..++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 81 ~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~k 153 (281)
T 3cc6_A 81 IIEE---EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA----SPECVK 153 (281)
T ss_dssp EECS---SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----ETTEEE
T ss_pred EEcC---CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC----CCCcEE
Confidence 9875 356899999999999999988766789999999999999999999999999999999999998 567999
Q ss_pred EEecCCcccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 951 IGDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 951 LiDFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+|||+++...... ......+|+.|+|||++.+..+
T Consensus 154 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 154 LGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp ECCCCGGGCC---------CCCCCGGGCCHHHHHHCCC
T ss_pred eCccCCCcccccccccccccCCCCcceeCchhhccCCC
Confidence 99999998654432 1233457889999999975543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=255.19 Aligned_cols=184 Identities=29% Similarity=0.425 Sum_probs=134.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||.||+|.+ +++.||||++..... ....+.+.+|+.++++++||||+++++++.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-------QTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-------chhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 45678999999999999999999987 578899998865321 122346789999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHh-------ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQK-------KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~-------~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
. .+.+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++ .+
T Consensus 84 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~ 157 (303)
T 2vwi_A 84 V--KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG----ED 157 (303)
T ss_dssp S--SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TT
T ss_pred e--cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEc----CC
Confidence 8 4679999999999999999974 234589999999999999999999999999999999999998 56
Q ss_pred CeEEEEecCCccccccc------cccCCCCCCCCccccccccCCccCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQT------LVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~------~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+.+||+|||+++..... .......||+.|+|||++.+....+.++|
T Consensus 158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D 209 (303)
T 2vwi_A 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKAD 209 (303)
T ss_dssp CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHH
T ss_pred CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhh
Confidence 78999999998754322 11234569999999999875444444444
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=271.71 Aligned_cols=180 Identities=29% Similarity=0.536 Sum_probs=149.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.+..++|++.+.||+|+||+||+|+++ +..||||+++.... ..+.|.+|+.+|++++||||+++++++..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~iv~l~~~~~~ 254 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM---------SVEAFLAEANVMKTLQHDKLVKLHAVVTK 254 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB---------CHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc---------cHHHHHHHHHHHhhCCCCCEeeEEEEEeC
Confidence 456678999999999999999999985 67799999985421 12478899999999999999999999864
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
..+++||||+.+|+|.++|.... ..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 255 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~D 327 (454)
T 1qcf_A 255 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS----ASLVCKIAD 327 (454)
T ss_dssp ---SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEEC----TTCCEEECS
T ss_pred ---CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEC----CCCcEEEee
Confidence 56899999999999999997543 3578889999999999999999999999999999999998 667999999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+++...... ......+|+.|+|||++.+..+ +.++|
T Consensus 328 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 367 (454)
T 1qcf_A 328 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSD 367 (454)
T ss_dssp TTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCC-CHHHH
T ss_pred CCCceEcCCCceeccCCCcccccccCHHHhccCCC-CcHHH
Confidence 99998764332 2234457889999999975543 33444
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-27 Score=250.30 Aligned_cols=174 Identities=29% Similarity=0.452 Sum_probs=141.4
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~ 873 (993)
...++|++++.||+|+||.||+|++ +++.||||++...... .+.+.+|+.+++++ +||||+++++++.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---------EEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---------THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---------HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3567899999999999999999998 5788999998754211 13677899999999 7999999999998
Q ss_pred cCC----CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 874 DGP----DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 874 d~s----~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
... .+.+++||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~----~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT----ENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEc----CCCC
Confidence 642 46799999999999999999864 34688999999999999999999999999999999999998 5678
Q ss_pred EEEEecCCcccccccc-ccCCCCCCCCccccccccC
Q 001940 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~G 983 (993)
+||+|||++....... ......||+.|+|||++.+
T Consensus 168 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (326)
T 2x7f_A 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203 (326)
T ss_dssp EEECCCTTTC-------------CCGGGCCHHHHC-
T ss_pred EEEeeCcCceecCcCccccccccCCccccChhhhcc
Confidence 9999999998654332 2334579999999999974
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-28 Score=259.57 Aligned_cols=180 Identities=32% Similarity=0.525 Sum_probs=149.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..++|++.+.||+|+||+||+|+++ ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 106 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS--------QGIEEFETEIETLSFCRHPHLVSLIGFCDE-- 106 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS--------SHHHHHHHHHHGGGSCCCTTBCCEEEECCC--
T ss_pred HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh--------HHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 4568999999999999999999985 78899998765321 123468899999999999999999999887
Q ss_pred CCcEEEEEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+|
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----~~~~~kl~D 182 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLD----ENFVPKITD 182 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEEC----TTCCEEECC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEEC----CCCCEEEee
Confidence 567899999999999999986543 3488999999999999999999999999999999999998 667999999
Q ss_pred cCCccccccc---cccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+++..... .......||+.|+|||++.+..+ +.++|
T Consensus 183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 223 (321)
T 2qkw_B 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSD 223 (321)
T ss_dssp CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHH
T ss_pred cccccccccccccccccccCCCccccCHHHhcCCCC-Ccccc
Confidence 9999864322 22334568999999999976543 34444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=245.86 Aligned_cols=182 Identities=30% Similarity=0.480 Sum_probs=148.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
....|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+.+|+.++++++||||+++++++...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC------HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 3455899999999999999999884 566899998764321 22345788999999999999999999998752
Q ss_pred --CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCCCCCCeEEE
Q 001940 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 876 --s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
....+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++. .++.+||
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~---~~~~~kl 173 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKI 173 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEE
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC---CCCCEEE
Confidence 2356899999999999999997653 4889999999999999999999999 999999999999962 3468999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+|||++....... .....||+.|+|||++.+. .+.++|
T Consensus 174 ~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~D 211 (290)
T 1t4h_A 174 GDLGLATLKRASF-AKAVIGTPEFMAPEMYEEK--YDESVD 211 (290)
T ss_dssp CCTTGGGGCCTTS-BEESCSSCCCCCGGGGGTC--CCTHHH
T ss_pred eeCCCcccccccc-cccccCCcCcCCHHHHhcc--CCCcch
Confidence 9999997654432 2345799999999998754 444444
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=249.05 Aligned_cols=176 Identities=34% Similarity=0.585 Sum_probs=141.7
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
...+..++|++.+.||+|+||+||+++++++.||||+++... ..+.+.+|+.++++++||||+++++++.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 334566889999999999999999999999999999987432 1246889999999999999999999976
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccC-ccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k-~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+. .+.+++||||+.+++|.+++..... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~~l~ 159 (278)
T 1byg_A 85 EE-KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVS 159 (278)
T ss_dssp CC---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEEC
T ss_pred cC-CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEe----CCCcEEEe
Confidence 53 4578999999999999999976532 378899999999999999999999999999999999998 56789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ....+|+.|+|||++.+..+
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 160 DFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp CCCC--------------CCTTTSCHHHHHHCCC
T ss_pred eccccccccccc--cCCCccccccCHHHhCCCCC
Confidence 999998654432 23457899999999876543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=253.17 Aligned_cols=180 Identities=34% Similarity=0.532 Sum_probs=148.6
Q ss_pred cccccCCCceEEEEecccCceEEEEEEE------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
...+...+|++++.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.++++++||||++
T Consensus 35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~ 106 (326)
T 2w1i_A 35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST--------EEHLRDFEREIEILKSLQHDNIVK 106 (326)
T ss_dssp --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC--------SHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC--------HHHHHHHHHHHHHHHhCCCCCeee
Confidence 3445667899999999999999999985 46779999987531 122357889999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
+++++.......+++||||+++++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++
T Consensus 107 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~----~~~ 182 (326)
T 2w1i_A 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE----NEN 182 (326)
T ss_dssp EEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETT
T ss_pred EEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc----CCC
Confidence 9999887545578999999999999999988766799999999999999999999999999999999999998 567
Q ss_pred eEEEEecCCccccccccc----cCCCCCCCCccccccccCCc
Q 001940 948 VCKIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~ 985 (993)
.+||+|||+++....... .....+|..|+|||++.+..
T Consensus 183 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 224 (326)
T 2w1i_A 183 RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224 (326)
T ss_dssp EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE
T ss_pred cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC
Confidence 999999999987643321 23345788899999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=264.54 Aligned_cols=173 Identities=24% Similarity=0.321 Sum_probs=143.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC--CCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr--HPNIVrL~G~f 872 (993)
.+...+|++++.||+|+||+||+|... ++.||||++..... .....+.+.+|+.+|++|+ |+||+++++++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc------cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 345567999999999999999999884 67799999976422 1233467889999999997 59999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. .+.++|||| +.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ ++.+||+
T Consensus 126 ~~--~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-----~~~~kl~ 196 (390)
T 2zmd_A 126 IT--DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLI 196 (390)
T ss_dssp EC--SSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-----SSCEEEC
T ss_pred ec--CCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-----CCeEEEE
Confidence 87 567999999 56899999998764 588889999999999999999999999999999999995 2579999
Q ss_pred ecCCcccccccc---ccCCCCCCCCccccccccC
Q 001940 953 DLGLSKVKQQTL---VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 953 DFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~G 983 (993)
|||+++...... .....+||+.|+|||++.+
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHC
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhh
Confidence 999998764332 2345679999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=250.66 Aligned_cols=178 Identities=29% Similarity=0.460 Sum_probs=147.1
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.+.||+|+||+||+|++. ++.||||+++... .....+.+.+|+.+++++ +||||+++
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-------CcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45678999999999999999999863 3669999987542 112235788999999999 69999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCc---------------cCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT---------------IDRRKRLIIAMDAAFGMEYLHGKNIVHFDLK 933 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~---------------Lse~~~lkIalQIL~GLeYLHs~gIIHRDIK 933 (993)
++++... ...+++||||+.+++|.+++...... +++..++.++.||+.||.|||+.+|+|||||
T Consensus 97 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 175 (316)
T 2xir_A 97 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175 (316)
T ss_dssp EEEECCT-TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEecC-CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 9998864 45689999999999999999865432 7899999999999999999999999999999
Q ss_pred CCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 934 CENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 934 PeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 176 p~Nil~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 176 ARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp GGGEEEC----GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cceEEEC----CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 9999998 55789999999998653321 2234568899999999876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=252.20 Aligned_cols=181 Identities=27% Similarity=0.408 Sum_probs=134.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCc-----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGS-----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt-----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
.+..++|++.+.||+|+||+||+|++... .||||+++...... ...+.+.+|+.++++++||||+++++
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~ 92 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS------SDIEEFLREAACMKEFDHPHVAKLVG 92 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C------HHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH------HHHHHHHHHHHHHHHCCCCceehhhc
Confidence 35667899999999999999999987532 69999987543211 22457889999999999999999999
Q ss_pred EEEcCCCC----cEEEEEeeccCCcHHHHHHhcc-----CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEcc
Q 001940 871 IVRDGPDG----SLATVTEFMVNGSLKQFLQKKD-----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNM 941 (993)
Q Consensus 871 ~f~d~s~~----~L~LVmEYm~GGSL~dlL~~~~-----k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~ 941 (993)
++...... ..++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~- 171 (323)
T 3qup_A 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA- 171 (323)
T ss_dssp EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc-
Confidence 99873221 2389999999999999996532 2488999999999999999999999999999999999998
Q ss_pred CCCCCCeEEEEecCCccccccccc---cCCCCCCCCccccccccCCcc
Q 001940 942 RDPQRPVCKIGDLGLSKVKQQTLV---SGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 942 ~d~e~g~VKLiDFGLAk~~~~~~~---s~s~~GTp~YmAPEVL~Gk~y 986 (993)
.++.+||+|||+++....... .....+|+.|+|||++.+..+
T Consensus 172 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (323)
T 3qup_A 172 ---EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY 216 (323)
T ss_dssp ---TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC
T ss_pred ---CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC
Confidence 667999999999986543321 223457889999999976643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=253.16 Aligned_cols=177 Identities=28% Similarity=0.482 Sum_probs=147.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNI 865 (993)
.+..++|++.+.||+|+||.||+|++. +..||||+++... .....+.+.+|+.+++++ +||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~i 103 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-------TEKDLSDLVSEMEMMKMIGKHKNI 103 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-------cHHHHHHHHHHHHHHHHhhcCCCE
Confidence 345678999999999999999999873 4569999987532 123345788999999999 89999
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
+++++++.+ .+.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||
T Consensus 104 v~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 181 (334)
T 2pvf_A 104 INLLGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181 (334)
T ss_dssp CCEEEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred eeEEEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 999999987 567999999999999999998643 237889999999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||||+|||++ .++.+||+|||+++...... ......+|+.|+|||++.+..
T Consensus 182 Dlkp~NIll~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 235 (334)
T 2pvf_A 182 DLAARNVLVT----ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235 (334)
T ss_dssp CCSGGGEEEC----TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE
T ss_pred CCccceEEEc----CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC
Confidence 9999999998 66789999999998654332 223345788999999987654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=252.64 Aligned_cols=169 Identities=30% Similarity=0.527 Sum_probs=144.0
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh--cCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS--LHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~--LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+|+++++.||||++.... ...+.+|..+++. ++||||+++++++.....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE-----------ERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG-----------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh-----------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 579999999999999999999999999999986431 1356678888877 789999999999987422
Q ss_pred --CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCCEEEccCCCCCC
Q 001940 878 --GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH--------GKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 878 --~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLH--------s~gIIHRDIKPeNILLd~~d~e~g 947 (993)
..+++||||+.+++|.+++.+. .+++..++.++.||+.||.||| +.+|+||||||+|||++ .++
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~----~~~ 184 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNG 184 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC----TTS
T ss_pred ccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC----CCC
Confidence 2799999999999999999764 4899999999999999999999 89999999999999998 567
Q ss_pred eEEEEecCCcccccccc-----ccCCCCCCCCccccccccCCc
Q 001940 948 VCKIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 227 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccc
Confidence 89999999998654432 234557999999999998653
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=246.67 Aligned_cols=181 Identities=21% Similarity=0.301 Sum_probs=144.7
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||+||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+..+...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----------~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE 76 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----------CCHHHHHHHHHHHTTSTTCCCEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----------hHHHHHHHHHHHhcCCCCCCeeeeecCC
Confidence 357899999999999999999996 5778999987654321 2467899999999999988888777543
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....++||||+ +++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ ..+.+||+|||
T Consensus 77 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~~~~kL~Dfg 153 (296)
T 4hgt_A 77 -GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFG 153 (296)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGG-GTTCEEECCCT
T ss_pred -CCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccC-CCCeEEEecCc
Confidence 56789999999 9999999987666799999999999999999999999999999999999993222 56789999999
Q ss_pred Cccccccccc--------cCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~~--------s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+++....... .....||+.|+|||++.+..+ +.++|
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 197 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDD 197 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhH
Confidence 9986544321 235679999999999987654 33444
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=250.32 Aligned_cols=171 Identities=30% Similarity=0.485 Sum_probs=141.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+.|++++.||+|+||.||+|++. ++.||+|++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--------EELEDYIVEIEILATCDHPYIVKLLGAYYH- 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--------HHHHHHHHHHHHHhcCCCCCEeeeeeeeee-
Confidence 3467999999999999999999995 77899999875421 113468889999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~----~~~~~kl~Dfg 162 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT----LEGDIRLADFG 162 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC----TTSCEEECCCH
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC----CCCCEEEEECC
Confidence 5689999999999999999987666799999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccc-cccCCCCCCCCcccccccc
Q 001940 956 LSKVKQQT-LVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 956 LAk~~~~~-~~s~s~~GTp~YmAPEVL~ 982 (993)
++...... .......||+.|+|||++.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHHHHHHHHHC-----CCGGGCCHHHHH
T ss_pred CCccccccccccccccCChhhcCCeeec
Confidence 97643221 1223457999999999984
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-27 Score=246.30 Aligned_cols=179 Identities=26% Similarity=0.432 Sum_probs=150.5
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..+.|++++.||+|+||.||+|+.. ++.||||++....... ..+.+.+|+.+++.++||||+++++++.+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 91 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-------EIEDIQQEITVLSQCDSPYVTKYYGSYLK- 91 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-------THHHHHHHHHHHHHCCCTTBCCEEEEEEE-
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-------HHHHHHHHHHHHHhCCCCCEeEEEEEEec-
Confidence 3456999999999999999999874 7789999997643211 13468899999999999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 92 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~----~~~~~kl~Dfg 164 (303)
T 3a7i_A 92 -DTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS----EHGEVKLADFG 164 (303)
T ss_dssp -TTEEEEEEECCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCT
T ss_pred -CCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC----CCCCEEEeecc
Confidence 57899999999999999999753 489999999999999999999999999999999999998 56789999999
Q ss_pred Ccccccccc-ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 956 LSKVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 956 LAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
++....... ......||+.|+|||++.+..+. .++|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~D 201 (303)
T 3a7i_A 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKAD 201 (303)
T ss_dssp TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBC-THHH
T ss_pred cceecCccccccCccCCCcCccCHHHHhcCCCC-chhh
Confidence 998654432 23456799999999999876543 3444
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=4.2e-27 Score=245.20 Aligned_cols=175 Identities=33% Similarity=0.504 Sum_probs=146.5
Q ss_pred ccCCCceEEE-EecccCceEEEEEEE----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVR-ELGSGTYGSVYHGKW----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile-~LGeGgFGtVYKAk~----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|.+.+ .||+|+||.||+|.+ .+..||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-------chhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4556788887 999999999999986 35669999987541 12234578899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.. +.+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||
T Consensus 79 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~----~~~~~kl 151 (287)
T 1u59_A 79 CQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKI 151 (287)
T ss_dssp EES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEE
T ss_pred ecC---CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc----CCCCEEE
Confidence 954 568999999999999999987666799999999999999999999999999999999999998 5679999
Q ss_pred EecCCcccccccc----ccCCCCCCCCccccccccCCc
Q 001940 952 GDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 952 iDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+|||+++...... ......||+.|+|||++.+..
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (287)
T 1u59_A 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189 (287)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred CcccceeeeccCcceeeccccccccccccCHHHhccCC
Confidence 9999998654321 122345789999999987554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=253.46 Aligned_cols=166 Identities=27% Similarity=0.314 Sum_probs=124.1
Q ss_pred EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcEEE
Q 001940 806 RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L~L 882 (993)
+.||+|+||+||+|+++ ++.||||++.... ...+.+|+.+++.+. ||||+++++++.+ ...+++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~l 83 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-----------EANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFL 83 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGG-----------HHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEE
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhh-----------hhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEE
Confidence 67999999999999984 7789999987531 135678999999997 9999999999987 578999
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccc
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQ 962 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~ 962 (993)
||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ ....+||+|||+++....
T Consensus 84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 84 VMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN-DNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp EECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTTCEECCC
T ss_pred EEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC-CcccEEEeccccceecCC
Confidence 999999999999998754 589999999999999999999999999999999999997433 345899999999986543
Q ss_pred c-cccCCCCCCCCccccccccCCcc
Q 001940 963 T-LVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 963 ~-~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
. ......+||+.|+|||++.+..+
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~~ 186 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQNGY 186 (325)
T ss_dssp ----------------------CCC
T ss_pred CCCcccccCCCcCccCHHHhcCCCC
Confidence 3 22345678999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=251.75 Aligned_cols=177 Identities=31% Similarity=0.504 Sum_probs=147.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcce
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVS 867 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVr 867 (993)
.+..++|++.+.||+|+||.||+|.+.+ ..||||+++... .....+.+.+|+.+++++ +||||++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~iv~ 114 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHENIVN 114 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCCeee
Confidence 4567889999999999999999999842 359999987532 112345788999999999 8999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKC 934 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKP 934 (993)
+++++.+ .+.+++||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||
T Consensus 115 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 115 LLGACTH--GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp EEEEECS--SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEec--CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 9999987 567999999999999999997542 3478999999999999999999999999999999
Q ss_pred CCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 935 ENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 935 eNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+|||++ .++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 193 ~NIl~~----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 242 (333)
T 2i1m_A 193 RNVLLT----NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV 242 (333)
T ss_dssp GGCEEE----GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC
T ss_pred ceEEEC----CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC
Confidence 999998 56799999999998653322 223455788999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=253.89 Aligned_cols=182 Identities=25% Similarity=0.299 Sum_probs=136.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||+||+|++. ++.||||++....... ..+.+|+..++.++||||++++++|....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---------NRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---------CHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---------HHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 368999999999999999999984 7789999986542211 14556788889999999999999997522
Q ss_pred C-----CcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEccCCCCC
Q 001940 877 D-----GSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLH--GKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 877 ~-----~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLH--s~gIIHRDIKPeNILLd~~d~e~ 946 (993)
. ..+++||||+.+ +|.+.+.. ....+++..+..|+.||+.||.||| +.+|+||||||+|||++. .+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~---~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE---AD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET---TT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC---CC
Confidence 1 238899999975 55544432 3455889999999999999999999 999999999999999982 25
Q ss_pred CeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+||+|||+++............||+.|+|||++.+....+.++||
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 215 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDI 215 (360)
T ss_dssp TEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred CcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHH
Confidence 79999999999977665555567799999999999887767776664
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=250.51 Aligned_cols=174 Identities=25% Similarity=0.354 Sum_probs=130.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f 872 (993)
.+...+|++.++||+|+||.||+|++ +++.||||++.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE--------EEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS--------HHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc--------hHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 34556899999999999999999998 57889999986431 122356889999999996 99999999998
Q ss_pred Ec------CCCCcEEEEEeeccCCcHHHHHHh--ccCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccC
Q 001940 873 RD------GPDGSLATVTEFMVNGSLKQFLQK--KDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMR 942 (993)
Q Consensus 873 ~d------~s~~~L~LVmEYm~GGSL~dlL~~--~~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~ 942 (993)
.. .....+++||||+ +|+|.+++.. ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~-- 172 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-- 172 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC--
T ss_pred cccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC--
Confidence 53 2234589999999 5799998875 3345899999999999999999999999 99999999999998
Q ss_pred CCCCCeEEEEecCCccccccccc-------------cCCCCCCCCcccccccc
Q 001940 943 DPQRPVCKIGDLGLSKVKQQTLV-------------SGGVRGTLPWMAPELLS 982 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~~~-------------s~s~~GTp~YmAPEVL~ 982 (993)
.++.+||+|||+++....... .....||+.|+|||++.
T Consensus 173 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 173 --NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp --TTSCEEBCCCTTCBCCSSCC-------------------------------
T ss_pred --CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 567899999999986543211 11345899999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=266.45 Aligned_cols=173 Identities=15% Similarity=0.099 Sum_probs=137.9
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHH---HHHhhcCCCCcceEE----
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEA---LLLSSLHHPNVVSFY---- 869 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi---~ILr~LrHPNIVrL~---- 869 (993)
.++|++.+.||+|+||+||+|++ +++.||||++........ ...+.+.+|+ .+|++++|||||+++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS-----NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCT-----THHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccch-----HHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 46799999999999999999986 478899999986433222 1235688899 556666899999998
Q ss_pred ---EEEEcCCC----------C-----cEEEEEeeccCCcHHHHHHhccC------ccCHHHHHHHHHHHHHHHHHHHhC
Q 001940 870 ---GIVRDGPD----------G-----SLATVTEFMVNGSLKQFLQKKDR------TIDRRKRLIIAMDAAFGMEYLHGK 925 (993)
Q Consensus 870 ---G~f~d~s~----------~-----~L~LVmEYm~GGSL~dlL~~~~k------~Lse~~~lkIalQIL~GLeYLHs~ 925 (993)
+++.+... + ..+|||||+ +|+|.+++..... .+++..++.|+.||+.||.|||+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 77665311 1 378999999 7899999986432 233578888999999999999999
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCC
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
+|+||||||+|||++ .++.+||+|||+|+.... .....+| +.|+|||++.+.
T Consensus 226 ~ivHrDikp~NIll~----~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 226 GLVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp TEECSCCCGGGEEEC----TTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHH
T ss_pred CeecCCCCHHHEEEc----CCCCEEEEechhheecCC--cccCCCC-cCccChhhhccc
Confidence 999999999999998 567999999999986543 2335668 999999999866
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-27 Score=250.50 Aligned_cols=176 Identities=32% Similarity=0.518 Sum_probs=140.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.+..++|++.+.||+|+||+||+|+++++.||||++.... ..+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 72 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES----------ERKAFIVELRQLSRVNHPNIVKLYGACLN- 72 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT----------HHHHHHHHHHHHHHCCCTTBCCEEEBCTT-
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh----------HHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 3456789999999999999999999999999999986321 12468899999999999999999998764
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccC--ccCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCCEEEccCCCCCC-eE
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDR--TIDRRKRLIIAMDAAFGMEYLHG---KNIVHFDLKCENLLVNMRDPQRP-VC 949 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k--~Lse~~~lkIalQIL~GLeYLHs---~gIIHRDIKPeNILLd~~d~e~g-~V 949 (993)
..++||||+++++|.+++..... .++...++.++.||+.||.|||+ ++|+||||||+|||++ .++ .+
T Consensus 73 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~----~~~~~~ 145 (307)
T 2eva_A 73 ---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV----AGGTVL 145 (307)
T ss_dssp ---TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE----TTTTEE
T ss_pred ---CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe----CCCCEE
Confidence 37999999999999999986543 36888999999999999999999 8999999999999998 333 58
Q ss_pred EEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+|||+++..... .....||+.|+|||++.+..+ +.++|
T Consensus 146 kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~D 185 (307)
T 2eva_A 146 KICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNY-SEKCD 185 (307)
T ss_dssp EECCCCC--------------CCTTSSCHHHHTCCCC-CTHHH
T ss_pred EEcccccccccccc--cccCCCCCceEChhhhCCCCC-CcHHH
Confidence 99999999765432 223469999999999987643 34444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=271.64 Aligned_cols=176 Identities=31% Similarity=0.592 Sum_probs=149.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+...+|++.++||+|+||.||+|+++ +..||||+++..... .+.|.+|+.+|++++||||++++++|.
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~l~~~~~ 286 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---------VEEFLKEAAVMKEIKHPNLVQLLGVCT 286 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---------hHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 445678999999999999999999996 678999998754211 246889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.++||||||.+|+|.++|... ...+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+
T Consensus 287 ~--~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~ 360 (495)
T 1opk_A 287 R--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG----ENHLVKVA 360 (495)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----GGGCEEEC
T ss_pred c--CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC----CCCcEEEe
Confidence 7 56799999999999999999864 34589999999999999999999999999999999999998 56789999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ......+|+.|+|||++.+..+
T Consensus 361 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 361 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp CTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE
T ss_pred ecccceeccCCceeecCCCcCCcceeCHhHHhcCCC
Confidence 999998764332 2234457889999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=253.55 Aligned_cols=179 Identities=29% Similarity=0.522 Sum_probs=141.0
Q ss_pred cccccCCCceEEEEecccCceEEEEEEEc--Ccce----EEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDV----AIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~k--gt~V----AVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
...+...+|++++.||+|+||+||+|++. ++.+ |+|.+....... ..+.+.+|+.++++++||||++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~-------~~~~~~~E~~~l~~l~hp~iv~ 81 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK-------ANKEILDEAYVMASVDNPHVCR 81 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC-------CHHHHHHHHHHHTTCCBTTBCC
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH-------HHHHHHHHHHHHHhCCCCCeeE
Confidence 34466789999999999999999999983 4544 666554322111 1246789999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCC
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g 947 (993)
+++++.. +..++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++
T Consensus 82 ~~~~~~~---~~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~----~~~ 154 (327)
T 3lzb_A 82 LLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQ 154 (327)
T ss_dssp CCEEEES---SSEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETT
T ss_pred EEEEEec---CCceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc----CCC
Confidence 9999987 348899999999999999988777799999999999999999999999999999999999998 567
Q ss_pred eEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 948 VCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
.+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 155 ~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3lzb_A 155 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp EEEECCTTC----------------CCCGGGSCHHHHHHCCC
T ss_pred CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC
Confidence 89999999998654332 1223457889999999986654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=252.41 Aligned_cols=182 Identities=23% Similarity=0.358 Sum_probs=148.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|++. ++.||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 81 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-------KPLFALRTLREIKILKHFKHENIITIFNIQRPD 81 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-------SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-------cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccc
Confidence 4578999999999999999999985 7789999986421 122345678999999999999999999987653
Q ss_pred C---CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 P---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 s---~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ...+++||||+. ++|.+++... .+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 82 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~----~~~~~kl~ 154 (353)
T 2b9h_A 82 SFENFNEVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLIN----SNCDLKVC 154 (353)
T ss_dssp CSTTCCCEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEEC
T ss_pred ccCccceEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc----CCCcEEEE
Confidence 1 367899999995 6999998763 489999999999999999999999999999999999998 66789999
Q ss_pred ecCCcccccccc-----------ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL-----------VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~-----------~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++...... ......||+.|+|||++.+....+.++||
T Consensus 155 Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 206 (353)
T 2b9h_A 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206 (353)
T ss_dssp CCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHH
T ss_pred ecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhH
Confidence 999998654221 12235789999999998765555555553
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=256.20 Aligned_cols=185 Identities=24% Similarity=0.285 Sum_probs=146.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC--------CCCc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--------HPNV 865 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr--------HPNI 865 (993)
.+..++|+++++||+|+||+||+|++. ++.||||+++.. ....+.+.+|+.+++.++ |+||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i 103 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---------EHYTETALDEIRLLKSVRNSDPNDPNREMV 103 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---------CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence 344578999999999999999999874 678999998743 122356788999999986 7889
Q ss_pred ceEEEEEEcC--CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEcc
Q 001940 866 VSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNM 941 (993)
Q Consensus 866 VrL~G~f~d~--s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~ 941 (993)
+++++++... ....+++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.
T Consensus 104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 9999998731 245799999999 66666655543 35689999999999999999999998 9999999999999973
Q ss_pred CCC---------------------------------------------CCCeEEEEecCCccccccccccCCCCCCCCcc
Q 001940 942 RDP---------------------------------------------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976 (993)
Q Consensus 942 ~d~---------------------------------------------e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~Ym 976 (993)
++. ....+||+|||+++..... .....||+.|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~ 260 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYR 260 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGC
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCccc
Confidence 310 1137999999999876543 33467999999
Q ss_pred ccccccCCccCCCCCCC
Q 001940 977 APELLSGKSHMVTEKEL 993 (993)
Q Consensus 977 APEVL~Gk~y~tse~DI 993 (993)
|||++.+..+ +.++||
T Consensus 261 aPE~~~~~~~-~~~~Di 276 (397)
T 1wak_A 261 SLEVLIGSGY-NTPADI 276 (397)
T ss_dssp CHHHHHTSCC-CTHHHH
T ss_pred CChhhcCCCC-CcHHHH
Confidence 9999988764 345553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=246.93 Aligned_cols=176 Identities=31% Similarity=0.592 Sum_probs=149.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
.+..++|++.+.||+|+||+||+|.++ +..||||++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 79 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------EVEEFLKEAAVMKEIKHPNLVQLLGVCT 79 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---------HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---------HHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 456678999999999999999999985 67799999874321 1346889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.+++||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 80 ~--~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~~l~ 153 (288)
T 3kfa_A 80 R--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVA 153 (288)
T ss_dssp S--SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred c--CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc----CCCCEEEc
Confidence 7 56799999999999999999864 34589999999999999999999999999999999999998 55789999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ......+|+.|+|||++.+..+
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 189 (288)
T 3kfa_A 154 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189 (288)
T ss_dssp CCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCC
T ss_pred cCccceeccCCccccccCCccccCcCChhhhccCCC
Confidence 999998664332 2234457889999999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=256.72 Aligned_cols=182 Identities=25% Similarity=0.351 Sum_probs=151.9
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchh---------HHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSE---------RERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~e---------re~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
...++|++++.||+|+||.||+|+++++.||||++........... .....+.+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 3457899999999999999999999999999999986543221100 0011247889999999999999999
Q ss_pred EEEEEEcCCCCcEEEEEeeccCCcHHHH------HHhc-cCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEE
Q 001940 868 FYGIVRDGPDGSLATVTEFMVNGSLKQF------LQKK-DRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLV 939 (993)
Q Consensus 868 L~G~f~d~s~~~L~LVmEYm~GGSL~dl------L~~~-~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILL 939 (993)
+++++.+ .+.+++||||+.+++|.++ +... ...+++..++.|+.||+.||.|||+ .+|+||||||+|||+
T Consensus 108 ~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 108 CEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred EEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999998 5789999999999999998 5542 4568999999999999999999999 999999999999999
Q ss_pred ccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCc
Q 001940 940 NMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 940 d~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+ .++.+||+|||++...... ......||+.|+|||++.+..
T Consensus 186 ~----~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 226 (348)
T 2pml_X 186 D----KNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNES 226 (348)
T ss_dssp C----TTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCC
T ss_pred c----CCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCC
Confidence 8 6678999999999876444 334567999999999998773
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=242.11 Aligned_cols=175 Identities=28% Similarity=0.475 Sum_probs=145.0
Q ss_pred CCceEEEEecccCceEEEEEEEc--Cc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt---~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
..|++.++||+|+||+||+|++. +. .||||++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-------EMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-------cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 35677899999999999999873 22 58999886421 12234578899999999999999999999986
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
. +...++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 94 ~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~----~~~~~kl~Df 168 (298)
T 3pls_A 94 P-EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD----ESFTVKVADF 168 (298)
T ss_dssp S-SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECCT
T ss_pred C-CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc----CCCcEEeCcC
Confidence 4 3445899999999999999988777789999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc-----ccCCCCCCCCccccccccCCcc
Q 001940 955 GLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 955 GLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+++...... ......||+.|+|||++.+..+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 205 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCC
Confidence 9998553321 2234568899999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.84 Aligned_cols=178 Identities=26% Similarity=0.453 Sum_probs=138.2
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++.+.||+|+||.||+|.. +++.||||+++...... ....+.+.+|+.++++++|+||+++++++..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 103 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD-----AKARADCIKEIDLLKQLNHPNVIKYYASFIE- 103 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCC-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-
Confidence 346799999999999999999987 47889999997543221 2234578899999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHh---ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQK---KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~---~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.+.+++||||+.+++|.+++.. ....+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 104 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~----~~~~~kl~ 178 (310)
T 2wqm_A 104 -DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT----ATGVVKLG 178 (310)
T ss_dssp -TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEEC
T ss_pred -CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEc----CCCCEEEE
Confidence 5789999999999999999875 345589999999999999999999999999999999999998 56789999
Q ss_pred ecCCcccccccc-ccCCCCCCCCccccccccCCcc
Q 001940 953 DLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 953 DFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+++...... ......||+.|+|||++.+..+
T Consensus 179 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (310)
T 2wqm_A 179 DLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 213 (310)
T ss_dssp CC------------------CCSSCCHHHHTTCCC
T ss_pred eccceeeecCCCccccccCCCeeEeChHHhCCCCC
Confidence 999988654332 2234569999999999987643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=246.08 Aligned_cols=178 Identities=25% Similarity=0.426 Sum_probs=146.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+++.+ ++.||+|++...... ....+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 78 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT 78 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC------HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence 467999999999999999999984 778999999754321 123457889999999999999999999987654
Q ss_pred CCcEEEEEeeccCCcHHHHHHhcc---CccCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEccCCCCCCe
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKD---RTIDRRKRLIIAMDAAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~---k~Lse~~~lkIalQIL~GLeYLHs~g-----IIHRDIKPeNILLd~~d~e~g~ 948 (993)
...+++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++ .++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~----~~~~ 154 (279)
T 2w5a_A 79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQN 154 (279)
T ss_dssp GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEEC----SSSC
T ss_pred CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEc----CCCC
Confidence 678999999999999999997542 34899999999999999999999999 99999999999998 6678
Q ss_pred EEEEecCCcccccccc-ccCCCCCCCCccccccccCCcc
Q 001940 949 CKIGDLGLSKVKQQTL-VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 193 (279)
T 2w5a_A 155 VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY 193 (279)
T ss_dssp EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-C
T ss_pred EEEecCchheeeccccccccccCCCccccChHHhccCCC
Confidence 9999999998654322 1223468999999999987643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-27 Score=262.55 Aligned_cols=180 Identities=24% Similarity=0.359 Sum_probs=133.5
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||.||+|.+ +++.||||++..... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc------CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 47899999999999999999987 477899999875321 1223457889999999999999999999987531
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~----~~~~~kL~ 174 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKIL 174 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEEC
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEEC----CCCCEEEe
Confidence 25689999999 8999999875 3589999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....||+.|+|||++.+...++.++||
T Consensus 175 DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 213 (367)
T 2fst_X 175 DFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDI 213 (367)
T ss_dssp C-----------------CCCTTCCHHHHTTCCSCCTTHHH
T ss_pred ecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhH
Confidence 99999875433 3346799999999999886667777664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=243.45 Aligned_cols=175 Identities=31% Similarity=0.580 Sum_probs=146.4
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..+..++|++++.||+|+||.||+|++++ ..||||+++..... .+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---------HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 34556789999999999999999999864 57999998754211 246789999999999999999999987
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ +.+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 79 ~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~----~~~~~kl~ 151 (279)
T 1qpc_A 79 Q---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIA 151 (279)
T ss_dssp S---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEEC
T ss_pred C---CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEc----CCCCEEEC
Confidence 5 45899999999999999997543 3589999999999999999999999999999999999998 66789999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCc
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
|||+++...... ......+|+.|+|||++.+..
T Consensus 152 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 186 (279)
T 1qpc_A 152 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186 (279)
T ss_dssp CCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE
T ss_pred CCcccccccCcccccccCCCCccCccChhhhccCC
Confidence 999998764432 223445788999999987544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.94 E-value=4.3e-27 Score=247.91 Aligned_cols=182 Identities=28% Similarity=0.410 Sum_probs=145.9
Q ss_pred CCCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc---CCCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L---rHPNIVrL~G~f 872 (993)
.++|++++.||+|+||.||+|++. ++.||||+++......... ..+.+|+.+++.+ +||||+++++++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~------~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 83 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 83 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCC------chhhHHHHHHHhhhccCCCCeEeeeeee
Confidence 468999999999999999999883 5679999997653321111 1344566666555 899999999998
Q ss_pred Ec---CCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 873 RD---GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 873 ~d---~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
.. .....+++||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~----~~~~ 158 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQ 158 (326)
T ss_dssp EEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCC
T ss_pred eecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEc----CCCC
Confidence 72 12467899999996 69999997653 3489999999999999999999999999999999999998 5678
Q ss_pred EEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+||+|||+++............||+.|+|||++.+..+ +.++|
T Consensus 159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~D 201 (326)
T 1blx_A 159 IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVD 201 (326)
T ss_dssp EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHH
T ss_pred EEEecCcccccccCCCCccccccccceeCHHHHhcCCC-Ccchh
Confidence 99999999987665544556779999999999987653 34444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=259.64 Aligned_cols=181 Identities=22% Similarity=0.296 Sum_probs=145.4
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
...+|++.+.||+|+||+||+|++. +..||+|++..... ...+|+.+|+.++||||++++++|....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~~~ 105 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYSNG 105 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEEES
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEecC
Confidence 3457999999999999999999984 45599998865321 1226899999999999999999986532
Q ss_pred ----CCcEEEEEeeccCCcHHHHHH--hccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~--~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
...+++||||+.++.+..+.. .....+++..++.|+.||+.||.|||+.+|+||||||+|||++. .++.+|
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~---~~~~~k 182 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP---PSGVLK 182 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEE
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcC---CCCcEE
Confidence 223889999997654443332 23456899999999999999999999999999999999999972 357899
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+|+............||+.|+|||++.+...++.++||
T Consensus 183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (394)
T 4e7w_A 183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDI 225 (394)
T ss_dssp ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHH
Confidence 9999999877555555567899999999999887777777664
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=251.19 Aligned_cols=177 Identities=33% Similarity=0.496 Sum_probs=143.7
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--Ccc--eEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~--VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G 870 (993)
.+..++|++.+.||+|+||.||+|+++ +.. ||||+++.... ....+.+.+|+.+++++ +||||+++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~-------~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 93 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLG 93 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccc-------hHHHHHHHHHHHHHHhccCCCchhhhce
Confidence 345578999999999999999999874 443 49998874321 12234688999999999 8999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCE 935 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPe 935 (993)
++.+ .+.+++||||+++++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+
T Consensus 94 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 171 (327)
T 1fvr_A 94 ACEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171 (327)
T ss_dssp EEEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eeee--CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence 9988 578999999999999999997653 35899999999999999999999999999999999
Q ss_pred CEEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCc
Q 001940 936 NLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 936 NILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
|||++ .++.+||+|||+++............+|+.|+|||++.+..
T Consensus 172 NIl~~----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 172 NILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp GEEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE
T ss_pred eEEEc----CCCeEEEcccCcCccccccccccCCCCCccccChhhhcccc
Confidence 99998 56789999999998554433333455788999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=246.29 Aligned_cols=182 Identities=24% Similarity=0.367 Sum_probs=142.1
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||.||+|+++ ++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 80 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD--------PQSVKHALREIKIIRRLDHDNIVKVFEILGPS 80 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS--------HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTT
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC--------hHHHHHHHHHHHHHHhcCCCCeeEEEEecccc
Confidence 4578999999999999999999985 7789999987431 22345788999999999999999999998532
Q ss_pred ------------CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC
Q 001940 876 ------------PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 876 ------------s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d 943 (993)
....+++||||+. ++|.+++.+. .+++..++.|+.||+.||.|||+.+|+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~-- 155 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT-- 155 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET--
T ss_pred ccccccccccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC--
Confidence 2367899999996 6999999653 4889999999999999999999999999999999999972
Q ss_pred CCCCeEEEEecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 944 PQRPVCKIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.++.+||+|||+++...... ......||..|+|||++.+....+.++||
T Consensus 156 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 156 -EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp -TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred -CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 34689999999998654321 12334579999999998775555555553
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=251.40 Aligned_cols=182 Identities=29% Similarity=0.498 Sum_probs=146.3
Q ss_pred cccccCCCceEEEEecccCceEEEEEEE-------cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcc
Q 001940 794 LQTIKNDDLEEVRELGSGTYGSVYHGKW-------RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 794 i~~i~~ddYeile~LGeGgFGtVYKAk~-------kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIV 866 (993)
...+..++|++++.||+|+||.||+|++ .+..||||++.... .......+.+|+.++++++||||+
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv 96 (327)
T 2yfx_A 24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-------SEQDELDFLMEALIISKFNHQNIV 96 (327)
T ss_dssp SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-------CHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-------chhhHHHHHHHHHHHhhCCCCCCC
Confidence 4456678899999999999999999984 35579999986431 112234788999999999999999
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEc
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVN 940 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd 940 (993)
++++++.+ .+.+++||||+.+++|.+++.... ..+++..++.++.||+.||.|||+.+|+||||||+|||++
T Consensus 97 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~ 174 (327)
T 2yfx_A 97 RCIGVSLQ--SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174 (327)
T ss_dssp CEEEEECS--SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred eEEEEEcC--CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEe
Confidence 99999987 467899999999999999998653 3488999999999999999999999999999999999998
Q ss_pred cCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCc
Q 001940 941 MRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 941 ~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
.++ ....+||+|||+++...... ......||+.|+|||++.+..
T Consensus 175 ~~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 221 (327)
T 2yfx_A 175 CPG-PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221 (327)
T ss_dssp CSS-TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC
T ss_pred cCC-CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC
Confidence 544 45679999999987543221 223346899999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=246.11 Aligned_cols=182 Identities=23% Similarity=0.308 Sum_probs=148.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEE---cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC------Ccc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW---RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP------NVV 866 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~---kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP------NIV 866 (993)
.+..++|++++.||+|+||+||+|.+ .++.||||+++.. ....+.+.+|+.+++.++|+ +|+
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 80 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---------DRYCEAARSEIQVLEHLNTTDPNSTFRCV 80 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHHCTTCTTCBC
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---------CchhHHHHHHHHHHHHhhhcCCCCceeeE
Confidence 34467899999999999999999987 3677999998742 12235677899999888765 499
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCC-
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDP- 944 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~- 944 (993)
++++++.. .+.+++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++..+.
T Consensus 81 ~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 81 QMLEWFEH--HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp CEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred eeeccccc--CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 99999988 57899999999 899999997654 35889999999999999999999999999999999999984321
Q ss_pred --------------CCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 945 --------------QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 945 --------------e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
.++.+||+|||+++..... .....||+.|+|||++.+..+ +.++|
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~D 216 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGW-SQPCD 216 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCC-CTHHH
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCC-Ccchh
Confidence 0567999999999865433 235679999999999987654 34444
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-28 Score=261.00 Aligned_cols=181 Identities=14% Similarity=0.087 Sum_probs=131.1
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc--CCCCcceEE------
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL--HHPNVVSFY------ 869 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L--rHPNIVrL~------ 869 (993)
.+|++.+.||+|+||+||+|++. ++.||||++...... .....+.+.+|+.+++.| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-----SRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-----HHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-----cccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 35999999999999999999974 678999999875321 223345677785544444 699988755
Q ss_pred -EEEEcCCC---------------CcEEEEEeeccCCcHHHHHHhccCccCHHHH------HHHHHHHHHHHHHHHhCCc
Q 001940 870 -GIVRDGPD---------------GSLATVTEFMVNGSLKQFLQKKDRTIDRRKR------LIIAMDAAFGMEYLHGKNI 927 (993)
Q Consensus 870 -G~f~d~s~---------------~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~------lkIalQIL~GLeYLHs~gI 927 (993)
+++..... ..+||||||+. ++|.+++......+.+..+ +.|+.||+.||.|||+++|
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 55543221 34899999997 8999999876555566666 7888999999999999999
Q ss_pred eecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCC-ccCCCCCC
Q 001940 928 VHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK-SHMVTEKE 992 (993)
Q Consensus 928 IHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk-~y~tse~D 992 (993)
+||||||+||||+ .++.+||+|||+|+....... ...+|+.|+|||++.+. ..++.++|
T Consensus 216 vHrDikp~NIll~----~~~~~kL~DFG~a~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~~D 275 (371)
T 3q60_A 216 VHGHFTPDNLFIM----PDGRLMLGDVSALWKVGTRGP--ASSVPVTYAPREFLNASTATFTHALN 275 (371)
T ss_dssp EETTCSGGGEEEC----TTSCEEECCGGGEEETTCEEE--GGGSCGGGCCHHHHTCSEEECCHHHH
T ss_pred ccCcCCHHHEEEC----CCCCEEEEecceeeecCCCcc--CccCCcCCcChhhccCCCCCcCcccc
Confidence 9999999999998 667899999999987654321 34577999999999762 23344444
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-27 Score=248.41 Aligned_cols=178 Identities=25% Similarity=0.301 Sum_probs=143.9
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||++.+ +++.||||+++....... ....+.+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI----PNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS----TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc----chhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 36799999999999999999998 467899999986432110 112357889999999999999999999997655
Q ss_pred CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
...+++||||+.++ |.+++... ...+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~----~~~~~kl~dfg 154 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT----TGGTLKISALG 154 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCCT
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc----CCCcEEeeccc
Confidence 67899999999766 77777653 45689999999999999999999999999999999999998 56789999999
Q ss_pred Cccccccc---cccCCCCCCCCccccccccCCc
Q 001940 956 LSKVKQQT---LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 956 LAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
++...... .......||+.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (305)
T 2wtk_C 155 VAEALHPFAADDTCRTSQGSPAFQPPEIANGLD 187 (305)
T ss_dssp TCEECCTTCSSCEECCCCSCGGGCCHHHHTCCS
T ss_pred cccccCccccccccccCCCCCCCcChhhccCcc
Confidence 99865422 2233556999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=244.18 Aligned_cols=174 Identities=28% Similarity=0.371 Sum_probs=145.3
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++.+.||+|+||.||+++.. ++.||||+++..... ..+.+.+|+.++++++||||+++++++.+ .
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 78 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--------RDSSLENEIAVLKKIKHENIVTLEDIYES--T 78 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEEC--S
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--------chHHHHHHHHHHHhCCCCCeeehhhhccc--C
Confidence 56999999999999999999984 788999999854211 12357789999999999999999999987 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++||||+.+++|.+++.... .+++..++.++.||+.||.|||+.+|+||||||+|||+...+ .++.+||+|||++
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~-~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 79 THYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE-ENSKIMITDFGLS 156 (304)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS-TTCCEEBCSCSTT
T ss_pred CEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC-CCCCEEEccCCcc
Confidence 78999999999999999987654 488999999999999999999999999999999999994322 5678999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCcc
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+...... .....||+.|+|||++.+..+
T Consensus 157 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 184 (304)
T 2jam_A 157 KMEQNGI-MSTACGTPGYVAPEVLAQKPY 184 (304)
T ss_dssp CCCCCBT-THHHHSCCCBCCTTTBSSCSC
T ss_pred eecCCCc-cccccCCCCccChHHhccCCC
Confidence 8654332 223468999999999987643
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=254.53 Aligned_cols=183 Identities=20% Similarity=0.219 Sum_probs=141.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-----CcceEEEEeeccccCCCchhHH------HHHHHHHHHHHHHhhcCCCC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-----GSDVAIKRIKASCFAGKPSERE------RLIADFWKEALLLSSLHHPN 864 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-----gt~VAVKvIkk~~~~~k~~ere------~~ie~f~rEi~ILr~LrHPN 864 (993)
.+..++|++.+.||+|+||+||+|++. +..||||++..... ...++ .....+.+|+.+++.++|||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG---PLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C---HHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc---chHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 345678999999999999999999984 46799999875421 11111 11234678899999999999
Q ss_pred cceEEEEEEcC--CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccC
Q 001940 865 VVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMR 942 (993)
Q Consensus 865 IVrL~G~f~d~--s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~ 942 (993)
|+++++++... ....+++||||+ +++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++.+
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 99999998762 246799999999 999999997665 68999999999999999999999999999999999999833
Q ss_pred CCCCCeEEEEecCCcccccccc--------ccCCCCCCCCccccccccCCc
Q 001940 943 DPQRPVCKIGDLGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 943 d~e~g~VKLiDFGLAk~~~~~~--------~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
+ .+.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 188 ~--~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 236 (345)
T 2v62_A 188 N--PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA 236 (345)
T ss_dssp S--TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC
T ss_pred C--CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC
Confidence 2 2389999999998653321 113457999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=244.06 Aligned_cols=178 Identities=33% Similarity=0.535 Sum_probs=138.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc---Cc--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR---GS--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k---gt--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
.+..++|++++.||+|+||+||+|+++ ++ .||||+++...... ....+.+.+|+.++++++||||+++++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~ 88 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFIREVNAMHSLDHRNLIRLYG 88 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCC-----HHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence 455678999999999999999999873 22 48999987543221 123467889999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
++... .+++||||+.+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ .++.+|
T Consensus 89 ~~~~~---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~----~~~~~k 161 (291)
T 1u46_A 89 VVLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVK 161 (291)
T ss_dssp EECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEE
T ss_pred EEccC---CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc----CCCCEE
Confidence 99863 38999999999999999987766789999999999999999999999999999999999998 567999
Q ss_pred EEecCCcccccccc----ccCCCCCCCCccccccccCCc
Q 001940 951 IGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 951 LiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
|+|||+++...... ......+|+.|+|||++.+..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence 99999998654322 123445788999999987654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=255.80 Aligned_cols=179 Identities=27% Similarity=0.376 Sum_probs=145.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|.+. ++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 114 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 114 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc------chhHHHHHHHHHHHHHhcCCCCchhhhhheeccC
Confidence 468999999999999999999884 77899999875421 2233467889999999999999999999998742
Q ss_pred CC----cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 DG----SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~~----~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.. .+++||||+. ++|.+++.. .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 115 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~----~~~~~kL~ 186 (371)
T 4exu_A 115 SLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKIL 186 (371)
T ss_dssp SSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEEC
T ss_pred CcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEEC----CCCCEEEE
Confidence 21 2499999995 788888743 389999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....||+.|+|||++.+....+.++||
T Consensus 187 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 225 (371)
T 4exu_A 187 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDI 225 (371)
T ss_dssp STTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHH
T ss_pred ecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhH
Confidence 99999865443 3356789999999999886666666664
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=243.30 Aligned_cols=177 Identities=28% Similarity=0.432 Sum_probs=143.2
Q ss_pred ccccCCCceEEE-EecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 795 QTIKNDDLEEVR-ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 795 ~~i~~ddYeile-~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
..+...+|++.+ .||+|+||.||+|.+. ++.||||+++.... .....+.+.+|+.+++.++||||++++
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~ 84 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMI 84 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc------CHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 345567899998 9999999999999663 46699999875421 122345788999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.. +.+++||||+.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+
T Consensus 85 ~~~~~---~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~----~~~~~ 156 (291)
T 1xbb_A 85 GICEA---ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYA 156 (291)
T ss_dssp EEEES---SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEE
T ss_pred EEECC---CCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe----CCCcE
Confidence 99943 56899999999999999998754 489999999999999999999999999999999999998 56799
Q ss_pred EEEecCCccccccccc----cCCCCCCCCccccccccCCc
Q 001940 950 KIGDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+|||+++....... .....||+.|+|||++.+..
T Consensus 157 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 196 (291)
T 1xbb_A 157 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196 (291)
T ss_dssp EECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred EEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC
Confidence 9999999986543321 12234678999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=260.18 Aligned_cols=175 Identities=26% Similarity=0.465 Sum_probs=136.5
Q ss_pred CCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
..|++.+.||+|+||+||+|++.. ..||||+++... . ....+.+.+|+.++++++||||+++++++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--D-----IGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--C-----SHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--C-----HHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 358889999999999999998732 248999886421 1 1224578899999999999999999999765
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
. .+..++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 162 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~----~~~~~kL~DF 236 (373)
T 3c1x_A 162 S-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADF 236 (373)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECCC
T ss_pred C-CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEEC----CCCCEEEeec
Confidence 3 4578999999999999999987777789999999999999999999999999999999999998 6679999999
Q ss_pred CCcccccccc-----ccCCCCCCCCccccccccCCcc
Q 001940 955 GLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 955 GLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|+++...... ......+|+.|+|||++.+..+
T Consensus 237 G~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 273 (373)
T 3c1x_A 237 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273 (373)
T ss_dssp ---------------------CCGGGSCHHHHHHCCC
T ss_pred cccccccccccccccccCCCCCcccccChHHhcCCCC
Confidence 9998653321 1233457889999999976543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=249.63 Aligned_cols=183 Identities=22% Similarity=0.311 Sum_probs=145.1
Q ss_pred CCceEE-EEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcC
Q 001940 800 DDLEEV-RELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (993)
Q Consensus 800 ddYeil-e~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~ 875 (993)
+.|.+. +.||+|+||+||+|+.. ++.||||+++....... ....+.+|+.+++.+. ||||+++++++.+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~- 100 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQD------CRAEILHEIAVLELAKSCPRVINLHEVYEN- 100 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEE------CHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchH------HHHHHHHHHHHHHhccCCCCEEEEEEEEEe-
Confidence 356676 89999999999999885 78899999986532211 1246788999999995 6999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+.+++|.+++... ...+++..++.|+.||+.||.|||+.+|+||||||+|||++... ..+.+||+||
T Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~-~~~~~kL~Df 178 (327)
T 3lm5_A 101 -TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY-PLGDIKIVDF 178 (327)
T ss_dssp -SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT-TBCCEEECCG
T ss_pred -CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC-CCCcEEEeeC
Confidence 57799999999999999998643 35689999999999999999999999999999999999998432 3578999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+++............||+.|+|||++.+..+. .+.|
T Consensus 179 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~D 215 (327)
T 3lm5_A 179 GMSRKIGHACELREIMGTPEYLAPEILNYDPIT-TATD 215 (327)
T ss_dssp GGCEEC---------CCCGGGCCHHHHTTCCCC-THHH
T ss_pred ccccccCCccccccccCCcCccCCeeecCCCCC-chhh
Confidence 999877655445567899999999999876543 3444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=244.72 Aligned_cols=180 Identities=28% Similarity=0.425 Sum_probs=137.5
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|++.+.||+|+||.||+|++.. ..||||+++.... .....+.+.+|+.++++++||||++++++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS------SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC------CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc------chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 455789999999999999999998742 3699999875421 12234578899999999999999999999
Q ss_pred EEcCCCC---cEEEEEeeccCCcHHHHHHh-----ccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC
Q 001940 872 VRDGPDG---SLATVTEFMVNGSLKQFLQK-----KDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 872 f~d~s~~---~L~LVmEYm~GGSL~dlL~~-----~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d 943 (993)
+.+.... ..++||||+.+++|.+++.. ....+++..++.|+.||+.||.|||+.+|+||||||+|||++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~--- 181 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--- 181 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC---
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---
Confidence 9874322 46999999999999999853 234589999999999999999999999999999999999998
Q ss_pred CCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCcc
Q 001940 944 PQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 944 ~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
.++.+||+|||+++...... ......+|+.|+|||++.+..+
T Consensus 182 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 182 -DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp -TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred -CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence 56789999999998654322 1223457889999999986543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=263.89 Aligned_cols=174 Identities=32% Similarity=0.584 Sum_probs=141.8
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.+..++|++.++||+|+||.||+|++++ ..||||+++..... .+.|.+|+.+|++++||||+++++++.+
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 250 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 4556789999999999999999999965 56999999854311 1368899999999999999999999875
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+.+++||||+.+|+|.++|... ...+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|
T Consensus 251 ---~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~----~~~~~kl~D 323 (452)
T 1fmk_A 251 ---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVAD 323 (452)
T ss_dssp ---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECC
T ss_pred ---CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC----CCCCEEECC
Confidence 4689999999999999999753 34589999999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCc
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+++...... ......+|+.|+|||++.+..
T Consensus 324 fG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 357 (452)
T 1fmk_A 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357 (452)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCC
T ss_pred CccceecCCCceecccCCcccccccCHhHHhcCC
Confidence 99998754332 123345788999999987654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=251.01 Aligned_cols=170 Identities=16% Similarity=0.190 Sum_probs=142.2
Q ss_pred cCCCceEEEEecccCceEEEEEEEc----------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcce
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR----------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVS 867 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k----------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVr 867 (993)
..++|++.+.||+|+||.||+|++. ++.||||++... +.+.+|+.++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv~ 106 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQVN 106 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchhh
Confidence 3578999999999999999999884 568999998753 24678999999999999987
Q ss_pred ---------------EEEEEEcCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 868 ---------------FYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 868 ---------------L~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
+++++... .+.+++||||+ +++|.+++... ...+++..++.|+.||+.||.|||+.+|+|||
T Consensus 107 ~~~~~~~~~~~~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 184 (352)
T 2jii_A 107 KWKKLYSTPLLAIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184 (352)
T ss_dssp HHHHHTTCTTCSCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred hhhhhccCCccCccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 66776653 46899999999 99999999875 35699999999999999999999999999999
Q ss_pred CCCCCEEEccCCCCCC--eEEEEecCCcccccccc--------ccCCCCCCCCccccccccCCcc
Q 001940 932 LKCENLLVNMRDPQRP--VCKIGDLGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 932 IKPeNILLd~~d~e~g--~VKLiDFGLAk~~~~~~--------~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
|||+|||++ .++ .+||+|||+++...... ......||+.|+|||++.+..+
T Consensus 185 ikp~NIl~~----~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (352)
T 2jii_A 185 VTAENIFVD----PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP 245 (352)
T ss_dssp CCGGGEEEE----TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred CCHHHEEEc----CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence 999999998 455 89999999998654322 1134579999999999987643
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=244.38 Aligned_cols=173 Identities=25% Similarity=0.390 Sum_probs=128.9
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||.||+|+++ ++.||||++..... .....+.+.++..+++.++||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~- 95 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN------KEENKRILMDLDVVLKSHDCPYIVQCFGTFIT- 95 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC------HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCceeeEEEEEec-
Confidence 4568999999999999999999984 78899999975421 12223345556667889999999999999988
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+++||||+ ++.+..++......+++..++.|+.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 96 -~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~----~~~~~kl~df 169 (318)
T 2dyl_A 96 -NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD----ERGQIKLCDF 169 (318)
T ss_dssp -SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEEC----TTSCEEECCC
T ss_pred -CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEEC----CCCCEEEEEC
Confidence 56899999999 6777777766566789999999999999999999996 999999999999998 5678999999
Q ss_pred CCccccccccccCCCCCCCCccccccccC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
|+++............||+.|+|||++.+
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp TTC--------------CCTTCCHHHHC-
T ss_pred CCchhccCCccccccCCCccccChhhccc
Confidence 99987655444445679999999999963
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=242.86 Aligned_cols=174 Identities=32% Similarity=0.442 Sum_probs=142.0
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|.....||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 90 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--------RYSQPLHEEIALHKHLKHKNIVQYLGSFSE- 90 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------HHHHHHHHHHHTCCCTTBCCEEEEEEE-
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--------HHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-
Confidence 344555556899999999999998 467799999875421 123468899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+++||||+.+++|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+|||++. .++.+||+|
T Consensus 91 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~---~~~~~kl~D 166 (295)
T 2clq_A 91 -NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT---YSGVLKISD 166 (295)
T ss_dssp -TTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTCCEEECC
T ss_pred -CCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC---CCCCEEEee
Confidence 578999999999999999998653 24568888999999999999999999999999999999982 257899999
Q ss_pred cCCccccccc-cccCCCCCCCCccccccccCC
Q 001940 954 LGLSKVKQQT-LVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 954 FGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk 984 (993)
||+++..... .......||+.|+|||++.+.
T Consensus 167 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (295)
T 2clq_A 167 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198 (295)
T ss_dssp TTTCEESCC-----CCCCCCGGGCCHHHHHHG
T ss_pred cccccccCCCCCcccccCCCccccChhhhcCC
Confidence 9999865432 223456799999999999754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-27 Score=269.00 Aligned_cols=175 Identities=32% Similarity=0.575 Sum_probs=147.4
Q ss_pred ccccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
..+..++|++.++||+|+||.||+|++++ ..||||+++..... .+.|.+|+.+|++|+|+||+++++++.
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~E~~~l~~l~hpniv~~~~~~~ 332 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVS 332 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---------HHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34566789999999999999999999965 56999999854311 136889999999999999999999987
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ +.++||||||.+|+|.++|... ...+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+||+
T Consensus 333 ~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~----~~~~~kl~ 405 (535)
T 2h8h_A 333 E---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVA 405 (535)
T ss_dssp S---SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred e---ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc----CCCcEEEc
Confidence 5 5689999999999999999753 34589999999999999999999999999999999999998 56789999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCc
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
|||+++...... ......+|+.|+|||++.+..
T Consensus 406 DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 440 (535)
T 2h8h_A 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440 (535)
T ss_dssp CTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC
T ss_pred ccccceecCCCceecccCCcCcccccCHHHhccCC
Confidence 999998764332 223445788999999987654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=258.42 Aligned_cols=179 Identities=21% Similarity=0.251 Sum_probs=145.2
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc------CCCCcceEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL------HHPNVVSFY 869 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L------rHPNIVrL~ 869 (993)
...+|+++++||+|+||+||+|++. ++.||||+++... ...+.+.+|+.+++.+ .|+||++++
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK---------RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc---------chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 4567999999999999999999884 6789999987431 1224566777777776 577999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCe
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPV 948 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~ 948 (993)
+++.. .+.+++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+||||+.++ ...
T Consensus 166 ~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~--~~~ 240 (429)
T 3kvw_A 166 ENFTF--RNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG--RSG 240 (429)
T ss_dssp EEEEE--TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT--SCC
T ss_pred eeccc--CCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC--Ccc
Confidence 99998 57899999999 479999987654 4589999999999999999999999999999999999998332 123
Q ss_pred EEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 949 CKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 949 VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+||+|||+|+..... ....+||+.|+|||++.+..+ +.++||
T Consensus 241 vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di 282 (429)
T 3kvw_A 241 IKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARY-GMPIDM 282 (429)
T ss_dssp EEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCC-CTHHHH
T ss_pred eEEeecccceecCCc--ccccCCCCCccChHHHhCCCC-CchHHH
Confidence 999999999765443 335679999999999988764 445553
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.2e-27 Score=247.02 Aligned_cols=173 Identities=27% Similarity=0.427 Sum_probs=125.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHH-HHhhcCCCCcceEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEAL-LLSSLHHPNVVSFYGIV 872 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~-ILr~LrHPNIVrL~G~f 872 (993)
.+..++|++++.||+|+||.||+|.++ ++.||||+++.... ......+.+|+. +++.++||||+++++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~~~~h~niv~~~~~~ 90 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-------EKEQKQLLMDLDVVMRSSDCPYIVQFYGAL 90 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-------HHHHHHHHHHHHHHHSSCCCTTBCCEEEEE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-------chHHHHHHHHHHHHHHcCCCCcEeeeeeEE
Confidence 456688999999999999999999985 78899999975421 111234445555 77888999999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHh----ccCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEEEccCCCCCC
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQK----KDRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRP 947 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~----~~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNILLd~~d~e~g 947 (993)
.+ .+.+++||||+. ++|.+++.. ....+++..+..|+.|++.||.|||+. +|+||||||+|||++ .++
T Consensus 91 ~~--~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~----~~~ 163 (327)
T 3aln_A 91 FR--EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD----RSG 163 (327)
T ss_dssp EC--SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE----TTT
T ss_pred Ee--CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc----CCC
Confidence 87 578999999996 588887763 245689999999999999999999998 999999999999998 667
Q ss_pred eEEEEecCCccccccccccCCCCCCCCcccccccc
Q 001940 948 VCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 948 ~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
.+||+|||+++............||+.|+|||++.
T Consensus 164 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERID 198 (327)
T ss_dssp EEEECCCSSSCC-----------------------
T ss_pred CEEEccCCCceecccccccccCCCCccccCceeec
Confidence 99999999998765544444557999999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-27 Score=250.89 Aligned_cols=179 Identities=27% Similarity=0.376 Sum_probs=145.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++.+.||+|+||.||+|.++ ++.||||++..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 96 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ------SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS 96 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEeccccc------chHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence 468999999999999999999884 77899999875321 2233457889999999999999999999998742
Q ss_pred C----CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 D----GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ~----~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
. ..+++||||+. ++|.+++.. .+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~----~~~~~kl~ 168 (353)
T 3coi_A 97 SLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN----EDCELKIL 168 (353)
T ss_dssp SGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC----TTCCEEEC
T ss_pred ccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeEC----CCCcEEEe
Confidence 2 23599999996 688887743 389999999999999999999999999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++..... .....||+.|+|||++.+....+.++||
T Consensus 169 Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 207 (353)
T 3coi_A 169 DFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDI 207 (353)
T ss_dssp STTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHH
T ss_pred ecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhH
Confidence 99999865433 2345789999999999886666666664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=269.34 Aligned_cols=181 Identities=31% Similarity=0.480 Sum_probs=144.0
Q ss_pred ccCCCceEEE-EecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVR-ELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile-~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..+++.+.+ .||+|+||.||+|.++ +..||||+++..... ...+.+.+|+.+|++++|||||+++++
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-------~~~~~~~~E~~il~~l~hpniv~l~~~ 404 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-------ADTEEMMREAQIMHQLDNPYIVRLIGV 404 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS-------TTHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh-------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3455666666 8999999999999874 345999999864211 113478899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.. +.+++|||||.+|+|.++|......+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||
T Consensus 405 ~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~----~~~~vkL 477 (613)
T 2ozo_A 405 CQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV----NRHYAKI 477 (613)
T ss_dssp EES---SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred ecc---CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc----CCCcEEE
Confidence 976 458999999999999999987766799999999999999999999999999999999999998 5679999
Q ss_pred EecCCccccccccc----cCCCCCCCCccccccccCCccCCCCCC
Q 001940 952 GDLGLSKVKQQTLV----SGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 952 iDFGLAk~~~~~~~----s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+|||+++....... .....+|+.|+|||++.+..+ +.++|
T Consensus 478 ~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sD 521 (613)
T 2ozo_A 478 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSD 521 (613)
T ss_dssp CCCSTTTTCC--------------CCTTSCHHHHHHCCC-CHHHH
T ss_pred eeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCC-CcHHH
Confidence 99999987543211 122346789999999976543 33444
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=250.78 Aligned_cols=175 Identities=30% Similarity=0.440 Sum_probs=143.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.+..++|++.+.||+|+||.||+|++++ .||||+++........ .+.+.+|+.++++++|+||+++++++.+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 100 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQ------LKAFKREVMAYRQTRHENVVLFMGACMS- 100 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCC------CCCCCTTGGGGTTCCCTTBCCCCEEEEC-
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHH------HHHHHHHHHHHhcCCCCCEeEEEEEEec-
Confidence 4566889999999999999999999876 5999998764322111 1246678999999999999999999997
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+.+++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ ++.+||+|||
T Consensus 101 -~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-----~~~~~l~Dfg 174 (319)
T 2y4i_B 101 -PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-----NGKVVITDFG 174 (319)
T ss_dssp -SSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-------CCEECCCS
T ss_pred -CCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-----CCCEEEeecC
Confidence 4679999999999999999987766789999999999999999999999999999999999996 3579999999
Q ss_pred Cccccccc------cccCCCCCCCCccccccccCC
Q 001940 956 LSKVKQQT------LVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 956 LAk~~~~~------~~s~s~~GTp~YmAPEVL~Gk 984 (993)
+++..... .......||+.|+|||++.+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 209 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCB
T ss_pred CccccccccccccccccccCCCcccccChHHhhhc
Confidence 98754211 122334589999999999863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=263.38 Aligned_cols=175 Identities=31% Similarity=0.476 Sum_probs=139.1
Q ss_pred ccccCCCceEEEEecccCceE-EEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEE
Q 001940 795 QTIKNDDLEEVRELGSGTYGS-VYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIV 872 (993)
Q Consensus 795 ~~i~~ddYeile~LGeGgFGt-VYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f 872 (993)
..+...+|++.+.||+|+||+ ||++..+++.||||++...... .+.+|+.+|+.+ +|||||++++++
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----------~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----------FADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----------ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred EEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----------HHHHHHHHHHhccCCCCcCeEEEEE
Confidence 345556799999999999998 5566778999999998754321 245789999999 799999999999
Q ss_pred EcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEE
Q 001940 873 RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKI 951 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKL 951 (993)
.+ ...+|+||||+. |+|.+++........+..++.|+.||+.||.|||+.+|+||||||+|||++..+ .....+||
T Consensus 88 ~~--~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 88 KD--RQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EE--TTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred ec--CCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 87 577999999995 699999987665556666778999999999999999999999999999996432 13456889
Q ss_pred EecCCccccccc----cccCCCCCCCCccccccccC
Q 001940 952 GDLGLSKVKQQT----LVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 952 iDFGLAk~~~~~----~~s~s~~GTp~YmAPEVL~G 983 (993)
+|||+|+..... .......||+.|+|||++.+
T Consensus 165 ~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp CCTTEEECC------------CCSCTTSCCGGGTSC
T ss_pred ecccceeeccCCCcceeeccccCCCcCccChhhhhc
Confidence 999999876433 12345679999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=249.68 Aligned_cols=184 Identities=23% Similarity=0.294 Sum_probs=149.3
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-----------C
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----------H 862 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-----------H 862 (993)
.+..++|++++.||+|+||+||+|++ +++.||||++.... ...+.+.+|+.+++++. |
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc---------cchhhhhHHHHHHHHhhcccccchhcccc
Confidence 34567899999999999999999997 47789999987431 12346778888888886 8
Q ss_pred CCcceEEEEEEcCC--CCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCCEE
Q 001940 863 PNVVSFYGIVRDGP--DGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGK-NIVHFDLKCENLL 938 (993)
Q Consensus 863 PNIVrL~G~f~d~s--~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~-gIIHRDIKPeNIL 938 (993)
+||+++++++.... ...+++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+|||
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 99999999988632 22789999999 99999999864 34589999999999999999999998 9999999999999
Q ss_pred EccCC--CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 939 VNMRD--PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 939 Ld~~d--~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
++..+ ...+.+||+|||+++..... .....||+.|+|||++.+..+ +.++|
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~D 217 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW-GCGAD 217 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC-CTHHH
T ss_pred EeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCC-CchHh
Confidence 96432 24458999999999876543 234579999999999988754 44444
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-27 Score=247.65 Aligned_cols=186 Identities=21% Similarity=0.267 Sum_probs=143.6
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc----CCCCcceEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL----HHPNVVSFYGI 871 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L----rHPNIVrL~G~ 871 (993)
..++|++.+.||+|+||.||+|++ +++.||||++......... .......+.+|+.+++++ +|+||++++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS--PLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc--cchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 457899999999999999999988 4778999999765332111 111123456788899888 89999999999
Q ss_pred EEcCCCCcEEEEEee-ccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 872 VRDGPDGSLATVTEF-MVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 872 f~d~s~~~L~LVmEY-m~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+.. .+..++|||| +.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++. .++.+|
T Consensus 107 ~~~--~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~---~~~~~k 180 (312)
T 2iwi_A 107 FET--QEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL---RRGCAK 180 (312)
T ss_dssp C-------CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET---TTTEEE
T ss_pred Eec--CCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC---CCCeEE
Confidence 887 4678999999 78999999998754 4899999999999999999999999999999999999972 346899
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+|||+++...... .....||..|+|||++.+..+...+.|
T Consensus 181 l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~D 221 (312)
T 2iwi_A 181 LIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPAT 221 (312)
T ss_dssp ECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHH
T ss_pred EEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccch
Confidence 99999998765443 345679999999999987666544444
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=247.37 Aligned_cols=189 Identities=20% Similarity=0.227 Sum_probs=151.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC--CCCcceEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGI 871 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr--HPNIVrL~G~ 871 (993)
....++|++.+.||+|+||.||+|++ +++.||||+++.......... ...+.+.+|+.++++++ |+||++++++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 34567899999999999999999988 477899999986543221000 00124567899999996 5999999999
Q ss_pred EEcCCCCcEEEEEeeccC-CcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 872 VRDGPDGSLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~G-GSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+.. .+.+++||||+.+ ++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++. .++.+|
T Consensus 117 ~~~--~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~---~~~~~k 190 (320)
T 3a99_A 117 FER--PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL---NRGELK 190 (320)
T ss_dssp EEC--SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEE
T ss_pred Eec--CCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC---CCCCEE
Confidence 987 5679999999976 89999998754 4899999999999999999999999999999999999972 346899
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++...... .....||+.|+|||++.+..+.+.++||
T Consensus 191 L~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di 232 (320)
T 3a99_A 191 LIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAV 232 (320)
T ss_dssp ECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHH
T ss_pred EeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchH
Confidence 99999998765442 3346799999999999877665554453
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=243.18 Aligned_cols=176 Identities=24% Similarity=0.312 Sum_probs=142.6
Q ss_pred ccccccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC--CCCcceEE
Q 001940 793 GLQTIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFY 869 (993)
Q Consensus 793 ~i~~i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr--HPNIVrL~ 869 (993)
....+..++|++++.||+|+||.||++++. ++.||||++..... .....+.+.+|+.++++++ |+||++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~~iv~~~ 94 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA------DNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC------CHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc------cccchHHHHHHHHHHHhccccCCceEEEE
Confidence 444566778999999999999999999884 67799999975422 1233467889999999997 59999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
+++.+ .+.+++||| +.+++|.+++.... .+++..++.|+.||+.||.|||+.+|+||||||+|||++ ++.+
T Consensus 95 ~~~~~--~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-----~~~~ 165 (313)
T 3cek_A 95 DYEIT--DQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGML 165 (313)
T ss_dssp EEEEC--SSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-----TTEE
T ss_pred EEeec--CCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-----CCeE
Confidence 99987 567999999 55899999998754 588999999999999999999999999999999999996 2689
Q ss_pred EEEecCCcccccccc---ccCCCCCCCCccccccccC
Q 001940 950 KIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 950 KLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~G 983 (993)
||+|||+++...... ......||+.|+|||++.+
T Consensus 166 kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp EECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred EEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence 999999998654332 1234569999999999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=239.38 Aligned_cols=182 Identities=20% Similarity=0.288 Sum_probs=146.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--C-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC------cc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--G-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN------VV 866 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--g-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN------IV 866 (993)
.+..++|++++.||+|+||+||+|.+. + +.||||+++... ...+.+.+|+.+++.++|++ |+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 85 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG---------KYREAARLEINVLKKIKEKDKENKFLCV 85 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHHCTTSCSCBC
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc---------cchhHHHHHHHHHHHHhhcCCCCceeEE
Confidence 344678999999999999999999884 3 579999987421 12346778999999987666 89
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC--
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-- 943 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-- 943 (993)
.+++++.. .+.+++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++..+
T Consensus 86 ~~~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 86 LMSDWFNF--HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CEEEEEEE--TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred Eeeeeeee--CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 99999987 57899999999 667777766543 4689999999999999999999999999999999999995321
Q ss_pred -------------CCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCC
Q 001940 944 -------------PQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 944 -------------~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
...+.+||+|||+++..... .....||+.|+|||++.+..+ +.++|
T Consensus 163 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~D 221 (355)
T 2eu9_A 163 TLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGW-AQPCD 221 (355)
T ss_dssp EEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCC-CTHHH
T ss_pred ccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCC-CCccc
Confidence 15678999999999865433 234679999999999987654 33444
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=274.17 Aligned_cols=170 Identities=24% Similarity=0.296 Sum_probs=140.5
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
+..++|++.+.||+|+||+||+|.+. ++.||||++.... . ....+.+.+|+.++++++||||+++++++.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~---~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 149 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG---D----AEAQAMAMAERQFLAEVVHPSIVQIFNFVE 149 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC---C----HHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC---C----HHHHHHHHHHHHHHHhcCCCCcCeEeeeEe
Confidence 34578999999999999999999884 6789999886431 1 123457889999999999999999999998
Q ss_pred cCCCC---cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 874 DGPDG---SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 874 d~s~~---~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
..... .+||||||+.+++|.+++.. .+++..++.|+.||+.||.|||+.+||||||||+|||++ . +.+|
T Consensus 150 ~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~----~-~~~k 221 (681)
T 2pzi_A 150 HTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----E-EQLK 221 (681)
T ss_dssp EECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----S-SCEE
T ss_pred ecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----C-CcEE
Confidence 74221 16999999999999998765 589999999999999999999999999999999999997 3 3799
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
|+|||+++..... ....||+.|||||++.+.
T Consensus 222 l~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 222 LIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp ECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC
T ss_pred EEecccchhcccC---CccCCCccccCHHHHcCC
Confidence 9999999876543 456799999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=270.35 Aligned_cols=169 Identities=17% Similarity=0.112 Sum_probs=128.1
Q ss_pred EecccCceEEEEEEE--cCcceEEEEeeccccCC--CchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcCCCCcEE
Q 001940 807 ELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAG--KPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 807 ~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~--k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~s~~~L~ 881 (993)
.++.|++|.+..++. .++.+|||++.+..... .....+...++|.+|+.+|+++ .|+||+++++++++ ++.+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~y 318 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSGW 318 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEEE
Confidence 467777777766543 68899999998654322 2233455567899999999999 69999999999998 67899
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
|||||++|++|.++|.+.+. ++.. +|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+...
T Consensus 319 LVMEyv~G~~L~d~i~~~~~-l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~----~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEE-IDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD----ARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCC-CCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC----TTSCEEECCCTTEESCC
T ss_pred EEEecCCCCcHHHHHHhCCC-CCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC----CCCCEEEeecccCeeCC
Confidence 99999999999999987653 5543 4788999999999999999999999999998 66789999999998764
Q ss_pred cc-cccCCCCCCCCccccccccCCc
Q 001940 962 QT-LVSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 962 ~~-~~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
.. ......+||+.|||||++.|+.
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~~ 415 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAENK 415 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC----
T ss_pred CCCccccCceechhhccHHHhCCCC
Confidence 43 2334567999999999998763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=241.47 Aligned_cols=175 Identities=26% Similarity=0.328 Sum_probs=124.6
Q ss_pred cCCCceEEE-EecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 798 KNDDLEEVR-ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile-~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
..++|++++ .||+|+||+||+|+++ ++.||||++.... . ...+....++.++|+||+++++++..
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---------~---~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---------K---ARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---------H---HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---------H---HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 456899965 6999999999999985 7889999986431 0 11222334677899999999999875
Q ss_pred C--CCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 875 G--PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 875 ~--s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
. ....+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ ..+.+||
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~-~~~~~kl 172 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE-KDAVLKL 172 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-TTCCEEE
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC-CCceEEE
Confidence 2 2345899999999999999998754 4689999999999999999999999999999999999998543 4577999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCcc
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+|||+++...... .....||+.|+|||++.+..+
T Consensus 173 ~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~ 206 (336)
T 3fhr_A 173 TDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKY 206 (336)
T ss_dssp CCCTTCEEC-----------------------CHH
T ss_pred eccccceeccccc-cccCCCCcCccChhhhCCCCC
Confidence 9999998665432 234578999999999866543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=267.30 Aligned_cols=172 Identities=29% Similarity=0.481 Sum_probs=137.3
Q ss_pred EEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEE
Q 001940 806 RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~ 881 (993)
++||+|+||+||+|.+. ++.||||+++..... ....+.+.+|+.+|++++|||||++++++.. ..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~ 445 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------PALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 445 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC------GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC------HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEE
Confidence 48999999999999763 456999999764321 1123578899999999999999999999975 4589
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
+|||||.+|+|.++|... ..+++..++.|+.||+.||.|||+.+||||||||+||||+ .++.+||+|||+++...
T Consensus 446 lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~----~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 520 (635)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEECCTTHHHHTT
T ss_pred EEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe----CCCCEEEEEcCCccccc
Confidence 999999999999999765 4589999999999999999999999999999999999998 56799999999998654
Q ss_pred ccc----ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 962 QTL----VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 962 ~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
... ......||+.|+|||++.+..+ +.++|
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~sD 554 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSD 554 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCC-CHHHH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCC-CcHHH
Confidence 322 1223457889999999976544 33444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=257.74 Aligned_cols=176 Identities=20% Similarity=0.285 Sum_probs=143.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE-EEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY-GIVR 873 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~-G~f~ 873 (993)
...++|+++++||+|+||.||+|++. ++.||||++...... ..+.+|+.+++.|+|.+++..+ .++.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 34578999999999999999999974 788999988754322 1466899999999875555444 4444
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
. ....+|||||+ +++|.+++......+++..++.|+.||+.||.|||+++||||||||+||||+..+ ..+.+||+|
T Consensus 74 ~--~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~-~~~~vkL~D 149 (483)
T 3sv0_A 74 E--GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIID 149 (483)
T ss_dssp E--TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTTCEEECC
T ss_pred e--CCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCC-CCCeEEEEe
Confidence 4 56789999999 9999999987666799999999999999999999999999999999999994322 567899999
Q ss_pred cCCccccccccc--------cCCCCCCCCccccccccCCcc
Q 001940 954 LGLSKVKQQTLV--------SGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 954 FGLAk~~~~~~~--------s~s~~GTp~YmAPEVL~Gk~y 986 (993)
||+++....... .....||+.|+|||++.+..+
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 190 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ 190 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCCCC
Confidence 999987644322 225679999999999987754
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=244.90 Aligned_cols=179 Identities=25% Similarity=0.244 Sum_probs=145.7
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CC-----CcceEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HP-----NVVSFY 869 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HP-----NIVrL~ 869 (993)
..++|++.+.||+|+||+||+|++. ++.||||+++.. ......+.+|+.+++.++ |+ +|++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---------KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---------HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---------HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 3578999999999999999999884 677999998743 122345677888888875 44 499999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCCEEEccCCCCC
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLH--GKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLH--s~gIIHRDIKPeNILLd~~d~e~ 946 (993)
+++.. .+.+++||||+. ++|.+++.... ..+++..++.|+.||+.||.||| +.+|+||||||+|||++.+ ..
T Consensus 123 ~~~~~--~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~--~~ 197 (382)
T 2vx3_A 123 RHFMF--RNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP--KR 197 (382)
T ss_dssp EEEEE--TTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST--TS
T ss_pred eeecc--CCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC--CC
Confidence 99988 578999999995 69999998654 45899999999999999999999 5799999999999999632 45
Q ss_pred CeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+.+||+|||+++..... .....||+.|+|||++.+..+ +.++||
T Consensus 198 ~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~Di 241 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPY-DLAIDM 241 (382)
T ss_dssp CCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCC-CTHHHH
T ss_pred CcEEEEeccCceecccc--cccccCCccccChHHHcCCCC-CcHHHH
Confidence 78999999999876543 335679999999999988754 345553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=265.68 Aligned_cols=176 Identities=28% Similarity=0.515 Sum_probs=144.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|++.+.||+|+||.||+|.+.. ..||||+++... .....+.+.+|+.+|++++||||++++++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 445789999999999999999998842 348999876431 12334578899999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.+ +.+++||||+.+|+|.+++......+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||
T Consensus 460 ~~~---~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~----~~~~vkL 532 (656)
T 2j0j_A 460 ITE---NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKL 532 (656)
T ss_dssp ECS---SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred Eec---CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe----CCCCEEE
Confidence 854 568999999999999999987766789999999999999999999999999999999999998 5679999
Q ss_pred EecCCccccccccc--cCCCCCCCCccccccccCCcc
Q 001940 952 GDLGLSKVKQQTLV--SGGVRGTLPWMAPELLSGKSH 986 (993)
Q Consensus 952 iDFGLAk~~~~~~~--s~s~~GTp~YmAPEVL~Gk~y 986 (993)
+|||+++....... .....||+.|||||++.+..+
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHCCC
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCC
Confidence 99999987644322 223457889999999976543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-26 Score=252.31 Aligned_cols=172 Identities=28% Similarity=0.375 Sum_probs=131.0
Q ss_pred cCCCceEEEEecccCceEEEEE-EEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHG-KWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKA-k~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~f~d~ 875 (993)
..+.|.+.+.||+|+||+||.+ ..+++.||||++.... .+.+.+|+.+|+++ +||||+++++++.+
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~- 80 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----------CDIALMEIKLLTESDDHPNVIRYYCSETT- 80 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----------HHHHHHHHHHHHhccCCCCcCeEEEEEec-
Confidence 3456777899999999999654 5578999999987531 12467899999876 89999999999887
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCcc------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC------
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTI------DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD------ 943 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~L------se~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d------ 943 (993)
.+.+++||||+ +|+|.+++....... .+..++.|+.||+.||.|||+.+|+||||||+|||++..+
T Consensus 81 -~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 81 -DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp -SSEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred -CCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 57899999999 469999998653211 2224567999999999999999999999999999997432
Q ss_pred ---CCCCeEEEEecCCcccccccc-----ccCCCCCCCCccccccccC
Q 001940 944 ---PQRPVCKIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 944 ---~e~g~VKLiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~G 983 (993)
.....+||+|||+++...... ......||+.|+|||++.+
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 245689999999998765432 1234579999999999976
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-25 Score=258.88 Aligned_cols=162 Identities=18% Similarity=0.165 Sum_probs=127.0
Q ss_pred EEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEEEEE
Q 001940 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVT 884 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~LVm 884 (993)
.+.||+|+||+||+|++.++.+|+|++................+++.+|+.+|++++||||+++..++.. .+..||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lVm 418 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD--LDNKRIMM 418 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE--TTTTEEEE
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe--CCccEEEE
Confidence 4689999999999998899999999877644333323333445678999999999999999955444444 34579999
Q ss_pred eeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc
Q 001940 885 EFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL 964 (993)
Q Consensus 885 EYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~ 964 (993)
||+++++|.+++.. ++.|+.||+.||+|||+++|+||||||+|||++ . .+||+|||+|+......
T Consensus 419 E~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~----~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD----K--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES----S--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC----C--eEEEEECccCEECCCcc
Confidence 99999999999875 457899999999999999999999999999998 3 89999999999765432
Q ss_pred c--------cCCCCCCCCccccccccC
Q 001940 965 V--------SGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 965 ~--------s~s~~GTp~YmAPEVL~G 983 (993)
. ....+||+.|||||++.+
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 1 235679999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-25 Score=264.15 Aligned_cols=186 Identities=28% Similarity=0.402 Sum_probs=151.4
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc--
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD-- 874 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d-- 874 (993)
.++|++.+.||+|+||.||+|.+ +++.||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-------~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~ 85 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-------SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ 85 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-------CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-------CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence 36799999999999999999987 47889999987531 12234578899999999999999999998755
Q ss_pred --CCCCcEEEEEeeccCCcHHHHHHhcc--CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 875 --GPDGSLATVTEFMVNGSLKQFLQKKD--RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 875 --~s~~~L~LVmEYm~GGSL~dlL~~~~--k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
...+..++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.++ ....+|
T Consensus 86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g-~~~~vK 164 (676)
T 3qa8_A 86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP-QRLIHK 164 (676)
T ss_dssp CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS-SSCEEE
T ss_pred cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC-CceeEE
Confidence 22567899999999999999998643 2588889999999999999999999999999999999998543 445699
Q ss_pred EEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++............||+.|+|||++.+..+ +.++||
T Consensus 165 L~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDI 206 (676)
T 3qa8_A 165 IIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDY 206 (676)
T ss_dssp ECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCC-STTHHH
T ss_pred EcccccccccccccccccccCCcccCChHHhccCCC-CchhHH
Confidence 999999998766555566789999999999987654 344443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=239.75 Aligned_cols=170 Identities=16% Similarity=0.111 Sum_probs=126.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC-CCc---------c-
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNV---------V- 866 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH-PNI---------V- 866 (993)
..|++.+.||+|+||+||+|++. ++.||||+++...... ....+.+.+|+.+++.++| .|+ +
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-----~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-----SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-----HHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 45888899999999999999985 8899999987432211 1223568899999999987 221 1
Q ss_pred -----------eEEEEEEcCC---CCcEEEEEeeccCCcHHHHHHh------ccCccCHHHHHHHHHHHHHHHHHHHhCC
Q 001940 867 -----------SFYGIVRDGP---DGSLATVTEFMVNGSLKQFLQK------KDRTIDRRKRLIIAMDAAFGMEYLHGKN 926 (993)
Q Consensus 867 -----------rL~G~f~d~s---~~~L~LVmEYm~GGSL~dlL~~------~~k~Lse~~~lkIalQIL~GLeYLHs~g 926 (993)
.++.++.... ...++++|+++ +++|.++++. ....+++..++.|+.||+.||.|||+++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 1111111111 23467777765 7899999852 2445788899999999999999999999
Q ss_pred ceecCCCCCCEEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCcccccccc
Q 001940 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLS 982 (993)
Q Consensus 927 IIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~ 982 (993)
||||||||+||||+ .++.+||+|||+++..... ....+| +.|||||++.
T Consensus 232 iiHrDiKp~NILl~----~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 232 LVHTYLRPVDIVLD----QRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp EECSCCCGGGEEEC----TTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHH
T ss_pred cccCCcccceEEEe----cCCeEEEEeccceeecCCc--cccCCC-CceeCchhhh
Confidence 99999999999998 5678999999999866544 345678 9999999994
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3e-23 Score=219.54 Aligned_cols=148 Identities=13% Similarity=0.080 Sum_probs=127.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+..++|++.+.||+|+||.||+|++. ++.||||++....... ....+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-----DDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-----HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-----HHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 44578999999999999999999985 7889999998653221 2334678899999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+|+||||+++++|.+++++. .....++.|+.||+.||.|||+.||+||||||+|||++ .++.+||+++
T Consensus 103 --~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~----~~g~~kl~~~ 173 (286)
T 3uqc_A 103 --RAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS----IDGDVVLAYP 173 (286)
T ss_dssp --TTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE----TTSCEEECSC
T ss_pred --CCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc----CCCCEEEEec
Confidence 57899999999999999999643 35557888999999999999999999999999999998 6678999988
Q ss_pred CCcc
Q 001940 955 GLSK 958 (993)
Q Consensus 955 GLAk 958 (993)
+...
T Consensus 174 ~~~~ 177 (286)
T 3uqc_A 174 ATMP 177 (286)
T ss_dssp CCCT
T ss_pred cccC
Confidence 7654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.1e-23 Score=216.47 Aligned_cols=148 Identities=25% Similarity=0.345 Sum_probs=125.5
Q ss_pred CCceEE-EEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHH-hhcCCCCcceEEEEEEc-
Q 001940 800 DDLEEV-RELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPNVVSFYGIVRD- 874 (993)
Q Consensus 800 ddYeil-e~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~IL-r~LrHPNIVrL~G~f~d- 874 (993)
++|.++ +.||+|+||.||+|.. +++.||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~ 83 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYENL 83 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------HHHHHHHHHHHHhccCCCchhHHhhhhhh
Confidence 568787 7899999999999988 4778999998642 2455777777 66789999999999875
Q ss_pred -CCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 875 -GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 875 -~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
.....+++||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++..+ .++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~~~kl~ 162 (299)
T 3m2w_A 84 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKLT 162 (299)
T ss_dssp ETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-TTCCEEEC
T ss_pred cCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-CCCcEEEe
Confidence 22457899999999999999998754 3589999999999999999999999999999999999998432 36789999
Q ss_pred ecCCccccc
Q 001940 953 DLGLSKVKQ 961 (993)
Q Consensus 953 DFGLAk~~~ 961 (993)
|||+++...
T Consensus 163 Dfg~a~~~~ 171 (299)
T 3m2w_A 163 DFGFAKETT 171 (299)
T ss_dssp CCTTCEECT
T ss_pred ccccccccc
Confidence 999998654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.4e-21 Score=208.14 Aligned_cols=155 Identities=17% Similarity=0.044 Sum_probs=117.4
Q ss_pred cCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCC--chhHH--------HHHHHHHHHHHHHhhcCCCCcc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGK--PSERE--------RLIADFWKEALLLSSLHHPNVV 866 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k--~~ere--------~~ie~f~rEi~ILr~LrHPNIV 866 (993)
....|++.+.||+|+||.||+|.+ +++.||||+++....... ...+. .....+.+|+.+|++++ | +
T Consensus 88 ~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 88 SGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 345688899999999999999998 477899999975422111 11111 23467889999999999 4 5
Q ss_pred eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCC
Q 001940 867 SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946 (993)
Q Consensus 867 rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~ 946 (993)
++++++.. +.+++||||+++++|.+ +.. .....++.||+.||.|||+.||+||||||+|||++ +
T Consensus 165 ~v~~~~~~---~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-----~ 228 (282)
T 1zar_A 165 AVPKVYAW---EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-----E 228 (282)
T ss_dssp SSCCEEEE---ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-----T
T ss_pred CcCeEEec---cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-----C
Confidence 55555543 45799999999999988 421 12346899999999999999999999999999997 3
Q ss_pred CeEEEEecCCccccccccccCCCCCCCCccccccccC
Q 001940 947 PVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSG 983 (993)
Q Consensus 947 g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~G 983 (993)
+.+||+|||+|+. +..|+|||++.+
T Consensus 229 ~~vkl~DFG~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE------------CCCCCHHHHHHH
Confidence 5899999999863 345788888753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=186.98 Aligned_cols=144 Identities=17% Similarity=0.113 Sum_probs=108.0
Q ss_pred ceEEEEecccCceEEEEEEE--cCcc--eEEEEeeccccCCCc----------------hhHHHHHHHHHHHHHHHhhcC
Q 001940 802 LEEVRELGSGTYGSVYHGKW--RGSD--VAIKRIKASCFAGKP----------------SERERLIADFWKEALLLSSLH 861 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~--kgt~--VAVKvIkk~~~~~k~----------------~ere~~ie~f~rEi~ILr~Lr 861 (993)
|++.+.||+|+||.||+|.+ +++. ||||+++........ ..+......+.+|+.+|++|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78889999999999999988 6888 999997654211100 001222346889999999998
Q ss_pred CCCc--ceEEEEEEcCCCCcEEEEEeeccC-C----cHHHHHHhccCccCHHHHHHHHHHHHHHHHHHH-hCCceecCCC
Q 001940 862 HPNV--VSFYGIVRDGPDGSLATVTEFMVN-G----SLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLH-GKNIVHFDLK 933 (993)
Q Consensus 862 HPNI--VrL~G~f~d~s~~~L~LVmEYm~G-G----SL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLH-s~gIIHRDIK 933 (993)
|++| ..++.. +..+|||||+.+ | +|.+++.. .++..+..++.||+.||.||| +.||+|||||
T Consensus 129 ~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 129 EAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred hCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 8764 444442 236899999942 3 67766432 234456788999999999999 9999999999
Q ss_pred CCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 934 CENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 934 PeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
|+|||++ . .++|+|||+|....
T Consensus 199 p~NILl~----~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYI----D--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEES----S--SEEECCCTTCEETT
T ss_pred HHHEEEc----C--cEEEEECcccccCC
Confidence 9999997 3 79999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.7e-15 Score=169.06 Aligned_cols=146 Identities=11% Similarity=0.006 Sum_probs=102.0
Q ss_pred CceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCC------------chh--HHHHHHHHHHHHHHHhhcCCCCc
Q 001940 801 DLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGK------------PSE--RERLIADFWKEALLLSSLHHPNV 865 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k------------~~e--re~~ie~f~rEi~ILr~LrHPNI 865 (993)
=|++.+.||+|+||.||+|.. +|+.||||+++......+ ... +........+|...|.+|.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 389999999999999999987 588899999875322110 000 11111123467888888865554
Q ss_pred c--eEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC
Q 001940 866 V--SFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD 943 (993)
Q Consensus 866 V--rL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d 943 (993)
. ..++. . ..+|||||+.|++|..++. . .....++.||+.+|.+||+.|||||||||.|||++.++
T Consensus 176 ~vp~p~~~--~----~~~LVME~i~G~~L~~l~~-----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ--S----RHTIVMSLVDALPMRQVSS-----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE--E----TTEEEEECCSCEEGGGCCC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec--c----CceEEEEecCCccHhhhcc-----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCC
Confidence 3 33332 2 2479999999988865432 1 12346778999999999999999999999999998443
Q ss_pred CC------CCeEEEEecCCccc
Q 001940 944 PQ------RPVCKIGDLGLSKV 959 (993)
Q Consensus 944 ~e------~g~VKLiDFGLAk~ 959 (993)
.. ...+.|+||+-+-.
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 10 11489999997653
|
| >2cu1_A Mitogen-activated protein kinase kinase kinase 2; PB1 domain, MAPK/ERK kinase kinase 2, MEK kinase 2, MEKK 2, signaling protein; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.9e-12 Score=119.36 Aligned_cols=77 Identities=23% Similarity=0.426 Sum_probs=68.2
Q ss_pred ecCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEecc
Q 001940 46 VGGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSH 125 (993)
Q Consensus 46 vGG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf~~ 125 (993)
.+||+|||.|+|.++|.||..|+.+.||..+.|.|+ +++.||+++|+|||++.||+|||.. ....||+||-+.
T Consensus 15 ~~GEkRIi~f~RPv~f~eL~~Kv~~~fGq~ldL~y~----n~EllIpl~sQeDLDkaIellDrss---~~kSLrIlL~~~ 87 (103)
T 2cu1_A 15 HRGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT----NNELVIPLTTQDDLDKAVELLDRSI---HMKSLKILLVIN 87 (103)
T ss_dssp ETTEEEEEEEESSCCHHHHHHHHHHHHSSCEEEEEC----SSSSCEECCSHHHHHHHHHHHHHCS---SCCSEEEEEEEC
T ss_pred ecCeEEEEeccCCccHHHHHHHHHHHhCCeeeEEEe----cceEEEeccCHHHHHHHHHHHccCC---cccceEEEEecC
Confidence 478999999999999999999999999999999999 8999999999999999999999962 224488888876
Q ss_pred CCCC
Q 001940 126 SDQD 129 (993)
Q Consensus 126 ~~~~ 129 (993)
....
T Consensus 88 ~~~~ 91 (103)
T 2cu1_A 88 GSTQ 91 (103)
T ss_dssp CCCS
T ss_pred CCCc
Confidence 6543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=2.9e-11 Score=124.56 Aligned_cols=141 Identities=18% Similarity=0.083 Sum_probs=109.5
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~ 878 (993)
..|++...++.|+++.||++...+..+++|+......... ..+.+|+.+++.|. +..+.++++++.+ .+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~--------~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~ 83 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFERH--DG 83 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEEEE--TT
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCH--------HHHHHHHHHHHHHhcCCCCCeEEEEEec--CC
Confidence 3588888999999999999988788999999875321111 14678888998885 6778899998876 57
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG---------------------------------- 924 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs---------------------------------- 924 (993)
..|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred ceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 7899999999999987632 112234677889999999998
Q ss_pred -------------------------CCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 925 -------------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 925 -------------------------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
..++|+|+++.|||++ ....+.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK----DGKVSGFIDLGRSGRA 214 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE----TTEEEEECCCTTCEEE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE----CCcEEEEEEchhcccC
Confidence 3489999999999997 3345679999988643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=4.4e-10 Score=113.74 Aligned_cols=134 Identities=16% Similarity=0.078 Sum_probs=93.8
Q ss_pred CceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC--cceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN--VVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN--IVrL~G~f~d~s~ 877 (993)
.+.+....+.|..+.||++... +..++||+...... ..+.+|+.+++.+.+.+ +.+++++... .
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~-----------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~ 87 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----------NELQDEAARLSWLATTGVPCAAVLDVVTE--A 87 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----------SCHHHHHHHHHHHHTTTCCBCCEEEEEEC--S
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc-----------hhhhHHHHHHHHHHhCCCCCCeEEEeccC--C
Confidence 4555443345666999999764 56799998764311 14567888888886444 5668887766 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN------------------------------- 926 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g------------------------------- 926 (993)
+..++||||++|.+|. ... .+. ..++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDL 158 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSC
T ss_pred CCCEEEEEecCCcccC--cCc----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhh
Confidence 5689999999998884 211 111 245566777777777643
Q ss_pred ---------------------------ceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 927 ---------------------------IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 927 ---------------------------IIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
++|+|++|.|||++ .+..++|+||+.+...
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~----~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 159 DEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE----NGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE----TTEEEEECCCTTCEEE
T ss_pred hhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE----CCcEEEEEcchhcccC
Confidence 99999999999997 4456679999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.3e-09 Score=118.05 Aligned_cols=147 Identities=18% Similarity=0.185 Sum_probs=107.3
Q ss_pred ceEEEEecccCceEEEEEEEcCcceEEEEee--ccccCCCchhHHHHHHHHHHHHHHHhhcC--CCCcceEEEEEEcCCC
Q 001940 802 LEEVRELGSGTYGSVYHGKWRGSDVAIKRIK--ASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIVRDGPD 877 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~kgt~VAVKvIk--k~~~~~k~~ere~~ie~f~rEi~ILr~Lr--HPNIVrL~G~f~d~s~ 877 (993)
...++.|+.|.++.||+....+..+++|+.. ..... .....+.+|+.+++.|. +..+.+++.++.+...
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~-------~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLL-------PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSSCEEEEECCCC-----------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred CceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCC-------CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 3456889999999999998888889999765 32111 01135678999999887 4568889888776321
Q ss_pred -CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh--------------------------------
Q 001940 878 -GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-------------------------------- 924 (993)
Q Consensus 878 -~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-------------------------------- 924 (993)
+..|+||||++|..|.+. ....++...+..++.+++..|..||+
T Consensus 113 ~g~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp TSSCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 558999999998877431 11235677788889999999999997
Q ss_pred --------------------------CCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 925 --------------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 925 --------------------------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
..++|+|+++.|||++.++ ...+.|+||+++...
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~--~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE--PRVLAVLDWELSTLG 249 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS--SCEEEECCCTTCEEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC--CcEEEEECccccccC
Confidence 3689999999999998332 135799999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=6e-06 Score=88.45 Aligned_cols=141 Identities=21% Similarity=0.192 Sum_probs=90.9
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCC---CcceEEEEEEcCCCCcE
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHP---NVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHP---NIVrL~G~f~d~s~~~L 880 (993)
.++.++.|....||+. +..+++|+-.. ......+.+|..+|+.|.+. .|.+++.+... ..+..
T Consensus 23 ~v~~l~~G~~n~v~~v---g~~~VlR~~~~----------~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~ 88 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV---NGDWVFRFPKS----------QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNP 88 (306)
T ss_dssp CEEEEEECSSEEEEEE---TTTEEEEEESS----------HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCE
T ss_pred eeeecCCCcceeEEEE---CCEEEEEecCC----------chHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCce
Confidence 3466888999999988 67889997431 11234688999999999752 35677766653 24667
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG------------------------------------ 924 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs------------------------------------ 924 (993)
++||||++|..|.+..-. .++......++.++...|..||+
T Consensus 89 ~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~ 165 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLD 165 (306)
T ss_dssp EEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSC
T ss_pred EEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccc
Confidence 899999999887653111 12222233333333333333332
Q ss_pred ------------------------CCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 925 ------------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 925 ------------------------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..++|+|+++.|||++.++.....+.|+||+.+....
T Consensus 166 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 166 ESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred hhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2569999999999998422123456899999887543
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.37 E-value=1e-06 Score=93.35 Aligned_cols=138 Identities=18% Similarity=0.196 Sum_probs=94.8
Q ss_pred EEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCC--cceEEEEEEcCC-CCcEE
Q 001940 806 RELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPN--VVSFYGIVRDGP-DGSLA 881 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPN--IVrL~G~f~d~s-~~~L~ 881 (993)
+.|+.|....||+.. ..+++|+.... .....+.+|..+|+.+. +.. +.+++....... ...-|
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~~----------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKHS----------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESSH----------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCCc----------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 458999999999864 56899975422 12346788999998884 332 445554433211 12458
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG------------------------------------- 924 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs------------------------------------- 924 (993)
+||||++|.+|.+... ..++..++..++.+++..|..||+
T Consensus 93 ~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 8999999988865332 125566666777777777777775
Q ss_pred ---------------------CCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 925 ---------------------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 925 ---------------------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..++|+|+++.|||++.+ ....+.|+||+.+....
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCC
Confidence 247999999999999832 14568899999987643
|
| >1vd2_A Protein kinase C, IOTA type; PB1 domain, OPCA motif, APKC, ZIP/P62, MEK5, molecular recognition, transferase; NMR {Homo sapiens} SCOP: d.15.2.2 PDB: 1wmh_A | Back alignment and structure |
|---|
Probab=98.31 E-value=4.9e-06 Score=76.18 Aligned_cols=71 Identities=20% Similarity=0.329 Sum_probs=61.8
Q ss_pred CceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 48 GETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 48 G~tri~~v~r~~~f~~l~~kl~~~~~~----~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
|+.|++.|+.+++|.+|..||.++|+. .+++||- +|| ..+|++++|+||+..+.-|..- +.+.|.+.+|
T Consensus 15 gdi~~~~v~~~i~~~~L~~kv~~~~~~~~~~~f~lky~--DEe-GD~itisSd~EL~eAl~l~~~n----~~~~l~ihvf 87 (89)
T 1vd2_A 15 GDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEE-GDPCTVSSQLELEEAFRLYELN----KDSELLIHVF 87 (89)
T ss_dssp SCEEEEEECTTCCHHHHHHHHHHHTTCCSSCCEEEEEC--CSS-SCCEECCSHHHHHHHHHHHHHT----SCCCEEEEEE
T ss_pred CeEEEEECCCCCCHHHHHHHHHHHhCCCCCCeEEEEEE--CCC-CCcccccCHHHHHHHHHHHHcc----CCCCEEEEEc
Confidence 347899999999999999999999984 4999998 776 8999999999999999988774 3367999999
Q ss_pred cc
Q 001940 124 SH 125 (993)
Q Consensus 124 ~~ 125 (993)
|.
T Consensus 88 ~~ 89 (89)
T 1vd2_A 88 PC 89 (89)
T ss_dssp EC
T ss_pred cC
Confidence 73
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=5.9e-05 Score=77.67 Aligned_cols=132 Identities=18% Similarity=0.168 Sum_probs=87.4
Q ss_pred EecccCce-EEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGTYG-SVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGgFG-tVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~L~L 882 (993)
.+..|..+ .||+.... +..+++|+-... ....+.+|...|+.|. +--+.+++.++.+ .+..++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~l 97 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----------VANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWL 97 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----------CHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEE
Confidence 44445544 68987653 567899976532 1235678888888775 3346788888877 467899
Q ss_pred EEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 001940 883 VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGK------------------------------------- 925 (993)
Q Consensus 883 VmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~------------------------------------- 925 (993)
|||+++|.++.+...... .....++.++...|..||+.
T Consensus 98 vme~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 98 LTTAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999988877653211 11122333444444444421
Q ss_pred ---------------------CceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 926 ---------------------NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 926 ---------------------gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
.++|+|+.+.|||++ ..+.+-|+||+.+...
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~----~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD----EGKLIGCIDVGRVGIA 224 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE----TTEEEEECCCTTCEEE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE----CCeEEEEEECcccccC
Confidence 279999999999998 4456679999998754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=8.6e-06 Score=87.77 Aligned_cols=83 Identities=8% Similarity=-0.032 Sum_probs=54.3
Q ss_pred ceEEEEe-cccCceEEEEEEEc--------CcceEEEEeeccc---cCCCchhHHHHHHHHHHHHHHHhhcCC---CCcc
Q 001940 802 LEEVREL-GSGTYGSVYHGKWR--------GSDVAIKRIKASC---FAGKPSERERLIADFWKEALLLSSLHH---PNVV 866 (993)
Q Consensus 802 Yeile~L-GeGgFGtVYKAk~k--------gt~VAVKvIkk~~---~~~k~~ere~~ie~f~rEi~ILr~LrH---PNIV 866 (993)
...++.| +.|....+|+.... +..+++|+..... .... ..+.+|+.+|+.|.. ..+.
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~--------~~~~~E~~~l~~L~~~~~vpvP 93 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPT--------YRLDHQFEVIRLVGELTDVPVP 93 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSC--------CCHHHHHHHHHHHHHHCCSCCC
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCch--------hHHHHHHHHHHHHhhcCCCCCC
Confidence 4456788 88989999998765 6778999765432 1000 134567777776642 3567
Q ss_pred eEEEEEEcCC-CCcEEEEEeeccCCcH
Q 001940 867 SFYGIVRDGP-DGSLATVTEFMVNGSL 892 (993)
Q Consensus 867 rL~G~f~d~s-~~~L~LVmEYm~GGSL 892 (993)
+++.++.+.. .+..++||||++|..|
T Consensus 94 ~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 94 RVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp CEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred cEEEEccCCCccCCceEEEEecCCCCh
Confidence 7887765531 1456899999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00026 Score=74.66 Aligned_cols=31 Identities=23% Similarity=0.229 Sum_probs=26.6
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
..++|+|+++.|||++ .++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~----~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG----ENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEEC----GGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEe----CCCcEEEEehhhccc
Confidence 5899999999999996 345799999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.0004 Score=76.27 Aligned_cols=83 Identities=20% Similarity=0.085 Sum_probs=48.2
Q ss_pred eEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--C-CcceEEEEEEcCCC
Q 001940 803 EEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--P-NVVSFYGIVRDGPD 877 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--P-NIVrL~G~f~d~s~ 877 (993)
...+.||.|.++.||++.. .++.++||............. .....++..|..+|+.+.. + .+.+++.+ + .
T Consensus 33 ~~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~-~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d--~ 107 (397)
T 2olc_A 33 LTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESW-PLTIDRARIESSALIRQGEHVPHLVPRVFYS--D--T 107 (397)
T ss_dssp CEEEECCSSSSEEEEEEEC----CEEEEEEECCC-------C-CCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E--T
T ss_pred eEEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCC-cCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c--C
Confidence 3467899999999999965 457899998653211000000 0001245567778777642 3 34466644 2 2
Q ss_pred CcEEEEEeeccCC
Q 001940 878 GSLATVTEFMVNG 890 (993)
Q Consensus 878 ~~L~LVmEYm~GG 890 (993)
...++||||+.+.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 3357999999764
|
| >2jrh_A Mitogen-activated protein kinase kinase kinase 3; kinase signaling domain, transferase; NMR {Homo sapiens} PDB: 2pph_A | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0014 Score=59.78 Aligned_cols=73 Identities=25% Similarity=0.526 Sum_probs=63.1
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEeccC
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFSHS 126 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf~~~ 126 (993)
-||-|||-++|.++|.||..|+...+|..+.|-|- +- .-+|.+.|.|||+.-++-.||-. .--.||+.|-...
T Consensus 12 ~gEKRIi~f~RPvkf~dl~qkv~~afGq~ldl~y~--nn--EL~iPL~~Q~DLDkAvelLDrs~---~mkSLRIlL~~~~ 84 (94)
T 2jrh_A 12 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRSS---SMKSLRILLLSQD 84 (94)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHCSSEEEEEE--CS--SCEEECCSHHHHHHHHHHHHHST---TTTEEEEEEEECS
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eeEEeccCHHHHHHHHHHhccCc---cccceEEEEEcCC
Confidence 48999999999999999999999999999999998 32 46999999999999999999942 2345899998654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0013 Score=73.26 Aligned_cols=78 Identities=21% Similarity=0.229 Sum_probs=45.4
Q ss_pred EEEEecccCceEEEEEEEcCcceEEEEeecccc-CCC--c--hhHHHHHHHHHHHHHHH-hhcCCCCcceEEEEEEcCCC
Q 001940 804 EVRELGSGTYGSVYHGKWRGSDVAIKRIKASCF-AGK--P--SERERLIADFWKEALLL-SSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~-~~k--~--~ere~~ie~f~rEi~IL-r~LrHPNIVrL~G~f~d~s~ 877 (993)
.++.||.|..+.||++...+..++||....... ... . ..+ ..+..|+..+ .......+.+++.+. .
T Consensus 38 ~i~~l~~G~~n~vyrv~~~~~~~vvK~~~p~~~~~~~~~~~~~~~----~~~E~e~l~~~~~~~~~~vP~v~~~~----~ 109 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVGSSGSLVIKQALPYIRCIGESWPMTKER----AYFEATTLRKHGNLSPDHVPEVYHFD----R 109 (420)
T ss_dssp EEEECCCSSSCEEEEEECSSCEEEEEECCSBCTTTCTTSBCCTTH----HHHHHHHHHHHHHHSGGGSCCEEEEE----T
T ss_pred EEEEccCCCcEEEEEEEcCCceEEEEECchhhcccCcccccchhH----HHHHHHHHHHHHhhCCCCCCeEEEEC----C
Confidence 457899999999999987777899995432111 000 0 011 1122232222 222334567777664 2
Q ss_pred CcEEEEEeec-cC
Q 001940 878 GSLATVTEFM-VN 889 (993)
Q Consensus 878 ~~L~LVmEYm-~G 889 (993)
+..++||||+ ++
T Consensus 110 ~~~~lv~e~l~~g 122 (420)
T 2pyw_A 110 TMALIGMRYLEPP 122 (420)
T ss_dssp TTTEEEECCCCTT
T ss_pred CccEEEEeecCCc
Confidence 4568999999 76
|
| >2c60_A Human mitogen-activated protein kinase kinase kinase 3 isoform 2; MAP3K3, MAP/ERK kinase kinase 3, MAPKKK3, MEKK3, serine threonine phosphorylation; HET: MSE; 1.25A {Homo sapiens} SCOP: d.15.2.2 PDB: 2o2v_B | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0016 Score=60.64 Aligned_cols=71 Identities=27% Similarity=0.523 Sum_probs=60.9
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEec
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFS 124 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf~ 124 (993)
-||.|||-++|.++|.||..|+...+|..+.|-|- + =.-+|.+.|.|||+.-|+..||-.. --.||+.|-.
T Consensus 39 ~gEKRIiqf~RPvkf~dl~qkv~~afGq~ldl~y~--n--nEL~IPL~~Q~DLDkAvelLDrs~~---mkSLRIlL~~ 109 (111)
T 2c60_A 39 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--N--NELSILLKNQDDLDKAIDILDRSSS---MKSLRILLLS 109 (111)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--C--SSCEEECCSHHHHHHHHHHHHHCSS---CCSEEEEEEC
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--c--ceEEEecccHHHHHHHHHHhccCcc---ccceEEEEec
Confidence 48999999999999999999999999999999998 3 2469999999999999999999422 2348888764
|
| >2npt_B Mitogen-activated protein kinase kinase kinase 2; MAP2K5, MEK5, MKK PRKMK5, MAP kinase kinase 5, PHOX, PHOX-domain; 1.75A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0015 Score=60.16 Aligned_cols=71 Identities=25% Similarity=0.481 Sum_probs=60.9
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEec
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLFS 124 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf~ 124 (993)
-||-|||-++|.+.|.||..|+...||..+.|-|- +. .-+|-+.|.|||+.-|+-.||-.. --.||+.|-.
T Consensus 28 ~gEkRIi~f~RPv~f~el~~kv~~afGq~ldl~y~--nn--EL~iPL~~Q~DLDkAvelLDrs~~---~kSLrIlL~~ 98 (100)
T 2npt_B 28 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRSIH---MKSLKILLVI 98 (100)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHCSS---CCSEEEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cc--eeEEecccHHHHHHHHHHhccCcc---ccceEEEEec
Confidence 47999999999999999999999999999999998 32 469999999999999999999422 2348888764
|
| >1q1o_A Cell division control protein 24; PB1 domain, PCCR, PC motif, OPCA motif, yeast, cell polarity, protein-protein interaction; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 2kfj_A 2kfk_B | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0021 Score=59.88 Aligned_cols=68 Identities=22% Similarity=0.244 Sum_probs=54.2
Q ss_pred CceeEEEccCCCChHHHHHHHHHHhCC--------ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001940 48 GETRIVSLPRDVTYEELMSRMRELYEG--------AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (993)
Q Consensus 48 G~tri~~v~r~~~f~~l~~kl~~~~~~--------~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR 119 (993)
++++.|.|+.+|+|.+|..|+.+.++. .+.|||| .|| ...|.+.+||||.-.+++..... .++|-
T Consensus 22 ~d~~~i~V~~~i~f~~L~~kI~~Kl~~~~~~~i~~~~klkYk--DEd-GD~Vtl~sddDl~~A~e~~~e~~----~~~l~ 94 (98)
T 1q1o_A 22 SEIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DED-GDFVVLGSDEDWNVAKEMLAENN----EKFLN 94 (98)
T ss_dssp CEEEEEEECTTCCHHHHHHHHHHHHHHHCSSCCCCCCCEEEE--CSS-SCEEEECSHHHHHHHHHHHHHTT----CCEEE
T ss_pred CcEEEEEecCCCCHHHHHHHHHHHHcCCccccccceeEEEEE--cCC-CCEEEEcCHHHHHHHHHHHHhhh----cCeEE
Confidence 689999999999999999999776552 2689999 664 48999999999999999885431 35565
Q ss_pred EEE
Q 001940 120 IFL 122 (993)
Q Consensus 120 ~fl 122 (993)
+.+
T Consensus 95 Iwv 97 (98)
T 1q1o_A 95 IRL 97 (98)
T ss_dssp EEE
T ss_pred EEE
Confidence 554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0031 Score=68.73 Aligned_cols=79 Identities=23% Similarity=0.142 Sum_probs=60.1
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC---CCCcceEEEEEEcCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDGPD 877 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr---HPNIVrL~G~f~d~s~ 877 (993)
.....+.|+.|.+..+|+....+..++||+..... ...+..|...|+.|. ...+.+++.+... .
T Consensus 37 ~i~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~~-----------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~ 103 (312)
T 3jr1_A 37 FIKHKEKLYSGEMNEIWLINDEVQTVFVKINERSY-----------RSMFRAEADQLALLAKTNSINVPLVYGIGNS--Q 103 (312)
T ss_dssp CCCEEEEECCSSSSEEEEEESSSCEEEEEEEEGGG-----------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--S
T ss_pred ceeeeEEeCCccceeeeEEEECCCeEEEEeCCccc-----------HHHHHHHHHHHHHHHhhCCCCcceEEEEeec--C
Confidence 34566889999999999998878889999876321 235678888887774 3567888887765 4
Q ss_pred CcEEEEEeeccCCcH
Q 001940 878 GSLATVTEFMVNGSL 892 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL 892 (993)
+..++||||+++..+
T Consensus 104 g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 104 GHSFLLLEALNKSKN 118 (312)
T ss_dssp SEEEEEEECCCCCCC
T ss_pred CceEEEEEeccCCCC
Confidence 678999999998743
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0076 Score=63.30 Aligned_cols=82 Identities=20% Similarity=0.165 Sum_probs=56.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC---CCcceEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH---PNVVSFYGI 871 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH---PNIVrL~G~ 871 (993)
.+...+..-++.+|.|..+.||+.+. +|+.|+||+........ ...|..|...|+.|.- --+.+++++
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--------~~~~~~Ea~~L~~L~~~~~vpvP~v~~~ 82 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--------DGLFRAEALGLDWLGRSFGSPVPQVAGW 82 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--------TTHHHHHHHHHHHHTCSTTCCSCCEEEE
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--------hhHHHHHHHHHHHHHhhCCCCcceEEec
Confidence 34455677789999999999999988 57889999765332111 1246678888887742 235566654
Q ss_pred EEcCCCCcEEEEEeeccCCc
Q 001940 872 VRDGPDGSLATVTEFMVNGS 891 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGS 891 (993)
.. -++||||+.++.
T Consensus 83 ~~------~~lv~e~l~~~~ 96 (288)
T 3f7w_A 83 DD------RTLAMEWVDERP 96 (288)
T ss_dssp ET------TEEEEECCCCCC
T ss_pred cC------ceEEEEeecccC
Confidence 21 378999998653
|
| >1pqs_A Cell division control protein 24; alpha and beta protein, cell cycle; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1tz1_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0018 Score=57.77 Aligned_cols=68 Identities=22% Similarity=0.257 Sum_probs=55.8
Q ss_pred ceeEEEccCCCChHHHHHHHHHHhC--------CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEE
Q 001940 49 ETRIVSLPRDVTYEELMSRMRELYE--------GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRI 120 (993)
Q Consensus 49 ~tri~~v~r~~~f~~l~~kl~~~~~--------~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~ 120 (993)
+++.|.|+-+|+|.+|..|+.+.++ ..+.|||| .|| +..|++.+||||.--++...... .++|-+
T Consensus 2 D~~~i~V~~~i~f~~L~~kI~~kl~~~~~~~~~~~~~lkYk--DEd-GD~Vti~sddDl~~A~~~~~~~~----~~~lei 74 (77)
T 1pqs_A 2 EIFTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DED-GDFVVLGSDEDWNVAKEMLAENN----EKFLNI 74 (77)
T ss_dssp CEEEEECTTCCCSHHHHHHHHHHTTTTTSSCSCSTTCCEEE--ETT-TEEEECCSTTHHHHHHHHHHHHC----CCEEEE
T ss_pred CEEEEEeCCCCCHHHHHHHHHHHHcccccccccceeEEEEE--cCC-CCEEEEcCHHHHHHHHHHHHhhh----cCeEEE
Confidence 6899999999999999999988776 23789999 664 68999999999999888775432 466777
Q ss_pred EEe
Q 001940 121 FLF 123 (993)
Q Consensus 121 flf 123 (993)
.+|
T Consensus 75 Wv~ 77 (77)
T 1pqs_A 75 RLY 77 (77)
T ss_dssp ECC
T ss_pred EEC
Confidence 665
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.005 Score=65.13 Aligned_cols=143 Identities=14% Similarity=0.120 Sum_probs=77.8
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-----CCCcceEE-E--EE
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----HPNVVSFY-G--IV 872 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-----HPNIVrL~-G--~f 872 (993)
....++.|+.|....+|+....+..+++|+..... .. ..+..|..+++.|. -|.++... | +.
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~--------~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EK--------NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESSCCEEEEEECC-----C--------CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CH--------HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE
Confidence 44556788889889999998876689999887521 00 12334555555543 33333210 0 00
Q ss_pred EcCCCCcEEEEEeeccCCcHH-----------HH---HHhc----cCc-------cCHHHHHH------------HHHHH
Q 001940 873 RDGPDGSLATVTEFMVNGSLK-----------QF---LQKK----DRT-------IDRRKRLI------------IAMDA 915 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGSL~-----------dl---L~~~----~k~-------Lse~~~lk------------IalQI 915 (993)
.. .+..++||+|++|..+. .. ++.. ... ..|...+. +...+
T Consensus 93 ~~--~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l 170 (322)
T 2ppq_A 93 EL--SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 170 (322)
T ss_dssp EE--TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred EE--CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHH
Confidence 11 24578999999875421 11 1111 000 01111000 01123
Q ss_pred HHHHHHHHh-------CCceecCCCCCCEEEccCCCCCCeEEEEecCCccc
Q 001940 916 AFGMEYLHG-------KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV 959 (993)
Q Consensus 916 L~GLeYLHs-------~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~ 959 (993)
...+++|.+ .+++|+|+.+.|||++ .+..+.|+||+.+..
T Consensus 171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~----~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL----GDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE----TTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhCcccCCcccCCCCCCccCEEEe----CCceEEEecchhccC
Confidence 444555552 3799999999999997 334557999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0037 Score=66.16 Aligned_cols=71 Identities=13% Similarity=0.061 Sum_probs=42.2
Q ss_pred EEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc-ceEEEEEEcCCCCcEEEE
Q 001940 805 VRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDGPDGSLATV 883 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI-VrL~G~f~d~s~~~L~LV 883 (993)
++.|+.|....+|+. ..+++|+......... ...+|..+++.+..-.+ .++++... ..-++|
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~~---------~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEYI---------NRANEAVAAREAAKAGVSPEVLHVDP----ATGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC----CC---------CHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCcccee---------CHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEE
Confidence 578989999999998 6789998764321110 12246666655542222 45555422 223689
Q ss_pred Eeec-cCCcH
Q 001940 884 TEFM-VNGSL 892 (993)
Q Consensus 884 mEYm-~GGSL 892 (993)
+||+ .+.+|
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 65444
|
| >2kkc_A Sequestosome-1; P62, PB1, autophagy, ubiquitin-proteasome system, NF-KB signaling, alternative splicing, apoptosis, cytoplasm, differentiation; NMR {Rattus norvegicus} PDB: 2ktr_B | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0041 Score=58.27 Aligned_cols=66 Identities=26% Similarity=0.357 Sum_probs=54.2
Q ss_pred cCceeEEEccCC-----------CChHHHHHHHHHHhC----CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcC
Q 001940 47 GGETRIVSLPRD-----------VTYEELMSRMRELYE----GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGS 111 (993)
Q Consensus 47 GG~tri~~v~r~-----------~~f~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~ 111 (993)
|.|.|=++++++ .+|.+|+.++.++|. ..|.|||. +|| .-||.+++||||...+..-
T Consensus 19 ~~EiRRF~l~~~~~p~~~~~~~~~s~~~L~~~V~~lFp~l~~~~f~l~Y~--Ded-GDlItiSsDeEL~~Al~~~----- 90 (102)
T 2kkc_A 19 AREIRRFSFCFSPEPEAEAAAGPGPCERLLSRVAVLFPALRPGGFQAHYR--AER-GDLVAFSSDEELTMAMSYV----- 90 (102)
T ss_dssp EEEEEEEEEESSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE--CTT-CCEEEECSHHHHHHHHHHC-----
T ss_pred CCceEEEEeccCCCcccccccccccHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEEecCHHHHHHHHHhc-----
Confidence 689999999874 489999999999984 46999999 555 5799999999999887632
Q ss_pred CCCCCeEEEEE
Q 001940 112 GDGFTRLRIFL 122 (993)
Q Consensus 112 ~~~~~rlR~fl 122 (993)
+..-||||+
T Consensus 91 --~~~~lRlyV 99 (102)
T 2kkc_A 91 --KDDIFRIYI 99 (102)
T ss_dssp --CSSEEEEEE
T ss_pred --CCCeEEEEE
Confidence 135689987
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0073 Score=64.53 Aligned_cols=36 Identities=22% Similarity=0.148 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
..++|+|+.+.|||++.+......+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 479999999999999732111257899999988754
|
| >2ktr_A Sequestosome-1; autophagy, NF-KB signaling, HOMO-oligomer, PB1 dimer, signaling protein, transport protein; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0061 Score=58.44 Aligned_cols=66 Identities=26% Similarity=0.350 Sum_probs=53.8
Q ss_pred cCceeEEEccCC-----------CChHHHHHHHHHHhC----CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcC
Q 001940 47 GGETRIVSLPRD-----------VTYEELMSRMRELYE----GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGS 111 (993)
Q Consensus 47 GG~tri~~v~r~-----------~~f~~l~~kl~~~~~----~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~ 111 (993)
++|.|-++++++ .+|.+|+.|+.+++. ..|.|||. .|| .-||.+++||||..-+..-
T Consensus 34 ~~EIRRF~l~~~~~p~~~~~~~~~s~~~L~~kV~~lFp~L~~~~f~l~Yk--DEd-GDlItISsDeEL~~Al~~~----- 105 (117)
T 2ktr_A 34 AREIRRFSFCFSPEPEAEAAAGPGPSERLLSRVAVLFPALRPGGFQAHYR--AER-GDLVAFSSDEELTMAMSYV----- 105 (117)
T ss_dssp EEEEEEEEECSSSCSCSSSCCSCCHHHHHHHHHHHHCTTSCSSCEEEEEE--CTT-CCEEEECSHHHHHHHHHHC-----
T ss_pred CCcEEEEEeccCCCccccccccCCCHHHHHHHHHHHccccCCCcEEEEEE--CCC-CCEEEecCHHHHHHHHHhc-----
Confidence 579999999865 399999999999994 46999999 554 5799999999998877642
Q ss_pred CCCCCeEEEEE
Q 001940 112 GDGFTRLRIFL 122 (993)
Q Consensus 112 ~~~~~rlR~fl 122 (993)
+..-||||+
T Consensus 106 --~~~~lRlyV 114 (117)
T 2ktr_A 106 --KDDIFRIYI 114 (117)
T ss_dssp --CSSEEEEEE
T ss_pred --CCCeEEEEE
Confidence 135789987
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0085 Score=67.66 Aligned_cols=72 Identities=13% Similarity=0.308 Sum_probs=47.2
Q ss_pred EEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc-ceEEEEEE
Q 001940 804 EVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVR 873 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI-VrL~G~f~ 873 (993)
.++.|+.|....||++... +..+++|+.... .. . ..+.+|..+++.|...+| .++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~--~-----~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET--E-----SHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC--H-----HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc--H-----HHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 4577888989999999874 367899987431 10 0 133467777777753333 66776654
Q ss_pred cCCCCcEEEEEeeccCCc
Q 001940 874 DGPDGSLATVTEFMVNGS 891 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGS 891 (993)
+ .+||||++|.+
T Consensus 147 ~------g~v~e~l~G~~ 158 (429)
T 1nw1_A 147 G------GRLEEYIPSRP 158 (429)
T ss_dssp T------EEEECCCCEEE
T ss_pred C------CEEEEEeCCcc
Confidence 2 38999998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.0045 Score=67.35 Aligned_cols=73 Identities=8% Similarity=0.088 Sum_probs=42.0
Q ss_pred EEEEecccCceEEEEEEEcC----------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC-cceEEEEE
Q 001940 804 EVRELGSGTYGSVYHGKWRG----------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFYGIV 872 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kg----------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN-IVrL~G~f 872 (993)
.++.|+.|....+|+....+ ..+++|+......... ....|..+++.|.-.+ +.++++.+
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~---------~~~~E~~~l~~L~~~g~~P~~~~~~ 107 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELY---------NTISEFEVYKTMSKYKIAPQLLNTF 107 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTS---------CHHHHHHHHHHHHHTTSSCCEEEEE
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcccee---------cHHHHHHHHHHHHhcCCCCceEEec
Confidence 34678888889999998754 5788887654211100 1235666666664223 44666543
Q ss_pred EcCCCCcEEEEEeeccCCc
Q 001940 873 RDGPDGSLATVTEFMVNGS 891 (993)
Q Consensus 873 ~d~s~~~L~LVmEYm~GGS 891 (993)
. -++||||++|..
T Consensus 108 ~------~~~v~e~i~G~~ 120 (369)
T 3c5i_A 108 N------GGRIEEWLYGDP 120 (369)
T ss_dssp T------TEEEEECCCSEE
T ss_pred C------CcEEEEEecCCc
Confidence 1 168999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.062 Score=61.56 Aligned_cols=74 Identities=16% Similarity=0.118 Sum_probs=47.4
Q ss_pred EEEEecccCceEEEEEEEcC--cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc-ceEEEEEEcCCCCcE
Q 001940 804 EVRELGSGTYGSVYHGKWRG--SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-VSFYGIVRDGPDGSL 880 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~kg--t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI-VrL~G~f~d~s~~~L 880 (993)
.++.|+.|-...+|+....+ ..+++|+........ . ...+|..+++.|...+| .++++.+. +
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--i-------dR~~E~~vl~~L~~~gl~P~ll~~~~---~--- 176 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--I-------NREREKKISCILYNKNIAKKIYVFFT---N--- 176 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--S-------CHHHHHHHHHHHTTSSSBCCEEEEET---T---
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--c-------CHHHHHHHHHHHHhcCCCCCEEEEeC---C---
Confidence 45788888889999998866 778999875421110 0 11367778888864444 56777653 2
Q ss_pred EEEEeeccCCcH
Q 001940 881 ATVTEFMVNGSL 892 (993)
Q Consensus 881 ~LVmEYm~GGSL 892 (993)
.+||||++|.+|
T Consensus 177 G~v~e~I~G~~l 188 (458)
T 2qg7_A 177 GRIEEFMDGYAL 188 (458)
T ss_dssp EEEEECCCSEEC
T ss_pred eEEEEeeCCccC
Confidence 359999987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.84 E-value=0.032 Score=59.11 Aligned_cols=74 Identities=12% Similarity=0.065 Sum_probs=43.5
Q ss_pred EEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC--CCcceEEEE-----EEcCCC
Q 001940 806 RELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH--PNVVSFYGI-----VRDGPD 877 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH--PNIVrL~G~-----f~d~s~ 877 (993)
..|+ |....||+.... ++.+++|+...... . . ..+..|..+++.|.. -.+.+++.. ... .
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~---~----~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~--~ 99 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--T---A----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--Q 99 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--C---H----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--T
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--C---H----HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE--C
Confidence 4566 888899988764 55799998863211 0 1 234456666665531 123444332 111 3
Q ss_pred CcEEEEEeeccCCc
Q 001940 878 GSLATVTEFMVNGS 891 (993)
Q Consensus 878 ~~L~LVmEYm~GGS 891 (993)
+..++||+|++|..
T Consensus 100 g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 100 GFYFAVFPSVGGRQ 113 (328)
T ss_dssp TEEEEEEECCCCEE
T ss_pred CEEEEEEEecCCCC
Confidence 45688999998754
|
| >1wj6_A KIAA0049 protein, RSGI RUH-024; PB1 domain, protein binding, structural genomics, riken structural genomics/proteomics initiative; NMR {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=95.74 E-value=0.097 Score=48.90 Aligned_cols=86 Identities=20% Similarity=0.312 Sum_probs=64.2
Q ss_pred CCCCeEEEEeecCCeeecCCCCCCeeeecCceeEEEccCCCChHHHHHHHHHHhCC-ceEEEeeCCCCCCCceeeecChh
Q 001940 19 DDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDD 97 (993)
Q Consensus 19 ~~~~~vk~mcsyGG~i~pr~~d~~l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~~-~~~lkyqLp~edld~LisV~~de 97 (993)
.-...|.|-+.|.|++. .-.|+-.|.++|.||.+.+...|+- ++.|||- +|| +-.|+|++++
T Consensus 10 ~m~~~v~lkV~f~ge~~--------------rF~Vs~~~~~tweel~~mvk~~f~L~~~~IkY~--DEe-nD~V~i~Sq~ 72 (101)
T 1wj6_A 10 SMEPQVTLNVTFKNEIQ--------------SFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--DEE-NEEVSINSQG 72 (101)
T ss_dssp SSCSCEEEEEEETTEEE--------------EEEESCTTTSCHHHHHHHHHHHHCCSSBCCEEE--CTT-SCEECCCSHH
T ss_pred ccCccEEEEEEEcCCee--------------EEEecCCCCCCHHHHHHHHHHHcCCCceEEEEe--cCC-CCEEEEecHH
Confidence 34556778777776653 1125567899999999999999994 6999998 666 7899999999
Q ss_pred hHHHHHHHHHHhcCCCCCCeEEEEEeccC
Q 001940 98 DVINMMEEYEKLGSGDGFTRLRIFLFSHS 126 (993)
Q Consensus 98 Dl~~m~~eydr~~~~~~~~rlR~flf~~~ 126 (993)
+++.++.-+.+ +.-.|++++|-..
T Consensus 73 E~eEAlkva~k-----~~n~L~m~V~~~~ 96 (101)
T 1wj6_A 73 EYEEALKMAVK-----QGNQLQMQVHEGS 96 (101)
T ss_dssp HHHHHHHHHHH-----HTSEEEEECCBCC
T ss_pred HHHHHHHHhcc-----CCCEEEEEEeecc
Confidence 98887764433 2356899988633
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=95.54 E-value=0.026 Score=63.21 Aligned_cols=140 Identities=12% Similarity=0.134 Sum_probs=76.9
Q ss_pred EEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcC
Q 001940 806 RELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~ 875 (993)
+.|..|-...+|+.... +..+++|+.... .. . ...+.+|..+++.|. +.-..++++.+.+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~--~-----~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQ--G-----VDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----C--C-----HHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cc--h-----HHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 56777888889998763 367888876321 00 0 124457888887775 2223566666543
Q ss_pred CCCcEEEEEeeccCCcHH--------------HHHH---hc----cCccC--HHHHHHHHHHHH----------------
Q 001940 876 PDGSLATVTEFMVNGSLK--------------QFLQ---KK----DRTID--RRKRLIIAMDAA---------------- 916 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~--------------dlL~---~~----~k~Ls--e~~~lkIalQIL---------------- 916 (993)
.+||||++|..|. +.|. .. .+... +.++.++..++.
T Consensus 126 -----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 200 (379)
T 3feg_A 126 -----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMY 200 (379)
T ss_dssp -----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHT
T ss_pred -----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhH
Confidence 3899999875442 1111 11 11111 233444433321
Q ss_pred ---HHHHHHH----h----CCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 917 ---FGMEYLH----G----KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 917 ---~GLeYLH----s----~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
..++.|. . ..++|+|+.+.|||++.++...+.+.|+||..+...
T Consensus 201 ~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~ 255 (379)
T 3feg_A 201 SLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYN 255 (379)
T ss_dssp THHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcC
Confidence 1233332 2 268999999999999843222368999999998743
|
| >1oey_A P67-PHOX, neutrophil cytosol factor 2; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=95.49 E-value=0.021 Score=51.76 Aligned_cols=69 Identities=16% Similarity=0.203 Sum_probs=53.6
Q ss_pred eeeecCceeEEEccCCCChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001940 43 LRYVGGETRIVSLPRDVTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (993)
Q Consensus 43 l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR 119 (993)
..|- .|..|.|+++++|++|..||++-.+- .+.|.|.=+ +=..++ +.+||||+.++. ..+.+||.
T Consensus 10 V~~~--~tvairvp~~~~y~~L~~~l~~kL~l~~~~~~LsYk~~--~s~~~v-i~~d~dl~~aw~-------~~~n~~Lt 77 (83)
T 1oey_A 10 VHYK--YTVVMKTQPGLPYSQVRDMVSKKLELRLEHTKLSYRPR--DSNELV-PLSEDSMKDAWG-------QVKNYCLT 77 (83)
T ss_dssp EESS--SEEEEEECTTCCHHHHHHHHHHHTTCCGGGCCEEECCT--TCSSCE-ECCTTTHHHHHT-------TCBTTEEE
T ss_pred EEEE--EEEEEECCCCCCHHHHHHHHHHHhCCCcceeEEEeeCC--CCCCee-ccChHHHHHHHH-------hccCCcEE
Confidence 3455 79999999999999999999998774 478999844 556788 999999998763 12335787
Q ss_pred EEEe
Q 001940 120 IFLF 123 (993)
Q Consensus 120 ~flf 123 (993)
|+..
T Consensus 78 L~C~ 81 (83)
T 1oey_A 78 LWCE 81 (83)
T ss_dssp EEEC
T ss_pred EEEe
Confidence 7754
|
| >2bkf_A Zinc-finger protein NBR1 (NEXT to breast cancer 1; PB1 domain, interaction domain, Z finger; 1.56A {Homo sapiens} SCOP: d.15.2.2 PDB: 2g4s_A | Back alignment and structure |
|---|
Probab=95.06 E-value=0.13 Score=46.99 Aligned_cols=69 Identities=19% Similarity=0.330 Sum_probs=53.8
Q ss_pred cCceeE--EEccCCCChHHHHHHHHHHhC-CceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 47 GGETRI--VSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 47 GG~tri--~~v~r~~~f~~l~~kl~~~~~-~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
.||++. |+-.|.++|.||.+.+...|+ .++.|||- +|| +-.|+|+++++++.++.-+.. +.-.|++++|
T Consensus 14 ~ge~~rf~vs~~~~~tweel~~mvk~~f~L~~~~ikY~--DEe-nD~v~i~Sq~E~eEAlkva~k-----~~n~L~m~v~ 85 (87)
T 2bkf_A 14 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--DEE-NEEVSINSQGEYEEALKMAVK-----QGNQLQMQVH 85 (87)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--CTT-SCEEEECSHHHHHHHHHHHHH-----TTTEEEEEEE
T ss_pred cCCeeEEEeccCCCCCHHHHHHHHHHHcCCCceEEEEE--cCC-CCEEEEecHHHHHHHHHHhcc-----CCCEEEEEEe
Confidence 456666 445779999999999999999 46999998 666 789999999998877764433 2355888776
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.086 Score=59.97 Aligned_cols=73 Identities=12% Similarity=0.005 Sum_probs=45.8
Q ss_pred EEEEecccCceEEEEEEEc---------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEE
Q 001940 804 EVRELGSGTYGSVYHGKWR---------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVR 873 (993)
Q Consensus 804 ile~LGeGgFGtVYKAk~k---------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~ 873 (993)
.++.|..|-...+|+.... +..+++|+......... +..+|..+++.|. +.-..++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i---------dR~~E~~~l~~L~~~gi~P~l~~~~~ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY---------DSKVELDVFRYLSNINIAPNIIADFP 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC---------CHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc---------CHHHHHHHHHHHHhcCCCCCEEEEcC
Confidence 4567777888999999875 57789998654321110 1235666666664 222456665432
Q ss_pred cCCCCcEEEEEeeccCCc
Q 001940 874 DGPDGSLATVTEFMVNGS 891 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGS 891 (993)
-++||||++|..
T Consensus 145 ------~~~I~efI~G~~ 156 (424)
T 3mes_A 145 ------EGRIEEFIDGEP 156 (424)
T ss_dssp ------TEEEEECCCSEE
T ss_pred ------CCEEEEEeCCcc
Confidence 178999998865
|
| >1wmh_B Partitioning defective-6 homolog alpha; kinase, PB1 domain, OPCA motif, APKC, cell polarity, transferase/cell cycle complex; 1.50A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=94.34 E-value=0.14 Score=46.63 Aligned_cols=67 Identities=25% Similarity=0.386 Sum_probs=52.7
Q ss_pred eecCceeEEEccCC--CChHHHHHHHHHHhCC---ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEE
Q 001940 45 YVGGETRIVSLPRD--VTYEELMSRMRELYEG---AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLR 119 (993)
Q Consensus 45 YvGG~tri~~v~r~--~~f~~l~~kl~~~~~~---~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR 119 (993)
.-|+|.|=.+++|+ .+|.+|..+|..+... +|.|+|. .+| ..||.++|||+|.. .-+.+++ =||
T Consensus 12 kf~aE~RRFs~d~~~~~~fe~f~~lv~~lh~L~~~~f~i~Y~--D~d-GDLlpInnDdnl~~-------Al~~a~p-lLR 80 (86)
T 1wmh_B 12 KFDAEFRRFALPRASVSGFQEFSRLLRAVHQIPGLDVLLGYT--DAH-GDLLPLTNDDSLHR-------ALASGPP-PLR 80 (86)
T ss_dssp EETTEEEEEEEEGGGCCCHHHHHHHHHHHTTCTTCCCEEEEE--CTT-SCEEECCSHHHHHH-------HTTSSSS-CEE
T ss_pred ecCCeeeEeEccCCCCCCHHHHHHHHHHHcCCCCCCEEEEEE--CCC-CCEeeecCHHHHHH-------HHHhCCC-cEE
Confidence 45788999999987 8999999999998863 6999999 444 57999999998753 2233343 789
Q ss_pred EEE
Q 001940 120 IFL 122 (993)
Q Consensus 120 ~fl 122 (993)
||+
T Consensus 81 l~I 83 (86)
T 1wmh_B 81 LLV 83 (86)
T ss_dssp EEE
T ss_pred EEE
Confidence 987
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.73 E-value=0.48 Score=51.35 Aligned_cols=33 Identities=21% Similarity=0.207 Sum_probs=27.2
Q ss_pred CCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 925 KNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 925 ~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
..++|+|+.+.|||++ .++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~~----~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG----NEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEEC----GGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEEe----CCCeEEEEECCCCeeCC
Confidence 3699999999999997 34578999999887543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.97 E-value=0.35 Score=53.77 Aligned_cols=35 Identities=17% Similarity=0.144 Sum_probs=27.0
Q ss_pred CceecCCCCCCEEEccCC--CCCCeEEEEecCCcccc
Q 001940 926 NIVHFDLKCENLLVNMRD--PQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d--~e~g~VKLiDFGLAk~~ 960 (993)
.++|+|+.+.|||+..+. .+...++++||.+|...
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 367999999999995321 24568999999998753
|
| >1ip9_A BEM1 protein; ubiquitin alpha/beta roll, signaling protein; NMR {Saccharomyces cerevisiae} SCOP: d.15.2.2 PDB: 1ipg_A 2kfk_A | Back alignment and structure |
|---|
Probab=91.69 E-value=1 Score=40.99 Aligned_cols=54 Identities=20% Similarity=0.287 Sum_probs=41.9
Q ss_pred ceeEEEccCCCChHHHHHHHHHHhCC-ceEEEeeCCCCCCCceeeecChhhHHHHHHH
Q 001940 49 ETRIVSLPRDVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEE 105 (993)
Q Consensus 49 ~tri~~v~r~~~f~~l~~kl~~~~~~-~~~lkyqLp~edld~LisV~~deDl~~m~~e 105 (993)
+--+|.||-+|+|.+|..||..-... ++.+.+-. +|.... .+.+|+||...|..
T Consensus 22 DIiAIrvP~di~~~~L~dKi~~RLk~~~~~l~~yk-de~~g~--~i~sD~dl~~aiqr 76 (85)
T 1ip9_A 22 DIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTKL-FDGSGE--EIKTDSQVSNIIQA 76 (85)
T ss_dssp CCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEECC-SSSCCS--CCCSHHHHHHHHHT
T ss_pred cEEEEECCCCCCHHHHHHHHHHHhcccceEEEEec-CCCCCC--cccCHHHHHHHHHh
Confidence 44589999999999999999998775 45443333 665555 99999999998763
|
| >1oey_J P40-PHOX, neutrophil cytosol factor 4; immune system, PB1 heterodimer/complex, NADPH oxidase, PB1 D heterodimerization; 2.0A {Homo sapiens} SCOP: d.15.2.2 | Back alignment and structure |
|---|
Probab=90.69 E-value=0.63 Score=43.66 Aligned_cols=57 Identities=19% Similarity=0.418 Sum_probs=47.6
Q ss_pred cCceeEEEccCCC----ChHHHHHHHHHHhCC-ceEEEeeCCCCCCCceeeecChhhHHHHHHHH
Q 001940 47 GGETRIVSLPRDV----TYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEEY 106 (993)
Q Consensus 47 GG~tri~~v~r~~----~f~~l~~kl~~~~~~-~~~lkyqLp~edld~LisV~~deDl~~m~~ey 106 (993)
|-.+|=|+|.-++ +|.||+..+...+.. +++|+|+=+. .-||-+.+||||.-|+.+-
T Consensus 17 ~~~irdI~veedl~~~P~ykdLl~lmr~~F~~~DIaLNYrD~e---GDLIrilddeDv~lmi~~s 78 (107)
T 1oey_J 17 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAE---GDLVRLLSDEDVALMVRQA 78 (107)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTT---SCEEECCSHHHHHHHHHHC
T ss_pred CceeeeEEEccccccCCCHHHHHHHHHHHhcccceeeeeecCC---CCEEEEcchHHHHHHHHHh
Confidence 4567788887765 799999999998885 6999999444 3589999999999999886
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 993 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-38 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-38 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-37 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-37 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-34 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-33 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-33 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-33 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-25 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-25 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-25 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-15 | |
| d1ip9a_ | 85 | d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker' | 6e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 59/193 (30%), Positives = 94/193 (48%), Gaps = 17/193 (8%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
I + + + +GSG++G+VY GKW G DVA+K + + + + F E +
Sbjct: 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLN------VTAPTPQQLQAFKNEVGV 57
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L H N++ F G LA VT++ SL L + + K + IA A
Sbjct: 58 LRKTRHVNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK---QQTLVSGGVRGTL 973
GM+YLH K+I+H DLK N+ ++ + KIGD GL+ VK + + G++
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
Query: 974 PWMAPELLSGKSH 986
WMAPE++ +
Sbjct: 171 LWMAPEVIRMQDK 183
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-40
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 18/193 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEA 854
+K+DD E++ ELG+G G V+ + S +A K I + + +E
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-------HLEIKPAIRNQIIREL 55
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+L + P +V FYG DG ++ E M GSL Q L+K R I + +++
Sbjct: 56 QVLHECNSPYIVGFYGAFYS--DGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIA 112
Query: 915 AAFGMEYLHGKN-IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTL 973
G+ YL K+ I+H D+K N+LVN R K+ D G+S ++ + V GT
Sbjct: 113 VIKGLTYLREKHKIMHRDVKPSNILVNSRG----EIKLCDFGVSGQLIDSMANSFV-GTR 167
Query: 974 PWMAPELLSGKSH 986
+M+PE L G +
Sbjct: 168 SYMSPERLQGTHY 180
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 2e-40
Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 18/191 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ +L+ ++ +G G +G V G +RG+ VA+K IK + F EA +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----------NDATAQAFLAEASV 53
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMDA 915
++ L H N+V G++ + G L VTE+M GSL +L+ + R+ + L ++D
Sbjct: 54 MTQLRHSNLVQLLGVIVE-EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
MEYL G N VH DL N+LV+ + V K+ D GL+K T +G + + W
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDN----VAKVSDFGLTKEASSTQDTG--KLPVKW 166
Query: 976 MAPELLSGKSH 986
APE L K
Sbjct: 167 TAPEALREKKF 177
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 6e-40
Identities = 61/193 (31%), Positives = 91/193 (47%), Gaps = 18/193 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I DL ++ELG+G +G V +GKWR DVAIK IK + +F +EA
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---------EFIEEAK 51
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ +L H +V YG+ + +TE+M NG L +L++ ++ L + D
Sbjct: 52 VMMNLSHEKLVQLYGVCTK--QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 109
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
MEYL K +H DL N LVN + V K+ D GLS+ + S G + +
Sbjct: 110 CEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 165
Query: 974 PWMAPELLSGKSH 986
W PE+L
Sbjct: 166 RWSPPEVLMYSKF 178
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 2e-38
Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 17/186 (9%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
++RE+G G++G+VY + VAIK++ S + D KE L L
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKL 72
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN + + G + + V E+ + + K + + + + A G+
Sbjct: 73 RHPNTIQYRGCYLR--EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLA 129
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPEL 980
YLH N++H D+K N+L++ + K+GD G + + GT WMAPE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASIMAPA---NSFVGTPYWMAPEV 182
Query: 981 LSGKSH 986
+
Sbjct: 183 ILAMDE 188
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-38
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 17/190 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D E + ELG G +G VY + + + A K I ++ E + D+ E +L
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVID--------TKSEEELEDYMVEIDIL 63
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+S HPN+V + +L + EF G++ + + +R + + ++
Sbjct: 64 ASCDHPNIVKLLDAFYY--ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL-VSGGVRGTLPWM 976
+ YLH I+H DLK N+L K+ D G+S +T+ GT WM
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 177
Query: 977 APELLSGKSH 986
APE++ ++
Sbjct: 178 APEVVMCETS 187
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 56/193 (29%), Positives = 89/193 (46%), Gaps = 18/193 (9%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
I +L V+E+GSG +G V+ G W VAIK I+ + + DF +EA
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---------DFIEEAE 52
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
++ L HP +V YG+ + + V EFM +G L +L+ + L + +D
Sbjct: 53 VMMKLSHPKLVQLYGVCLE--QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 110
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGTL 973
GM YL ++H DL N LV + V K+ D G+++ Q S G + +
Sbjct: 111 CEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 166
Query: 974 PWMAPELLSGKSH 986
W +PE+ S +
Sbjct: 167 KWASPEVFSFSRY 179
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 7e-38
Identities = 59/189 (31%), Positives = 93/189 (49%), Gaps = 17/189 (8%)
Query: 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
L+ E+G G++ +VY G +VA ++ SER+R F +EA +L
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQR----FKEEAEMLKG 64
Query: 860 LHHPNVVSFYGIVRDGPDG--SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L HPN+V FY G + VTE M +G+LK +L++ + +
Sbjct: 65 LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILK 123
Query: 918 GMEYLH--GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
G+++LH I+H DLKC+N+ + KIGDLGL+ +K+ + + V GT +
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDLGLATLKRASF-AKAVIGTPEF 179
Query: 976 MAPELLSGK 984
MAPE+ K
Sbjct: 180 MAPEMYEEK 188
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 21/198 (10%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E + +G+G+YG + + G + K + S E E LL
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD------YGSMTEAEKQMLVSEVNLL 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR---TIDRRKRLIIAMD 914
L HPN+V +Y + D + +L V E+ G L + K + +D L +
Sbjct: 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117
Query: 915 AAFGMEYLH-----GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGG 968
++ H G ++H DLK N+ ++ + K+GD GL++ + T +
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNVKLGDFGLARILNHDTSFAKA 173
Query: 969 VRGTLPWMAPELLSGKSH 986
GT +M+PE ++ S+
Sbjct: 174 FVGTPYYMSPEQMNRMSY 191
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-37
Identities = 55/194 (28%), Positives = 91/194 (46%), Gaps = 20/194 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ + L+ V LG+G +G V+ G + + VA+K +K + F EA
Sbjct: 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---------AFLAEAN 60
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRT-IDRRKRLIIAMD 914
L+ L H +V Y +V P + +TE+M NGSL FL+ + K L +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM ++ +N +H DL+ N+LV+ CKI D GL+++ + G +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTL----SCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 973 LPWMAPELLSGKSH 986
+ W APE ++ +
Sbjct: 174 IKWTAPEAINYGTF 187
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-37
Identities = 51/189 (26%), Positives = 88/189 (46%), Gaps = 15/189 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D E R LG G +G+VY + + S +A+K + + E+ + +E +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-----EKAGVEHQLRREVEIQ 60
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S L HPN++ YG D + + E+ G++ + LQK + D ++ + A
Sbjct: 61 SHLRHPNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELAN 117
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+ Y H K ++H D+K ENLL+ KI D G S + + GTL ++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAG----ELKIADFGWSVHAPSSR-RTTLCGTLDYLP 172
Query: 978 PELLSGKSH 986
PE++ G+ H
Sbjct: 173 PEMIEGRMH 181
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 59/199 (29%), Positives = 85/199 (42%), Gaps = 21/199 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I DL + +LG G++G V G+W VA+K +K + + DF
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-----SQPEAMDDFI 59
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+E + SL H N++ YG+V P + VTE GSL L+K
Sbjct: 60 REVNAMHSLDHRNLIRLYGVVLTPP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 116
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
A+ A GM YL K +H DL NLL+ RD + KIGD GL + ++
Sbjct: 117 AVQVAEGMGYLESKRFIHRDLAARNLLLATRD----LVKIGDFGLMRALPQNDDHYVMQE 172
Query: 968 GVRGTLPWMAPELLSGKSH 986
+ W APE L ++
Sbjct: 173 HRKVPFAWCAPESLKTRTF 191
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (354), Expect = 6e-37
Identities = 43/194 (22%), Positives = 81/194 (41%), Gaps = 14/194 (7%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
Q D + + ELGSG +G V+ + G K I P ++ +
Sbjct: 24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVK----N 75
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E +++ LHHP +++ + D + + EF+ G L + +D + + +
Sbjct: 76 EISIMNQLHHPKLINLHDAFED--KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 133
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGT 972
A G++++H +IVH D+K EN++ + KI D GL+ + T
Sbjct: 134 RQACEGLKHMHEHSIVHLDIKPENIMCETKKA--SSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 973 LPWMAPELLSGKSH 986
+ APE++ +
Sbjct: 192 AEFAAPEIVDREPV 205
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-36
Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 23/202 (11%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLI 847
L+ +K + ++++ LGSG +G+VY G W VAIK ++ + +
Sbjct: 3 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-------EATSPKAN 55
Query: 848 ADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRK 907
+ EA +++S+ +P+V GI ++ +T+ M G L ++++ I +
Sbjct: 56 KEILDEAYVMASVDNPHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 908 RLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTL 964
L + A GM YL + +VH DL N+LV KI D GL+K+ +++
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHVKITDFGLAKLLGAEEKEY 168
Query: 965 VSGGVRGTLPWMAPELLSGKSH 986
+ G + + WMA E + + +
Sbjct: 169 HAEGGKVPIKWMALESILHRIY 190
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 58/200 (29%), Positives = 82/200 (41%), Gaps = 23/200 (11%)
Query: 797 IKNDDLEEV-RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFW 851
+K D+L ELG G +GSV G +R DVAIK +K + +
Sbjct: 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-------QGTEKADTEEMM 57
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EA ++ L +P +V G+ + L V E G L +FL K I +
Sbjct: 58 REAQIMHQLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 114
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSG 967
+ GM+YL KN VH DL N+L+ R KI D GLSK
Sbjct: 115 LHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKISDFGLSKALGADDSYYTARS 170
Query: 968 GVRGTLPWMAPELLSGKSHM 987
+ L W APE ++ +
Sbjct: 171 AGKWPLKWYAPECINFRKFS 190
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-36
Identities = 57/192 (29%), Positives = 82/192 (42%), Gaps = 19/192 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + V+ LG G YG V R ++ VA+K + + KE +
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-------MKRAVDCPENIKKEICIN 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L+H NVV FYG R E+ G L + + D +
Sbjct: 58 KMLNHENVVKFYGHRR--EGNIQYLFLEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMA 114
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGVRGTLP 974
G+ YLHG I H D+K ENLL++ RD KI D GL+ V + + + GTLP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERD----NLKISDFGLATVFRYNNRERLLNKMCGTLP 170
Query: 975 WMAPELLSGKSH 986
++APELL +
Sbjct: 171 YVAPELLKRREF 182
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 51/198 (25%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFW 851
I+ + +E R +G G +G V+ G + + VAIK K + + F
Sbjct: 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-------NCTSDSVREKFL 56
Query: 852 KEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
+EAL + HP++V G++ + P + + E G L+ FLQ + ++D ++
Sbjct: 57 QEALTMRQFDHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILY 113
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGV 969
A + + YL K VH D+ N+LV+ D K+GD GLS+ +
Sbjct: 114 AYQLSTALAYLESKRFVHRDIAARNVLVSSND----CVKLGDFGLSRYMEDSTYYKASKG 169
Query: 970 RGTLPWMAPELLSGKSHM 987
+ + WMAPE ++ +
Sbjct: 170 KLPIKWMAPESINFRRFT 187
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 135 bits (341), Expect = 3e-35
Identities = 48/189 (25%), Positives = 79/189 (41%), Gaps = 14/189 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + ELG+G +G V+ R G++ A K + P E ++ KE +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM------TPHESDK--ETVRKEIQTM 77
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S L HP +V+ + D D + + EFM G L + + + + + +
Sbjct: 78 SVLRHPTLVNLHDAFED--DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 135
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+ ++H N VH DLK EN++ + K+ D GL+ GT + A
Sbjct: 136 GLCHMHENNYVHLDLKPENIMFTTKRS--NELKLIDFGLTAHLDPKQSVKVTTGTAEFAA 193
Query: 978 PELLSGKSH 986
PE+ GK
Sbjct: 194 PEVAEGKPV 202
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 30/203 (14%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS 859
+ +G G +G V+ GKWRG +VA+K ER E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFS------SREERSWF---REAEIYQTVM 53
Query: 860 LHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N++ F +G L V+++ +GSL +L + T++ + +A+ A
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIK--LALSTAS 111
Query: 918 GMEYLH--------GKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL-----SKVKQQTL 964
G+ +LH I H DLK +N+LV C I DLGL S +
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG----TCCIADLGLAVRHDSATDTIDI 167
Query: 965 VSGGVRGTLPWMAPELLSGKSHM 987
GT +MAPE+L +M
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINM 190
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (331), Expect = 2e-34
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 26/221 (11%)
Query: 780 IEP-TIAE-AEAIARGLQTIKNDDLEEVRELGSGTYGSVYHGKWRGSD-----VAIKRIK 832
I+P T + EA+ + I ++ + +G+G +G V G + VAIK +K
Sbjct: 4 IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63
Query: 833 ASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSL 892
E+ DF EA ++ HPNV+ G+V + +TEFM NGSL
Sbjct: 64 -------SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK--STPVMIITEFMENGSL 114
Query: 893 KQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952
FL++ D + + + A GM+YL N VH DL N+LVN VCK+
Sbjct: 115 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCKVS 170
Query: 953 DLGLSKV------KQQTLVSGGVRGTLPWMAPELLSGKSHM 987
D GLS+ + G + + W APE + +
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (330), Expect = 2e-34
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 20/195 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEA 854
++ D+ +LG G YG VY G W+ VA+K +K E + +F KEA
Sbjct: 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEA 64
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-TIDRRKRLIIAM 913
++ + HPN+V G+ + +TEFM G+L +L++ +R + L +A
Sbjct: 65 AVMKEIKHPNLVQLLGVCTR--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ--QTLVSGGVRG 971
+ MEYL KN +H DL N LV + K+ D GLS++ G +
Sbjct: 123 QISSAMEYLEKKNFIHRDLAARNCLVGENH----LVKVADFGLSRLMTGDTYTAHAGAKF 178
Query: 972 TLPWMAPELLSGKSH 986
+ W APE L+
Sbjct: 179 PIKWTAPESLAYNKF 193
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-34
Identities = 52/194 (26%), Positives = 83/194 (42%), Gaps = 23/194 (11%)
Query: 802 LEEVRELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
LE+ +ELGSG +G+V G ++ VA+K +K + L + EA ++
Sbjct: 10 LED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILK------NEANDPALKDELLAEANVM 62
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L +P +V GI S V E G L ++LQ+ R + + + + +
Sbjct: 63 QQLDNPYIVRMIGICEAE---SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSM 118
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTL 973
GM+YL N VH DL N+L+ + KI D GLSK + + +
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQH----YAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 974 PWMAPELLSGKSHM 987
W APE ++
Sbjct: 175 KWYAPECINYYKFS 188
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 56/194 (28%), Positives = 89/194 (45%), Gaps = 20/194 (10%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-VAIKRIKASCFAGKPSERERLIADFWKEAL 855
I + L +LG G +G V+ G W G+ VAIK +K + + F +EA
Sbjct: 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---------AFLQEAQ 64
Query: 856 LLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQF-LQKKDRTIDRRKRLIIAMD 914
++ L H +V Y +V + P + VTE+M GSL F + + + + + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV--KQQTLVSGGVRGT 972
A GM Y+ N VH DL+ N+LV + VCK+ D GL+++ + G +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 973 LPWMAPELLSGKSH 986
+ W APE
Sbjct: 178 IKWTAPEAALYGRF 191
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 6e-34
Identities = 59/223 (26%), Positives = 85/223 (38%), Gaps = 46/223 (20%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
++LE + LGSG +G V + G VA+K +K SERE
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREA---- 86
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR------- 901
E +++ L H N+V+ G G + + E+ G L +L+ K
Sbjct: 87 LMSELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 902 ---------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQR 946
+ L A A GME+L K+ VH DL N+LV
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT----HG 200
Query: 947 PVCKIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSH 986
V KI D GL++ +V G R + WMAPE L +
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-34
Identities = 55/215 (25%), Positives = 82/215 (38%), Gaps = 35/215 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ L + LG+G +G V G VA+K +K S +ERE
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREA---- 72
Query: 850 FWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK--------- 899
E +LS L +H N+V+ G G +TE+ G L FL++K
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ +D L + A GM +L KN +H DL N+L+ +C
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-THGRITKICDF 189
Query: 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
G K +V G R + WMAPE + +
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 9e-34
Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 23/201 (11%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD------VAIKRIKASCFAGKPSERERLIADF 850
I + + +G+G +G VY G + S VAIK +K E+ DF
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-------AGYTEKQRVDF 56
Query: 851 WKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
EA ++ H N++ G++ + +TE+M NG+L +FL++KD + +
Sbjct: 57 LGEAGIMGQFSHHNIIRLEGVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVS 966
+ A GM+YL N VH DL N+LVN VCK+ D GLS+V + T +
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 967 GGVRGTLPWMAPELLSGKSHM 987
G + + W APE +S +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFT 191
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 7/190 (3%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D + ELGSG + V + + G A K IK K S R D +E +
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRT--KSSRRGVSREDIEREVSI 66
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + HPNV++ + + + + + E + G L FL +K+ + +
Sbjct: 67 LKEIQHPNVITLHEVYEN--KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ-IL 123
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+ YLH I HFDLK EN+++ R+ +P KI D GL+ + GT ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 977 APELLSGKSH 986
APE+++ +
Sbjct: 184 APEIVNYEPL 193
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 19/191 (9%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
++G G G+VY G +VAI+++ + ++E +I E L+
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELII----NEILV 70
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+ +PN+V++ L V E++ GSL + + + + +
Sbjct: 71 MRENKNPNIVNYLDSYLV--GDELWVVMEYLAGGSLTDVVTETCMDEGQIAA--VCRECL 126
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPW 975
+E+LH ++H D+K +N+L+ M K+ D G + + + GT W
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 976 MAPELLSGKSH 986
MAPE+++ K++
Sbjct: 183 MAPEVVTRKAY 193
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 3e-33
Identities = 53/190 (27%), Positives = 78/190 (41%), Gaps = 13/190 (6%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
D + LG+G + V + + VAIK I GK E +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-------GSMENEIAV 60
Query: 857 LSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
L + HPN+V+ I G L + + + G L + +K R +
Sbjct: 61 LHKIKHPNIVALDDIYES--GGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVL 117
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
++YLH IVH DLK ENLL D + I D GLSK++ V GT ++
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKI-MISDFGLSKMEDPGSVLSTACGTPGYV 176
Query: 977 APELLSGKSH 986
APE+L+ K +
Sbjct: 177 APEVLAQKPY 186
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 6e-33
Identities = 56/220 (25%), Positives = 87/220 (39%), Gaps = 46/220 (20%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIADFWK 852
+++E VR++G G +G V+ + G VA+K +K + ADF +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-------EEASADMQADFQR 65
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR----------- 901
EA L++ +PN+V G+ G + + E+M G L +FL+
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVG--KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 902 ------------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949
+ ++L IA A GM YL + VH DL N LV + V
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG----ENMVV 179
Query: 950 KIGDLGLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSH 986
KI D GLS+ G + WM PE + +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-33
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 17/197 (8%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
+ + +D + + LG G++ +V + + AIK ++ + +E + +
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK-----RHIIKENKVPYVTR 57
Query: 853 EALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIA 912
E ++S L HP V Y +D D L + NG L ++++K + R A
Sbjct: 58 ERDVMSRLDHPFFVKLYFTFQD--DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA 115
Query: 913 MDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV---KQQTLVSGGV 969
+ +EYLHGK I+H DLK EN+L+N + +I D G +KV + + +
Sbjct: 116 -EIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFGTAKVLSPESKQARANSF 170
Query: 970 RGTLPWMAPELLSGKSH 986
GT +++PELL+ KS
Sbjct: 171 VGTAQYVSPELLTEKSA 187
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 6e-33
Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 22/192 (11%)
Query: 806 RELGSGTYGSVYHGKWRGSD-----VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+G G +G VYHG +D A+K + ++ F E +++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-------RITDIGEVSQFLTEGIIMKDF 85
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPNV+S GI +GS V +M +G L+ F++ + + + + A GM+
Sbjct: 86 SHPNVLSLLGICLR-SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK-----QQTLVSGGVRGTLPW 975
+L K VH DL N +++ ++ K+ D GL++ G + + W
Sbjct: 145 FLASKKFVHRDLAARNCMLD----EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 976 MAPELLSGKSHM 987
MA E L +
Sbjct: 201 MALESLQTQKFT 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 2e-32
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 33/210 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS----DVAIKRIKASCFAGKPSERERLIADFWK 852
+ +D++ +G G +G V + + D AIKR+K + DF
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-------EYASKDDHRDFAG 59
Query: 853 EALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------- 900
E +L L HHPN+++ G G L E+ +G+L FL+K
Sbjct: 60 ELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117
Query: 901 ----RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956
T+ ++ L A D A GM+YL K +H DL N+LV + V KI D GL
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG----ENYVAKIADFGL 173
Query: 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
S+ ++ + R + WMA E L+ +
Sbjct: 174 SRGQEVYVKKTMGRLPVRWMAIESLNYSVY 203
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 2e-32
Identities = 34/189 (17%), Positives = 70/189 (37%), Gaps = 15/189 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ +LG G +G V+ S K +K K +++ KE +L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVL----VKKEISIL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ H N++ + L + EF+ + + + ++ R+ +
Sbjct: 56 NIARHRNILHLHESFES--MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+++LH NI HFD++ EN++ R KI + G ++ + + + A
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRR--SSTIKIIEFGQARQLKPGDNFRLLFTAPEYYA 171
Query: 978 PELLSGKSH 986
PE+
Sbjct: 172 PEVHQHDVV 180
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 125 bits (314), Expect = 2e-32
Identities = 46/191 (24%), Positives = 74/191 (38%), Gaps = 11/191 (5%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRI-KASCFAGKPSERERLIADFWKEALL 856
++ E LG G V + + A+K I + E + L KE +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 857 LSSLH-HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDA 915
L + HPN++ + V + M G L +L +K T+ ++ I
Sbjct: 63 LRKVSGHPNIIQLKDTYET--NTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRAL 119
Query: 916 AFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW 975
+ LH NIVH DLK EN+L++ K+ D G S V GT +
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 175
Query: 976 MAPELLSGKSH 986
+APE++ +
Sbjct: 176 LAPEIIECSMN 186
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (305), Expect = 3e-31
Identities = 37/192 (19%), Positives = 78/192 (40%), Gaps = 10/192 (5%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+D E LG G V+ + DVA+K ++A + F +EA
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-----ARDPSFYLRFRREAQN 60
Query: 857 LSSLHHPNVVSFYGIV--RDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
++L+HP +V+ Y V E++ +L+ + + + ++ + + D
Sbjct: 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIAD 119
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
A + + H I+H D+K N++++ + + + ++ + V GT
Sbjct: 120 ACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 975 WMAPELLSGKSH 986
+++PE G S
Sbjct: 180 YLSPEQARGDSV 191
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 14/190 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + LG G++G V+ +++ AIK +K + E + ++ +L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKD-VVLMDDDVECTMV---EKRVLS 57
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ HP + + + +L V E++ G L +Q + D + A +
Sbjct: 58 LAWEHPFLTHMFCTFQT--KENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIIL 114
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWM 976
G+++LH K IV+ DLK +N+L++ KI D G+ K + GT ++
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGH----IKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 977 APELLSGKSH 986
APE+L G+ +
Sbjct: 171 APEILLGQKY 180
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-30
Identities = 49/203 (24%), Positives = 79/203 (38%), Gaps = 22/203 (10%)
Query: 793 GLQTIKN---DDLEEVRE-LGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERL 846
GLQ KN DD + + LG G G V + A+K ++ + RE
Sbjct: 1 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVE 56
Query: 847 IADFWKEALLLSSLHHPNVVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKK-DRTI 903
+ + P++V + + L V E + G L +Q + D+
Sbjct: 57 L--------HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
R+ I ++YLH NI H D+K ENLL + P + K+ D G +K
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN-AILKLTDFGFAKETTSH 167
Query: 964 LVSGGVRGTLPWMAPELLSGKSH 986
T ++APE+L + +
Sbjct: 168 NSLTTPCYTPYYVAPEVLGPEKY 190
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 121 bits (304), Expect = 3e-30
Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 12/189 (6%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D R +G G +G VY + G A+K + K + E L + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLV 61
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S+ P +V L+ + + M G L L + + R A
Sbjct: 62 STGDCPFIVCMSYAFHT--PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE-IIL 118
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+E++H + +V+ DLK N+L++ + +I DLGL+ + GT +MA
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLGLACDFSKKK-PHASVGTHGYMA 173
Query: 978 PELLSGKSH 986
PE+L
Sbjct: 174 PEVLQKGVA 182
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-30
Identities = 52/209 (24%), Positives = 80/209 (38%), Gaps = 32/209 (15%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
+ + + RELG G++G VY G +G VAIK + + R +
Sbjct: 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-------EAASMRERIE 69
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-------- 901
F EA ++ + +VV G+V + E M G LK +L+
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 902 -TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV- 959
K + +A + A GM YL+ VH DL N +V + KIGD G+++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA----EDFTVKIGDFGMTRDI 183
Query: 960 --KQQTLVSGGVRGTLPWMAPELLSGKSH 986
G + WM+PE L
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVF 212
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-29
Identities = 54/215 (25%), Positives = 86/215 (40%), Gaps = 36/215 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD-------VAIKRIKASCFAGKPSERERLIAD 849
D L+ + LG G +G V G D VA+K +K + + A
Sbjct: 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK------EGATHSEHRAL 63
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDR-------- 901
+ +L+ HH NVV+ G P G L + EF G+L +L+ K
Sbjct: 64 MSELKILIHIGHHLNVVNLLGACTK-PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 902 -------TIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954
+ + + A GME+L + +H DL N+L++ ++ V KI D
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS----EKNVVKICDF 178
Query: 955 GLSKV---KQQTLVSGGVRGTLPWMAPELLSGKSH 986
GL++ + G R L WMAPE + + +
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-29
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 35/215 (16%)
Query: 797 IKNDDLEEVRELGSGTYGSVYHGKWRGSD---------VAIKRIKASCFAGKPSERERLI 847
+ D L + LG G +G V + G D VA+K +K E+ +
Sbjct: 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-------SDATEKDL 62
Query: 848 ADFWKEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKK------- 899
+D E ++ + H N+++ G DG L + E+ G+L+++LQ +
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 900 --------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951
+ + + + A A GMEYL K +H DL N+LV + + +
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMK-IADF 179
Query: 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSH 986
G + R + WMAPE L + +
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 2e-28
Identities = 51/189 (26%), Positives = 93/189 (49%), Gaps = 16/189 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + +R LG+G++G V+ + R G A+K +K R + + E L+L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-----VRLKQVEHTNDERLML 58
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
S + HP ++ +G +D + + +++ G L L+K R + + A +
Sbjct: 59 SIVTHPFIIRMWGTFQD--AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA-EVCL 115
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
+EYLH K+I++ DLK EN+L++ + KI D G +K + + GT ++A
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGFAKYVPDVTYT--LCGTPDYIA 169
Query: 978 PELLSGKSH 986
PE++S K +
Sbjct: 170 PEVVSTKPY 178
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-28
Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 19/197 (9%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEAL 855
+ E V E+G G YG V+ + G VA+KR++ + E + +E
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVA 59
Query: 856 LLSSL---HHPNVVSFYGIVRDGP---DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRL 909
+L L HPNVV + + + L V E + + + +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 910 IIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGV 969
+ G+++LH +VH DLK +N+LV K+ D GL+++ + V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG----QIKLADFGLARIYSFQMALTSV 175
Query: 970 RGTLPWMAPELLSGKSH 986
TL + APE+L S+
Sbjct: 176 VVTLWYRAPEVLLQSSY 192
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-27
Identities = 36/193 (18%), Positives = 62/193 (32%), Gaps = 12/193 (6%)
Query: 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALL 856
+ LGSG +GSVY G VAIK ++ + E +L
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNG--TRVPMEVVL 60
Query: 857 LSSLH--HPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L + V+ S + E + +
Sbjct: 61 LKKVSSGFSGVIRLLDWFER--PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
+ + H ++H D+K EN+L+ D R K+ D G + + T+ + GT
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGSGALLKDTVYT-DFDGTRV 174
Query: 975 WMAPELLSGKSHM 987
+ PE + +
Sbjct: 175 YSPPEWIRYHRYH 187
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-27
Identities = 49/191 (25%), Positives = 83/191 (43%), Gaps = 15/191 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
++ ++V ++G GTYG VY + + G VA+K+I+ +E E + + +E LL
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L+HPN+V ++ + L V EF+ K I
Sbjct: 56 KELNHPNIVKLLDVIHT--ENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW-M 976
G+ + H ++H DLK +NLL+N K+ D GL++ + + W
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 169
Query: 977 APELLSGKSHM 987
APE+L G +
Sbjct: 170 APEILLGCKYY 180
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (278), Expect = 3e-27
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 21/196 (10%)
Query: 794 LQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFW 851
++ DD + VR+LG G Y V+ V +K +K P ++++
Sbjct: 29 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-------PVKKKK----IK 77
Query: 852 KEALLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+E +L +L PN+++ IV+D + A V E + N KQ Q +
Sbjct: 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 133
Query: 911 IAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR 970
+ ++Y H I+H D+K N+++ D + ++ D GL++
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMI---DHEHRKLRLIDWGLAEFYHPGQEYNVRV 190
Query: 971 GTLPWMAPELLSGKSH 986
+ + PELL
Sbjct: 191 ASRYFKGPELLVDYQM 206
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-27
Identities = 44/199 (22%), Positives = 72/199 (36%), Gaps = 21/199 (10%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ +G G YG V VAIK+I P E + +E +L
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS-------PFEHQTYCQRTLREIKILLRF 63
Query: 861 HHPNVVSFYGIVRDG--PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
H N++ I+R + ++ L + L K + + G
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQILRG 121
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKV----KQQTLVSGGVRGTLP 974
++Y+H N++H DLK NLL+N KI D GL++V T T
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLN----TTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 975 WMAPELLSGKSHMVTEKEL 993
+ APE++ ++
Sbjct: 178 YRAPEIMLNSKGYTKSIDI 196
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 2e-26
Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 24/200 (12%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
E++ ++G GT+G V+ + R G VA+K++ +E+E +E +L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 63
Query: 858 SSLHHPNVVSFYGIVRDGP------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLII 911
L H NVV+ I R GS+ V +F + + + ++
Sbjct: 64 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 123
Query: 912 AMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVS----- 966
M G+ Y+H I+H D+K N+L+ + V K+ D GL++ S
Sbjct: 124 QM-LLNGLYYIHRNKILHRDMKAANVLIT----RDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 967 GGVRGTLPWMAPELLSGKSH 986
TL + PELL G+
Sbjct: 179 TNRVVTLWYRPPELLLGERD 198
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 6e-26
Identities = 43/189 (22%), Positives = 85/189 (44%), Gaps = 16/189 (8%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
D + ++ LG+G++G V K + G+ A+K + + + + I E +L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDK-----QKVVKLKQIEHTLNEKRIL 95
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+++ P +V +D + L V E++ G + L++ R A
Sbjct: 96 QAVNFPFLVKLEFSFKDNSN--LYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVL 152
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
EYLH ++++ DLK ENLL++ + ++ D G +K + + + GT +A
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAKRVKGRTWT--LCGTPEALA 206
Query: 978 PELLSGKSH 986
PE++ K +
Sbjct: 207 PEIILSKGY 215
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 105 bits (263), Expect = 2e-25
Identities = 39/193 (20%), Positives = 70/193 (36%), Gaps = 23/193 (11%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R++GSG++G +Y G G +VAIK + E+ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLEC----------VKTKHPQLHIESKIYKMMQG 61
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
+ G +G + ++ SL+ R + L++A +EY+
Sbjct: 62 GVGIPTIRWC--GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--------VKQQTLVSGGVRGTLP 974
H KN +H D+K +N L+ + V I D GL+K + + GT
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 975 WMAPELLSGKSHM 987
+ + G
Sbjct: 179 YASINTHLGIEQS 191
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 15/190 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+D + ++ LG GT+G V + + G A+K ++ K +A E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVL 59
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
+ HP + + + L V E+ G L L ++ + R R A +
Sbjct: 60 QNTRHPFLTALKYAFQT--HDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA-EIVS 116
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK-VKQQTLVSGGVRGTLPWM 976
+EYLH +++V+ D+K ENL+++ + KI D GL K GT ++
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 977 APELLSGKSH 986
APE+L +
Sbjct: 173 APEVLEDNDY 182
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 103 bits (258), Expect = 6e-25
Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 15/189 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLS 858
+ + ++G GTYG VY + G A+K+I+ E E + + +E +L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 859 SLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFG 918
L H N+V Y ++ L ++ LK+ L + ++ + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVL---VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 919 MEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPW-MA 977
+ Y H + ++H DLK +NLL+N KI D GL++ + W A
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREG----ELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 978 PELLSGKSH 986
P++L G
Sbjct: 169 PDVLMGSKK 177
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 103 bits (258), Expect = 6e-25
Identities = 38/193 (19%), Positives = 74/193 (38%), Gaps = 23/193 (11%)
Query: 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH 862
R +G G++G ++ G VAIK + S+ +L ++ LL
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDEYRTYKLLAGCTGI 63
Query: 863 PNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYL 922
PNV F G +G + ++ SL+ L R + + A ++ +
Sbjct: 64 PNVYYF------GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 923 HGKNIVHFDLKCENLLVNMRDPQRPVC-KIGDLGLSKVKQQTLVS--------GGVRGTL 973
H K++V+ D+K +N L+ + + + D G+ K + + + GT
Sbjct: 118 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 974 PWMAPELLSGKSH 986
+M+ G+
Sbjct: 178 RYMSINTHLGREQ 190
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-25
Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 13/187 (6%)
Query: 803 EEVRELGSGTYGSVYHGKWRGSD--VAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
E++ LG G + +VY + + ++ VAIK+IK + ++ + +E LL L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQEL 57
Query: 861 HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGME 920
HPN++ +++ V +FM + + M G+E
Sbjct: 58 SHPNIIGLLDAFGH--KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM-TLQGLE 114
Query: 921 YLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVR-GTLPWMAPE 979
YLH I+H DLK NLL++ + V K+ D GL+K + + T + APE
Sbjct: 115 YLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 980 LLSGKSH 986
LL G
Sbjct: 171 LLFGARM 177
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-24
Identities = 39/203 (19%), Positives = 77/203 (37%), Gaps = 23/203 (11%)
Query: 792 RGLQTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIAD 849
+G + + + +G+G++G VY K G VAIK++ ++
Sbjct: 12 QGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRF---- 59
Query: 850 FWKEALLLSSLHHPNVVSFYGIVRDGPDGS----LATVTEFMVNGSLKQFLQ--KKDRTI 903
+E ++ L H N+V + L V +++ + + +T+
Sbjct: 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 904 DRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT 963
+ + Y+H I H D+K +N + DP V K+ D G +K +
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN---LLLDPDTAVLKLCDFGSAKQLVRG 176
Query: 964 LVSGGVRGTLPWMAPELLSGKSH 986
+ + + APEL+ G +
Sbjct: 177 EPNVSYICSRYYRAPELIFGATD 199
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 7e-24
Identities = 43/194 (22%), Positives = 79/194 (40%), Gaps = 15/194 (7%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
E++ ++G GTYG+V+ K R VA+KR++ + E + + +E LL
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 858 SSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAF 917
L H N+V + ++ +L V EF K F + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTL--VFEFCDQDLKKYFDSCNGDLDPEIVKSFLF-QLLK 112
Query: 918 GMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMA 977
G+ + H +N++H DLK +NLL+N K+ + GL++ + W
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNG----ELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 978 PELLSGKSHMVTEK 991
P + + + +
Sbjct: 169 PPDVLFGAKLYSTS 182
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 7e-23
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 21/190 (11%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+++ +GSG YG+V G+ VAIK++ +P + E ++E LL +
Sbjct: 21 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY------RPFQSELFAKRAYRELRLLKHM 74
Query: 861 HHPNVVSFYGIVRDGPDGSLAT----VTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
H NV+ + T V FM G+ L K ++ + + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-LGEDRIQFLVYQML 131
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+ Y+H I+H DLK NL VN + KI D GL++ + T +
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVN----EDCELKILDFGLARQADSEMTG--YVVTRWYR 185
Query: 977 APELLSGKSH 986
APE++
Sbjct: 186 APEVILNWMR 195
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 5e-22
Identities = 45/200 (22%), Positives = 90/200 (45%), Gaps = 19/200 (9%)
Query: 800 DDLEEVRELGSGTYGSVY-----HGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEA 854
++ E ++ LG+G YG V+ G G A+K +K + K E E
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH----TRTER 79
Query: 855 LLLSSL-HHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAM 913
+L + P +V+ + + + L + +++ G L L +++R + ++ +
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQT--ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG- 136
Query: 914 DAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK--VKQQTLVSGGVRG 971
+ +E+LH I++ D+K EN+L++ + D GLSK V +T + G
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGH----VVLTDFGLSKEFVADETERAYDFCG 192
Query: 972 TLPWMAPELLSGKSHMVTEK 991
T+ +MAP+++ G +
Sbjct: 193 TIEYMAPDIVRGGDSGHDKA 212
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (238), Expect = 6e-22
Identities = 39/191 (20%), Positives = 78/191 (40%), Gaps = 20/191 (10%)
Query: 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL 860
+ ++ +GSG G V +VAIK++ +P + + ++E +L+ +
Sbjct: 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS------RPFQNQTHAKRAYRELVLMKCV 73
Query: 861 HHPNVVSFYGIVRDGP----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAA 916
+H N++S + + V E M + + +D + +
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQML 129
Query: 917 FGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWM 976
G+++LH I+H DLK N++V KI D GL++ + + T +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 185
Query: 977 APELLSGKSHM 987
APE++ G +
Sbjct: 186 APEVILGMGYK 196
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 4e-19
Identities = 45/192 (23%), Positives = 80/192 (41%), Gaps = 19/192 (9%)
Query: 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLL 857
+ + + +GSG YGSV G VA+K++ +P + ++E LL
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS------RPFQSIIHAKRTYRELRLL 71
Query: 858 SSLHHPNVVSFYGIVRDG---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
+ H NV+ + + + + ++ L ++ + T D + LI +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI- 130
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLP 974
G++Y+H +I+H DLK NL VN KI D GL++ + T
Sbjct: 131 -LRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKILDFGLARHTDDEMTG--YVATRW 183
Query: 975 WMAPELLSGKSH 986
+ APE++ H
Sbjct: 184 YRAPEIMLNWMH 195
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.1 bits (209), Expect = 4e-18
Identities = 41/200 (20%), Positives = 76/200 (38%), Gaps = 7/200 (3%)
Query: 795 QTIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWK 852
+ K+ VR+LG G + +V+ K + VA+K ++ + +E E +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 853 EA--LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLI 910
+A S+ +++ + V F V G L KK +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 911 --IAMDAAFGMEYLHGK-NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTLVSG 967
I+ G++Y+H + I+H D+K EN+L+ + D + +I L
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 968 GVRGTLPWMAPELLSGKSHM 987
T + +PE+L G
Sbjct: 188 NSIQTREYRSPEVLLGAPWG 207
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 72.1 bits (176), Expect = 6e-15
Identities = 26/164 (15%), Positives = 45/164 (27%), Gaps = 30/164 (18%)
Query: 806 RELGSGTYGSVYHGK-WRGSDVAIKRIKAS----------CFAGKPSERERLIADFWKEA 854
+ +G G +V++ + + +K K G I E
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 855 LLLSSLHHPNVVSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMD 914
L L V Y + A + E + L + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN------AVLMELIDAKELYRVRVENPDEV--------LDM 111
Query: 915 AAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958
+ + + IVH DL N+LV+ I D S
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-----WIIDFPQSV 150
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 85 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 51.7 bits (124), Expect = 6e-09
Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 5/69 (7%)
Query: 42 KLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALVSVVNDDDVI 100
K Y + + L D TY+EL S++ + L+ + D + D V
Sbjct: 16 KFYY-KDDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTKLFDGSG---EEIKTDSQVS 71
Query: 101 NMMEEYEKL 109
N+++ K+
Sbjct: 72 NIIQAKLKI 80
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 993 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.98 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.98 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1ip9a_ | 85 | Bud emergence mediator Bemp1 {Baker's yeast (Sacch | 98.37 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.22 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.42 | |
| d2c60a1 | 80 | Mitogen-activated protein kinase kinase kinase 3, | 97.35 | |
| d2bkfa1 | 85 | Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Hum | 97.21 | |
| d2nptb1 | 82 | Mitogen-activated protein kinase kinase kinase 2, | 97.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.86 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.78 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 94.66 | |
| d1wmha_ | 83 | Protein kinase C, iota type {Human (Homo sapiens) | 93.33 | |
| d1oeyj_ | 105 | Neutrophil cytosol factor 4 (p40phox component of | 90.76 | |
| d1pqsa_ | 77 | Cell division control protein 24, CDC24, C-termina | 90.55 | |
| d2npta1 | 105 | Mitogen activated protein kinase kinase 5, Map2k5 | 89.51 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-37 Score=324.29 Aligned_cols=181 Identities=30% Similarity=0.422 Sum_probs=154.2
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|+++ ++.||||+++..... ...+.+.+|+.+|++++|||||++++++.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-- 74 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-------DCPENIKKEICINKMLNHENVVKFYGHRRE-- 74 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEE--
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-------hHHHHHHHHHHHHHhCCCCCEeeEeeeecc--
Confidence 357999999999999999999984 778999999764321 122468899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||++|+|.++|... ..+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~----~~~~~KL~DFG~ 149 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD----ERDNLKISDFGL 149 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC----TTCCEEECCCTT
T ss_pred CceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC----CCCCEEEccchh
Confidence 57899999999999999999654 3589999999999999999999999999999999999998 567899999999
Q ss_pred ccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+..... ......+||+.|||||++.+..+++.++||
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~Di 189 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHH
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceee
Confidence 9875432 234567899999999999998887766675
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-36 Score=314.05 Aligned_cols=182 Identities=27% Similarity=0.449 Sum_probs=155.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||+||+|+++ ++.||||++.+.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~- 77 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-----KAGVEHQLRREVEIQSHLRHPNILRLYGYFHD- 77 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-----ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-
Confidence 4468999999999999999999984 678999999764321 11223568899999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+|+|||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||
T Consensus 78 -~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~~kl~DFG 151 (263)
T d2j4za1 78 -ATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG----SAGELKIADFG 151 (263)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEECCCC
T ss_pred -CCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec----CCCCEeecccc
Confidence 578999999999999999998654 489999999999999999999999999999999999998 56789999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+...... .....||+.|||||++.+..+ +.++||
T Consensus 152 ~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~-~~~~Di 187 (263)
T d2j4za1 152 WSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH-DEKVDL 187 (263)
T ss_dssp SCSCCCCCC-CEETTEEGGGCCHHHHTTCCC-CTTHHH
T ss_pred eeeecCCCc-ccccCCCCcccCHHHHcCCCC-Cchhhh
Confidence 998765443 235679999999999998765 456664
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=324.13 Aligned_cols=182 Identities=31% Similarity=0.489 Sum_probs=154.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
++..++|+++++||+|+||+||+|+++ ++.||||+++.... . ...+.+.+|+.+|++++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---P----AIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---T----THHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC---H----HHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356789999999999999999999984 77899999976421 1 12246889999999999999999999999
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.+|||||||++|+|.+++.+.+ .+++..++.++.||+.||.|||+ .+|+||||||+||||+ .++.+||+
T Consensus 75 ~--~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~----~~~~vkl~ 147 (322)
T d1s9ja_ 75 S--DGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN----SRGEIKLC 147 (322)
T ss_dssp C--SSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC----TTCCEEEC
T ss_pred E--CCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC----CCCCEEEe
Confidence 8 578999999999999999998765 48999999999999999999997 4999999999999998 66789999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+..... .....+||+.|||||++.+..| +.++||
T Consensus 148 DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y-~~~~Di 186 (322)
T d1s9ja_ 148 DFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQSDI 186 (322)
T ss_dssp CCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCC-CTTHHH
T ss_pred eCCCccccCCC-ccccccCCccccCchHHcCCCC-CcHHHH
Confidence 99999976443 2345789999999999998765 456664
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-36 Score=315.42 Aligned_cols=184 Identities=32% Similarity=0.552 Sum_probs=151.1
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
++..++|++.++||+|+||+||+|++++ .||||+++...... ...+.|.+|+.+|++++|||||++++++.+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~------~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~- 75 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP------QQLQAFKNEVGVLRKTRHVNILLFMGYSTA- 75 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCT------THHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCH------HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-
Confidence 4567889999999999999999998765 59999997653322 124578899999999999999999998764
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
+.++||||||++|+|.++|......+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||
T Consensus 76 --~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~----~~~~~Kl~DFG 149 (276)
T d1uwha_ 76 --PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH----EDLTVKIGDFG 149 (276)
T ss_dssp --SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----TTSSEEECCCC
T ss_pred --cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc----CCCCEEEcccc
Confidence 468999999999999999987767799999999999999999999999999999999999998 66799999999
Q ss_pred Cccccccc---cccCCCCCCCCccccccccCCc--cCCCCCCC
Q 001940 956 LSKVKQQT---LVSGGVRGTLPWMAPELLSGKS--HMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~--y~tse~DI 993 (993)
+|+..... .......||+.|||||++.+.. .++.++||
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDi 192 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDV 192 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHH
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhh
Confidence 99876432 2234567999999999997653 24455554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=310.64 Aligned_cols=189 Identities=26% Similarity=0.381 Sum_probs=160.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|+++ ++.||||++++........ ....+.+.+|+.+|++|+|||||+++++|.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR--GVSREDIEREVSILKEIQHPNVITLHEVYEN-- 84 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh--hHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 357999999999999999999984 7789999998754432211 1123578899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||++|+|.++|.+.. .+++..++.|+.||+.||+|||+.+|+||||||+|||++.++.....+||+|||+
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred CCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 578999999999999999998764 5899999999999999999999999999999999999986654556799999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+............||+.|||||++.+..+ +.++||
T Consensus 164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~Di 199 (293)
T d1jksa_ 164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADM 199 (293)
T ss_dssp CEECTTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHH
T ss_pred hhhcCCCccccccCCCCcccCHHHHcCCCC-CCcccc
Confidence 998766655666789999999999987654 555664
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-35 Score=313.53 Aligned_cols=178 Identities=22% Similarity=0.407 Sum_probs=153.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|+++ ++.||||+++...... .+.+.+|+.+|++++|||||+++++|.+
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 88 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------KELIINEILVMRENKNPNIVNYLDSYLV-- 88 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--------HHHHHHHHHHHHHCCCTTBCCEEEEEEE--
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--------HHHHHHHHHHHHhCCCCCEeeEeEEEEE--
Confidence 357999999999999999999874 8889999998653221 2468899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||++|+|.+++.+. .+++..++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+
T Consensus 89 ~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~vkl~DFG~ 162 (293)
T d1yhwa1 89 GDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG----MDGSVKLTDFGF 162 (293)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTT
T ss_pred CCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC----CCCcEeeccchh
Confidence 57899999999999999988654 489999999999999999999999999999999999998 567899999999
Q ss_pred ccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+..... ......+||+.|||||++.+..+ +.++||
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~Di 199 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDI 199 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSCB-CTHHHH
T ss_pred heeeccccccccccccCCCccChhhhcCCCC-Cchhce
Confidence 9876433 23456789999999999998765 446664
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=312.80 Aligned_cols=183 Identities=24% Similarity=0.424 Sum_probs=142.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+++ ++.||||+++..... +...+.+.+|+.+|++++|||||++++++.+...
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT------EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC------HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC------HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 57999999999999999999884 778999999765321 2234578899999999999999999999987656
Q ss_pred CcEEEEEeeccCCcHHHHHHhc---cCccCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCCEEEccCCCCCCeE
Q 001940 878 GSLATVTEFMVNGSLKQFLQKK---DRTIDRRKRLIIAMDAAFGMEYLHGKN-----IVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~---~k~Lse~~~lkIalQIL~GLeYLHs~g-----IIHRDIKPeNILLd~~d~e~g~V 949 (993)
+.+|||||||++|+|.+++.+. ...+++..++.|+.||+.||.|||+.+ ||||||||+||||+ .++.+
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~----~~~~v 153 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD----GKQNV 153 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEEC----TTSCE
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcC----CCCcE
Confidence 7899999999999999998642 356999999999999999999999876 99999999999998 66789
Q ss_pred EEEecCCccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+|+..... ......+||+.|||||++.+..+ +.++||
T Consensus 154 kl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DI 197 (269)
T d2java1 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDI 197 (269)
T ss_dssp EECCHHHHHHC-----------CCCSCCCHHHHTTCCC-CHHHHH
T ss_pred EEeeccceeecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHH
Confidence 99999999876543 23456789999999999987765 345554
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-35 Score=318.68 Aligned_cols=184 Identities=24% Similarity=0.357 Sum_probs=157.9
Q ss_pred ccCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
+.-++|++++.||+|+||+||+|+. +++.||||++++...... ...+.+.+|+.+|++++|||||+++++|++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAK-----DEVAHTVTESRVLQNTRHPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHSCCCTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCH-----HHHHHHHHHHHHHHhCCCCCEEEEEeeecc
Confidence 3456899999999999999999998 478899999986533211 123567899999999999999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.+|+|||||.+|+|.+++.+.. .+++..++.++.||+.||+|||+++||||||||+|||++ .++.+||+||
T Consensus 77 --~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~----~~g~vkl~DF 149 (337)
T d1o6la_ 77 --HDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD----KDGHIKITDF 149 (337)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCC
T ss_pred --ccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec----CCCCEEEeec
Confidence 678999999999999999998765 488999999999999999999999999999999999998 6689999999
Q ss_pred CCcccccc-ccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQ-TLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~-~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|+.... .......+||+.|||||++.++.| +.++||
T Consensus 150 G~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y-~~~~Di 188 (337)
T d1o6la_ 150 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 188 (337)
T ss_dssp TTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCB-CTTHHH
T ss_pred ccccccccCCcccccceeCHHHhhhhhccCCCC-Chhhcc
Confidence 99997543 334456789999999999999877 556664
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=313.52 Aligned_cols=180 Identities=26% Similarity=0.421 Sum_probs=152.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
+.|++++.||+|+||+||+|+++ ++.||||+++..... ..+.+.+|+.+|++++|||||++++++.+ .
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--------~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~ 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--------ELEDYMVEIDILASCDHPNIVKLLDAFYY--E 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--------GGGGTHHHHHHHHHCCCTTBCCEEEEEEE--T
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--------HHHHHHHHHHHHHhCCCCCCCeEEEEEee--C
Confidence 46999999999999999999984 678999999754211 12467899999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.++||||||++|+|.+++.+....+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||+|
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~----~~~~~Kl~DFG~a 157 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT----LDGDIKLADFGVS 157 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTTC
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC----CCCCEEEEechhh
Confidence 789999999999999999887767799999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCc----cCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKS----HMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~----y~tse~DI 993 (993)
+..... ......+||+.|||||++.+.. .++.++||
T Consensus 158 ~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~Di 198 (288)
T d2jfla1 158 AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 198 (288)
T ss_dssp EECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHH
T ss_pred hccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhH
Confidence 865433 2334678999999999996432 23445554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=307.95 Aligned_cols=181 Identities=30% Similarity=0.549 Sum_probs=145.6
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
+..++|+++++||+|+||+||+|++. ++.||||+++..... .++|.+|+.++++++|||||+++|+|.+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~- 71 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---------EEDFIEEAEVMMKLSHPKLVQLYGVCLE- 71 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc---------HHHHHHHHHHHHhcCCCCcccccceecc-
Confidence 34578999999999999999999985 567999998754221 1368899999999999999999999987
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+++||||+++|+|.+++......+++..++.|+.||+.||+|||+.+|+||||||+|||++ .++.+||+|||
T Consensus 72 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~----~~~~~Kl~DFG 146 (263)
T d1sm2a_ 72 -QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG----ENQVIKVSDFG 146 (263)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC----GGGCEEECSCC
T ss_pred -CCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec----CCCCeEecccc
Confidence 5679999999999999999988777799999999999999999999999999999999999998 66789999999
Q ss_pred Ccccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 147 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DV 185 (263)
T d1sm2a_ 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDV 185 (263)
T ss_dssp ------------------CTTSCCHHHHTTCCC-CHHHHH
T ss_pred hheeccCCCceeecceecCcccCChHHhcCCCC-Cchhhh
Confidence 998664432 2234579999999999988764 445554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-35 Score=313.99 Aligned_cols=183 Identities=29% Similarity=0.439 Sum_probs=152.6
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|++++.||+|+||+||+|+++ ++.||||++++.... .+...+.+.+|+.+|++++|||||+++++|.+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~- 79 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLDHPFFVKLYFTFQD- 79 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHcc-----CHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-
Confidence 3467999999999999999999984 778999999864321 11223578899999999999999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+|||||||++|+|.+++...+ .+++..++.++.||+.||.|||+.+||||||||+|||++ .++.+||+|||
T Consensus 80 -~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~----~~~~vkl~DFG 153 (288)
T d1uu3a_ 80 -DEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN----EDMHIQITDFG 153 (288)
T ss_dssp -SSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECCCT
T ss_pred -CCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC----CCceEEecccc
Confidence 578999999999999999987664 489999999999999999999999999999999999998 66789999999
Q ss_pred Cccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+..... ......+||+.|||||++.+..+ +.++||
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~Di 193 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDL 193 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCC-CHHHHH
T ss_pred cceecccCCcccccccccCCccccCceeeccCCC-Ccccce
Confidence 99876432 23345679999999999998765 345554
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-35 Score=316.13 Aligned_cols=183 Identities=28% Similarity=0.366 Sum_probs=139.6
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.+.|++++.||+|+||+||+|+++ ++.||||++.+..... ..+.+.+|+.+|++++|||||++++++.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-------KEGSMENEIAVLHKIKHPNIVALDDIYES-- 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-------HHHHHHHHHHHHHhCCCCCCCcEEEEEEE--
Confidence 356999999999999999999984 7789999998654321 12467899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||++|+|.++|.+.+ .+++..+..|+.||+.||+|||+++|+||||||+|||+...+ .++.+||+|||+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~-~~~~vkl~DFG~ 156 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD-EDSKIMISDFGL 156 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-TTCCEEECCC--
T ss_pred CCEEEEEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC-CCceEEEeccce
Confidence 578999999999999999997654 589999999999999999999999999999999999997443 567899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+...........+||+.|||||++.+..| +.++||
T Consensus 157 a~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~~~Di 192 (307)
T d1a06a_ 157 SKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVDC 192 (307)
T ss_dssp ----------------CTTSCHHHHTTCCC-CTHHHH
T ss_pred eEEccCCCeeeeeeeCccccCcHHHcCCCC-CcHHHh
Confidence 997766555566789999999999998765 455664
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.5e-35 Score=319.72 Aligned_cols=181 Identities=26% Similarity=0.369 Sum_probs=156.5
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+++ ++.||||++.... ....+.+.+|+.+|++|+|||||+++++|.+ .
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~ 95 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFED--D 95 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--T
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 47999999999999999999984 7789999987532 1123578899999999999999999999998 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|||||||++|+|.++|.+....+++..++.|+.||+.||.|||++|||||||||+|||++.+ .++.+||+|||+|
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~--~~~~vkL~DFG~a 173 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK--RSNELKLIDFGLT 173 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC--CCCeEEEeecchh
Confidence 78999999999999999997666679999999999999999999999999999999999999633 3478999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+............||+.|||||++.+..+. .++||
T Consensus 174 ~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~Di 208 (350)
T d1koaa2 174 AHLDPKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDM 208 (350)
T ss_dssp EECCTTSCEEEECSCTTTCCHHHHHTCCBC-HHHHH
T ss_pred eecccccccceecCcccccCHHHHcCCCCC-hhHhh
Confidence 987665555567899999999999987663 44553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-34 Score=310.41 Aligned_cols=178 Identities=26% Similarity=0.454 Sum_probs=151.3
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
.|++++.||+|+||+||+|++. ++.||||+++..... .....+.+.+|+.+|++|+|||||+++++|.+ .+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~ 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-----SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EH 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSC-----HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TT
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE--CC
Confidence 4999999999999999999984 677999999864321 23345678999999999999999999999998 57
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.+|||||||.+|+|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~----~~~~~Kl~DFG~a~ 163 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS----EPGLVKLGDFGSAS 163 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE----TTTEEEECCCTTCB
T ss_pred EEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC----CCCCEEEeeccccc
Confidence 899999999999997766554 4589999999999999999999999999999999999998 66899999999998
Q ss_pred ccccccccCCCCCCCCccccccccCC--ccCCCCCCC
Q 001940 959 VKQQTLVSGGVRGTLPWMAPELLSGK--SHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~~s~s~~GTp~YmAPEVL~Gk--~y~tse~DI 993 (993)
..... ...+||+.|||||++.+. ..++.++||
T Consensus 164 ~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~Di 197 (309)
T d1u5ra_ 164 IMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDV 197 (309)
T ss_dssp SSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHH
T ss_pred ccCCC---CccccCccccCHHHHhccCCCCcCchhhh
Confidence 76443 356799999999999764 335556664
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-34 Score=302.29 Aligned_cols=179 Identities=30% Similarity=0.499 Sum_probs=148.6
Q ss_pred ceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC--CC
Q 001940 802 LEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--PD 877 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~--s~ 877 (993)
|++.++||+|+||+||+|+++ ++.||||++...... ....+.+.+|+.+|++++|||||+++++|.+. ..
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 84 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT------KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 84 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC------HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence 467789999999999999985 667999998865321 12245788999999999999999999998752 24
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKN--IVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~g--IIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
..+|||||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+++ |+||||||+|||++. .++.+||+|||
T Consensus 85 ~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---~~~~~Kl~DFG 160 (270)
T d1t4ha_ 85 KCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLG 160 (270)
T ss_dssp EEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS---TTSCEEECCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC---CCCCEEEeecC
Confidence 56899999999999999997654 5899999999999999999999998 999999999999962 35689999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+...... ....+||+.|||||++.+. ++.++||
T Consensus 161 la~~~~~~~-~~~~~GT~~Y~aPE~~~~~--~~~~~DI 195 (270)
T d1t4ha_ 161 LATLKRASF-AKAVIGTPEFMAPEMYEEK--YDESVDV 195 (270)
T ss_dssp GGGGCCTTS-BEESCSSCCCCCGGGGGTC--CCTHHHH
T ss_pred cceeccCCc-cCCcccCccccCHHHhCCC--CCCcCch
Confidence 998654442 3456899999999999764 4556664
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-34 Score=310.73 Aligned_cols=180 Identities=28% Similarity=0.452 Sum_probs=154.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|+++ ++.||||++++.... +....+.+.+|+.+|++++|||||++++++.+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-- 75 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-- 75 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC--
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-----CHHHHHHHHHHHHHHHhccCcChhheeeeEee--
Confidence 357999999999999999999984 788999999864321 11224578899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|+|||||.||+|..++.... .+++..++.++.||+.||.|||+++||||||||+||||+ .++.+||+|||+
T Consensus 76 ~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~----~~g~vkL~DFG~ 150 (316)
T d1fota_ 76 AQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD----KNGHIKITDFGF 150 (316)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC----TTSCEEECCCSS
T ss_pred CCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc----CCCCEEEecCcc
Confidence 678999999999999999987665 478888899999999999999999999999999999998 667999999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+..... ....+||+.|||||++.++.|. .++||
T Consensus 151 a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~-~~~Di 184 (316)
T d1fota_ 151 AKYVPDV--TYTLCGTPDYIAPEVVSTKPYN-KSIDW 184 (316)
T ss_dssp CEECSSC--BCCCCSCTTTCCHHHHTTCCBC-TTHHH
T ss_pred ceEeccc--cccccCcccccCHHHHcCCCCC-chhhc
Confidence 9876543 3457899999999999988765 46664
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-34 Score=315.42 Aligned_cols=181 Identities=23% Similarity=0.333 Sum_probs=155.9
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|++++.||+|+||+||+|+++ ++.||||+++.... ...+.+.+|+.+|++|+|||||+++++|.+ +
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~ 98 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--------LDKYTVKNEISIMNQLHHPKLINLHDAFED--K 98 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--------HHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--S
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch--------hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--C
Confidence 57999999999999999999984 78899999875421 112467899999999999999999999998 6
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|||||||++|+|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+.. ..+.+||+|||+|
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~--~~~~vkL~DFGla 176 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK--KASSVKIIDFGLA 176 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST--TCCCEEECCCTTC
T ss_pred CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc--CCCeEEEeecccc
Confidence 78999999999999999887776679999999999999999999999999999999999999743 3578999999999
Q ss_pred cccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+............||+.|||||++.+..+ +.++||
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di 211 (352)
T d1koba_ 177 TKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDM 211 (352)
T ss_dssp EECCTTSCEEEECSSGGGCCHHHHTTCCB-CHHHHH
T ss_pred eecCCCCceeeccCcccccCHHHHcCCCC-CCccch
Confidence 98776655556789999999999988765 344443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.3e-35 Score=308.85 Aligned_cols=182 Identities=31% Similarity=0.592 Sum_probs=153.6
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVR 873 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~ 873 (993)
++..++|++.++||+|+||+||+|+++ ++.||||+++.... . .++|.+|+.+|++++|||||+++++|.
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~----~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----E----VEEFLKEAAVMKEIKHPNLVQLLGVCT 83 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-----C----HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-----h----HHHHHHHHHHHHhCCCCCEecCCccEe
Confidence 355678999999999999999999984 67899999875421 1 246889999999999999999999998
Q ss_pred cCCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 874 DGPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 874 d~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
+ .+.+++|||||++|+|.++|.+. ...+++..++.|+.||+.||+|||+++|+||||||+||||+ .++.+||+
T Consensus 84 ~--~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~----~~~~~Kl~ 157 (287)
T d1opja_ 84 R--EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG----ENHLVKVA 157 (287)
T ss_dssp S--SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEEC
T ss_pred e--CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC----CCCcEEEc
Confidence 7 56799999999999999999754 45689999999999999999999999999999999999998 56799999
Q ss_pred ecCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 158 DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~Di 199 (287)
T d1opja_ 158 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDV 199 (287)
T ss_dssp CCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCC-SHHHHH
T ss_pred cccceeecCCCCceeeccccccccccChHHHcCCCC-Cchhhh
Confidence 999999764432 2334568999999999987755 345553
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=303.12 Aligned_cols=181 Identities=30% Similarity=0.560 Sum_probs=151.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
++..++|++++.||+|+||+||+|+++ ++.||||+++..... .+.|.+|+.+|++++|||||++++++.+
T Consensus 9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~---------~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---------PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC---------HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 455678999999999999999999996 467999999754211 1368899999999999999999998765
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+.+++||||+++|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+||+|
T Consensus 80 ---~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~----~~~~~Kl~D 152 (272)
T d1qpca_ 80 ---EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS----DTLSCKIAD 152 (272)
T ss_dssp ---SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTSCEEECC
T ss_pred ---CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeee----cccceeecc
Confidence 45799999999999999876433 3589999999999999999999999999999999999998 678999999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDv 193 (272)
T d1qpca_ 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDV 193 (272)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHH
T ss_pred ccceEEccCCccccccccCCcccccChHHHhCCCC-Cchhhh
Confidence 99999765432 2345679999999999986654 445554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-34 Score=300.97 Aligned_cols=184 Identities=32% Similarity=0.552 Sum_probs=147.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
++..++|++.++||+|+||+||+|+++. ..||||+++.... ......|.+|+.+|++++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-------EKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-------hHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 4556789999999999999999998853 2589999875321 12234688999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
|++.+ .+.+++|||||.+++|.+++......+++..++.|+.||+.||+|||+.+||||||||+||||+ .++.+
T Consensus 76 g~~~~--~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~----~~~~~ 149 (283)
T d1mqba_ 76 GVISK--YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN----SNLVC 149 (283)
T ss_dssp EEECS--SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCE
T ss_pred EEEec--CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEEC----CCCeE
Confidence 99987 5679999999999999999988777799999999999999999999999999999999999998 67899
Q ss_pred EEEecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 150 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI 196 (283)
T d1mqba_ 150 KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDV 196 (283)
T ss_dssp EECCCCC-----------------CCCGGGSCHHHHHSCCC-CHHHHH
T ss_pred EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCC-CCcccc
Confidence 999999998754321 2234568999999999987654 345553
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.7e-34 Score=311.70 Aligned_cols=186 Identities=24% Similarity=0.310 Sum_probs=154.1
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
..++|+++++||+|+||+||+|+++ ++.||||++.+...... ..........+|+.+++.++|||||+++++|.+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~--~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~- 78 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHT- 78 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHH--TCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchh--hHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-
Confidence 4578999999999999999999984 78899999975432211 111222334456778888899999999999998
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
.+.+|||||||++|+|.++|.+.. .+++..++.|+.||+.||+|||+++||||||||+|||++ ..+.+||+|||
T Consensus 79 -~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~----~~g~iKl~DFG 152 (364)
T d1omwa3 79 -PDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD----EHGHVRISDLG 152 (364)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----SSSCEEECCCT
T ss_pred -CCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEc----CCCcEEEeeec
Confidence 578999999999999999997764 488999999999999999999999999999999999998 66799999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+...... ....+||+.|||||++.+...++.++||
T Consensus 153 la~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~Di 189 (364)
T d1omwa3 153 LACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADW 189 (364)
T ss_dssp TCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHH
T ss_pred eeeecCCCc-ccccccccccchhHHhhcCCCCCcccch
Confidence 998765443 3456799999999999876666777775
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.3e-33 Score=296.55 Aligned_cols=179 Identities=26% Similarity=0.291 Sum_probs=156.1
Q ss_pred CCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCc-hhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEc
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKP-SERERLIADFWKEALLLSSLH-HPNVVSFYGIVRD 874 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~-~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d 874 (993)
.++|++++.||+|+||+||+|+. +++.||||++++....... ...+...+.+.+|+.+|++|+ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 36899999999999999999998 4788999999876543322 223445567899999999997 9999999999998
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
++.+|||||||++|+|.++|.... .+++..++.|+.||+.||+|||+++|+||||||+|||++ .++.+||+||
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~----~~~~~kl~DF 154 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD----DDMNIKLTDF 154 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----TTCCEEECCC
T ss_pred --CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEc----CCCCeEEccc
Confidence 678999999999999999998765 589999999999999999999999999999999999998 6679999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGK 984 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk 984 (993)
|+|+...........+||+.|+|||++.+.
T Consensus 155 G~a~~~~~~~~~~~~~gt~~y~~PE~~~~~ 184 (277)
T d1phka_ 155 GFSCQLDPGEKLREVCGTPSYLAPEIIECS 184 (277)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHH
T ss_pred hheeEccCCCceeeeeccCCCCCHHHhhcc
Confidence 999987665555667899999999999743
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-33 Score=300.92 Aligned_cols=184 Identities=33% Similarity=0.545 Sum_probs=142.9
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--Cc---ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GS---DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt---~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
.+..++|++.++||+|+||+||+|+++ ++ .||||++.... .....+.|.+|+.+|++|+|||||++++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~g 94 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-------TEKQRRDFLSEASIMGQFDHPNVIHLEG 94 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCCccEEE
Confidence 455678999999999999999999884 22 37888876431 1223457899999999999999999999
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+|.+ .+.+++|||||++|+|.+++......+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+|
T Consensus 95 ~~~~--~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~----~~~~~K 168 (299)
T d1jpaa_ 95 VVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN----SNLVCK 168 (299)
T ss_dssp EECS--SSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEE
T ss_pred EEee--CCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEEC----CCCcEE
Confidence 9987 5679999999999999999988777799999999999999999999999999999999999998 678999
Q ss_pred EEecCCccccccccc------cCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTLV------SGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~~------s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+|+....... .....||+.|||||++.+..+ +.++||
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDv 216 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDV 216 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCC-CHHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCC-Cccccc
Confidence 999999986543321 123457999999999987654 344553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-34 Score=309.23 Aligned_cols=180 Identities=24% Similarity=0.392 Sum_probs=154.9
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|+++ ++.||||++++.... .....+.+.+|+.+|+.++|||||++++++.+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~-----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-- 112 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-----KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-- 112 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-----HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHcc-----CHHHHHHHHHHHHHHHHcCCCcEeeccccccc--
Confidence 368999999999999999999984 788999999764321 11223578899999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
...+++||||+.+|+|.+++.+.+ .+++..++.|+.||+.||.|||+++||||||||+||||+ .++.+||+|||+
T Consensus 113 ~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~----~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 113 NSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID----QQGYIQVTDFGF 187 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTSCEEECCCTT
T ss_pred ccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC----CCCCEEeeecee
Confidence 578999999999999999997765 489999999999999999999999999999999999998 567999999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+..... .....||+.|||||++.++.+. .++||
T Consensus 188 a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~-~~~Di 221 (350)
T d1rdqe_ 188 AKRVKGR--TWTLCGTPEALAPEIILSKGYN-KAVDW 221 (350)
T ss_dssp CEECSSC--BCCCEECGGGCCHHHHTTCCBC-THHHH
T ss_pred eeecccc--cccccCccccCCHHHHcCCCCC-ccccc
Confidence 9976543 3457899999999999987664 45554
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-34 Score=305.15 Aligned_cols=183 Identities=30% Similarity=0.439 Sum_probs=148.5
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcCc-------ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRGS-------DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kgt-------~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.++||+|+||+||+|++.+. .||||++..... ......+.+|+.+|+++ +|||||++
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-------SSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-------HHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 4557899999999999999999988532 489998865421 12234688999999998 89999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc----------------------CccCHHHHHHHHHHHHHHHHHHHhCC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD----------------------RTIDRRKRLIIAMDAAFGMEYLHGKN 926 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~----------------------k~Lse~~~lkIalQIL~GLeYLHs~g 926 (993)
+++|.+ .+.++||||||++|+|.++|+... ..+++..++.|+.||+.||.|||+++
T Consensus 107 ~~~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 107 LGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEee--CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999988 567999999999999999997643 23788899999999999999999999
Q ss_pred ceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 927 IVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 927 IIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||||||||+|||++ .++.+||+|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 185 IiHRDlKp~Nill~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~Di 249 (325)
T d1rjba_ 185 CVHRDLAARNVLVT----HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDV 249 (325)
T ss_dssp EEETTCSGGGEEEE----TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHH
T ss_pred eeeccCchhccccc----cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-Ccceec
Confidence 99999999999998 67899999999998654432 2335568999999999986654 445553
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-34 Score=296.36 Aligned_cols=180 Identities=33% Similarity=0.567 Sum_probs=154.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
..++|+++++||+|+||+||+|+++ ++.||||++++.... .+.|.+|+.++++++||||++++|+|.+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~---------~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-- 70 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---------EDEFIEEAKVMMNLSHEKLVQLYGVCTK-- 70 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC---------HHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC---------HHHHHHHHHHHHhcCCCceeeEEEEEee--
Confidence 4578999999999999999999996 457999999864321 1368899999999999999999999987
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+++||||+.+|+|.+++......+++..+++|+.||+.||+|||+++|+||||||+|||++ .++.+||+|||+
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~----~~~~~kl~DfG~ 146 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN----DQGVVKVSDFGL 146 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC----TTCCEEECCCSS
T ss_pred CCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc----CCCcEEECcchh
Confidence 5779999999999999999887777799999999999999999999999999999999999998 667999999999
Q ss_pred cccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+...... ......||+.|||||++.++.+. .++||
T Consensus 147 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDi 184 (258)
T d1k2pa_ 147 SRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDI 184 (258)
T ss_dssp CCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC-HHHHH
T ss_pred heeccCCCceeecccCCCCCcCCcHHhcCCCCC-cceee
Confidence 98654332 22345699999999999877653 45554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-33 Score=296.13 Aligned_cols=182 Identities=31% Similarity=0.486 Sum_probs=150.1
Q ss_pred ccCCCceEEEE-ecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRE-LGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~-LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|.+.+. ||+|+||+||+|.++ +..||||+++... .....++|.+|+.+|++++|||||+++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-------~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-------EKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-------CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-------CHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 34567888884 999999999999774 3359999987532 12234578999999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.+ +.+|||||||++|+|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++ .++.+||
T Consensus 78 ~~~---~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~----~~~~~Kl 150 (285)
T d1u59a_ 78 CQA---EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV----NRHYAKI 150 (285)
T ss_dssp EES---SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----ETTEEEE
T ss_pred ecc---CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec----cCCceee
Confidence 875 358999999999999999877766799999999999999999999999999999999999998 5679999
Q ss_pred EecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 151 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDV 195 (285)
T d1u59a_ 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDV 195 (285)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHH
T ss_pred ccchhhhcccccccccccccccccCccccChHHHhCCCC-Cccchh
Confidence 9999998654322 2234568999999999976643 344443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-34 Score=300.07 Aligned_cols=181 Identities=27% Similarity=0.350 Sum_probs=146.0
Q ss_pred eEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcE
Q 001940 803 EEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSL 880 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L 880 (993)
+.+++||+|+||+||+|+++ ++.||||+++...... ......+.+.+|+.+|++++|||||++++++.+ .+.+
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~--~~~~ 75 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSE---AKDGINRTALREIKLLQELSHPNIIGLLDAFGH--KSNI 75 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC--TTCC
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhh---hhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCce
Confidence 35789999999999999884 7789999997653221 122233568899999999999999999999998 5679
Q ss_pred EEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcccc
Q 001940 881 ATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVK 960 (993)
Q Consensus 881 ~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~ 960 (993)
||||||+.++++..++. ....+++..+..|+.||+.||+|||+++|+||||||+|||++ ..+.+||+|||+|+..
T Consensus 76 ~ivmE~~~~~~~~~~~~-~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~----~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 76 SLVFDFMETDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD----ENGVLKLADFGLAKSF 150 (299)
T ss_dssp EEEEECCSEEHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECCCGGGSTT
T ss_pred eehhhhhcchHHhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEec----CCCccccccCcccccc
Confidence 99999998877766654 445688999999999999999999999999999999999998 6679999999999876
Q ss_pred cccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 961 QQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 961 ~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.... .....+||+.|||||++.+...++.++||
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 184 (299)
T d1ua2a_ 151 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDM 184 (299)
T ss_dssp TSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHH
T ss_pred CCCcccccceecChhhccHHHHccCCCCChhhhh
Confidence 4432 33456799999999999887777777775
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-33 Score=296.34 Aligned_cols=182 Identities=27% Similarity=0.395 Sum_probs=151.4
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||+||+|++. ++.||||+++..... +...+.+.+|+.+|++++|||||+++++|.+ .
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~ 73 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET------EGVPSTAIREISLLKELNHPNIVKLLDVIHT--E 73 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--T
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC------hHHHHHHHHHHHHHHhCCCCcEEEecccccc--c
Confidence 68999999999999999999984 788999999754321 1223578899999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+|+||||+.++.+..+.......+++..++.|+.||+.||+|||+++||||||||+|||++ .++.+||+|||+|
T Consensus 74 ~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~----~~~~~kl~DFG~a 149 (298)
T d1gz8a_ 74 NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN----TEGAIKLADFGLA 149 (298)
T ss_dssp TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECSTTHH
T ss_pred cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeec----ccCcceeccCCcc
Confidence 789999999965544444445556699999999999999999999999999999999999998 5678999999999
Q ss_pred cccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+..... .......||+.|+|||++....+.+.++||
T Consensus 150 ~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~Di 186 (298)
T d1gz8a_ 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186 (298)
T ss_dssp HHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHH
T ss_pred eeccCCcccceeecccceeeehhhhccccCCCccccc
Confidence 866433 334456799999999999998888888775
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-33 Score=301.33 Aligned_cols=181 Identities=18% Similarity=0.228 Sum_probs=155.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|.++ ++.||||+++... .. ...+.+|+.+|++++|||||+++++|.+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~------~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~-- 72 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG------TD---QVLVKKEISILNIARHRNILHLHESFES-- 72 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT------HH---HHHHHHHHHHHHHSCCTTBCCEEEEEEE--
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc------cc---HHHHHHHHHHHHhCCCCCCCeEEEEEEE--
Confidence 467999999999999999999984 6789999997542 11 1357799999999999999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||.||+|.++|......+++..++.|+.||+.||+|||+.||+||||||+|||++.+ ....+||+|||+
T Consensus 73 ~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~--~~~~ikl~DFG~ 150 (321)
T d1tkia_ 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR--RSSTIKIIEFGQ 150 (321)
T ss_dssp TTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS--SCCCEEECCCTT
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC--CceEEEEcccch
Confidence 578999999999999999998776679999999999999999999999999999999999999743 346899999999
Q ss_pred ccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
++............||+.|+|||++.+..+ ..++||
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~~-~~~~Di 186 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDM 186 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCEE-CHHHHH
T ss_pred hhccccCCcccccccccccccchhccCCCC-Cchhhc
Confidence 997765554555679999999999987765 345553
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-33 Score=299.74 Aligned_cols=180 Identities=23% Similarity=0.280 Sum_probs=150.8
Q ss_pred CCCceEEE-EecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhh-cCCCCcceEEEEEEc
Q 001940 799 NDDLEEVR-ELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSS-LHHPNVVSFYGIVRD 874 (993)
Q Consensus 799 ~ddYeile-~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~-LrHPNIVrL~G~f~d 874 (993)
.++|+++. .||+|+||+||+|++. ++.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~~ 76 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 76 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence 35799885 5999999999999984 778999998743 245678888654 589999999999875
Q ss_pred --CCCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 875 --GPDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 875 --~s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
..+..+|||||||+||+|.++|.+.+ ..+++..++.|+.||+.||+|||+.+|+||||||+|||++..+ ..+.+||
T Consensus 77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~-~~~~~Kl 155 (335)
T d2ozaa1 77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR-PNAILKL 155 (335)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-TTCCEEE
T ss_pred cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-ccccccc
Confidence 23467999999999999999998653 4699999999999999999999999999999999999998544 5678999
Q ss_pred EecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+|+...........+||+.|||||++.+..|. .++||
T Consensus 156 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~-~~~Di 196 (335)
T d2ozaa1 156 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDM 196 (335)
T ss_dssp CCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGS-HHHHH
T ss_pred cccceeeeccCCCccccccCCcccCCcHHHcCCCCC-HHHHH
Confidence 999999977666556677899999999999877653 34453
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3e-33 Score=299.22 Aligned_cols=183 Identities=28% Similarity=0.515 Sum_probs=148.0
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc--Cc----ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR--GS----DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFY 869 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k--gt----~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~ 869 (993)
.++..+|+++++||+|+||+||+|++. ++ +||||+++.... ....+.|.+|+.+|++++|||||+++
T Consensus 5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~HpnIv~l~ 77 (317)
T d1xkka_ 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-------PKANKEILDEAYVMASVDNPHVCRLL 77 (317)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-------HHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 345678999999999999999999884 33 478888764321 11235789999999999999999999
Q ss_pred EEEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
++|.+ +..+++|||+.+++|.+++......+++..++.|+.||+.||.|||+++||||||||+|||++ .++.+
T Consensus 78 g~~~~---~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~----~~~~~ 150 (317)
T d1xkka_ 78 GICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK----TPQHV 150 (317)
T ss_dssp EEEES---SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE----ETTEE
T ss_pred EEEec---CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC----CCCCe
Confidence 99986 357899999999999999988877899999999999999999999999999999999999998 66799
Q ss_pred EEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 151 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDv 196 (317)
T d1xkka_ 151 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDV 196 (317)
T ss_dssp EECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC-CHHHHH
T ss_pred EeeccccceecccccccccccccccCccccChHHHhcCCC-Chhhhh
Confidence 999999998754322 2234568999999999987654 445553
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.8e-33 Score=299.02 Aligned_cols=181 Identities=25% Similarity=0.385 Sum_probs=151.2
Q ss_pred CCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHH-hhcCCCCcceEEEEEEcCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLL-SSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~IL-r~LrHPNIVrL~G~f~d~s 876 (993)
++|++++.||+|+||+||+|++ +++.||||++++...... ...+.+..|..++ +.++|||||++++++.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-- 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-----DDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-- 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHT-----TCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccCh-----HHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--
Confidence 6899999999999999999998 478899999986432211 1123455666665 47899999999999998
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+.+|||||||++|+|.+++.... .+++..++.++.||+.||+|||+++|+||||||+|||++ ..+.+||+|||+
T Consensus 75 ~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~----~~~~~kl~DFG~ 149 (320)
T d1xjda_ 75 KENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD----KDGHIKIADFGM 149 (320)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC----TTSCEEECCCTT
T ss_pred CCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeec----CCCceeccccch
Confidence 578999999999999999998765 488999999999999999999999999999999999998 667999999999
Q ss_pred ccccccc-cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 957 SKVKQQT-LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 957 Ak~~~~~-~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+..... .......||+.|||||++.+..+. .++||
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di 186 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDW 186 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHH
T ss_pred hhhcccccccccccCCCCCcCCHHHHcCCCCC-chhhh
Confidence 9865432 334456899999999999988765 56664
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.98 E-value=2.6e-32 Score=285.57 Aligned_cols=184 Identities=22% Similarity=0.341 Sum_probs=146.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|++. ++.||||+++..... .....+.+.+|+.+|+.++|||||++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-----DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-----CHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 578999999999999999999974 788999999865322 1233467899999999999999999999998643
Q ss_pred C--CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 877 D--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 877 ~--~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
. ..+||||||++|++|.+++...+ .+++..++.|+.||+.||+|||++|||||||||+|||++ .++.++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~----~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS----ATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----TTSCEEECCC
T ss_pred CCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC----ccccceeehh
Confidence 2 34899999999999999987664 489999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++...... .....+||+.|||||++.+..+. .++||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~Di 197 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDV 197 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCC-HHHHH
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCC-cceec
Confidence 9987543322 23456799999999999887553 34553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.5e-33 Score=291.20 Aligned_cols=182 Identities=27% Similarity=0.510 Sum_probs=141.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|++.+.||+|+||+||+|++.. ..||||+++... .....+.|.+|+.+|++++|||||+++++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 76 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-------SDSVREKFLQEALTMRQFDHPHIVKLIGV 76 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-------SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 455789999999999999999998842 247888775321 12334578999999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.+ +.+++||||+.+|+|.+++......+++..++.++.||+.||.|||+.+||||||||+|||++ .++.+||
T Consensus 77 ~~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~----~~~~~Kl 149 (273)
T d1mp8a_ 77 ITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS----SNDCVKL 149 (273)
T ss_dssp ECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE----ETTEEEE
T ss_pred Eec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec----CCCcEEE
Confidence 864 568999999999999999887777799999999999999999999999999999999999998 6679999
Q ss_pred EecCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 150 ~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~-~~~~Di 192 (273)
T d1mp8a_ 150 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDV 192 (273)
T ss_dssp CC-------------------CCGGGCCHHHHHHCCC-SHHHHH
T ss_pred ccchhheeccCCcceeccceecCcccchhhHhccCCC-CCcccc
Confidence 9999998754332 2344568999999999987654 345553
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-33 Score=293.22 Aligned_cols=186 Identities=20% Similarity=0.236 Sum_probs=152.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC--CCCcceEEEEEEc
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIVRD 874 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr--HPNIVrL~G~f~d 874 (993)
.++|++.++||+|+||+||+|++. ++.||||++++.......... ...++.+|+.+|++++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~--~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELP--NGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECT--TCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhh--HHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 467999999999999999999984 788999999865433211100 0123568999999997 8999999999998
Q ss_pred CCCCcEEEEEeeccC-CcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVN-GSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~G-GSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.+.+++||||+.+ ++|.+++.+.. .+++..++.|+.||+.||+|||+++|+||||||+|||++. ..+.+||+|
T Consensus 81 --~~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~---~~~~vkl~D 154 (273)
T d1xwsa_ 81 --PDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL---NRGELKLID 154 (273)
T ss_dssp --SSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---TTTEEEECC
T ss_pred --CCeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec---CCCeEEECc
Confidence 5789999999976 68888887654 5899999999999999999999999999999999999973 236899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|+...... .....||+.|||||++.+..+++.++||
T Consensus 155 FG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~~~~~~~Di 193 (273)
T d1xwsa_ 155 FGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAV 193 (273)
T ss_dssp CTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHH
T ss_pred cccceeccccc-ccccccCCCcCCHHHHcCCCCCCccccc
Confidence 99998765443 3457899999999999988777666664
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.1e-33 Score=292.42 Aligned_cols=184 Identities=28% Similarity=0.462 Sum_probs=140.7
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|+++++||+|+||+||+|++.+ +.||||+++.... ....+.+.+|..++.++ +|+||+.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-------HSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-------HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-------cHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 455789999999999999999998742 4699999875321 12234667777777766 68999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLK 933 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIK 933 (993)
++++... ...+++|||||++|+|.++|.... ..+++..++.|+.||+.||.|||+++|||||||
T Consensus 83 ~~~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 83 LGACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp EEEECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeeeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 9988764 457899999999999999997542 247899999999999999999999999999999
Q ss_pred CCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 934 CENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 934 PeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+||||+ .++.+||+|||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 162 p~NILl~----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDi 219 (299)
T d1ywna1 162 ARNILLS----EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDV 219 (299)
T ss_dssp GGGEEEC----GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHH
T ss_pred ccceeEC----CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-Ccccce
Confidence 9999998 56799999999998654322 2345679999999999987654 455554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=288.37 Aligned_cols=173 Identities=28% Similarity=0.472 Sum_probs=139.2
Q ss_pred EEecccCceEEEEEEEc----CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCCcEE
Q 001940 806 RELGSGTYGSVYHGKWR----GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDGSLA 881 (993)
Q Consensus 806 e~LGeGgFGtVYKAk~k----gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~~L~ 881 (993)
++||+|+||+||+|.++ ++.||||+++.... .....+.|.+|+.+|++++|||||+++++|.+ +.++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~ 83 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN------DPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 83 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC------CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEE
Confidence 47999999999999874 24599999875421 11234578999999999999999999999875 3578
Q ss_pred EEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCccccc
Q 001940 882 TVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQ 961 (993)
Q Consensus 882 LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~ 961 (993)
||||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+++||||||||+|||++ .++.+||+|||+|+...
T Consensus 84 lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~----~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV----TQHYAKISDFGLSKALR 158 (277)
T ss_dssp EEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE----ETTEEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc----ccCcccccchhhhhhcc
Confidence 9999999999999997654 489999999999999999999999999999999999998 66799999999998654
Q ss_pred ccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 962 QTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 962 ~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
... ......||+.|||||++.+..+ +.++||
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDi 193 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDV 193 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHH
T ss_pred ccccccccccccCCCceecCchhhcCCCC-Cchhhh
Confidence 321 2234569999999999986654 334443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.5e-33 Score=295.03 Aligned_cols=181 Identities=31% Similarity=0.571 Sum_probs=145.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRD 874 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d 874 (993)
.+..++|++.+.||+|+||+||+|++++ +.||||+++..... .+.|.+|+.+|++++|+|||+++++|.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~---------~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---------PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---------HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC---------HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 3556789999999999999999999964 56999999754221 1468899999999999999999999865
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhc-cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKK-DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~-~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
+.+++|||||.+|+|..++... ...+++..++.|+.||+.||.|||+++|+||||||+||||+ .++.+||+|
T Consensus 84 ---~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~----~~~~~kl~D 156 (285)
T d1fmka3 84 ---EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG----ENLVCKVAD 156 (285)
T ss_dssp ---SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----GGGCEEECC
T ss_pred ---CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC----CCCcEEEcc
Confidence 4579999999999999988653 34589999999999999999999999999999999999998 567899999
Q ss_pred cCCcccccccc--ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTL--VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~--~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|+...... ......||+.|||||++.+..+ +.++||
T Consensus 157 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI 197 (285)
T d1fmka3 157 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDV 197 (285)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCC-CHHHHH
T ss_pred cchhhhccCCCceeeccccccccccChHHHhCCCC-CcHHhh
Confidence 99998764332 2234569999999999986655 345553
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=2.6e-32 Score=291.20 Aligned_cols=177 Identities=23% Similarity=0.324 Sum_probs=153.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDG 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~ 875 (993)
.++|+++++||+|+||+||+|++. ++.||||+++... .+++.+|+.+|+.+. ||||++++++|...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----------KKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----------HHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----------HHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 467999999999999999999984 7789999987531 135778999999996 99999999999876
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecC
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLG 955 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFG 955 (993)
....+++|||||.+++|..+. +.+++..++.|+.||+.||+|||++||+||||||+||||+. .+..+||+|||
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~---~~~~vkl~DFG 175 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH---EHRKLRLIDWG 175 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---TTTEEEECCGG
T ss_pred CCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC---CCCeeeecccc
Confidence 667899999999999997654 35899999999999999999999999999999999999983 23579999999
Q ss_pred CccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 956 LSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 956 LAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|+............||+.|+|||++.+...++.++||
T Consensus 176 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di 213 (328)
T d3bqca1 176 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 213 (328)
T ss_dssp GCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHH
T ss_pred cceeccCCCcccccccCccccCcccccCCCCCCcccch
Confidence 99987665556677899999999999988877777775
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.4e-32 Score=286.58 Aligned_cols=184 Identities=27% Similarity=0.379 Sum_probs=149.7
Q ss_pred CCCceEEEEecccCceEEEEEEEc---CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc---CCCCcceEEEEE
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR---GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL---HHPNVVSFYGIV 872 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k---gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L---rHPNIVrL~G~f 872 (993)
.++|+++++||+|+||+||+|++. ++.||||+++......... ..+.+|+.+|+.| +||||++++++|
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH------HHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 468999999999999999999984 4458999997654322111 1344566665554 899999999998
Q ss_pred EcC---CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeE
Q 001940 873 RDG---PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 873 ~d~---s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
... ....++++|||+.++.+..........+++..++.|+.||+.||+|||+++||||||||+|||++ ..+.+
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~----~~~~~ 155 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT----SSGQI 155 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCE
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEc----CCCCe
Confidence 642 23578999999988887766666666799999999999999999999999999999999999998 66799
Q ss_pred EEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 950 KIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 950 KLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|||+++............||+.|||||++.+..| +.++||
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y-~~~~Di 198 (305)
T d1blxa_ 156 KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDL 198 (305)
T ss_dssp EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHH
T ss_pred eecchhhhhhhcccccCCCcccChhhcCcchhcCCCC-Chhehh
Confidence 9999999998766666677889999999999988765 455554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.3e-33 Score=289.72 Aligned_cols=180 Identities=33% Similarity=0.593 Sum_probs=145.5
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG 875 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~ 875 (993)
.+..++|++++.||+|+||.||+|+++++.||||+++... ..+.|.+|+.++++++||||++++++|.+.
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 72 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------------HHHHHTHHHHTTCCCTTBCCEEEEECCC
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----------HHHHHHHHHHHHHhCCCCCEeeEEEEEEec
Confidence 4556789999999999999999999999999999997532 124688999999999999999999998653
Q ss_pred CCCcEEEEEeeccCCcHHHHHHhcc-CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 876 PDGSLATVTEFMVNGSLKQFLQKKD-RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 876 s~~~L~LVmEYm~GGSL~dlL~~~~-k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
.+.++|||||+++|+|.++|.... ..+++..++.|+.||+.||.|||+.+|+||||||+|||++ .++.+||+||
T Consensus 73 -~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~----~~~~~kl~df 147 (262)
T d1byga_ 73 -KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS----EDNVAKVSDF 147 (262)
T ss_dssp ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTSCEEECCC
T ss_pred -CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheec----CCCCEeeccc
Confidence 356899999999999999997643 3589999999999999999999999999999999999998 6789999999
Q ss_pred CCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+++..... .....+|+.|+|||++.+..+ +.++||
T Consensus 148 g~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~-t~~sDI 183 (262)
T d1byga_ 148 GLTKEASST--QDTGKLPVKWTAPEALREKKF-STKSDV 183 (262)
T ss_dssp CC--------------CCTTTSCHHHHHHCCC-CHHHHH
T ss_pred ccceecCCC--CccccccccCCChHHHhCCCC-ChHHHH
Confidence 999876543 234568999999999987654 455554
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=1.4e-32 Score=291.73 Aligned_cols=184 Identities=31% Similarity=0.529 Sum_probs=151.2
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC-------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG-------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg-------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
++..++|++++.||+|+||+||+|++++ +.||||+++... .....++|.+|+.+|++++||||+++
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-------ChHHHHHHHHHHHHHHhcCCCCcccc
Confidence 3456789999999999999999999854 569999987532 12234578999999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------------CccCHHHHHHHHHHHHHHHHHHHhC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------------RTIDRRKRLIIAMDAAFGMEYLHGK 925 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-----------------------k~Lse~~~lkIalQIL~GLeYLHs~ 925 (993)
+++|.+ .+.+++||||+.+|+|.++|.... ..+++..++.|+.||+.||+|||+.
T Consensus 82 ~~~~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 82 LGVCAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 999987 567999999999999999996432 2378889999999999999999999
Q ss_pred CceecCCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 926 NIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 926 gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+||||||||+||||+ .++.+||+|||+|+...... ......||+.|||||++.+..+. .++||
T Consensus 160 ~ivHrDlKp~NILld----~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDV 225 (301)
T d1lufa_ 160 KFVHRDLATRNCLVG----ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDV 225 (301)
T ss_dssp TCCCSCCSGGGEEEC----GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHH
T ss_pred CeEeeEEcccceEEC----CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhh
Confidence 999999999999998 56789999999998654332 23356789999999999876543 45554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.7e-33 Score=290.90 Aligned_cols=184 Identities=32% Similarity=0.510 Sum_probs=142.2
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~ 871 (993)
+..++|++++.||+|+||+||+|+++. ..||||+++...... ....+.|.+|+.+|++++|||||+++|+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-----~~~~~~~~~Ei~~l~~l~H~nIv~~~g~ 79 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-----PEAMDDFIREVNAMHSLDHRNLIRLYGV 79 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-----HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 456789999999999999999998742 258999987654322 2234679999999999999999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
|.+ ..+++||||+++|+|.+++......+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||
T Consensus 80 ~~~---~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~----~~~~vkl 152 (273)
T d1u46a_ 80 VLT---PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA----TRDLVKI 152 (273)
T ss_dssp ECS---SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE----ETTEEEE
T ss_pred Eee---cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc----cccceee
Confidence 975 457899999999999999887777799999999999999999999999999999999999998 5679999
Q ss_pred EecCCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 952 GDLGLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+|||+++...... ......||..|+|||++.+.. ++.++||
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di 197 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDT 197 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHH
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhh
Confidence 9999999764332 233456889999999998764 3444453
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.97 E-value=3.6e-32 Score=284.85 Aligned_cols=181 Identities=25% Similarity=0.384 Sum_probs=149.5
Q ss_pred CCceEEEEecccCceEEEEEEEc-CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR-GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPDG 878 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k-gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~~ 878 (993)
++|+++++||+|+||+||+|+++ ++.||||+++...... ...+.+.+|+.+|++++|||||+++++|.+ .+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~ 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIVKLYDVIHT--KK 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG------CCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SS
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh------HHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CC
Confidence 58999999999999999999985 6789999997653221 123478899999999999999999999998 57
Q ss_pred cEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCcc
Q 001940 879 SLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLSK 958 (993)
Q Consensus 879 ~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLAk 958 (993)
.++++|||+.++.|..+.. ....+++..+..|+.||+.||+|||+.+||||||||+|||++ .++.+||+|||+|.
T Consensus 74 ~~~i~~e~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~----~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 74 RLVLVFEHLDQDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN----REGELKIADFGLAR 148 (286)
T ss_dssp CEEEEEECCSEEHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTSCEEECCTTHHH
T ss_pred ceeEEEEeehhhhHHHHHh-hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc----CCCCEEecccccce
Confidence 7999999997666666554 445699999999999999999999999999999999999998 66789999999998
Q ss_pred cccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 959 VKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 959 ~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
...... ......||+.|+|||++.+..+.+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~Di 184 (286)
T d1ob3a_ 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184 (286)
T ss_dssp HHCC---------CCCTTCCHHHHTTCCSCCTHHHH
T ss_pred ecccCccccceecccchhhhHHHHhCCCCCCcceee
Confidence 754432 23455689999999999988888888775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.4e-32 Score=291.23 Aligned_cols=183 Identities=32% Similarity=0.486 Sum_probs=149.0
Q ss_pred ccCCCceEEEEecccCceEEEEEEEcC--c--ceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceEEEE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWRG--S--DVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSFYGI 871 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~kg--t--~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL~G~ 871 (993)
++.++|++.++||+|+||+||+|++++ . .||||+++.... ....+.|.+|+.+|+++ +|||||+++++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-------KDDHRDFAGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-------hHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence 455789999999999999999998853 3 478888764321 11234788999999999 79999999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhc---------------cCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCC
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKK---------------DRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCEN 936 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~---------------~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeN 936 (993)
|.+ .+.+++||||+++|+|.++|... ...+++..++.++.||+.||.|||+.+|+||||||+|
T Consensus 80 ~~~--~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~N 157 (309)
T d1fvra_ 80 CEH--RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157 (309)
T ss_dssp EEE--TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred Eec--CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccce
Confidence 998 67899999999999999999653 3468999999999999999999999999999999999
Q ss_pred EEEccCCCCCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 937 LLVNMRDPQRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 937 ILLd~~d~e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||++ .++.+||+|||+|+............||..|+|||.+.+..+ +.++||
T Consensus 158 IL~~----~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDv 209 (309)
T d1fvra_ 158 ILVG----ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDV 209 (309)
T ss_dssp EEEC----GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHH
T ss_pred EEEc----CCCceEEccccccccccccccccceecCCcccchHHhccCCC-Ccccee
Confidence 9998 567899999999987665555556679999999999987655 344553
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=288.11 Aligned_cols=178 Identities=21% Similarity=0.283 Sum_probs=147.3
Q ss_pred CceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC---
Q 001940 801 DLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG--- 875 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~--- 875 (993)
+|+.+++||+|+||+||+|+++ ++.||||+++.... .+.+|+.+|++++|+||++++++|...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~ 88 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSGEK 88 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC--C
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecCcc
Confidence 6999999999999999999984 77899999976421 123689999999999999999998642
Q ss_pred -CCCcEEEEEeeccCCcHHHHHH--hccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 876 -PDGSLATVTEFMVNGSLKQFLQ--KKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 876 -s~~~L~LVmEYm~GGSL~dlL~--~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
....+|||||||.++.+..++. .....+++..++.|+.||+.||+|||++||+||||||+|||++.+ ...+||+
T Consensus 89 ~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~---~~~~kl~ 165 (350)
T d1q5ka_ 89 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPD---TAVLKLC 165 (350)
T ss_dssp CSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTT---TCCEEEC
T ss_pred CCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecC---CCceeEe
Confidence 2345899999997664444432 234568999999999999999999999999999999999999832 2479999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+++............||+.|+|||++.+...+..++||
T Consensus 166 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DI 206 (350)
T d1q5ka_ 166 DFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206 (350)
T ss_dssp CCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHH
T ss_pred cccchhhccCCcccccccccccccChHHhhcccCCCcceee
Confidence 99999977665555667899999999999988888888775
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=286.72 Aligned_cols=180 Identities=24% Similarity=0.369 Sum_probs=148.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|.++ ++.||||+++.... .+...+.+.+|+.+|++++|||||+++++|....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ------SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS------SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc------ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 468999999999999999999984 78899999975421 2234467889999999999999999999998632
Q ss_pred ----CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEE
Q 001940 877 ----DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIG 952 (993)
Q Consensus 877 ----~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLi 952 (993)
...+|+||||+ +.+|..+++.. .+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~----~~~~~kl~ 163 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN----EDCELKIL 163 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEEC
T ss_pred cccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcc----cccccccc
Confidence 23579999999 77888887653 489999999999999999999999999999999999998 67799999
Q ss_pred ecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 953 DLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 953 DFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|+..... .....||+.|||||++.+..+.+.++||
T Consensus 164 Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di 202 (346)
T d1cm8a_ 164 DFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDI 202 (346)
T ss_dssp CCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHH
T ss_pred cccceeccCCc--cccccccccccCHHHHcCCCCCCccchh
Confidence 99999876554 3456799999999999988888888875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-32 Score=286.79 Aligned_cols=171 Identities=30% Similarity=0.467 Sum_probs=140.0
Q ss_pred CCceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC--
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD-- 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~-- 877 (993)
.+|.+.+.||+|+||+||+|+++++.||||+++... .+ . ..+..|+..+++++|||||++++++.+...
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~------~~-~--~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE------ER-S--WFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG------HH-H--HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc------hh-H--HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 468889999999999999999999999999986431 11 1 122346666678899999999999986432
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCCEEEccCCCCCCeE
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHG--------KNIVHFDLKCENLLVNMRDPQRPVC 949 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs--------~gIIHRDIKPeNILLd~~d~e~g~V 949 (993)
..+|+|||||++|+|.++|++. .+++..++.++.|++.||.|||+ ++||||||||+||||+ .++.+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~----~~~~~ 147 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK----KNGTC 147 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEEC----TTSCE
T ss_pred eEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEc----CCCCe
Confidence 3689999999999999999865 48899999999999999999996 5999999999999998 66899
Q ss_pred EEEecCCcccccccc-----ccCCCCCCCCccccccccCCc
Q 001940 950 KIGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKS 985 (993)
Q Consensus 950 KLiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~ 985 (993)
||+|||+++...... ......||+.|||||++.+..
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 188 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCS
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccc
Confidence 999999998664322 234567999999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.8e-31 Score=285.56 Aligned_cols=182 Identities=22% Similarity=0.310 Sum_probs=147.1
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|+++ ++.||||++++.. .....+.+.+|+.+|++|+||||+++++++....
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-------HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-------CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-------ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 357999999999999999999884 8889999987532 1233457889999999999999999999997632
Q ss_pred C--CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEec
Q 001940 877 D--GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDL 954 (993)
Q Consensus 877 ~--~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDF 954 (993)
. ...+++++|+.+|+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+ ..+.+||+||
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~----~~~~~kl~Df 153 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TTCDLKICDF 153 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTCCEEECCC
T ss_pred ccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEEC----CCCCEEEccc
Confidence 1 2234555667799999999764 489999999999999999999999999999999999998 6678999999
Q ss_pred CCcccccccc----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 955 GLSKVKQQTL----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 955 GLAk~~~~~~----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|+...... .....+||+.|+|||++.....+..++||
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~Di 196 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDI 196 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHH
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhh
Confidence 9998654332 23456799999999999877777777775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-31 Score=284.47 Aligned_cols=183 Identities=29% Similarity=0.460 Sum_probs=151.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceE
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSF 868 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL 868 (993)
++..++|++.+.||+|+||+||+|.++ ++.||||+++... .......|.+|+.++++++|||||++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-------~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-------CHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-------ChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 456678999999999999999999874 3579999987432 11223578899999999999999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------CccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEE
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLV 939 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILL 939 (993)
+++|.. .+.+++|||||.+|+|.+++.... ..+++..++.|+.||+.||.|||+++|+||||||+||||
T Consensus 89 ~~~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 89 LGVVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp EEEECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 999987 567899999999999999986432 236888999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 940 NMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 940 d~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
+ .++.+||+|||+|+...... ......||+.|||||.+.+..+. .++|
T Consensus 167 d----~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~D 217 (308)
T d1p4oa_ 167 A----EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSD 217 (308)
T ss_dssp C----TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHH
T ss_pred c----CCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccc
Confidence 8 67899999999998654332 23345689999999999876543 4444
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.5e-31 Score=279.31 Aligned_cols=184 Identities=26% Similarity=0.353 Sum_probs=146.5
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|+++++||+|+||+||+|+++ ++.||||++........ ..+++.+|+.+|++++|+||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~------~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG------FPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTS------SCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH------HHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 468999999999999999999984 78899999876533221 1246778999999999999999999986521
Q ss_pred ------CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 877 ------DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 877 ------~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
.+.+|+||||+.++.+.. +......+++..++.|+.||+.||+|||+.+|+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~-~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~----~~~~~k 157 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGL-LSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT----RDGVLK 157 (318)
T ss_dssp --------CEEEEEECCCEEHHHH-HTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC----TTSCEE
T ss_pred ccccccCceEEEEEeccCCCccch-hhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeec----CCCcEE
Confidence 356899999997666554 444455688999999999999999999999999999999999998 667999
Q ss_pred EEecCCcccccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 951 IGDLGLSKVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 951 LiDFGLAk~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|+|||+++...... .....+||+.|+|||++.+...++.++||
T Consensus 158 l~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Di 205 (318)
T d3blha1 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDL 205 (318)
T ss_dssp ECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHH
T ss_pred eeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHc
Confidence 99999997554221 22345799999999999988777778775
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=282.87 Aligned_cols=184 Identities=29% Similarity=0.504 Sum_probs=147.4
Q ss_pred cccCCCceEEEEecccCceEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCc
Q 001940 796 TIKNDDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNV 865 (993)
Q Consensus 796 ~i~~ddYeile~LGeGgFGtVYKAk~kg---------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNI 865 (993)
.+..++|++++.||+|+||.||+|+..+ ..||||+++... .......+.+|...+.++ +||||
T Consensus 9 ~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~e~~~l~~~~~HpnI 81 (299)
T d1fgka_ 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-------TEKDLSDLISEMEMMKMIGKHKNI 81 (299)
T ss_dssp BCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-------CHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-------ChHHHHHHHHHHHHHHHhcCCCeE
Confidence 3556789999999999999999998742 358999987542 122345788898888888 79999
Q ss_pred ceEEEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc---------------CccCHHHHHHHHHHHHHHHHHHHhCCceec
Q 001940 866 VSFYGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD---------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHF 930 (993)
Q Consensus 866 VrL~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~---------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHR 930 (993)
|+++++|.+ ++.+++|||||++|+|.++|.... ..+++..++.|+.||+.||+|||+.+||||
T Consensus 82 v~~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHr 159 (299)
T d1fgka_ 82 INLLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHR 159 (299)
T ss_dssp CCEEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred Eeccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEee
Confidence 999999987 578999999999999999997543 348999999999999999999999999999
Q ss_pred CCCCCCEEEccCCCCCCeEEEEecCCcccccccc---ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 931 DLKCENLLVNMRDPQRPVCKIGDLGLSKVKQQTL---VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 931 DIKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~~---~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||||+|||++ .++.+||+|||+++...... ......||+.|||||++.+..| +.++||
T Consensus 160 DiKp~NiLl~----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~Di 220 (299)
T d1fgka_ 160 DLAARNVLVT----EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDV 220 (299)
T ss_dssp CCSGGGEEEC----TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHH
T ss_pred eecccceeec----CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-Cchhhh
Confidence 9999999998 66789999999999765432 2344679999999999987654 445554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-30 Score=272.20 Aligned_cols=181 Identities=27% Similarity=0.393 Sum_probs=154.2
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
++|+++++||+|+||+||+|++. ++.||||+++..... +...+.+.+|+.+|+.++||||++++++|.+ .
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~ 73 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLKELKHKNIVRLHDVLHS--D 73 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS------TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--S
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC------hHHHHHHHHHHHHHHhcCcCCEEeecccccc--c
Confidence 57999999999999999999984 677999999765321 1234578899999999999999999999998 5
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
..+++|||++.+++|..++... +.+++..++.++.|++.||+|||+++|+||||||+|||++ ..+.+||+|||+|
T Consensus 74 ~~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~----~~~~~kl~DFG~a 148 (292)
T d1unla_ 74 KKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN----RNGELKLANFGLA 148 (292)
T ss_dssp SEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----TTCCEEECCCTTC
T ss_pred cceeEEeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc----cCCceeeeecchh
Confidence 7799999999999888887654 4588999999999999999999999999999999999998 5678999999999
Q ss_pred ccccccc-ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......+++.|+|||++.+..+.+.++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di 185 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHH
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhc
Confidence 8765433 33345678999999999988887777775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.7e-31 Score=281.53 Aligned_cols=178 Identities=26% Similarity=0.483 Sum_probs=146.7
Q ss_pred eEEEEecccCceEEEEEEEcC-----cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCCC
Q 001940 803 EEVRELGSGTYGSVYHGKWRG-----SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGPD 877 (993)
Q Consensus 803 eile~LGeGgFGtVYKAk~kg-----t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s~ 877 (993)
.+.++||+|+||+||+|++.. ..||||+++... .....++|.+|+.+|++++|||||+++|++.+. +
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~ 101 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-------DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-E 101 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-------CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-T
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-------CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-C
Confidence 346789999999999998842 248999986421 123346799999999999999999999998763 4
Q ss_pred CcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCCc
Q 001940 878 GSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGLS 957 (993)
Q Consensus 878 ~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGLA 957 (993)
+.+++|||||++++|.+++......+++..++.|+.||+.||.|||+.+|+||||||+||||+ .++.+||+|||++
T Consensus 102 ~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~----~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 102 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD----EKFTVKVADFGLA 177 (311)
T ss_dssp TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC----TTCCEEECSSGGG
T ss_pred CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeEC----CCCCEEEecccch
Confidence 679999999999999999988777788999999999999999999999999999999999998 6679999999999
Q ss_pred ccccccc-----ccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 958 KVKQQTL-----VSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 958 k~~~~~~-----~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
+...... ......||+.|+|||++.+..+ +.++||
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI 217 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDV 217 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHH
T ss_pred hhccccccccceecccccccccccChHHHhcCCC-CChhHh
Confidence 8654322 2234568999999999876543 444453
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=8.9e-31 Score=275.83 Aligned_cols=180 Identities=21% Similarity=0.299 Sum_probs=145.4
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcCC
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDGP 876 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~s 876 (993)
.++|++++.||+|+||+||+|++. ++.||||++...... ..+.+|+.+++.++|+|++..+..+...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~i~~~l~~~~~i~~~~~~~~~- 74 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----------PQLHIESKIYKMMQGGVGIPTIRWCGAE- 74 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----------CCHHHHHHHHHHSTTSTTCCCEEEEEEE-
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----------HHHHHHHHHHHHccCCCcccEEEEEEec-
Confidence 467999999999999999999984 778999998764321 1466899999999888766665555432
Q ss_pred CCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEecCC
Q 001940 877 DGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGDLGL 956 (993)
Q Consensus 877 ~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiDFGL 956 (993)
.+..++||||+ +++|.+.+......+++..++.++.||+.||+|||+++||||||||+|||++..+ .+..+||+|||+
T Consensus 75 ~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~-~~~~vkl~DFG~ 152 (299)
T d1ckia_ 75 GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK-KGNLVYIIDFGL 152 (299)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG-GTTCEEECCCSS
T ss_pred CCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC-CCceeeeeccCc
Confidence 56789999999 6778777777667799999999999999999999999999999999999987544 456899999999
Q ss_pred cccccccc--------ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 957 SKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 957 Ak~~~~~~--------~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
|+...... ......||+.|||||++.+..+ +.++|
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~D 195 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDD 195 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCC-CChhh
Confidence 99764322 2345679999999999998765 34444
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=7.5e-30 Score=269.93 Aligned_cols=181 Identities=18% Similarity=0.256 Sum_probs=149.3
Q ss_pred cCCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC-CCcceEEEEEEc
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGIVRD 874 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH-PNIVrL~G~f~d 874 (993)
..++|+++++||+|+||+||+|++. ++.||||++...... ..+.+|+.+++.|.| +||+.+++++..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----------PQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----------CCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----------HHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 3568999999999999999999984 778999998754221 135678888888875 899999999887
Q ss_pred CCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCC-CCCCeEEEEe
Q 001940 875 GPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRD-PQRPVCKIGD 953 (993)
Q Consensus 875 ~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d-~e~g~VKLiD 953 (993)
....++||||+ +++|.+++......++...++.|+.|++.||+|||++|||||||||+|||++... ...+.+||+|
T Consensus 73 --~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 --GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp --TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred --CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 57899999999 8999999988777799999999999999999999999999999999999997432 1356899999
Q ss_pred cCCcccccccc--------ccCCCCCCCCccccccccCCccCCCCCC
Q 001940 954 LGLSKVKQQTL--------VSGGVRGTLPWMAPELLSGKSHMVTEKE 992 (993)
Q Consensus 954 FGLAk~~~~~~--------~s~s~~GTp~YmAPEVL~Gk~y~tse~D 992 (993)
||+|+...... .....+||+.|||||++.++.+. .++|
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~D 195 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDD 195 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHH
Confidence 99998654321 23356799999999999987653 3444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.1e-30 Score=275.07 Aligned_cols=183 Identities=30% Similarity=0.453 Sum_probs=151.3
Q ss_pred ccCCCceEEEEecccCceEEEEEEEc-------CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhc-CCCCcceE
Q 001940 797 IKNDDLEEVRELGSGTYGSVYHGKWR-------GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSL-HHPNVVSF 868 (993)
Q Consensus 797 i~~ddYeile~LGeGgFGtVYKAk~k-------gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~L-rHPNIVrL 868 (993)
+..++|++.++||+|+||.||+|++. ++.||||+++.... ......|.+|+.+++++ +|||||++
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~E~~~~~~l~~HpnIv~~ 92 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-------LTEREALMSELKVLSYLGNHMNIVNL 92 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-------HHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC-------HHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 55678999999999999999999873 34699999975421 12234788999999999 69999999
Q ss_pred EEEEEcCCCCcEEEEEeeccCCcHHHHHHhcc-----------------CccCHHHHHHHHHHHHHHHHHHHhCCceecC
Q 001940 869 YGIVRDGPDGSLATVTEFMVNGSLKQFLQKKD-----------------RTIDRRKRLIIAMDAAFGMEYLHGKNIVHFD 931 (993)
Q Consensus 869 ~G~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~-----------------k~Lse~~~lkIalQIL~GLeYLHs~gIIHRD 931 (993)
+++|.+ ...++||||||++|+|.++|.... ..+++..++.|+.||+.||+|||+++|||||
T Consensus 93 ~g~~~~--~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrD 170 (311)
T d1t46a_ 93 LGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD 170 (311)
T ss_dssp EEEECS--SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEee--CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999987 467899999999999999997543 2488999999999999999999999999999
Q ss_pred CCCCCEEEccCCCCCCeEEEEecCCccccccc---cccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 932 LKCENLLVNMRDPQRPVCKIGDLGLSKVKQQT---LVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 932 IKPeNILLd~~d~e~g~VKLiDFGLAk~~~~~---~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
|||+|||++ ..+.+||+|||+++..... .......||+.|||||++.+.. ++.++||
T Consensus 171 LKp~NIl~~----~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DI 230 (311)
T d1t46a_ 171 LAARNILLT----HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDV 230 (311)
T ss_dssp CSGGGEEEE----TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHH
T ss_pred ccccccccc----ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccc
Confidence 999999998 6679999999999865432 2334567999999999997654 3445553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=278.75 Aligned_cols=181 Identities=23% Similarity=0.344 Sum_probs=148.8
Q ss_pred CCCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC-
Q 001940 799 NDDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG- 875 (993)
Q Consensus 799 ~ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~- 875 (993)
.++|+++++||+|+||+||+|+++ ++.||||++++... .....+.+.+|+.+|++|+|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ------SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 367999999999999999999874 78899999975421 122235688999999999999999999998753
Q ss_pred --CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 876 --s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
.....++||+|+.+|+|.+++... .+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~----~~~~~kl~d 164 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN----EDCELKILD 164 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTCCEEECC
T ss_pred ccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccc----ccccccccc
Confidence 123456677788899999999654 489999999999999999999999999999999999998 667899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+|...... .....||+.|+|||++.+..+.+.++||
T Consensus 165 fg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~Di 202 (348)
T d2gfsa1 165 FGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDI 202 (348)
T ss_dssp C----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHH
T ss_pred cchhcccCcc--cccccccccccCchhhcCCccCCcccch
Confidence 9999866543 3456799999999999998888888875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.6e-30 Score=275.93 Aligned_cols=179 Identities=23% Similarity=0.337 Sum_probs=136.6
Q ss_pred CCceEEEEecccCceEEEEEEEc--CcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCcceEEEEEEcC--
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNVVSFYGIVRDG-- 875 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G~f~d~-- 875 (993)
++|+++++||+|+||+||+|+++ ++.||||++..... ......++.+|+.+|++++|||||+++++|...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ------NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS------SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc------CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 57999999999999999999984 78899999986532 122345788999999999999999999999753
Q ss_pred --CCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEEEe
Q 001940 876 --PDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKIGD 953 (993)
Q Consensus 876 --s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKLiD 953 (993)
....+|+|||||.++ |.+.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 91 ~~~~~~~~iv~Ey~~~~-l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~----~~~~~kl~d 162 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK----SDCTLKILD 162 (355)
T ss_dssp TTTCCEEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC----TTCCEEECC
T ss_pred cccCceeEEEEeccchH-HHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccc----cccceeeec
Confidence 236799999999654 445443 3478999999999999999999999999999999999998 567899999
Q ss_pred cCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 954 LGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 954 FGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
||+++............||+.|+|||++.+..+ ..++||
T Consensus 163 f~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~Di 201 (355)
T d2b1pa1 163 FGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDI 201 (355)
T ss_dssp CCC---------------CCTTCCHHHHTTCCC-CTTHHH
T ss_pred hhhhhccccccccccccccccccChhhhcCCCC-CCCccc
Confidence 999987766666667789999999999998654 455664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.9e-30 Score=276.83 Aligned_cols=185 Identities=23% Similarity=0.360 Sum_probs=151.0
Q ss_pred cCCCceEEEEecccCceEEEEEEE-----cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCC-CCcceEEEE
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW-----RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHH-PNVVSFYGI 871 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~-----kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrH-PNIVrL~G~ 871 (993)
..++|++++.||+|+||+||+|+. +++.||||++++......... .+.+.+|+.+|++++| |||++++++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~----~~~~~~E~~il~~l~h~pnIv~~~~~ 97 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT----TEHTRTERQVLEHIRQSPFLVTLHYA 97 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESS----GGGCCCHHHHHHHHHTCTTBCCEEEE
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHH----HHHHHHHHHHHHhccCCCeEEEeeee
Confidence 346799999999999999999986 367799999976543221111 2357789999999976 899999999
Q ss_pred EEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEEE
Q 001940 872 VRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCKI 951 (993)
Q Consensus 872 f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VKL 951 (993)
+.+ ...+++||||+.+|+|.+++..... +.+..++.++.||+.||+|||+++|+||||||+|||++ .++.+||
T Consensus 98 ~~~--~~~~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~----~~~~vkL 170 (322)
T d1vzoa_ 98 FQT--ETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD----SNGHVVL 170 (322)
T ss_dssp EEE--TTEEEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC----TTSCEEE
T ss_pred ecc--CCceeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeec----CCCCEEE
Confidence 998 5789999999999999999987654 67888899999999999999999999999999999998 5678999
Q ss_pred EecCCccccccc--cccCCCCCCCCccccccccCCcc-CCCCCCC
Q 001940 952 GDLGLSKVKQQT--LVSGGVRGTLPWMAPELLSGKSH-MVTEKEL 993 (993)
Q Consensus 952 iDFGLAk~~~~~--~~s~s~~GTp~YmAPEVL~Gk~y-~tse~DI 993 (993)
+|||+|+..... .......||+.|+|||++.+..+ ++.++||
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDI 215 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDW 215 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHH
T ss_pred eeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhh
Confidence 999999865432 22345679999999999987664 4445664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=1.1e-25 Score=240.70 Aligned_cols=184 Identities=23% Similarity=0.270 Sum_probs=140.9
Q ss_pred cCCCceEEEEecccCceEEEEEEE--cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-----------CCC
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKW--RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-----------HPN 864 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~--kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-----------HPN 864 (993)
.+.+|+++++||+|+||+||+|++ +++.||||++++.. ...+.+.+|+.+++.++ |+|
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---------~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---------VYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---------HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---------cchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 445799999999999999999988 47889999997542 11235667888877775 578
Q ss_pred cceEEEEEEcCCCCcEEEEEeeccCCcHHHH--HHhccCccCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCCEEEcc
Q 001940 865 VVSFYGIVRDGPDGSLATVTEFMVNGSLKQF--LQKKDRTIDRRKRLIIAMDAAFGMEYLHG-KNIVHFDLKCENLLVNM 941 (993)
Q Consensus 865 IVrL~G~f~d~s~~~L~LVmEYm~GGSL~dl--L~~~~k~Lse~~~lkIalQIL~GLeYLHs-~gIIHRDIKPeNILLd~ 941 (993)
|+++++++........+++|+++..+..... .......+.+..+..++.||+.||.|||+ .||+||||||+||||+.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 9999999876545667777777765543332 23344568889999999999999999997 89999999999999974
Q ss_pred CCC--CCCeEEEEecCCccccccccccCCCCCCCCccccccccCCccCCCCCCC
Q 001940 942 RDP--QRPVCKIGDLGLSKVKQQTLVSGGVRGTLPWMAPELLSGKSHMVTEKEL 993 (993)
Q Consensus 942 ~d~--e~g~VKLiDFGLAk~~~~~~~s~s~~GTp~YmAPEVL~Gk~y~tse~DI 993 (993)
.+. ....+||+|||.|...... ....+||+.|+|||++.+..+. .++||
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~Di 212 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG-CGADI 212 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC-THHHH
T ss_pred cCcccccceeeEeecccccccccc--cccccccccccChhhccccCCC-ccccc
Confidence 431 1235999999999865443 3456799999999999987664 45554
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=2.3e-21 Score=191.60 Aligned_cols=141 Identities=18% Similarity=0.035 Sum_probs=106.8
Q ss_pred ceEEEEecccCceEEEEEEE-cCcceEEEEeeccccCC----------CchhHHHHHHHHHHHHHHHhhcCCCCcceEEE
Q 001940 802 LEEVRELGSGTYGSVYHGKW-RGSDVAIKRIKASCFAG----------KPSERERLIADFWKEALLLSSLHHPNVVSFYG 870 (993)
Q Consensus 802 Yeile~LGeGgFGtVYKAk~-kgt~VAVKvIkk~~~~~----------k~~ere~~ie~f~rEi~ILr~LrHPNIVrL~G 870 (993)
+.+.++||+|+||+||+|++ +++.||||+++...... ...........+.+|..++.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 35789999999999999987 57889999876432110 00111222345667899999999999999887
Q ss_pred EEEcCCCCcEEEEEeeccCCcHHHHHHhccCccCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCCEEEccCCCCCCeEE
Q 001940 871 IVRDGPDGSLATVTEFMVNGSLKQFLQKKDRTIDRRKRLIIAMDAAFGMEYLHGKNIVHFDLKCENLLVNMRDPQRPVCK 950 (993)
Q Consensus 871 ~f~d~s~~~L~LVmEYm~GGSL~dlL~~~~k~Lse~~~lkIalQIL~GLeYLHs~gIIHRDIKPeNILLd~~d~e~g~VK 950 (993)
+.. .++||||+.+..+.+ ++......++.||+.+|.|||+.||+||||||+|||++ . ..++
T Consensus 82 ~~~------~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~-~~~~ 142 (191)
T d1zara2 82 WEG------NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----E-EGIW 142 (191)
T ss_dssp EET------TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----T-TEEE
T ss_pred ecC------CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----C-CCEE
Confidence 632 279999998765532 33444567899999999999999999999999999997 2 3589
Q ss_pred EEecCCccccc
Q 001940 951 IGDLGLSKVKQ 961 (993)
Q Consensus 951 LiDFGLAk~~~ 961 (993)
|+|||+|....
T Consensus 143 liDFG~a~~~~ 153 (191)
T d1zara2 143 IIDFPQSVEVG 153 (191)
T ss_dssp ECCCTTCEETT
T ss_pred EEECCCcccCC
Confidence 99999997654
|
| >d1ip9a_ d.15.2.2 (A:) Bud emergence mediator Bemp1 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Bud emergence mediator Bemp1 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=98.37 E-value=4.1e-07 Score=80.21 Aligned_cols=75 Identities=19% Similarity=0.226 Sum_probs=61.2
Q ss_pred CCCCCCCCCCeEEEEeecCCeeecCCCCCCeeeecCceeEEEccCCCChHHHHHHHHHHhC-CceEEEeeCCCCCCCcee
Q 001940 13 STAGSNDDVPRVKFLCSFLGRILPRPQDGKLRYVGGETRIVSLPRDVTYEELMSRMRELYE-GAVVLKYQQPDEDLDALV 91 (993)
Q Consensus 13 ~~~~~~~~~~~vk~mcsyGG~i~pr~~d~~l~YvGG~tri~~v~r~~~f~~l~~kl~~~~~-~~~~lkyqLp~edld~Li 91 (993)
+..++..+..+||+-+.|+ ++++++.|+.+++|.+|+.|+++.++ ..+.|||+ .|| +.+|
T Consensus 2 ~~~s~~~~~~~ikVKv~~~----------------~D~~~~~l~~~it~~dL~~kI~~rf~~~~~~lkY~--Ded-gd~v 62 (85)
T d1ip9a_ 2 AMGSSTSGLKTTKIKFYYK----------------DDIFALMLKGDTTYKELRSKIAPRIDTDNFKLQTK--LFD-GSGE 62 (85)
T ss_dssp CCSCCCCCCCCEEEEECBT----------------TCCEEEEECSCCCHHHHHHHHHHHHTSSCEEEEEC--CSS-SCCS
T ss_pred CCCCCCCCCCCEEEEEEEC----------------CcEEEEEeCCCCCHHHHHHHHHHHhCCCceEEEEE--cCC-CCEE
Confidence 3344445566788888775 56789999999999999999999987 46999999 554 6789
Q ss_pred eecChhhHHHHHHHH
Q 001940 92 SVVNDDDVINMMEEY 106 (993)
Q Consensus 92 sV~~deDl~~m~~ey 106 (993)
+++||+||+.+|++.
T Consensus 63 ~i~sD~Dl~~ai~~~ 77 (85)
T d1ip9a_ 63 EIKTDSQVSNIIQAK 77 (85)
T ss_dssp CCCSHHHHHHHHHTT
T ss_pred EEeCHHHHHHHHHhc
Confidence 999999999999744
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.22 E-value=4.2e-06 Score=83.38 Aligned_cols=85 Identities=13% Similarity=0.011 Sum_probs=57.7
Q ss_pred CceEEEEecccCceEEEEEEEcCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC-CCCcceEEEEEEcCCCCc
Q 001940 801 DLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH-HPNVVSFYGIVRDGPDGS 879 (993)
Q Consensus 801 dYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr-HPNIVrL~G~f~d~s~~~ 879 (993)
.|+..+..+.++.+.||+....+..++||+......... ..+.+|..+++.|. +--+.+++.+..+ .+.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~--------~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~ 84 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT--------YDVEREKDMMLWLEGKLPVPKVLHFERH--DGW 84 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST--------TCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTE
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch--------hhHHHHHHHHHHHhccCCCCcEEEEEec--CCc
Confidence 456555555555679999988888899998765432211 13456777776664 3335677777666 467
Q ss_pred EEEEEeeccCCcHHHH
Q 001940 880 LATVTEFMVNGSLKQF 895 (993)
Q Consensus 880 L~LVmEYm~GGSL~dl 895 (993)
.++||++++|.++.+.
T Consensus 85 ~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEE 100 (263)
T ss_dssp EEEEEECCSSEEHHHH
T ss_pred eEEEEEeccccccccc
Confidence 8999999998877554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.42 E-value=0.00021 Score=70.46 Aligned_cols=73 Identities=16% Similarity=0.123 Sum_probs=46.7
Q ss_pred EecccC-ceEEEEEEEcC-cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcC--CCCcceEEEEEEcCCCCcEEE
Q 001940 807 ELGSGT-YGSVYHGKWRG-SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLH--HPNVVSFYGIVRDGPDGSLAT 882 (993)
Q Consensus 807 ~LGeGg-FGtVYKAk~kg-t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~Lr--HPNIVrL~G~f~d~s~~~L~L 882 (993)
.+..|. .+.||+...++ ..+++|........ .+..|...|+.|. .-.+.+++.+..+ .+..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~-----------~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN-----------ELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS-----------CHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh-----------HHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEE
Confidence 445554 46899998864 45788876543211 2445666666554 2335677777665 467899
Q ss_pred EEeeccCCcH
Q 001940 883 VTEFMVNGSL 892 (993)
Q Consensus 883 VmEYm~GGSL 892 (993)
||+|++|.++
T Consensus 84 v~~~i~G~~~ 93 (255)
T d1nd4a_ 84 LLGEVPGQDL 93 (255)
T ss_dssp EEECCSSEET
T ss_pred EEEeeecccc
Confidence 9999987654
|
| >d2c60a1 d.15.2.2 (A:43-122) Mitogen-activated protein kinase kinase kinase 3, MEKK 3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 3, MEKK 3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.35 E-value=0.00055 Score=58.72 Aligned_cols=70 Identities=26% Similarity=0.499 Sum_probs=60.2
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
-||-|||-++|.++|.||..|+.+.||..+.+-|- +. .-+|.++|.+||+.-|+-.||- +.-++ ||+.|-
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~--El~IPl~~Q~DLDkAvellDrs-~~~ks--LrilL~ 79 (80)
T d2c60a1 10 NGERRIIAFSRPVKYEDVEHKVTTVFGQPLDLHYM--NN--ELSILLKNQDDLDKAIDILDRS-SSMKS--LRILLL 79 (80)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHSSCCEEEEE--CS--SCEEECCSHHHHHHHHHHHHHC-SSCCS--EEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeeEEe--cC--eEEEecccHHHHHHHHHHHccC-cccce--eEEEEe
Confidence 48999999999999999999999999999999998 33 4579999999999999999994 22232 888774
|
| >d2bkfa1 d.15.2.2 (A:1-85) Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Next to BRCA1 gene 1 protein, NBR1 (KIAA0049) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.21 E-value=0.00078 Score=59.11 Aligned_cols=69 Identities=19% Similarity=0.307 Sum_probs=52.3
Q ss_pred cCceeE--EEccCCCChHHHHHHHHHHhCC-ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 47 GGETRI--VSLPRDVTYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 47 GG~tri--~~v~r~~~f~~l~~kl~~~~~~-~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
||+|+- |+++++.+|.+|.++++..++. +|.|||. .+| +-.|.++||+||+.-++-.-+ ....||++++
T Consensus 12 ~~dt~RF~ls~~~~~~~~~L~~~i~~rf~l~~~~lkY~--Ddd-~e~v~l~~d~dl~E~~~~a~~-----~~~~irl~v~ 83 (85)
T d2bkfa1 12 KNEIQSFLVSDPENTTWADIEAMVKVSFDLNTIQIKYL--DEE-NEEVSINSQGEYEEALKMAVK-----QGNQLQMQVH 83 (85)
T ss_dssp TTEEEEEEESCGGGCCHHHHHHHHHHHHTCSSEEEEEE--CTT-SCEEEECSHHHHHHHHHHHHH-----TTTEEEEEEE
T ss_pred CCceEEEEecCCCCCcHHHHHHHHHHhcCcccceEEEE--cCC-CCEEEEecHHHHHHHHHHHhc-----CCCEEEEEEe
Confidence 344443 6778999999999999999984 6999998 444 679999999999866654422 2255787775
|
| >d2nptb1 d.15.2.2 (B:42-123) Mitogen-activated protein kinase kinase kinase 2, MEKK 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen-activated protein kinase kinase kinase 2, MEKK 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.15 E-value=0.00094 Score=57.50 Aligned_cols=70 Identities=26% Similarity=0.464 Sum_probs=60.3
Q ss_pred cCceeEEEccCCCChHHHHHHHHHHhCCceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 47 GGETRIVSLPRDVTYEELMSRMRELYEGAVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 47 GG~tri~~v~r~~~f~~l~~kl~~~~~~~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
-||.|||-++|.+.|.||..|+.+.||..+.+-|- +. .-+|.++|.+||+.-++-.||- +.-++ ||+.|.
T Consensus 10 ~gEkRIi~f~RPv~~~dl~~kv~~afGq~ldl~y~--n~--EL~IPl~~Q~DLDkAvellDrs-~~~ks--LrilL~ 79 (82)
T d2nptb1 10 RGEKRILQFPRPVKLEDLRSKAKIAFGQSMDLHYT--NN--ELVIPLTTQDDLDKAVELLDRS-IHMKS--LKILLV 79 (82)
T ss_dssp TTEEEEEEECSSCCHHHHHHHHHHHHTSCEEEEEE--ET--TEEEECCCHHHHHHHHHHHHHC-SSCCS--EEEEEE
T ss_pred cCceEEEecCCCccHHHHHHHHHHHhCCeeeEEEe--cC--eEEEecccHHHHHHHHHHHccC-ccccc--eEEEEE
Confidence 48999999999999999999999999999999998 32 5799999999999999999994 22333 787764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.94 E-value=0.0013 Score=70.57 Aligned_cols=79 Identities=20% Similarity=0.112 Sum_probs=45.9
Q ss_pred EEEecccCceEEEEEEEc--CcceEEEEeeccccC-C--CchhHHHHHHHHHHHHHHHhhcC---CCCcceEEEEEEcCC
Q 001940 805 VRELGSGTYGSVYHGKWR--GSDVAIKRIKASCFA-G--KPSERERLIADFWKEALLLSSLH---HPNVVSFYGIVRDGP 876 (993)
Q Consensus 805 le~LGeGgFGtVYKAk~k--gt~VAVKvIkk~~~~-~--k~~ere~~ie~f~rEi~ILr~Lr---HPNIVrL~G~f~d~s 876 (993)
.+.||.|....||+.... ++.++||.-...... + .... ..+...|...|+.+. ...+.+++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~----~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~--- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLT----IDRARIESSALIRQGEHVPHLVPRVFYSDT--- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCC----TTHHHHHHHHHHHHHTTCGGGSCCEEEEET---
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCC----HHHHHHHHHHHHHhhhhCCCCcceEEEEcC---
Confidence 567999999999999763 567899964321110 0 0000 112345666666553 234666765532
Q ss_pred CCcEEEEEeeccCCc
Q 001940 877 DGSLATVTEFMVNGS 891 (993)
Q Consensus 877 ~~~L~LVmEYm~GGS 891 (993)
...++|||++.+..
T Consensus 104 -~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 -EMAVTVMEDLSHLK 117 (392)
T ss_dssp -TTTEEEECCCTTSE
T ss_pred -CCCEEEEeccCCcc
Confidence 23578999997654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.86 E-value=0.012 Score=59.80 Aligned_cols=36 Identities=8% Similarity=0.075 Sum_probs=26.0
Q ss_pred cCCCceEEEEecccCceEEEEEEEcCcceEEEEeec
Q 001940 798 KNDDLEEVRELGSGTYGSVYHGKWRGSDVAIKRIKA 833 (993)
Q Consensus 798 ~~ddYeile~LGeGgFGtVYKAk~kgt~VAVKvIkk 833 (993)
......-.+.|..|--.+.|+.+.++..+++|++..
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~ 51 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEK 51 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC
T ss_pred CCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCC
Confidence 344566667788888899999998888899999864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.78 E-value=0.011 Score=62.91 Aligned_cols=76 Identities=14% Similarity=0.302 Sum_probs=46.6
Q ss_pred CCceEEEEecccCceEEEEEEEcC---------cceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCC-cceEE
Q 001940 800 DDLEEVRELGSGTYGSVYHGKWRG---------SDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPN-VVSFY 869 (993)
Q Consensus 800 ddYeile~LGeGgFGtVYKAk~kg---------t~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPN-IVrL~ 869 (993)
+++++ +.|+.|-.-.+|++.... ..|++++.... . .. ....+|..+++.+.-.+ ..+++
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~--~~-----idr~~E~~i~~~ls~~gl~Pkll 111 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---E--TE-----SHLVAESVIFTLLSERHLGPKLY 111 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---C--CH-----HHHHHHHHHHHHHHHTTSSSCEE
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---c--hh-----hHHHHHHHHHHHHHhCCCCCeEE
Confidence 34444 678888889999998642 23555554311 1 11 12346777777775333 45777
Q ss_pred EEEEcCCCCcEEEEEeeccCCcH
Q 001940 870 GIVRDGPDGSLATVTEFMVNGSL 892 (993)
Q Consensus 870 G~f~d~s~~~L~LVmEYm~GGSL 892 (993)
+++.+ .+||||++|..|
T Consensus 112 ~~~~~------g~I~efi~g~~l 128 (395)
T d1nw1a_ 112 GIFSG------GRLEEYIPSRPL 128 (395)
T ss_dssp EEETT------EEEECCCCEEEC
T ss_pred EEcCC------ceEEEEeccccC
Confidence 77653 689999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=94.66 E-value=0.015 Score=60.18 Aligned_cols=69 Identities=14% Similarity=0.131 Sum_probs=39.7
Q ss_pred cCceEEEEEEE-cCcceEEEEeeccccCCCchhHHHHHHHHHHHHHHHhhcCCCCc-----ceEE--EEEEcCCCCcEEE
Q 001940 811 GTYGSVYHGKW-RGSDVAIKRIKASCFAGKPSERERLIADFWKEALLLSSLHHPNV-----VSFY--GIVRDGPDGSLAT 882 (993)
Q Consensus 811 GgFGtVYKAk~-kgt~VAVKvIkk~~~~~k~~ere~~ie~f~rEi~ILr~LrHPNI-----VrL~--G~f~d~s~~~L~L 882 (993)
+--..||+++. +|+.+++|+.+..... .+.+..|...+..|....| +..- ..+.. .+..+.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s---------~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~--~~~~~~ 101 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERWT---------ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH--QGFYFA 101 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTSC---------HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE--TTEEEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCCC---------HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeee--eeEEEE
Confidence 33468999987 5778999998753111 1245567777666642221 1110 01111 356788
Q ss_pred EEeeccCC
Q 001940 883 VTEFMVNG 890 (993)
Q Consensus 883 VmEYm~GG 890 (993)
+++|+.|.
T Consensus 102 l~~~~~G~ 109 (325)
T d1zyla1 102 VFPSVGGR 109 (325)
T ss_dssp EEECCCCE
T ss_pred EEeecCCc
Confidence 99998764
|
| >d1wmha_ d.15.2.2 (A:) Protein kinase C, iota type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Protein kinase C, iota type species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.33 E-value=0.45 Score=40.83 Aligned_cols=70 Identities=21% Similarity=0.342 Sum_probs=55.3
Q ss_pred CceeEEEccCCCChHHHHHHHHHHhCC----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhcCCCCCCeEEEEEe
Q 001940 48 GETRIVSLPRDVTYEELMSRMRELYEG----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLGSGDGFTRLRIFLF 123 (993)
Q Consensus 48 G~tri~~v~r~~~f~~l~~kl~~~~~~----~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~~~~~~~rlR~flf 123 (993)
|+--|..++-+|+|.+|...+.++|+- .|++|+= +|+-| =++|+++.+|+.-+-.|..- +-.-|-+-+|
T Consensus 10 G~i~it~~~~~it~e~l~~evr~~C~f~~~q~fT~KWi--DeEGD-PCTISSQmEL~EA~RLye~n----~dseL~iHVF 82 (83)
T d1wmha_ 10 GDIMITHFEPSISFEGLCNEVRDMCSFDNEQLFTMKWI--DEEGD-PCTVSSQLELEEAFRLYELN----KDSELLIHVF 82 (83)
T ss_dssp TEEEEEEECTTCCHHHHHHHHHHHTTCCTTCCCEEEEE--CTTSC-EEECCSHHHHHHHHHHHHHT----TCSCEEEEEE
T ss_pred CeEEEEecCCCccHHHHHHHHHHHhCCCcCCcEEEEEE--cCCCC-ceeeecHHHHHHHHHHHHcc----CCcceEEEec
Confidence 333489999999999999999999985 4899997 66645 58899999998888877653 2344777777
Q ss_pred c
Q 001940 124 S 124 (993)
Q Consensus 124 ~ 124 (993)
|
T Consensus 83 P 83 (83)
T d1wmha_ 83 P 83 (83)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1oeyj_ d.15.2.2 (J:) Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Neutrophil cytosol factor 4 (p40phox component of NADPH oxidase) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.76 E-value=0.29 Score=43.45 Aligned_cols=56 Identities=21% Similarity=0.463 Sum_probs=49.3
Q ss_pred cCceeEEEccCCC----ChHHHHHHHHHHhCC-ceEEEeeCCCCCCCceeeecChhhHHHHHHH
Q 001940 47 GGETRIVSLPRDV----TYEELMSRMRELYEG-AVVLKYQQPDEDLDALVSVVNDDDVINMMEE 105 (993)
Q Consensus 47 GG~tri~~v~r~~----~f~~l~~kl~~~~~~-~~~lkyqLp~edld~LisV~~deDl~~m~~e 105 (993)
|+.+|=|+|.-++ +|.||+..+...++. +++|-|.=|..| ||-+-+|||++-|+.|
T Consensus 15 ~~~~rDI~veedl~~~P~ykdLl~lmr~~f~~~dIaLNYrD~eGD---LIRllddeDv~LMv~~ 75 (105)
T d1oeyj_ 15 ISTIKDIAVEEDLSSTPLLKDLLELTRREFQREDIALNYRDAEGD---LVRLLSDEDVALMVRQ 75 (105)
T ss_dssp EEEEEEEEECSCTTCCCCHHHHHHHHHHHHCCSSEEEEEECTTSC---EEECCSHHHHHHHHHH
T ss_pred cceeeeEEEccccccCccHHHHHHHHHHHhccceeEeeeecCCCC---EEEEcchhhHHHHHHH
Confidence 6889999998875 799999999998885 699999977655 8999999999999987
|
| >d1pqsa_ d.15.2.2 (A:) Cell division control protein 24, CDC24, C-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Cell division control protein 24, CDC24, C-terminal domain species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=90.55 E-value=0.18 Score=42.88 Aligned_cols=57 Identities=19% Similarity=0.260 Sum_probs=45.5
Q ss_pred eEEEccCCCChHHHHHHHHHHh---CC-----ceEEEeeCCCCCCCceeeecChhhHHHHHHHHHHhc
Q 001940 51 RIVSLPRDVTYEELMSRMRELY---EG-----AVVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKLG 110 (993)
Q Consensus 51 ri~~v~r~~~f~~l~~kl~~~~---~~-----~~~lkyqLp~edld~LisV~~deDl~~m~~eydr~~ 110 (993)
-.|.|+.+|+|.+|..|+.+.. +. -..|||| .|| .-.|.+.+|||..--++++....
T Consensus 4 fTLvV~~~i~f~~L~~kI~~Kia~~~~~~~~~~~rlrY~--DeD-GD~V~i~sddd~~~a~~~~~e~~ 68 (77)
T d1pqsa_ 4 FTLLVEKVWNFDDLIMAINSKISNTHNNNISPITKIKYQ--DED-GDFVVLGSDEDWNVAKEMLAENN 68 (77)
T ss_dssp EEEECTTCCCSHHHHHHHHHHTTTTTSSCSCSTTCCEEE--ETT-TEEEECCSTTHHHHHHHHHHHHC
T ss_pred EEEEEEcCcCHHHHHHHHHHHHHhccCCCCCccceEEEE--cCC-CCEEEEeccchHHHHHHHHHhcc
Confidence 3678999999999999996533 32 1379999 666 56899999999999999987653
|
| >d2npta1 d.15.2.2 (A:4-108) Mitogen activated protein kinase kinase 5, Map2k5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: beta-Grasp (ubiquitin-like) superfamily: CAD & PB1 domains family: PB1 domain domain: Mitogen activated protein kinase kinase 5, Map2k5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.51 E-value=0.32 Score=43.08 Aligned_cols=53 Identities=19% Similarity=0.405 Sum_probs=41.8
Q ss_pred EccCCCChHHHHHHHHHHhCCc--eEEEeeCCCCCCCceeeecChhhHHHHHHHHHHh
Q 001940 54 SLPRDVTYEELMSRMRELYEGA--VVLKYQQPDEDLDALVSVVNDDDVINMMEEYEKL 109 (993)
Q Consensus 54 ~v~r~~~f~~l~~kl~~~~~~~--~~lkyqLp~edld~LisV~~deDl~~m~~eydr~ 109 (993)
.-++.++|.++...++....-. -.+.|. +||-|. |.|.+||+|..||.=|.-.
T Consensus 31 ~~~~~l~F~dvL~~i~q~~p~at~taFEYE--DEdGDR-ITVRSDEEl~AMisyy~~~ 85 (105)
T d2npta1 31 HSGPQLLFRDVLDVIGQVLPEATTTAFEYE--DEDGDR-ITVRSDEEMKAMLSYYYST 85 (105)
T ss_dssp CC--CCCHHHHHHHHHHHSTTSCCSEEEEE--CTTSCE-EEECSHHHHHHHHHHHHHH
T ss_pred cCCceeeHHHHHHHHHHhcccccccceeec--cccCCE-eEEccHHHHHHHHHHHHHH
Confidence 3347899999999999988743 468887 777665 8999999999999988543
|